Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"5WQX",,"X-RAY DIFFRACTION",2.6,52.71,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M Tris-HCl PH 7.4, 0.8M sodium citrate",293,"10.1016/j.bmc.2017.10.024",,"5WQX",63.21,"2.29","2.29","Covalent bond formation of synthetic ligand with hPPARg-LBD","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","5WQX"
"5WR0",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M Tris-HCl PH 7.4, 0.8M sodium citrate",293,"10.1016/j.bmc.2017.10.024",,"5WR0",63.66,"2.85","2.85","Huisgen cycloaddition for PPARg-LBD labeling by soaking method","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","5WR0"
"5WR1",,"X-RAY DIFFRACTION",2.62,53.11,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M Tris-HCl PH 7.4, 0.8M sodium citrate",293,"10.1016/j.bmc.2017.10.024",,"5WR1",63.25,"2.34","2.34","Covalent bond formation of bifunctional ligand with hPPARg-LBD","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","5WR1"
"5WR7",,"X-RAY DIFFRACTION",3.11,60.52,"VAPOR DIFFUSION",,"0.05-0.15M KH2PO4, 0.1M MES pH 6.25, 1.5-2.5M NaCl, 0.05-0.15M NaH2PO4, 0.01M TCEP HCl",277,"10.1158/1535-7163.MCT-17-1180",,"5WR7",35.32,"2.76","2.76","Crystal structure of Trk-A complexed with a selective inhibitor CH7057288","HIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYL","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","5WR7"
"5WRN",,"X-RAY DIFFRACTION",2.42,49.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Sodium cacodylate 
15% PEG 4000",293,,,"5WRN",200.85,"2.39","2.39","Human thymidylate synthase complexed with dCMP","MPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5WRN"
"5WRQ",,"X-RAY DIFFRACTION",2.31,46.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M AMMONIUM SULFATE, 100mM TRIS",298,,,"5WRQ",79.78,"2.65","2.65","Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor","HMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5WRQ"
"5WRR",,"X-RAY DIFFRACTION",5.06,75.68,"VAPOR DIFFUSION",7.5,"ammonium sulfate, HEPES, PEG 400",291,"10.7554/eLife.23990",,"5WRR",102.35,"2.506","2.506","Crystal structure of Fam20A","SSKLQALFAHPLYNVPEEPPLLGAEDSLLASQEALRYYRRKVARWNRRHKMYREQMNLTSLDPPLQLRLEASWVQFHLGINRHGLYSRSSPVVSKLLQDMRHFPTISADYSQDEKALLGACDCTQIVKPSGVHLKLVLRFSDFGKAMFKPMRQQRDEETPVDFFYFIDFQRHNAEIAAFHLDRILDFRRVPPTVGRIVNVTKEILEVTKNEILQSVFFVSPASNVCFFAKCPYMCKTEYAVCGKPHLLEGSLSAFLPSLNLAPRLSVPNPWIRSYTLAGKEEWEVNPLYCDTVKQIYPYNNSQRLLNVIDMAIFDFLIGNMDRHHYEMFTKFGDDGFLIHLDNARGFGRHSHDEISILSPLSQCCMIKKKTLLHLQLLAQADYRLSDVMRESLLEDQLSPVLTEPHLLALDRRLQTILRTVEGCIVAHGQQSVIVDGP","Homo sapiens","FAM20A, UNQ9388/PRO34279","Pseudokinase FAM20A","1","5WRR"
"5WRS",,"X-RAY DIFFRACTION",5.12,75.98,"VAPOR DIFFUSION",7.5,"ammonium sulfate, HEPES, PEG 400",291,"10.7554/eLife.23990",,"5WRS",103.16,"2.75","2.75","Crystal Structure of Fam20A in complex with ATP","SSKLQALFAHPLYNVPEEPPLLGAEDSLLASQEALRYYRRKVARWNRRHKMYREQMNLTSLDPPLQLRLEASWVQFHLGINRHGLYSRSSPVVSKLLQDMRHFPTISADYSQDEKALLGACDCTQIVKPSGVHLKLVLRFSDFGKAMFKPMRQQRDEETPVDFFYFIDFQRHNAEIAAFHLDRILDFRRVPPTVGRIVNVTKEILEVTKNEILQSVFFVSPASNVCFFAKCPYMCKTEYAVCGKPHLLEGSLSAFLPSLNLAPRLSVPNPWIRSYTLAGKEEWEVNPLYCDTVKQIYPYNNSQRLLNVIDMAIFDFLIGNMDRHHYEMFTKFGDDGFLIHLDNARGFGRHSHDEISILSPLSQCCMIKKKTLLHLQLLAQADYRLSDVMRESLLEDQLSPVLTEPHLLALDRRLQTILRTVEGCIVAHGQQSVIVDGP","Homo sapiens","FAM20A, UNQ9388/PRO34279","Pseudokinase FAM20A","1","5WRS"
"5WRW",,"X-RAY DIFFRACTION",3.51,64.94,"VAPOR DIFFUSION, HANGING DROP",,"(NH4)2SO4",277,"10.1093/jmcb/mjx010",,"5WRW",111.06,"2.91","2.91","Structure of human apo-SRP72","MASGGSGGVSVPALWSEVNRYGQNGDFTRALKTVNKILQINKDDVTALHCKVVCLIQNGSFKEALNVINTHTKVLANNSLSFEKAYCEYRLNRIENALKTIESANQQTDKLKELYGQVLYRLERYDECLAVYRDLVRNSQDDYDEERKTNLSAVVAAQSNWEK","Homo sapiens","SRP72","Signal recognition particle subunit SRP72","1","5WRW"
"5WRY",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M AMMONIUM SULFATE, 100mM TRIS",298,,,"5WRY",79.75,"2.3","2.3","Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor","HMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5WRY"
"5WRZ",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M AMMONIUM SULFATE, 100mM TRIS",298,,,"5WRZ",79.4,"2.2","2.2","Structure of human PARP1 catalytic domain bound to a phthalazinone inhibitor","HMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5WRZ"
"5WS0",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M AMMONIUM SULFATE, 100mM TRIS",298,,"7U6","5WS0",79.42,"2.6","2.6","Structure of human PARP1 catalytic domain bound to a benzoimidazole inhibitor","HMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5WS0"
"5WS1",,"X-RAY DIFFRACTION",2.3,46.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M AMMONIUM SULFATE, 100mM TRIS",298,,"7U9","5WS1",79.42,"1.9","1.9","Structure of human PARP1 catalytic domain bound to a benzoimidazole inhibitor","HMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5WS1"
"5WS7",,"X-RAY DIFFRACTION",1.9,35.21,"VAPOR DIFFUSION, HANGING DROP",,"sodium citrate, tris, NaCl",293,"10.1074/jbc.M116.749713",,"5WS7",37.1,"1","1","Crystal structure of human MTH1(G2K/C87A/C104S mutant) in complex with 2-oxo-dATP","MKASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFATDSIQGTPVESDEMRPSWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","5WS7"
"5WT7",,"SOLUTION NMR",,,,,,,"10.1007/s12104-017-9786-z",,"5WT7",15.71,,,"FAS1-IV domain of Human Periostin","GAMEKSLHEKLKQDKRFSTFLSLLEAADLKELLTQPGDWTLFVPTNDAFKGMTSEEKEILIRDKNALQNIILYHLTPGVFIGKGFEPGVTNILKTTQGSKIFLKEVNDTLLVNELKSKESDIMTTNGVIHVVDKLLYPAD","Homo sapiens","POSTN, OSF2","Periostin","1","5WT7"
"5WTC",,"X-RAY DIFFRACTION",2.34,47.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.5M AMMONIUM SULFATE, 100mM TRIS",298,,,"5WTC",79.81,"2.2","2.2","Structure of human PARP1 catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor","HMKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5WTC"
"5WTD",,"X-RAY DIFFRACTION",3.84,67.94,"VAPOR DIFFUSION",6.6,"PIPES-Na 100 mM, disodium malonate 8 mM, PEG3350 17%, glycerol 18%",298,"10.1016/j.jinorgbio.2022.111885",,"5WTD",75.54,"2.501","2.501","Structure of human serum transferrin bound ruthenium at N-lobe","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","5WTD"
"5WTQ",,"X-RAY DIFFRACTION",2.62,53.11,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.0 M lithium sulfate, 0.1 M Tris-HCl (pH 8.5), and 10 mM nickel chloride",293,"10.1002/pro.3153",,"5WTQ",56.6,"1.9","1.9","Crystal structure of human proteasome-assembling chaperone PAC4","GSHMEGLVVAAGGDVSLHNFSARLWEQLVHFHVMRLTDSLFLWVGATPHLRNLAVAMSSRYDSIPVSTSLLGDTSDTTSTGLAQRLARKTNKQVFVSYNLQNTDSNFALLVENRIKEEMEAFPEKF","Homo sapiens","PSMG4, C6orf86, PAC4","Proteasome assembly chaperone 4","1","5WTQ"
"5WU1",,"X-RAY DIFFRACTION",2.53,51.43,"VAPOR DIFFUSION, HANGING DROP",,"Hepes pH 7.5, PEG3350, Tacsimate",277,"10.1038/ncomms15788",,"5WU1",124.58,"2.8","2.8","Crystal structure of apo human Tut1, form I","MGAAPDSHQLAKALAEAADVGAQMIKLVGLRELSEAERQLRSLVVALMQEVFTEFFPGCVVHPFGSSINSFDVHGCDLDLFLDLGDLEEPQPVPKLPPASPLLEDREEGDLGKASELAETPKEEKAEGAAMLELVGSILRGCVPGVYRVQTVPSARRPVVKFAHRPSGLHGDVSLSNRLALHNSRFLSLASELDGRVRPLVYTLRAWAQGRGLSGSGPLLSNYALTLLVIYFLQTRDPPVLPTVSQLTQKAGEGEQVEVDGWDCSFPRDASRLEPSINVEPLSSLLAQFFSAVSSWDLRGSLLSLREGQALPVAGGLPSNLWEGLRLGPLNLQDPFDLSHNVAANVTSRVAGRLQNCCRAAANYARSLQYQRRSSRGRDWGLLPLLQPSSPSSLLSATPIPLPLAPFTQLTAALVQVFREALGCHIEQATKRTRSEGGGTGQGEAGKGASLPSSASWRCALWHRVWQGRRRARRRLQQQTKEGAGGGAGTRAGWLATEAQVTQELKGLSGGEERPETEPLLSFVASVSPADRMLTVTPLQDPQGLFPDLHHFLQVFLPQAIRHLKLEHHHHHH","Homo sapiens","TUT1, RBM21","Speckle targeted PIP5K1A-regulated poly(A) polymerase","1","5WU1"
"5WU2",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, HANGING DROP",,"Hepes pH 7.5, PEG3350, Tacsimate",277,"10.1038/ncomms15788",,"5WU2",125.95,"2.95","2.95","Crystal structure of human Tut1 bound with BaUTP, form I","MGAAPDSHQLAKALAEAADVGAQMIKLVGLRELSEAERQLRSLVVALMQEVFTEFFPGCVVHPFGSSINSFDVHGCDLDLFLDLGDLEEPQPVPKLPPASPLLEDREEGDLGKASELAETPKEEKAEGAAMLELVGSILRGCVPGVYRVQTVPSARRPVVKFAHRPSGLHGDVSLSNRLALHNSRFLSLCSELDGRVRPLVYTLRAWAQGRGLSGSGPLLSNYALTLLVIYFLQTRDPPVLPTVSQLTQKAGEGEQVEVDGWDCSFPRDASRLEPSINVEPLSSLLAQFFSAVSSWDLRGSLLSLREGQALPVAGGLPSNLWEGLRLGPLNLQDPFDLSHNVAANVTSRVAGRLQNCCRAAANYCRSLQYQRRSSRGRDWGLLPLLQPSSPSSLLSATPIPLPLAPFTQLTAALVQVFREALGCHIEQATKRTRSEGGGTGQGEAGKGASLPSSASWRCALWHRVWQGRRRARRRLQQQTKEGAGGGAGTRAGWLATEAQVTQELKGLSGGEERPETEPLLSFVASVSPADRMLTVTPLQDPQGLFPDLHHFLQVFLPQAIRHLKLEHHHHHH","Homo sapiens","TUT1, RBM21","Speckle targeted PIP5K1A-regulated poly(A) polymerase","1","5WU2"
"5WU3",,"X-RAY DIFFRACTION",2.52,51.22,"VAPOR DIFFUSION, HANGING DROP",,"Hepes pH 7.5, PEG3350, Tacsimate",277,"10.1038/ncomms15788",,"5WU3",125.72,"2.703","2.703","Crystal structure of human Tut1 bound with MgUTP, form II","MGAAPDSHQLAKALAEAADVGAQMIKLVGLRELSEAERQLRSLVVALMQEVFTEFFPGCVVHPFGSSINSFDVHGCDLDLFLDLGDLEEPQPVPKLPPASPLLEDREEGDLGKASELAETPKEEKAEGAAMLELVGSILRGCVPGVYRVQTVPSARRPVVKFAHRPSGLHGDVSLSNRLALHNSRFLSLASELDGRVRPLVYTLRAWAQGRGLSGSGPLLSNYALTLLVIYFLQTRDPPVLPTVSQLTQKAGEGEQVEVDGWDCSFPRDASRLEPSINVEPLSSLLAQFFSAVSSWDLRGSLLSLREGQALPVAGGLPSNLWEGLRLGPLNLQDPFDLSHNVAANVTSRVAGRLQNCCRAAANYARSLQYQRRSSRGRDWGLLPLLQPSSPSSLLSATPIPLPLAPFTQLTAALVQVFREALGCHIEQATKRTRSEGGGTGQGEAGKGASLPSSASWRCALWHRVWQGRRRARRRLQQQTKEGAGGGAGTRAGWLATEAQVTQELKGLSGGEERPETEPLLSFVASVSPADRMLTVTPLQDPQGLFPDLHHFLQVFLPQAIRHLKLEHHHHHH","Homo sapiens","TUT1, RBM21","Speckle targeted PIP5K1A-regulated poly(A) polymerase","1","5WU3"
"5WU4",,"X-RAY DIFFRACTION",2.56,51.94,"VAPOR DIFFUSION, HANGING DROP",,"Hepes pH 7.5, PEG3350, Tacsimate",297,"10.1038/ncomms15788",,"5WU4",125.77,"2.8","2.8","Crystal structure of human Tut1 bound with MgATP, form II","MGAAPDSHQLAKALAEAADVGAQMIKLVGLRELSEAERQLRSLVVALMQEVFTEFFPGCVVHPFGSSINSFDVHGCDLDLFLDLGDLEEPQPVPKLPPASPLLEDREEGDLGKASELAETPKEEKAEGAAMLELVGSILRGCVPGVYRVQTVPSARRPVVKFAHRPSGLHGDVSLSNRLALHNSRFLSLCSELDGRVRPLVYTLRAWAQGRGLSGSGPLLSNYALTLLVIYFLQTRDPPVLPTVSQLTQKAGEGEQVEVDGWDCSFPRDASRLEPSINVEPLSSLLAQFFSAVSSWDLRGSLLSLREGQALPVAGGLPSNLWEGLRLGPLNLQDPFDLSHNVAANVTSRVAGRLQNCCRAAANYCRSLQYQRRSSRGRDWGLLPLLQPSSPSSLLSATPIPLPLAPFTQLTAALVQVFREALGCHIEQATKRTRSEGGGTGQGEAGKGASLPSSASWRCALWHRVWQGRRRARRRLQQQTKEGAGGGAGTRAGWLATEAQVTQELKGLSGGEERPETEPLLSFVASVSPADRMLTVTPLQDPQGLFPDLHHFLQVFLPQAIRHLKLEHHHHHH","Homo sapiens","TUT1, RBM21","Speckle targeted PIP5K1A-regulated poly(A) polymerase","1","5WU4"
"5WU5",,"X-RAY DIFFRACTION",3.13,66.4,"VAPOR DIFFUSION, HANGING DROP",,"Sodium Cacodylate pH 7.0, PEG4000, Tacsimate",277,"10.1038/ncomms15788",,"5WU5",249.53,"3.404","3.404","Crystal structure of apo human Tut1, form III","MGAAPDSHQLAKALAEAADVGAQMIKLVGLRELSEAERQLRSLVVALMQEVFTEFFPGCVVHPFGSSINSFDVHGCDLDLFLDLGDLEEPQPVPKLPPASPLLEDREEGDLGKASELAETPKEEKAEGAAMLELVGSILRGCVPGVYRVQTVPSARRPVVKFCHRPSGLHGDVSLSNRLALHNSRFLSLCSELDGRVRPLVYTLRCWAQGRGLSGSGPLLSNYALTLLVIYFLQTRDPPVLPTVSQLTQKAGEGEQVEVDGWDCSFPRDASRLEPSINVEPLSSLLAQFFSAVSSWDLRGSLLSLREGQALPVAGGLPSNLWEGLRLGPLNLQDPFDLSHNVAANVTSRVAGRLQNCCRAAANYCRSLQYQRRSSRGRDWGLLPLLQPSSPSSLLSATPIPLPLAPFTQLTAALVQVFREALGCHIEQATKRTRSEGGGTGQGEAGKGASLPSSASWRCALWHRVWQGRRRARRRLQQQTKEGAGGGAGTRAGWLATEAQVTQELKGLSGGEERPETEPLLSFVASVSPADRMLTVTPLQDPQGLFPDLHHFLQVFLPQAIRHLKLEHHHHHH","Homo sapiens","TUT1, RBM21","Speckle targeted PIP5K1A-regulated poly(A) polymerase","1","5WU5"
"5WU6",,"X-RAY DIFFRACTION",3.4,68.6,"VAPOR DIFFUSION, HANGING DROP",,"Tris pH 7.0, PEG3350, MgCl2.",277,"10.1038/ncomms15788",,"5WU6",211.49,"3.209","3.209","Crystal structure of apo human Tut1, form IV","MGLRSVFVSGFPRDVDSAQLSEYFLAFGPVASVVMDKDKGVFAIVEMGDVGAREAVLSQSQHSLGGHRLRVRPREQKEFQSPASKSPKGAAPDSHQLAKALAEAADVGAQMIKLVGLRELSEAERQLRSLVVALMQEVFTEFFPGCVVHPFGSSINSFDVHGCDLDLFLDLGDLEEPQPVPKLPPASPLLEDREEGDLGKASELAETPKEEKAEGAAMLELVGSILRGCVPGVYRVQTVPSARRPVVKFAHRPSGLHGDVSLSNRLALHNSRFLSLASELDGRVRPLVYTLRAWAQGRGLSGSGPLLSNYALTLLVIYFLQTRDPPVLPTVSQLTQKAGEGEQVEVDGWDCSFPRDASRLEPSINVEPLSSLLAQFFSAVSSWDLRGSLLSLREGQALPVAGGLPSNLWEGLRLGPLNLQDPFDLSHNVAANVTSRVAGRLQNCCRAAANYARSLQYQRRSSRGRDWGLLPLLQPSSLEHHHHHH","Homo sapiens","TUT1, RBM21","Speckle targeted PIP5K1A-regulated poly(A) polymerase","1","5WU6"
"5WUU",,"X-RAY DIFFRACTION",1.8,31.6,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,"10.1016/j.bmcl.2017.03.012","7UU","5WUU",17.04,"1.724","1.724","Complex structure of the first bromodomain of BRD4 with an inhibitor that containing a 2H-chromen-2-one ring","MGHHHHHHENLYFQMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5WUU"
"5WUV",,"X-RAY DIFFRACTION",3.17,61.17,"VAPOR DIFFUSION, HANGING DROP",,"0.1M bis-Tris pH5.5, 0.2M Ammunium sulfate, 25% PEG3350",293,"10.3390/ijms18010228",,"5WUV",47.33,"1.952","1.952","Crystal structure of Certolizumab Fab","DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"light chain","1","5WUV"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKT","Homo sapiens",,"heavy chain","2","5WUV"
"5WVD",,"X-RAY DIFFRACTION",2.69,54.32,"VAPOR DIFFUSION, HANGING DROP",6.2,"polyethylene glycol 3350, ammonium sulfate, citrate buffer (pH 6.2), MgCl2",277,"10.1107/S2053230X18002108",,"5WVD",70.19,"3","3","Structure of Mnk1 in complex with DS12881479","GPLGSTDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKG","Homo sapiens","MKNK1, MNK1","MAP kinase interacting serine/threonine kinase 1","1","5WVD"
"5WWQ",,"X-RAY DIFFRACTION",2.49,50.62,"VAPOR DIFFUSION",8.6,"2% Dioxane, 0.1M Bicine, 18% (w/v) PEG 8000, 10 mM Yttrium(III) chloride hexahydrate",289,"10.1093/nar/gkx473",,"5WWQ",105.81,"2.815","2.815","Crystal structure of human NSun6","MSIFPKISLRPEVENYLKEGFMNKEIVTALGKQEAERKFETLLKHLSHPPSFTTVRVNTHLASVQHVKNLLLDELQKQFNGLSVPILQHPDLQDVLLIPVIGPRKNIKKQQCEAIVGAQCGNAVLRGAHVYAPGIVSASQFMKAGDVISVYSDIKGKCKKGAKEFDGTKVFLGNGISELSRKEIFSGLPELKGMGIRMTEPVYLSPSFDSVLPRYLFLQNLPSALVSHVLNPQPGEKILDLCAAPGGKTTHIAALMHDQGEVIALDKIFNKVEKIKQNALLLGLNSIRAFCFDGTKAVKLDMVEDTEGEPPFLPESFDRILLDAPCSGMGQRPNMACTWSVKEVASYQPLQRKLFTAAVQLLKPEGVLVYSTCTITLAENEEQVAWALTKFPCLQLQPQEPQIGGEGMRGAGLSCEQLKQLQRFDPSAVPLPDTDMDSLREARREDMLRLANKDSIGFFIAKFVKCKSTLEHHHHHH","Homo sapiens","NSUN6, NOPD1","Putative methyltransferase NSUN6","1","5WWQ"
"5WWZ",,"X-RAY DIFFRACTION",2.5,50.83,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Ammonium sulfate",277,"10.1074/jbc.M117.797746",,"5WWZ",29.7,"2.5","2.5","Crystal structure of the KH2 domain of human RNA-binding E3 ubiquitin-protein ligase MEX-3C","MGHHHHHHMSPNLPGQTTVQVRVPYRVVGLVVGPKGATIKRIQQQTHTYIVTPSRDKEPVFEVTGMPENVDRAREEIEMHIAMRTG","Homo sapiens","MEX3C, RKHD2, RNF194, BM-013","RNA-binding E3 ubiquitin-protein ligase MEX3C","1","5WWZ"
"5WXS",,"X-RAY DIFFRACTION",2.12,41.9,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate, pH 4.6, 2.0M ammonium sulfate supplemented with 5% polyethylene glycol 400",298,,,"5WXS",28.77,"2.3","2.3","Crystal structure of uPA in complex with S2444","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5WXS"
"5WXT",,"X-RAY DIFFRACTION",2.17,43.3,"VAPOR DIFFUSION, SITTING DROP",,"50 mM sodium citrate, pH 4.6, and 2.0 M ammonium sulfate supplemented with 5% polyethylene glycol 400",298,,,"5WXT",28.89,"2.1","2.1","Crystal structure of uPA-S195A in complex with S2444","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5WXT"
"5WY0",,"X-RAY DIFFRACTION",2.05,39.9,"EVAPORATION",,"0.1 M Tris pH 7.5, 0.2 M Magnesium chloride, 10% (w/v) PEG 3350",290,"10.1074/jbc.RA117.000837",,"5WY0",26.52,"2.001","2.001","Crystal structure of the methyltranferase domain of human HEN1 in complex with AdoMet","GSLYRQRYQFVKNLVDQHEPKKVADLGCGDTSLLRLLKVNPCIELLVGVDINEDKLRWRGDSLAPFLGDFLKPRDLNLTITLYHGSVVERDSRLLGFDLITCIELIEHLDSGDLARFPEVVFGYLSPSMIVISTPNSEFNPLFPSVTLRDSDHKFEWTRMEFQTWALYVANRYDYSVEFTGVGEPPAGAENVGYCTQIGIFRKNGGKATESCLSEQHDQHVYKAVFTTSY","Homo sapiens","HENMT1, C1orf59","Small RNA 2'-O-methyltransferase","1","5WY0"
"5WY9",,"X-RAY DIFFRACTION",1.88,34.75,"VAPOR DIFFUSION, SITTING DROP",,"0.05M Potassium thiocyanate, 30%PEG MME 2000",277.15,,,"5WY9",20.24,"1.45","1.45","Apo form crystal structure of human Lipocalin PGDS .","MAPEAQVSVQPNFQQDKFLGRWFSAGLASNSSWLREKKAALSMCKSVVAPATDGGLNLTSTFLRKNQCETRTMLLQPAGSLGSYSYRSPHWGSTYSVSVVETDYDQYALLYSQGSKGPGEDFRMATLYSRTQTPRAELKEKFTAFCKAQGFTEDTIVFLPQTDKCMTEQAHHHHHH","Homo sapiens","PTGDS, PDS","Prostaglandin-H2 D-isomerase","1","5WY9"
"5WYN",,"X-RAY DIFFRACTION",2.48,50.31,"VAPOR DIFFUSION, HANGING DROP",,"Sodium phosphate monobasic monohydrate
Potassium phosphate monobasic
Sodium chloride",295,"10.1042/BSR20181072",,"5WYN",36.42,"2.05","2.05","HtrA2 Pathogenic Mutant","MAVPSPPPASPRSQYNFIADVVEKTAPAVVYIEILDRHPFLGREVPISNGSGFVVAADGLIVTNAHVVADRRRVRVRLLSGDTYEAVVTAVDPVADIATLRIQTKEPLPTLPLGRSADVRQGEFVVAMGSPFALQNTITSGIVCSAQRPARDLGLPQTNVEYIQTDAAIDFGNSGGPLVNLDGEVIGVNTMKVTAGISFAIPSDRLREFLHRGEKKNSSSGISGSQRRYIGVMMLTLSPSILAELQLREPSFPDVQHGVLIHKVILGSPAHRAGLRPGDVILAIGEQMVQNAEDVWEAVRTQSQLAVQIRRGRETLTLYVTPEVTEHHHHHH","Homo sapiens","HTRA2, OMI, PRSS25","Serine protease HTRA2, mitochondrial","1","5WYN"
"5WYX",,"X-RAY DIFFRACTION",2.57,52.06,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000, calcium chloride, Tris-HCl, ethylene glycol",293,"10.1038/nchembio.2518","CU8","5WYX",191.51,"2.4","2.4","Crystal structure of human TLR8 in complex with CU-CPT8m","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","5WYX"
"5WYZ",,"X-RAY DIFFRACTION",2.53,51.45,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000, calcium chloride, Tris-HCl, ethylene glycol",293,"10.1038/nchembio.2518","7VF","5WYZ",191.06,"2.3","2.3","Crystal structure of human TLR8 in complex with CU-CPT9b","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","5WYZ"
"5WZM",,"X-RAY DIFFRACTION",3.39,63.7,"VAPOR DIFFUSION",,"2.2M Sodium chloride, 0.1M BIS-TRIS propane pH 7.0",277,"10.1038/s41598-017-11219-8",,"5WZM",14.37,"2","2","Crystal structure of human secreted phospholipase A2 group IIE","VQFGVMIEKMTGKSALQYNDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","5WZM"
"5WZO",,"X-RAY DIFFRACTION",3.38,63.56,"VAPOR DIFFUSION",,"2.2M Sodium chloride, 0.1M BIS-TRIS propane pH 7.0",277,"10.1038/s41598-017-11219-8",,"5WZO",14.85,"1.9","1.9","Crystal structure of human secreted phospholipase A2 group IIE, crystallized with calcium","NLVQFGVMIEKMTGKSALQYNDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","5WZO"
"5WZS",,"X-RAY DIFFRACTION",3.38,63.63,"VAPOR DIFFUSION",,"2.2 M Sodium chloride, 0.1 M BIS-TRIS propane pH 7.0",277,"10.1038/s41598-017-11219-8","7W9","5WZS",14.65,"2.3","2.3","Crystal structure of human secreted phospholipase A2 group IIE with Compound 8","NLVQFGVMIEKMTGKSALQYNDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","5WZS"
"5WZT",,"X-RAY DIFFRACTION",3.36,63.43,"VAPOR DIFFUSION",,"2.2M Sodium chloride, 0.1M BIS-TRIS propane pH 7.0",277,"10.1038/s41598-017-11219-8","7W6","5WZT",14.64,"2.4","2.4","Crystal structure of human secreted phospholipase A2 group IIE with Compound 14","NLVQFGVMIEKMTGKSALQYNDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","5WZT"
"5WZU",,"X-RAY DIFFRACTION",3.34,63.15,"VAPOR DIFFUSION",,"2.2M Sodium chloride, 0.1M BIS-TRIS propane pH 7.0",277,"10.1038/s41598-017-11219-8","7W3","5WZU",14.7,"2.2","2.2","Crystal structure of human secreted phospholipase A2 group IIE with Compound 24","NLVQFGVMIEKMTGKSALQYNDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","5WZU"
"5WZV",,"X-RAY DIFFRACTION",3.39,63.73,"VAPOR DIFFUSION",,"2.2M Sodium chloride, 0.1M BIS-TRIS propane pH 7.0",277,"10.1038/s41598-017-11219-8","7W0","5WZV",14.8,"2.2","2.2","Crystal structure of human secreted phospholipase A2 group IIE with Me-indoxam","NLVQFGVMIEKMTGKSALQYNDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","5WZV"
"5WZW",,"X-RAY DIFFRACTION",3.39,63.67,"VAPOR DIFFUSION",,"2.2M Sodium chloride, 0.1M BIS-TRIS propane pH 7.0",277,"10.1038/s41598-017-11219-8","U8D","5WZW",14.89,"1.95","1.95","Crystal structure of human secreted phospholipase A2 group IIE with LY311727","NLVQFGVMIEKMTGKSALQYNDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","5WZW"
"5X02",,"X-RAY DIFFRACTION",3.02,59.21,"VAPOR DIFFUSION, HANGING DROP",6.7,"2.2-2.4M Na/K Phosphate, 0.1M CAPS (pH6.7), 0.2M Litium Sulfate",293,"10.1182/blood-2017-05-786657","F6M","5X02",40.83,"2.401","2.401","Crystal structure of the FLT3 kinase domain bound to the inhibitor FF-10101","GPGHKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV","Homo sapiens","FLT3, CD135, FLK2, STK1","Receptor-type tyrosine-protein kinase FLT3","1","5X02"
,,,,,,,,,,,,,,,,,"Homo sapiens","FLT3, CD135, FLK2, STK1"
"5X0I",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, HANGING DROP",,"KCl, Tris, PEG3350",277,"10.1038/s42003-019-0343-4",,"5X0I",243.03,"2.64","2.64","Crystal structure of PKM2 R399E mutant complexed with FBP and serine","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELERLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","5X0I"
"5X16",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Sodium citrate tribasic dihydrate pH 5.6, 35% v/v tert-Butanol",277.15,,,"5X16",35.87,"1.97","1.97","Sirt6 apo structure","VNYAAGLSPYADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMKHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRINGSIPAGPKQE","Homo sapiens","SIRT6, SIR2L6","NAD-dependent protein deacetylase sirtuin-6","1","5X16"
"5X1A",,"X-RAY DIFFRACTION",2.78,55.79,"VAPOR DIFFUSION, SITTING DROP",,"PEG 8000, Tris pH 8.5, DTT",293,"10.1038/s41598-017-11031-4",,"5X1A",57.38,"1.821","1.821","Crystal Structure of Human CRMP-2","MSYQGKKNIPRITSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAELRGVPRGLYDGPVCEVSVTPKTVTPASSAKTSPAK","Homo sapiens","DPYSL2, CRMP2, ULIP2","Dihydropyrimidinase-related protein 2","1","5X1A"
"5X1C",,"X-RAY DIFFRACTION",2.8,56.11,"VAPOR DIFFUSION, SITTING DROP",,"ammonium sulfate, Tris pH 7.0",293,"10.1038/s41598-017-11031-4",,"5X1C",106.1,"2.101","2.101","Crystal Structure of Human CRMP-2 without C-terminal Tail","VLFQGPTSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAE","Homo sapiens","DPYSL2, CRMP2, ULIP2","Dihydropyrimidinase-related protein 2","1","5X1C"
"5X1D",,"X-RAY DIFFRACTION",2.75,55.35,"VAPOR DIFFUSION, SITTING DROP",,"PEG 6000, tri-sodium citrate pH 5.6, Lithium sulfate",293,"10.1038/s41598-017-11031-4",,"5X1D",57.31,"2.2","2.2","Crystal Structure of T246A-N247A Human CRMP-2 Mutant","MSYQGKKNIPRITSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQAACPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAELRGVPRGLYDGPVCEVSVTPKTVTPASSAKTSPAK","Homo sapiens","DPYSL2, CRMP2, ULIP2","Dihydropyrimidinase-related protein 2","1","5X1D"
"5X1G","4.5","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.jmb.2017.03.022",,"5X1G",4.41,"4.5",,"WHAMM's Microtubule binding motif","IQMKRDKIKEEEQKKKEWINQERQKTLQRLRSFK","Homo sapiens","WHAMM, KIAA1971, WHDC1","WASP homolog-associated protein with actin, membranes and microtubules","1","5X1G"
"5X1O",,"X-RAY DIFFRACTION",2.17,43.23,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Sodium citrate, 0.2M Ammonium acetate, 30% PEG 4000",298,,,"5X1O",33.71,"1.9","1.9","PI(4,5)P2 lipid binding induced a reorientation of FGF2 molecules near membrane surface to facilitate the unconventional oligomerization-dependent secretion process as revealed by a combined FTIR/NMR/X-ray study","PALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS","Homo sapiens","FGF2, FGFB","Fibroblast growth factor 2","1","5X1O"
"5X1V",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION",6.5,"PEG 3350, tryptone, MES",293,"10.1016/j.bmc.2017.05.004",,"5X1V",242.75,"2.1","2.1","PKM2 in complex with compound 2","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","5X1V"
"5X1W",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION",6.5,"PEG 3350, tryptone, MES",293,"10.1016/j.bmc.2017.05.004",,"5X1W",242.8,"3","3","PKM2 in complex with compound 5","MGSSHHHHHHSSGLVPRGSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","5X1W"
"5X23",,"X-RAY DIFFRACTION",3.84,67.93,"VAPOR DIFFUSION, SITTING DROP",,"1.5 M ammonium sulfate, 0.1 M Tris pH8.5, 12% glycerol",291,"10.1021/acs.biochem.7b00795",,"5X23",56.29,"2","2","Crystal structure of CYP2C9 genetic variant A477T (*30) in complex with multiple losartan molecules","MAKKTSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFTSVPPFYQLCFIPIHHHH","Homo sapiens","CYP2C9, CYP2C10","Cytochrome P450 2C9","1","5X23"
"5X24",,"X-RAY DIFFRACTION",4.04,69.55,"VAPOR DIFFUSION, SITTING DROP",,"1.8M ammonium sulfate, 0.1M BIS-TRIS pH 6.5 and 2% (v/v) Polyethylene glycol monomethyl ether 550",291,"10.1021/acs.biochem.7b00795",,"5X24",55.83,"2.48","2.48","Crystal structure of CYP2C9 genetic variant I359L (*3) in complex with multiple losartan molecules","MAKKTSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYLDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPIHHHH","Homo sapiens","CYP2C9, CYP2C10","Cytochrome P450 2C9","1","5X24"
"5X26",,"X-RAY DIFFRACTION",3.42,64.04,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH7.8, 40% PEG400, 0.15M NaCl, 5mM tris(2-carboxyethyl)-phosphine (TCEP)",293,"10.18632/oncotarget.24113","7XO","5X26",37.83,"2.951","2.951","Crystal structure of EGFR 696-1022 L858R in complex with SKLB(3)","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5X26"
"5X27",,"X-RAY DIFFRACTION",3.43,64.12,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.1M Hepes pH 7.8, 40% PEG 400, 0.15M NaCl, 5mM tris(2-carboxyethyl)-phosphine (TCEP)",293,"10.18632/oncotarget.24113","7XR","5X27",37.85,"2.952","2.952","Crystal structure of EGFR 696-1022 L858R in complex with SKLB(5)","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5X27"
"5X28",,"X-RAY DIFFRACTION",3.44,64.22,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH7.8, 40% PEG400, 0.15M NaCl, 5mM tris(2-carboxyethyl)-phosphine (TCEP)",293,"10.18632/oncotarget.24113",,"5X28",37.87,"2.952","2.952","Crystal structure of EGFR 696-1022 L858R in complex with SKLB(6)","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5X28"
"5X2A",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bis-Tris 5.0, 22.5% PEG 3350, 5mM TCEP",293,"10.18632/oncotarget.24113","7XO","5X2A",154.62,"1.85","1.85","Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(3)","GSTSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5X2A"
"5X2C",,"X-RAY DIFFRACTION",2.61,52.93,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bis-Tris 5.0, 22.5% PEG 3350, 5mM TCEP",293,"10.18632/oncotarget.24113","7XR","5X2C",77.04,"2.05","2.05","Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(5)","GSTSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5X2C"
"5X2F",,"X-RAY DIFFRACTION",2.06,40.41,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bis-Tris 5.0, 22.5% PEG 3350, 5mM TCEP",293,"10.18632/oncotarget.24113",,"5X2F",152.83,"2.2","2.2","Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(6)","GSTSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5X2F"
"5X2K",,"X-RAY DIFFRACTION",3.71,66.87,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Glycine pH 8.0, 38% PEG 300, 0.1M NaCl, 5mM tris(2-carboxyethyl)-phosphine (TCEP)",293,"10.18632/oncotarget.24113","0UN","5X2K",37.83,"3.201","3.201","Crystal structure of EGFR 696-1022 T790M in complex with WZ4003","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5X2K"
"5X2L",,"X-RAY DIFFRACTION",2.63,53.3,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 5mM MgCl2, 10% Ethylene Glycol, 0.1M bis-Tris pH6.0",293,"10.1016/j.bmcl.2017.12.021",,"5X2L",75.89,"1.806","1.806","Crystal Structure of Human Serine Racemase","MCAQYCISFADVEKAHINIRDSIHLTPVLTSSILNQLTGRNLFFKCELFQKTGSFKIRGALNAVRSLVPDALERKPKAVVTHSSGNHGQALTYAAKLEGIPAYIVVPQTAPDCKKLAIQAYGASIVYCEPSDESRENVAKRVTEETEGIMVHPNQEPAVIAGQGTIALEVLNQVPLVDALVVPVGGGGMLAGIAITVKALKPSVKVYAAEPSNADDCYQSKLKGKLMPNLYPPETIADGVKSSIGLNTWPIIRDLVDDIFTVTEDEIKCATQLVWERMKLLIEPTAGVGVAAVLSQHFQTVSPEVKNICIVLSGGNVDLTSSITWVKQAERPASYQSVSVLEHHHHHH","Homo sapiens","SRR","Serine racemase","1","5X2L"
"5X3N",,"X-RAY DIFFRACTION",1.77,30.36,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Magnesium formate dihydrate, 20%(w/v) Polyethylene glycol 3350",289,,,"5X3N",8.86,"1.649","1.649","Crystal structure of DiUb-K6","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","5X3N"
"5X3P",,"X-RAY DIFFRACTION",1.96,37.22,"VAPOR DIFFUSION",,"0.1M Tris pH 8.8, 35% v/v Polyethylene glycol 400, 0.1M LiCl",289,"10.1016/j.bbrc.2017.03.005",,"5X3P",28.9,"1.999","1.999","Crystal structure of the UBX domain of human UBXD7","GGSGPKAQLMLRYPDGKREQITLPEQAKLLALVKHVQSKGYPNERFELLTNFPRRKLSHLDYDITMQEAGLCPQETVFVQERN","Homo sapiens","UBXN7, KIAA0794, UBXD7","UBX domain-containing protein 7","1","5X3P"
"5X3V",,"X-RAY DIFFRACTION",3.55,65.36,"EVAPORATION",7.4,"0.2M Ammonium sulfate, 0.1M Bis-Tris (pH 7.0), 20%(w/v) Polyethylene glycol 3350",291,,,"5X3V",110.74,"2.85","2.85","Structure of human SHMT2 protein mutant","MAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNRYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEHKLAAALEHHHHHH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","1","5X3V"
"5X49",,"X-RAY DIFFRACTION",2.74,55.14,"MICROBATCH",,"10 mM TrisCl, 100 mM NaCl, 50 mM HEPES, 10% PEG 3350, 2.5 mM Apstatin",294,"10.1074/jbc.M117.783357",,"5X49",104.9,"1.65","1.65","Crystal Structure of Human mitochondrial X-prolyl Aminopeptidase (XPNPEP3)","GSHPHLLRPGEVTPGLSQVEYALRRHKLMSLIQKEAQGQSGTDQTVVVLSNPTYYMSNDIPYTFHQDNNFLYLCGFQEPDSILVLQSLPGKQLPSHKAILFVPRRDPSRELWDGPRSGTDGAIALTGVDEAYTLEEFQHLLPKMKAETNMVWYDWMRPSHAQLHSDYMQPLTEAKAKSKNKVRGVQQLIQRLRLIKSPAEIERMQIAGKLTSQAFIETMFTSKAPVEEAFLYAKFEFECRARGADILAYPPVVAGGNRSNTLHYVKNNQLIKDGEMVLLDGGCESSCYVSDITRTWPVNGRFTAPQAELYEAVLEIQRDCLALCFPGTSLENIYSMMLTLIGQKLKDLGIMKNIKENNAFKAARKYCPHHVGHYLGMDVHDTPDMPRSLPLQPGMVITIEPGIYIPEDDKDAPEKFRGLGVRIEDDVVVTQDSPLILSADCPKEMNDIEQICSQAS","Homo sapiens","XPNPEP3","Probable Xaa-Pro aminopeptidase 3","1","5X49"
"5X4F",,"SOLUTION NMR",,,,,,,"10.1038/s41598-017-06263-3",,"5X4F",8.5,,,"Solution Structure of the N-terminal Domain of TDP-43","MSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGASGLRYRNPVSQSMRGVRLVEGILHAPDAGWGNLVYVVNY","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","5X4F"
"5X4M",,"X-RAY DIFFRACTION",2.98,58.66,"VAPOR DIFFUSION, SITTING DROP",6.5,"Bis-Tris, potassium/sodium tartrate",293,"10.1021/acs.jmedchem.7b00313","7ZF","5X4M",16.47,"1.65","1.65","Crystal structure of the BCL6 BTB domain in complex with Compound 1","LDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","5X4M"
"5X4N",,"X-RAY DIFFRACTION",3.04,59.52,"VAPOR DIFFUSION, SITTING DROP",6.5,"Bis-Tris, potassium/sodium tartrate",293,"10.1021/acs.jmedchem.7b00313","7ZL","5X4N",16.57,"1.94","1.94","Crystal structure of the BCL6 BTB domain in complex with Compound 4","LDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","5X4N"
"5X4O",,"X-RAY DIFFRACTION",2.99,58.84,"VAPOR DIFFUSION, SITTING DROP",6.5,"Bis-Tris, potassium/sodium tartrate",293,"10.1021/acs.jmedchem.7b00313","YAM","5X4O",16.8,"2.05","2.05","Crystal structure of the BCL6 BTB domain in complex with Compound 5","LDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","5X4O"
"5X4P",,"X-RAY DIFFRACTION",3.06,59.86,"VAPOR DIFFUSION, SITTING DROP",6.5,"Bis-Tris, potassium/sodium tartrate",293,"10.1021/acs.jmedchem.7b00313","7ZO","5X4P",16.55,"2.06","2.06","Crystal structure of the BCL6 BTB domain in complex with Compound 6","LDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","5X4P"
"5X4Q",,"X-RAY DIFFRACTION",3.05,59.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"Bis-Tris, potassium/sodium tartrate",293,"10.1021/acs.jmedchem.7b00313","7Z6","5X4Q",16.76,"2","2","Crystal structure of the BCL6 BTB domain in complex with Compound 7","LDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","5X4Q"
"5X4W",,"X-RAY DIFFRACTION",3.19,61.46,"VAPOR DIFFUSION, SITTING DROP",,"100mM HEPES, pH 7.0, 10% PEG 6000",298,"10.1074/jbc.M117.787267",,"5X4W",36.1,"2.1","2.1","Mutant human thymidylate synthase A191K crystallized in a sulfate-free condition","SMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMKLPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X4W"
"5X4X",,"X-RAY DIFFRACTION",3.26,62.3,"VAPOR DIFFUSION, SITTING DROP",,"100mM Tris, pH 8.5, 0.2M lithium sulfate, 1.26M ammonium sulfate",298,"10.1074/jbc.M117.787267",,"5X4X",36.1,"2.31","2.31","Mutant human thymidylate synthase A191K crystallized in a sulfate-containing condition","SMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMKLPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X4X"
"5X4Y",,"X-RAY DIFFRACTION",3.28,62.51,"VAPOR DIFFUSION, SITTING DROP",,"100mM MES, pH 6.5, 1.6M ammonium sulfate, 10% 1,4-dioxane",298,"10.1074/jbc.M117.787267",,"5X4Y",36.04,"2.2","2.2","Mutant human thymidylate synthase M190K crystallized in a sulfate-containing condition","SMPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLKALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X4Y"
"5X52",,"X-RAY DIFFRACTION",2.25,45.45,"VAPOR DIFFUSION, HANGING DROP",7,"32% PEG3350, 50 mM pottasium phosphate buffer",277,"10.1016/j.bbapap.2017.04.004",,"5X52",134.15,"3.005","3.005","Human serum albumin complexed with octanoate and N-acetyl-L-methionine","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","5X52"
"5X57",,"X-RAY DIFFRACTION",2.32,46.87,"EVAPORATION",6.5,"Sodium cacodylate trihydrate, (NH4)2SO4, PEG 4000",293,"10.1038/ncomms15375",,"5X57",9.48,"1.45","1.45","Structure of GAR domain of ACF7","YRPTTDADKIEDEVTRQVAQCKCAKRFQVEQIGENKYRFGDSQQLRLVRILRSTVMVRVGGGWMALDEFLVKNDPCRARGR","Homo sapiens","MACF1, ABP620, ACF7, KIAA0465, KIAA1251, KIAA0754","Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5","1","5X57"
"5X5A",,"X-RAY DIFFRACTION",2.41,48.95,"VAPOR DIFFUSION, HANGING DROP",,"100mM sodium calcodylate, pH 6.5, 25% PEG 4000",298,"10.1074/jbc.M117.787267",,"5X5A",200.09,"2.39","2.39","Human thymidylate synthase bound with phosphate ion","SMPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X5A"
"5X5D",,"X-RAY DIFFRACTION",2.41,49.02,"VAPOR DIFFUSION, HANGING DROP",6.5,"100mM sodium calcodylate, pH 6.5, 25% PEG 4000",298,"10.1074/jbc.M117.787267","UMP","5X5D",201.37,"2","2","Human thymidylate synthase bound with dUMP","SMPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X5D"
"5X5O",,"X-RAY DIFFRACTION",1.85,33.42,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Trimethylamine N-oxide dehydrate, 0.1 M Tris, 20% w/v Polyethylene glycol monomethyl ether 2000, pH8.5",293,"10.1021/acs.jmedchem.7b00572","7Z0","5X5O",35.86,"1.868","1.868","Crystal structure of ZAK in complex with compound D2829","GAMGSGASFVQIKFDDLQFFENCGGGSFGSVYRAKWISQDKEVAVKKLLKIEKEAEILSVLSHRNIIQFYGVILEPPNYGIVTEYASLGSLYDYINSNRSEEMDMDHIMTWATDVAKGMHYLHMEAPVKVIHRDLKSRNVVIAADGVLKICDFGASRFHNHTTHMSLVGTFPWMAPEVIQSLPVSETCDTYSYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLHQCWEADAKKRPSFKQIISILESMSNDTSLPDKCNSFLHNKAEWRCEIEATLERLKKLERDLSFKEQELK","Homo sapiens","ZAK, MLTK, HCCS4, MAP3K20","Mitogen-activated protein kinase kinase kinase MLT","1","5X5O"
"5X5P",,"X-RAY DIFFRACTION",3.83,67.9,"VAPOR DIFFUSION, SITTING DROP",6.6,"PIPES-Na 100mM pH 6.6, disodium malonate 8mM, PEG 3350 18%, glycerol 17%",298,"10.1016/j.jinorgbio.2022.111885",,"5X5P",76.27,"2.7","2.7","Human serum transferrin bound to ruthenium NTA","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","5X5P"
"5X5Q",,"X-RAY DIFFRACTION",2.31,46.74,"VAPOR DIFFUSION, HANGING DROP",6.5,"100mM sodium calcodylate, pH 6.5, 25% PEG 4000",298,"10.1074/jbc.M117.787267","D16","5X5Q",204.12,"2.79","2.79","Human thymidylate synthase complexed with dUMP and raltitrexed","SMPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X5Q"
"5X66",,"X-RAY DIFFRACTION",2.38,48.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"100mM sodium calcodylate, pH 6.5, 25% PEG 4000",298,"10.1074/jbc.M117.787267","MTX, UMP","5X66",204.1,"1.99","1.99","Human thymidylate synthase in complex with dUMP and methotrexate","SMPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X66"
"5X67",,"X-RAY DIFFRACTION",2.35,47.71,"VAPOR DIFFUSION, HANGING DROP",,"100mM sodium calcodylate, pH 6.5, 25% PEG 4000",298,"10.1074/jbc.M117.787267","7Z9, UMP","5X67",67.69,"2.13","2.13","Human thymidylate synthase in complex with dUMP and nolatrexed","SMPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X67"
"5X68",,"X-RAY DIFFRACTION",3.17,61.2,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris (pH 8.5), 13% polyethylene glycol 4000, and 15% glycerol",295,"10.1016/j.chembiol.2018.01.008",,"5X68",90.14,"2.1","2.1","Crystal Structure of Human KMO","MRGSGSMDSSVIQRKKVAVIGGGLVGSLQACFLAKRNFQIDVYEAREDTRVATFTRGRSINLALSHRGRQALKAVGLEDQIVSQGIPMRARMIHSLSGKKSAIPYGTKSQYILSVSRENLNKDLLTAAEKYPNVKMHFNHRLLKCNPEEGMITVLGSDKVPKDVTCDLIVGCDGAYSTVRSHLMKKPRFDYSQQYIPHGYMELTIPPKNGDYAMEPNYLHIWPRNTFMMIALPNMNKSFTCTLFMPFEEFEKLLTSNDVVDFFQKYFPDAIPLIGEKLLVQDFFLLPAQPMISVKCSSFHFKSHCVLLGDAAHAIVPFFGQGMNAGFEDCLVFDELMDKFSNDLSLCLPVFSRLRIPDDHAISDLSMYNYIEMRAHVNSSAAALEHHHHHH","Homo sapiens","KMO","Kynurenine 3-monooxygenase","1","5X68"
"5X69",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, HANGING DROP",,"100mM sodium calcodylate, pH 6.5, 25% PEG 4000",298,"10.1074/jbc.M117.787267",,"5X69",201.17,"2.69","2.69","Human thymidylate synthase with a fragment bound in the dimer interface","SMPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV","Homo sapiens","TYMS, TS, OK/SW-cl.29","Thymidylate synthase","1","5X69"
"5X6T",,"SOLUTION NMR",,,,,,,"10.1002/pro.3301",,"5X6T",6.17,,,"N-terminal Zinc Finger of Synaptotagmin-like Protein 4","SDRTCARCQESLGRLSPKTNTCRGCNHLVCRDCRIQESNGTWRCKVCAKEIEL","Homo sapiens","SYTL4","Synaptotagmin-like protein 4","1","5X6T"
"5X72",,"X-RAY DIFFRACTION",2.95,58.31,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium citrate dibasic, 20% w/v Polyethylene glycol 3350",277,"10.1021/acs.jmedchem.7b01243","P69, P59","5X72",18.08,"1.95","1.95","The crystal Structure PDE delta in complex with (rac)-p9","MSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","5X72"
"5X73",,"X-RAY DIFFRACTION",2.98,58.78,"VAPOR DIFFUSION, SITTING DROP",5,"8% v/v Tacsimate, 20% w/v Polyethylene glycol 3350",277,"10.1021/acs.jmedchem.7b01243","P59","5X73",18.08,"2.5","2.5","The crystal Structure PDE delta in complex with R-p9","MSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","5X73"
"5X74",,"X-RAY DIFFRACTION",2.96,58.41,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M Sodium acetate, 30 %(v/v) PEG 300",277,"10.1021/acs.jmedchem.7b01243","JAY","5X74",17.99,"2.25","2.25","The crystal Structure PDE delta in complex with compound (R, R)-1g","MSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLISAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","5X74"
"5X79",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 22% PEG8000, 20 mM calcium chloride, 10 mM DTT",277,"10.1039/c7cc05829b",,"5X79",47.98,"1.9","1.9","Human GST Pi conjugated with novel inhibitor, GS-ESF","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","5X79"
"5X83",,"X-RAY DIFFRACTION",2.7,54.49,"VAPOR DIFFUSION",6.5,"0.1M Sodium Phosphate Monobasic Monohydrate, 0.1M Potassium Phosphate Monobasic, 0.1M MES Monohydrate pH 6.5, 2.0M Sodium Chloride",291,"10.1007/s13238-017-0439-x",,"5X83",70.76,"2.997","2.997","Structure of DCC FN456 domains","DESQVPDQPSSLHVRPQTNCIIMSWTPPLNPNIVVRGYIIGYGVGSPYAETVRVDSKQRYYSIERLESSSHYVISLKAFNNAGEGVPLYESATTRGSGGSGGSGGSGGSGGSGGSG","Homo sapiens","DCC, IGDCC1","Netrin receptor DCC","1","5X83"
,,,,,,,,,,,,,,,,"GMLPPVGVQAVALTHDAVRVSWADNSVPKNQKTSEVRLYTVRWRTSFSASAKYKSEDTTSLSYTATGLKPNTMYEFSVMVTKNRRSSTWSMTAHATTYEAAPTSAPKDLTVITREGKPRAVIVSWQPPLEANGKITAYILFYTLDKNIPIDDWIMETISGDRLTHQIMDLNLDTMYYFRIQARNSKGVGPLSDPILFRTLKLEVLFQ","Homo sapiens","DCC, IGDCC1","Netrin receptor DCC","2","5X83"
"5X8I",,"X-RAY DIFFRACTION",2.37,48.17,"VAPOR DIFFUSION, SITTING DROP",9,"2% (v/v) PEG 200, 20% (v/v) tacsimate (pH 7.0), 0.1M HEPES (pH 9.0)",291,"10.1021/acs.jmedchem.7b00665","SQZ","5X8I",81.95,"1.902","1.902","Crystal structure of human CLK1 in complex with compound 25","MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSILEHHHHHH","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","5X8I"
"5X8S",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Hepes pH7.5, 5% PEG4000, temperature 295K",295,"10.1111/gtc.12494","6Q5","5X8S",60.71,"2.2","2.2","Crystal Structure of the mutant Human ROR gamma Ligand Binding Domain With Ursolic acid.","EAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","5X8S"
"5X9B",,"X-RAY DIFFRACTION",3.28,62.55,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M L-Proline, 0.1 M HEPES pH 7.0, 6% PEG3350",289,"10.1371/journal.pone.0211459",,"5X9B",37.45,"2.7","2.7","Crystal structure of the cytosolic domain of human MiD51","GPLGSMSLQEKLLTYYRNRAAIPAGEQARAKQAAVDICAELRSFLRAKLPDMPLRDMYLSGSLYDDLQVVTADHIQLIVPLVLEQNLWSCIPGEDTIMNVPGFFLVRRENPEYFPRGSSYWDRCVVGGYLSPKTVADTFEKVVAGSINWPAIGSLLDYVIRPAPPPEALTLEVQYERDKHLFIDFLPSVTLGDTVLVAKPHRLAQYDNLWRLSLRPAETARLRALDQADSGCRSLCLKILKAICKSTPALGHLTASQLTNVILHLAQEEADWSPDMLADRFLQALRGLISYLEAGVLPSALNPKVNLFAELTPEEIDELGYTLYCSLSEPEVLLQT","Homo sapiens","MID51, MIEF1, SMCR7L","Mitochondrial dynamics protein MID51","1","5X9B"
"5X9C",,"X-RAY DIFFRACTION",2.87,57.11,"VAPOR DIFFUSION, HANGING DROP",7,"0.6 M NaH2PO4/K2HPO4, pH 7.0",289,,,"5X9C",74.89,"1.85","1.85","Crystal structure of the cytosolic domain of human MiD51","GPLGSMSLQEKLLTYYRNRAAIPAGEQARAKQAAVDICAELRSFLRAKLPDMPLRDMYLSGSLYDDLQVVTADHIQLIVPLVLEQNLWSCIPGEDTIMNVPGFFLVRRENPEYFPRGSSYWDRCVVGGYLSPKTVADTFEKVVAGSINWPAIGSLLDYVIRPAPPPEALTLEVQYERDKHLFIDFLPSVTLGDTVLVAKPHRLAQYDNLWRLSLRPAETARLRALDQADSGCRSLCLKILKAICKSTPALGHLTASQLTNVILHLAQEEADWSPDMLADRFLQALRGLISYLEAGVLPSALNPKVNLFAELTPEEIDELGYTLYCSLSEPEVLLQT","Homo sapiens","MID51, MIEF1, SMCR7L","Mitochondrial dynamics protein MID51","1","5X9C"
"5X9O",,"X-RAY DIFFRACTION",2.99,58.85,"VAPOR DIFFUSION, SITTING DROP",6.5,"Bis-Tris, potassium/sodium tartrate",293,"10.1016/j.bmc.2017.07.037","80R","5X9O",16.69,"1.58","1.58","Crystal structure of the BCL6 BTB domain in complex with Compound 1a","LDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","5X9O"
"5X9P",,"X-RAY DIFFRACTION",3,59.06,"VAPOR DIFFUSION, SITTING DROP",6.5,"Bis-Tris, potassium/sodium tartrate",293,"10.1016/j.bmc.2017.07.037","80L","5X9P",16.68,"1.86","1.86","Crystal structure of the BCL6 BTB domain in complex with Compound 5","LDYKDDDDKENLYFQGADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","5X9P"
"5X9S",,"X-RAY DIFFRACTION",2.36,47.92,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Ca acetate, 20%(w/v) PEG8000, 0.1M MES (pH6.0)",293,"10.1002/1873-3468.12759",,"5X9S",22.04,"2.5","2.5","Crystal structure of fully modified H-Ras-GppNHp","GPLGSDMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHLPKTGNPPDESGPGSMSSKC","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","5X9S"
"5XAC",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 3,350, 0.1M HEPES pH 7.5, 200mM NaCl.",293,"10.1016/j.bbrc.2017.06.173",,"5XAC",61.13,"1.701","1.701","CLIR - LC3B","DDTIDDFVTIEPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETFG","Homo sapiens","MAP1LC3B, MAP1ALC3","Microtubule-associated proteins 1A/1B light chain 3B","1","5XAC"
"5XAE",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, HANGING DROP",7,"Pentaerythritol propoxylate, 0.1M HEPES pH 7.0, 0.2M Potassium chloride.",293,"10.1016/j.bbrc.2017.06.173",,"5XAE",66.38,"1.996","1.996","mutNLIR_LC3B","IVDEAEELGEQESDIDEFDLLEGPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETFG","Homo sapiens","MAP1LC3B, MAP1ALC3","Microtubule-associated proteins 1A/1B light chain 3B","1","5XAE"
"5XAH",,"X-RAY DIFFRACTION",2.41,48.87,"EVAPORATION",,"Sodium Tartrate, PEG3350",291,"10.1016/j.jmb.2018.01.015",,"5XAH",180.47,"3.004","3.004","Crystal structure of human Importin4","GSAFFDEKEDTCAAVGEISVNTSVAFLPYMESVFEEVFKLLECPHLNVRKAAHEALGQFCCALHKACQSCPSEPNTAALQAALARVVPSYMQAVNRERERQVVMAVLEALTGVLRSCGTLTLKPPGRLAELCGVLKAVLQRKTACQDTDEEEEEEDDDQAEYDAMLLEHAGEAIPALAAAAGGDSFAPFFAGFLPLLVCKTKQGCTVAEKSFAVGTLAETIQGLGAASAQFVSRLLPVLLSTAQEADPEVRSNAIFGMGVLAEHGGHPAQEHFPKLLGLLFPLLARERHDRVRDNICGALARLLMASPTRKPEPQVLAALLHALPLKEDLEEWVTIGRLFSFLYQSSPDQVIDVAPELLRICSLILADNKIPPDTKAALLLLLTFLAKQHTDSFQAALGSLPVDKAQELQAVLGLS","Homo sapiens","IPO4, IMP4B, RANBP4","Importin-4","1","5XAH"
"5XAJ",,"X-RAY DIFFRACTION",3.29,62.57,"VAPOR DIFFUSION, SITTING DROP",,"Ammonium acetate, Bis Tris Propane pH 5.5, PEG 10,000",293.15,"10.1128/JVI.00406-17",,"5XAJ",186.03,"2.5","2.5","Structural mimicry of the dengue virus envelope glycoprotein revealed by the crystallographic study of an idiotype-anti-idiotype Fab complex.","EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCAVGLPVDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"Fab E1 heavy chain","4","5XAJ"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGRSLRLSCAASGFSFSSYGMHWVRQAPGKGLEWVAVIWYDGSKTYYGDSVKGRFTISKDNSKKMVNLQMDSLGVEDTAFYYCARGIAGGWAFWGIDLWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCAA","Homo sapiens",,"FabHM14c10 heavy chain","1","5XAJ"
,,,,,,,,,,,,,,,,"DIVMTQSPGTLSLSPGERATLSCRASQNVYSYLGWYQHKPGRSPRLLIFGVTSRATGVPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYAGSAYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FabHM14c10 light chain","2","5XAJ"
,,,,,,,,,,,,,,,,"LSYELTQPPSVSVAPGQTARMTCGGNNIGTKSVHWYQQKPGQAPVLVVYNDRDRPSGIPERFSGSNSGNTATLTISRVEDGDEADYFCQVWDNYSDHVIFGGGTKLTVLGAPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTEC","Homo sapiens",,"Fab E1 light chain","3","5XAJ"
,,,,,,,,,,,,,,,,"EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCAVGLPVDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Fab E1 heavy chain","5","5XAJ"
"5XAW",,"X-RAY DIFFRACTION",2.44,49.56,"BATCH MODE",,"10% (w/v) PEG1000, 10% (w/v) PEG 8000",293,"10.1074/jbc.M117.786509",,"5XAW",29.2,"2.101","2.101","Parallel homodimer structures of voltage-gated sodium channel beta4 for cell-cell adhesion","SLEVSVGKATDIYAVNGTEILLPCTFSSCFGFEDLHFRWTYNSSDAFKILIEGTVKNEKSDPKVTLKDDDRITLVGSTKEKMNNISIVLRDLEFSDTGKYTCHVKNPKENNLQHHATIFLQVV","Homo sapiens","SCN4B","Sodium channel subunit beta-4","1","5XAW"
"5XB1","3","ELECTRON MICROSCOPY",,,,,,,"10.1002/anie.201800516",,"5XB1",450.63,"3",,"human ferritin mutant - E-helix deletion","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMG","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","5XB1"
"5XDK",,"X-RAY DIFFRACTION",3.4,63.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.07 M HEPES pH7.5, 0.9 M tri-sodium citrate, 5 mM TCEP.",293,"10.18632/oncotarget.18588","8JC","5XDK",38.21,"2.346","2.346","Crystal structure of EGFR 696-1022 T790M in complex with CO-1686","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5XDK"
"5XDL",,"X-RAY DIFFRACTION",3.26,62.32,"VAPOR DIFFUSION, HANGING DROP",7.8,"0.1 M HEPES pH 7.8, 40% PEG 400, 0.15 M NaCl, 5 mM tris(2-carboxyethyl)-phosphine (TCEP)",293,"10.18632/oncotarget.18588","8JC","5XDL",38.24,"2.7","2.7","Crystal structure of EGFR 696-1022 L858R in complex with CO-1686","GSTSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5XDL"
"5XDN",,"X-RAY DIFFRACTION",2.95,58.24,"VAPOR DIFFUSION, SITTING DROP",6.5,"36% PEG300, 0.1 M MES (pH 6.5), 0.1 M NaCl",293,"10.1002/pro.3211",,"5XDN",65.51,"3.15","3.15","Crystal structure of human voltage-dependent anion channel 1 (hVDAC1) in P22121 space group","MRGSHHHHHHGSMAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA","Homo sapiens","VDAC1, VDAC","Voltage-dependent anion-selective channel protein 1","1","5XDN"
"5XDO",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION, SITTING DROP",7,"45% PEG300, 0.1 M HEPES (pH 7.0), 0.15 M NaCl, 11 mM spermidine",293,"10.1002/pro.3211",,"5XDO",65.4,"3.1","3.1","Crystal structure of human voltage-dependent anion channel 1 (hVDAC1) in C222 space group","MRGSHHHHHHGSMAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQA","Homo sapiens","VDAC1, VDAC","Voltage-dependent anion-selective channel protein 1","1","5XDO"
"5XDR",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, SITTING DROP",,"PEG4000, lithium sulfate, sodium acetate",293,"10.1107/S2053230X17007336",,"5XDR",79.76,"2","2","Crystal structure of human DEAH-box RNA helicase DHX15 in complex with ADP","GPEFSLPQCINPFTNLPHTPRYYDILKKRLQLPVWEYKDRFTDILVRHQSFVLVGETGSGKTTQIPQWCVEYMRSLPGPKRGVACTQPRRVAAMSVAQRVADEMDVMLGQEVGYSIRFEDCSSAKTILKYMTDGMLLREAMNDPLLERYGVIILDEAHERTLATDILMGVLKEVVRQRSDLKVIVMSATLDAGKFQIYFDNCPLLTIPGRTHPVEIFYTPEPERDYLEAAIRTVIQIHMCEEEEGDLLLFLTGQEEIDEACKRIKREVDDLGPEVGDIKIIPLYSTLPPQQQQRIFEPPPPKKQNGAIGRKVVVSTNIAETSLTIDGVVFVIDPGFAKQKVYNPRIRVESLLVTAISKASAQQRAGRAGRTRPGKCFRLYTEKAYKTEMQDNTYPEILRSNLGSVVLQLKKLGIDDLVHFDFMDPPAPETLMRALELLNYLAALNDDGDLTELGSMMAEFPLDPQLAKMVIASCDYNCSNEVLSITAMLSVPQCFVRPTEAKKAADEAKMRFAHIDGDHLTLLNVYHAFKQNHESVQWCYDNFINYRSLMSADNVRQQLSRIMDRFNLPRRSSDFTSRDYYINIRKALVTGYFMQVAHLERTGHYLTVKDNQVVQLHPSTVLDHKPEWVLYNEFVLTTKNYIRTCTDIKPEWLVKIAPQYYDMSNFPQCEAKRQLDRIIAKLQSKEYSQY","Homo sapiens","DHX15, DBP1, DDX15","Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15","1","5XDR"
"5XE1",,"X-RAY DIFFRACTION",3,58.99,"VAPOR DIFFUSION",9.5,"10% (w/v) PEG-8000, 0.1M CHES pH 9.5, 0.2M NaCl",293,"10.1016/j.bbrc.2017.04.061",,"5XE1",92.54,"3.2","3.2","Crystal structure of the indoleamine 2,3-dioxygenagse 1 (IDO1) complexed with INCB14943","MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","5XE1"
"5XEJ",,"X-RAY DIFFRACTION",3.72,66.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES(pH7.5), 65% Sat. AS, 2% PEG400",298,"10.1107/S2059798321000474",,"5XEJ",37.9,"2.5","2.5","Crystal Structure of Macrophage Migration Inhibitory Factor bound to MTX","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","5XEJ"
"5XEK",,"SOLUTION NMR",,,,,,,,,"5XEK",5.05,,,"C-terminal zinc finger of RING finger protein 141","EEECCICMDGRADLILPCAHSFCQKCIDKWSDRHRNCPICRL","Homo sapiens","RNF141, ZNF230","RING finger protein 141","1","5XEK"
"5XF0",,"SOLUTION NMR",,,,,,,"10.1007/s13238-017-0443-1",,"5XF0",12.01,,,"Solution structure of the IgI domain of CD147","MIQLHGPPRVKAVKSSEHINEGETAMLVCKSESVPPVTDWAWYKITDSEDKALMNGSESRFFVSSSQGRSELHIENLNMEADPGQYRCNGTSSKGSDQAIITLRVRSH","Homo sapiens","BSG, UNQ6505/PRO21383","Basigin","1","5XF0"
"5XF7",,"X-RAY DIFFRACTION",2.37,48.21,"VAPOR DIFFUSION, HANGING DROP",7,"21% (w/v) PEG 3350 and 0.1 M succinic acid, pH 7.0",289,"10.1074/jbc.M117.797290",,"5XF7",66.34,"2.381","2.381","Crystal structure of human protein disulfide isomerase-like protein of the testis","MGSSHHHHHHSEDPMSPEVNAGVSSIHITKPVHILEERSLLVLTPAGLTQMLNQTRFLMVLFHNPSSKQSRNLAEELGKAVEIMGKGKNGIGFGKVDITIEKELQQEFGITKAPELKLFFEGNRSEPISCKGVVESAALVVWLRRQISQKAFLFNSSEQVAEFVISRPLVIVGFFQDLEEEVAELFYDVIKDFPELTFGVITIGNVIGRFHVTLDSVLVFKKGKIVNRQKLINDSTNKQELNRVIKQHLTDFVIEYNTENKDLISELHIMSHMLLFVSKSSESYGIIIQHYKLASKEFQNKILFILVDADEPRNGRVFKYFRVTEVDIPSVQILNLSSDARYKMPSDDITYESLKKFGRSFLSKNATKHQSSEEIPKYWDQGLVKQLVGKNFNVVVFDKEKDVFVMFYAPWSKKCKMLFPLLEELGRKYQNHSTIIIAKIDVTANDIQLMYLDRYPFFRLFPSGSQQAVLYKGEHTLKGFSDFLESHIKTKIEDEDELLSVEQNEVIEEEVLAEEKEVPMMRKGLPEQQSPELENMTKYVSKLEEPAGKKKTSEEVVVVVAKPKGPPVQKKKPKVKEEL","Homo sapiens","PDILT","Protein disulfide-isomerase-like protein of the testis","1","5XF7"
"5XFC",,"X-RAY DIFFRACTION",2.47,50.24,"BATCH MODE",7,"HEPES-NaOH, PEG4000",293,"10.1107/S2052252517008557",,"5XFC",36.13,"1.4","1.4","Serial femtosecond X-ray structure of a stem domain of human O-mannose beta-1,2-N-acetylglucosaminyltransferase solved by Se-SAD using XFEL (refined against 13,000 patterns)","GPLGSGSGPRRVLDVEVYSSRSKVYVAVDGTTVLEDEAREQGRGIHVIVLNQATGHVMAKRVFDTYSPHEDEAMVLFLNMVAPGRVLICTVKDEGSFHLKDTAKALLRSLGSQAGPALGWRDTWAFVGRKGGPVFGEKHSKSPALSSWGDPVLLKTDVPLSSAE","Homo sapiens","POMGNT1, MGAT1.2, UNQ746/PRO1475","Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1","1","5XFC"
"5XFF",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, HANGING DROP",,"0.65 M NH4H2PO4",277,"10.1039/c8cc07546h",,"5XFF",35.15,"2.7","2.7","Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550L)","GPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGAFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVILECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","5XFF"
"5XFJ",,"X-RAY DIFFRACTION",2.58,52.28,"VAPOR DIFFUSION, HANGING DROP",,"0.65M NH2H2PO4",277,"10.1039/c8cc07546h",,"5XFJ",35.17,"3.25","3.25","Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550M)","GPLLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGAFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIMECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEE","Homo sapiens","FGFR4, JTK2, TKF","Fibroblast growth factor receptor 4","1","5XFJ"
"5XFN",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-pH 8.0, 10% PEG 3350, 22% ethylene glycerol",277,"10.1038/nature23881",,"5XFN",36.22,"1.9","1.9","Structure of the N-terminal domains of PHF1","SGPRPRLWEGQDVLARWTDGLLYLGTIKKVDSAREVCLVQFEDDSQFLVLWKDISPAALPGEELLCCVCRSETVVPGNRLVSCEKCRHAYHQDCHVPRAPAPGEGEGTSWVCRQCVFAIATKRGGALKKGPYARAMLGMKLSLPYGLKGLDWDAGHLSNRQQSYCYCGGPGEWNLKMLQCRSCLQWFHEACTQCLSKPLLYGDRFYEFECCVCRGGPEKVRRLQLRWVDVAHLVLYHLSVCCKKKYFDFDREILPFTSENWDSLLLGELSDTPKGERSSRLLSALNSHKDRFISGREIKKRKCLFGLHARMPPPVE","Homo sapiens","PHF1, PCL1","PHD finger protein 1","1","5XFN"
"5XFO",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Tris-pH 8.0, 10% PEG 3350, 22% ethylene glycerol",277,"10.1038/nature23881",,"5XFO",36.22,"1.9","1.9","Structure of the N-terminal domains of PHF1","SGPRPRLWEGQDVLARWTDGLLYLGTIKKVDSAREVCLVQFEDDSQFLVLWKDISPAALPGEELLCCVCRSETVVPGNRLVSCEKCRHAYHQDCHVPRAPAPGEGEGTSWVCRQCVFAIATKRGGALKKGPYARAMLGMKLSLPYGLKGLDWDAGHLSNRQQSYCYCGGPGEWNLKMLQCRSCLQWFHEACTQCLSKPLLYGDRFYEFECCVCRGGPEKVRRLQLRWVDVAHLVLYHLSVCCKKKYFDFDREILPFTSENWDSLLLGELSDTPKGERSSRLLSALNSHKDRFISGREIKKRKCLFGLHARMPPPVE","Homo sapiens","PHF1, PCL1","PHD finger protein 1","1","5XFO"
"5XG4",,"X-RAY DIFFRACTION",2.09,41.08,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate at pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1039/c6fo01825d","QUE","5XG4",28.28,"3","3","Crystal structure of uPA in complex with quercetin","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","5XG4"
"5XG7",,"X-RAY DIFFRACTION",2.1,41.32,"EVAPORATION",,"PEG",298,"10.1038/s41598-018-19465-0",,"5XG7",16.42,"1.55","1.55","Galectin-13/Placental Protein 13 crystal structure","GSHMSSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFRFRVHFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","5XG7"
"5XG8",,"X-RAY DIFFRACTION",2.12,41.93,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1038/s41598-018-19465-0",,"5XG8",16.08,"1.55","1.55","Galectin-13/Placental Protein 13 variant R53H crystal structure","SSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFHFRVHFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","5XG8"
"5XGC",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3,350, MgCl2, HEPES",283,"10.1074/jbc.M117.792556",,"5XGC",55.03,"2.1","2.1","Crystal structure of SmgGDS-558","GPLGSQSSCKAKVANIIAEVAKNEFMRIPCVDAGLISPLVQLLNSKDQEVLLQTGRALGNICYDSHSLQAQLINMGVIPTLVKLLGIHCQNAALTEMCLVAFGNLAELESSKEQFASTNIAEELVKLFKKQIEHDKREMIFEVLAPLAENDAIKLQLVEAGLVECLLEIVQQKVDSDKEDDITELKTGSDLMVLLLLGDESMQKLFEGGKGSVFQRVLSWIPSNNHQLQLAGALAIANFARNDANCIHMVDNGIVEKLMDLLDRHVEDGNVTVQHAALSALRNLAIPVINKAKMLSAGVTEAVLKFLKSEMPPVQFKLLGTLRMLIDAQAEAAEQLGKNVKLVERLVEWCEAKDHAGVMGESNRLLSALIRHSKSKDVIKTIVQSGGIKHLVTMATSEHVIMQNEALVALALIAALELGTAEKDLESAKLVQILHRLLADERSAPEIKYNSMVLICALMGSECLHKEVQDLAFLDVVSKLRSHENKSVAQQASLTEQRLTVES","Homo sapiens","RAP1GDS1, SMGGDS","Rap1 GTPase-GDP dissociation stimulator 1","1","5XGC"
"5XGM",,"X-RAY DIFFRACTION",3.47,64.51,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.1M NaCl,0.05M Glycine pH 9.5, 39% PEG 300",293,"10.1016/j.bbrc.2017.04.138",,"5XGM",38.03,"2.952","2.952","Crystal structure of EGFR 696-1022 T790M in complex with Go6976","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5XGM"
"5XGN",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M NaCl, 0.1M Hepes pH7.5, 22% PEG 4000",293,"10.1016/j.bbrc.2017.04.138",,"5XGN",75.72,"3","3","Crystal structure of EGFR 696-1022 T790M/C797S in complex with Go6976","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5XGN"
"5XGS",,"X-RAY DIFFRACTION",2.3,46.61,"VAPOR DIFFUSION, HANGING DROP",7,"HEPES, PEG 20000",293,"10.1002/pro.3210",,"5XGS",91.84,"2","2","Crystal structure of human WBSCR16","SRSRREAAEAEAEVPVVQYVGERAARADRVFVWGFSFSGALGVPSFVVPSSGPGPRAGARPRRRIQPVPYRLELDQKISSAACGYGFTLLSSKTADVTKVWGMGLNKDSQLGFHGGGYEYVLEPSPVSLPLDRPQETRVLQVSCGRAHSLVLTDREGVFSMGNNSYGQCGRKVVENEIYSESHRVHRMQDFDGQVVQVACGQDHSLFLTDKGEVYSCGWGADGQTGLGHYNITSSPTKLGGDLAGVNVIQVATYGDCCLAVSADGGLFGWGNSEYLQLASVTDSTQVNVPRCLHFSGVGKVRQAACGGTGCAVLNGEGHVFVWGYGILGKGPNLVESAVPEMIPPTLFGLTEFNPEIQVSRIRCGLSHFAALTNKGELFVWGKNIRGCLGIGRLEDQYFPWRVTMPGEPVDVACGVDHMVTLAKSFI","Homo sapiens","RCC1L, WBSCR16","RCC1-like G exchanging factor-like protein","1","5XGS"
"5XHE",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"22% PEG 2000, 5mM b-ME, 10% Glycerol, 50mM Tris-Cl",293,"10.1080/07391102.2017.1353441",,"5XHE",13.88,"1.4","1.4","Crystal structure analysis of the second bromodomain of BRD2 covalently linked to b-mercaptoethanol","HMQDPEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","5XHE"
"5XHK",,"X-RAY DIFFRACTION",2.24,45.07,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG MME 2000, 10% Glycerol, Tris-Cl",293,"10.1080/07391102.2017.1353441",,"5XHK",13.85,"1.28","1.28","Crystal structure of the BRD2-BD2 in complex with phenanthridinone","AAHGSNPEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","5XHK"
"5XHS",,"X-RAY DIFFRACTION",2.3,46.42,"VAPOR DIFFUSION, HANGING DROP",5.5,"23% PEG 3350, 0.1 M Bis-Tris pH 5.5, 0.2M NaCl",293,,,"5XHS",32.11,"2.19","2.19","Crystal structure of SIRT5 complexed with a fluorogenic small-molecule substrate SuBKA","MGHHHHHHSGENLYFQGASARPSSSMADFRKFFAKAKHIVIISGAGVSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRAIAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPICPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELAHCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEALA","Homo sapiens","SIRT5, SIR2L5","NAD-dependent protein deacylase sirtuin-5, mitochondrial","1","5XHS"
"5XHT",,"SOLUTION NMR",,,,,,,"10.1002/pro.3389",,"5XHT",6.99,,,"The PHD finger of human Kiaa1045 protein","EMCDVCEVWTAESLFPCRVCTRVFHDGCLRRMGYIQGDSAAEVTEMAHTETGWSCHYCDN","Homo sapiens","PHF24, KIAA1045","PHD finger protein 24","1","5XHT"
"5XHY",,"X-RAY DIFFRACTION",2.12,42.12,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG3350, 0.2M NaNO3, 0.1M HEPES, 10% EtGhly, PH 6.5",277,,,"5XHY",15.15,"1.976","1.976","BRD4 bound with compound Bdi1","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5XHY"
"5XI1",,"SOLUTION NMR",,,,,,,"10.1021/acschembio.7b00699",,"5XI1",6.41,,,"Structural Insight of Flavonoids binding to CAG repeat RNA that causes Huntington's Disease (HD) and Spinocerebellar Ataxia (SCAs)","CCGCAGCGG","Homo sapiens",,"RNA (5'-R(P*CP*CP*GP*CP*AP*GP*CP*GP*G)-3')","1","5XI1"
"5XI2",,"X-RAY DIFFRACTION",2.18,43.57,"VAPOR DIFFUSION, HANGING DROP",,"1.5M NAFORMATE, 5% GLYCEROL",293,,"8F9","5XI2",15.1,"1.909","1.909","BRD4 bound with compound Bdi2","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5XI2"
"5XI3",,"X-RAY DIFFRACTION",2.06,40.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.5M NAFORMATE, 5% GLYCEROL",293,,"8F6","5XI3",15.09,"1.674","1.674","BRD4 bound with compound Bdi3","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5XI3"
"5XI4",,"X-RAY DIFFRACTION",2.2,43.99,"VAPOR DIFFUSION, HANGING DROP",,"2.3 M NAFORMATE, 10% GLYCEROL",293,,"8F0","5XI4",15.1,"1.486","1.486","BRD4 bound with compound Bdi4","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5XI4"
"5XI9",,"SOLUTION NMR",,,,,,,"10.3390/molecules23030528",,"5XI9",20.32,,,"Solution structure for human HSP70 substrate binding domain","HMGDKSENVQDLLLLDVAPLSLGLETAGGVMTALIKRNSTIPTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDIDANGILNVTATDKSTGKANKITITNDKGRLSKEEIERMVQEAEKYKAEDEVQRERVSAKNALESYAFNMKSAVEDEGLKGKISE","Homo sapiens","HSPA1A, HSP72, HSPA1, HSX70","Heat shock 70 kDa protein 1A","1","5XI9"
"5XIR",,"SOLUTION NMR",,,,,,,"10.3390/molecules23030528",,"5XIR",20.37,,,"Solution structure for human HSP70 substrate binding domain L542Y mutant","HMGDKSENVQDLLLLDVAPLSLGLETAGGVMTALIKRNSTIPTKQTQIFTTYSDNQPGVLIQVYEGERAMTKDNNLLGRFELSGIPPAPRGVPQIEVTFDIDANGILNVTATDKSTGKANKITITNDKGRLSKEEIERMVQEAEKYKAEDEVQRERVSAKNAYESYAFNMKSAVEDEGLKGKISE","Homo sapiens","HSPA1A, HSP72, HSPA1, HSX70","Heat shock 70 kDa protein 1A","1","5XIR"
"5XIX",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION, HANGING DROP",,"glycerol, potassium phosphate, PEG 8000",295,"10.1016/j.ijbiomac.2018.08.171",,"5XIX",218.52,"2.25","2.25","The canonical domain of human asparaginyl-tRNA synthetase","MGSSHHHHHHSSGLVPRGSHMAKKITIKNDPSLPEPKCVKIGALEGYRGQRVKVFGWVHRLRRQGKNLMFLVLRDGTGYLQCVLADELCQCYNGVLLSTESSVAVYGMLNLTPKGKQAPGGHELSCDFWELIGLAPAGGADNLINEESDVDVQLNNRHMMIRGENMSKILKARSMVTRCFRDHFFDRGYYEVTPPTLVQTQVEGGATLFKLDYFGEEAFLTQSSQLYLETCLPALGDVFCIAQSYRAEQSRTRRHLAEYTHVEAECPFLTFDDLLNRLEDLVCDVVDRILKSPAGSIVHELNPNFQPPKRPFKRMNYSDAIVWLKEHDVKKEDGTFYEFGEDIPEAPERLMTDTINEPILLCRFPVEIKSFYMQRCPEDSRLTESVDVLMPNVGEIVGGSMRIFDSEEILAGYKREGIDPTPYYWYTDQRKYGTCPHGGYGLGLERFLTWILNRYHIRDVCLYPRFVQRCTP","Homo sapiens","NARS, NARS1, NRS","Asparagine--tRNA ligase, cytoplasmic","1","5XIX"
"5XJV",,"X-RAY DIFFRACTION",2.03,39.27,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM Tris-HCl (pH 8.5), 20% ethanol",291,"10.1016/j.phrs.2017.10.006",,"5XJV",40.72,"1.69","1.69","Two intermediate states of conformation switch in dual specificity phosphatase 13a","MAETSLPELGGEDKATPAPSILELEELLRAGKSSASRVDEVWPNLFIGDAATANNRFELWKLGITHVLNAAHKGLYAQGGPDFYGSSVSYLGVPAHDLPDFDISAYFSSAADFIHRALNTPGAKVLVHSVVGVSRSATLVLAYLMLHQRLSLRQAVITVRQHRWVFPNRGFLHQLARLDQQLRGA","Homo sapiens","DUSP13, BEDP, DUSP13A, MDSP","Dual specificity protein phosphatase 13 isoform A","1","5XJV"
"5XJY","4.1","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2017.05.020",,"5XJY",261.95,"4.1",,"Cryo-EM structure of human ABCA1","MADYKDDDDKSGPDEVDASGRMACWPQLRLLLWKNLTFRRRQTCQLLLEVAWPLFIFLILISVRLSYPPYEQHECHFPNKAMPSAGTLPWVQGIICNANNPCFRYPTPGEAPGVVGNFNKSIVARLFSDARRLLLYSQKDTSMKDMRKVLRTLQQIKKSSSNLKLQDFLVDNETFSGFLYHNLSLPKSTVDKMLRADVILHKVFLQGYQLHLTSLCNGSKSEEMIQLGDQEVSELCGLPREKLAAAERVLRSNMDILKPILRTLNSTSPFPSKELAEATKTLLHSLGTLAQELFSMRSWSDMRQEVMFLTNVNSSSSSTQIYQAVSRIVCGHPEGGGLKIKSLNWYEDNNYKALFGGNGTEEDAETFYDNSTTPYCNDLMKNLESSPLSRIIWKALKPLLVGKILYTPDTPATRQVMAEVNKTFQELAVFHDLEGMWEELSPKIWTFMENSQEMDLVRMLLDSRDNDHFWEQQLDGLDWTAQDIVAFLAKHPEDVQSSNGSVYTWREAFNETNQAIRTISRFMECVNLNKLEPIATEVWLINKSMELLDERKFWAGIVFTGITPGSIELPHHVKYKIRMDIDNVERTNKIKDGYWDPGPRADPFEDMRYVWGGFAYLQDVVEQAIIRVLTGTEKKTGVYMQQMPYPCYVDDIFLRVMSRSMPLFMTLAWIYSVAVIIKGIVYEKEARLKETMRIMGLDNSILWFSWFISSLIPLLVSAGLLVVILKLGNLLPYSDPSVVFVFLSVFAVVTILQCFLISTLFSRANLAAACGGIIYFTLYLPYVLCVAWQDYVGFTLKIFASLLSPVAFGFGCEYFALFEEQGIGVQWDNLFESPVEEDGFNLTTSVSMMLFDTFLYGVMTWYIEAVFPGQYGIPRPWYFPCTKSYWFGEESDEKSHPGSNQKRISEICMEEEPTHLKLGVSIQNLVKVYRDGMKVAVDGLALNFYEGQITSFLGHNGAGKTTTMSILTGLFPPTSGTAYILGKDIRSEMSTIRQNLGVCPQHNVLFDMLTVEEHIWFYARLKGLSEKHVKAEMEQMALDVGLPSSKLKSKTSQLSGGMQRKLSVALAFVGGSKVVILDEPTAGVDPYSRRGIWELLLKYRQGRTIILSTHHMDEADVLGDRIAIISHGKLCCVGSSLFLKNQLGTGYYLTLVKKDVESSLSSCRNSSSTVSYLKKEDSVSQSSSDAGLGSDHESDTLTIDVSAISNLIRKHVSEARLVEDIGHELTYVLPYEAAKEGAFVELFHEIDDRLSDLGISSYGISETTLEEIFLKVAEESGVDAETSDGTLPARRNRRAFGDKQSCLRPFTEDDAADPNDSDIDPESRETDLLSGMDGKGSYQVKGWKLTQQQFVALLWKRLLIARRSRKGFFAQIVLPAVFVCIALVFSLIVPPFGKYPSLELQPWMYNEQYTFVSNDAPEDTGTLELLNALTKDPGFGTRCMEGNPIPDTPCQAGEEEWTTAPVPQTIMDLFQNGNWTMQNPSPACQCSSDKIKKMLPVCPPGAGGLPPPQRKQNTADILQDLTGRNISDYLVKTYVQIIAKSLKNKIWVNEFRYGGFSLGVSNTQALPPSQEVNDAIKQMKKHLKLAKDSSADRFLNSLGRFMTGLDTKNNVKVWFNNKGWHAISSFLNVINNAILRANLQKGENPSHYGITAFNHPLNLTKQQLSEVALMTTSVDVLVSICVIFAMSFVPASFVVFLIQERVSKAKHLQFISGVKPVIYWLSNFVWDMCNYVVPATLVIIIFICFQQKSYVSSTNLPVLALLLLLYGWSITPLMYPASFVFKIPSTAYVVLTSVNLFIGINGSVATFVLELFTDNKLNNINDILKSVFLIFPHFCLGRGLIDMVKNQAMADALERFGENRFVSPLSWDLVGRNLFAMAVEGVVFFLITVLIQYRFFIRPRPVNAKLSPLNDEDEDVRRERQRILDGGGQNDILEIKELTKIYRRKRKPAVDRICVGIPPGECFGLLGVNGAGKSSTFKMLTGDTTVTRGDAFLNKNSILSNIHEVHQNMGYCPQFDAITELLTGREHVEFFALLRGVPEKEVGKVGEWAIRKLGLVKYGEKYAGNYSGGNKRKLSTAMALIGGPPVVFLDEPTTGMDPKARRFLWNCALSVVKEGRSVVLTSHSMEECEALCTRMAIMVNGRFRCLGSVQHLKNRFGDGYTIVVRIAGSNPDLKPVQDFFGLAFPGSVLKEKHRNMLQYQLPSSLSSLARIFSILSQSKKRLHIEDYSVSQTTLDQVFVNFAKDQSDDDHLKDLSLHKNQTVVDVAVLTSFLQDEKVKESYVLEGSDEVDAVEGSHHHHHHHHHH","Homo sapiens","ABCA1, ABC1, CERP","ATP-binding cassette sub-family A member 1","1","5XJY"
"5XK4",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1705718114",,"5XK4",8.66,,,"Retracted state of S65-phosphorylated ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","5XK4"
"5XK5",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1705718114",,"5XK5",8.66,,,"Relaxed state of S65-phosphorylated ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","5XK5"
"5XKM",,"X-RAY DIFFRACTION",2.12,41.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM tris HCl, pH 7.50, 410 mM magnesium chloride hexahydrate, 29.3%w/v PEG 3350",293,"10.1021/acs.jmedchem.7b00709","87R","5XKM",244.25,"2.16","2.16","Crystal structure of human phosphodiesterase 2A in complex with 6-methyl-N-(1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide","GHASDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5XKM"
"5XM2",,"X-RAY DIFFRACTION",3.22,61.83,"VAPOR DIFFUSION, HANGING DROP",,"Buffer composition of protein solution:20mM Hepes pH7.0, 200mM NaCl,1mM DTT,1Mm EDTA,5%Glycerol; Composition of reservoir protein: 0.1 M Sodium citrate tribasic dihydrate pH 5.0, 23% v/v Jeffamine ED-2001 pH 7.0; Protein concentration 19.7 (mg /ml);",292,"10.1016/j.bbrc.2018.11.150",,"5XM2",99.24,"2.187","2.187","Human N-terminal domain of FACT complex subunit SPT16","MAVTLDKDAYYRRVKRLYSNWRKGEDEYANVDAIVVSVGVDEEIVYAKSTALQTWLFGYELTDTIMVFCDDKIIFMASKKKVEFLKQIANTKGNENANGAPAITLLIREKNESNKSSFDKMIEAIKESKNGKKIGVFSKDKFPGEFMKSWNDCLNKEGFDKIDISAVVAYTIAVKEDGELNLMKKAASITSEVFNKFFKERVMEIVDADEKVRHSKLAESVEKAIEEKKYLAGADPSTVEMCYPPIIQSGGNYNLKFSVVSDKNHMHFGAITCAMGIRFKSYCSNLVRTLMVDPSQEVQENYNFLLQLQEELLKELRHGVKICDVYNAVMDVVKKQKPELLNKITKNLGFGMGIEFREGSLVINSKNQYKLKKGMVFSINLGFSDLTNKEGKKPEEKTYALFIGDTVLVDEDGPATVLTSVKKKVKNVGIFLKNEDE","Homo sapiens","SUPT16H, FACT140, FACTP140","FACT complex subunit SPT16","1","5XM2"
"5XME",,"SOLUTION NMR",,,,,,,"10.1038/s41598-017-07348-9",,"5XME",14.43,,,"Solution structure of C-terminal domain of TRADD","MHHHHHHSSGRGSAQTFLFQGQPVVNRPLSLKDQQTFARSVGLKWRKVGRSLQRGCRALRDPALDSLAYEYEREGLYEQAFQLLRRFVQAEGRRATLQRLVEALEENELTSLAEDLLGLTDPNGGLA","Homo sapiens","TRADD","Tumor necrosis factor receptor type 1-associated DEATH domain protein","1","5XME"
"5XMH",,"X-RAY DIFFRACTION",2.92,57.81,"VAPOR DIFFUSION, SITTING DROP",8.5,"Tris-HCl, sodium acetate, PEG 4000",293,"10.1074/jbc.M117.814475",,"5XMH",144.7,"2.8","2.8","Crystal structure of an IgM rheumatoid factor YES8c in complex with IgG1 Fc","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","5XMH"
,,,,,,,,,,,,,,,,"MEIVLTQSPGTLSLSPGERATLSCRASQSISSSYLAWYQQRPGQAPRLLIYGASTRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"YES8c light chain","2","5XMH"
,,,,,,,,,,,,,,,,"MQVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYPISWVRQAPGQGLEWVGGIIPLFGTANYAQRFQGRVTITADESTRTAYMEVSTLRSEDTAVYYCARGIASAGTPDYFFYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"YES8c heavy chain","3","5XMH"
"5XMX",,"X-RAY DIFFRACTION",2.36,47.85,"VAPOR DIFFUSION, HANGING DROP",8,"40mM Bis-Tris-propane (pH 8.0), 20% (w/v) polyethylene glycol (PEG) 8000, 200mM KCl, 6% propanol, 1mM CaCl2, 5% n-Octyl-b-D-thioglucoside",298,"10.1016/j.bmcl.2017.10.037","89L","5XMX",63.73,"2","2","Co-crystal structure of Inhibitor compound in complex with human PPARdelta LBD","GSHMQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5XMX"
"5XNG",,"SOLUTION NMR",,,,,,,"10.1021/acsami.7b13714",,"5XNG",2.18,,,"EFK17A structure in Microgel MAA60","EFKRIVQRIKDFLRNLV","Homo sapiens","CAMP, CAP18, FALL39, HSD26","Cathelicidin antimicrobial peptide","1","5XNG"
"5XNQ",,"X-RAY DIFFRACTION",3.79,67.53,"VAPOR DIFFUSION, SITTING DROP",4.5,"2% PEG 3000, 0.1 M sodium acetate, 0.2 M lithium sulfate",293,"10.1038/s41467-017-02414-2",,"5XNQ",42.24,"2.802","2.802","Crystal structures of human SALM5","PGDPQICPKRCVCQILSPNLATLCAKKGLLFVPPNIDRRTVELRLADNFVTNIKRKDFANMTSLVDLTLSRNTISFITPHAFADLRNLRALHLNSNRLTKITNDMFSGLSNLHHLILNNNQLTLISSTAFDDVFALEELDLSYNNLETIPWDAVEKMVSLHTLSLDHNMIDNIPKGTFSHLHKMTRLDVTSNKLQKLPPDPLFQRAQVLATSGIISPSTFALSFGGNPLHCNCELLWLRRLSREDDLETCASPPLLTGRYFWSIPEEEFLCEPPLITRHTHEMRVLEGQRATLRCKARGDPEPAIHWISPEGKLISNATRSLVYDNGTLDILITTVKDTGAFTCIASNPAGEATQIVDLHIIAAAHHHHHH","Homo sapiens","LRFN5, C14orf146, SALM5","Leucine-rich repeat and fibronectin type-III domain-containing protein 5","1","5XNQ"
"5XP1",,"X-RAY DIFFRACTION",4.22,70.61,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M BIS-TRIS pH 6.0, 18% POLYETHYLENE GLYCOL 3350, 0.12M AMMONIUM SULFATE",293.15,"10.1111/febs.14181",,"5XP1",95.57,"2.88","2.88","Structure of monomeric mutant of REI immunoglobulin light chain variable domain crystallized at pH 6","ADIQMTQSPSSLSASVGDRVTITCQASQDIIKYLNWYQQTPGKAPKLLIYEASNLQAGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQYQSLPKTFGQGTKLQITR","Homo sapiens","IGKV1D-33","Immunoglobulin kappa variable 1D-33","1","5XP1"
"5XPI",,"X-RAY DIFFRACTION",3.17,64.93,"VAPOR DIFFUSION, SITTING DROP",5.2,"2.7 M Na formate and 0.1 M Na acetate pH 5.2",293,"10.1177/2472555218766278","8C3","5XPI",18.83,"2.2","2.2","Structure of UHRF1 TTD in complex with NV01","WDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERP","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","5XPI"
"5XQD",,"X-RAY DIFFRACTION",2.84,56.65,"VAPOR DIFFUSION, HANGING DROP",,"20%(w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate, pH 6.5,",277,,"8CF","5XQD",26.05,"1.6","1.6","Crystal structure of Human Hsp90 with FS2","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5XQD"
"5XQE",,"X-RAY DIFFRACTION",2.93,58.03,"VAPOR DIFFUSION, HANGING DROP",,"25%(w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate",277,,"8CO","5XQE",26.06,"1.699","1.699","Crystal structure of Human Hsp90 with FS3","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5XQE"
"5XQH",,"X-RAY DIFFRACTION",2.66,53.77,"VAPOR DIFFUSION, HANGING DROP",,"11% PEG 4000, 100mM MES pH 6.5, 5mM DTT",277.15,"10.1038/s41598-017-04120-x",,"5XQH",30.33,"2.04","2.04","Crystal structure of truncated human Rogdi","SGERAVLEEEFRWLLHDEVHAVLKQLQDILKEASLRFTLPGSGTEGPAKQENFILGSCGTDQVKGVLTLQGDALSQADVNLKMPRNNQLLHFAFREDKQWKLQQIQDARNHVSQAIYLLTSRDQSYQFKTGAEVLKLMDAVMLQLTRARNRLTTPATLTLPEIAASGLTRMFAPALPSDLLVNVYINLNKLCLTVYQLHALQPNSTKNFRPAGGAVLHSPGAMFEWGSQRLEVSHVHKVECVIPWLNDALVYFTVSLQLCQQLKDKIS","Homo sapiens","ROGDI","Protein rogdi homolog","1","5XQH"
"5XQI",,"X-RAY DIFFRACTION",4.71,73.88,"VAPOR DIFFUSION, HANGING DROP",,"2M sodium chloride, 130mM magnesium chloride, 100mM TRIS pH 7.0",277.15,"10.1038/s41598-017-04120-x",,"5XQI",129.74,"2.8","2.8","Crystal structure of full-length human Rogdi","SGMATVMAATAAERAVLEEEFRWLLHDEVHAVLKQLQDILKEASLRFTLPGSGTEGPAKQENFILGSCGTDQVKGVLTLQGDALSQADVNLKMPRNNQLLHFAFREDKQWKLQQIQDARNHVSQAIYLLTSRDQSYQFKTGAEVLKLMDAVMLQLTRARNRLTTPATLTLPEIAASGLTRMFAPALPSDLLVNVYINLNKLCLTVYQLHALQPNSTKNFRPAGGAVLHSPGAMFEWGSQRLEVSHVHKVECVIPWLNDALVYFTVSLQLCQQLKDKISVFSSYWSYRPF","Homo sapiens","ROGDI","Protein rogdi homolog","1","5XQI"
"5XQY",,"X-RAY DIFFRACTION",4.05,69.4,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl pH 8.0, 2.0M AMMONIUM PHOSPHATE MONOBASIC",277.15,"10.1111/febs.14181",,"5XQY",95.57,"2.9","2.9","Structure of monomeric mutant of REI immunoglobulin light chain variable domain crystallized at pH 8","ADIQMTQSPSSLSASVGDRVTITCQASQDIIKYLNWYQQTPGKAPKLLIYEASNLQAGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQYQSLPKTFGQGTKLQITR","Homo sapiens","IGKV1D-33","Immunoglobulin kappa variable 1D-33","1","5XQY"
"5XR5",,"X-RAY DIFFRACTION",2.89,57.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"15~20% PEG 3350, 5mM magnesium chloride, 500mM ammonium phosphate, 100mM Bis-Tris pH 6.5",277,,"8CR","5XR5",26.07,"1.6","1.6","Crystal structure of Human Hsp90 with FS4","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5XR5"
"5XR9",,"X-RAY DIFFRACTION",2.91,57.68,"VAPOR DIFFUSION, HANGING DROP",,"20-25%(w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate, pH 6.5",277,,"8CU","5XR9",26.08,"1.501","1.501","Crystal structure of Human Hsp90 with FS6","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5XR9"
"5XRB",,"X-RAY DIFFRACTION",2.93,58.01,"VAPOR DIFFUSION, HANGING DROP",,,,,"8DU","5XRB",26.06,"1.65","1.65","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ5","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5XRB"
"5XRD",,"X-RAY DIFFRACTION",2.84,56.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"15~20% PEG 3350, 5mM magnesium chloride, 500mM ammonium phosphate, 100mM Bis-Tris pH 6.5",277,,,"5XRD",26.04,"1.3","1.3","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FS7","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5XRD"
"5XRE",,"X-RAY DIFFRACTION",2.89,57.37,"VAPOR DIFFUSION, HANGING DROP",6.5,"20%-25%(w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate, pH 6.5",277,,,"5XRE",26.14,"1.497","1.497","Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor JX1","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5XRE"
"5XRG",,"X-RAY DIFFRACTION",2.72,54.86,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRG",16.85,"1.55","1.55","Galectin-10/Charcot-Leyden crystal protein crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRG"
"5XRH",,"X-RAY DIFFRACTION",2.71,54.63,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRH",16.75,"1.55","1.55","Galectin-10/Charcot-Leyden crystal protein crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRH"
"5XRI",,"X-RAY DIFFRACTION",2.81,56.23,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRI",16.81,"1.68","1.68","Galectin-10/Charcot-Leyden crystal protein-C29A crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLAAFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRI"
"5XRJ",,"X-RAY DIFFRACTION",2.77,55.58,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRJ",16.69,"1.9","1.9","Galectin-10/Charcot-Leyden crystal protein variant H53A crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFAFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRJ"
"5XRK",,"X-RAY DIFFRACTION",2.75,55.27,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRK",16.81,"1.7","1.7","Galectin-10/Charcot-Leyden crystal protein variant C57A crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVAFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRK"
"5XRL",,"X-RAY DIFFRACTION",2.79,55.87,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRL",16.8,"2.004","2.004","Galectin-10/Charcot-Leyden crystal protein variant N65A crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMASREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRL"
"5XRM",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRM",16.73,"1.998","1.998","Galectin-10/Charcot-Leyden crystal protein variant W72A crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAAKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRM"
"5XRN",,"X-RAY DIFFRACTION",2.75,55.34,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRN",16.79,"1.6","1.6","Galectin-10/Charcot-Leyden crystal protein variant K73A crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWAQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRN"
"5XRO",,"X-RAY DIFFRACTION",2.75,55.26,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRO",16.79,"1.6","1.6","Galectin-10/Charcot-Leyden crystal protein variant Q74A crystal structure","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKAQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRO"
"5XRP",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris",298,"10.1093/glycob/cwx107",,"5XRP",16.79,"2.001","2.001","Galectin-10/Charcot-Leyden crystal protein variant Q75A","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQAVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5XRP"
"5XRR",,"X-RAY DIFFRACTION",1.54,20.21,"VAPOR DIFFUSION, HANGING DROP",8,"2.5 M NaCl, 0.1 M imidazole pH 8.0, 0.2 M zinc acetate",289,"10.1038/s41594-018-0050-8",,"5XRR",0.73,"1.503","1.503","Crystal structure of FUS (54-59) SYSSYG","SYSSYG","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","5XRR"
"5XRX",,"SOLUTION NMR",,,,,,,"10.1021/acsami.7b13714",,"5XRX",2.18,,,"EFK17DA structure in Microgel MAA60","EFKRIVQRIKDFLRNLV","Homo sapiens","CAMP, CAP18, FALL39, HSD26","Cathelicidin antimicrobial peptide","1","5XRX"
"5XS3",,"X-RAY DIFFRACTION",2.36,47.88,"VAPOR DIFFUSION, SITTING DROP",,"1.2M Ammonium chloride, 0.1M MES pH 6.0, 20%(w/v) PEG 6000",277.15,"10.1016/j.jid.2017.05.036",,"5XS3",44.51,"2.5","2.5","Crystal structure of HLA Class I antigen","MQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSGDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRD","Homo sapiens",,"Light Chain","2","5XS3"
,,,,,,,,,,,,,,,,"VRSRRCLRL","Homo sapiens",,"P","3","5XS3"
,,,,,,,,,,,,,,,,"SHSMRYFDTAVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQADRVNLRKLRGYYNQSEDGSHTLQWMYGCDLGPDGRLLRGYDQSAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQWRAYLEGTCVEWLRRYLENGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPARITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRW","Homo sapiens",,"Heavy Chain","1","5XS3"
"5XSG","0.73","ELECTRON CRYSTALLOGRAPHY",,,,,,,"10.1038/s41594-018-0050-8",,"5XSG",0.66,"0.73, 0.73","0.73","Ultrahigh resolution structure of FUS (37-42) SYSGYS determined by MicroED","SYSGYS","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","5XSG"
"5XSR",,"X-RAY DIFFRACTION",3.64,66.19,"VAPOR DIFFUSION, HANGING DROP",,"80mM NaCl, 1.9M (NH4)2SO4",293,"10.1016/j.ejmech.2018.01.018","8EC","5XSR",40.09,"2.3","2.3","novel orally efficacious inhibitors complexed with PARP1","GPLGSKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5XSR"
"5XST",,"X-RAY DIFFRACTION",3.63,66.09,"VAPOR DIFFUSION, HANGING DROP",,"80mM NaCl, 1.9M (NH4)2SO4",283,"10.1016/j.ejmech.2018.01.018","8E6","5XST",39.57,"2.3","2.3","novel orally efficacious inhibitors complexed with PARP1","SKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFK","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5XST"
"5XSU",,"X-RAY DIFFRACTION",2.5,50.86,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 7.5, 1% PEG400, 2.1M (NH4)2SO4",293,"10.1016/j.ejmech.2018.01.018","8E3","5XSU",161.06,"2.4","2.4","novel orally efficacious inhibitors complexed with PARP1","GPLGSKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKT","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","5XSU"
"5XTS",,"X-RAY DIFFRACTION",2.68,54.13,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) polyethylene glycol 20,000, 0.1M imidazole (pH 7.0)",291.15,"10.1016/j.str.2017.11.006",,"5XTS",70.58,"2","2","Crystal structure of the CysR-CTLD3 fragment of human MR at basic/neutral pH","TRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSKTDWVAITLYACDSKSEFQKWECKNDTLLGIKGEDLFFNYGNRQEKNIMLYKGSGLWSRWKIYGTTDNLCSRGYEAMYTLLGNANGATCAFPFKFENKWYADCTSAGRSDGWLWCGTTTDYDTDKLFGYCPLKFEGSESLWNKDPLTSVSYQINSKSALTWHQARKSCQQQNAELLSITEIHEQTYLTGLTSSLTSGLWIGLNSLSFNSGWQWSDRSPFRYLNWLPGSPSAEPGKSCVSLNPGKNAKWENLECVQKLGYICKKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKIHRDEKKIQRDALTTCRKEGGDLTSIHTIEELDFIISQLGYEPNDELWIGLNDIKIQMYFEWSDGTPVTFTKWLRGEPSHENNRQEDCVVMKGKDGYWADRGCEWPLGYICKMKSRSQGPEIVEVEKGCRKGWKKHHFYCYMIGHTLSTFAEANQTCNNENAYLTTIEDRYEQAFLTSFVGLRPEKYFWTGLSDIQTKGTFQWTIEEEVRFTHWNSDMPGRKPGCVAMRTGIAGGLWDVLKCDEKAKFVCKHWAHHHHHH","Homo sapiens","MRC1, CLEC13D, CLEC13DL, MRC1L1","Macrophage mannose receptor 1","1","5XTS"
"5XTW",,"X-RAY DIFFRACTION",2.72,54.82,"VAPOR DIFFUSION, HANGING DROP",6,"6% (v/v) tacsimate (pH 6.0), 0.1M MES monohydrate (pH 6.0), 25% (w/v) polyethylene glycol 4,000",291.15,"10.1016/j.str.2017.11.006",,"5XTW",437.11,"3.2","3.2","Crystal structure of the CysR-CTLD2 fragment of human MR at acidic pH","TRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSKTDWVAITLYACDSKSEFQKWECKNDTLLGIKGEDLFFNYGNRQEKNIMLYKGSGLWSRWKIYGTTDNLCSRGYEAMYTLLGNANGATCAFPFKFENKWYADCTSAGRSDGWLWCGTTTDYDTDKLFGYCPLKFEGSESLWNKDPLTSVSYQINSKSALTWHQARKSCQQQNAELLSITEIHEQTYLTGLTSSLTSGLWIGLNSLSFNSGWQWSDRSPFRYLNWLPGSPSAEPGKSCVSLNPGKNAKWENLECVQKLGYICKKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKIHRDEKKIQRDALTTCRKEGGDLTSIHTIEELDFIISQLGYEPNDELWIGLNDIKIQMYFEWSDGTPVTFTKWLRGEPSHENNRQEDCVVMKGKDGYWADRGCEWPLGYICKMKSHHHHHH","Homo sapiens","MRC1, CLEC13D, CLEC13DL, MRC1L1","Macrophage mannose receptor 1","1","5XTW"
"5XUI",,"X-RAY DIFFRACTION",2.14,42.48,"VAPOR DIFFUSION, SITTING DROP",,"50mM Bis-tris propane pH6.0, 50mM Magnesium sulfate, 15% PEG 3350, VAPOR DIFFUSION, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.1248/cpb.c17-00836",,"5XUI",79.69,"2.77","2.77","Crystal structure of PDE10A in complex with 2-methyl-5-[2-([1,2,4]triazolo[1,5-a]pyrimidin-2-yl)et hyl]pyrazolo[1,5-a]pyrimidin-7-ol","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5XUI"
"5XUJ",,"X-RAY DIFFRACTION",2.21,39.57,"VAPOR DIFFUSION, SITTING DROP",,"50mM Bis-tris propane pH6.0, 50mM Magnesium sulfate, 15% PEG 3350, VAPOR DIFFUSION, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.1248/cpb.c17-00836",,"5XUJ",79.64,"2.44","2.44","Crystal structure of PDE10A in complex with 7-(4-chlorophenyl)-2-methylpyrazolo[1,5-a]pyrimidine","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5XUJ"
"5XV7",,"X-RAY DIFFRACTION",2.95,58.37,"VAPOR DIFFUSION, HANGING DROP",,"11% PEG 4000
100mM sodium citrate (pH 5.6) 
200mM ammonium acetate",289,"10.1016/j.chembiol.2018.01.013","EMH","5XV7",43.16,"2.32","2.32","SRPK1 in complex with Alectinib","YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIVMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS","Homo sapiens","SRPK1","serine-arginine (SR) protein kinase 1","1","5XV7"
"5XVA",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION",6.5,"0.1 M Imidazole pH 6.5, 1.0 M sodium acetate trihydrate",291,"10.1021/acs.jmedchem.7b01342","8FU","5XVA",33.67,"1.847","1.847","Crystal Structure of PAK4 in complex with inhibitor CZH216","SSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","5XVA"
"5XVF",,"X-RAY DIFFRACTION",2.96,58.47,"VAPOR DIFFUSION",7.5,"0.1 M HEPES pH 7.5, 25% PEG3350.",291,"10.1021/acs.jmedchem.7b01342","8FR","5XVF",33.04,"2.655","2.655","Crystal Structure of PAK4 in complex with inhibitor CZH062","SSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQN","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","5XVF"
"5XVG",,"X-RAY DIFFRACTION",2.05,40.08,"VAPOR DIFFUSION",7.5,"0.1 M HEPES pH 7.5, 0.5M Magnesium formate dihydrate",291,"10.1021/acs.jmedchem.7b01342","8FX","5XVG",33.93,"2.1","2.1","Crystal Structure of PAK4 in complex with inhibitor CZH226","SSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","5XVG"
"5XWM",,"X-RAY DIFFRACTION",5.09,75.84,"VAPOR DIFFUSION, SITTING DROP",,"Na malonate or Tascimate",277,"10.1038/s41467-019-08429-1",,"5XWM",178.32,"2.45","2.45","human ERp44 zinc-bound form","GSHMASEITSLDTENIDEILNNADVALVNFYADWCRFSQMLHPIFEEASDVIKEEFPNENQVVFARVDCDQHSDIAQRYRISKYPTLKLFRNGMMMKREYRGQRSVKALADYIRQQKSDPIQEIRDLAEITTLDRSKRNIIGYFEQKDSDNYRVFERVANILHDDCAFLSAFGDVSKPERYSGDNIIYKPPGHSAPDMVYLGAMTNFDVTYNWIQDKCVPLVREITFENGEELTEEGLPFLILFHMKEDTESLEIFQNEVARQLISEKGTINFLHADCDKFRHPLLHIQKTPADCPVIAIDSFRHMYVFGDFKDVLIPGKLKQFVFDLHSGKLHREFHHGPDPTDTAPGEQAQDVASSPPESSFQKLAPSEYRYTLLRDRDEL","Homo sapiens","ERP44, KIAA0573, TXNDC4, UNQ532/PRO1075","Endoplasmic reticulum resident protein 44","1","5XWM"
"5XWS",,"X-RAY DIFFRACTION",3.82,67.79,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 3350, 0.2M ammonium tartrate",293,"10.1038/s41467-017-02417-z",,"5XWS",41.81,"3.084","3.084","Crystal structure of SALM5 LRR-Ig","QICPKRCVCQILSPNLATLCAKKGLLFVPPNIDRRTVELRLADNFVTNIKRKDFANMTSLVDLTLSRNTISFITPHAFADLRNLRALHLNSNRLTKITNDMFSGLSNLHHLILNNNQLTLISSTAFDDVFALEELDLSYNNLETIPWDAVEKMVSLHTLSLDHNMIDNIPKGTFSHLHKMTRLDVTSNKLQKLPPDPLFQRAQVLATSGIISPSTFALSFGGNPLHCNCELLWLRRLSREDDLETCASPPLLTGRYFWSIPEEEFLCEPPLITRHTHEMRVLEGQRATLRCKARGDPEPAIHWISPEGKLISNATRSLVYDNGTLDILITTVKDTGAFTCIASNPAGEATQIVDLHIIKLPHHHHHH","Homo sapiens","LRFN5, C14orf146, SALM5","Leucine-rich repeat and fibronectin type-III domain-containing protein 5","1","5XWS"
"5XXD",,"X-RAY DIFFRACTION",2.25,45.33,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Magnesium acetate, 17% PEG3350",298,,,"5XXD",49.56,"2.314","2.314","Crystal structure of SmyD3 in complex with covalent inhibitor 1","PLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANI","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Smyd3 methyltransferase","1","5XXD"
"5XXG",,"X-RAY DIFFRACTION",2.25,45.21,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Magnesium acetate and 17% PEG 3350",298,,,"5XXG",49.64,"2.14","2.14","Crystal structure of SmyD3 in complex with covalent inhibitor 2","PLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANI","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","SMYD3","1","5XXG"
"5XXH",,"X-RAY DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG 3350, 0.2M MgCl2, 0.1M Tris HCl, PH 8.5",277,"10.1016/j.ejmech.2018.01.087","E0D","5XXH",16.31,"1.62","1.62","Crystal Structure Analysis of the CBP","MKKGHHHHHHLVPRGSRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","5XXH"
"5XXI",,"X-RAY DIFFRACTION",4.08,69.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% (w/v) PEG-8000 and 0.1M HEPES pH7.5",291,"10.1021/acs.biochem.7b00795",,"5XXI",54.69,"2.3","2.3","Crystal structure of CYP2C9 in complex with multiple losartan molecules","KLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPI","Homo sapiens","CYP2C9, CYP2C10","Cytochrome P450 2C9","1","5XXI"
"5XXJ",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Magnesium acetate, 17% PEG 3350",298,,,"5XXJ",49.71,"1.689","1.689","Crystal structure of SmyD3 in complex with covalent inhibitor 3","PLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANI","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","SMYD3","1","5XXJ"
"5XY1",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"23% PEG3350, 0.1M NaCl and 0.1M HEPES pH 7.5",277,,,"5XY1",32.2,"2.7","2.7","Crystal structure of Lyn kinase domain in complex with N-(1H-indazol-6-yl)-8-(piperidin-4-yloxy)-6-propylquinazolin-2-amine","GAMGSAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQP","Homo sapiens","LYN, JTK8","Tyrosine-protein kinase Lyn","1","5XY1"
"5XYL",,"SOLUTION NMR",,,,,,,,,"5XYL",18.68,,,"Solution Structure of Skp1 from Homo sapiens","MPSIKLQSSDGEIFEVDVEIAKQSVTIKTMLEDLGMDDEGDDDPVPLPNVNAAILKKVIQWCTHHKDDPPPPEDDENKEKRTDDIPVWDQEFLKVDQGTLFELILAANYLDIKGLLDVTCKTVANMIKGKTPEEIRKTFNIKNDFTEEEEAQVRKENQWCEEK","Homo sapiens","SKP1, EMC19, OCP2, SKP1A, TCEB1L","S-phase kinase-associated protein 1","1","5XYL"
"5XYX",,"X-RAY DIFFRACTION",3.12,60.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"Sodium citrate, Ammonium sulfate, HEPES",298,"10.1021/acs.jmedchem.7b01075","FTZ","5XYX",43.81,"2.61","2.61","The structure of p38 alpha in complex with a triazol inhibitor","MGSSHHHHHHSSGLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","5XYX"
"5XYY",,"X-RAY DIFFRACTION",3.02,59.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"Sodium citrate, Ammonium sulfate, HEPES",298,"10.1021/acs.jmedchem.7b01075","P0F","5XYY",43.83,"1.7","1.7","The structure of p38 alpha in complex with a triazol inhibitor","MGSSHHHHHHSSGLVPRGSHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","5XYY"
"5XYZ",,"X-RAY DIFFRACTION",2.82,56.38,"VAPOR DIFFUSION, HANGING DROP",,"0.1M LiSO4, 0.1M citric acid pH 5.5, 6% PEG 10000",298,"10.1021/acs.jmedchem.7b01075",,"5XYZ",62.59,"2.64","2.64","The structure of human BTK kinase domain in complex with a covalent inhibitor","GGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","5XYZ"
"5XZR",,"X-RAY DIFFRACTION",2.11,37.72,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Sodium formate, 0.1 M Bicine pH 8.5, 15% w/v PEG 5000MME",291,"10.1021/acs.jmedchem.7b01520",,"5XZR",64.24,"2.8","2.8","The atomic structure of SHP2 E76A mutant in complex with allosteric inhibitor 9b","MGSSHHHHHHSSGLVPRGSHMASMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAALVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQK","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","5XZR"
"5Y03",,"X-RAY DIFFRACTION",2.12,41.85,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1038/s41598-018-19465-0",,"5Y03",16.4,"2.12","2.12","Galectin-13/Placental Protein 13 variant R53H crystal structure","GSHMSSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFHFRVHFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","5Y03"
"5Y0F",,"X-RAY DIFFRACTION",1.93,36.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH6.5",293,"10.1016/j.ejmech.2018.05.007","8JO","5Y0F",17.29,"1.54","1.54","Crystal structure of human FABP4 complexed with ligand 2-fluoro-5-((4-methoxynaphthalene)-1-sulfonamido) benzoic acid","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","5Y0F"
"5Y0G",,"X-RAY DIFFRACTION",1.93,36.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6 M sodium citrate, pH 6.5",293,"10.1016/j.ejmech.2018.05.007","8JL","5Y0G",17.29,"1.542","1.542","Crystal structure of human FABP4 complexed with ligand 4-Fluoro-3-((4-methoxynaphthalene)-1-sulfonamido) benzoic acid","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","5Y0G"
"5Y0U",,"SOLUTION NMR",,,,,,,"10.1007/s13238-017-0483-6",,"5Y0U",12.38,,,"The solution structure of AEBP2 C2H2 zinc fingers","MGHHHHHHNNIAYNCCWDQCQACFNSSPDLADHIRSIHVDGQRGGVFVCLWKGCKVYNTPSTSQSWLQRHMLTHSGDKPFKCVVGGCNASFASQGGLARHVPTHFSQQN","Homo sapiens","AEBP2","Zinc finger protein AEBP2","1","5Y0U"
"5Y0X",,"X-RAY DIFFRACTION",1.97,37.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH6.5",293,"10.1016/j.ejmech.2018.05.007","8JR","5Y0X",17.29,"1.604","1.604","Crystal structure of human FABP4 complexed with ligand 2-fluoro-3-((4-methoxynaphthalene)-1-sulfonamido)benzoic acid","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","5Y0X"
"5Y0Z",,"X-RAY DIFFRACTION",2.17,43.2,"VAPOR DIFFUSION, SITTING DROP",5.5,"25%(w/v) PEG 3350, 0.1M BisTris, pH 5.5",293,"10.1098/rstb.2017.0070","8K9","5Y0Z",67.49,"2","2","Human SIRT2 in complex with a specific inhibitor, NPD11033","GSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","5Y0Z"
"5Y12",,"X-RAY DIFFRACTION",1.95,36.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH6.5",293,"10.1016/j.ejmech.2018.05.007","8JX","5Y12",17.25,"1.75","1.75","Crystal structure of human FABP4 complexed with ligand 5-((4-methoxynaphthalene)-1-sulfonamido)pentanoic acid","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","5Y12"
"5Y13",,"X-RAY DIFFRACTION",1.95,37.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M trisodium citrate, PH 6.5",293,"10.1016/j.ejmech.2018.05.007","8K0","5Y13",17.3,"1.75","1.75","Crystal structure of human FABP4 complexed with ligand 5-((4-bromonaphthalene)-1-sulfonamido)pentanoic acid","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","5Y13"
"5Y15",,"X-RAY DIFFRACTION",1.97,37.59,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM Tris-HCl pH 8.5, 300 mM NaCl, and 26% [w/v] polyethylene glycol 3350",293,"10.1371/journal.pone.0187701",,"5Y15",41.39,"2.1","2.1","Crystal structure of human DUSP28","MGSSHHHHHHSSGLVPRGSHMMGPAEAGRRGAASPVPPPLVRVAPSLFLGSARAAGAEEQLARAGVTLCVNVSRQQPGPQAPGVAELRVPVFDDPAEDLLAHLEPTCAAMEAAVRAGGACLVYSKNGRSRSAAVCTAYLMRHRGLSLAKAFQMVKSARPVAEPNPGFWSQLQKYEEALQAQSCLQGEPPALGLGPEA","Homo sapiens","DUSP28","Dual specificity phosphatase 28","1","5Y15"
"5Y16",,"X-RAY DIFFRACTION",2,38.48,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM Tris-HCl pH 8.5, 100 mM NaCl,  28% [w/v] polyethylene glycol 3350",293,"10.1371/journal.pone.0187701",,"5Y16",41.45,"2.399","2.399","Crystal structure of human DUSP28(Y102H)","MGSSHHHHHHSSGLVPRGSHMMGPAEAGRRGAASPVPPPLVRVAPSLFLGSARAAGAEEQLARAGVTLCVNVSRQQPGPQAPGVAELRVPVFDDPAEDLLAHLEPTCAAMEAAVRAGGACLVHSKNGRSRSAAVCTAYLMRHRGLSLAKAFQMVKSARPVAEPNPGFWSQLQKYEEALQAQSCLQGEPPALGLGPEA","Homo sapiens","DUSP28","Dual specificity phosphatase 28","1","5Y16"
"5Y1Y",,"X-RAY DIFFRACTION",2.05,40.04,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,"10.1039/c7ob02369c","HNQ","5Y1Y",15.07,"1.912","1.912","Complex structure of nitroxoline with the first bromodomain of BRD4","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Y1Y"
"5Y22",,"SOLUTION NMR",,,,,,,,,"5Y22",2.62,,,"NMR-Based Model of the 22 Amino Acid Peptide in Polysialyltransferase Domain (PSTD) of the Polysialyltransferase ST8Sia IV","LRLIHAVRGYWLTNKVPIKRPS","Homo sapiens","ST8SIA4, PST, PST1, SIAT8D","22AA-PSTD peptide","1","5Y22"
"5Y25",,"X-RAY DIFFRACTION",3.56,69.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"100mM HEPES pH7.5, 10% PEG 10000, 8% ethylene glycol",293,"10.1038/s41589-018-0204-3",,"5Y25",38.74,"3.102","3.102","EGFR kinase domain mutant (T790M/L858R) with covalent ligand NS-062","MHHHHHHAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5Y25"
"5Y2I",,"X-RAY DIFFRACTION",3.01,63.6,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, MES",289,,"8KX","5Y2I",60.53,"1.917","1.917","Phosphoglycerate mutase 1 (PGAM1) complexed with its inhibitor PGMI-004A","MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","5Y2I"
"5Y2K",,"X-RAY DIFFRACTION",2.72,54.73,"VAPOR DIFFUSION, SITTING DROP",9,"0.1 M Bicine pH9.0, 2% v/v 1,4-Dioxane, 10% w/v PEG20000",291,,,"5Y2K",193.58,"2.1","2.1","A human antibody AF4H1L1","QVQLVESGGGVVQPGTSLRLSCEASGFTSSAYAMHWVRQAPGKGLEWVAVITFDGGYQYYADSVKGRFTISRDISRNTLHLHMNSLRAEDTAVYYCARDPLTKLLPFDWVSGGYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK","Homo sapiens",,"a group 2 HA binding antibody AF4H1K1 Fab heavy chain","1","5Y2K"
,,,,,,,,,,,,,,,,"SYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGTGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECSHHHHHH","Homo sapiens",,"a group 2 HA binding antibody AF4H1K1 Fab light chain","2","5Y2K"
"5Y2O",,"X-RAY DIFFRACTION",2.25,41.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES NaOH pH 7.5, 17.5% PEG 8000, 10% EG",297,"10.1038/s41598-017-17082-x","8N6","5Y2O",67.11,"1.801","1.801","Structure of PPARgamma ligand binding domain-pioglitazone complex","MGSSHHHHHHSSGLVPRGSAMGSESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","5Y2O"
"5Y2R",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate
100 mM TrisHCl pH 7.8",293,"10.1107/S2052252517017626",,"5Y2R",29.49,"1","1","2.5 atm CO2-pressurized human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5Y2R"
"5Y2S",,"X-RAY DIFFRACTION",2.08,40.99,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.3 M sodium citrate
100 mM TrisHCl pH 7.8",293,"10.1107/S2052252517017626",,"5Y2S",29.53,"0.9","0.9","7.0 atm CO2-pressurized human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5Y2S"
"5Y2T",,"X-RAY DIFFRACTION",2.16,46.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES NaOH pH7.5, 17.5% PEG 8000, 10% DMSO",297,"10.1038/s41598-017-17082-x",,"5Y2T",67.71,"1.7","1.7","Structure of PPARgamma ligand binding domain - lobeglitazone complex","MGSSHHHHHHSSGLVPRGSAMGSESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","5Y2T"
"5Y2U",,"X-RAY DIFFRACTION",3.02,63.12,"VAPOR DIFFUSION, HANGING DROP",,"8% PEG3350
100mM MES 6.0",289,,"AZN","5Y2U",60.71,"1.98","1.98","X-ray structure of Phosphoglycerate Mutase 1(PGAM1) complexed with a small molecule","MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","5Y2U"
"5Y30",,"X-RAY DIFFRACTION",2.83,56.58,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 4000, 0.2 M ammonium acetate, 0.1 M tri-sodium citrate (pH 5.5)",293,"10.1038/s41467-018-03947-w",,"5Y30",23.81,"1.781","1.781","Crystal structure of LGI1 LRR domain","DAAQPARRARRTYEAYPAKPKCPAVCTCTKDNALCENARSIPRTVPPDVISLSFVRSGFTEISEGSFLFTPSLQLLLFTSNSFDVISDDAFIGLPHLEYLFIENNNIKSISRHTFRGLKSLIHLSLANNNLQTLPKDIFKGLDSLTNVDLRGNSFNCDCKLKWLVEWLGHTNATVEDIYCEGPPEYKKRKINSLSSKDFDCIIKHHHHHH","Homo sapiens","LGI1, EPT, UNQ775/PRO1569","Leucine-rich glioma-inactivated protein 1","1","5Y30"
"5Y35",,"X-RAY DIFFRACTION",3.04,63.37,"VAPOR DIFFUSION, HANGING DROP",,"MES, pH 6.0, PEG3350",289,,,"5Y35",60.47,"1.994","1.994","Phosphoglycerate mutase 1 complexed with a small molecule inhibitor KH1","MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","5Y35"
"5Y3N",,"X-RAY DIFFRACTION",2.64,53.49,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, sodium cacodylate, calcium acetate",293,"10.1021/acs.jmedchem.7b00978","8MF","5Y3N",57.8,"2.4","2.4","Structure of TRAP1 complexed with DN401","STQTAEDKEEPLHSIISSTESVQGSTSKHEFQAETKKLLDIVARSLYSEKEVFIRELISNASDALEKLRHKLVSDGQALPEMEIHLQTNAEKGTITIQDTGIGMTQEELVSNLGTIARSGSKAFLDALQNQAEASSKIIGQFGVGFYSAFMVADRVEVYSRSAAPGSLGYQWLSDGSGVFEIAEASGVRTGTKIIIHLKSDCKEFSSEARVRDVVTKYSNFVSFPLYLNGRRMNTLQAIWMMDPKDVREWQHEEFYRYVAQAHDKPRYTLHYKTDAPLNIRSIFYVPDMKPSMFDVSRELGSSVALYSRKVLIQTKATDILPKWLRFIRGVVDSEDIPLNLSRELLQESALIRKLRDVLQQRLIKFFIDQSKKDAEKYAKFFEDYGLFMREGIVTATEQEVKEDIAKLLRYESSALPSGQLTSLSEYASRMRAGTRNIYYLCAPNRHLAEHSPYYEAMKKKDTEVLFCFEQFDELTLLHLREFDKKKLISVETDIVVDHYKE","Homo sapiens","TRAP1, HSP75","Heat shock protein 75 kDa, mitochondrial","1","5Y3N"
"5Y3O",,"X-RAY DIFFRACTION",2.66,53.75,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, sodium cacodylate, calcium acetate",293,"10.1021/acs.jmedchem.7b00978","8M9","5Y3O",57.74,"2.7","2.7","Structure of TRAP1 complexed with DN320","STQTAEDKEEPLHSIISSTESVQGSTSKHEFQAETKKLLDIVARSLYSEKEVFIRELISNASDALEKLRHKLVSDGQALPEMEIHLQTNAEKGTITIQDTGIGMTQEELVSNLGTIARSGSKAFLDALQNQAEASSKIIGQFGVGFYSAFMVADRVEVYSRSAAPGSLGYQWLSDGSGVFEIAEASGVRTGTKIIIHLKSDCKEFSSEARVRDVVTKYSNFVSFPLYLNGRRMNTLQAIWMMDPKDVREWQHEEFYRYVAQAHDKPRYTLHYKTDAPLNIRSIFYVPDMKPSMFDVSRELGSSVALYSRKVLIQTKATDILPKWLRFIRGVVDSEDIPLNLSRELLQESALIRKLRDVLQQRLIKFFIDQSKKDAEKYAKFFEDYGLFMREGIVTATEQEVKEDIAKLLRYESSALPSGQLTSLSEYASRMRAGTRNIYYLCAPNRHLAEHSPYYEAMKKKDTEVLFCFEQFDELTLLHLREFDKKKLISVETDIVVDHYKE","Homo sapiens","TRAP1, HSP75","Heat shock protein 75 kDa, mitochondrial","1","5Y3O"
"5Y3S",,"X-RAY DIFFRACTION",3.09,60.25,"VAPOR DIFFUSION, HANGING DROP",6.4,"1.6M Sodium Potassium Phosphate, 100mM HEPES, pH 6.4",298,,,"5Y3S",91.37,"2.451","2.451","Crystal structure of human NLRP1 leucine rich repeat domain","GSVDVPVTDAYWQILFSVLKVTRNLKELDLSGNSLSHSAVKSLCKTLRRPRCLLETLRLAGCGLTAEDCKDLAFGLRANQTLTELDLSFNVLTDAGAKHLCQRLRQPSCKLQRLQLVSCGLTSDCCQDLASVLSASPSLKELDLQQNNLDDVGVRLLCEGLRHPACKLIRLGLDQTTLSDEMRQELRALEQEKPQLLIFSRRKPS","Homo sapiens","NLRP1, CARD7, DEFCAP, KIAA0926, NAC, NALP1","NACHT, LRR and PYD domains-containing protein 1","1","5Y3S"
"5Y3U",,"SOLUTION NMR",,,,,,,,,"5Y3U",2.62,,,"NMR-Based Model of the 22 Amino Acid Peptide in Polysialyltransferase Domain (PSTD) of the Polysialyltransferase ST8Sia IV in the Presence of Polysialic Acid (PolySia)","LRLIHAVRGYWLTNKVPIKRPS","Homo sapiens","ST8SIA4, PST, PST1, SIAT8D","PSTD-22AA-PolySia","1","5Y3U"
"5Y41",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, HANGING DROP",5.5,"PEG 3350, MES pH 5.5 and MgCl2",291,"10.1038/s41589-020-0553-6",,"5Y41",62.18,"2.05","2.05","Crystal Structure of LIGAND-BOUND NURR1-LBD","MVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSPPVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF","Homo sapiens","NR4A2, NOT, NURR1, TINUR","Nuclear receptor subfamily 4 group A member 2","1","5Y41"
"5Y45",,"X-RAY DIFFRACTION",1.65,25.33,"VAPOR DIFFUSION",7,"0.1 M HEPES pH 7.0, 30% v/v Jeffamine, M-600",293,"10.1021/acs.biochem.7b01010",,"5Y45",14.72,"1.03","1.03","Crystal structure of a collagen-like peptide with interruption sequence","GPPGPPGPPGPPALPGPPGPPGPPGPP","Homo sapiens",,"collagen-like peptide","1","5Y45"
"5Y46",,"X-RAY DIFFRACTION",1.91,35.67,"VAPOR DIFFUSION",7,"0.2 M Zinc acetate dihydrate, 20% w/v Polyethylene glycol 3350",293,"10.1021/acs.biochem.7b01010",,"5Y46",7.55,"1.03","1.03","Crystal structure of a collagen-like peptide with interruption sequence","GPPGPPGPPGPPALPGPPGPPGPPGPP","Homo sapiens",,"collagen-like peptide","1","5Y46"
"5Y4E",,"X-RAY DIFFRACTION",3.13,60.72,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES (pH 7.0), 1 M ammonium sulfate, 0.5% w/v PEG 8000",289,"10.7554/eLife.29150",,"5Y4E",62.05,"2.341","2.341","Crystal Structure of AnkB Ankyrin Repeats R8-14 in complex with autoinhibition segment AI-b","DGGEYLRPEDLKELGDDSLPSSQFLDGMNYLRYSLEGGRSLVPRGSGSRNGITPLHVASKRGNTNMVKLLLDRGGQIDAKTRDGLTPLHCAARSGHDQVVELLLERGAPLLARTKNGLSPLHMAAQGDHVECVKHLLQHKAPVDDVTLDYLTALHVAAHCGHYRVTKLLLDKRANPNARALNGFTPLHIACKKNRIKVMELLVKYGASIQAITESGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGETALHMAARAGQVEVVRCLKVVTEEVTT","Homo sapiens","ANK2","Ankyrin-2,Ankyrin-2","1","5Y4E"
,,,,,,,,,,,,,,,,,"Homo sapiens","ANK2"
"5Y4F",,"X-RAY DIFFRACTION",2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M CaCl2, 0.1 M HEPES (pH 7.5), 28% v/v PEG 400",289,"10.7554/eLife.29150",,"5Y4F",94.81,"1.953","1.953","Crystal Structure of AnkB Ankyrin Repeats R13-24 in complex with autoinhibition segment AI-c","SGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGETALHMAARAGQVEVVRCLLRNGALVDARAREEQTPLHIASRLGKTEIVQLLLQHMAHPDAATTNGYTPLHISAREGQVDVASVLLEAGAAHSLATKKGFTPLHVAAKYGSLDVAKLLLQRRAAADSAGKNGLTPLHVAAHYDNQKVALLLLEKGASPHATAKNGYTPLHIAAKKNQMQIASTLLNYGAETNIVTKQGVTPLHLASQEGHTDMVTLLLDKGANIHMSTKSGLTSLHLAAQEDKVNVADILTKHGADQDAHTKLGYTPLIVACHYGNVKMVNFLLKQGANVNAKTKNGYTPLHQAAQQGHTHIINVLLQHGAKPNATTANGNTALAIAKRLGYISVVDTLKVVTEEVTTTTTTITEKHKLNVPETMTEVLDVSDEEGDDTMTGDGGEYLRPEDLKELGDD","Homo sapiens","ANK2, ANKB","Ankyrin-2","1","5Y4F"
"5Y4M",,"X-RAY DIFFRACTION",1.89,35,"VAPOR DIFFUSION, SITTING DROP",6.2,"20% PEG8000,100 mM Na2HPO4/KH2PO4, pH 6.2, 200 mM NaCl",296,"10.1016/j.jaut.2018.09.012",,"5Y4M",17.22,"1.31","1.31","Discoidin domain of human CASPR2","APGDPCDEPLVSGLPHVAFSSSSSISGSYSPGYAKINKRGGAGGWSPSDSDHYQWLQVDFGNRKQISAIATQGRYSSSDWVTQYRMLYSDTGRNWKPYHQDGNIWAFPGNINSDGVVRHELQHPIIARYVRIVPLDWNGEGRIGLRIEVYGCAA","Homo sapiens","CNTNAP2, CASPR2, KIAA0868","human CASPR2 Disc domain","1","5Y4M"
"5Y56",,"X-RAY DIFFRACTION",2.92,57.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.5M (NH4)2SO4, 10% Glycerol, 0.1M Tris-Hcl (pH 7.5)",293,"10.1074/jbc.M116.771188",,"5Y56",50.08,"2.653","2.653","Fc mutant (K392D/K409D/D399K)","GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYDTTPPVLKSDGSFFLYSDLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSL","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","5Y56"
"5Y5E",,"X-RAY DIFFRACTION",3.44,64.24,"VAPOR DIFFUSION",,"2.2M Sodium chloride, 0.1M BIS-TRIS propane pH 7.0",277,"10.1038/s41598-017-11219-8",,"5Y5E",14.98,"1.8","1.8","Crystal structure of phospholipase A2 with inhibitor","NLVQFGVMIEKMTGKSALQYGDYGCYCGIGGSHWPVDQTDWCCHAHDCCYGRLEKLGCEPKLEKYLFSVSERGIFCAGRTTCQRLTCECDKRAALCFRRNLGTYNRKYAHYPNKLCTGPTPPC","Homo sapiens","PLA2G2E","Group IIE secretory phospholipase A2","1","5Y5E"
"5Y5N",,"X-RAY DIFFRACTION",2.65,53.56,"VAPOR DIFFUSION",,"0.1M Bis-Tris buffer pH 5.5 
15%(w/v) PEG5000 MME",289,"10.1039/c7sc02738a","8NO","5Y5N",38.23,"2.3","2.3","Crystal structure of human Sirtuin 2 in complex with a selective inhibitor","GSGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDLGETPFDDIATFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","5Y5N"
"5Y5T",,"X-RAY DIFFRACTION",2.08,40.77,"VAPOR DIFFUSION, HANGING DROP",,"10-20% PEG 3350, 100mM Tris-HCl, pH 8.5",277,"10.14348/molcells.2018.2219","8OR","5Y5T",34.64,"1.8","1.8","Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","5Y5T"
"5Y5U",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, HANGING DROP",,"10-20% PEG 3350, 100mM Tris-HCl, pH 8.5",277,"10.14348/molcells.2018.2219","8OU","5Y5U",69.22,"2.14","2.14","Crystal structures of spleen tyrosine kinase in complex with a novel inhibitor","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNLEHHHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","5Y5U"
"5Y64",,"X-RAY DIFFRACTION",2.97,58.63,"VAPOR DIFFUSION, HANGING DROP",6,"MES, PEG3350",289,,,"5Y64",60.55,"2.149","2.149","Phosphoglycerate mutase 1 H11 phosphorylated form complexed with KH1","MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","5Y64"
,,,,,,,,,,,,,,,,"MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","2","5Y64"
"5Y65",,"X-RAY DIFFRACTION",2.99,58.81,"VAPOR DIFFUSION, HANGING DROP",,"MES pH 6.0, 8%PEG3350",289,,,"5Y65",60.58,"2.554","2.554","Phosphoglycerate mutase 1 complexed with a small molecule inhibitor KH2","MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","5Y65"
,,,,,,,,,,,,,,,,"MAAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRKAMEAVAAQGKAKKLEHHHHHH","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","2","5Y65"
"5Y6K",,"X-RAY DIFFRACTION",3.84,67.95,"VAPOR DIFFUSION, SITTING DROP",6.6,"PIPES-Na 0.1M pH 6.6, disodium malonate 8mM, PEG 3350 17%, glycerol 18%",298,"10.1039/c7mt00275k",,"5Y6K",76.52,"2.86","2.86","Human serum trnasferrin bound to a fluorescent probe","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","5Y6K"
"5Y7D",,"X-RAY DIFFRACTION",2.98,58.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 4.3M NaCl",295,"10.3390/molecules24193529",,"5Y7D",18.86,"1.71","1.71","Crystal structure of human Endothelial-overexpressed LPS associated factor 1","GMKFGCLSFRQPYAGFVLNGIKTVETRWRPLLSSQRNCTIAVHIAHRDWEGDAWRELLVERLGMTPAQIQTLLRKGEKFGRGVIAGLVDIGETLQCPEDLTPDEVVELENQAVLTNLKQKYLTVISNPRWLLEPIPRKGGKDVFQVDIPEHLIPLGHEVLE","Homo sapiens","CXorf40A, CXorf40, EOLA1","Protein CXorf40A","1","5Y7D"
"5Y7H",,"X-RAY DIFFRACTION",2.68,54.16,"VAPOR DIFFUSION, HANGING DROP",,"20~28% (w/v) polyethylene glycol 4000, 0.1M HEPES or Tris pH 7.5~8.5",295,"10.1016/j.bbrc.2017.10.101",,"5Y7H",170.19,"3","3","Crystal structure of human DPP4 in complex with inhibitor3","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","5Y7H"
"5Y7J",,"X-RAY DIFFRACTION",2.87,57.16,"VAPOR DIFFUSION, HANGING DROP",,"20~28% (w/v) polyethylene glycol 4000, 0.1M HEPES or Tris pH 7.5~8.5",295,"10.1016/j.bbrc.2017.10.101",,"5Y7J",339.46,"2.521","2.521","Crystal structure of human DPP4 in complex with inhibitor2","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","5Y7J"
"5Y7K",,"X-RAY DIFFRACTION",2.88,57.3,"VAPOR DIFFUSION, HANGING DROP",,"20~28% (w/v) polyethylene glycol 4000, 0.1M HEPES or Tris pH 7.5~8.5",295,"10.1016/j.bbrc.2017.10.101","8VU","5Y7K",339.46,"2.512","2.512","Crystal structure of human DPP4 in complex with inhibitor1","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","5Y7K"
"5Y7L",,"SOLUTION NMR",,,,,,,"10.1038/s41598-018-23016-y",,"5Y7L",14.11,,,"Solution structure of Hbeta4 extracellular loop of BK potassium channel","QDLQATEANCTVLSVQQIGEVFECTFTCGADCRGTSQYPCVQVYVNNSESNSRALLHSDEHQLLTNPKCSYIPPCKRENQKNLESVMNWQQYWKDEIGSQPFTCYFNQHQRPDDVLLHRTHD","Homo sapiens","KCNMB4","Calcium-activated potassium channel subunit beta-4","1","5Y7L"
"5Y7N",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION, HANGING DROP",9,"100mM Tris, 30-35% PEG 6000, 3-5% 1,6-Hexanediol, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"5Y7N",37.11,"2.5","2.5","Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diol","MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQNEHEVGEAIQEKIQEKAVKREDLFIVSKLWPTFFERPLVRKAFEKTLKDLKLSYLDVYLIHWPQGFKSGDDLFPKDDKGNAIGGKATFLDAWEAMEELVDEGLVKALGVSNFSHFQIEKLLNKPGLKYKPVTNQVECHPYLTQEKLIQYCHSKGITVTAYSPLGSPDRPWAKPEDPSLLEDPKIKEIAAKHKKTAAQVLIRFHIQRNVIVIPKSVTPARIVENIQVFDFKLSDEEMATILSFNRNWRACNVLQSSHLEDYPFNAEY","Homo sapiens","AKR1B10, AKR1B11","Aldo-keto reductase family 1 member B10","1","5Y7N"
"5Y7X",,"X-RAY DIFFRACTION",2.67,59.16,"VAPOR DIFFUSION, HANGING DROP",,"10% PEG 8000, 40mM Bis-Tris propane pH 8.5, 2.5% 1,2-propanediol, 200mM KCl, 10mM DTT",291,,,"5Y7X",68.35,"1.699","1.699","Human Peroxisome proliferator-activated receptor (PPAR) delta in complexed with a potent and selective agonist","MGSSHHHHHHSSGLVPRGSHMQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5Y7X"
"5Y86",,"X-RAY DIFFRACTION",1.85,33.4,"VAPOR DIFFUSION, SITTING DROP",8.2,"1M NaH2PO4 and K2HPO4 (pH8.2)",290.15,"10.1016/j.jmb.2018.04.001","HRM","5Y86",67.12,"1.9","1.9","Crystal structure of kinase","MGGTARGPGRKDAGPPGAGLPPQQRRLGDGVYDTFMMIDETKCPPCSNVLCNPSEPPPPRRLNMTTEQFTGDHTQHFLDGGEMKVEQLFQEFGNRKSNTIQSDGISDSEKCSPTVSQGKSSDCLNTVKSNSSSKAPKVVPLTPEQALKQYKHHLTAYEKLEIINYPEIYFVGPNAKKRHGVIGGPNNGGYDDADGAYIHVPRDHLAYRYEVLKIIGKGSFGQVARVYDHKLRQYVALKMVRNEKRFHRQAAEEIRILEHLKKQDKTGSMNVIHMLESFTFRNHVCMAFELLSIDLYELIKKNKFQGFSVQLVRKFAQSILQSLDALHKNKIIHCDLKPENILLKHHGRSSTKVIDFGSSCFEYQKLYTYIQSRFYRAPEIILGSRYSTPIDIWSFGCILAELLTGQPLFPGEDEGDQLACMMELLGMPPPKLLEQSKRAKYFINSKGIPRYCSVTTQADGRVVLVGGRSRRGKKRGPPGSKDWGTALKGCDDYLFIEFLKRCLHWDPSARLTPAQALRHPWISKSVPRPLTTIDKVSGKRVVNPASAFQGLGSKLPPVVGIANKLKANLMSETNGSIPLCSVLPKLIS","Homo sapiens","DYRK3","Dual specificity tyrosine-phosphorylation-regulated kinase 3","1","5Y86"
"5Y8C",,"X-RAY DIFFRACTION",1.98,37.9,"VAPOR DIFFUSION, SITTING DROP",8.2,"20% PEG3350, 0.2M NaNO3, 0.1M HEPES, 10% EtGhly,pH 8.2",277,"10.1021/acs.jmedchem.8b00103","8P9","5Y8C",17.23,"1.42","1.42","Crystal Structure Analysis of the BRD4","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Y8C"
"5Y8U",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350, sodium citrate",277,"10.1016/j.bbrc.2017.09.025",,"5Y8U",36.85,"2.92","2.92","Crystal structure of the C276S mutant of MAP2K7","TGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLSDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSGVLSQPHLPFFRHHHHHH","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","5Y8U"
"5Y8V",,"X-RAY DIFFRACTION",2.46,50.1,"EVAPORATION",6,"0.1M MES pH 6.5, 1.6M MgSO4",291,"10.1073/pnas.1717664115",,"5Y8V",66.36,"2.61","2.61","Crystal structure of GAS41","IVKPIVYGNVARYFGKKREEDGHTHQWTVYVKPYRNEDMSAYVKKIQFKLHESYGNPLRVVTKPPYEITETGWGEFEIIIKIFFIDPNERPVTLYHLLKLFQSDTNAMLGKKTVVSEFYDEMIFQDPTAMMQQLLTTSRQ","Homo sapiens","YEATS4, GAS41","YEATS domain-containing protein 4","1","5Y8V"
"5Y8W",,"X-RAY DIFFRACTION",2.22,44.67,"VAPOR DIFFUSION, SITTING DROP",8.2,"20% PEG3350, 0.2M NaNO3, 0.1M HEPES, 10% EtGhly,pH8.2",277,"10.1021/acs.jmedchem.8b00103","8PU","5Y8W",17.67,"1.76","1.76","Crystal Structure Analysis of the BRD4","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Y8W"
"5Y8Y",,"X-RAY DIFFRACTION",1.91,35.74,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG3350, 0.2M NaNO3, 0.1M HEPES, 10% EtGhly,pH7",277,"10.1021/acs.jmedchem.8b00103","8PX","5Y8Y",17.5,"1.87","1.87","Crystal Structure Analysis of the BRD4","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Y8Y"
"5Y8Z",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, SITTING DROP",7.2,"20% PEG3350, 0.2M NaNO3, 0.1M HEPES, 10% EtGhly,pH7.2",277,"10.1021/acs.jmedchem.8b00103","8Q3","5Y8Z",17.54,"1.84","1.84","Crystal Structure Analysis of the BRD4","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Y8Z"
"5Y90",,"X-RAY DIFFRACTION",2.31,46.82,"VAPOR DIFFUSION, SITTING DROP",7,"PEG3350, sodium citrate",277,"10.1016/j.bbrc.2017.09.025",,"5Y90",37.22,"1.3","1.3","MAP2K7 mutant -C218S","TGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTSAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSGVLSQPHLPFFRHHHHHH","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","5Y90"
"5Y93",,"X-RAY DIFFRACTION",1.92,35.97,"VAPOR DIFFUSION, SITTING DROP",8.3,"20% PEG3350, 0.2M NaNO3, 0.1M HEPES, 10% EtGhly,pH8.3",277,"10.1021/acs.jmedchem.8b00103","8Q9","5Y93",17.72,"1.62","1.62","Crystal Structure Analysis of the BRD4","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Y93"
"5Y94",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG3350, 0.2M NaNO3, 0.1M HEPES, 10% EtGhly,pH8.0",277,"10.1021/acs.jmedchem.8b00103","8QC","5Y94",17.43,"2","2","Crystal Structure Analysis of the BRD4","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Y94"
"5Y9K",,"X-RAY DIFFRACTION",2.13,42.13,"VAPOR DIFFUSION",7.5,"0.1 M HEPES pH 7.5, 0.2 M lithium sulfate monohydrate, 25% (w/v)polyethylene glycol 3,350",293,"10.1038/s41467-018-03620-2",,"5Y9K",47.75,"1.9","1.9","Structure of the belimumab Fab fragment","SSELTQDPAVSVALGQTVRVTCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCSSRDSSGNHWVFGGGTELTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"belimumab light chain","1","5Y9K"
,,,,,,,,,,,,,,,,"QVQLQQSGAEVKKPGSSVRVSCKASGGTFNNNAINWVRQAPGQGLEWMGGIIPMFGTAKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLLFPHHALSPWGRGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHHHHHH","Homo sapiens",,"belimumab heavy chain","2","5Y9K"
"5Y9L",,"X-RAY DIFFRACTION",2.52,51.12,"VAPOR DIFFUSION, SITTING DROP",,"PEG1000, PEG3350, 2-methyl-2,4-pentanediol, sodium nitrate, sodium hydrogen phosphate, ammonium sulfate, bicine/trizma buffer",293,"10.1016/j.bmcl.2017.10.030","8R3","5Y9L",25.02,"2.15","2.15","Human kallikrein 7 in complex with 1,3,6-trisubstituted 1,4-diazepane-7-one","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","5Y9L"
"5Y9M",,"X-RAY DIFFRACTION",2.25,45.31,"VAPOR DIFFUSION, SITTING DROP",8.5,"26% PEG 4000, 0.15 M Lithium sulfate monohydrate, 0.1 M TRIS hydrochloride (pH 8.5)",281,"10.1107/S2053230X18005204",,"5Y9M",80.95,"2.006","2.006","Crystal structure of CK2a2 form 3","GPLGSMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","5Y9M"
"5Y9T",,"X-RAY DIFFRACTION",3.33,63.02,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Hepes-Na 7.0-7.5, 1.3-1.5M potassium sodium tartrate",293,"10.1158/1535-7163.MCT-17-1033","8RC","5Y9T",38.47,"3.25","3.25","Crystal Structure of EGFR T790M mutant in complex with naquotinib","GSHMASGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5Y9T"
"5YA5",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Tris pH7.5, 15% glycerol, 12% MPD, 5% isopropanol, 15% PEG5Kmme",293,"10.1016/j.ejmech.2017.11.073","6TD","5YA5",36.4,"1.89","1.89","CRYSTAL STRUCTURE OF c-MET IN COMPLEX WITH NOVEL INHIBITOR","MGSSHHHHHHGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","5YA5"
"5YAK",,"X-RAY DIFFRACTION",2.61,52.89,"VAPOR DIFFUSION, HANGING DROP",,"0.17 M sodium acetate, 85 mM Tris-HCl (pH 8.5), 22.5 % w/v polyethylene glycol 4,000 and 15 % glycerol.",293.15,"10.1002/pro.3479","YOF","5YAK",187.16,"2.3","2.3","The crystal structure of human IYD Thr239 mutant with ligand 3-Fluorotyrosine (F-Tyr)","GEPRTRAEARPWVDEDLKDSSDLHQAEEDADEWQESEENVEHIPFSHNHYPEKEMVKRSQEFYELLNKRRSVRFISNEQVPMEVIDNVIRTAGTAPSGAHTEPWTFVVVKDPDVKHKIRKIIEEEEEINYMKRMGHRWVTDLKKLRTNWIKEYLDTAPILILIFKQVHGFAANGKKKVHYYNEISVSIACGILLAALQNAGLVTVTTAPLNCGPRLRVLLGRPAHEKLLMLLPVGYPSKEATVPDLKRKPLDQIMVTVHHHHHH","Homo sapiens","IYD, C6orf71, DEHAL1","Iodotyrosine deiodinase 1","1","5YAK"
"5YAV",,"X-RAY DIFFRACTION",3.06,59.85,"VAPOR DIFFUSION, HANGING DROP",4.6,"100Mm Sodium acetate Ph 4.6, 2.0M NaCl",277,,,"5YAV",17.66,"1.989","1.989","Fragment-based Drug Discovery of inhibitors to block PDEdelta-RAS protein-protein interaction","MSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","5YAV"
"5YAW",,"X-RAY DIFFRACTION",3.03,59.41,"VAPOR DIFFUSION, HANGING DROP",4.6,"100Mm Sodium acetate pH 4.6, 2.0M NaCl",277,,,"5YAW",17.81,"2.027","2.027","Fragment-based Drug Discovery of inhibitors to block PDEdelta-RAS protein-protein interaction","MSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","5YAW"
"5YB1",,"X-RAY DIFFRACTION",2.54,51.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG3350, MPD, DMSO",293,"10.1021/acs.molpharmaceut.8b00045",,"5YB1",136.59,"2.616","2.616","Structure and function of human serum albumin-metal agent complex","HKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAAL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","5YB1"
"5YBC",,"X-RAY DIFFRACTION",3.05,59.73,"VAPOR DIFFUSION, HANGING DROP",5.6,"20%(w/v) PEG400, 130mM NaCl, 60mM MgCl2, 100mM sodium citrate pH 5.6",277,"10.1107/S2053230X1801110X",,"5YBC",21.98,"2.5","2.5","X-ray structure of native ETS-domain domain of Ergp55","QIQLWQFLLELLSDSSNSSCITWEGTNGEFKMTDPDEVARRWGERKSKPNMNYDKLSRALRYYYDKNIMTKVHGKRYAYKFDFHGIAQALQP","Homo sapiens","ERG","Transcriptional regulator ERG","1","5YBC"
"5YBF",,"X-RAY DIFFRACTION",2.46,50.07,"VAPOR DIFFUSION, SITTING DROP",4.9,"15% PEG 3350, 0.1 M sodium acetate, 0.1 M zinc acetate",277,"10.1124/jpet.117.245050","8SR","5YBF",178.84,"1.5","1.5","Crystal structure of the GluA2o LBD in complex with glutamate and HBT1","GSNKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS","Homo sapiens","GRIA2, GLUR2","Glutamate receptor 2,Glutamate receptor 2","1","5YBF"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIA2, GLUR2"
"5YBG",,"X-RAY DIFFRACTION",2.48,50.31,"VAPOR DIFFUSION, SITTING DROP",4.9,"15% PEG 3350, 0.1 M sodium acetate, and 0.1 M zinc acetate",277,"10.1124/jpet.117.245050","8SO","5YBG",179.36,"1.52","1.52","Crystal structure of the GluA2o LBD in complex with glutamate and LY451395","GSNKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS","Homo sapiens","GRIA2, GLUR2","Glutamate receptor 2,Glutamate receptor 2","1","5YBG"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIA2, GLUR2"
"5YBJ",,"X-RAY DIFFRACTION",2.58,52.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES, pH 7.5, 0.2M Lithium sulfate monohydrate, 25% PEG 3350",291,"10.1074/jbc.M117.817494",,"5YBJ",27.59,"2.341","2.341","Structure of apo KANK1 ankyrin domain","GHMRERYELSEKMLSACNLLKNTINDPKALTSKDMRFCLNTLQHEWFRVSSQKSAIPAMVGDYIAAFEAISPDVLRYVINLADGNGNTALHYSVSHSNFEIVKLLLDADVCNVDHQNKAGYTPIMLAALAAVEAEKDMRIVEELFGCGDVNAKASQAGQTALMLAVSHGRIDMVKGLLACGADVNIQDDEGSTALMCASEHGHVEIVKLLLAQPGCNGHLEDNDGSTALSIALEAGHKDIAVLLYAHVNFAKA","Homo sapiens","KANK1, ANKRD15, KANK, KIAA0172","KN motif and ankyrin repeat domain-containing protein 1","1","5YBJ"
"5YBY",,"X-RAY DIFFRACTION",2.2,44.15,"VAPOR DIFFUSION, SITTING DROP",5.5,"ammonium sulfate, Tris-HCl",293,,,"5YBY",29.79,"1.429","1.429","Structure of human Gliomedin","ESMITSIGNPVQVLKVTETFGTWIRESANKSDDRIWVTEHFSGIMVKEFKDQPSLLNGSYTFIHLPYYFHGCGHVVYNNSLYYHKGGSNTLVRFEFGQETSQTLKLENALYFDRKYLFANSKTYFNLAVDEKGLWIIYASSVDGSSILVAQLDERTFSVVQHVNTTYPKSKAGNAFIARGILYVTDTKDMRVTFAFDLLGGKQINANFDLRTSQSVLAMLAYNMRDQHLYSWEDGHLMLYPVQFLSTTLNQ","Homo sapiens","GLDN, COLM, UNQ9339/PRO34011","Gliomedin","1","5YBY"
"5YC6",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate (pH 4.6), 2.0M ammonium sulfate supplemented with 5% PEG 400",298,,,"5YC6",28.3,"1.18","1.18","The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH4.6","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","5YC6"
"5YC7",,"X-RAY DIFFRACTION",2.17,43.22,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate (pH 4.6), 2.0M ammonium sulfate supplemented with 5% PEG 400",298,,,"5YC7",28,"2","2","The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH7.4","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","5YC7"
"5YD6",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, HANGING DROP",5.5,"PEG 3350, MES PH 5.5 AND MGCL2",291,,,"5YD6",123.69,"2.34","2.34","Crystal structure of PG-bound Nurr1-LBD","MVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSPPVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF","Homo sapiens","NR4A2, NOT, NURR1, TINUR","Nuclear receptor subfamily 4 group A member 2","1","5YD6"
"5YDE",,"X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Tris",293,"10.1038/s41598-017-15715-9",,"5YDE",12.76,"1.023","1.023","Crystal structure of a disease-related gene, hCDC73(1-111)","GMADVLSVLRQYNIQKKEIVVKGDEVIFGEFSWPKNVKTNYVVWGTGKEGQPREYYTLDSILFLLNNVHLSHPVYVRRAATENIPVVRRPDRKDLLGYLNGEASTSASIDRS","Homo sapiens","CDC73, C1orf28, HRPT2","Parafibromin","1","5YDE"
"5YDF",,"X-RAY DIFFRACTION",2.15,42.72,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Tris, magnesium chloride",293,"10.1038/s41598-017-15715-9",,"5YDF",23.3,"1.399","1.399","Crystal structure of a disease-related gene, hCDC73(1-100)","GMADVLSVLRQYNIQKKEIVVKGDEVIFGEFSWPKNVKTNYVVWGTGKEGQPREYYTLDSILFLLNNVHLSHPVYVRRAATENIPVVRRPDRKDLLGYLNG","Homo sapiens","CDC73, C1orf28, HRPT2","Parafibromin","1","5YDF"
"5YDX",,"SOLUTION NMR",,,,,,,"10.18632/oncotarget.23909",,"5YDX",6.58,,,"NMR structure of YAP1-2 WW1 domain with LATS1 PPxY motif complex","SFEIPDDVPLPAGWEMAKTSSGQRYFLNHIDQTTTWQDPRKAMGGGGNYQGPPPPYPKH","Homo sapiens","YAP1, YAP65","WW domain with PPxY motif","1","5YDX"
"5YDY",,"SOLUTION NMR",,,,,,,"10.18632/oncotarget.23909",,"5YDY",6,,,"NMR structure of YAP1-2 WW2 domain with LATS1 PPxY motif complex","SGPLPDGWEQAMTQDGEIYYINHKNKTTSWLDPRLDPRGGGGNRQPPPPYPLTA","Homo sapiens","YAP1, YAP65","WW2 domain and PPxY motif complex","1","5YDY"
"5YE7",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, HANGING DROP",6.6,"0.1M MOPS pH 6.6, 0.4M Li2SO4, 27% (w/v) (NH4)2SO4, 1M Na-Ac, 1.4% 1,4-butanediol",293,"10.1021/acs.jmedchem.7b01530","8U0","5YE7",88.87,"2.312","2.312","The crystal structure of Lp-PLA2 in complex with a novel inhibitor","GPLGSAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHI","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","5YE7"
"5YE8",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MOPS pH 6.6, 0.4M Li2SO4, 27% (w/v) (NH4)2SO4, 1M Na-Ac, 1.4% 1,4-butanediol",293,"10.1021/acs.jmedchem.7b01530","8U3","5YE8",88.23,"1.851","1.851","The crystal structure of Lp-PLA2 in complex with a novel inhibitor","GPLGSAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHI","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","5YE8"
"5YE9",,"X-RAY DIFFRACTION",2.4,48.76,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MOPS pH 6.6, 0.4M Li2SO4, 27% (w/v) (NH4)2SO4, 1M Na-Ac, 1.4% 1,4-butanediol",293,"10.1021/acs.jmedchem.7b01530","8U6","5YE9",89.01,"1.876","1.876","The crystal structure of Lp-PLA2 in complex with a novel inhibitor","GPLGSAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHI","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","5YE9"
"5YEA",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, HANGING DROP",,"0.1M MOPS pH 6.6, 0.4M Li2SO4, 27% (w/v) (NH4)2SO4, 1M Na-Ac, 1.4% 1,4-butanediol",293,"10.1021/acs.jmedchem.7b01530","8U9","5YEA",89.09,"1.805","1.805","The crystal structure of Lp-PLA2 in complex with a novel inhibitor","GPLGSAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTFLRLYYPSQDNDRLDTLWIPNKEYFWGLSKFLGTHWLMGNILRLLFGSMTTPANWNSPLRPGEKYPLVVFSHGLGAFRTLYSAIGIDLASHGFIVAAVEHRDRSASATYYFKDQSAAEIGDKSWLYLRTLKQEEETHIRNEQVRQRAKECSQALSLILDIDHGKPVKNALDLKFDMEQLKDSIDREKIAVIGHSFGGATVIQTLSEDQRFRCGIALDAWMFPLGDEVYSRIPQPLFFINSEYFQYPANIIKMKKCYSPDKERKMITIRGSVHQNFADFTFATGKIIGHMLKLKGDIDSNVAIDLSNKASLAFLQKHLGLHKDFDQWDCLIEGDDENLIPGTNINTTNQHI","Homo sapiens","PLA2G7, PAFAH","Platelet-activating factor acetylhydrolase","1","5YEA"
"5YEW",,"X-RAY DIFFRACTION",4.74,74.03,"VAPOR DIFFUSION, HANGING DROP",,"160mM potassium
thiocyanate, 16% PEG3350, 1% tacsimate (pH 7.0), 20mM HEPES, 2% PEG5000,
4% 1-propanol",289,"10.1038/s41594-018-0034-8",,"5YEW",143.91,"3.2","3.2","Structural basis for GTP hydrolysis and conformational change of mitofusin 1 in mediating mitochondrial fusion","MAEPVSPLKHFVLAKKAITAIFDQLLEFVTEGSHFVEATYKNPELDRIATEDDLVEMQGYKDKLSIIGEVLSRRHMKVAFFGRTSSGKSSVINAMLWDKVLPSGIGHITNCFLSVEGTDGDKAYLMTEGSDEKKSVKVNNQLAHALHMDKDLKAGCLVRVFWPKAKCALLRDDLVLVDSPGTDVTTELDSWIDKFCLDADVFVLVANSESTLMNTEKHFFHKVNERLSKPNIFILNNRWDASASEPEYMEDVRRQHMERCLHFLVEELKVVNALEAQNRIFFVSAKEVLSARKQKAQGMPESGVALAEGFHARLQEFQNFEQIFEECISQSAVKTKFEQHTIRAKQILATVKNIMDSVNLAAEDGSGSGSGGSEIARLPKEIDQLEKIQNNSKLLRNKAVQLENELENFTKQFLPSSNEES","Homo sapiens","MFN1","Mitofusin-1,Mitofusin-1 fusion protein","1","5YEW"
,,,,,,,,,,,,,,,,,"Homo sapiens","MFN1"
,,,,,,,,,,,,,,,,"MAEPVSPLKHFVLAKKAITAIFDQLLEFVTEGSHFVEATYKNPELDRIATEDDLVEMQGYKDKLSIIGEVLSRRHMKVAFFGRTSSGKSSVINAMLWDKVLPSGIGHITNCFLSVEGTDGDKAYLMTEGSDEKKSVKTVNQLAHALHMDKDLKAGCLVRVFWPKAKCALLRDDLVLVDSPGTDVTTELDSWIDKFCLDADVFVLVANSESTLMNTEKHFFHKVNERLSKPNIFILNNRWDASASEPEYMEDVRRQHMERCLHFLVEELKVVNALEAQNRIFFVSAKEVLSARKQKAQGMPESGVALAEGFHARLQEFQNFEQIFEECISQSAVKTKFEQHTIRAKQILATVKNIMDSVNLAAEDGSGSGSGGSEIARLPKEIDQLEKIQNNSKLLRNKAVQLENELENFTKQFLPSSNEES","Homo sapiens","MFN1","Mitofusin-1,Mitofusin-1 fusion protein","2","5YEW"
,,,,,,,,,,,,,,,,,"Homo sapiens","MFN1"
"5YEY",,"SOLUTION NMR",,,,,,,"10.1039/c8sc03813a",,"5YEY",6.66,,,"The structure of a chair-type G-quadruplex of the human telomeric variant in K+ solution","GGGTTAGGGTTAGGGTTTGGG","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*TP*GP*GP*G)-3')","1","5YEY"
"5YF0",,"X-RAY DIFFRACTION",4.51,72.72,"VAPOR DIFFUSION, SITTING DROP",6,"16% PEG8000, 0.1 M MES, pH 6.0, 0.2 M CaAc",291,"10.1038/s41422-018-0003-0",,"5YF0",86.15,"2.25","2.25","Crystal structure of CARNMT1 bound to SAM","GPLGSSTEEEEERLEREHFWKIINAFRYYGTSMHERVNRTERQFRSLPANQQKLLPQFLLHLDKIRKCIDHNQEILLTIVNDCIHMFENKEYGEDGNGKIMPASTFDMDKLKSTLKQFVRDWSETGKAERDACYQPIIKEILKNFPKERWDPSKVNILVPGAGLGRLAWEIAMLGYACQGNEWSFFMLFSSNFVLNRCSEINKYKLYPWIHQFSNNRRSADQIRPIFFPDVDPHSLPPGSNFSMTAGDFQEIYSECNTWDCIATCFFIDTAHNVIDYIDTIWKILKPGGIWINLGPLLYHFENLANELSIELSYEDIKNVVLQYGFKVEVEKESVLSTYTVNDLSMMKYYYECVLFVVRKPQ","Homo sapiens","CARNMT1, C9orf41","Carnosine N-methyltransferase","1","5YF0"
"5YF1",,"X-RAY DIFFRACTION",4.53,72.85,"VAPOR DIFFUSION, SITTING DROP",6,"16% PEG 8000, 0.1 M MES, pH 6.0, 0.2 M CaAc",291,"10.1038/s41422-018-0003-0","8V0","5YF1",86.51,"2.399","2.399","Crystal structure of CARNMT1 bound to carnosine and SFG","GPLGSSTEEEEERLEREHFWKIINAFRYYGTSMHERVNRTERQFRSLPANQQKLLPQFLLHLDKIRKCIDHNQEILLTIVNDCIHMFENKEYGEDGNGKIMPASTFDMDKLKSTLKQFVRDWSETGKAERDACYQPIIKEILKNFPKERWDPSKVNILVPGAGLGRLAWEIAMLGYACQGNEWSFFMLFSSNFVLNRCSEINKYKLYPWIHQFSNNRRSADQIRPIFFPDVDPHSLPPGSNFSMTAGDFQEIYSECNTWDCIATCFFIDTAHNVIDYIDTIWKILKPGGIWINLGPLLYHFENLANELSIELSYEDIKNVVLQYGFKVEVEKESVLSTYTVNDLSMMKYYYECVLFVVRKPQ","Homo sapiens","CARNMT1, C9orf41","Carnosine N-methyltransferase","1","5YF1"
"5YF2",,"X-RAY DIFFRACTION",4.44,72.32,"VAPOR DIFFUSION, SITTING DROP",6,"16% PEG8000, 0.1 M MES, pH 6.0, 0.2 M CaAc",291,"10.1038/s41422-018-0003-0",,"5YF2",86.52,"2.802","2.802","Crystal structure of CARNMT1 bound to anserine and SAH","GPLGSSTEEEEERLEREHFWKIINAFRYYGTSMHERVNRTERQFRSLPANQQKLLPQFLLHLDKIRKCIDHNQEILLTIVNDCIHMFENKEYGEDGNGKIMPASTFDMDKLKSTLKQFVRDWSETGKAERDACYQPIIKEILKNFPKERWDPSKVNILVPGAGLGRLAWEIAMLGYACQGNEWSFFMLFSSNFVLNRCSEINKYKLYPWIHQFSNNRRSADQIRPIFFPDVDPHSLPPGSNFSMTAGDFQEIYSECNTWDCIATCFFIDTAHNVIDYIDTIWKILKPGGIWINLGPLLYHFENLANELSIELSYEDIKNVVLQYGFKVEVEKESVLSTYTVNDLSMMKYYYECVLFVVRKPQ","Homo sapiens","CARNMT1, C9orf41","Carnosine N-methyltransferase","1","5YF2"
"5YF9",,"X-RAY DIFFRACTION",2.13,42.3,"VAPOR DIFFUSION, SITTING DROP",8.5,"24%w/v PEG 4000, 0.15 M Lithium Sulfate mono hydrate, 0.1 M Tris-HCl (pH 8.5)",277,"10.1107/S2053230X18005204",,"5YF9",81.33,"1.89","1.89","Crystal structure of CK2a2 form-2","GPLGSMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","5YF9"
"5YFG",,"SOLUTION NMR",,,,,,,"10.1093/jmcb/mjx045",,"5YFG",21.52,,,"SOLUTION STRUCTURE OF HUMAN MOG1","MEPTRDCPLFGGAFSAILPMGAIDVSDLRPVPDNQEVFCHPVTDQSLIVELLELQAHVRGEAAARYHFEDVGGVQGARAVHVESVQPLSLENLALRGRCQEAWVLSGKQQIAKENQQVAKDVTLHQALLRLPQYQTDLLLTFNQPPPDNRSSLGPENLSPAPWSLGDFEQLVTSLTLHDPNIFGPQVEHHHHHH","Homo sapiens","RANGRF, MOG1, RANGNRF, HSPC165, HSPC236, MDS5","Ran guanine nucleotide release factor","1","5YFG"
"5YFM",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Magnesium Chloride, 0.1 M Tris pH 8.5, 20% PEG 8000",298,,,"5YFM",142.46,"2.4","2.4","Human isocitrate dehydrogenase 1 bound with NADP","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","5YFM"
"5YFN",,"X-RAY DIFFRACTION",3.52,65.03,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES sodium pH7.5, 0.8 M sodium phosphate, 0.8 M potassium phosphate",298,,,"5YFN",95.72,"2.5","2.5","Human isocitrate dehydrogenase 1 bound with isocitrate","NLYFQSMMSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","5YFN"
"5YGI",,"X-RAY DIFFRACTION",2.58,52.34,"VAPOR DIFFUSION, HANGING DROP",,"1.2M Na/K phosphate, 25% glycerol, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2018.08.070",,"5YGI",40.66,"2.177","2.177","Crystal structure of human FPPS in complex with an inhibitor THZ93","NSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","5YGI"
"5YGP",,"X-RAY DIFFRACTION",2.81,56.22,"VAPOR DIFFUSION, HANGING DROP",,"2 M ammonium sulfate, sodium citrate 5.6, 10% glycerol",291,"10.1111/febs.14834",,"5YGP",206.77,"2.09","2.09","Human TNFRSF25 death domain mutant-D412E","MKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPAAAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYAAGKYDIKDVGVDNAGAKAGLTFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSAVNYGVTVLPTFKGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDAALAAAQTNAAAAAQLYDVMDAVPARRWKEFVRTLGLREAEIEAVEVEIGRFRDQQYEMLKRWRQQQPAGLGAVYAALERMGLEGCVEDLRSRLQRLEHHHHHH","Homo sapiens","TNFRSF25, APO3, DDR3, DR3, TNFRSF12, WSL, WSL1, UNQ455/PRO779","TNFRSF25 death domain","1","5YGP"
"5YGS",,"X-RAY DIFFRACTION",2.76,55.47,"VAPOR DIFFUSION, HANGING DROP",,"2.6 M ammonium sulfate, sodium citrate 5.6, 10% glycerol",291,"10.1111/febs.14834",,"5YGS",208.61,"2.691","2.691","Human TNFRSF25 death domain","MKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPAAAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYAAGKYDIKDVGVDNAGAKAGLTFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSAVNYGVTVLPTFKGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDAALAAAQTNAAAAAQLYDVMDAVPARRWKEFVRTLGLREAEIEAVEVEIGRFRDQQYEMLKRWRQQQPAGLGAVYAALERMGLDGCVEDLRSRLQRLEHHHHHH","Homo sapiens","TNFRSF25, APO3, DDR3, DR3, TNFRSF12, WSL, WSL1, UNQ455/PRO779","Human TNRSF25 death domain","1","5YGS"
"5YGX",,"X-RAY DIFFRACTION",3,58.94,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M sodium citrate tribasic pH6.5, 0.2M ammonium iodide, 19.3%(w/v) PEG5000MME",293,"10.1021/acs.jmedchem.8b00011","0B5","5YGX",47.64,"2.2","2.2","Structure of BACE1 in complex with N-(3-((4R,5R,6S)-2-amino-6-(1,1-difluoroethyl)-5-fluoro-4-methyl-5,6-dihydro-4H-1,3-oxazin-4-yl)-4-fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5YGX"
"5YGY",,"X-RAY DIFFRACTION",3.03,59.41,"VAPOR DIFFUSION, SITTING DROP",,"0.2M sodium citrate tribasic pH6.5, 0.2M ammonium iodide, 20.5%(w/v) PEG5000MME",293,"10.1021/acs.jmedchem.8b00002","0B6","5YGY",47.69,"2.3","2.3","Crystal Structure of BACE1 in complex with (S)-N-(3-(2-amino-6-(fluoromethyl)-4 -methyl-4H-1,3-oxazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5YGY"
"5YHN",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2018.05.018",,"5YHN",8.03,,,"Solution structure of the LEKTI Domain 4","AEKDFCKEYEKQVRNGRLFCTRESDPVRGPDGRMHGNKCALCAEIFKRRFSEENSKTDQNLGKAEEKTK","Homo sapiens","SPINK5","cDNA FLJ60407, highly similar to Serine protease inhibitor Kazal-type 5","1","5YHN"
"5YHU",,"X-RAY DIFFRACTION",2.74,55.11,"VAPOR DIFFUSION, HANGING DROP",,"200mM Calcium acetate, 100mM Tris-HCl pH 7.1, 19% PEG 3350",289,"10.1016/j.jsb.2018.04.007",,"5YHU",57.7,"1.85","1.85","Crystal structure of the DNA-binding domain of human myelin-gene regulatory factor","GPMADIGSLLQDSDSLSGSYLDPNYQSIKWQPHQQNKWATLYDANYKELPMLTYRVDADKGFNFSVGDDAFVCQKKNHFQVTVYIGMLGEPKYVKTPEGLKPLDCFYLKLHGVKLEALNQSINIEQSQSDRSKRPFNPVTVNLPPEQVTKVTVGRLHFSETTANNMRKKGKPNPDQRYFMLVVALQAHAQNQNYTLAAQISERIIVRASNPGQFESDSDVLWQRAQVPDTVFHHGRVGINTDRPDEALVVHGNVK","Homo sapiens","MYRF, C11orf9, KIAA0954, MRF","Myelin regulatory factor","1","5YHU"
"5YI5","3","ELECTRON MICROSCOPY",,,,,,,"10.1002/anie.201800516",,"5YI5",494.59,"3",,"human ferritin mutant - E-helix deletion","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLG","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","5YI5"
"5YJ4",,"SOLUTION NMR",,,,,,,"10.1038/s41598-018-31394-6",,"5YJ4",16.29,,,"structure for the protective mutant G127V of Human prion protein","MQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGVYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSS","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","5YJ4"
"5YJ5",,"SOLUTION NMR",,,,,,,"10.1038/s41598-018-31394-6",,"5YJ5",16.24,,,"structure for wildtype Human prion protein (M129)","MQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSS","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","5YJ5"
"5YJ8",,"X-RAY DIFFRACTION",2.21,44.31,"VAPOR DIFFUSION, SITTING DROP",4.6,"1.5M Ammonium sulfate, 0.1M Sodium acetate trihydrate, pH 4.6",293,"10.1111/febs.14469","8W9","5YJ8",7.43,"1.762","1.762","Identification of a small molecule inhibitor for the Tudor domain of TDRD3","HHHHHMMWKPGDECFALYWEDNKFYRAEVEALHSSGMTAVVKFIDYGNYEEVLLSNIKPI","Homo sapiens","TDRD3","Tudor domain-containing protein 3","1","5YJ8"
"5YJE",,"X-RAY DIFFRACTION",2.5,50.83,"VAPOR DIFFUSION, SITTING DROP",5.2,"0.12 M sodium citrate, 0.36-0.52 M ammonium sulfate, 0.02 M yttrium(III) chloride",293,"10.1038/s41467-018-05581-y",,"5YJE",126.24,"2.45","2.45","Crystal structure of HIRA(644-1017)","MGRPRKDSRLMPVSLSVQSPAALTAEKEAMCLSAPALALKLPIPSPQRAFTLQVSSDPSMYIEVENEVTVVGGVKLSRLKCNREGKEWETVLTSRILTAAGSCDVVCVACEKRMLSVFSTCGRRLLSPILLPSPISTLHCTGSYVMALTAAATLSVWDVHRQVVVVKEESLHSILAGSDMTVSQILLTQHGIPVMNLSDGKAYCFNPSLSTWNLVSDKQDSLAQCADFRSSLPSQDAMLCSGPLAIIQGRTSNSGRQAARLFSVPHVVQQETTLAYLENQVAAALTLQSSHEYRHWLLVYARYLVNEGFEYRLREICKDLLGPVHYSTGSQWESTVVGLRKRELLKELLPVIGQNLRFQRLFTECQEQLDILRDKLEGSS","Homo sapiens","HIRA, DGCR1, HIR, TUPLE1","Protein HIRA","1","5YJE"
"5YJF",,"X-RAY DIFFRACTION",1.89,34.96,"VAPOR DIFFUSION, SITTING DROP",5.8,"0.2M Sodium chloride, 0.1M BIS-TRIS pH 5.8, 25 %(w/v) PEG 3350",295,"10.1038/s41598-018-22081-7","8WO","5YJF",128.63,"2.49","2.49","Co-crystal structure of Human Nicotinamide N-methyltransferase (NNMT) with small molecule analog of Nicotinamide","MGSSHHHHHHSSGLVPRGSHMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT","Nicotinamide N-methyltransferase","1","5YJF"
"5YJG",,"X-RAY DIFFRACTION",3.93,68.73,"VAPOR DIFFUSION, SITTING DROP",,"Ammonium Sulfate, MES",293,"10.1002/1873-3468.13091",,"5YJG",71.02,"2.399","2.399","Structural insights into periostin functions","APGDPRENSNNHYDKILAHSRIRGRDQGPNVCALQQILGTKKKYFSTCKNWYKKSICGQKTTVLYECCPGYMRMEGMKGCPAVLPIDHVYGTLGIVGATTTQRYSDASKLREEIEGKGSFTYFAPSNEAWDNLDSDIRRGLESNVNVELLNALHSHMINKRMLTKDLKNGMIIPSMYNNLGLFINHYPNGVVTVNCARIIHGNQIATNGVVHVIDRVLTQIGTSIQDFIEAEDDLSSFRAAAITSDILEALGRDGHFTLFAPTNEAFEKLPRGVLERIMGDKVASEALMKYHILNTLQCSESIMGGAVFETLEGNTIEIGCDGDSITVNGIKMVNKKDIVTNNGVIHLIDQVLIPDSAKQVIELAGKQQTTFTDLVAQLGLASALRPDGEYTLLAPVNNAFSDDTLSMDQRLLKLILQNHILKVKVGLNELYNGQILETIGGKQLRVFVYRTAVCIENSCMEKGSKQGRNGAIHIFREIIKPAEKSLHEKLKQDKRFSTFLSLLEAADLKELLTQPGDWTLFVPTNDAFKGMTSEEKEILIRDKNALQNIILYHLTPGVFIGKGFEPGVTNILKTTQGSKIFLKEVNDTLLVNELKSKESDIMTTNGVIHVVDKLLYPAAAHHHHHHH","Homo sapiens","POSTN, OSF2","Periostin","1","5YJG"
"5YJH",,"X-RAY DIFFRACTION",3.92,68.62,"VAPOR DIFFUSION, SITTING DROP",,"Ammonium Sulfate. Sodium cacodylate",293,"10.1002/1873-3468.13091",,"5YJH",70.64,"2.957","2.957","Structural insights into periostin functions","APGDPRENNHYDKILAHSRIRGRDQGPNVCALQQILGTKKKYFSTAKNWYKKSICGQKTTVLYECCPGYMRMEGMKGCPAVLPIDHVYGTLGIVGATTTQRYSDASKLREEIEGKGSFTYFAPSNEAWDNLDSDIRRGLESNVNVELLNALHSHMINKRMLTKDLKNGMIIPSMYNNLGLFINHYPNGVVTVNCARIIHGNQIATNGVVHVIDRVLTQIGTSIQDFIEAEDDLSSFRAAAITSDILEALGRDGHFTLFAPTNEAFEKLPRGVLERIMGDKVASEALMKYHILNTLQCSESIMGGAVFETLEGNTIEIGCDGDSITVNGIKMVNKKDIVTNNGVIHLIDQVLIPDSAKQVIELAGKQQTTFTDLVAQLGLASALRPDGEYTLLAPVNNAFSDDTLSMDQRLLKLILQNHILKVKVGLNELYNGQILETIGGKQLRVFVYRTAVCIENSCMEKGSKQGRNGAIHIFREIIKPAEKSLHEKLKQDKRFSTFLSLLEAADLKELLTQPGDWTLFVPTNDAFKGMTSEEKEILIRDKNALQNIILYHLTPGVFIGKGFEPGVTNILKTTQGSKIFLKEVNDTLLVNELKSKESDIMTTNGVIHVVDKLLYPAAAHHHHHHH","Homo sapiens","POSTN, OSF2","Periostin","1","5YJH"
"5YJK",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, SITTING DROP",,"PEG1000, PEG3350, 2-methyl-2,4-pentanediol, sodium nitrate, sodium hydrogen phosphate, ammonium sulfate, bicine/trizma buffer",293,"10.1016/j.bmcl.2017.10.030","8VX","5YJK",25.09,"2.4","2.4","Human kallikrein 7 in complex with 1,4-diazepane-7-one 1-acetamide derivative","IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRRAQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKVYKDLLENSMLCAGIPDSKKNACNGDSGGPLVCRGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMKKHR","Homo sapiens","KLK7, PRSS6, SCCE","Kallikrein-7","1","5YJK"
"5YJM",,"X-RAY DIFFRACTION",2.8,56.09,"VAPOR DIFFUSION, HANGING DROP",6.8,"22% PEG8000, 5mM zinc chloride, 100mM MES buffer",293,"10.1016/j.bmcl.2017.11.031","8W3","5YJM",26.13,"1.9","1.9","Human chymase in complex with 7-oxo-3-(phenoxyimino)-1,4-diazepane derivative","IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGVAQGIVSYGRSDAKPPAVFTRISHYRPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","human chymase","1","5YJM"
"5YJO",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Magnesium acetate, 17% PEG3350",298,"10.1021/acsmedchemlett.9b00170",,"5YJO",49.62,"2.135","2.135","Crystal structure of SmyD3 in complex with covalent inhibitor 4","PLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANI","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","5YJO"
"5YJP",,"X-RAY DIFFRACTION",2.8,56.09,"VAPOR DIFFUSION, HANGING DROP",6.8,"22% PEG8000, 5mM zinc chloride and 100mM MES buffer",293,"10.1016/j.bmcl.2017.11.031","8W6","5YJP",26.07,"1.8","1.8","Human chymase in complex with 3-(ethoxyimino)-7-oxo-1,4-diazepane derivative","IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGVAQGIVSYGRSDAKPPAVFTRISHYRPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","human chymase","1","5YJP"
"5YKH",,"X-RAY DIFFRACTION",2.06,40.26,"VAPOR DIFFUSION, HANGING DROP",4.5,"20% PEG 3350, 0.25M NaH2PO4",293,"10.1093/nar/gky134",,"5YKH",48.35,"2.457","2.457","Crystal structure of the engineered nine-repeat PUF domain","MGSSHHHHHHSQDLEVLFQGPHMGRSRLLEDFRNNRYPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNYVIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLG","Homo sapiens","PUM1, KIAA0099, PUMH1","Pumilio homolog 1","1","5YKH"
,,,,,,,,,,,,,,,,,"Homo sapiens","PUM1, KIAA0099, PUMH1"
,,,,,,,,,,,,,,,,,"Homo sapiens","PUM1, KIAA0099, PUMH1"
"5YKP",,"X-RAY DIFFRACTION",2.56,51.88,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M Hepes pH-6.0, 19% PEG MME 2000",298,"10.1042/BCJ20180874",,"5YKP",34.77,"1.68","1.68","Human methionine aminopeptidase type 1b (F309M mutant) in complex with ovalicin","PYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","5YKP"
"5YKS",,"X-RAY DIFFRACTION",3.15,60.89,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1 M HEPES,  0.07 M Magnesium formate, 4.5% D-Sorbitol",277,"10.1016/j.bbrc.2017.10.105",,"5YKS",85.89,"2.9","2.9","Crystal structure of sucrose nonfermenting-related kinase (SNRK)","GSSHHHHHHSQDLEVLFQGPHMAGFKRGYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECKDLITRMLQRDPKRRASLEEIENHPWLQGVDPSPATKYNIPLVSYKNLSEEEHNSIIQRMVLGDIADRDAIVEALETNRYNHITATYFLLAERILREKQEKEIQTRSASPSNIK","Homo sapiens","SNRK, KIAA0096, SNFRK","SNF-related serine/threonine-protein kinase","1","5YKS"
"5YLT",,"X-RAY DIFFRACTION",2.25,45.27,"VAPOR DIFFUSION, HANGING DROP",,"0.1M TRIS-HCL PH 8.5, 34% PEG 6000",293,"10.1002/cmdc.201800233","SFG, C7N","5YLT",30.04,"1.69","1.69","Crystal structure of SET7/9 in complex with a cyproheptadine derivative","GSSGSSGKDNIRHGVCWIYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRPHFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAFQATQQK","Homo sapiens","SETD7, KIAA1717, KMT7, SET7, SET9","Histone-lysine N-methyltransferase SETD7","1","5YLT"
"5YNZ",,"X-RAY DIFFRACTION",2.81,56.16,"VAPOR DIFFUSION, HANGING DROP",6.5,"2M sodium chloride, 100mM MES sodium salt pH6.5, 200mM sodium acetate",298,"10.1016/j.bbrc.2018.09.153",,"5YNZ",42.73,"2.774","2.774","Crystal structure of the dihydroorotase domain (K1556A) of human CAD","MTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLALYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","5YNZ"
"5YOQ",,"X-RAY DIFFRACTION",2.29,46.35,"VAPOR DIFFUSION, HANGING DROP",7,"28%(w/v) PEG 3350, 10%(v/v) MPD, 50mM potassium phosphate buffer pH 7.0",288,"10.1016/j.bbrep.2018.01.006",,"5YOQ",133.66,"2.65","2.65","Human serum albumin complexed with sodium 4-phenylbutyrate","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","5YOQ"
"5YOU",,"X-RAY DIFFRACTION",2.13,42.17,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Naformate, 10% glycerol",293,,"8XX","5YOU",15.46,"1.503","1.503","Crystal structure of BRD4-BD1 bound with hjp64","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5YOU"
"5YOV",,"X-RAY DIFFRACTION",2,38.64,"VAPOR DIFFUSION, HANGING DROP",,"3.6M Naformate, 10% glycerol",293,"10.1016/j.ejmech.2018.02.070","8XR","5YOV",15.49,"1.451","1.451","Crystal structure of BRD4-BD1 bound with hjp126","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5YOV"
"5YP7",,"X-RAY DIFFRACTION",1.74,29.27,"VAPOR DIFFUSION, HANGING DROP",,"Bis Tris, PEG MME 200, PEG 600",293,"10.1038/s41467-018-05825-x",,"5YP7",11.97,"1.424","1.424","p62/SQSTM1 ZZ domain","VICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFS","Homo sapiens","SQSTM1, ORCA, OSIL","Sequestosome-1","1","5YP7"
"5YQ4",,"X-RAY DIFFRACTION",2.21,44.33,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M Sodium Citrate, pH 5, 20% PEG 6000",283,,,"5YQ4",32.55,"1.58","1.58","Crystal structure of kelch domain of KLHL20","SMQGPRTRPRKPIRCGEVLFAVGGWCSGDAISSVERYDPQTNEWRMVASMSKRRCGVGVSVLDDLLYAVGGHDGSSYLNSVERYDPKTNQWSSDVAPTSTCRTSVGVAVLGGFLYAVGGQDGVSCLNIVERYDPKENKWTRVASMSTRRLGVAVAVLGGFLYAVGGSDGTSPLNTVERYNPQENRWHTIAPMGTRRKHLGCAVYQDMIYAVGGRDDTTELSSAERYNPRTNQWSPVVAMTSRRSGVGLAVVNGQLMAVGGFDGTTYLKTIEVFDPDANTWRLYGGMNYRRLGGGVGVIK","Homo sapiens","KLHL20, KLEIP, KLHLX","Kelch-like protein 20","1","5YQ4"
"5YQ5",,"X-RAY DIFFRACTION",2.44,49.54,"VAPOR DIFFUSION, HANGING DROP",,"200 mM ammonium phosphate dibasic
24 % PEG 3350",293.15,"10.1038/s42003-018-0038-2",,"5YQ5",203.72,"2.17","2.17","Crystal structure of human osteomodulin","MRVLVLLACLAAASNAGSQYETYQWDEDYDQEPDDDYQTGFPFRQNVDYGVPFHQYTLGCVSECFCPTNFPSSMYCDNRKLKTIPNIPMHIQQLYLQFNEIEAVTANSFINATHLKEINLSHNKIKSQKIDYGVFAKLPNLLQLHLEHNNLEEFPFPLPKSLERLLLGYNEISKLQTNAMDGLVNLTMLDLCYNYLHDSLLKDKIFAKMEKLMQLNLCSNRLESMPPGLPSSLMYLSLENNSISSIPEKYFDKLPKLHTLRMSHNKLQDIPYNIFNLPNIVELSVGHNKLKQAFYIPRNLEHLYLQNNEIEKMNLTVMCPSIDPLHYHHLTYIRVDQNKLKEPISSYIFFCFPHIHTIYYGEQRSTNGQTIQLKTQVFRRFPDDDDESEDHDDPDNAHESPEQEGAEGHFDLHYYENQEAAADYKDDDDK","Homo sapiens","OMD, SLRR2C, UNQ190/PRO216","Osteomodulin","1","5YQ5"
"5YQL",,"X-RAY DIFFRACTION",2.15,42.78,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Magnesium Formate, 23-30% (v/v) Polyethylene glycol 3350",293,"10.1016/j.ejmech.2018.06.041","A2I","5YQL",35.05,"1.601","1.601","Crystal structure of Sirt2 in complex with selective inhibitor A2I","GASGSERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","5YQL"
"5YQM",,"X-RAY DIFFRACTION",2.14,42.49,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES PH6.8, 25%-30% PEG 3350",293,"10.1016/j.ejmech.2018.06.041",,"5YQM",35.21,"1.735","1.735","Crystal structure of Sirt2 in complex with selective inhibitor A29","GASGSERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","5YQM"
"5YQN",,"X-RAY DIFFRACTION",2.12,41.92,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES PH7.4, 30% PEG 3350",293,"10.1016/j.ejmech.2018.06.041","L55","5YQN",35.12,"1.6","1.6","Crystal structure of Sirt2 in complex with selective inhibitor L55","GASGSERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","5YQN"
"5YQO",,"X-RAY DIFFRACTION",2.14,42.42,"VAPOR DIFFUSION, HANGING DROP",,"2.1M DL-malic acid PH7.0",293,"10.1016/j.ejmech.2018.06.041","L5C","5YQO",35.02,"1.483","1.483","Crystal structure of Sirt2 in complex with selective inhibitor L5C","GASGSERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-dependent protein deacetylase sirtuin-2","1","5YQO"
"5YQX",,"X-RAY DIFFRACTION",1.87,34.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 20% PEG 3350, 10% EtGhly, 0.2M NaCl",277,"10.1016/j.ejmech.2018.04.034","E0K","5YQX",17.09,"1.82","1.82","Crystal Structure Analysis of the BRD4","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5YQX"
"5YR4",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M Hepes pH-6.0, 19% PEG MME 2000",298,"10.1042/BCJ20180874",,"5YR4",34.93,"1.82","1.82","Human methionine aminopeptidase type 1b (F309M mutant) in complex with TNP470","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLMHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","5YR4"
"5YR5",,"X-RAY DIFFRACTION",2.55,51.69,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.1M Bistris pH-6.2, 19% PEG3350, 5% glycerol",298,"10.1042/BCJ20180874",,"5YR5",34.64,"1.6","1.6","Human methionine aminopeptidase type 1b (F309L mutant) in complex with Ovalicin","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLLHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","5YR5"
"5YR6",,"X-RAY DIFFRACTION",2.56,52.03,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.1M Bistris pH-6.2, 19% PEG 3350, 5% Glycerol",298,"10.1042/BCJ20180874",,"5YR6",34.69,"1.75","1.75","Human methionine aminopeptidase type 1b (F309L mutant) in complex with TNP470","YRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLLHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMS","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","5YR6"
"5YR7",,"X-RAY DIFFRACTION",2.58,52.38,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.1M Bistris pH-6.2, 19% PEG 3350, 5% Glycerol",298,,,"5YR7",37.23,"2.06","2.06","Human methionine aminopeptidase type 1b (F309L mutant)","MGSSHHHHHHSSGLVPRGSHMPYRYTGKLRPHYPLMPTRPVPSYIQRPDYADHPLGMSESEQALKGTSQIKLLSSEDIEGMRLVCRLAREVLDVAAGMIKPGVTTEEIDHAVHLACIARNCYPSPLNYYNFPKSCCTSVNEVICHGIPDRRPLQEGDIVNVDITLYRNGYHGDLNETFFVGEVDDGARKLVQTTYECLMQAIDAVKPGVRYRELGNIIQKHAQANGFSVVRSYCGHGIHKLLHTAPNVPHYAKNKAVGVMKSGHVFTIEPMICEGGWQDETWPDGWTAVTRDGKRSAQFEHTLLVTDTGCEILTRRLDSARPHFMSQF","Homo sapiens","METAP1, KIAA0094","Methionine aminopeptidase 1","1","5YR7"
"5YRN","4.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-07447-9",,"5YRN",151.46,"4.1",,"Structure of RIP2 CARD domain","TNSAGIAQQWIQSKREDIVNQMTEACLNQSLDALLSRDLIMKEDYELVSTKPTRTSKVRQLLDTTDIQGEEFAKVIVQKLKDNKQMGLQPYPEILVVSRSPSLNLLQNKSM","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","5YRN"
"5YSO",,"X-RAY DIFFRACTION",2.65,53.58,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Ammonium fluoride, 20%(w/v) PEG 3350, 10mM Barium chloride dihydrate",291,"10.1158/1078-0432.CCR-18-3007",,"5YSO",82.4,"2.501","2.501","Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domain with DN200434","MLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","5YSO"
"5YSY",,"X-RAY DIFFRACTION",2.64,53.37,"VAPOR DIFFUSION, HANGING DROP",6.5,"50mM Mes, 1.4M ammonium sulphate",277,"10.1039/C8OB00158H",,"5YSY",29.41,"2","2","Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2R,3R)-5-[(E)-2-{(1R,3aS,7aR)-1-[(R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl}vinyl]-2-(3-hydroxypropyl)cyclohex-4-ene-1,3-diol","DSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","5YSY"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"5YT2",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"50mM Mes, 1.4M ammonium sulphate",277,"10.1039/C8OB00158H",,"5YT2",29.41,"2","2","Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2S,3R)-5-[(E)-2-{(1R,3aS,7aR)-1-[(R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl}vinyl]-2-(3-hydroxypropyl)cyclohex-4-ene-1,3-diol","DSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","5YT2"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"5YT3",,"X-RAY DIFFRACTION",2.54,51.61,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M HEPES, 12%(w/v) PEG3350, 0.1M ammonium citrate,",293,,,"5YT3",159.25,"2.9","2.9","Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 S218D and S222D mutant","ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDDMANDFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRAPGRPLASYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNHHHHHH","Homo sapiens","MAP2K1, hCG_24510, MEK1, PRKMK1","Mitogen-activated protein kinase kinase 1, isoform CRA_d","1","5YT3"
"5YT4",,"X-RAY DIFFRACTION",2.78,55.8,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1093/glycob/cwx107",,"5YT4",15.97,"2","2","Galectin-10 variant H53A soaked in glycerol for 5 minutes","SLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFAFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSY","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","5YT4"
"5YTO",,"X-RAY DIFFRACTION",3.26,62.23,"VAPOR DIFFUSION, HANGING DROP",,"sodium citrate, pH 6.0",293,"10.1002/1873-3468.13055","946","5YTO",193.2,"1.9","1.9","Crystal Structure of human Superoxide Dismutase I (hSOD1) in complex with a napthalene-catechol linked compound.","MKHHHHHHPMSDYDIPTTENLYFQGAMATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","5YTO"
"5YTU",,"X-RAY DIFFRACTION",3.18,61.3,"VAPOR DIFFUSION, HANGING DROP",,"Sodium Citrate, pH 6.0",300,"10.1002/1873-3468.13055","5FW","5YTU",192.46,"1.9","1.9","Structure of human SOD1 complexed with isoproteranol in C2221 space group","MKHHHHHHPMSDYDIPTTENLYFQGAMATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","5YTU"
"5YU7",,"X-RAY DIFFRACTION",5.14,76.07,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, Tacsimate, MPD, MgCl2, DTT",283,"10.1016/j.str.2018.06.014",,"5YU7",136.45,"3.301","3.301","CRYSTAL STRUCTURE OF EXPORTIN-5","MAMDQVNALCEQLVKAVTVMMDPNSTQRYRLEALKFCEEFKEKCPICVPCGLRLAEKTQVAIVRHFGLQILEHVVKFRWNGMSRLEKVYLKNSVMELIANGTLNILEEENHIKDALSRIVVEMIKREWPQHWPDMLIELDTLSKQGETQTELVMFILLRLAEDVVTFQTLPPQRRRDIQQTLTQNMERIFSFLLNTLQENVNKYQQVKTDTSQESKAQANCRVGVAALNTLAGYIDWVSMSHITAENCKLLEILCLLLNEQELQLGAAECLLIAVSRKGKLEDRKPLMVLFGDVAMHYILSAAQTADGGGLVEKHYVFLKRLCQVLCALGNQLCALLGADSDVETPSNFGKYLESFLAFTTHPSQFLRSSTQMTWGALFRHEILSRDPLLLAIIPKYLRASMTNLVKMGFPSKTDSPSCEYSRFDFDSDEDFNAFFNSSRAQQGEVMRLACRLDPKTSFQMAGEWLKYQLSTFLDAGSVNSCSAVGTGEGSLCSVFSPSFVQWEAMTLFLESVITQMFRTLNREEIPVNDGIELLQMVLNFDTKDPLILSCVLTNVSALFPFVTYRPEFLPQVFSKLFSSVTFETVEESKAPRTRAVRNVRRHACSSIIKMCRDYPQLVLPNFDMLYNHVKQLLSNELLLTQMEKCALMEALVLISNQFKNYERQKVFLEELMAPVASIWLSQDMHRVLSDVDAFIAYVGTDQKSCDPGLEDPCGLNRARMSFCVYSILGVVKRTCWPTDLEEAKAGGFVVGYTSSGNPIFRNPCTEQILKLLDNLLALIRTHNTLYAPEMLAKMAEPFTKALDMLDAEKSAILGLPQPLLELNDSPVFKTVLERMQRFFSTLYENCFHILGKAGPSMQQDFYTVEDLATQLLSSAFVNLNNIPDYRLRPMLRVFVKPLVLFCPPEHYEALVSPILGPLFTYLHMRLSQKWQVINQRSLLCGEDEAADENPESQEMLEEQLVRMLTREVMDLITVCCVSKKGADHSSAPPADGDDEEMMATEVTPSAMAELTDLGKCLMKHEDVCTALLITAFNSLAWKDTLSCQRTTSQLCWPLLKQVLSGTLLADAVTWLFTSVLKGLQMHGQHDGCMASLVHLAFQIYEALRPRYLEIRAVMEQIPEIQKDSLDQFDCKLLNPSLQKVADKRRKDQFKRLIAGCIGKPLGEQFRKEVHIKNLPSLFKKTKPMLETEVLDNDGGGLATIFEP","Homo sapiens","XPO5, KIAA1291, RANBP21","Exportin-5","1","5YU7"
"5YU9",,"X-RAY DIFFRACTION",2.2,44.04,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M sodium citrate (pH 5.0), 12% PEG 10000, 3% dioxane, 5 mM TCEP",293,"10.18632/oncotarget.11951","1E8","5YU9",152.47,"1.95","1.95","Crystal structure of EGFR 696-1022 T790M in complex with Ibrutinib","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5YU9"
"5YUF",,"X-RAY DIFFRACTION",3.13,60.65,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium Sulfate",293,"10.1038/s41467-018-03498-0",,"5YUF",22.99,"1.6","1.6","Crystal Structure of PML RING tetramer","EEEFQFLRCQQCQAEAKCPKLLPCLHTLCSGCLEASGMQCPICQAPWPLGA","Homo sapiens","PML, MYL, PP8675, RNF71, TRIM19","Protein PML","1","5YUF"
"5YUI",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, HANGING DROP",,"1.3M sodium citrate, 100mM TrisHCl pH 7.8",293,"10.1073/pnas.1520786113",,"5YUI",29.53,"1.2","1.2","CO2 release in human carbonic anhydrase II crystals: reveal histidine 64 and solvent dynamics","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5YUI"
"5YUJ",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION, HANGING DROP",,"1.3M sodium citrate, 100mM TrisHCl pH 7.8",293,"10.1073/pnas.1520786113",,"5YUJ",29.45,"1.25","1.25","CO2 release in human carbonic anhydrase II crystals: reveal histidine 64 and solvent dynamics","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5YUJ"
"5YUK",,"X-RAY DIFFRACTION",2.07,40.69,"VAPOR DIFFUSION, HANGING DROP",,"1.3 M sodium citrate, 100 mM TrisHCl pH 7.8",293,"10.1073/pnas.1520786113",,"5YUK",29.45,"1.45","1.45","CO2 release in human carbonic anhydrase II crystals: reveal histidine 64 and solvent dynamics","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5YUK"
"5YUL",,"X-RAY DIFFRACTION",3.84,67.94,"VAPOR DIFFUSION, HANGING DROP",,"Sodium Citrate pH 6.0",300,"10.1002/1873-3468.13055",,"5YUL",160.79,"1.9","1.9","Native Structure of hSOD1 in P6322 space group","MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","5YUL"
"5YV8",,"X-RAY DIFFRACTION",3.19,61.49,"VAPOR DIFFUSION, HANGING DROP",,"0.1M sodium cacodylate (pH 6.0), 0.2M Sodium acetate, 22% PEG 8000, 0.03M glycyl-glycyl-glycine",293,"10.1016/j.jmgm.2020.107599",,"5YV8",34.4,"1.927","1.927","Structure of CaMKK2 in complex with CKI-002","GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","5YV8"
"5YV9",,"X-RAY DIFFRACTION",3.25,62.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Na cocodylate pH 6.5, 0.2M Na acetate, 20% PEG 8000, 0.03M Glycyl-glycyl-glycine",293,"10.1016/j.jmgm.2020.107599",,"5YV9",34.29,"2.53","2.53","Structure of CaMKK2 in complex with CKI-009","GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","5YV9"
"5YVA",,"X-RAY DIFFRACTION",3.24,66.38,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M sodium cocodylate pH 6.5, 0.2M sodium acetate, 20% PEG 8000",293,"10.1016/j.jmgm.2020.107599",,"5YVA",34.34,"2.574","2.574","Structure of CaMKK2 in complex with CKI-010","GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","5YVA"
"5YVB",,"X-RAY DIFFRACTION",3.25,62.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M sodium cocodylate pH 6.5, 0.2M ammonium acetate, 32% PEG 8000",293,"10.1016/j.jmgm.2020.107599",,"5YVB",34.53,"2.02","2.02","Structure of CaMKK2 in complex with CKI-011","GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","5YVB"
"5YVC",,"X-RAY DIFFRACTION",3.23,61.94,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M sodium cocodylate pH 6.0, 0.2M sodium acetate, 20% PEG 8000, 0.03M xylitol",293,"10.1016/j.jmgm.2020.107599",,"5YVC",34.48,"2.02","2.02","Structure of CaMKK2 in complex with CKI-012","GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","5YVC"
"5YVE",,"X-RAY DIFFRACTION",3.97,69,"VAPOR DIFFUSION",,"0.05M MgCl2, 0.1M Glycine pH 9.0, 22-24% PEG 400",277,"10.1073/pnas.1800907115",,"5YVE",41.74,"3.4","3.4","Crystal structure of human P2X3 receptor in complex with the AF-219 negative allosteric modulator","SREFDFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5YVE"
"5YVN",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, HANGING DROP",4.6,"2 M Ammonium sulfate, 100 mM Sodium acetate",288,"10.1002/prot.25683",,"5YVN",28.25,"1.33","1.33","Human Glutathione Transferase Omega1","MSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","5YVN"
"5YVO",,"X-RAY DIFFRACTION",2.35,47.58,"VAPOR DIFFUSION, HANGING DROP",4.6,"2 M Ammonium sulfate, 100 mM Sodium Acetate",288,"10.1002/prot.25683",,"5YVO",28.68,"1.8","1.8","Human Glutathione Transferase Omega1 covalently bound to ML175 inhibitor","MSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","5YVO"
"5YWE",,"X-RAY DIFFRACTION",2.18,43.49,"LIQUID DIFFUSION",8.5,"35% PEG 6000, 5 mM DTT, 2mM MgCl2, 2mM Glutathione, 2% Dioxane, 50 mM Tris-HCL, pH 8.5",293,,,"5YWE",94.42,"1.68","1.68","Crystal structure of hematopoietic prostaglandin D synthase apo form","PNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","5YWE"
"5YWM",,"X-RAY DIFFRACTION",2.06,36.49,"VAPOR DIFFUSION",,"PEG 4000, Lithium sulfate monohydrate",277,,,"5YWM",40.48,"1.939","1.939","Crystal structure of CK2a2 form-1","GPLGSMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ","Homo sapiens","CSNK2A2, CK2A2","Casein kinase II subunit alpha'","1","5YWM"
"5YWX",,"X-RAY DIFFRACTION",2.22,44.49,"LIQUID DIFFUSION",8.5,"35% PEG6000, 5 mM DTT, 2 mM MgCl2, 2 mM Glutathione, 2% Dioxane, 50 mM Tris-HCl, pH 8.5",293,"10.1016/j.bmc.2018.08.014","93C","5YWX",95.95,"1.74","1.74","Crystal structure of hematopoietic prostaglandin D synthase in complex with F092","PNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","5YWX"
"5YX1",,"X-RAY DIFFRACTION",2.23,44.84,"LIQUID DIFFUSION",8.5,"35% PEG 6000, 5 mM DTT, 2 mM MgCl2, 2 mM Glutathione, 2% Dioxane, 50 mM Tris-HCl, pH 8.5",293,,,"5YX1",95.76,"1.39","1.39","Crystal structure of hematopoietic prostaglandin D synthase in complex with U004","PNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","5YX1"
"5YX9","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-018-0038-2",,"5YX9",425.81,"3.8",,"Cryo-EM structure of human TRPC6 at 3.8A resolution","MSQSPAFGPRRGSSPRGAAGAAARRNESQDYLLMDSELGEDGCPQAPLPCYGYYPCFRGSDNRLAHRRQTVLREKGRRLANRGPAYMFSDRSTSLSIEEERFLDAAEYGNIPVVRKMLEECHSLNVNCVDYMGQNALQLAVANEHLEITELLLKKENLSRVGDALLLAISKGYVRIVEAILSHPAFAEGKRLATSPSQSELQQDDFYAYDEDGTRFSHDVTPIILAAHCQEYEIVHTLLRKGARIERPHDYFCKCNDCNQKQKHDSFSHSRSRINAYKGLASPAYLSLSSEDPVMTALELSNELAVLANIEKEFKNDYKKLSMQCKDFVVGLLDLCRNTEEVEAILNGDVETLQSGDHGRPNLSRLKLAIKYEVKKFVAHPNCQQQLLSIWYENLSGLRQQTMAVKFLVVLAVAIGLPFLALIYWFAPCSKMGKIMRGPFMKFVAHAASFTIFLGLLVMNAADRFEGTKLLPNETSTDNAKQLFRMKTSCFSWMEMLIISWVIGMIWAECKEIWTQGPKEYLFELWNMLDFGMLAIFAASFIARFMAFWHASKAQSIIDANDTLKDLTKVTLGDNVKYYNLARIKWDPSDPQIISEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTVKDIFKFMVIFIMVFVAFMIGMFNLYSYYIGAKQNEAFTTVEESFKTLFWAIFGLSEVKSVVINYNHKFIENIGYVLYGVYNVTMVIVLLNMLIAMINSSFQEIEDDADVEWKFARAKLWFSYFEEGRTLPVPFNLVPSPKSLFYLLLKLKKWISELFQGHKKGFQEDAEMNKINEEKKLGILGSHEDLSKLSLDKKQVGHNKQPSIRSSEDFHLNSFNNPPRQYQKIMKRLIKRYVLQAQIDKESDEVNEGELKEIKQDISSLRYELLEEKSQNTEDLAELIRELGEKLSMEPNQEETNR","Homo sapiens","TRPC6, TRP6","Short transient receptor potential channel 6","1","5YX9"
"5YXH",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION, HANGING DROP",,"25% w/v PEG 1500",291,"10.1038/s41467-018-03035-z",,"5YXH",78.97,"2.04","2.04","Structure of Rheb-GDP","SPQSKSRKIAILGYRSVGKSSLTIQFVEGQFVDSYDPTIENTFTKLITVNGQEYHLQLVDTAGQDEYSIFPQTYSIDINGYILVYSVTSIKSFEVIKVIHGKLLDMVGKVQIPIMLVGNKKDLHMERVISYEEGKALAESWNAAFLESSAKENQTAVDVFRRIILEAEKLE","Homo sapiens","RHEB, RHEB2","GTP-binding protein Rheb","1","5YXH"
"5YXK",,"X-RAY DIFFRACTION",1.92,35.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris HCl pH 8.5, 2.4M Ammonium phosphate dibasic",298,,,"5YXK",51.75,"1.9","1.9","High resolution crystal structure of Human B7-2 IgV domain in P21 space group","SMLKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGRTSFDSDSWTLRLHNLQIKDKGLYQCIIHHKKPTGMIRIHQMNSELSVLA","Homo sapiens","CD86, CD28LG2","T-lymphocyte activation antigen CD86","1","5YXK"
"5YXZ",,"X-RAY DIFFRACTION",1.97,37.62,"VAPOR DIFFUSION, SITTING DROP",,"0.15M K Bromide, 30% w/v PEG MME 2000",295,,,"5YXZ",20.3,"1.7","1.7","Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI484","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5YXZ"
"5YY1",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, SITTING DROP",,"0.01M tri-Sodium citrate, 33% (w/v) PEG 6000",295,,,"5YY1",20.41,"1.69","1.69","Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI739","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5YY1"
"5YY8",,"X-RAY DIFFRACTION",2.08,40.91,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M Ammonium citrate tribasic pH 7.0, 20% PEG 3350",289,"10.1107/S2053230X18001577",,"5YY8",37.03,"1.979","1.979","Crystal structure of the Kelch domain of human NS1-BP","MGSSHHHHHHSQGSMTPKLSKSLSFEMQQDELIEKPMSPMQYARSGLGTAEMNGKLIAAGGYNREECLRTVECYNPHTDHWSFLAPMRTPRARFQMAVLMGQLYVVGGSNGHSDDLSCGEMYDSNIDDWIPVPELRTNRCNAGVCALNGKLYIVGGSDPYGQKGLKNCDVFDPVTKLWTSCAPLNIRRHQSAVCELGGYLYIIGGAESWNCLNTVERYNPENNTWTLIAPMNVARRGAGVAVLNGKLFVCGGFDGSHAISCVEMYDPTRNEWKMMGNMTSPRSNAGIATVGNTIYAVGGFDGNEFLNTVEVYNLESNEWSPYTKIFQF","Homo sapiens","IVNS1ABP, ARA3, FLARA3, KIAA0850, NS1, NS1BP, HSPC068, KLHL39","Influenza virus NS1A-binding protein","1","5YY8"
"5YYA",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris (pH 6.5), 200 mM ammonium acetate, 25% (w/v) polyethylene glycol (PEG) 3350",277,"10.1016/j.str.2018.11.012",,"5YYA",19.5,"1.7","1.7","Crystal structure of Tandem Tudor Domain of human UHRF1","SDEDMWDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEEDVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYDAEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERPGE","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 ubiquitin-protein ligase UHRF1","1","5YYA"
"5YZ1",,"X-RAY DIFFRACTION",1.97,37.5,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 6000, 100mM sodium citrate pH5.0",290,"10.1016/j.biocel.2020.105744",,"5YZ1",43.95,"1.97","1.97","Crystal structure of human Archease","MAKGGSRVSNPAVMAQEEEDVRDYNLTEEQKAIKAKYPPVNRKYEYLDHTADVQLHAWGDTLEEAFEQCAMAMFGYMTDTGTVEPLQTVEVETQGDDLQSLLFHFLDEWLYKFSADEFFIPREVKVLSIDQRNFKLRSIGWGEEFSLSKHPQGTEVKAITYSAMQVYNEENPEVFVIIDILEHHHHHH","Homo sapiens","ZBTB8OS","Protein archease","1","5YZ1"
"5YZ5",,"X-RAY DIFFRACTION",2.78,55.71,"VAPOR DIFFUSION, SITTING DROP",5.6,"12% PEG 4000, 0.1M sodium citrate pH 5.6, 0.1M lithium sulfate",293,"10.1247/csf.17025",,"5YZ5",57.56,"1.8","1.8","Crystal Structure of Human CRMP-2 with T509D-T514D-S518D-S522D mutations","MSYQGKKNIPRITSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAELRGVPRGLYDGPVCEVSVDPKTVDPASDAKTDPAK","Homo sapiens","DPYSL2, CRMP2, ULIP2","Dihydropyrimidinase-related protein 2","1","5YZ5"
"5YZ9",,"SOLUTION NMR, SOLUTION SCATTERING",,,,,,,"10.1007/s13238-018-0518-7",,"5YZ9",11.88,,,"zinc finger domain of METTL3-METTL14 N6-methyladenosine methyltransferase","AHMSIVEKFRSRGRAQVQEFCDYGTKEECMKASDADRPCRKLHFRRIINKHTDESLGDCSFLNTCFHMDTCKYVHYEIDASMDSEAPGSKDHTPSQELALTQ","Homo sapiens","METTL3, MTA70","N6-adenosine-methyltransferase catalytic subunit","1","5YZ9"
"5YZA",,"X-RAY DIFFRACTION",2.7,54.39,"VAPOR DIFFUSION, SITTING DROP",,"12% PEG 4000, 0.1M sodium citrate pH 5.6, 0.1M lithium sulfate",293,"10.1247/csf.17025",,"5YZA",57.41,"2.3","2.3","Crystal Structure of Human CRMP-2 with S522D mutation","MSYQGKKNIPRITSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAELRGVPRGLYDGPVCEVSVTPKTVTPASSAKTDPAK","Homo sapiens","DPYSL2, CRMP2, ULIP2","Dihydropyrimidinase-related protein 2","1","5YZA"
"5YZB",,"X-RAY DIFFRACTION",2.77,55.59,"VAPOR DIFFUSION, SITTING DROP",,"14% PEG 3000, 0.1M tri-sodium citrate pH 5.5",277,"10.1247/csf.17025",,"5YZB",57.47,"2.8","2.8","Crystal Structure of Human CRMP-2 with S522D-T509D-T514D-S518D mutations crystallized with GSK3b","MSYQGKKNIPRITSDRLLIKGGKIVNDDQSFYADIYMEDGLIKQIGENLIVPGGVKTIEAHSRMVIPGGIDVHTRFQMPDQGMTSADDFFQGTKAALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSKSCCDYSLHVDISEWHKGIQEEMEALVKDHGVNSFLVYMAFKDRFQLTDCQIYEVLSVIRDIGAIAQVHAENGDIIAEEQQRILDLGITGPEGHVLSRPEEVEAEAVNRAITIANQTNCPLYITKVMSKSSAEVIAQARKKGTVVYGEPITASLGTDGSHYWSKNWAKAAAFVTSPPLSPDPTTPDFLNSLLSCGDLQVTGSAHCTFNTAQKAVGKDNFTLIPEGTNGTEERMSVIWDKAVVTGKMDENQFVAVTSTNAAKVFNLYPRKGRIAVGSDADLVIWDPDSVKTISAKTHNSSLEYNIFEGMECRGSPLVVISQGKIVLEDGTLHVTEGSGRYIPRKPFPDFVYKRIKARSRLAELRGVPRGLYDGPVCEVSVDPKTVDPASDAKTDPAK","Homo sapiens","DPYSL2, CRMP2, ULIP2","Dihydropyrimidinase-related protein 2","1","5YZB"
"5YZJ",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 400, 100mM HEPES/Sodium hydroxide pH 7.5, 200mM Magnesium chloride",290,,,"5YZJ",43.59,"2.79","2.79","Crystal structure of human Archease mutant D51A","MAKGGSRVSNPAVMAQEEEDVRDYNLTEEQKAIKAKYPPVNRKYEYLDHTAAVQLHAWGDTLEEAFEQCAMAMFGYMTDTGTVEPLQTVEVETQGDDLQSLLFHFLDEWLYKFSADEFFIPREVKVLSIDQRNFKLRSIGWGEEFSLSKHPQGTEVKAITYSAMQVYNEENPEVFVIIDILEHHHHHH","Homo sapiens","ZBTB8OS","Protein archease","1","5YZJ"
"5YZL",,"X-RAY DIFFRACTION",2.22,44.53,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 400, 100mM HEPES/Sodium hydroxide pH 7.5, 200mM Magnesium chloride",290,,,"5YZL",43.59,"3.4","3.4","Crystal structure of human Archease D178A","MAKGGSRVSNPAVMAQEEEDVRDYNLTEEQKAIKAKYPPVNRKYEYLDHTADVQLHAWGDTLEEAFEQCAMAMFGYMTDTGTVEPLQTVEVETQGDDLQSLLFHFLDEWLYKFSADEFFIPREVKVLSIDQRNFKLRSIGWGEEFSLSKHPQGTEVKAITYSAMQVYNEENPEVFVIIAILEHHHHHH","Homo sapiens","ZBTB8OS","Protein archease","1","5YZL"
"5Z02",,"X-RAY DIFFRACTION",1.92,36.02,"VAPOR DIFFUSION, HANGING DROP",,"0.2 Ammonium acetate, 20% ammonium sulfate",291,,"NUT","5Z02",13.54,"1.35","1.35","Crystal structure of HIS6-tagged Mdm2 with nutlin-3a","GSSHHHHHHSQDLENLYFQGSQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQ","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","5Z02"
"5Z0B",,"X-RAY DIFFRACTION",2.46,49.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG600, Ammonium sulfate, MES",296,,,"5Z0B",207.98,"2.17","2.17","Crystal structure of plasma-derived human serum albumin","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","5Z0B"
"5Z0S",,"X-RAY DIFFRACTION",2.71,54.58,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris pH 6.5, 0.3M (NH4)2SO4, 15-20% PEG10000, 5% EG",277,"10.3390/molecules23030698",,"5Z0S",70.99,"2.45","2.45","Crystal structure of FGFR1 kinase domain in complex with a novel inhibitor","AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","5Z0S"
"5Z14",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000, calcium chloride, Tris-HCl, ethylene glycol",293,,,"5Z14",190.71,"2.8","2.8","Crystal structure of human TLR8 in complex with CU-CPT9a","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","5Z14"
"5Z15",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000, calcium chloride, Tris-HCl, ethylene glycol",293,,,"5Z15",191.28,"2.9","2.9","Crystal structure of human TLR8 in complex with CU-CPT9c","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","5Z15"
"5Z1C",,"X-RAY DIFFRACTION",2.16,43.15,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate (pH 4.6), 2.0M ammonium sulfate supplemented with 5% PEG 400",298,,,"5Z1C",27.82,"1.45","1.45","The crystal structure of uPA in complex with 4-Iodobenzylamine at pH7.4","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","5Z1C"
"5Z1D",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, sodium citrate",277,"10.1016/j.chembiol.2018.10.011",,"5Z1D",37.5,"2.28","2.28","MAP2K7 C276S mutant-inhibitor","MTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLSDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSGVLSQPHLPFFRHHHHHH","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","5Z1D"
"5Z1E",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, sodium citrate",277,"10.1016/j.chembiol.2018.10.011",,"5Z1E",37.26,"2.3","2.3","MAP2K7 C218S mutant-inhibitor","MTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTSAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSGVLSQPHLPFFRHHHHHH","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","5Z1E"
"5Z1R",,"X-RAY DIFFRACTION",1.97,37.41,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.1M HEPES, 10% EtGhly, PH8.2",277,"10.1021/acsmedchemlett.8b00003","EFL","5Z1R",17.55,"1.62","1.62","Crystal Structure Analysis of the BRD4","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z1R"
"5Z1S",,"X-RAY DIFFRACTION",1.93,36.11,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.1M HEPES, 10% EtGhly, PH7.0",277,"10.1021/acsmedchemlett.8b00003","EFM","5Z1S",17.64,"1.42","1.42","Crystal Structure Analysis of the BRD4(1)","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z1S"
"5Z1T",,"X-RAY DIFFRACTION",1.92,36.05,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.1M HEPES, 10% EtGhly, PH7.5",277,"10.1021/acsmedchemlett.8b00003","EFN","5Z1T",17.66,"1.42","1.42","Crystal Structure Analysis of the BRD4(1)","MKKGHHHHHHLVPRGSNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z1T"
"5Z2C",,"X-RAY DIFFRACTION",3.3,62.76,"VAPOR DIFFUSION, HANGING DROP",4,"1.4M sodium formate, 0.1M sodium acetate",293,"10.1038/s41586-018-0433-3",,"5Z2C",451.49,"2.594","2.594","Crystal structure of ALPK-1 N-terminal domain in complex with ADP-heptose","MNNQKVVAVLLQECKQVLDQLLLEAPDVSEEDKSEDQRCRALLPSELRTLIQEAKEMKWPFVPEKWQYKQAVGPEDKTNLKDVIGAGLQQLLASLRASILARDCAAAAAIVFLVDRFLYGLDVSGKLLQVAKGLHKLQPATPIAPQVVIRQARISVNSGKLLKAEYILSSLISNNGATGTWLYRNESDKVLVQSVCIQIRGQILQKLGMWYEAAELIWASIVGYLALPQPDKKGLSTSLGILADIFVSMSKNDYEKFKNNPQINLSLLKEFDHHLLSAAEACKLAAAFSAYTPLFVLTAVNIRGTCLLSYSSSNDCPPELKNLHLCEAKEAFEIGLLTKRDDEPVTGKQELHSFVKAAFGLTTVHRRLHGETGTVHAASQLCKEAMGKLYNFSTSSRSQDREALSQEVMSVIAQVKEHLQVQSFSNVDDRSYVPESFECRLDKLIL","Homo sapiens","ALPK1, KIAA1527, LAK","Alpha-protein kinase 1","1","5Z2C"
"5Z2S",,"X-RAY DIFFRACTION",1.84,33.27,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000",273,"10.1038/s41375-018-0093-1",,"5Z2S",6.29,"1.5","1.5","Crystal structure of DUX4-HD2 domain","GSHMAVTGSQTALLLRAFEKDRFPGIAAREELARETGLPESRIQIWFQNRRARHP","Homo sapiens","DUX4, DUX10","Double homeobox protein 4","1","5Z2S"
"5Z55",,"SOLUTION NMR",,,,,,,"10.1007/s12104-017-9797-9",,"5Z55",9.56,,,"NMR Solution Structure of the Kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)","GSKCYNSTGVDYRGTVSVTKSGRQCQPWNSQYPHTHTFTALRFPELNGGHSYCRNPGNQKEAPWCFTLDENFKSDLCDIPACDSK","Homo sapiens","ROR1, NTRKR1","Inactive tyrosine-protein kinase transmembrane receptor ROR1","1","5Z55"
"5Z5O",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, HANGING DROP",,"100mM Na-K Phosphate 6.2, 20 % MPD, 12mM (NH4)2SO4, 10% PEG 3350",293,"10.1111/febs.14655",,"5Z5O",52.31,"1.92","1.92","Structure of Pycnonodysostosis disease related I249T mutant of human cathepsin K","MGSSHHHHHHSSGLVPRGSHMLYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQ","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","2","5Z5O"
,,,,,,,,,,,,,,,,"MGSSHHHHHHSSGLVPRGSHMLYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVDYRKKGYVTPVKNQGQCGSSWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVATDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","5Z5O"
"5Z5T",,"X-RAY DIFFRACTION",2.06,40.18,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,"10.1038/s41389-018-0093-z",,"5Z5T",15.11,"1.991","1.991","The first bromodomain of BRD4 with compound BDF-2141","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z5T"
"5Z5U",,"X-RAY DIFFRACTION",2,38.58,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,"10.1038/s41389-018-0093-z",,"5Z5U",15.13,"1.631","1.631","The first bromodomain of BRD4 with compound BDF-2254","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z5U"
"5Z5V",,"X-RAY DIFFRACTION",2.01,38.89,"VAPOR DIFFUSION, SITTING DROP",,"10-15% glycerol, 4M sodium formate",289,"10.1038/s41389-018-0093-z","96X","5Z5V",15.17,"1.66","1.66","The first bromodomain of BRD4 with compound BDF-1253","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z5V"
"5Z5W",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-05242-0",,"5Z5W",1.56,,,"VFR12 in complex with LPS micelles","VFRLKKWIQKVI","Homo sapiens","F2","Peptide from Prothrombin","1","5Z5W"
"5Z5X",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-05242-0",,"5Z5X",2.28,,,"HVF18 in complex with LPS micelles","HVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Peptide from Prothrombin","1","5Z5X"
"5Z6Q",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, SITTING DROP",,"3M (NH4)2SO4, 100mM NH4Cl",293,"10.1002/1873-3468.13075",,"5Z6Q",42.78,"3","3","Crystal structure of AAA of Spastin","GPGSSGAVPKRKDPLTHTSNSLPRSKTVMKTGSAGLSGHHRAPSYSGLSMVSGVKQGSGPAPTTHKGTPKTNRTNKPSTPTTATRKKKDLKNFRNVDSNLANLIMNEIVDNGTAVKFDDIAGQDLAKQALQEIVILPSLRPELFTGLRAPARGLLLFGPPGNGKTMLAKAVAAESNATFFNISAASLTSKYVGEGEKLVRALFAVARELQPSIIFIDEVDSLLCERREGEHDASRRLKTEFLIEFDGVQSAGDDRVLVMGATNRPQELDEAVLRRFIKRVYVSLPNEETRLLLLKNLLCKQGSPLTQKELAQLARMTDGYSGSDLTALAKDAALGPIRELKPEQVKNMSASEMRNIRLSDFTESLKKIKRSVSPQTLEAYIRWNKDFGDTTV","Homo sapiens","SPAST, ADPSP, FSP2, KIAA1083, SPG4","Spastin","1","5Z6Q"
"5Z6R",,"X-RAY DIFFRACTION",2.29,46.22,"VAPOR DIFFUSION, HANGING DROP",8.2,"25MM TRIS-HCL, 1MM DTT, 1MM MGCL2, 1MM ATP, 2% PEG 3350, 20MM KSCN",293,,,"5Z6R",43.25,"3","3","SPASTIN AAA WITH ATP","GPGSSGAVPKRKDPLTHTSNSLPRSKTVMKTGSAGLSGHHRAPSYSGLSMVSGVKQGSGPAPTTHKGTPKTNRTNKPSTPTTATRKKKDLKNFRNVDSNLANLIMNEIVDNGTAVKFDDIAGQDLAKQALQEIVILPSLRPELFTGLRAPARGLLLFGPPGNGKTMLAKAVAAESNATFFNISAASLTSKYVGEGEKLVRALFAVARELQPSIIFIDQVDSLLCERREGEHDASRRLKTEFLIEFDGVQSAGDDRVLVMGATNRPQELDEAVLRRFIKRVYVSLPNEETRLLLLKNLLCKQGSPLTQKELAQLARMTDGYSGSDLTALAKDAALGPIRELKPEQVKNMSASEMRNIRLSDFTESLKKIKRSVSPQTLEAYIRWNKDFGDTTV","Homo sapiens","SPAST, ADPSP, FSP2, KIAA1083, SPG4","Spastin","1","5Z6R"
"5Z7A",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, SITTING DROP",6.7,"PEG 3350, 0.2 M potassium sulfate",289,"10.1073/pnas.1811421115",,"5Z7A",30.55,"2.38","2.38","Crystal structure of NDP52 SKICH region","MEETIKDPPTSAVLLDHCHFSQVIFNSVEKFYIPGGDVTCHYTFTQHFIPRRKDWIGIFRVGWKTTREYYTFMWVTLPIDLNNKSAKQQEVQFKAYYLPKDDEYYQFCYVDEDGVVRGASIPFQFR","Homo sapiens","CALCOCO2, NDP52","Calcium-binding and coiled-coil domain-containing protein 2","1","5Z7A"
"5Z80",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-05810-4",,"5Z80",9.61,,,"Solution structure for the 1:1 complex of a platinum(II)-based tripod bound to a hybrid-1 human telomeric G-quadruplex","AAAGGGTTAGGGTTAGGGTTAGGGAA","Homo sapiens",,"G-quadruplex DNA (26-MER)","1","5Z80"
"5Z8F",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-05810-4",,"5Z8F",21.96,,,"Solution structure for the unique dimeric 4:2 complex of a platinum(II)-based tripod bound to a hybrid-1 human telomeric G-quadruplex","AAAGGGTTAGGGTTAGGGTTAGGGAA","Homo sapiens",,"G-quadruplex DNA (26-MER)","1","5Z8F"
"5Z8G",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, SITTING DROP",,"4M sodium formate, 15% glycerol",289.15,,"99L","5Z8G",15.54,"1.701","1.701","BRD4 Bromodomain 1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z8G"
"5Z8J",,"X-RAY DIFFRACTION",3.05,59.63,"EVAPORATION",8.5,"3.4M 1,6-Hexanediol, 0.1M Tris-HCl",297,"10.1186/s12951-019-0512-0",,"5Z8J",21.03,"2.3","2.3","Human mitochondrial ferritin mutant - E27C/E62C/C102G/C130G","PAAGPSRVRQNFHPDSEAAINRQINLCLYASYVYLSMAYYFSRDDVALNNFSRYFLHQSRECTEHAEKLMRLQNQRGGRIRLQDIKKPEQDDWESGLHAMEGALLLEKNVNQSLLELHALASDKGDPHLGDFLETYYLNEQVKSIKELGDHVHNLVKMGAPDAGLAEYLFDTHTLGNENKQN","Homo sapiens","FTMT","Ferritin, mitochondrial","1","5Z8J"
"5Z8R",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",,"4M sodium formate, 15% glycerol",289,,,"5Z8R",15.46,"2","2","BRD4 Bromodomain 1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z8R"
"5Z8S",,"X-RAY DIFFRACTION",3.05,59.74,"EVAPORATION",,"0.1M Tris-HCl, 3.4M 1,6-Hexanediol",293,"10.1186/s12951-019-0512-0",,"5Z8S",21.2,"1.973","1.973","Human Mitochondrial ferritin mutant - C102A/C130A/E27C/E61C/E62C","PAAGPSRVRQNFHPDSEAAINRQINLCLYASYVYLSMAYYFSRDDVALNNFSRYFLHQSRCCTEHAEKLMRLQNQRGGRIRLQDIKKPEQDDWESGLHAMEGALLLEKNVNQSLLELHALASDKGDPHLGDFLETYYLNEQVKSIKELGDHVHNLVKMGAPDAGLAEYLFDTHTLGNENKQN","Homo sapiens","FTMT","Ferritin, mitochondrial","1","5Z8S"
"5Z8U",,"X-RAY DIFFRACTION",2.86,57,"EVAPORATION",,"Bicine, MgCl2",293,"10.1186/s12951-019-0512-0",,"5Z8U",41.97,"1.9","1.9","Human mitochondrial ferritin mutant - C102A/C130A","PAAGPSRVRQNFHPDSEAAINRQINLELYASYVYLSMAYYFSRDDVALNNFSRYFLHQSREETEHAEKLMRLQNQRGGRIRLQDIKKPEQDDWESGLHAMEAALLLEKNVNQSLLELHALASDKGDPHLADFLETYYLNEQVKSIKELGDHVHNLVKMGAPDAGLAEYLFDTHTLGNENKQN","Homo sapiens","FTMT","Ferritin, mitochondrial","1","5Z8U"
"5Z8X",,"X-RAY DIFFRACTION",4.4,72.04,"VAPOR DIFFUSION, SITTING DROP",5,"18% PEG 3350, 0.1 M ammonium sulfate, 0.1 M sodium malonate",293,"10.1038/s41467-018-06333-8",,"5Z8X",161.21,"3.15","3.15","Crystal structure of human LRRTM2","CPPKCRCEKLLFYCDSQGFHSVPNALDKGSLGLSLRHNHITELERDQFASFSQLTWLHLDHNQISTVKEDAFQGLYKLKELILSSNKIFYLPNTTFTQLINLQNLDLSFNQLSSLHPELFYGLRKLQTLHLRSNSLRTIPVRLFWDCRSLEFLDLSTNRLRSLARNGFAGLIKLRELHLEHNQLTKINFAHFLRLSSLHTLFLQWNKISNLTCGMEWTWGTLEKLDLTGNEIKAIDLTVFETMPNLKILLMDNNKLNSLDSKILNSLRSLTTVGLSGNLWECSARICALASWLGSFQGRWEHSILCHSPDHTQGEDILDAVHGFQLCWNLSTTVTVMATTHHHHHH","Homo sapiens","LRRTM2, KIAA0416, LRRN2","Leucine-rich repeat transmembrane neuronal protein 2","1","5Z8X"
"5Z8Z",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, SITTING DROP",,"4M sodium formate, 15% glycerol",289,,,"5Z8Z",15.46,"1.8","1.8","BRD4 Bromodomain 1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z8Z"
"5Z90",,"X-RAY DIFFRACTION",2.06,40.25,"VAPOR DIFFUSION, SITTING DROP",,"4M sodium formate, 15% glycerol",289,,"99U","5Z90",15.43,"1.8","1.8","BRD4 Bromodomain 1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z90"
"5Z91",,"X-RAY DIFFRACTION",3,58.98,"EVAPORATION",,"Bicine, MgCl2",293,"10.1186/s12951-019-0512-0",,"5Z91",21.42,"3.004","3.004","Human mitochondrial ferritin mutant bound with gold ions","PAAGPSRVRQNFHPDSEAAINRQINLELYASYVYLSMAYYFSRDDVALNNFSRYFLHQSREETEHAEKLMRLQNQRGGRIRLQDIKKPEQDDWESGLHAMECALLLEKNVNQSLLELHALASDKGDPHLCDFLETYYLNEQVKSIKELGDHVHNLVKMGAPDAGLAEYLFDTHTLGNENKQN","Homo sapiens","FTMT","Ferritin, mitochondrial","1","5Z91"
"5Z9C",,"SOLUTION NMR",,,,,,,"10.1128/JVI.02056-17",,"5Z9C",14.14,,,"Solution NMR structures of BRD4 first bromodomain with small compound MMQO","PNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z9C"
"5Z9K",,"X-RAY DIFFRACTION",2.11,41.7,"VAPOR DIFFUSION, SITTING DROP",,"4M sodium formate, 15% glycerol",289,,,"5Z9K",15.46,"1.89","1.89","BRD4 Bromodomain 1 with an inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5Z9K"
"5ZA1",,"X-RAY DIFFRACTION",3.32,62.95,"VAPOR DIFFUSION, SITTING DROP",,"0.1M BisTris propane pH6.5, 0.9M Ammonium tartrate",293,"10.1016/j.bmcl.2018.09.032","9A0","5ZA1",56.05,"2.52","2.52","Ligand complex of RORgt LBD","GSHNASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVV","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","5ZA1"
"5ZA7",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","HMX","5ZA7",28.85,"1.7","1.7","uPA-HMA","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZA7"
"5ZA8",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","27I","5ZA8",28.8,"1.9","1.9","uPA-BB2-27F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZA8"
"5ZA9",,"X-RAY DIFFRACTION",2.15,42.74,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","50I","5ZA9",28.84,"1.62","1.62","uPA-BB2-50F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZA9"
"5ZAE",,"X-RAY DIFFRACTION",2.14,42.55,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","EAU","5ZAE",28.88,"1.73","1.73","uPA-6F-HMA","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZAE"
"5ZAF",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","28I","5ZAF",28.79,"1.65","1.65","uPA-BB2-28F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZAF"
"5ZAG",,"X-RAY DIFFRACTION",2.15,42.79,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","94I","5ZAG",28.8,"1.95","1.95","uPA-BB2-94F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZAG"
"5ZAH",,"X-RAY DIFFRACTION",2.14,42.43,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","30I","5ZAH",28.83,"2.98","2.98","uPA-BB2-30F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZAH"
"5ZAJ",,"X-RAY DIFFRACTION",2.14,42.42,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","32I","5ZAJ",28.86,"1.65","1.65","uPA-31F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZAJ"
"5ZAN",,"X-RAY DIFFRACTION",2.81,56.3,"EVAPORATION",,"0.22M Sodium citrate tribasic dihydrate pH 6.0, 10%(v/v) 2-Propanol, 22(w/v) Polyethylene glycol 4,000",293,,,"5ZAN",32.99,"2.85","2.85","Crystal Structure of Aurora-A in complex with a new Quinazoline inhibitor","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","5ZAN"
"5ZAS",,"X-RAY DIFFRACTION",3.2,61.57,"VAPOR DIFFUSION, SITTING DROP",,"50mM cacodylate pH 6.0, 20mM magnesium acetate, 0.5mM spermine, 100mM NaCl, 25% MPD",277,"10.1039/c9sc02807b",,"5ZAS",6.27,"1.56","1.56","Crystal structure of 5-formylcytosine containing decamer dsDNA","CCAGCGCTGG","Homo sapiens",,"DNA (5'-D(*CP*CP*AP*GP*(5FC)P*GP*CP*TP*GP*G)-3')","1","5ZAS"
"5ZAT",,"X-RAY DIFFRACTION",2.11,37.37,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium succinat pH 5.5, 20mM MgCl2, 0.5mM spermine, 3.0 ammonium sulfate",277,"10.1039/c9sc02807b",,"5ZAT",6.18,"1.06","1.06","Crystal structure of 5-carboxylcytosine containing decamer dsDNA","CCAGXGCTGG","Homo sapiens",,"DNA (5'-D(*CP*CP*AP*GP*(CAC)P*GP*CP*TP*GP*G)-3')","1","5ZAT"
"5ZAZ",,"SOLUTION NMR",,,,,,,"10.1371/journal.pbio.2006525",,"5ZAZ",5.65,,,"Solution structure of integrin b2 monomer tranmembrane domain in bicelle","PVDESRESVAGPNIAAIVGGTVAGIVLIGILLLVIWKALIHLSDLREYRRFE","Homo sapiens","ITGB2, CD18, MFI7","Integrin beta-2","1","5ZAZ"
"5ZBG","4.36","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-018-0038-2",,"5ZBG",389.86,"4.36",,"Cryo-EM structure of human TRPC3 at 4.36A resolution","MEGSPSLRRMTVMREKGRRQAVRGPAFMFNDRGTSLTAEEERFLDAAEYGNIPVVRKMLEESKTLNVNCVDYMGQNALQLAVGNEHLEVTELLLKKENLARIGDALLLAISKGYVRIVEAILNHPGFAASKRLTLSPCEQELQDDDFYAYDEDGTRFSPDITPIILAAHCQKYEVVHMLLMKGARIERPHDYFCKCGDCMEKQRHDSFSHSRSRINAYKGLASPAYLSLSSEDPVLTALELSNELAKLANIEKEFKNDYRKLSMQCKDFVVGVLDLCRDSEEVEAILNGDLESAEPLEVHRHKASLSRVKLAIKYEVKKFVAHPNCQQQLLTIWYENLSGLREQTIAIKCLVVLVVALGLPFLAIGYWIAPCSRLGKILRSPFMKFVAHAASFIIFLGLLVFNASDRFEGITTLPNITVTDYPKQIFRVKTTQFTWTEMLIMVWVLGMMWSECKELWLEGPREYILQLWNVLDFGMLSIFIAAFTARFLAFLQATKAQQYVDSYVQESDLSEVTLPPEIQYFTYARDKWLPSDPQIISEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTVKDIFKFMVLFIMVFFAFMIGMFILYSYYLGAKVNAAFTTVEESFKTLFWSIFGLSEVTSVVLKYDHKFIENIGYVLYGIYNVTMVVVLLNMLIAMINSSYQEIEDDSDVEWKFARSKLWLSYFDDGKTLPPPFSLVPSPKSFVYFIMRIVNFPKCRRRRLQKDIEMGMGNSKSRLNLFTQSNSRVFESHSFNSILNQPTRYQQIMKRLIKRYVLKAQVDKENDEVNEGELKEIKQDISSLRYELLEDKSQATEELAILIHKLSEKLNPSMLRCE","Homo sapiens","TRPC3, TRP3","Short transient receptor potential channel 3","1","5ZBG"
"5ZBZ",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, HANGING DROP",7,"Sodium malonate",293,"10.1016/j.chembiol.2019.07.010","SAU","5ZBZ",25.36,"1.30860259206","1.30860259206","Crystal structure of the DEAD domain of Human eIF4A with sanguinarine","GEGVIESNWNEIVDSFDDMNLSESLLRGIYAYGFEKPSAIQQRAILPCIKGYDVIAQAQSGTGKTATFAISILQQIELDLKATQALVLAPTRELAQQIQKVVMALGDYMGASCHACIGGTNVRAEVQKLQMEAPHIIVGTPGRVFDMLNRRYLSPKYIKMFVLDEADEMLSRGFKDQIYDIFQKLNSNTQVVLLSATMPSDVLEVTKKFMRDPIRILVKK","Homo sapiens","EIF4A1, DDX2A, EIF4A","Eukaryotic initiation factor 4A-I","1","5ZBZ"
"5ZC4",,"X-RAY DIFFRACTION",3,58.94,"VAPOR DIFFUSION, HANGING DROP",7,"100% Tacsimate",293,,,"5ZC4",17.94,"1.906","1.906","Crystal Structure of RNF13 RING domain","MNRLRKDQLKKLPVHKFKKGDEYDVCAICLDEYEDGDKLRILPCSHAYHCKCVDPWLTKTKKTCPVCKQKVVPSQG","Homo sapiens","RNF13, RZF","E3 ubiquitin-protein ligase RNF13","1","5ZC4"
"5ZC5",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate pH 4.6, 1.95M (NH4)2SO4, 0.03% NaN3, 5% PEG 400",298,"10.1021/acs.jmedchem.8b00838","09I","5ZC5",28.85,"1.9","1.9","uPA-NU-09F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator chain B","1","5ZC5"
"5ZC6",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.8b00680",,"5ZC6",19.68,,,"Solution structure of H-RasT35S mutant protein in complex with KBFM123","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPSIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","5ZC6"
"5ZCK",,"X-RAY DIFFRACTION",1.52,19.07,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M magnesium chloride, 0.1 M sodium cacodylate, 20% (v/v) PEG 200",293,"10.1016/j.cell.2018.03.032",,"5ZCK",0.42,"1.271","1.271","Structure of the RIP3 core region","VQVG","Homo sapiens","RIPK3, RIP3","peptide from Receptor-interacting serine/threonine-protein kinase 3","1","5ZCK"
"5ZD0",,"SOLUTION NMR",,,,,,,"10.1002/anie.201900840",,"5ZD0",8.46,,,"Solution structure of human ubiquitin with three alanine mutations in living eukaryotic cells by in-cell NMR spectroscopy","MQIFVKTATGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLAFAGKQLEDGRTLSDYNIQKESTLHLALRLRGG","Homo sapiens","UBB","ubiquitin","1","5ZD0"
"5ZE3",,"X-RAY DIFFRACTION",2.96,58.44,"VAPOR DIFFUSION, HANGING DROP",,"28% PEG 2000, 100mM Li2SO4, 100mM HEPES, pH 7.6",291,"10.1073/pnas.1720859115",,"5ZE3",103.03,"2.4","2.4","Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state","AYKPEQPLVRLRGGAYIGEGRVEVLKNGEWGTVCDDKWDLVSASVVCRELGFGSAKEAVTGSRLGQGIGPIHLNEIQCTGNEKSIIDCKFNAESQGCNHEEDAGVRCNTPAMGLQKKLRLNGGRNPYEGRVEVLVERQGSLVWGMVCGQNWGIVEAMVVCRQLGLGFASNAFQETWYWHGDVNSNKVVMSGVKCSGTELSLAHCRHDGEDVACPQGGVQYGAGVACSETAPDLVLNAEMVQQTTYLEDRPMFLLQCAMEENCLSASAAQTDPTTGYRRLLRFSSQIHNNGQSDFRPKNGRHAWIWHDCHRHYHSMEVFTHYDLLNLNGTKVAEGHKASFCLEDTECEGDIQKNYECANFGDQGITMGCWDMYRHDIDCQWVDITDVPPGDYLFQVVINPNFEVAESDYSNNIMKCRSRYDGHRIWMYNCHIGGSFSEETEKKFEHFSGLLNNQLSPQ","Homo sapiens","LOXL2","Lysyl oxidase homolog 2","1","5ZE3"
"5ZF4",,"X-RAY DIFFRACTION",3.41,63.9,"VAPOR DIFFUSION, HANGING DROP",4.9,"100MM SODIUM ACETATE, 1.8-1.9M AMMONIUM SULPHATE, 40MM C11DAO, 20.8MM DDAO, 2MM DIHYDROOROTATE",293,"10.3389/fphar.2018.00997","9BL","5ZF4",44.3,"1.66","1.66","Structure of human dihydroorotate dehydrogenase in complex with 275-10-COOMe","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","5ZF4"
"5ZF6",,"X-RAY DIFFRACTION",2.36,47.85,"VAPOR DIFFUSION, HANGING DROP",,"0.1M citrate buffer (pH 5.0), 10% (v/v) 2-propanol, 26% (v/v) polyethylene glycol 400",298.15,"10.1093/nar/gky642",,"5ZF6",141.43,"2.796","2.796","Crystal structure of the dimeric human PNPase","MGSSHHHHHHSSGLVPRGSHMASAVAVDLGNRKLEISSGKLARFADGSAVVQSGDTAVMVTAVSKTKPSPSQFMPLVVDYRQKAAAAGRIPTNYLRREIGTSDKEILTSRIIDRSIRPLFPAGYFYDTQVLCNLLAVDGVNEPDVLAINGASVALSLSDIPWNGPVGAVRIGIIDGEYVVNPTRKEMSSSTLNLVVAGAPKSQIVMLEASAENILQQDFCHAIKVGVKYTQQIIQGIQQLVKETGVTKRTPQKLFTPSPEIVKYTHKLAMERLYAVFTDYEHDKVSRDEAVNKIRLDTEEQLKEKFPEADPYEIIESFNVVAKEVFRSIVLNEYKRCDGRDLTSLRNVSCEVDMFKTLHGSALFQRGQTQVLCTVTFDSLESGIKSDQVITAINGIKDKNFMLHYEFPPYATNEIGKVTGLNRRELGHGALAEKALYPVIPRDFPFTIRVTSEVLESNGSSSMASACGGSLALMDSGVPISSAVAGVAIGLVTKTDPEKGEIEDYRLLTDILGIEDYNGDMDFKIAGTNKGITALQADIKLPGIPIKIVMEAIQQASVAKKEILQIMNKTISKPRASRKENGPVVETVQVPLSKRAKFVGPGGYNLKKLQAETGVTISQVDEETFSVFAPTPSAMHEARDFITEICK","Homo sapiens","PNPT1, PNPASE","Polyribonucleotide nucleotidyltransferase 1, mitochondrial","1","5ZF6"
"5ZF7",,"X-RAY DIFFRACTION",3.41,63.92,"VAPOR DIFFUSION, HANGING DROP",4.9,"100MM SODIUM ACETATE, 1.8-1.9M AMMONIUM SULPHATE, 40MM C11DAO, 20.8MM DDAO, 2MM DIHYDROOROTATE",293,"10.3389/fphar.2018.00997","CHW","5ZF7",44.01,"1.79","1.79","Structure of human dihydroorotate dehydrogenase in complex with 277-9-OH","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","5ZF7"
"5ZF8",,"X-RAY DIFFRACTION",3.4,63.82,"VAPOR DIFFUSION, HANGING DROP",4.9,"100MM SODIUM ACETATE, 1.8-1.9M AMMONIUM SULPHATE, 40MM C11DAO, 20.8MM DDAO, 2MM DIHYDROOROTATE",293,"10.3389/fphar.2018.00997","9BO","5ZF8",44.17,"1.7","1.7","Structure of human dihydroorotate dehydrogenase in complex with 277-11-OAc","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","5ZF8"
"5ZF9",,"X-RAY DIFFRACTION",3.41,63.96,"VAPOR DIFFUSION, HANGING DROP",4.9,"100MM SODIUM ACETATE, 1.8-1.9M AMMONIUM SULPHATE, 40MM C11DAO, 20.8MM DDAO, 2MM DIHYDROOROTATE",293,"10.3389/fphar.2018.00997","9BR","5ZF9",44.07,"1.77","1.77","Structure of human dihydroorotate dehydrogenase in complex with 280-12","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","5ZF9"
"5ZFA",,"X-RAY DIFFRACTION",3.4,63.83,"VAPOR DIFFUSION, HANGING DROP",4.9,"100MM SODIUM ACETATE, 1.8-1.9M AMMONIUM SULPHATE, 40MM C11DAO, 20.8MM DDAO, 2MM DIHYDROOROTATE",293,"10.3389/fphar.2018.00997","9BU","5ZFA",44.12,"1.75","1.75","Structure of human dihydroorotate dehydrogenase in complex with 287-12-OCOiPr","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","5ZFA"
"5ZFB",,"X-RAY DIFFRACTION",3.42,64,"VAPOR DIFFUSION, HANGING DROP",4.9,"100MM SODIUM ACETATE, 1.8-1.9M AMMONIUM SULPHATE, 40MM C11DAO, 20.8MM DDAO, 2MM DIHYDROOROTATE",293,"10.3389/fphar.2018.00997",,"5ZFB",44.31,"2","2","Structure of human dihydroorotate dehydrogenase in complex with ascofuranone (open-form)","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","5ZFB"
"5ZG1",,"X-RAY DIFFRACTION",2.34,47.48,"VAPOR DIFFUSION, SITTING DROP",4.9,"15% PEG 3350, 0.1M SODIUM ACETATE, 0.1M ZINC ACETATE",277,"10.1038/s41386-018-0213-7","9C0","5ZG1",60.22,"1.32","1.32","Crystal structure of the GluA2o LBD in complex with glutamate and Compound-2","GSNKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS","Homo sapiens","GLUR2","Glutamate receptor 2","1","5ZG1"
,,,,,,,,,,,,,,,,,"Homo sapiens","GLUR2"
"5ZG2",,"X-RAY DIFFRACTION",2.16,43.05,"VAPOR DIFFUSION, SITTING DROP",4.9,"15% PEG 3350, 0.1 M SODIUM ACETATE, 0.1 M ZINC ACETATE",277,"10.1038/s41386-018-0213-7",,"5ZG2",60.5,"1.25","1.25","Crystal structure of the GluA2o LBD in complex with ZK200775 and Compound-2","GSNKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS","Homo sapiens","GLUR2","Glutamate receptor 2","1","5ZG2"
,,,,,,,,,,,,,,,,,"Homo sapiens","GLUR2"
"5ZG3",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, SITTING DROP",4.9,"15% PEG 3350, 0.1M SODIUM ACETATE, 0.1M ZINC ACETATE",277,"10.1038/s41386-018-0213-7","9C6","5ZG3",179.4,"1.65","1.65","Crystal structure of the GluA2o LBD in complex with glutamate and TAK-137","GSNKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS","Homo sapiens","GLUR2","Glutamate receptor 2","1","5ZG3"
,,,,,,,,,,,,,,,,,"Homo sapiens","GLUR2"
"5ZGD",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"ammonium sulfate, HEPES",289.15,"10.1038/s41467-019-09902-7",,"5ZGD",0.88,"1.401","1.401","hnRNPA1 reversible amyloid core GFGGNDNFG (residues 209-217) determined by X-ray","GFGGNDNFG","Homo sapiens","HNRNPA1, HNRPA1","GLY-PHE-GLY-GLY-ASN-ASP-ASN-PHE-GLY","1","5ZGD"
"5ZGG",,"SOLUTION NMR",,,,,,,"10.1016/j.chembiol.2018.09.007",,"5ZGG",7.66,,,"NMR structure of p75NTR transmembrane domain in complex with NSC49652","TRGTTDNLIPVYCSILAAVVVGLVAYIAFKRWNS","Homo sapiens","NGFR, TNFRSF16","Tumor necrosis factor receptor superfamily member 16","1","5ZGG"
"5ZGL",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M  ammonium sulfate, 30% PEG 4000",289.15,"10.1038/s41467-019-09902-7",,"5ZGL",1.11,"0.95","0.95","hnRNP A1 segment GGGYGGS (residues 234-240)","GGGYGGS","Homo sapiens","HNRNPA1, HNRPA1","7-mer peptide from Heterogeneous nuclear ribonucleoprotein A1","1","5ZGL"
"5ZHU",,"X-RAY DIFFRACTION",2.56,51.87,"VAPOR DIFFUSION, HANGING DROP",,"0.2M (NH4)2SO4, 0.1M HEPES pH7.0, 22.5% PEG 3350",289,"10.1016/j.jsb.2018.04.007",,"5ZHU",63.12,"2.202","2.202","Crystal structure of the DNA-binding domain of human myelin-gene regulatory factor","QSIKWQPHQQNKWATLYDANYKELPMLTYRVDADKGFNFSVGDDAFVCQKKNHFQVTVYIGMLGEPKYVKTPEGLKPLDCFYLKLHGVKLEALNQSINIEQSQSDRSKRPFNPVTVNLPPEQVTKVTVGRLHFSETTANNMRKKGKPNPDQRYFMLVVALQAHAQNQNYTLAAQISERIIVRA","Homo sapiens","MYRF, C11orf9, KIAA0954, MRF","Myelin regulatory factor","1","5ZHU"
"5ZI6",,"X-RAY DIFFRACTION",2.23,44.93,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M Ammonium Acetate, 0.1M Bis-Tris pH 6.5, 25%(w/v) PEG3350",291,"10.1002/pro.3473",,"5ZI6",49.49,"2.2","2.2","The RING domain structure of MEX-3C","KHDCVICFENEVIAALVPCGHNLFCMECANKICEKRTPSCPVCQTAVTQAIQIHS","Homo sapiens","MEX3C, RKHD2, RNF194, BM-013","RNA-binding E3 ubiquitin-protein ligase MEX3C","1","5ZI6"
"5ZIB",,"X-RAY DIFFRACTION",2.59,52.43,"VAPOR DIFFUSION, SITTING DROP",7,"0.15M DL-malic acid (pH 7.0), 20% (w/v) polyethylene glycol (PEG) 3350",293,"10.1038/s41467-018-05931-w",,"5ZIB",71.81,"1.9","1.9","Crystal structure of human GnT-V luminal domain in apo form","GKDGSTAVPSLVALEKINVADIINGAQEKCVLPPMDGYPHCEGKIKWMKDMWRSDPCYADYGVDGSTCSFFIYLSEVENWCPHLPWRAKNPYEEADHNSLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMKKVVGNRSGCPTVGDRIVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL","Homo sapiens","MGAT5, GGNT5","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A","1","5ZIB"
"5ZIC",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M Hepes (pH 7.0), 0.1M magnesium chloride, 15 % (w/v) PEG 4000",293,"10.1038/s41467-018-05931-w",,"5ZIC",120.72,"2.1","2.1","Crystal structure of human GnT-V luminal domain in complex with acceptor sugar","GKDGSNSLAEIRTDFNILYSMMKKHEEFRWMRLRIRRMADAWIQAIKSLAEKQNLEKRKRKKVLVHLGLLTKESGFKIAETAFSGGPLGELVQWSDLITSLYLLGHDIRISASLAELKEIMKGGGGIVELIYIDIVGLAQFKKTLGPSWVHYQCMLRVLDSFGTEPEFNHANYAQSKGHKTPWGKWNLNPQQFYTMFPHTPDNSFLGFVVEQHLNSSDIHHINEIKRQNQSLVYGKVDSFWKNKKIYLDIIHTYMEVHATVYGSSTKNIPSYVKNHGILSGRDLQFLLRETKLFVGLGFPYEGPAPLEAIANGCAFLNPKFNPPKSSKNTDFFIGKPTLRELTSQHPYAEVFIGRPHVWTVDLNNQEEVEDAVKAILNQKIEPYMPYEFTCEGMLQRINAFIEKQDFCHGQVMWPPLSALQVKLAEPGQSCKQVCQESQLICEPSFFQHLNKDKDMLKYKVTCQSSELAKDILVPSFDPKNKHCVFQGDLLLFSCAGAHPRHQRVCPCRDFIKGQVALCKDCL","Homo sapiens","MGAT5, GGNT5","Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A","1","5ZIC"
,,,,,,,,,,,,,,,,,"Homo sapiens","MGAT5, GGNT5"
"5ZID",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, HANGING DROP",,"100mM Tris pH 8, 18% PEG 3350, 200mM NaCl",289,,"9EL","5ZID",172.44,"3","3","Crystal Structure of human DPP-IV in complex with HL2","RKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPGHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","5ZID"
"5ZJ6",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris-HCl (pH 8.5)
25 % (v/v) PEG 10,000",288,"10.1016/j.pep.2018.05.005","VSE","5ZJ6",66.17,"1.696","1.696","Crystal structure of HCK kinase complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine","GSSGSSGMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","5ZJ6"
"5ZJ9",,"X-RAY DIFFRACTION",2.26,45.67,"VAPOR DIFFUSION, HANGING DROP",,"15%(w/v) PEG 4000, 0.2M ammonium acetate, 0.1M Na citrate at pH 8.0, 10%(v/v) glycerol.",293,"10.1016/j.ejmech.2018.09.040","9E6","5ZJ9",158.59,"2.6","2.6","human D-amino acid oxidase complexed with 5-chlorothiophene-3-carboxylic acid","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLS","Homo sapiens","DAO, DAMOX","D-amino-acid oxidase","1","5ZJ9"
"5ZJA",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, HANGING DROP",,"15%(w/v) PEG 4000, 0.2M ammonium acetate, 0.1M Na citrate at pH 8.0, and 10%(v/v) glycerol",293,"10.1016/j.ejmech.2018.09.040","9E9","5ZJA",158.41,"2.6","2.6","human D-amino acid oxidase complexed with 5-chlorothiophene-2-carboxylic acid","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLS","Homo sapiens","DAO, DAMOX","D-amino-acid oxidase","1","5ZJA"
"5ZJD",,"X-RAY DIFFRACTION",2.53,51.33,"VAPOR DIFFUSION, HANGING DROP",,"8% Tacsimate (pH 7.0), 20% polyethylene glycol (PEG) 3350",293,"10.3390/cancers11070963",,"5ZJD",305.6,"2.394","2.394","Lactate dehydrogenase with NADH and MLA","HHHHHHATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","5ZJD"
"5ZJE",,"X-RAY DIFFRACTION",2.41,48.93,"VAPOR DIFFUSION, HANGING DROP",6,"0.2M soduim malonnate, 20% Polyethylene glycol(PEG) 3350",293,"10.3390/cancers11070963",,"5ZJE",449.8,"2.929","2.929","LDHA-mla","HHHHHHATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","5ZJE"
"5ZJF",,"X-RAY DIFFRACTION",2.92,57.93,"VAPOR DIFFUSION, HANGING DROP",7,"8% Tacsimate (pH 7.0), 20% Polyethylene glycol (PEG) 3350",293,"10.3390/cancers11070963",,"5ZJF",449.51,"2.602","2.602","LDHA-MA","HHHHHHATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","5ZJF"
"5ZJW",,"X-RAY DIFFRACTION",2.07,40.68,"VAPOR DIFFUSION",6.5,"0.1 M Bis-tris pH 6.5, 25% PEG 3350, 0.2 M NaCl",291,,"9EO","5ZJW",34.23,"1.798","1.798","Crystal Structure of PAK4 in complex with inhibitor CZg353","SSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","5ZJW"
"5ZK3",,"X-RAY DIFFRACTION",2.55,51.75,"LIPIDIC CUBIC PHASE",,"50mM MES-NaOH pH 6.2-7.0, 26-32% PEG300, 300~500mM Ammonium Fluoride, 1% 1,2,3-heptanetriol, 0.5mM QNB and 5% DMSO",293,"10.1038/s41589-018-0152-y",,"5ZK3",47.63,"2.6","2.6","Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with QNB","GPMDDSTDSSDNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNARVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATRLEVLFQ","Homo sapiens","CHRM2","Muscarinic acetylcholine receptor M2,Apo-cytochrome b562,Muscarinic acetylcholine receptor M2","1","5ZK3"
,,,,,,,,,,,,,,,,,"Homo sapiens","CHRM2"
,,,,,,,,,,,,,,,,,"Homo sapiens","CHRM2"
"5ZKB",,"X-RAY DIFFRACTION",3.29,62.67,"LIPIDIC CUBIC PHASE",,"50mM MES-NaOH pH 6.2-7.0, 18 % PEG300, 100mM Magnesium acetate, 1% 1,2,3-heptanetriol, 0.5mM AF-DX 384 and 5% DMSO",293,"10.1038/s41589-018-0152-y",,"5ZKB",47.77,"2.95","2.95","Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with AF-DX 384","GPMDDSTDSSDNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNARVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATRLEVLFQ","Homo sapiens","CHRM2","Muscarinic acetylcholine receptor M2,Apo-cytochrome b562,Muscarinic acetylcholine receptor M2","1","5ZKB"
,,,,,,,,,,,,,,,,,"Homo sapiens","CHRM2"
,,,,,,,,,,,,,,,,,"Homo sapiens","CHRM2"
"5ZKC",,"X-RAY DIFFRACTION",2.54,51.66,"LIPIDIC CUBIC PHASE",,"50mM MES-NaOH pH 6.2-7.0, 26-32 % PEG300, 300~500mM Ammonium Fluoride, 1% 1,2,3-heptanetriol, 0.5mM NMS and 5% DMSO",293,"10.1038/s41589-018-0152-y","3C0","5ZKC",47.61,"2.3","2.3","Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with NMS","GPMDDSTDSSDNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNARVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIADLEDNWETLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTRNAYIQKYLPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATRLEVLFQ","Homo sapiens","CHRM2","Muscarinic acetylcholine receptor M2,Apo-cytochrome b562,Muscarinic acetylcholine receptor M2","1","5ZKC"
,,,,,,,,,,,,,,,,,"Homo sapiens","CHRM2"
,,,,,,,,,,,,,,,,,"Homo sapiens","CHRM2"
"5ZLC",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","DGT","5ZLC",41.15,"2","2","Binary complex of human DNA Polymerase Mu with MndGTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","5ZLC"
"5ZLD",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.1c00281",,"5ZLD",8.56,,,"SOLUTION NMR STRUCTURE OF A 14-MER DOUBLE STRANDED DNA DUPLEX CGCGAAATTTCGCG","CGCGAAATTTCGCG","Homo sapiens",,"DNA (5'-D(*CP*GP*CP*GP*AP*AP*AP*TP*TP*TP*CP*GP*CP*G)-3')","1","5ZLD"
"5ZLE",,"X-RAY DIFFRACTION",2.45,49.75,"LIPIDIC CUBIC PHASE",6.5,"20%(v/v) Jeffamine ED-2003, 0.1 M HEPES",293,"10.1038/s42003-018-0121-8",,"5ZLE",33.6,"2.6","2.6","Human duodenal cytochrome b (Dcytb) in substrate free form","MAMEGYWRFLALLGSALLVGFLSVIFALVWVLHYREGLGWDGSALEFNWHPVLMVTGFVFIQGIAIIVYRLPWTWKCSKLLMKSIHAGLNAVAAILAIISVVAVFENHNVNNIANMYSLHSWVGLIAVICYLLQLLSGFSVFLLPWAPLSLRAFLMPIHVYSGIVIFGTVIATALMGLTEKLIFSLRDPAYSTFPPEGVFVNTLGLLILVFGALIFWIVTRPQWKRPKEPNSTILHPNGGTEQGARGSMPAYSGNNMDKSDSELNSEVAARKRNLALDEAGQRSTMVELVPR","Homo sapiens","CYBRD1, DCYTB, FRRS3","Cytochrome b reductase 1","1","5ZLE"
"5ZLG",,"X-RAY DIFFRACTION",2.48,50.33,"LIPIDIC CUBIC PHASE",6.5,"20%(v/v) Jeffamine ED-2003, 0.1 M HEPES",293,"10.1038/s42003-018-0121-8",,"5ZLG",34.01,"2.8","2.8","Human duodenal cytochrome b (Dcytb) in zinc ion and ascorbate bound form","MAMEGYWRFLALLGSALLVGFLSVIFALVWVLHYREGLGWDGSALEFNWHPVLMVTGFVFIQGIAIIVYRLPWTWKCSKLLMKSIHAGLNAVAAILAIISVVAVFENHNVNNIANMYSLHSWVGLIAVICYLLQLLSGFSVFLLPWAPLSLRAFLMPIHVYSGIVIFGTVIATALMGLTEKLIFSLRDPAYSTFPPEGVFVNTLGLLILVFGALIFWIVTRPQWKRPKEPNSTILHPNGGTEQGARGSMPAYSGNNMDKSDSELNSEVAARKRNLALDEAGQRSTMVELVPR","Homo sapiens","CYBRD1, DCYTB, FRRS3","Cytochrome b reductase 1","1","5ZLG"
"5ZLQ",,"X-RAY DIFFRACTION",3.83,67.88,"VAPOR DIFFUSION, SITTING DROP",4.5,"Ammonium sulfate, Sodium acetate",293,"10.1371/journal.pone.0204355",,"5ZLQ",18.27,"2","2","Crystal Structure of C1orf123","GPMGKIALQLKATLENITNLRPVGEDFRWYLKMKCGNCGEISDKWQYIRLMDSVALKGGRGSASMVQKCKLCARENSIEILSSTIKPYNAEDNENFKTIVEFECRGLEPVDFQPQAGFAAEGVESGTAFSDINLQEKDWTDYDEKAQESVGIYEVTHQFVKC","Homo sapiens","C1orf123, CZIB","UPF0587 protein C1orf123","1","5ZLQ"
"5ZM5",,"X-RAY DIFFRACTION",4.82,74.48,"VAPOR DIFFUSION, HANGING DROP",6.2,"100mM Sodium Cacodylate, pH 6.2, 1.2M Sodium Citrate",293,"10.1038/s41467-019-08791-0",,"5ZM5",50.37,"2.6","2.6","Crystal structure of human ORP1-ORD in complex with cholesterol at 2.6 A resolution","MRTSLPSPMFSRNDFSIWSILRKCIGMELSKITMPVIFNEPLSFLQRLTEYMEHTYLIHKASSLSDPVERMQCVAAFAVSAVASQWERTGKPFNPLLGETYELVRDDLGFRLISEQVSHHPPISAFHAEGLNNDFIFHGSIYPKLKFWGKSVEAEPKGTITLELLEHNEAYTWTNPTCCVHNIIVGKLWIEQYGNVEIINHKTGDKCVLNFKPCGLFGKELHKVEGYIQDKSKKKLCALYGKWTECLYSVDPATFDAYKKNDKKNTEEKKNSKQMSTSEELDEMPVPDSESVFIIPGSVLLWRIAPRPPNSAQMYNFTSFAMVLNEVDKDMESVIPKTDCRLRPDIRAMENGEIDQASEEKKRLEEKQRAARKNRSKSEEDWKTRWFHQGPNPYNGAQDWIYSGSYWDRNYFNLPDIYLEHHHHHH","Homo sapiens","OSBPL1A, ORP1, OSBP8, OSBPL1, OSBPL1B","Oxysterol-binding protein-related protein 1","1","5ZM5"
"5ZM6",,"X-RAY DIFFRACTION",2.84,56.74,"VAPOR DIFFUSION, HANGING DROP",5.7,"100mM Sodium acetate, pH5.7, 1.4M Ammonium Tartrate",293,"10.1038/s41467-019-08791-0",,"5ZM6",103.27,"2.7","2.7","Crystal structure of ORP1-ORD in complex with PI(4,5)P2","MDALSNGIKKHRTSLPSPMFSRNDFSIWSILRKCIGMELSKITMPVIFNEPLSFLQRLTEYMEHTYLIHKASSLSDPVERMQCVAAFAVSAVASQWERTGKPFNPLLGETYELVRDDLGFRLISEQVSHHPPISAFHAEGLNNDFIFHGSIYPKLKFWGKSVEAEPKGTITLELLEHNEAYTWTNPTCCVHNIIVGKLWIEQYGNVEIINHKTGDKCVLNFKPCGLFGKELHKVEGYIQDKSKKKLCALYGKWTECLYSVDPATFDAYKKNDKKNTEEKKNSKQMSTSEELDEMPVPDSESVFIIPGSVLLWRIAPRPPNSAQMYNFTSFAMVLNEVDKDMESVIPKTDCRLRPDIRAMENGEIDQASEEKKRLEEKQRAARKNRSKSEEDWKTRWFHQGPNPYNGAQDWIYSGSYWDRNYFNLPDIYLEHHHHHH","Homo sapiens","OSBPL1A, ORP1, OSBP8, OSBPL1, OSBPL1B","Oxysterol-binding protein-related protein 1","1","5ZM6"
"5ZM7",,"X-RAY DIFFRACTION",2.74,55.14,"VAPOR DIFFUSION, HANGING DROP",4.6,"100mM Sodium acetate, pH 4.6, 2.0M Sodium formate",293,"10.1038/s41467-019-08791-0",,"5ZM7",50.91,"3.401","3.401","Crystal structure of ORP1-ORD in complex with cholesterol at 3.4 A resolution","MDALSNGIKKHRTSLPSPMFSRNDFSIWSILRKCIGMELSKITMPVIFNEPLSFLQRLTEYMEHTYLIHKASSLSDPVERMQCVAAFAVSAVASQWERTGKPFNPLLGETYELVRDDLGFRLISEQVSHHPPISAFHAEGLNNDFIFHGSIYPKLKFWGKSVEAEPKGTITLELLEHNEAYTWTNPTCCVHNIIVGKLWIEQYGNVEIINHKTGDKCVLNFKPCGLFGKELHKVEGYIQDKSKKKLCALYGKWTECLYSVDPATFDAYKKNDKKNTEEKKNSKQMSTSEELDEMPVPDSESVFIIPGSVLLWRIAPRPPNSAQMYNFTSFAMVLNEVDKDMESVIPKTDCRLRPDIRAMENGEIDQASEEKKRLEEKQRAARKNRSKSEEDWKTRWFHQGPNPYNGAQDWIYSGSYWDRNYFNLPDIYLEHHHHHH","Homo sapiens","OSBPL1A, ORP1, OSBP8, OSBPL1, OSBPL1B","Oxysterol-binding protein-related protein 1","1","5ZM7"
"5ZM8",,"X-RAY DIFFRACTION",2.88,57.24,"VAPOR DIFFUSION, HANGING DROP",6.5,"100mM MES pH 6.5, 50mM MgCl2, 8% isopropanol, 1.5% PEG3350",294,"10.1016/j.molcel.2018.11.014",,"5ZM8",107.64,"2.7","2.7","Crystal structure of ORP2-ORD in complex with PI(4,5)P2","MGSSHHHHHHSQDLEVLFQGPHMERPSQENGIQKHRTSLPAPMFSRSDFSVWTILKKCVGLELSKITMPIAFNEPLSFLQRITEYMEHVYLIHRASCQPQPLERMQSVAAFAVSAVASQWERTGKPFNPLLGETYELIREDLGFRFISEQVSHHPPISAFHSEGLNHDFLFHGSIYPKLKFWGKSVEAEPRGTITLELLKHNEAYTWTNPTCCVHNVIIGKLWIEQYGTVEILNHRTGHKCVLHFKPCGLFGKELHKVEGHIQDKNKKKLFMIYGKWTECLWGIDPVSYESFKKQERRGDHLRKAKLDEDSGKADSDVADDVPVAQETVQVIPGSKLLWRINTRPPNSAQMYNFTSFTVSLNELETGMEKTLPPTDCRLRPDIRGMENGNMDLASQEKERLEEKQREARRERAKEEAEWQTRWFYPGNNPYTGTPDWLYAGDYFERNFSDCPDIY","Homo sapiens","OSBPL2, KIAA0772, ORP2","Oxysterol-binding protein-related protein 2","1","5ZM8"
"5ZMA",,"X-RAY DIFFRACTION",2.71,54.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Hepes 7.5, 200mM Nacl, 20% PEG 3350",293,"10.1158/1535-7163.MCT-18-1239",,"5ZMA",100.11,"3.175","3.175","Structural basis for an allosteric Eya2 phosphatase inhibitor","GPLGSPEFSKRSSDPSPAGDNEIERVFVWDLDETIIIFHSLLTGTFASRYGKDTTTSVRIGLMMEEMIFNLADTHLFFNDLEDCDQIHVDDVSSDDNGQDLSTYNFSADGFHSSAPGANLCLGSGVHGGVDWMRKLAFRYRRVKEMYNTYKNNVGGLIGTPKRETWLQLRAELEALTDLWLTHSLKALNLINSRPNCVNVLVTTTQLIPALAKVLLYGLGSVFPIENIYSATKTGKESCFERIMQRFGRKAVYVVIGDGVEEEQGAKKHNMPFWRISCHADLEALRHALELEYL","Homo sapiens","EYA2, EAB1","Eyes absent homolog 2","1","5ZMA"
"5ZMJ",,"X-RAY DIFFRACTION",2.46,54.83,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M Potassium sodium tartrate tetrahydrate, 0.1M Sodium citrate tribasic dihydrate pH 5.6, 2.0M Ammonium sulfate",293,"10.1107/S2053230X1901238X",,"5ZMJ",52.37,"1.81","1.81","Crystal structure of the Fab region of a neutralizing fully human antibody against GM-CSF","MDWTWRILFLVAAATGAPSQVHLVQSGSELKKPGASVKVSCKASGYSFSRYGIKWVRQAPGQGLEWMGWINTRSGVPAYAQGFTGRFVFSLDTSVDTAFLEISSLKTEDTGIYYCATRPPRFYDKTEYWEDGFDVWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKS","Homo sapiens",,"Heavy chain of a Fab fraction of human IgG","1","5ZMJ"
,,,,,,,,,,,,,,,,"MAGFPLLLTLLTHCAGSWAQSVLTQPPSASGTPGQSVNISCSGSSSNIGNSYVYWYQQLPGTAPKLLIYRNNRRPSGVPDRFSGSKSDTSASLAISGLRSEDEADYYCATWDDSLSGRLFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Light chain of a Fab fraction of human IgG","2","5ZMJ"
"5ZMZ",,"X-RAY DIFFRACTION",1.48,17,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M magnesium chloride, 0.1M Sodium HEPES, pH 7.0, 25% (v/v) PEG 200",293,,,"5ZMZ",0.43,"1.4","1.4","Amyloid core of RIP1","IQIG","Homo sapiens","RIPK1, RIP, RIP1","Amyloid core of RIP1","1","5ZMZ"
"5ZN0",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2,38.45,"VAPOR DIFFUSION",8.5,"0.1M Tris-HCl, 0.85M ammonium sulfate, 5% acetonitrile, 2mM DTT",293,"10.1016/j.jmb.2018.09.018",,"5ZN0",39.54,"1.1, 1.9","1.1, 1.9","Joint X-ray/neutron structure of protein kinase ck2 alpha subunit","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYAHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGAMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","5ZN0"
"5ZN1",,"X-RAY DIFFRACTION",2,38.58,"VAPOR DIFFUSION",8.5,"0.1M Tris-HCl, 1.2M ammonium sulfate, 5% acetonitrile, 2mM DTT",293,"10.1016/j.jmb.2018.09.018",,"5ZN1",39.54,"1.05","1.05","X-ray structure of protein kinase ck2 alpha subunit in D2O","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYAHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGAMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","5ZN1"
"5ZN2",,"X-RAY DIFFRACTION",1.99,38.23,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl, 1.2M ammonium sulfate, 5% acetonitrile, 2mM DTT",293,"10.1016/j.jmb.2018.09.018",,"5ZN2",39.47,"1.2","1.2","X-ray structure of protein kinase ck2 alpha subunit H148A mutant","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYAASMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGAMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","5ZN2"
"5ZN3",,"X-RAY DIFFRACTION",1.99,38.19,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl, 1.2M ammonium sulfate, 5% acetonitrile, 2mM DTT",293,"10.1016/j.jmb.2018.09.018",,"5ZN3",39.48,"1.5","1.5","X-ray structure of protein kinase ck2 alpha subunit H148S mutant","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYASSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGAMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","5ZN3"
"5ZN4",,"X-RAY DIFFRACTION",1.99,38.2,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl, 1.2M ammonium sulfate, 5% acetonitrile, 2mM DTT",293,"10.1016/j.jmb.2018.09.018",,"5ZN4",39.51,"1.651","1.651","X-ray structure of protein kinase ck2 alpha subunit H148N mutant","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYANSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGAMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","5ZN4"
"5ZN5",,"X-RAY DIFFRACTION",1.99,38.1,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl, 1.2M ammonium sulfate, 5% acetonitrile, 2mM DTT",293,"10.1016/j.jmb.2018.09.018",,"5ZN5",39.6,"1.7","1.7","X-ray structure of protein kinase ck2 alpha subunit H148A mutant","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","5ZN5"
"5ZN9",,"X-RAY DIFFRACTION",2.14,42.62,"VAPOR DIFFUSION, SITTING DROP",,"0.1M LiSO4; 0.1M Tris; pH 8.5; 25% PEG3350",291.15,,,"5ZN9",26.46,"1.776","1.776","Crystal structure of PX domain","DYTEKQAVPISVPRYKHVEQNGEKFVVYNVYMAGRQLCSKRYREFAILHQNLKREFANFTFPRLPGKWPFSLSEQQLDARRRGLEEYLEKVCSIRVIGESDIMQEFLSES","Homo sapiens","SNX27, KIAA0488, My014","Sorting nexin-27","1","5ZN9"
"5ZND",,"X-RAY DIFFRACTION",2.06,40.43,"VAPOR DIFFUSION, HANGING DROP",8,"0.2M ammonium citrate (pH=8.0), 0.1M Tris-HCl (pH=8.0), 22% (w/v) PEG 3350",293,"10.1021/jacs.8b09760",,"5ZND",15.76,"3","3","8-mer nanotube derived from 24-mer rHuHF nanocage","MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFI","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","5ZND"
"5ZNF",,"SOLUTION NMR",,,,,,,"10.1021/bi00228a004",,"5ZNF",3.68,,,"ALTERNATING ZINC FINGERS IN THE HUMAN MALE ASSOCIATED PROTEIN ZFY: 2D NMR STRUCTURE OF AN EVEN FINGER AND IMPLICATIONS FOR ""JUMPING-LINKER"" DNA RECOGNITION","KTYQCQYCEYRSADSSNLKTHIKTKHSKEK","Homo sapiens","ZFY","ZINC FINGER","1","5ZNF"
"5ZNL",,"X-RAY DIFFRACTION",2.12,41.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes (pH 7.5), 0.2M MgCl2, 18% PEG 3350, 50mM 2-mercaptoethanol",277,"10.1021/acs.jmedchem.8b01763",,"5ZNL",75.9,"2.8","2.8","Crystal structure of PDE10A catalytic domain complexed with LHB-6","MSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5ZNL"
"5ZO6",,"X-RAY DIFFRACTION",1.74,29.34,"VAPOR DIFFUSION, HANGING DROP",5.2,"sodium acetate trihydrate, sodium chloride dehydrate, PEG 1500, MPD",298,"10.1111/febs.15092",,"5ZO6",17.89,"1.7","1.7","Crystal structure of C166, a backbone circularized G-CSF","SSLPQSFLLKSLEQVRKIQGDGAALQEKLCATYKLCHPEELVLLGHSLGIPWAPLSSCPSQALQLAGCLSQLHSGLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQQMEELGMAPALQPTQGAMPAFASAFQRRAGGVLVASHLQSFLEVSYRVLRHLG","Homo sapiens","CSF3, C17orf33, GCSF","Granulocyte colony-stimulating factor","1","5ZO6"
"5ZO7",,"X-RAY DIFFRACTION",2.22,44.59,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG 3350, 0.1M MES, 0.2M Ammonium Sulfate",293,"10.1021/acsomega.8b00778","5C5","5ZO7",84.54,"2.6","2.6","Kinesin spindle protein Eg5 in complex with STLC-type inhibitor PVEI0138","MNHKVHMKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQKLQHHHHHH","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","5ZO7"
"5ZO8",,"X-RAY DIFFRACTION",2.24,45.21,"VAPOR DIFFUSION, SITTING DROP",6.5,"24-34% PEG 3350, 0.1M MES, 0.2M Ammonium Sulfate",293,"10.1021/acsomega.8b00778","4C5","5ZO8",84.72,"2.2","2.2","Eg5 motor domain in complex with STLC-type inhibitor PVEI0021 (P21 type)","MNHKVHMKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQKLQHHHHHH","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","5ZO8"
"5ZO9",,"X-RAY DIFFRACTION",2.2,43.99,"VAPOR DIFFUSION, SITTING DROP",6.5,"24-34% PEG 3350, 0.1M MES, 0.2M Ammonium Sulfate",293,"10.1021/acsomega.8b00778","4C5","5ZO9",84.72,"2.7","2.7","Eg5 motor domain in complex with STLC-type inhibitor PVEI0021 (C2 type)","MNHKVHMKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQKLQHHHHHH","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","5ZO9"
"5ZOD",,"X-RAY DIFFRACTION",1.83,32.91,"VAPOR DIFFUSION, SITTING DROP",7.8,"PEG 3350, MgCl2, Tris, KCl",298,"10.1093/nar/gky911",,"5ZOD",37.87,"1.9","1.9","Crystal Structure of hFen1 in apo form","MGIQGLAKLIADVAPSAIRENDIKSYFGRKVAIDASMSIYQFLIAVRQGGDVLQNEEGETTSHLMGMFYRTIRMMENGIKPVYVFDGKPPQLKSGELAKRSERRAEAEKQLQQAQAAGAEQEVEKFTKRLVKVTKQHNDECKHLLSLMGIPYLDAPSEAEASCAALVKAGKVYAAATEDMDCLTFGSPVLMRHLTASEAKKLPIQEFHLSRILQELGLNQEQFVDLCILLGSDYCESIRGIGPKRAVDLIQKHKSIEEIVRRLDPNKYPVPENWLHKEAHQLFLEPEVLDPESVELKWSEPNEEELIKFMCGEKQFSEERIRSGVKRLSKSRQ","Homo sapiens","FEN1, RAD2","Flap endonuclease 1","1","5ZOD"
"5ZQL",,"X-RAY DIFFRACTION",2.48,50.39,"VAPOR DIFFUSION, HANGING DROP",,"0.3 M Lithium citrate acetate pH6.0
20% (v/v) PEG 3,350",298,"10.1016/j.celrep.2019.01.020",,"5ZQL",70.13,"3.007","3.007","crystal structure of human katanin AAA ATPase domain","DSTGYDKDLVEALERDIISQNPNVRWDDIADLVEAKKLLKEAVVLPMWMPEFFKGIRRPWKGVLMVGPPGTGKTLLAKAVATECKTTFFNVSSSTLTSKYRGESEKLVRLLFEMARFYSPATIFIDQIDSICSRRGTSEEHEASRRVKAELLVQMDGVGGTSENDDPSKMVMVLAATNFPWDIDEALRRRLEKRIYIPLPSAKGREELLRISLRELELADDVDLASIAENMEGYSGADITNVCRDASLMAMRRRIEGLTPEEIRNLSKEEMHMPTTMEDFEMALKKVSKSVSAADIERYEKWIFEFGSC","Homo sapiens","KATNA1","Katanin p60 ATPase-containing subunit A1","1","5ZQL"
"5ZQM",,"X-RAY DIFFRACTION",2.88,57.35,"VAPOR DIFFUSION, HANGING DROP",,"0.4 M Calcium acetate 
20% (v/v) PEG 3,350",298,"10.1016/j.celrep.2019.01.020",,"5ZQM",35.54,"2.9","2.9","Crystal structure of human katanin AAA ATPase domain complex with ATPgammaS","AADSTGYDKDLVEALERDIISQNPNVRWDDIADLVEAKKLLKEAVVLPMWMPEFFKGIRRPWKGVLMVGPPGTGKTLLAKAVATECKTTFFNVSSSTLTSKYRGESEKLVRLLFEMARFYSPATIFIDEIDSICSRRGTSEEHEASRRVKAELLVQMDGVGGTSENDDPSKMVMVLAATNFPWDIDEALRRRLEKRIYIPLPSAKGREELLRISLRELELADDVDLASIAENMEGYSGADITNVCRDASLMAMRRRIEGLTPEEIRNLSKEEMHMPTTMEDFEMALKKVSKSVSAADIERYEKWIFEFG","Homo sapiens","KATNA1","Katanin p60 ATPase-containing subunit A1","1","5ZQM"
"5ZQO",,"X-RAY DIFFRACTION",2.67,53.99,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris pH 6.5, 2% PEG MME 550, 1.8M ammonium sulfate",277,"10.1021/acs.jmedchem.8b01888","9GX","5ZQO",25.39,"2.06","2.06","Tankyrase-2 in complex with compound 1a","NTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMK","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","5ZQO"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","5ZQO"
"5ZQP",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris pH 8.5, 2.4M (NH4)2HPO4",277,"10.1021/acs.jmedchem.8b01888","9H3","5ZQP",25.21,"1.99","1.99","Tankyrase-2 in complex with compound 12","NTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMK","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","5ZQP"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","5ZQP"
"5ZQQ",,"X-RAY DIFFRACTION",2.69,54.36,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris pH 8.5, 2.4M (NH4)2HPO4",277,"10.1021/acs.jmedchem.8b01888",,"5ZQQ",25.13,"2.29","2.29","Tankyrase-2 in complex with compound 52","MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","5ZQQ"
,,,,,,,,,,,,,,,,"NTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMK","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","5ZQQ"
"5ZQR",,"X-RAY DIFFRACTION",2.62,53.02,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris pH 8.5, 2.4M (NH4)2HPO4",277,"10.1021/acs.jmedchem.8b01888","9H9","5ZQR",25.37,"1.75","1.75","Tankyrase-2 in complex with compound 40c","NTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMK","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","5ZQR"
,,,,,,,,,,,,,,,,"MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","5ZQR"
"5ZQU",,"X-RAY DIFFRACTION",2.36,47.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"200mM sodium bromide, 20% polyethylene glycol 3350",293,"10.1002/1873-3468.13301","9HF","5ZQU",111.56,"2.60038789589","2.60038789589","Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN","GSSHSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","5ZQU"
"5ZQY",,"X-RAY DIFFRACTION",2.11,41.84,"VAPOR DIFFUSION, HANGING DROP",6,"MES pH 6.0, PEG MME 2000",298,"10.1074/jbc.RA118.004284",,"5ZQY",38.46,"1.577","1.577","Crystal structure of a poly(ADP-ribose) glycohydrolase","GPGSSLSRFRGCLAGALLGDCVGSFYEAHDTVDLTSVLRHVQSLEPDPGTPGSERTEALYYTDDTAMARALVQSLLAKEAFDEVDMAHRFAQEYKKDPDRGYGAGVVTVFKKLLNPKCRDVFEPARAQFNGKGSYGNGGAMRVAGISLAYSSVQDVQKFARLSAQLTHASSLGYNGAILQALAVHLALQGESSSEHFLKQLLGHMEDLEGDAQSVLDARELGMEERPYSSRLKKIGELLDQASVTREEVVSELGNGIAAFESVPTAIYCFLRCMEPDPEIPSAFNSLQRTLIYSISLGGDTDTIATMAGAIAGAYYGMDQVPESWQQSCEGYEETDILAQSLHRVFQKS","Homo sapiens","ADPRHL2, ARH3, ADPRS","Poly(ADP-ribose) glycohydrolase ARH3","1","5ZQY"
"5ZR3",,"X-RAY DIFFRACTION",2.52,55.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 6000, 200mM NaCl, 50mM Tris pH 7.5",277,"10.1021/acs.jmedchem.8b01085","9J0","5ZR3",108.72,"2.5","2.5","Crystal structure of Hsp90-alpha N-terminal domain in complex with 4-(3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)-3-methylbenzamide","HMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5ZR3"
"5ZRM",,"X-RAY DIFFRACTION",3.32,62.92,"VAPOR DIFFUSION, HANGING DROP",,"MES, pH 6.0, PEG3350",289,,,"5ZRM",54.13,"2.28","2.28","Phosphoglycerate mutase 1 complexed with a small molecule inhibitor In-AC","AAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGD","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","2","5ZRM"
,,,,,,,,,,,,,,,,"AAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGD","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","5ZRM"
"5ZRT",,"X-RAY DIFFRACTION",2.28,45.95,"VAPOR DIFFUSION",6.5,"0.2M magnesium chloride hexahydrate, 0.1M sodium citrate tribasic buffer pH 6.5, 20% polyethylene glycol 3350",293,"10.7717/peerj.5377",,"5ZRT",41.31,"1.9","1.9","Crystal structure of human C1ORF123 protein","MGSSHHHHHHSSGLVPRGSHMGKIALQLKATLENITNLRPVGEDFRWYLKMKCGNCGEISDKWQYIRLMDSVALKGGRGSASMVQKCKLCARENSIEILSSTIKPYNAEDNENFKTIVEFECRGLEPVDFQPQAGFAAEGVESGTAFSDINLQEKDWTDYDEKAQESVGIYEVTHQFVKC","Homo sapiens","C1orf123, CZIB","UPF0587 protein C1orf123","1","5ZRT"
"5ZS7",,"X-RAY DIFFRACTION",3.06,59.85,"VAPOR DIFFUSION, HANGING DROP",,"MES, pH 6.0, PEG 3350",289,,,"5ZS7",53.64,"2.68","2.68","Acetylation of lysine 100 in Phosphoglycerate mutase 1","AAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGD","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","2","5ZS7"
,,,,,,,,,,,,,,,,"AYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGD","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","5ZS7"
"5ZS8",,"X-RAY DIFFRACTION",3.03,59.38,"VAPOR DIFFUSION, HANGING DROP",,"MES, pH 6.0, PEG 3350",289,,,"5ZS8",54.87,"2.2","2.2","Acetylation of lysine 100 of Phosphoglycerate mutase 1 complexed with KH_ol","AAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVRK","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","2","5ZS8"
,,,,,,,,,,,,,,,,"AAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAKRGGQALRDAGYEFDICFTSVQKRAIRTLWTVLDAIDQMWLPVVRTWRLNERHYGGLTGLNKAETAAKHGEAQVKIWRRSYDVPPPPMEPDHPFYSNISKDRRYADLTEDQLPSCESLKDTIARALPFWNEEIVPQIKEGKRVLIAAHGNSLRGIVKHLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGD","Homo sapiens","PGAM1, PGAMA, CDABP0006","Phosphoglycerate mutase 1","1","5ZS8"
"5ZSU","4.25","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0109-6",,"5ZSU",571.63,"4.25",,"Structure of the human homo-hexameric LRRC8A channel at 4.25 Angstroms","MIPVTELRYFADTQPAYRILKPWWDVFTDYISIVMLMIAVFGGTLQVTQDKMICLPCKWVTKDSCNDSFRGWAAPGPEPTYPNSTILPTPDTGPTGIKYDLDRHQYNYVDAVCYENRLHWFAKYFPYLVLLHTLIFLACSNFWFKFPRTSSKLEHFVSILLKCFDSPWTTRALSETVVEESDPKPAFSKMNGSMDKKSSTVSEDVEATVPMLQRTKSRIEQGIVDRSETGVLDKKEGEQAKALFEKVKKFRTHVEEGDIVYRLYMRQTIIKVIKFILIICYTVYYVHNIKFDVDCTVDIESLTGYRTYRCAHPLATLFKILASFYISLVIFYGLICMYTLWWMLRRSLKKYSFESIREESSYSDIPDVKNDFAFMLHLIDQYDPLYSKRFAVFLSEVSENKLRQLNLNNEWTLDKLRQRLTKNAQDKLELHLFMLSGIPDTVFDLVELEVLKLELIPDVTIPPSIAQLTGLKELWLYHTAAKIEAPALAFLRENLRALHIKFTDIKEIPLWIYSLKTLEELHLTGNLSAENNRYIVIDGLRELKRLKVLRLKSNLSKLPQVVTDVGVHLQKLSINNEGTKLIVLNSLKKMANLTELELIRCDLERIPHSIFSLHNLQEIDLKDNNLKTIEEIISFQHLHRLTCLKLWYNHIAYIPIQIGNLTNLERLYLNRNKIEKIPTQLFYCRKLRYLDLSHNNLTFLPADIGLLQNLQNLAITANRIETLPPELFQCRKLRALHLGNNVLQSLPSRVGELTNLTQIELRGNRLECLPVELGECPLLKRSGLVVEEDLFNTLPPEVKERLWRADKEQAGTENLYFQ","Homo sapiens","LRRC8A, KIAA1437, LRRC8, SWELL1, UNQ221/PRO247","Volume-regulated anion channel subunit LRRC8A","1","5ZSU"
"5ZSW",,"SOLUTION NMR",,,,,,,,,"5ZSW",9.68,,,"RBM10-RRM2 domain and its lung cancer related mutant","GHMDTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIVEAAQLLQILQALHPPLTIDGKTINVEFAKGS","Homo sapiens","RBM10, DXS8237E, GPATC9, GPATCH9, KIAA0122","RNA-binding protein 10","1","5ZSW"
"5ZSY",,"SOLUTION NMR",,,,,,,,,"5ZSY",9.58,,,"RBM10-RRM2 domain and its lung cancer related mutant","GHMDTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIEAAQLLQILQALHPPLTIDGKTINVEFAKGS","Homo sapiens","RBM10, DXS8237E, GPATC9, GPATCH9, KIAA0122","RNA-binding protein 10","1","5ZSY"
"5ZTF",,"X-RAY DIFFRACTION",3.53,65.16,"LIPIDIC CUBIC PHASE",,"28-34% polyethylene glycol 250 dimethylethanol, 
100 mM tris(hydroxymethyl)aminomethane 
100 mM potassium thiocyanate",293,"10.1016/j.celrep.2019.03.106",,"5ZTF",118.37,"3.45","3.45","Structure of Ca2+ ATPase","MGGVAMPGAEDDVVRENLYFQGKDGLAAMENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYSTDTNFSDMFWS","Homo sapiens","ATP2A2, ATP2B","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2","1","5ZTF"
"5ZTN",,"X-RAY DIFFRACTION",2.63,53.31,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M ammonium citrate tribasic, 12%-20% PEG 3350,pH 7.0",291,"10.1073/pnas.1806797115","CUR","5ZTN",99.78,"2.496","2.496","The crystal structure of human DYRK2 in complex with Curcumin","MHHHHHHSSGVDLGTENLYFQSMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR","Homo sapiens","DYRK2","Dual specificity tyrosine-phosphorylation-regulated kinase 2","1","5ZTN"
"5ZTO",,"X-RAY DIFFRACTION",3.64,66.23,"VAPOR DIFFUSION, HANGING DROP",8,"0.05M HEPES pH 8.0, 0.2M ZnSO4, 25% PEG 600",298,,"9JO","5ZTO",38.29,"2.649","2.649","Crystal structure of EGFR 696-1022 T790M/C797S in complex with D3003","GAMGGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5ZTO"
"5ZUN",,"X-RAY DIFFRACTION",2.73,55.03,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M Bis-Tris, 10% PEG3350",293,"10.1021/acs.jmedchem.8b00824","9JX","5ZUN",34.53,"1.35","1.35","Crystal structure of human monoacylglycerol lipase in complex with compound 3l","GSMPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWAPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNSVLPNLSSGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP","Homo sapiens","MGLL","Monoglyceride lipase","1","5ZUN"
"5ZV2",,"X-RAY DIFFRACTION",2.83,56.5,"VAPOR DIFFUSION",7,"17.70 % PEG-5000-MME, 0.20 M (NH4)2SO4, 0.10 M Tris pH 7.00, Cryo 25% Ethylenglycole in reservoir solution.",277,"10.1002/cam4.1517",,"5ZV2",70.5,"2.86","2.86","FGFR-1 in complex with ligand lenvatinib","SSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","5ZV2"
"5ZWJ",,"X-RAY DIFFRACTION",2.41,48.9,"VAPOR DIFFUSION, HANGING DROP",,"26% PEG 4000, 0.1 M KCl, 0.05 M Tris pH 7.5-8.0",293,"10.1016/j.bbrc.2018.05.154","9LL","5ZWJ",41.22,"2.9","2.9","Crystal structure of EGFR 675-1022 T790M/C797S/V948R in complex with EAI045","GRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGSLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGHHHHHH","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5ZWJ"
"5ZWK",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, Sodium chloride, Hepes",291.15,,,"5ZWK",155.77,"2.104","2.104","Crystal structure of Human liver fructose-1,6-bisphoaphatase complex with fructose-1,6-bisphophate and AMP","MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYAKDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQLEHHHHHHHH","Homo sapiens","FBP1, hCG_1640493","Fructose-1,6-bisphosphatase 1","1","5ZWK"
"5ZXB",,"X-RAY DIFFRACTION",2.27,45.78,"EVAPORATION",6.3,"0.1M Bis-Tris pH6.3
0.2M AmSO4
28% PEG3350
10mM DTT",291,"10.1021/acs.jmedchem.8b00882","9KO","5ZXB",64.08,"2.198","2.198","Crystal structure of ACK1 with compound 10d","LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT","Homo sapiens","TNK2, ACK1","Activated CDC42 kinase 1","1","5ZXB"
"5ZXD",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, HANGING DROP",,"potassium thiocyanate, PEG 3350, sodium citrate, glycerol",289.15,"10.1016/j.str.2018.05.019",,"5ZXD",127.17,"2.288","2.288","Crystal structure of ATP-bound human ABCF1","NASDIKLEKFSISAHGKELFVNADLYIVAGRRYGLVGPNGKGKTTLLKHIANRALSIPPNIDVLLCEQEVVADETPAVQAVLRADTKRLKLLEEERRLQGQLEQGDDTAAERLEKVYEELRATGAAAAEAKARRILAGLGFDPEMQNRPTQKFSGGWRMRVSLARALFMEPTLLMLDEPTNHLDLNAVIWLNNYLQGWRKTLLIVSHDQGFLDDVCTDIIHLDAQRLHYYRGNYMTFKKMYQQKQKELLKQYEKQEKKLKELKAGGKSTKQAEKQTKEALTRKQQKCRRKNQDEESQEAPELLKRPKEYTVRFTFPDPPPLSPPVLGLHGVTFGYQGQKPLFKNLDFGIDMDSRICIVGPNGVGKSTLLLLLTGKLTPTHGEMRKNHRLKIGFFNQQYAEQLRMEETPTEYLQRGFNLPYQDARKCLGRFGLESHAHTIQICKLSGGQKARVVFAELACREPDVLILDEPTNNLDIESIDALGEAINEYKGAVIVVSHDARLITETNCQLWVVEEQSVSQIDGDFEDYKREVLEALGEVMVSHHHH","Homo sapiens","ABCF1, ABC50","ATP-binding cassette sub-family F member 1","1","5ZXD"
"5ZXE",,"X-RAY DIFFRACTION",2.49,50.62,"VAPOR DIFFUSION, HANGING DROP",7.4,"PEG 8000, Ammonium sulphate",298,,,"5ZXE",15.31,"1.3","1.3","Structure of a consensus sequence derived from the FGF family","MRLRRLYCRTGGFHLQILPDGRVDGTREDNSPYSLLEIRAVEVGVVAIKGVKSGRYLAMNKKGRLYGSKHFTDECKFKERLLENGYNTYSSAKYRRGWYVALNKNGRPKKGNRTRRTQKATHFLPLPVSG","Homo sapiens",,"Consensus sequence based basic form of fibroblast growth factor","1","5ZXE"
"5ZXF",,"X-RAY DIFFRACTION",2.41,49,"VAPOR DIFFUSION, HANGING DROP",,"0.2M NaOAc, 1.2M AmSO4, Seeding.",291,,"NUT","5ZXF",10.85,"1.25","1.25","The 1.25A Crystal structure of His6-tagged Mdm2 in complex with nutlin-3a","QETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","5ZXF"
"5ZXI",,"X-RAY DIFFRACTION",2.32,50,"VAPOR DIFFUSION, HANGING DROP",8,"40mM Bis-Tris-propane (pH 8.0), 10% (w/v) polyethylene glycol (PEG) 8000, 200mM KCl, 6% propanol, 1mM CaCl2",298,"10.1021/acsmedchemlett.8b00287",,"5ZXI",63.75,"2.1","2.1","Co-crystal structure of an Inhibitor in complex with human PPARdelta LBD","GSHMQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5ZXI"
"5ZXK",,"X-RAY DIFFRACTION",2.44,49.65,"VAPOR DIFFUSION, SITTING DROP",,"CALCIUM ACETATE HYDRATE, PEG8000,
 SODIUM CACODYLATE",289,"10.1016/j.immuni.2019.02.016","H6P","5ZXK",22.92,"1.96","1.96","Crystal structure of intracellular B30.2 domain of BTN3A1 in complex with HMBPP","MGAYNEWKKALFKPADVILDPKTANPILLVSEDQRSVQRAKEPQDLPDNPERFNWHYCVLGCESFISGRHYWEVEVGDRKEWHIGVCSKNVQRKGWVKMTPENGFWTMGLTDGNKYRTLTEPRTNLKLPKPPKKVGVFLDYETGDISFYNAVDGSHIHTFLDVSFSEALYPVFRILTLEPTALTICPALEHHHHHH","Homo sapiens","BTN3A1, BTF5","Butyrophilin subfamily 3 member A1","1","5ZXK"
"5ZXW",,"X-RAY DIFFRACTION",2.11,41.78,"VAPOR DIFFUSION, HANGING DROP",8.3,"2.7M ammonium sulfate",281,,"SO4","5ZXW",29.98,"1.316","1.316","Crystal structure of human carbonic anhydrase II crystallized by ammonium sulfate","GPGLNSMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5ZXW"
"5ZYG",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCl buffer, pH 5.9, 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"5ZYG",27.48,"1.8","1.8","Crystal structure of CERT START domain in complex with compound B5","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","5ZYG"
"5ZYH",,"X-RAY DIFFRACTION",2.57,52.05,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCl buffer, pH 5.9, containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"5ZYH",27.49,"1.95","1.95","Crystal structure of CERT START domain in complex with compound E5","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","5ZYH"
"5ZYI",,"X-RAY DIFFRACTION",2.56,51.97,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCl buffer, pH 5.9, containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"5ZYI",27.51,"1.9","1.9","Crystal structure of CERT START domain in complex with compound E16","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","5ZYI"
"5ZYJ",,"X-RAY DIFFRACTION",2.54,51.64,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCl buffer, pH 5.9, containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"5ZYJ",27.6,"1.9","1.9","Crystal structure of CERT START domain in complex with compound E16A","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","5ZYJ"
"5ZYK",,"X-RAY DIFFRACTION",2.57,52.06,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCl buffer, pH 5.9, containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"5ZYK",27.5,"1.55","1.55","Crystal structure of CERT START domain in complex with compound E25","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","5ZYK"
"5ZYL",,"X-RAY DIFFRACTION",2.55,51.82,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCl buffer, pH 5.9, containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"5ZYL",27.6,"1.8","1.8","Crystal structure of CERT START domain in complex with compound E25A","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","5ZYL"
"5ZYM",,"X-RAY DIFFRACTION",2.55,51.69,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1M trisodium citrate/HCl buffer, pH 5.9, containing 24% PEG3350 and 0.2% n-octyl-beta-D-glucoside",293,,,"5ZYM",27.6,"1.9","1.9","Crystal structure of CERT START domain in complex with compound E25B","GPTHRFVQKVEEMVQNHMTYSLQDVGGDANWQLVVEEGEMKVYRREVEENGIVLDPLKATHAVKGVTGHEVCNYFWNVDVRNDWETTIENFHVVETLADNAIIIYQTHKRVWPASQRDVLYLSVIRKIPALTENDPETWIVCNFSVDHDSAPLNNRCVRAKINVAMICQTLVSPPEGNQEISRDNILCKITYVANVNPGGWAPASVLRAVAKREYPKFLKRFTSYVQEKTAGKPILF","Homo sapiens","CERT, CERT1, COL4A3BP, STARD11","LIPID-TRANSFER PROTEIN CERT","1","5ZYM"
"5ZYW",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, HANGING DROP",,"0.35 M di-sodium tartrate, 21% PEG 3350 and 0.1 M MnCl2",291.15,"10.1093/nar/gky855",,"5ZYW",29.92,"2.2","2.2","The crystal structure of apo-HsMGME1 with Mn2+","GEDRRVPQNWFPIFNPERSDKPNASDPSVPLKIPLQRNVIPSVTRVLQQTMTKQQVFLLERWKQRMILELGEDGFKEYTSNVFLQGKRFHEALESILSPQETLKERDENLLKSGYIESVQHILKDVSGVRALESAVQHETLNYIGLLDCVAEYQGKLCVIDWKTSEKPKPFIQSTFDNPLQVVAYMGAMNHDTNYSFQVQCGLIVVAYKDGSPAHPHFMDAELCSQYWTKWLLRLEEYTEKKKNQNIQKPEYSE","Homo sapiens","MGME1, C20orf72, DDK1","Mitochondrial genome maintenance exonuclease 1","1","5ZYW"
"5ZYX",,"SOLUTION NMR",,,,,,,"10.1021/acs.bioconjchem.9b00290",,"5ZYX",2.7,,,"Solution NMR structure of K30 peptide in 10 mM dioctanoyl phosphatidylglycerol (D8PG)","RWKRHISEQLRRRDRLQRQA","Homo sapiens","ATG16L1, APG16L, UNQ9393/PRO34307","ARG-TRP-LYS-ARG-HIS-ILE-SER-GLU-GLN-LEU-ARG-ARG-ARG-ASP-ARG-LEU-GLN-ARG-GLN-ALA","1","5ZYX"
"5ZZ0",,"X-RAY DIFFRACTION",1.82,32.56,"VAPOR DIFFUSION, HANGING DROP",,"Peg 6000 (20%), 100mM Sodium acetate, 200mM Calcium Chloride Dihydrate, pH 5",293,"10.1038/s41598-018-30951-3",,"5ZZ0",30.54,"2.635","2.635","HUMAN GELSOLIN FROM RESIDUES GLU28 TO ARG161 WITH CALCIUM","EHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQR","Homo sapiens","GSN","Gelsolin","1","5ZZ0"
"5ZZ2",,"X-RAY DIFFRACTION",3.07,59.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Cacodylate Sodium (pH 6.5), 0.2 M MgSO4, 18% PEG3350, 2.5% ethanol",298,"10.1021/acs.jmedchem.8b01209","9M0","5ZZ2",38.35,"2.6","2.6","Crystal structure of PDE5 in complex with inhibitor LW1634","EETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","5ZZ2"
"5ZZ3",,"X-RAY DIFFRACTION",2.54,51.51,"VAPOR DIFFUSION, SITTING DROP",,"SODIUM CITRATE, IMIDAZOLE PH 8.0, 1
 -PROPANOL., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K",291,"10.1016/j.immuni.2019.02.016",,"5ZZ3",32.56,"3","3","Crystal structure of intracellular B30.2 domain of BTN3A3","MGSSHHHHHHSSGLVPRGSHMENLYFQGAGAGAAYHEWKMALFKPADVILDPDTANAILLVSEDQRSVQRAEEPRDLPDNPERFEWRYCVLGCENFTSGRHYWEVEVGDRKEWHIGVCSKNVERKKGWVKMTPENGYWTMGLTDGNKYRALTEPRTNLKLPEPPRKVGIFLDYETGEISFYNATDGSHIYTFPHASFSEPLYPVFRILTLEPTALTICPIPKEVESSPDPDLVPDHSLETPLTPGLANESGEPQAEVTSLLLPAHPGAEVSPSATTNQNHKLQARTEALY","Homo sapiens","BTN3A3, BTF3","Butyrophilin, subfamily 3, member A3 isoform b variant","1","5ZZ3"
"5ZZ4",,"X-RAY DIFFRACTION",2.34,47.36,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M imidazole(pH7.0), 0.1 M Potassium thiocyanate, 30% w/v PEG MME 2000, 4% Polypropylene glycol P 400",277,"10.1021/acs.jmedchem.8b01147","9M3","5ZZ4",190.47,"2.9","2.9","Crystal structure of bruton's tyrosine kinase in complex with inhibitor 2e","GAMGGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","5ZZ4"
"621P",,"X-RAY DIFFRACTION",2,38.63,,,,,"10.1016/0092-8674(90)90018-a",,"621P",19.43,"2.4","2.4","THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","H-RAS P21 PROTEIN","1","621P"
"6A0A",,"X-RAY DIFFRACTION",1.77,30.46,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Na Chloride, 0.1M Bis-Tris pH 6.5, 25% w/v PEG 3350",289,"10.1016/j.bbrc.2018.12.018",,"6A0A",8.32,"1.502","1.502","Structure of a triple-helix region of human collagen type III","PPGPPGPPGIPGEKGPAGERGPPGPPGPPG","Homo sapiens",,"collagen type III peptide","1","6A0A"
"6A0C",,"X-RAY DIFFRACTION",1.89,35.09,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 400, 0.1M Na Acetate pH 4.6, 0.1M Cadmium Chloride",289,"10.1016/j.bbrc.2018.12.018",,"6A0C",8.39,"1.501","1.501","Structure of a triple-helix region of human collagen type III","PPGPPGPPGFRGPAGPNGIPGPPGPPGPPG","Homo sapiens",,"collagen type III peptide","1","6A0C"
"6A0E",,"X-RAY DIFFRACTION",2.15,42.79,"VAPOR DIFFUSION, HANGING DROP",4.8,"PEG 3350, Potassium phosphate monobasic",295,"10.3390/biom10010163",,"6A0E",72.14,"1.947","1.947","Crystal structure of human protein N-terminal asparagine amidohydrolase (NTAN1)","MPLLVEGRRVRLPQSAGDLVRAHPPLEERARLLRGQSVQQVGPQGLLYVQQRELAVTSPKDGSISILGSDDATTCHIVVLRHTGNGATCLTHCDGTDTKAEVPLIMNSIKSFSDHAQCGRLEVHLVGGFSDDRQLSQKLTHQLLSEFDRQEDDIHLVTLCVTELNDREENENHFPVIYGIAVNIKTAEIYRASFQDRGPEEQLRAARTLAGGPMISIYDAETEQLRIGPYSWTPFPHVDFWLHQDDKQILENLSTSPLAEPPHFVEHIRSTLMFLKKHPSPAHTLFSGNKALLYKKNEDGLWEKISSPGSLEHHHHHH","Homo sapiens","NTAN1","Protein N-terminal asparagine amidohydrolase","1","6A0E"
"6A0I",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION, HANGING DROP",4.8,"PEG 3350, potassium phosphate monobasic",295,"10.3390/biom10010163",,"6A0I",73.87,"1.996","1.996","Crystal structure of human protein N-terminal asparagine amidohydrolase (NTAN1) C75S mutant","MPLLVEGRRVRLPQSAGDLVRAHPPLEERARLLRGQSVQQVGPQGLLYVQQRELAVTSPKDGSISILGSDDATTSHIVVLRHTGNGATCLTHCDGTDTKAEVPLIMNSIKSFSDHAQCGRLEVHLVGGFSDDRQLSQKLTHQLLSEFDRQEDDIHLVTLCVTELNDREENENHFPVIYGIAVNIKTAEIYRASFQDRGPEEQLRAARTLAGGPMISIYDAETEQLRIGPYSWTPFPHVDFWLHQDDKQILENLSTSPLAEPPHFVEHIRSTLMFLKKHPSPAHTLFSGNKALLYKKNEDGLWEKISSPGSLEHHHHHH","Homo sapiens","NTAN1","Protein N-terminal asparagine amidohydrolase","1","6A0I"
"6A1C",,"X-RAY DIFFRACTION",2,38.41,"VAPOR DIFFUSION, SITTING DROP",,"ethyleneglycol",277,"10.1126/sciadv.aau9060",,"6A1C",42.53,"1.68","1.68","Crystal structure of the CK2a1-go289 complex","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6A1C"
"6A1F",,"X-RAY DIFFRACTION",2.47,50.15,"VAPOR DIFFUSION, SITTING DROP",,"2.0M Ammonium sulfate",293,"10.1016/j.bmcl.2018.09.010","9OF","6A1F",42.89,"1.5","1.5","Crystal structure of human DYRK1A in complex with compound 14","GPMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6A1F"
"6A1G",,"X-RAY DIFFRACTION",2.37,48.08,"VAPOR DIFFUSION, SITTING DROP",,"20% w/v Polyethylene glycol monomethyl ether 2000",293,"10.1016/j.bmcl.2018.09.010","9OL","6A1G",84.48,"2.15","2.15","Crystal structure of human DYRK1A in complex with compound 32","GPMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6A1G"
"6A1S",,"X-RAY DIFFRACTION",2.78,55.68,"VAPOR DIFFUSION, HANGING DROP",,"Bistris",298,"10.1093/glycob/cwy087",,"6A1S",16.7,"1.63","1.63","Charcot-Leyden crystal protein/Galectin-10 variant E33A","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNAPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6A1S"
"6A1T",,"X-RAY DIFFRACTION",2.78,55.78,"VAPOR DIFFUSION, HANGING DROP",,"Bistris",298,"10.1093/glycob/cwy087",,"6A1T",17.04,"1.97","1.97","Charcot-Leyden crystal protein/Galectin-10 variant E33A with lactose","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNAPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6A1T"
"6A1U",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",,"Bistris",298,"10.1093/glycob/cwy087",,"6A1U",16.74,"1.62","1.62","Charcot-Leyden crystal protein/Galectin-10 variant E33D","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNDPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6A1U"
"6A1V",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION, HANGING DROP",,"Bistris",298,"10.1093/glycob/cwy087",,"6A1V",16.75,"1.984","1.984","Charcot-Leyden crystal protein/Galectin-10 variant E33Q","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNQPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6A1V"
"6A1X",,"X-RAY DIFFRACTION",2.72,54.75,"VAPOR DIFFUSION, HANGING DROP",,"Bistris",298,"10.1093/glycob/cwy087",,"6A1X",16.64,"1.99","1.99","Charcot-Leyden crystal protein/Galectin-10 variant W127A","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVARDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6A1X"
"6A1Y",,"X-RAY DIFFRACTION",2.76,55.4,"VAPOR DIFFUSION, HANGING DROP",,"Bistris",298,"10.1093/glycob/cwy087",,"6A1Y",16.66,"1.63","1.63","Charcot-Leyden crystal protein/Galectin-10 variant Y35A","GSHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPALQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6A1Y"
"6A32",,"X-RAY DIFFRACTION",1.93,36.36,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bis-Tris pH 5.5, 27% PEG 3350",293,,,"6A32",40.6,"1.87","1.87","Crystal structure of PDGFRA kinase domain mutant T674I","GAMDKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIIEYCFYGDLVNYLHKNRDSFLSHKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSD","Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA","Platelet-derived growth factor receptor alpha","1","6A32"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDGFRA, PDGFR2, RHEPDGFRA"
"6A3N",,"X-RAY DIFFRACTION",4.79,74.3,"VAPOR DIFFUSION, HANGING DROP",7.4,"2.5M Na formate, 0.1M HEPES (pH 7.5), 5% xylitol",277,"10.1021/acs.jmedchem.8b01041",,"6A3N",77.08,"2.6","2.6","Crystal structure of the PDE9 catalytic domain in complex with inhibitor 2","KYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKK","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","6A3N"
"6A3Z",,"SOLUTION NMR",,,,,,,,,"6A3Z",6.65,,,"Zinc finger domain from the HRD1 Protein","ATPEELQAMDNVCIICREEMVTGAKRLPCNHIFHTSCLRSWFQRQQTCPTCRMDVL","Homo sapiens","SYVN1, HRD1, KIAA1810","E3 ubiquitin-protein ligase synoviolin","1","6A3Z"
"6A4I",,"X-RAY DIFFRACTION",2.71,59.89,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG3350",293,,,"6A4I",188.95,"2.65","2.65","Crystal Structure of human TDO inhibitor complex","MGSSHHHHHHSSGLVPRGSHMPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEKVLNAQELQSETKGNKIHDEHLFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSVILKLLVQQFSILETMTALDFNDFREYLSPASGFQSLQFRLLENKIGVLQNMRVPYNRRHYRDNFKGEENELLLKSEQEKTLLELVEAWLERTPGLEPHGFNFWGKLEKNITRGLEEEFIRIQAKEESEEKEEQVAEFQKQKEVLLSLFDEKRHEHLLSKGERRLSYRALQGALMIYFYREEPRFQVPFQLLTSLMDIDSLMTKWRYNHVCMVHRMLGSKAGTGGSSGYHYLRSTVSDRYKVFVDLFNLSTYLIPRHWIPKMNPTIHKF","Homo sapiens","TDO2, TDO","Tryptophan 2,3-dioxygenase","1","6A4I"
"6A62",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1042/BSR20181787",,"6A62",16.29,"2.03","2.03","Placental protein 13/galectin-13 variant R53HH57RD33G with Lactose","SSLPVPYKLPVSLSVGSCVIIKGTPIHSFINGPQLQVDFYTDMDEDSDIAFHFRVRFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","6A62"
"6A63",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1042/BSR20181787",,"6A63",16.35,"1.63","1.63","Placental protein 13/galectin-13 variant R53HH57R with Lactose","SSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFHFRVRFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","6A63"
"6A64",,"X-RAY DIFFRACTION",2.1,41.42,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1042/BSR20181787",,"6A64",16.25,"1.63","1.63","Placental protein 13/galectin-13 variant R53HR55NH57RD33G with Lactose","SSLPVPYKLPVSLSVGSCVIIKGTPIHSFINGPQLQVDFYTDMDEDSDIAFHFNVRFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","6A64"
"6A65",,"X-RAY DIFFRACTION",2.07,40.71,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1042/BSR20181787",,"6A65",16.06,"1.771","1.771","Placental protein 13/galectin-13 variant R53HR55N with Tris","SSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFHFNVHFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","6A65"
"6A66",,"X-RAY DIFFRACTION",2.12,42.11,"VAPOR DIFFUSION, HANGING DROP",,"PEG",298,"10.1042/BSR20181787",,"6A66",16.52,"1.4","1.4","Placental protein 13/galectin-13 variant R53H with Tris","GSHMSSLPVPYKLPVSLSVGSCVIIKGTPIHSFINDPQLQVDFYTDMDEDSDIAFHFRVHFGNHVVMNRREFGIWMLEETTDYVPFEDGKQFELCIYVHYNEYEIKVNGIRIYGFVHRIPPSFVKMVQVSRDISLTSVCVCN","Homo sapiens","LGALS13, PLAC8","Galactoside-binding soluble lectin 13","1","6A66"
"6A6B","3.07","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41422-018-0075-x",,"6A6B",75.01,"3.07",,"cryo-em structure of alpha-synuclein fiber","VLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQ","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6A6B"
"6A6K",,"X-RAY DIFFRACTION",2.59,52.54,"VAPOR DIFFUSION, HANGING DROP",,"0.1M BIS-TRIS pH6.5, 16 %(w/v) PEG 10K, 3% MetOH",291,"10.1021/acs.jmedchem.8b01296",,"6A6K",82.4,"2.9","2.9","Crystal structure of Estrogen-related Receptor-3 (ERR-gamma) ligand binding domain with DN201000","MLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV","Homo sapiens","ESRRG, ERR3, ERRG2, KIAA0832, NR3B3","Estrogen-related receptor gamma","1","6A6K"
"6A6P",,"X-RAY DIFFRACTION",2.97,58.62,"LIQUID DIFFUSION",6.5,"0.2~0.3M Sodium flouride, 0.1M MES(pH 6.5)",291.15,,,"6A6P",64.41,"2.1","2.1","Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd)LBD in Complex with DN003316","QVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDM","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","6A6P"
"6A71",,"X-RAY DIFFRACTION",2.71,54.54,"VAPOR DIFFUSION, SITTING DROP",7.5,"20%PEG8000,0.1M MES pH6.0,0.2M Ca(OAc)2",286,"10.1038/s41467-018-08102-z",,"6A71",15.34,"1.6","1.6","Crystal Structure of Human ATP7B and TM Complex","TCSTTLIAIAGMTCASCVHSIEGMISQLEGVQQISVSLAEGTATVLYNPAVISPEELRAAIEDMGFEASVVS","Homo sapiens","ATP7B, PWD, WC1, WND","ATP7B protein","1","6A71"
"6A72",,"X-RAY DIFFRACTION",2.65,53.64,"VAPOR DIFFUSION, SITTING DROP",,"20%PEG8000,0.1M MES pH6.0,0.2M Ca(oAc)2",286,"10.1038/s41467-018-08102-z",,"6A72",15.14,"2.1","2.1","Copper transporter protein","TCSTTLIAIAGMTCASCVHSIEGMISQLEGVQQISVSLAEGTATVLYNPAVISPEELRAAIEDMGFEASVVS","Homo sapiens","ATP7B, PWD, WC1, WND","ATP7B protein","1","6A72"
"6A7A",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, HANGING DROP",,"23-27% (w/v) PEG 4000, 100 mM Hepes, 10mM CaCl2, 0.4M NaCl",289,"10.1016/j.bmc.2018.10.044",,"6A7A",39.87,"2.37","2.37","AKR1C1 complexed with new inhibitor with novel scaffold","MSYYHHHHHHEGVRTMDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEATKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWCNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAVEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY","Homo sapiens","AKR1C1, DDH, DDH1","Aldo-keto reductase family 1 member C1","1","6A7A"
"6A7B",,"X-RAY DIFFRACTION",2.1,41.54,"VAPOR DIFFUSION, HANGING DROP",,"15-20% (w/v) PEG 8000, 100 mM MES, 0.14M NaCl",289,"10.1016/j.bmc.2018.10.044",,"6A7B",76.33,"2.37","2.37","AKR1C3 complexed with new inhibitor with novel scaffold","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEY","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","6A7B"
"6A7C",,"X-RAY DIFFRACTION",2.4,48.81,"VAPOR DIFFUSION, HANGING DROP",,"2.7 M Ammonium sulphate, 100 mM K2HPO4, 3%(v/v) Ethanol",297,"10.1021/acsmedchemlett.8b00389","9QO","6A7C",22.81,"2.06","2.06","Human dihydrofolate reductase complexed with NADPH and BT1","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","6A7C"
"6A7E",,"X-RAY DIFFRACTION",2.52,51.12,"VAPOR DIFFUSION, HANGING DROP",,"2.78 M AMMONIUM SULPHATE, 100 mM K2HPO4, 3%(V/V) ETHANOL",297,"10.1021/acsmedchemlett.8b00389","9QR","6A7E",22.52,"1.85","1.85","Human dihydrofolate reductase complexed with NADPH and BT2","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","6A7E"
"6A7P",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, HANGING DROP",7,"32% PEG 3350, 50mM potassium phosphate buffer  pH 7.0",277,"10.1021/acsomega.8b02057","9SC","6A7P",134.41,"2.28","2.28","Human serum albumin complexed with aripiprazole","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6A7P"
"6A84",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris pH 8.5, 2.4M (NH4)2HPO4",277,"10.1021/acs.jmedchem.8b01888","9SU","6A84",25.14,"1.98","1.98","Tankyrase-2 in complex with compound 15d","MAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","2","6A84"
,,,,,,,,,,,,,,,,"NTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMK","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","6A84"
"6A8P",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION, HANGING DROP",6.8,"20 mM Mes (pH 6.8), 200 mM sodium chloride, 20 mM MgCl2, 6% PEG 3350, 5 mM DTT, 24% glycerol",293,"10.1371/journal.pone.0204707",,"6A8P",237.02,"2.537","2.537","Transglutaminase 2 mutant G224V in complex with GTP","MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTPANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRRSSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLEPFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGEEVKVRMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPALEHHHHHH","Homo sapiens","TGM2","Protein-glutamine gamma-glutamyltransferase 2","1","6A8P"
"6A8Y",,"SOLUTION NMR",,,,,,,,,"6A8Y",3.37,,,"YR26_SDS","YYHFWHRGVTKRSLSPHRPRHSRLQR","Homo sapiens","FURIN, FUR, PACE, PCSK3","YR26_SDS","1","6A8Y"
"6A9O",,"X-RAY DIFFRACTION",3.8,67.6,"VAPOR DIFFUSION, HANGING DROP",,"1.5M Sodium Citrate, pH 6.0",293,"10.1080/07391102.2018.1531787",,"6A9O",161.53,"2.5","2.5","Rational discovery of a SOD1 tryptophan oxidation inhibitor with therapeutic potential for amyotrophic lateral sclerosis","MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6A9O"
"6A9P",,"X-RAY DIFFRACTION",2.78,55.7,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM Tris-HCl pH 8.0, 400 mM NaCl and 22% (w/v) PEG10,000",295,"10.1016/j.bbrc.2018.08.066",,"6A9P",100.83,"2.51","2.51","Crystal structure of the human glial fibrillary acidic protein 1B domain","HMTKLADVYQAELRELRLRLDQLTANSARLEVERDNLAQDLATVRQKLQDETNLRLEAENNLAAYRQEADEATLARLDLERKIESLEEEIRFLRKIHEEEVRELQE","Homo sapiens","GFAP","Glial fibrillary acidic protein","1","6A9P"
"6A9Y",,"X-RAY DIFFRACTION",3.01,59.2,"VAPOR DIFFUSION",,"0.1M Tris, pH 8.0, 3.0 M NaCl",293,"10.1016/j.bbrc.2018.09.075",,"6A9Y",31.27,"2.7","2.7","The crystal structure of Mu homology domain of SGIP1","VDLGTENLYFQSADTLPVAAAFTETVNAYFKGADPSKCIVKITGEMVLSFPAGITRHFANNPSPAALTFRVINFSRLEHVLPNPQLLCCDNTQNDANTKEFWVNMPNLMTHLKKVSEQKPQATYYNVDMLKYQVSAQGIQSTPLNLAVNWRCEPSSTDLRIDYKYNTDAMTTAVALNNVQFLVPIDGGVTKLQAVLPPAVWNAEQQRILWKIPDISQKSENGGVGSLLARFQLSEGPSKPSPLVVQFTSEGSTLSGCDIELVGAGYRFSLIKKRFAAGKYLADN","Homo sapiens","SGIP1","SH3-containing GRB2-like protein 3-interacting protein 1","1","6A9Y"
"6AA3",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 1.8 mM ZnSO4, 6% sucrose, 0.1 M Bis-Tris pH 6.1",293,"10.1016/j.ejmech.2019.02.011",,"6AA3",19.28,"2.001","2.001","Crystal structure of MTH1 in apo form (cocktail No. 1)","MASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTVLEHHHHHH","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6AA3"
"6AA4",,"X-RAY DIFFRACTION",2.07,40.44,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 1.8mM ZnSO4, 6% sucrose, 0.1M Bis-Tris pH 6.1",293,"10.1016/j.ejmech.2019.02.011","MKS","6AA4",19.62,"1.9","1.9","Crystal structure of MTH1 in complex with alpha-mangostin (cocktail No. 9)","MASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTVLEHHHHHH","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6AA4"
"6AA5",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 1.8 mM ZnSO4, 6% sucrose, 0.1 M Bis-Tris pH 6.1",293,"10.1016/j.ejmech.2019.02.011","MKU","6AA5",19.69,"1.901","1.901","Crystal structure of MTH1 in complex with 3-isomangostin","MASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTVLEHHHHHH","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6AA5"
"6AAH",,"X-RAY DIFFRACTION",2.31,46.74,"VAPOR DIFFUSION",,"buffer, salt, precipitant",293,"10.1016/j.bmc.2018.08.005","9T6","6AAH",67.63,"1.83","1.83","Crystal structure of JAK1 in complex with peficitinib","VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6AAH"
"6AAJ",,"X-RAY DIFFRACTION",2.74,55.16,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate(pH6.5), 100mM ammonium phosphate, 20% PEG4000",293,"10.1016/j.bmc.2018.08.005","9T6","6AAJ",70.93,"2.37","2.37","Crystal structure of JAK2 in complex with peficitinib","GAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6AAJ"
"6AAK",,"X-RAY DIFFRACTION",2.72,54.87,"VAPOR DIFFUSION",,"buffer, salt, precipitant",293,"10.1016/j.bmc.2018.08.005","9T6","6AAK",132.74,"2.67","2.67","Crystal structure of JAK3 in complex with peficitinib","PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6AAK"
"6AAM",,"X-RAY DIFFRACTION",1.83,32.94,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Bis-Tris pH7.5, 0.2M sodium acetate, 10% glycerol, 20% PEG3350",277,"10.1016/j.bmc.2018.08.005","9T6","6AAM",34.34,"1.98","1.98","Crystal structure of TYK2 in complex with peficitinib","GPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGLAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6AAM"
"6AAR",,"X-RAY DIFFRACTION",1.93,36.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6 M ammonium sulfate, 0.1 M MES pH 6.5",293,"10.1107/S2059798320003940",,"6AAR",34.05,"1.95","1.95","Crystal structure of DAPK1 in complex with purpurin","MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSLEHHHHHH","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","6AAR"
"6AAS",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz505",,"6AAS",9.04,,,"Solution Structure for helix 45 in 3' end of 12S rRNA","GGUAAGUGUACUGGAAAGUGCACUUGCC","Homo sapiens",,"RNA (28-MER)","1","6AAS"
"6AC0",,"X-RAY DIFFRACTION",2.03,39.45,"VAPOR DIFFUSION, SITTING DROP",6,"1.6 M Na/KPO4, pH 6.0",293,"10.1016/j.molcel.2019.03.028",,"6AC0",13.55,"1.449","1.449","Crystal structure of TRADD death domain GlcNAcylated by EPEC effector NleB","PPPPAQTFLFQGQPVVNRPLSLKDQQTFARSVGLKWRKVGRSLQRGCRALRDPALDSLAYEYEREGLYEQAFQLLRRFVQAEGRRATLQRLVEALEENELTSLAEDLLGLTDPNGGLA","Homo sapiens","TRADD","Tumor necrosis factor receptor type 1-associated DEATH domain protein","1","6AC0"
"6AC5",,"X-RAY DIFFRACTION",1.79,31.26,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.2 M ammonium sulfate, 100 mM Bis-Tris  pH 5.5",293,"10.1016/j.molcel.2019.03.028",,"6AC5",13.26,"1.451","1.451","Crystal structure of RIPK1 death domain GlcNAcylated by EPEC effector NleB","NTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6AC5"
"6AC7",,"SOLUTION NMR",,,,,,,"10.1093/nar/gky1179",,"6AC7",7.25,,,"Structure of a (3+1) hybrid G-quadruplex in the PARP1 promoter","TGGGGTCCGAGGCGGGGCTTGGG","Homo sapiens",,"5'-D(*TP*GP*GP*GP*GP*TP*CP*CP*GP*AP*GP*GP*CP*GP*GP*GP*GP*CP*TP*TP*GP*GP*G)-3'","1","6AC7"
"6AC9",,"X-RAY DIFFRACTION",2.57,52.15,"VAPOR DIFFUSION, HANGING DROP",7,"27.5 % w/v PEG 3350, 0.2 M of ammonium sulfate, 0.1 M of HEPES (pH 7.0)",291,"10.1002/pro.3552",,"6AC9",171.42,"2.07","2.07","Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP","MPRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEEHHHHHH","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6AC9"
"6ACB",,"X-RAY DIFFRACTION",2.81,56.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Cacodylate Sodium (pH6.5), 0.2 M MgSO4, 18% PEG3350, 2.5% ethanol",298,"10.1021/acs.jmedchem.8b01209",,"6ACB",38.49,"2.8","2.8","Crystal structure of PDE5 in complex with inhibitor LW1805","EETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","6ACB"
"6ACR",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES, 1.6 M Ammonium sulfate",293,"10.1248/cpb.c18-00598","9TO","6ACR",70.33,"2.01","2.01","Crystal structure of human ALK2 kinase domain with R206H mutation in complex with RK-59638","SMQRTVAHQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6ACR"
"6ADE",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION, SITTING DROP",7.7,"4M sodium formate, pH 7.7",293,,,"6ADE",109.39,"3.15","3.15","Crystal structure of phosphorylated mutant of glyceraldehyde 3-phosphate dehydrogenase from human placenta at 3.15A resolution","MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLLGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE","Homo sapiens","GAPDH, GAPD, CDABP0047, OK/SW-cl.12","Glyceraldehyde-3-phosphate dehydrogenase","1","6ADE"
"6ADG",,"X-RAY DIFFRACTION",2.69,54.31,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Magnesium chloride hexahydrate, 0.1M Tris pH 8.5, 25%(w/v) Polyethylene glycol 3,350, 0.1M Cesium chloride",293,"10.1016/j.bbrc.2018.08.068","9UO","6ADG",146.78,"3","3","Crystal Structures of IDH1 R132H in complex with AG-881","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6ADG"
"6ADI",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2M Sodium chloride, 0.1M BIS-TRIS pH 6.5, 25%(w/v) Polyethylene glycol 3,350",293,"10.1016/j.bbrc.2018.08.068","9UO","6ADI",96.99,"1.969","1.969","Crystal Structures of IDH2 R140Q in complex with AG-881","MDKRIKVAKPVVEMDGDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIQNILGGTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHSCFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGFGSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKDLAGCIHGLSNVKLNEHFLNTTDFLDTIKSNLDRALGRQHHHHHH","Homo sapiens","IDH2","Isocitrate dehydrogenase [NADP], mitochondrial","1","6ADI"
"6AEC",,"X-RAY DIFFRACTION",2.47,50.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","ATP","6AEC",41.25,"1.72","1.72","Binary complex of human DNA Polymerase Mu with MnATP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6AEC"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6AED",,"X-RAY DIFFRACTION",6.44,80.91,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris, pH 8.5, 25%(v/v) tert-butanol",277,"10.1038/s41423-019-0258-5",,"6AED",43.58,"3.797","3.797","Crystal Structure of the four Ig-like domain of LILRB2(LIR2/ILT4/CD85d)","GIQPKPTLWAEPDSVITQGSPVTLSCQGSLEAQEYRLYREKKSASWITRIRPELVKNGQFHIPSITWEHTGRYGCQYYSRARWSELSDPLVLVMTGAYPKPTLSAQPSPVVTSGGRVTLQCESQVAFGGFILCKEGEEEHPQCLNSQPHARGSSRAIFSVGPVSPNRRWSHRCYGYDLNSPYVWSSPSDLLELLVPGVSKKPSLSVQPGPVMAPGESLTLQCVSDVGYDRFVLYKEGERDLRQLPGRQPQAGLSQANFTLGPVSRSYGGQYRCYGAHNLSSECSAPSDPLDILITGQIRGTPFISVQPGPTVASGENVTLLCQSWRQFHTFLLTKAGAADAPLRLRSIHEYPKYQAEFPMSPVTSAHAGTYRCYGSLNSDPYLLSHPSEPLELVVS","Homo sapiens","LILRB2, ILT4, LIR2, MIR10","Leukocyte immunoglobulin-like receptor subfamily B member 2","1","6AED"
"6AEH",,"X-RAY DIFFRACTION",2.46,50.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","UTP","6AEH",41.32,"1.64","1.64","Binary complex of human DNA Polymerase Mu with MnUTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6AEH"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6AEJ",,"X-RAY DIFFRACTION",3.04,59.51,"VAPOR DIFFUSION, HANGING DROP",5.6,"10% (w/v) PEG 3350, 0.1M tri-sodium Citrate dehydrate pH5.6, 5.0mM 3-meT, 3.0mM NOG, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1126/scitranslmed.aau7116",,"6AEJ",54.51,"2.8","2.8","Crystal structure of human FTO in complex with small-molecule inhibitors","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAASNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO,Alpha-ketoglutarate-dependent dioxygenase FTO","1","6AEJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","FTO, KIAA1752"
"6AEZ",,"X-RAY DIFFRACTION",2.58,52.3,"VAPOR DIFFUSION, HANGING DROP",5,"0.2M ammonium sulfate, 0.1M BIS-TRIS pH 5, 16% (w/v) polyethylene glycol 3350",283,"10.1016/j.jmb.2019.12.049",,"6AEZ",24.47,"1.63","1.63","Crystal structure of human CCL5 trimer","MSPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLSMS","Homo sapiens","CCL5, D17S136E, SCYA5","C-C motif chemokine 5","1","6AEZ"
,,,,,,,,,,,,,,,,"MSPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS","Homo sapiens","CCL5, D17S136E, SCYA5","C-C motif chemokine 5","2","6AEZ"
"6AF5",,"X-RAY DIFFRACTION",3.08,60.08,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AF5",20.1,"1.65","1.65","DJ-1 after backsoaking","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AF5"
"6AF7",,"X-RAY DIFFRACTION",3.06,59.76,"VAPOR DIFFUSION, HANGING DROP",8.5,"pH 8.5, 100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AF7",20.17,"1.3","1.3","DJ-1 C106S unbound","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAISAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AF7"
"6AF9",,"X-RAY DIFFRACTION",3.08,60.01,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AF9",20.39,"1.39","1.39","DJ-1 with isatin bound (high concentration)","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AF9"
"6AFA",,"X-RAY DIFFRACTION",3.1,60.35,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFA",20.1,"1.65","1.65","DJ-1 with isatin (low concentration)","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFA"
"6AFB",,"X-RAY DIFFRACTION",3.04,59.48,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG-400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFB",20.31,"1.6","1.6","DJ-1 C106S incubated with isatin","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAISAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFB"
"6AFC",,"X-RAY DIFFRACTION",3.13,60.69,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG-400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFC",20.12,"1.45","1.45","DJ-1 with compound 4","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFC"
"6AFD",,"X-RAY DIFFRACTION",3.1,60.34,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG-400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFD",20.27,"1.48","1.48","DJ-1 with compound 6","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFD"
"6AFE",,"X-RAY DIFFRACTION",3.1,60.32,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFE",20.38,"1.5","1.5","DJ-1 with compound 7","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFE"
"6AFF",,"X-RAY DIFFRACTION",3.09,60.13,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFF",20.36,"1.6","1.6","DJ-1 with compound 8","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFF"
"6AFG",,"X-RAY DIFFRACTION",3.12,60.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFG",20.24,"1.5","1.5","DJ-1 with compound 9","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFG"
"6AFH",,"X-RAY DIFFRACTION",3.12,60.54,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFH",20.2,"1.65","1.65","DJ-1 with compound 10","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFH"
"6AFI",,"X-RAY DIFFRACTION",3.12,60.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFI",20.13,"1.65","1.65","DJ-1 with compound 11","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFI"
"6AFJ",,"X-RAY DIFFRACTION",3.11,60.4,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFJ",20.21,"1.48","1.48","DJ-1 with compound 13","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFJ"
"6AFL",,"X-RAY DIFFRACTION",3.08,60.12,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TRIS-HCl, 200mM sodium citrate, 30% PEG 400, 5mM DTT",293.15,"10.1021/acschembio.8b00701",,"6AFL",20.22,"1.6","1.6","DJ-1 with compound 15","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6AFL"
"6AFR",,"X-RAY DIFFRACTION",1.97,37.5,"VAPOR DIFFUSION, SITTING DROP",7.4,"The protein was concentrated to 8-10 mg mL-1 in the buffer containing 20mM HEPES, pH7.4, 100mM NaCl and 1mM DTT. The apo crystals of BRD4_BD1 were harvested by using sitting drop vapor-diffusion method in 4M sodium formate and 15% glycerol at 289.15K. Then the apo crystals were soaked into reservoir solution containing 1mM compound for 7 days.",289.15,"10.1016/j.ejmech.2018.11.018","9E3","6AFR",15.34,"1.998","1.998","Crystal Structure of the first bromodomain of human BRD4 in complex with 5-((4-fluoro-1H-imidazol-1-yl)methyl)quinolin-8-ol","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6AFR"
"6AG2",,"X-RAY DIFFRACTION",2.06,40.32,"VAPOR DIFFUSION, SITTING DROP",,"2.0M ammonium sulfate, 50mM sodium citrate (pH 4.6), 5% PEG 400",298,,,"6AG2",28.84,"1.77","1.77","uPA-HMA","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6AG2"
"6AG3",,"X-RAY DIFFRACTION",2.15,42.92,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate, pH 4.6, 2.0M ammonium sulfate supplemented with 5% polyethylene glycol 400",298,,,"6AG3",28.78,"2.48","2.48","Crystal structure of uPA in complex with 3,5-bis(azanyl)-N-carbamimidoyl-6-(2,4-dimethoxypyrimidin-5-yl)pyrazine-2-carboxamide","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6AG3"
"6AG7",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, SITTING DROP",,"50 mM sodium citrate, pH 4.6, and 2.0 M ammonium sulfate supplemented with 5% polyethylene glycol 400",298,,,"6AG7",27.86,"1.9","1.9","The crystal structure of uPA in complex with HMA-55F","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6AG7"
"6AG9",,"X-RAY DIFFRACTION",2.15,42.71,"VAPOR DIFFUSION, SITTING DROP",,"50mM sodium citrate, pH 4.6, 2.0M ammonium sulfate supplemented with 5% polyethylene glycol 400",298,,,"6AG9",28.85,"1.63","1.63","Crystal structure of uPA in complex with 3,5-bis(azanyl)-6-(1-benzofuran-2-yl)-N-carbamimidoyl-pyrazine-2- carboxamide","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","6AG9"
"6AGH",,"X-RAY DIFFRACTION",2.28,46.06,"VAPOR DIFFUSION, SITTING DROP",,"20 mM Tris-HCl pH 8.5, 200 mM NaCl, 1 mM EGTA, 2 mM DTT",293,"10.1016/j.celrep.2019.01.022",,"6AGH",79.48,"2.742","2.742","Crystal structure of EFHA1 in Apo-State","GSDGSFTVSAQKNVEHGIIYIGKPSLRKQRFMQFSSLEHEGEYYMTPRDFLFSVMFEQMERKTSVKKLTKKDIEDTLSGIQTAGCGSTFFRDLGDKGLISYTEYLFLLTILTKPHSGFHVAFKMLDTDGNEMIEKREFFKLQKIISKQDDLMTVKTNETGYQEAIVKEPEINTTLQMRFFGKRGQRKLHYKEFRRFMENLQTEIQEMEFLQFSKGLSFMRKEDFAEWLLFFTNTENKDIYWKNVREKLSAGESISLDEFKSFCHFTTHLEDFAIAMQMFSLAHRPVRLAEFKRAVKVATGQELSNNILDTVFKIFDLDGDECLSHEEFLGVLKNRMHRG","Homo sapiens","MICU2, EFHA1","Calcium uptake protein 2, mitochondrial","1","6AGH"
"6AGI",,"X-RAY DIFFRACTION",2.51,50.98,"VAPOR DIFFUSION, SITTING DROP",9.5,"20 mM CHES pH 9.5, 200 mM NaCl, 2 mM CaCl2, 2 mM DTT",293,"10.1016/j.celrep.2019.01.022",,"6AGI",89.74,"2.799","2.799","Crystal Structure of EFHA2 in Ca-binding State","GSTDIEDLDLYATSRERRFRLFASIECEGQLFMTPYDFILAVTTDEPKVAKTWKSLSKQELNQMLAETPPVWKGSSKLFRNLKEKGVISYTEYLFLLCILTKPHAGFRIAFNMFDTDGNEMVDKKEFLVLQEIFRKKNEKREIKGDEEKRAMLRLQLYGYHSPTNSVLKTDAEELVSRSYWDTLRRNTSQALFSDLAERADDITSLVTDTTLLVHFFGKKGKAELNFEDFYRFMDNLQTEVLEIEFLSYSNGMNTISEEDFAHILLRYTNVENTSVFLENVRYSIPEEKGITFDEFRSFFQFLNNLEDFAIALNMYNFASRSIGQDEFKRAVYVATGLKFSPHLVNTVFKIFDVDKDDQLSYKEFIGIMKDRLHRGFRGYKT","Homo sapiens","MICU3, EFHA2","Calcium uptake protein 3, mitochondrial","1","6AGI"
"6AGJ",,"X-RAY DIFFRACTION",2.49,50.51,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M imidazole pH 9.5, 15% ethanol, 0.2 M MgCl2.",293,"10.1016/j.celrep.2019.01.022",,"6AGJ",89.47,"2.999","2.999","Crystal Structure of EFHA2 in Apo State","GSTDIEDLDLYATSRERRFRLFASIECEGQLFMTPYDFILAVTTDEPKVAKTWKSLSKQELNQMLAETPPVWKGSSKLFRNLKEKGVISYTEYLFLLCILTKPHAGFRIAFNMFDTDGNEMVDKKEFLVLQEIFRKKNEKREIKGDEEKRAMLRLQLYGYHSPTNSVLKTDAEELVSRSYWDTLRRNTSQALFSDLAERADDITSLVTDTTLLVHFFGKKGKAELNFEDFYRFMDNLQTEVLEIEFLSYSNGMNTISEEDFAHILLRYTNVENTSVFLENVRYSIPEEKGITFDEFRSFFQFLNNLEDFAIALNMYNFASRSIGQDEFKRAVYVATGLKFSPHLVNTVFKIFDVDKDDQLSYKEFIGIMKDRLHRGFRGYKT","Homo sapiens","MICU3, EFHA2","Calcium uptake protein 3, mitochondrial","1","6AGJ"
"6AGP",,"SOLUTION NMR",,,,,,,"10.1126/sciadv.aav8945",,"6AGP",20.5,,,"Structure of Rac1 in the low-affinity state for Mg2+","MQAIKCVVVGDGAVGKTCLLISYTTNAFPGCYIPTVFDNYSANVMVDGKPVNLGLWDTAGQECYDRLRPLSYPCTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSACTQRGLKTVFDEAIRAVLCPPP","Homo sapiens","RAC1, TC25, MIG5","Ras-related C3 botulinum toxin substrate 1","1","6AGP"
"6AGW",,"X-RAY DIFFRACTION",2.98,58.69,"VAPOR DIFFUSION, HANGING DROP",,"(NH4)2SO4, Cacodylate, NaCl",298,"10.1038/s41418-018-0200-x",,"6AGW",22.2,"2.093","2.093","Pro-domain of Caspase-8","MDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEESNLSFLKELLFRINRLDLLITYLNTRKEEMERELQTPGRAQISAYRVMLYQISEEVSRSELRSFKFLLQEEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDILKRVCAQINKSLLKIINDYEEHHHHH","Homo sapiens","CASP8, MCH5","Caspase-8 pro-domain","1","6AGW"
"6AGX",,"X-RAY DIFFRACTION",2.51,51.04,"EVAPORATION",6.5,"0.2M Ammonium sulfate, 0.1M MES pH 6.5, 30%(w/v) PEG 5000 MME",298,,,"6AGX",140.2,"2.95","2.95","The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold","ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","6AGX"
"6AH4",,"X-RAY DIFFRACTION",5.1,75.87,"VAPOR DIFFUSION",,"Sodium chloride, Calcium acetate, PEG 400, ATP",297,"10.7554/eLife.47060","ATP","6AH4",128.03,"3.296","3.296","Structure of human P2X3 receptor in complex with ATP and Ca2+ ion","SREFDFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNE","Homo sapiens","P2RX3","P2X purinoceptor 3","1","6AH4"
"6AH5",,"X-RAY DIFFRACTION",4.92,74.99,"VAPOR DIFFUSION",,"Magnesium acetate tetrahydrate, Sodium acetate, PEG 400, ATP.",297,"10.7554/eLife.47060","ATP","6AH5",126.96,"3.819","3.819","Structure of human P2X3 receptor in complex with ATP and Mg2+ ion","SREFDFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNE","Homo sapiens","P2RX3","P2X purinoceptor 3","1","6AH5"
"6AHV",,"X-RAY DIFFRACTION",3.32,63,"EVAPORATION",7,"5% v/v TacsimateTM pH 7.0, 100mM Hepes pH 7.0, 10% w/v polyethylene glycol monomethyl ether 5000",277,"10.1016/j.cell.2018.10.003",,"6AHV",41.88,"2.6","2.6","Crystal structure of human RPP40","MATLRRLREAPRHLLVCEKSNFGNHKSRHRHLVQTHYYNYRVSFLIPECGILSEELKNLVMNTGPYYFVKNLPLHELITPEFISTFIKKGSCYALTYNTHIDEDNTVALLPNGKLILSLDKDTYEETGLQGHPSQFSGRKIMKFIVSIDLMELSLNLDSKKYERISWSFKEKKPLKFDFLLAWHKTGSEESTMMSYFSKYQIQEHQPKVALSTLRDLQCPVLQSSELEGTPEVSCRALELFDWLGAVFSNVDLNNEPNNFISTYCCPEPSTVVAKAYLCTITGFILPEKICLLLEHLCHYFDEPKLAPWVTLSVQGFADSPVSWEKNEHGFRKGGEHLYNFVIFNNQDYWLQMAVGANDHCPP","Homo sapiens","RPP40, RNASEP1","Ribonuclease P protein subunit p40","1","6AHV"
"6AHZ",,"SOLUTION NMR",,,,,,,"10.2174/1573406415666181218101623",,"6AHZ",4.13,,,"The NMR Structure of the Polysialyltranseferase Domain (PSTD) in Polysialyltransferase ST8siaIV","LKNKLKVRTAYPSLRLIHAVRGYWLTNKVPIKRPS","Homo sapiens","ST8SIA4, PST, PST1, SIAT8D","CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase","1","6AHZ"
"6AJV",,"X-RAY DIFFRACTION",1.92,36.05,"VAPOR DIFFUSION, SITTING DROP",8,"4M sodium formate, 0.1M tris-HCl pH 8.0",293,"10.1111/febs.14736","HCC","6AJV",16.56,"1.45","1.45","Crystal structure of BRD4 in complex with isoliquiritigenin and DMSO (Cocktail No. 3)","MHHHHHHMSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6AJV"
"6AJW",,"X-RAY DIFFRACTION",1.91,35.55,"VAPOR DIFFUSION, SITTING DROP",8,"4M sodium formate, 0.1M tris-HCl pH 8",293,"10.1111/febs.14736",,"6AJW",16.31,"1.401","1.401","Crystal structure of BRD4 in complex with DMSO (Cocktail No. 4)","MHHHHHHMSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6AJW"
"6AJX",,"X-RAY DIFFRACTION",1.87,34.19,"VAPOR DIFFUSION, SITTING DROP",,"4M sodium formate, 0.1M tris-HCl pH 8",293,"10.1111/febs.14736","HCC","6AJX",16.46,"1.887","1.887","Crystal structure of BRD4 in complex with isoliquiritigenin in the absence of DMSO","MHHHHHHMSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6AJX"
"6AJY",,"X-RAY DIFFRACTION",1.92,35.87,"VAPOR DIFFUSION, SITTING DROP",8,"4M sodium formate, 0.1M tris-HCl pH 8",293,"10.1111/febs.14736","A0R","6AJY",16.48,"1.6","1.6","Crystal structure of BRD4 in complex with 2',4'-dihydroxy-2-methoxychalcone","MHHHHHHMSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6AJY"
"6AJZ",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.12,41.91,"VAPOR DIFFUSION, SITTING DROP",,"2.9M sodium formate, 17mM Tris, 83mM Tris-HCl in D2O",293,"10.1111/febs.14736",,"6AJZ",16.58,"1.301, 1.847","1.301, 1.847","Joint nentron and X-ray structure of BRD4 in complex with colchicin","MHHHHHHMSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6AJZ"
"6AK4",,"X-RAY DIFFRACTION",2.99,58.9,"VAPOR DIFFUSION, HANGING DROP",5.6,"10.0% (W/V) PEG 3350, 100 MM SODIUM
 CITRATE, PH 5.6, 7% TERT-BUTANOL, 1 MM ZNSO4, 1 MM COMPOUND,
 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1126/scitranslmed.aau7116",,"6AK4",54.49,"2.8","2.8","Crystal structure of human FTO in complex with small-molecule inhibitors","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAASNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLEAKP","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO,Alpha-ketoglutarate-dependent dioxygenase FTO","1","6AK4"
,,,,,,,,,,,,,,,,,"Homo sapiens","FTO, KIAA1752"
"6AK5",,"X-RAY DIFFRACTION",2.62,53.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","GTP","6AK5",41.36,"1.7","1.7","Binary Complex of Human DNA Polymerase Mu with MnGTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6AK5"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6AK6",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 1.5 M Li2SO4",298,"10.1021/jacs.9b01741","CTP","6AK6",41.32,"1.75","1.75","Binary Complex of Human DNA Polymerase Mu with MnCTP","GSAAAPLSPAWMPAYACQRPTPLTHHNTGLSEALEILAEAAGFEGSEGRLLTFCRAASVLKALPSPVTTLSQLQGLPHFGEHSSRVVQELLEHGVCEEVERVRRSERYQTMKLFTQIFGVGVKTADRWYREGLRTLDDLREQPQKLTQQQKAGLQHHQDLSTPVLRSDVDALQQVVEEAVGQALPGATVTLTGGFRRGKLQGHDVDFLITHPKEGQEAGLLPRVMCRLQDQGLILYHQHQHSCCESPTRLAQQSHMDAFERSFCIFRLPQPGSWKAVRVDLVVAPVSQFPFALLGWTGSKLFQRELRRFSRKEKGLWLNSHGLFDPEQKTFFQAASEEDIFRHLGLEYLPPEQRNA","Homo sapiens","POLM, polmu","DNA-directed DNA/RNA polymerase mu","1","6AK6"
,,,,,,,,,,,,,,,,,"Homo sapiens","POLM, polmu"
"6AK7",,"X-RAY DIFFRACTION",4.77,74.19,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris, pH 8.5, 12% PEG 3350, 0.2 M MgCl2, 10 mM Mercaptoethanol",293,,,"6AK7",28.45,"2.605","2.605","Crystal structure of PPM1K-N94K","ISLAKVGCASQIGKRKENEDRFDFAQLTDEVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPKEANLETLLTLAFLEIDKAFSSHARLSADATLLTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTIDHTPERADEKERIKKCGGFVAWNQPHVNGRLAMTRSIGDLDLKTSGVIAEPETKRIKLHHADDSFLVLTTDGINFMVNSQEICDFVNQCHDPNEAAHAVTEQAIQYGTEDNSTAVVVPFGAW","Homo sapiens","PPM1K, PP2CM","Protein phosphatase 1K, mitochondrial","1","6AK7"
"6AKK",,"X-RAY DIFFRACTION",2.14,42.48,"VAPOR DIFFUSION, SITTING DROP",,"1.0 M (NH4)2HPO4 (ammonium dibasic phosphate); 
0.1 M acetate pH 4.5",289,"10.1038/s41421-018-0077-3",,"6AKK",12.94,"1.5","1.5","Crystal structure of the second Coiled-coil domain of SIKE1","STMGLLSQENTQIRDLQQENRELWISLEEHQDALELIMSKYRKQMLQLMVAKKA","Homo sapiens","SIKE1, SIKE","Suppressor of IKBKE 1","1","6AKK"
"6AKR",,"X-RAY DIFFRACTION",2.93,58.02,"EVAPORATION",,"0.1M HEPES, 18% PEG3350, 25% ethylene glycol, 10% isopropanol, pH 7.5",277.15,"10.1126/scisignal.aax0273",,"6AKR",168.73,"2.326","2.326","Crystal structure of the PDE4D catalytic domain in complex with osthole","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6AKR"
"6AKW",,"X-RAY DIFFRACTION",2.85,56.77,"EVAPORATION",,"100 mM sodium citrate, 12% PEG 3350, 8% isopropanol",293,"10.1016/j.ccell.2019.03.006","8S3","6AKW",57.05,"2.2","2.2","Crystal structure of RNA dioxygenase bound with an inhibitor","MGSSHHHHHHSSGLVPRGSHMTPKDDEFYQQWQLKYPKLILREASSVSEELHKEVQEAFLTLHKHGCLFRDLVRIQGKDLLTPVSRILIGNPGCTYKYLNTRLFTVPWPVKGSNIKHTEAEIAAACETFLKLNDYLQIETIQALEELAAKEKANEDAVPLCMSADFPRVGMGSSYNGQDEVDIKSRAAYNVTLLNFMDPQKMPYLKEEPYFGMGKMAVSWHHDENLVDRSAVAVYSYSCEGPEEESEDDSHLEGRDPDIWHVGFKISWDIETPGLAIPLHQGDCYFMLDDLNATHQHCVLAGSQPRFSSTHRVAECSTGTLDYILQRCQLALQNVCDDVDNDDVSLKSFEPAVLKQGEEIHNEVEFEWLRQFWFQGNRYRKCTDWWCQPMAQLEALWKKMEGVTNAVLHEVKREGLPVEQRNEILTAILASLTARQNLRREWHARCQSRIARTLPADQKPECRPYWEKDDASMPLPFDLTDIVSELRGQLLE","Homo sapiens","FTO, KIAA1752","Alpha-ketoglutarate-dependent dioxygenase FTO","1","6AKW"
"6ALB",,"X-RAY DIFFRACTION",2.9,57.63,"VAPOR DIFFUSION",6.5,"0.2 M Li2SO4, 0.1M Bis-Tris pH 6.5, 19% PEG3350",277,,"BKJ","6ALB",28.46,"2.053","2.053","CREBBP bromodomain in complex with Cpd 30 (1-(3-(3-(1-methyl-1H-pyrazol-4-yl)isoquinolin-8-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)","SRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLGYCCGRKYEFSPQTLCCYGKQLCTIPRDAAYYSYQNRYHFCEKCFTEIQGENVTLGDDPSQPQTTISKDQFEKKKNDTLDPEPFVDCKECGRKMHQICVLHYDIIWPSGFVCDNCL","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6ALB"
"6ALC",,"X-RAY DIFFRACTION",2.23,44.86,"VAPOR DIFFUSION",6.5,"0.2 M Li2SO4, 0.1M Bis-Tris pH 6.5, 19% PEG3350",277,"10.1016/j.bmcl.2017.11.025","BKD","6ALC",27.57,"1.391","1.391","CREBBP bromodomain in complex with Cpd 4 (1-(1-(cyclopropylmethyl)-3-(1H-indol-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)","AAFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQAL","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6ALC"
"6ALJ",,"X-RAY DIFFRACTION",2.24,45.2,"VAPOR DIFFUSION, HANGING DROP",,"40 MG/ML ALDH1A2, 0.2 M sodium citrate tribasic dehydrate, 20% w/v polyethylene glycol 3,350, 1.3 MM WIN18,446 and 10%DMSO",291.1,"10.1021/acschembio.7b00685","CW2","6ALJ",220.8,"1.89","1.89","ALDH1A2 liganded with NAD and compound WIN18,446","LPSPTPNLEIKYTKIFINNEWQNSESGRVFPVYNPATGEQVCEVQEADKADIDKAVQAARLAFSLGSVWRRMDASERGRLLDKLADLVERDRAVLATMESLNGGKPFLQAFYVDLQGVIKTFRYYAGWADKIHGMTIPVDGDYFTFTRHEPIGVCGQIIPWNFPLLMFAWKIAPALCCGNTVVIKPAEQTPLSALYMGALIKEAGFPPGVINILPGYGPTAGAAIASHIGIDKIAFTGSTEVGKLIQEAAGRSNLKRVTLELGGKSPNIIFADADLDYAVEQAHQGVFFNQGQCCTAGSRIFVEESIYEEFVRRSVERAKRRVVGSPFDPTTEQGPQIDKKQYNKILELIQSGVAEGAKLECGGKGLGRKGFFIEPTVFSNVTDDMRIAKEEIFGPVQEILRFKTMDEVIERANNSDFGLVAAVFTNDINKALTVSSAMQAGTVWINCYNALNAQSPFGGFKMSGNGREMGEFGLREYSEVKTVTVKIPQKNS","Homo sapiens","ALDH1A2, RALDH2","Aldehyde dehydrogenase 1A2","1","6ALJ"
"6ALZ",,"X-RAY DIFFRACTION",2.56,51.89,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 6000, 1 M lithium chloride, 0.1 M Tris pH 8.0",298,"10.1021/jacs.7b09368",,"6ALZ",70.01,"2.208","2.208","Crystal structure of Protein Phosphatase 1 bound to the natural inhibitor Tautomycetin","GHMGSLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAD","Homo sapiens","PPP1CA, PPP1A","Serine/threonine-protein phosphatase PP1-alpha catalytic subunit","1","6ALZ"
"6AM3",,"X-RAY DIFFRACTION",2.35,47.64,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M calcium chloride dihydrate, 0.1 M MES, pH 6.0, 22% PEG3350",277.15,"10.1074/jbc.RA118.006059",,"6AM3",33.21,"1.53","1.53","Regulator of G protein signaling (RGS) 17 in complex with Ca2+","SMNPTAEEVLSWSQNFDKMMKAPAGRNLFREFLRTEYSEENLLFWLACEDLKKEQNKKVIEEKARMIYEDYISILSPKEVSLDSRVREVINRNLLDPNPHMYEDAQLQIYTLMHRDSFPRFLNSQIYKSFVESTAGS","Homo sapiens","RGS17, RGSZ2","Regulator of G-protein signaling 17","1","6AM3"
"6AMJ",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION, SITTING DROP",,"12% PEG 8K, 0.1M Sodium cacodylate pH 6.0, 0.2M MgCl2",277,"10.1080/19420862.2018.1426421",,"6AMJ",95.65,"2.49","2.49","CAT192 Fab Wild Type","EIVLTQSPSSLSASVGDRVTITCRASQGIGDDLGWYQQKPGKAPILLIYGTSTLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCLQDSNYPLTFGGGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CAT192 Fab light chain","1","6AMJ"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKELEWVAVISYDGSIKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTGEYSGYDTDPQYSWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVHHHHHH","Homo sapiens",,"CAT192 Fab heavy chain","2","6AMJ"
"6AMM",,"X-RAY DIFFRACTION",2.69,54.33,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 8K, 0.1M Sodium cacodylate pH 6.5, 0.2M MgCl2",277,"10.1080/19420862.2018.1426421",,"6AMM",47.82,"2.8","2.8","CAT192 Fab Insertion Mutant H0/L1","EIVLTQSPSSLSASVGDRVTITCRASQGIGDDLGWYQQKPGKAPILLIYGTSTLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCLQDSNYPLTFGGGTRLEIKGRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CAT192 Fab Light chain","1","6AMM"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKELEWVAVISYDGSIKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTGEYSGYDTDPQYSWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVHHHHHH","Homo sapiens",,"CAT192 Fab Heavy chain","2","6AMM"
"6AMV",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.3470",,"6AMV",28.35,,,"Abl 1b Regulatory Module 'inhibiting state'","MGQQPGKVLGDQRRPSLPALHFIKGAGKRESSRHGGPHCNVFVEHEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWAEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWE","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6AMV"
"6AMW",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.3470",,"6AMW",28.35,,,"Abl1b Regulatory Module 'Activating' conformation","MGQQPGKVLGDQRRPSLPALHFIKGAGKRESSRHGGPHCNVFVEHEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWAEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWE","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6AMW"
"6AN1",,"X-RAY DIFFRACTION",2.54,51.5,"VAPOR DIFFUSION, HANGING DROP",,"0.9M tri-sodium citrate, 100mM Hepes, 3.5% 1,2-propanediol, pH 7.0",293,"10.3389/fendo.2018.00011","BKY","6AN1",65.63,"2.687","2.687","Crystal structure of the complex between PPARgamma LBD and the ligand AM-879","GSHMEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6AN1"
"6ANL",,"X-RAY DIFFRACTION",2.17,43.35,"VAPOR DIFFUSION, SITTING DROP",7.4,"15.% PEG 8000, 0.08M NP_HEPES, 0.02M NP_HEPES_Na",293,"10.1016/j.bmc.2017.12.031","T75","6ANL",42.11,"2","2","Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 MAP Kinase Inhibitors","GAMGSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","6ANL"
"6ANO",,"X-RAY DIFFRACTION",1.88,34.49,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM Tris (pH 8.0), 18% (w/v) PEG 4000",293,"10.1371/journal.pone.0186034",,"6ANO",23.05,"2.61","2.61","Crystal structure of human FLASH N-terminal domain","MSRNCLDLYEEILTEEGTAKEATYNDLQVEYGKCQLQMKELMKKFKEIQAQNFSLINENQSLKKNISALIKTARVEINRKDEEISNLHLEHHHHHH","Homo sapiens","CASP8AP2, FLASH, KIAA1315, RIP25","CASP8-associated protein 2","1","6ANO"
"6ANP",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION, SITTING DROP",6,"10.3% PEG 20K, 0.0938M MES pH 6.0, 2.5% DMSO",277,"10.1080/19420862.2018.1426421",,"6ANP",96.15,"2.45","2.45","CAT192 Fab Insertion Mutant H5/L0","EIVLTQSPSSLSASVGDRVTITCRASQGIGDDLGWYQQKPGKAPILLIYGTSTLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCLQDSNYPLTFGGGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CAT192 Fab Light chain","1","6ANP"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKELEWVAVISYDGSIKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTGEYSGYDTDPQYSWGQGTTVTVGGGGSSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVHHHHHH","Homo sapiens",,"CAT192 Fab Heavy chain","2","6ANP"
"6AO0",,"X-RAY DIFFRACTION",2.22,44.58,"VAPOR DIFFUSION, SITTING DROP",4.6,"2M Ammonium sulfate, 0.1M sodium acetate trihydrate pH 4.6",277,"10.1080/19420862.2018.1426421",,"6AO0",48.47,"2.35","2.35","CAT192 Fab Insertion Mutant H2/L2","EIVLTQSPSSLSASVGDRVTITCRASQGIGDDLGWYQQKPGKAPILLIYGTSTLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCLQDSNYPLTFGGGTRLEIKGGRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CAT192 Fab Light chain","1","6AO0"
,,,,,,,,,,,,,,,,"EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKELEWVAVISYDGSIKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARTGEYSGYDTDPQYSWGQGTTVTVSGGSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVHHHHHH","Homo sapiens",,"CAT192 Fab Heavy chain","2","6AO0"
"6AO4",,"X-RAY DIFFRACTION",2.66,53.78,"VAPOR DIFFUSION, SITTING DROP",7,"2.1 M DL-malic acid, pH 7.0",295,"10.1016/j.str.2018.03.002",,"6AO4",22.35,"2.901","2.901","Crystal structure of the human gasdermin D C-terminal domain","SVPAEGAFTEDFQGLRAEVETISKELELLDRELCQLLLEGLEGVLRDQLALRALEEALEQGQSLGPVEPLDGPAGAVLECLVLSSGMLVPELAIPVVYLLGALTMLSETQHKLLAEALESQTLLGPLELVGSLLEQSAPWQERSTMSLPPGLLGNSWGEGAPAWVLLDECGLELGEDTPHVCWEPQAQGRMCALYASLALLSGLSQEPH","Homo sapiens","GSDMD, DFNA5L, GSDMDC1, FKSG10","Gasdermin-D","1","6AO4"
"6AOZ",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION, SITTING DROP",7,"4% (w/v) tacsimate pH 7.0, 11 % (w/v) PEG 3350",293,"10.1371/journal.pone.0186034",,"6AOZ",45.58,"2.1","2.1","Crystal structure of human FLASH N-terminal domain C54S/C83A (Crystal form 1)","MSRNSLDLYEEILTEEGTAKEATYNDLQVEYGKAQLQMKELMKKFKEIQAQNFSLINENQSLKKNISALIKTARVEINRKDEEISNLHLEHHHHHH","Homo sapiens","CASP8AP2, FLASH, KIAA1315, RIP25","CASP8-associated protein 2","1","6AOZ"
"6AP0",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, SITTING DROP",,"100 mM sodium formate, 15% (w/v) PEG 3350, 3% (v/v) 1,6-hexanediol",293,"10.1371/journal.pone.0186034",,"6AP0",22.67,"2.581","2.581","Crystal structure of human FLASH N-terminal domain C54S/C83A (Crystal form 2)","MSRNSLDLYEEILTEEGTAKEATYNDLQVEYGKAQLQMKELMKKFKEIQAQNFSLINENQSLKKNISALIKTARVEINRKDEEISNLHLEHHHHHH","Homo sapiens","CASP8AP2, FLASH, KIAA1315, RIP25","CASP8-associated protein 2","1","6AP0"
"6AP9",,"X-RAY DIFFRACTION",2.56,51.93,"VAPOR DIFFUSION, HANGING DROP",6,"PEG 8000, MES, Ca(OAc)2",293,,,"6AP9",49.36,"1.55","1.55","Crystal Structure of hGSTP1-1 with S-nitrosation of Cys101","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GSTP1, FAEES3, GST3","Glutathione S-transferase P","1","6AP9"
"6APJ",,"X-RAY DIFFRACTION",2.52,51.28,"MICROBATCH",4.2,"0.1M Sodium Citrate (pH 4.2), 0.1M Ammonium Sulfate, and 24% (w/v) PEG 20000",277,"10.1038/nchembio.2539",,"6APJ",254.23,"3.1","3.1","Crystal Structure of human ST6GALNAC2","MGLPRGSFFWLLLLLTAACSGLLFALYFSAVQRYPGPAAGARDTTSFEAFFQSKASNSWTGKGQACRHLLHLAIQRHPHFRGLFNLSIPVLLWGDLFTPALWDRLSQHKAPYGWRGLSHQVIASTLSLLNGSESAKLFAPPRDTPPKCIRCAVVGNGGILNGSRQGPNIDAHDYVFRLNGAVIKGFERDVGTKTSFYGFTVNTMKNSLVSYWNLGFTSVPQGQDLQYIFIPSDIRDYVMLRSAILGVPVPEGLDKGDRPHAYFGPEASASKFKLLHPDFISYLTERFLKSKLINTHFGDLYMPSTGALMLLTALHTCDQVSAYGFITSNYWKFSDHYFERKMKPLIFYANHDLSLEAALWRDLHKAGILQLYQR","Homo sapiens","ST6GALNAC2, SIAT7B, SIATL1, STHM","Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2","1","6APJ"
"6APL",,"X-RAY DIFFRACTION",2.5,52.47,"MICROBATCH",4.2,"0.1M Sodium Citrate (pH 4.2), 0.1M Ammonium Sulfate, and 24% (w/v) PEG 20000",277,"10.1038/nchembio.2539",,"6APL",257.78,"2.35","2.35","Crystal Structure of human ST6GALNAC2 in complex with CMP","MGLPRGSFFWLLLLLTAACSGLLFALYFSAVQRYPGPAAGARDTTSFEAFFQSKASNSWTGKGQACRHLLHLAIQRHPHFRGLFNLSIPVLLWGDLFTPALWDRLSQHKAPYGWRGLSHQVIASTLSLLNGSESAKLFAPPRDTPPKCIRCAVVGNGGILNGSRQGPNIDAHDYVFRLNGAVIKGFERDVGTKTSFYGFTVNTMKNSLVSYWNLGFTSVPQGQDLQYIFIPSDIRDYVMLRSAILGVPVPEGLDKGDRPHAYFGPEASASKFKLLHPDFISYLTERFLKSKLINTHFGDLYMPSTGALMLLTALHTCDQVSAYGFITSNYWKFSDHYFERKMKPLIFYANHDLSLEAALWRDLHKAGILQLYQR","Homo sapiens","ST6GALNAC2, SIAT7B, SIATL1, STHM","Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2","1","6APL"
"6AQ1",,"X-RAY DIFFRACTION",2.09,41.12,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium cacodylate, pH 7.0, 2.3 M ammonium sulfate",293,"10.1016/j.ejmech.2018.04.050",,"6AQ1",31.22,"1.40000091001","1.40000091001","The crystal structure of human FABP3","GSHMVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","6AQ1"
"6AQB",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M NaH2PO4
0.1 M KH2PO4
0.1 M MES pH 6.5
1.5 M NaCl",298,"10.1074/jbc.RA117.000262",,"6AQB",15.95,"1.5","1.5","Structure of the SH3 domain of MLK3 bound to peptide generated from phage display","YANPVWTALFDYEPSGQDELALRKGDRVEVLSRDAAISGDEGWWAGQVGGQVGIFPSNYVSRGGGAPPIPPPR","Homo sapiens","MAP3K11, MLK3, PTK1, SPRK","Chimera protein of MLK3-SH3 and MIP (E.C.2.7.11.25)","1","6AQB"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP3K11, MLK3, PTK1, SPRK"
"6AR0",,"X-RAY DIFFRACTION",1.96,37.33,"VAPOR DIFFUSION, SITTING DROP",6.5,"Bis-Tris pH 6.5, 200 mM Li2SO4, 25% PEG 3350",293,"10.7554/eLife.30278",,"6AR0",15.79,"1.08","1.08","Structure of human SLMAP FHA domain","MPSALAIFTCRPNSHPFQERHVYLDEPIKIGRSVARCRPAQNNATFDCKVLSRNHALVWFDHKTGKFYLQDTKSSNGTFINSQRLSRGSEESPPCEILSGDIIQFGVDVTENTRKVTHGCIVSTIKLFLPDGMEARLRSD","Homo sapiens","SLMAP, KIAA1601, SLAP, UNQ1847/PRO3577","Sarcolemmal membrane-associated protein","1","6AR0"
"6AR4",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.1M BisTRIS pH 6.4",298,"10.1038/s41598-018-31680-3","BQA","6AR4",28.19,"1.69","1.69","Crystal structure of PICK1 in complex with the small molecule inhibitor 1o","MGHHHHHHHHLVPRGSMFADLDYDIEEDKLGIPTVPGKVTLQKDAQNLIGISIGGGAQYCPCLYIVQVFDNTPAALDGTVAAGDEITGVNGRSIKGKTKVEVAKMIQEVKGEVTIHYNKLQQSAV","Homo sapiens","PICK1, PRKCABP","PRKCA-binding protein","1","6AR4"
"6ARH",,"X-RAY DIFFRACTION",2.46,50.06,"VAPOR DIFFUSION",7.5,"25% PEG3350, 0.2 M sodium acetate, 0.1 M HEPES, pH 7.5",291,,,"6ARH",149.54,"1.6","1.6","Crystal structure of Human NAL at a resolution of 1.6 Angstrom","MGHHHHHHGENLYFQGGSMAFPKKKLQGLVAATITPMTENGEINFSVIGQYVDYLVKEQGVKNIFVNGTTGEGLSLSVSERRQVAEEWVTKGKDKLDQVIIHVGALSLKESQELAQHAAEIGADGIAVIAPFFLKPWTKDILINFLKEVAAAAPALPFYYYHIPALTGVKIRAEELLDGILDKIPTFQGLKFSDTDLLDFGQCVDQNRQQQFAFLFGVDEQLLSALVMGATGAVGSTYNYLGKKTNQMLEAFEQKDFSLALNYQFCIQRFINFVVKLGFGVSQTKAIMTLVSGIPMGPPRLPLQKASREFTDSAEAKLKSLDFLSFTDLKDGNLEAGS","Homo sapiens","NPL, C1orf13","N-acetylneuraminate lyase","1","6ARH"
"6ARJ",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Ammonium Sulfate, 0.1 M Tris pH 8.5, 18% w/v PEG3350",293,"10.1038/s41598-017-18446-z","BW4, SAH","6ARJ",162.93,"1.92","1.92","Crystal structure of CARM1 with EPZ022302 and SAH","SIARSVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGT","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6ARJ"
"6ARK",,"X-RAY DIFFRACTION",2.64,53.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"5% PEG 400, 2M (NH4)2SO4, 0.1M HEPES",293,"10.1021/acs.jcim.7b00399",,"6ARK",20.4,"1.75","1.75","Crystal Structure of compound 10 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6ARK"
"6ARP",,"X-RAY DIFFRACTION",2.99,58.82,"VAPOR DIFFUSION, HANGING DROP",,"100 mM sodium citrate, 1.6 M ammonium sulfate, 5% glycerol",293,,,"6ARP",95.7,"1.7","1.7","Structure of a mutant Cetuximab Fab fragment","QVQLKQSGPGLVQPSQSLSITCTVSGFDLTDYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain","2","6ARP"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYADESIDGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Cetuximab mutant light chain,Uncharacterized protein","1","6ARP"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6ARV",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Ammonium Sulfate, 0.1 M Tris pH 8.5, 18% w/v PEG3350",293,"10.1038/s41598-017-18446-z","SAH, BW7","6ARV",162.69,"2","2","Crystal structure of CARM1 with Compound 2 and SAH","SIARSVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGT","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6ARV"
"6ASA",,"X-RAY DIFFRACTION",1.93,36.11,"EVAPORATION",,"0.1 M Tris pH 8.5, 200 mM MgCl2, 25 % PEG 3350",293,"10.1021/acs.biochem.7b00974",,"6ASA",19.62,"2.545","2.545","KRAS mutant-D33E in GDP-bound","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYEPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6ASA"
"6ASE",,"X-RAY DIFFRACTION",1.9,35.13,"EVAPORATION",,"0.15 M Cesium chloride, 15 % PEG 3350, 40 mM MgCl2",293,"10.1021/acs.biochem.7b00974",,"6ASE",19.78,"1.554","1.554","KRAS mutant-A59G in GDP-bound","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTGGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6ASE"
"6ASH",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, SITTING DROP",4.6,"8% polyethylene glycol (PEG) 4000, 0.1 M sodium acetate",295,,,"6ASH",24.27,"1.423","1.423","Crystal structure of human Cathepsin K with a non-active site inhibitor at 1.42 Angstrom resolution","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLAPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","6ASH"
"6ASY",,"X-RAY DIFFRACTION",2.62,53.16,"VAPOR DIFFUSION, HANGING DROP",,"18-22% PEG 1000, 0.1 M phosphate citrate (pH 4.2-7.0), and 0.2 M Li2SO4",293.15,"10.1038/s41467-017-01310-z",,"6ASY",137.95,"1.85","1.85","BiP-ATP2","SEDVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSGDQDTGDLVLLDVCPLTLGIETVGGVMTKLIPRNTVVPTKKSQIFSVGGTVTIKVYEGERPLTKDNHLLGTFDLTGIPPAPRGVPQIEVTFEIDVNGILRVTAEDKGTGNKNKITITNDQNRLTPEEIERMVNDAEKFAEEDKKLKERIDTRNELESYAYSLKNQIGDKEKLGGKLSSEDKETMEKAVEEKIEWLESHQDADIEDFKAKKKELEEIVQPIISK","Homo sapiens","HSPA5, GRP78","78 kDa glucose-regulated protein","1","6ASY"
"6AT8",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M NaCl, 0.1 M Bis-Tris/HCl, 25% PEG3350 (w/v)",295,,,"6AT8",16.09,"1.105","1.105","1.1 Angstrom Resolution Structure of Human Cellular Retinol-Binding Protein IV","PADLSGTWTLLSSDNFEGYMLALGIDFATRKIAKLLKPQKVIEQNGDSFTIHTNSSLRNYFVKFKVGEEFDEDNRGLDNRKCKSLVIWDNDRLTCIQKGEKKNRGWTHWIEGDKLHLEMFCEGQVCKQTFQRALVPR","Homo sapiens","RBP7","Retinoid-binding protein 7","1","6AT8"
"6ATB",,"X-RAY DIFFRACTION",2.23,44.76,"VAPOR DIFFUSION, SITTING DROP",8,"18 % (v/v) glycerol
23 % (w/v) PEG 3350
200 mM NaCl
100 mM Tris/HCl pH 8.0",294,,"BWA","6ATB",230.23,"2.53","2.53","Crystal Structure of human NAMPT in complex with NVP-LOD812","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6ATB"
"6ATD",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, SITTING DROP",9.1,"0.2 M sodium phosphate, 20% (w/v) PEG 3350",277,"10.1021/acsomega.7b01318",,"6ATD",121.52,"2.5","2.5","Oxidized SHP2 forms a disulfide bond between Cys367 and Cys459","GHMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINADIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQ","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6ATD"
"6ATE",,"X-RAY DIFFRACTION",2.11,41.66,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, pH 6.5, 16%-20% PEG 3350, 350 mM - 420mM NaOAc",293,"10.1016/j.chembiol.2019.02.021",,"6ATE",33.18,"2.402","2.402","SRC kinase bound to covalent inhibitor","GHMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","6ATE"
"6ATO",,"X-RAY DIFFRACTION",2.23,44.89,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 200 MME, 25% (w/v), 0.1 M Tris HCl, pH 8.5",293,,,"6ATO",52.52,"1.55","1.55","Crystal structure of hGSTA1-1 complexed with GSH and MPD in each subunit","AEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","6ATO"
"6ATP",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 2000 MME, 20% (w/v), 0.05 M Tris HCl, pH 8.5",293,,,"6ATP",51.43,"1.7","1.7","Crystal structure of apo-hGSTA1-1 exhibiting a new conformation of C-terminal helix","AEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","6ATP"
"6ATQ",,"X-RAY DIFFRACTION",2.26,45.66,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 2000 MME, 25% (w/v), 0.1 M MES, 6.5",293,,,"6ATQ",51.75,"2","2","Crystal structure of apo-hGSTA1-1 exhibiting a new conformation of C-terminal helix","AEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","6ATQ"
"6ATR",,"X-RAY DIFFRACTION",2.4,48.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 2000 MME, 25% (w/v), 0.1 M MES, pH 6.5",293,,,"6ATR",53.17,"1.29","1.29","Crystal structure of hGSTA1-1 complexed with two GSH analogues in each subunit","AEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","6ATR"
"6ATU",,"X-RAY DIFFRACTION",2.46,50.02,"VAPOR DIFFUSION, SITTING DROP",7,"2.4M Na malonate pH 7.0",298,"10.1038/s41594-018-0033-9",,"6ATU",110.85,"2.4","2.4","Exploring Cystine Dense Peptide Space to Open a Unique Molecular Toolbox","GSAQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ","Homo sapiens","PI3, WAP3, WFDC14","Elafin","1","6ATU"
"6AU2",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG3350, 0.2M LiSO4, 0.1M Bis-Tris pH 6.5",293,"10.1016/j.bmc.2019.07.020",,"6AU2",26.1,"1.63","1.63","Crystal structure of SETDB1 Tudor domain with aryl triazole fragments","ENLYFQGDLIVSMRILGKKRTKTWHKGTLIAIQTVGPGKKYKVKFDNKGKSLLSGNHIAYDYHPPADKLYVGSRVVAKYKDGNQVWLYAGIVAETPNVKNKLRFLIFFDDGYASYVTQSELYPICRPLKKTWEDIEDISCRDFIEEYVTAYPNRPMVLLKSGQLIKTEWEGTWWKSRVEEVDGSLVRILFLDDKRCEWIYRGSTRLEPMFSMK","Homo sapiens","SETDB1, KIAA0067, KMT1E, ESET","Histone-lysine N-methyltransferase SETDB1","1","6AU2"
"6AU3",,"X-RAY DIFFRACTION",2.46,50.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG3350, 0.2M LiSO4, 0.1M Bis-Tris pH 6.5",293,,,"6AU3",25.58,"1.8","1.8","Crystal structure of SETDB1 Tudor domain with aryl triazole fragments","ENLYFQGDLIVSMRILGKKRTKTWHKGTLIAIQTVGPGKKYKVKFDNKGKSLLSGNHIAYDYHPPADKLYVGSRVVAKYKDGNQVWLYAGIVAETPNVKNKLRFLIFFDDGYASYVTQSELYPICRPLKKTWEDIEDISCRDFIEEYVTAYPNRPMVLLKSGQLIKTEWEGTWWKSRVEEVDGSLVRILFLDDKRCEWIYRGSTRLEPMFSMK","Homo sapiens","SETDB1, KIAA0067, KMT1E, ESET","Histone-lysine N-methyltransferase SETDB1","1","6AU3"
"6AU4",,"X-RAY DIFFRACTION",2.76,55.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% MPD
300mM KCl
50mM LiCl
50mM Sodium cacodylate",277.15,"10.1371/journal.pone.0205584",,"6AU4",14.25,"2.35","2.35","Crystal structure of the major quadruplex formed in the human c-MYC promoter","TGAGGGTGGGTAGGGTGGGTAA","Homo sapiens",,"DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3')","1","6AU4"
"6AU6",,"X-RAY DIFFRACTION",2.28,46.1,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris 8.5, 25% PEG8000, 10 mM TCEP hydrochloride",293,"10.1016/j.cell.2018.03.018",,"6AU6",44.71,"1.7","1.7","Crystal structure of GDP-bound human GNAS R201C mutant","AHMSKTEDQRNEEKAQREANKKIEKQLQKDKQVYRATHRLLLLGAGESGKSTIVKQMRILHVNGFNGDSEKATKVQDIKNNLKEAIETIVAAMSNLVPPVELANPENQFRVDYILSVMNVPDFDFPPEFYEHAKALWEDEGVRACYERSNEYQLIDCAQYFLDKIDVIKQADYVPSDQDLLRCCVLTSGIFETKFQVDKVNFHMFDVGGQRDERRKWIQSFNDVTAIIFVVASSSYNMVIREDNQTNRLQEALNLFKSIWNNRWLRTISVILFLNKQDLLAEKVLAGKSKIEDYFPEFARYTTPEDATPEPGEDPRVTRAKYFIRDEFLRISTASGDGRHYCYPHFTCAVDTENIRRVFNDCRDIIQRMHLRQYELL","Homo sapiens","GNAS, GNAS1, GSP","Guanine nucleotide-binding protein G(s) subunit alpha isoforms short","1","6AU6"
"6AUA",,"X-RAY DIFFRACTION",2.34,47.5,"VAPOR DIFFUSION, SITTING DROP",5.5,"100 MM CITRATE PH 5.5, 14% PEG 10, 000, 100 MM LI2SO4, 1 MM CGI2625",289,,,"6AUA",31.8,"1.66","1.66","CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI2625","SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSAYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDAN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6AUA"
"6AUB",,"X-RAY DIFFRACTION",2.31,46.73,"VAPOR DIFFUSION, SITTING DROP",7,"100 MM IMIDAZOLE PH 7.0, 14% PEG 10,000, 200 MM LI2SO4, 10 MM BETA MERCAPTOETHANOL, 0.75% (W/V) s-BOG",289,,,"6AUB",31.73,"1.65","1.65","CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI2815","WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEN","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6AUB"
"6AUD",,"X-RAY DIFFRACTION",2.41,48.89,"VAPOR DIFFUSION",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5",289,"10.1021/acsmedchemlett.7b00170",,"6AUD",111.18,"2.015","2.015","PI3K-gamma K802T in complex with Cpd 8 10-((1-(tert-butyl)piperidin-4-yl)sulfinyl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCTVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6AUD"
"6AUG",,"X-RAY DIFFRACTION",2.78,55.81,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.8M SODIUM CITRATE, 100mM MOPS, pH 7.6",293,"10.7554/eLife.43320",,"6AUG",63.89,"2.73","2.73","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with SR16832","GQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6AUG"
"6AUI","3.3","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.31502",,"6AUI",562.71,"3.3",,"Human ribonucleotide reductase large subunit (alpha) with dATP and CDP","MGSSHHHHHHSSGLVPRGSHMHVIKRDGRQERVMFDKITSRIQKLCYGLNMDFVDPAQITMKVIQGLYSGVTTVELDTLAAETAATLTTKHPDYAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTRPAANPIQFTLNKEKLKDKEKVSKEEEEKERNTAAMVCSLENRDECLMCGS","Homo sapiens","RRM1, RR1","Ribonucleoside-diphosphate reductase large subunit","1","6AUI"
"6AUM",,"X-RAY DIFFRACTION",2.41,49.09,"VAPOR DIFFUSION",7.5,"30% PEG 3350, 0-10% sucrose",277,"10.1016/j.bmcl.2018.01.003","BXV","6AUM",63.35,"2.95","2.95","Crystal structure of human soluble epoxide hydrolase complexed with trans-4-[4-(3-trifluoromethoxyphenyl-l-ureido)-cyclohexyloxy]-benzoic acid.","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKM","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","6AUM"
"6AUY",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b01356","BYJ","6AUY",100.29,"1.92","1.92","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 4-Methyl-6-(3-(3-(methylamino)propyl)phenethyl)pyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6AUY"
"6AUZ",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b01356","W68","6AUZ",99.95,"2","2","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-Fluoro-5-(3-(methylamino)propyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6AUZ"
"6AV0",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b01356","BYV","6AV0",99.97,"1.996","1.996","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 3-(2-(6-Amino-4-methylpyridin-2-yl)ethyl)-5-(3-(methylamino)propyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6AV0"
"6AV1",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b01356","W69","6AV1",99.98,"2.45","2.45","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-(3-(Dimethylamino)propyl)-5-fluorophenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6AV1"
"6AV2",,"X-RAY DIFFRACTION",2.74,55.4,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b01356","BY7","6AV2",100.08,"2.1","2.1","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 6-(3-(3-(dimethylamino)propyl)-5-(trifluoromethyl)phenethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6AV2"
"6AV3",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b01356","W79","6AV3",100.01,"1.95","1.95","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 4-Methyl-6-(2-(5-(3-((methylamino)methyl)phenyl)pyridin-3-yl)ethyl)pyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6AV3"
"6AV4",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b01356","W80","6AV4",100.38,"1.867","1.867","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 4-Methyl-6-(2-(5-(4-((methylamino)methyl)phenyl)pyridin-3-yl)ethyl)pyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6AV4"
"6AV5",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b01356","W82","6AV5",100.05,"1.9","1.9","Structure of human neuronal nitric oxide synthase R354A/G356D mutant heme domain in complex with 6-(2-(5-Fluoro-3'-((methylamino)methyl)-[1,1'-biphenyl]-3-yl)ethyl)-4-methylpyridin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6AV5"
"6AV6",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 MM TCEP",277,"10.1021/acs.jmedchem.7b01356","W68","6AV6",204.99,"2.08","2.08","Structure of human endothelial nitric oxide synthase heme domain in complex with 6-(3-Fluoro-5-(3-(methylamino)propyl)phenethyl)-4-methylpyridin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6AV6"
"6AV7",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 MM TCEP",277,"10.1021/acs.jmedchem.7b01356","W69","6AV7",205.04,"1.916","1.916","Structure of human endothelial nitric oxide synthase heme domain in complex with HW69","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6AV7"
"6AVI",,"X-RAY DIFFRACTION",2.8,56.01,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.8M SODIUM CITRATE, 100mM TRIS, pH 7.6",293,"10.7554/eLife.43320",,"6AVI",64.04,"2.29","2.29","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Nonanoic acid","GQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6AVI"
"6AVJ",,"X-RAY DIFFRACTION",2.91,57.78,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM bis-tris propane, 2.5 M ammonium sulfate, 3% v/v polyethylene glycol 400",293,"10.1073/pnas.1715842115",,"6AVJ",31.71,"1.9","1.9","Crystal structure of human Mitochondrial inner NEET protein (MiNT)/CISD3","PARSVVALKTPIKVELVAGKTYRWCVCGRSKKQPFCDGSCFFQRTGLSPLKFKAQETRMVALCTCKATQRPPYCDGTCRSERVQKAEVGSPL","Homo sapiens","CISD3","CDGSH iron-sulfur domain-containing protein 3, mitochondrial","1","6AVJ"
"6AVN",,"X-RAY DIFFRACTION",2.53,51.42,"VAPOR DIFFUSION, SITTING DROP",,"10% (v/v) glycerol, 0.1 M ammonium sulfate, 0.1 M HEPES (pH 7.5), 5% (w/v) PEG 3000 and 30% (v/v) PEG 400",293.15,"10.1038/s41467-018-04272-y",,"6AVN",47.07,"2.5","2.5","Crystal structure of unbound anti-HIV antibody Fab PGV19 at 2.5 A","EVRLVQSGAEVKKPGASVRVSCAASGYTFTDFDIHWLRQAPGRGLEWMGWVRPLGGGVSYARQFQGRVTMTRDFYIDTAFMDFRNLKMDDTALYFCARMGAAREWDFQYWGQGTRVLVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"PGV19 Fab heavy chain","1","6AVN"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTASSDFRGFSSVSWYQQVPGRAPKLLIFSVNRRPSGISHRFSGSKSGNTASLTISGLQIEDEADYHCNAYEFFGGGTKVFVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTEC","Homo sapiens",,"PGV19 Fab light chain","2","6AVN"
"6AVS",,"X-RAY DIFFRACTION",2.3,46.45,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES pH 7.0
8% PEG 3350",277,"10.1038/s41598-018-21432-8",,"6AVS",27.54,"2.02","2.02","Complex structure of JMJD5 and Symmetric Monomethyl-Arginine (MMA)","GGTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","Lysine-specific demethylase 8","1","6AVS"
"6AW0",,"X-RAY DIFFRACTION",3.48,64.66,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.8M Ammonium Sulphate, 1% PEG 3350, 0.1M Bis Tris pH 5.5",298,"10.15252/embj.201798664",,"6AW0",24.53,"2.43","2.43","Crystal structure of CEACAM3 L44Q","MAKLTIESMPLSVAEGKEVLLLVHNLPQHLFGYSWYKGERVDGNSQIVGYVIGTQQATPGAAYSGRETIYTNASLLIQNVTQNDIGFYTLQVIKSDLVNEEATGQFHVY","Homo sapiens","CEACAM3, CD66D, CGM1","Carcinoembryonic antigen-related cell adhesion molecule 3","1","6AW0"
"6AW1",,"X-RAY DIFFRACTION",3.56,65.41,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.0M Ammonium Sulphate, 1% PEG 3350, 0.1M Bis Tris pH 5.5",298,"10.15252/embj.201798664",,"6AW1",24.7,"2.1","2.1","Crystal structure of CEACAM3","MAKLTIESMPLSVAEGKEVLLLVHNLPQHLFGYSWYKGERVDGNSLIVGYVIGTQQATPGAAYSGRETIYTNASLLIQNVTQNDIGFYTLQVIKSDLVNEEATGQFHVY","Homo sapiens","CEACAM3, CD66D, CGM1","Carcinoembryonic antigen-related cell adhesion molecule 3","1","6AW1"
"6AWL",,"X-RAY DIFFRACTION",1.65,25.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"Protein was dissolved at 4.89 mg/mL in a buffer containing 10 mM HEPES pH 7.5, 100 mM NaCl, 0.3 mM TCEP. 200 nL of protein was mixed with 200 nL of reservoir in a SD2 plate. The reservoir consisted of 21% w/v PEG 3350, 0.25 M NaCl, and 0.1 M bistris pH 6.5.  Crystals were cryopreserved in 35% PEG 3350, 0.2 M NaCl and 0.1 M bistris buffer, pH 6.5.",293,"10.1016/j.molcel.2018.11.033",,"6AWL",72,"2","2","Crystal structure of human Coq9","MAAAAVSGALGRAGWRLLQLRCLPVARCRQALVPRAFHASAVGLRSSDEQKQQPPNSFSQQHSETQGAEKPDPESSHSPPRYTDQGGEEEEDYESEEQLQHRILTAALEFVPAHGWTAEAIAEGAQSLGLSSAAASMFGKDGSELILHFVTQCNTRLTRVLEEEQKLVQLGQAEKRKTDQFLRDAVETRLRMLIPYIEHWPRALSILMLPHNIPSSLSLLTSMVDDMWHYAGDQSTDFNWYTRRAMLAAIYNTTELVMMQDSSPDFEDTWRFLENRVNDAMNMGHTAKQVKSTGEALVQGLMGAAVTLKNLTGLNQRR","Homo sapiens","COQ9, C16orf49, HSPC326, PSEC0129","Ubiquinone biosynthesis protein COQ9, mitochondrial","1","6AWL"
"6AX1",,"X-RAY DIFFRACTION",2.46,50.04,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir Buffer: 0.07M sodium cacodylate pH 5.1-5.9 and 33-51% MPD

The protein is 20 mg/mL in a buffer of 15 mM HEPES pH 8.2; 2 mM TCEP; and 10% glycerol, with hexaethylene glycol monododecyl ether added to 0.1 mM.

Apo protein crystals obtained in this manner were transferred to a cryo-protectant solution consisting of 70 mM NaCacodylate pH 5.1; 10% MPD; 30% PEG-MME-2K, and 1mM of inhibitor compound. Crystals were soaked overnight, then flash-frozen in LN2.",298,"10.1021/acs.jmedchem.7b01531","C0S","6AX1",77.58,"2.26","2.26","Structure of human monoacylglycerol lipase bound to a covalent inhibitor","MASRGSHHHHHHGAGDRGPEFPSSMPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPPLEVDLQGDHGLSAWSHPQFEK","Homo sapiens","MGLL","Monoglyceride lipase","1","6AX1"
"6AX3",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, HANGING DROP",,"0.1M HEPES pH 7.0
8% PEG 3350",277,"10.1038/s41598-018-21432-8",,"6AX3",27.69,"2.25","2.25","Complex structure of JMJD5 and Symmetric Dimethyl-Arginine (SDMA)","GSGVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","Lysine-specific demethylase 8","1","6AX3"
"6AX5",,"SOLUTION NMR",,,,,,,"10.1038/s41467-021-22733-9",,"6AX5",9.57,,,"RPT1 region of INI1/SNF5/SMARCB1_HUMAN - SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1.","PEVLVPIRLDMEIDGQKLRDAFTWNMNEKLMTPEMFSEILCDDLDLNPLTFVPAIASAIRQQIESYPTDSILEDQSDQRVIIK","Homo sapiens","SMARCB1, BAF47, INI1, SNF5L1","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1","1","6AX5"
"6AXD",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2018.05.042",,"6AXD",7.81,,,"Structures of REV1 UBM2 domain complex with ubiquitin and with the first small-molecule that inhibits the REV1 UBM2-ubiquitin interaction","MGSSHHHHHHHHLNGSSLVPRGSIKSSGLESNSDAGINLIALPAFSQVDPEVFAALPAELQRELKAAYDQRQ","Homo sapiens","REV1, REV1L","DNA repair protein REV1","1","6AXD"
"6AXQ",,"X-RAY DIFFRACTION",2.44,49.67,"VAPOR DIFFUSION",8.2,"3.545 M Formate, 100 mM Tris-HCl pH 8.2, 10% glycerol",289,"10.1021/acs.jmedchem.7b01372","C2Y","6AXQ",55.42,"1.3","1.3","CREBBP bromodomain in complex with Cpd6 (methyl 1H-indole-3-carboxylate)","AAFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSL","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6AXQ"
"6AY2",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION",,"as published",295,"10.1021/acs.jmedchem.7b01430",,"6AY2",56.74,"1.6","1.6","Structure of CathB with covalently linked Compound 28","KLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTD","Homo sapiens","CTSB, CPSB","Cathepsin B","1","6AY2"
"6AY3",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION",6.5,"0.2M MgCl2, 0.1M Bis-Tris pH6.5, 22% PEG3350",277,"10.1021/acs.jmedchem.7b01372","C3J","6AY3",28.46,"1.391","1.391","CREBBP bromodomain in complex with Cpd16 (5-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-N-methyl-1H-indole-3-carboxamide)","KIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6AY3"
"6AY5",,"X-RAY DIFFRACTION",2.5,50.83,"VAPOR DIFFUSION",6.5,"0.2M MgCl2, 0.1M Bis-Tris pH6.5, 22% PEG3350",277,"10.1021/acs.jmedchem.7b01372","C3V","6AY5",14.51,"1.44","1.44","CREBBP bromodomain in complex with Cpd17 (5-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-3-methylbenzo[d]thiazol-2(3H)-one)","KIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6AY5"
"6AYD",,"X-RAY DIFFRACTION",2.88,57.29,"VAPOR DIFFUSION",,"1M succinate pH 7.0, 0.1M BisTrisPropane, 1% 1,6-hexanediol",277,"10.1021/acsmedchemlett.7b00296",,"6AYD",38.36,"3","3","Pim1 complexed with N-(6-(4-hydroxyphenyl)-1H-indazol-3-yl)cyclopropanecarboxamide","MHHHHHHSSGVDLGTENLYFQSMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6AYD"
"6AYE","4.06","ELECTRON MICROSCOPY",,,,,,,"10.1038/nsmb.3502",,"6AYE",258.5,"4.06",,"Human apo-TRPML3 channel at pH 7.4","GGGGSMADPEVVVSSCSSHEEENRCNFNQQTSPSEELLLEDQMRRKLKFFFMNPCEKFWARGRKPWKLAIQILKIAMVTIQLVLFGLSNQMVVAFKEENTIAFKHLFLKGYMDRMDDTYAVYTQSDVYDQLIFAVNQYLQLYNVSVGNHAYENKGTKQSAMAICQHFYKRGNIYPGNDTFDIDPEIETECFFVEPDEPFHIGTPAENKLNLTLDFHRLLTVELQFKLKAINLQTVRHQELPDCYDFTLTITFDNKAHSGRIKISLDNDISIRECKDWHVSGSIQKNTHYMMIFDAFVILTCLVSLILCIRSVIRGLQLQQEFVNFFLLHYKKEVSVSDQMEFVNGWYIMIIISDILTIIGSILKMEIQAKSLTSYDVCSILLGTSTMLVWLGVIRYLGFFAKYNLLILTLQAALPNVIRFCCCAAMIYLGYCFCGWIVLGPYHDKFRSLNMVSECLFSLINGDDMFATFAKMQQKSYLVWLFSRIYLYSFISLFIYMILSLFIALITDTYETIKQYQQDGFPETELRTFISECKDLPNSGKYRLEDDPPVSLFCCCKK","Homo sapiens","MCOLN3","Mucolipin-3","1","6AYE"
"6AYF","3.62","ELECTRON MICROSCOPY",,,,,,,"10.1038/nsmb.3502",,"6AYF",260.27,"3.62",,"TRPML3/ML-SA1 complex at pH 7.4","GGGGSMADPEVVVSSCSSHEEENRCNFNQQTSPSEELLLEDQMRRKLKFFFMNPCEKFWARGRKPWKLAIQILKIAMVTIQLVLFGLSNQMVVAFKEENTIAFKHLFLKGYMDRMDDTYAVYTQSDVYDQLIFAVNQYLQLYNVSVGNHAYENKGTKQSAMAICQHFYKRGNIYPGNDTFDIDPEIETECFFVEPDEPFHIGTPAENKLNLTLDFHRLLTVELQFKLKAINLQTVRHQELPDCYDFTLTITFDNKAHSGRIKISLDNDISIRECKDWHVSGSIQKNTHYMMIFDAFVILTCLVSLILCIRSVIRGLQLQQEFVNFFLLHYKKEVSVSDQMEFVNGWYIMIIISDILTIIGSILKMEIQAKSLTSYDVCSILLGTSTMLVWLGVIRYLGFFAKYNLLILTLQAALPNVIRFCCCAAMIYLGYCFCGWIVLGPYHDKFRSLNMVSECLFSLINGDDMFATFAKMQQKSYLVWLFSRIYLYSFISLFIYMILSLFIALITDTYETIKQYQQDGFPETELRTFISECKDLPNSGKYRLEDDPPVSLFCCCKK","Homo sapiens","MCOLN3","Mucolipin-3","1","6AYF"
"6AYG","4.65","ELECTRON MICROSCOPY",,,,,,,"10.1038/nsmb.3502",,"6AYG",258.5,"4.65",,"Human Apo-TRPML3 channel at pH 4.8","GGGGSMADPEVVVSSCSSHEEENRCNFNQQTSPSEELLLEDQMRRKLKFFFMNPCEKFWARGRKPWKLAIQILKIAMVTIQLVLFGLSNQMVVAFKEENTIAFKHLFLKGYMDRMDDTYAVYTQSDVYDQLIFAVNQYLQLYNVSVGNHAYENKGTKQSAMAICQHFYKRGNIYPGNDTFDIDPEIETECFFVEPDEPFHIGTPAENKLNLTLDFHRLLTVELQFKLKAINLQTVRHQELPDCYDFTLTITFDNKAHSGRIKISLDNDISIRECKDWHVSGSIQKNTHYMMIFDAFVILTCLVSLILCIRSVIRGLQLQQEFVNFFLLHYKKEVSVSDQMEFVNGWYIMIIISDILTIIGSILKMEIQAKSLTSYDVCSILLGTSTMLVWLGVIRYLGFFAKYNLLILTLQAALPNVIRFCCCAAMIYLGYCFCGWIVLGPYHDKFRSLNMVSECLFSLINGDDMFATFAKMQQKSYLVWLFSRIYLYSFISLFIYMILSLFIALITDTYETIKQYQQDGFPETELRTFISECKDLPNSGKYRLEDDPPVSLFCCCKK","Homo sapiens","MCOLN3","Mucolipin-3","1","6AYG"
"6AYL",,"X-RAY DIFFRACTION",2.13,42.25,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.6 M sodium citrate, pH 6.5",293,,,"6AYL",16.15,"1.86","1.86","Human adipocyte lipid-binding protein FABP4 in complex with fluorescein","QQMGRGSMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","6AYL"
"6AYW",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION, SITTING DROP",,"CamKII S3-K301, in 20mM imidazole pH 8.5, 0.3M sodium chloride, 5mM TCEP, was concentrated to 36 mg/ml and flash frozen in liquid nitrogen for long term storage at -80 C in 10 microL aliquots. The protein was thawed and diluted down to 12 mg/mL in the same buffer just prior to crystallization experiments. Sitting drop vapor diffusion droplets were assembled with 250 nL of 12 mg/mL CamKII, 0.6 mM inhibitor and 250 nL of reservoir solution 24% peg 3350, 0.2 M ammonium tartrate, 0.1 M arginine. Flat crystal plates (typically 0.03 mm x 0.2 mm x 0.4 mm in size) grew in 4-7 days at 20 C. A crystal seed suspension was prepared with ten crushed crystals combined into 100 uL of reservoir solution and stored at -80 C. A thirty fold seed dilution was prepared in the same solution for addition to protein droplets in a 1 to 1 volume ratio to enhance crystallization of difficult to crystallize inhibitors.",293,,"C2V","6AYW",70.01,"2.05","2.05","The structure of human CamKII with bound inhibitor","GHMSTTTCTRFTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLK","Homo sapiens","CAMK2D, CAMKD","Calcium/calmodulin-dependent protein kinase type II subunit delta","1","6AYW"
"6AZJ",,"X-RAY DIFFRACTION",2.06,40.37,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 mM Hepes pH 6.5, 30-36 % Jeffamine ED-2001",293,,"C5V","6AZJ",113.26,"2.53","2.53","Crystal Structure of human NAMPT in complex with NVP-LQN520","AHHHHHHSAAENLYFQGEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIE","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6AZJ"
"6AZU",,"X-RAY DIFFRACTION",2.96,58.4,"VAPOR DIFFUSION",,"20% PEG-3350, 0.2 M LiSO4, 0.1 M BT pH 5.5",298,"10.1073/pnas.1719190115",,"6AZU",183.87,"2.822","2.822","Holo IDO1 crystal structure","GSHMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6AZU"
"6AZV",,"X-RAY DIFFRACTION",3.01,59.16,"VAPOR DIFFUSION",,"22% PEG-3350, 0.2 M NH4 citrate pH 7",298,"10.1073/pnas.1719190115",,"6AZV",182.77,"2.755","2.755","IDO1/BMS-978587 crystal structure","GSHMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6AZV"
"6AZW",,"X-RAY DIFFRACTION",2.86,57,"VAPOR DIFFUSION",,"16% PEG 8K, 0.2 M NH4 acetate, 0.1 M CHES pH 8.75",298,"10.1073/pnas.1719190115",,"6AZW",89.48,"2.78","2.78","IDO1/FXB-001116 crystal structure","MISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6AZW"
"6AZX",,"X-RAY DIFFRACTION",2.99,58.87,"VAPOR DIFFUSION, SITTING DROP",,"200 mM di-ammonium hydrogen citrate, 20% (w/v) PEG 3350",294,"10.1016/j.immuni.2017.11.007",,"6AZX",95.76,"2.1","2.1","Crystal structure of the neutralizing anti-circumsporozoite protein 663 antibody","EVQLLESGGGLEQPGGSLRLSCVVSGFTFSNYAFNWVRQAPGKGLEWVAIIYRSGSRMYHADSVKGRFTISRDDSKNTLFLQMNNLRAEDTAVYYCTTLLIYESDVGVDFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKC","Homo sapiens",,"663 antibody, heavy chain","1","6AZX"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVSPGEPASISCRSTQSLIFGEHNYLDWYLQKPGQSPQLLIYLASNRASGVPDRFSGSGSGTYFTLKISRVEAEDFGVYYCVQTVQVPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"663 antibody, light chain","2","6AZX"
"6B00",,"X-RAY DIFFRACTION",1.97,37.42,"VAPOR DIFFUSION, HANGING DROP",,"50 mM Tris pH 8, 2.5 M ammonium sulfate",278,"10.1002/pro.3347",,"6B00",30.29,"0.9","0.9","Thermostabilized mutant of human carbonic anhydrase II - A65T L100H K154N L224S L240P A248T","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHTFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSANPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPTQPLKNRQIKASFKHHHHHH","Homo sapiens","CA2","Carbonic anhydrase 2","1","6B00"
,,,1.97,37.42,"VAPOR DIFFUSION, HANGING DROP",,"50 mM Tris pH 8, 2.5 M ammonium sulfate",278
,,,1.97,37.42,"VAPOR DIFFUSION, HANGING DROP",,"50 mM Tris pH 8, 2.5 M ammonium sulfate",278
,,,1.97,37.42,"VAPOR DIFFUSION, HANGING DROP",,"50 mM Tris pH 8, 2.5 M ammonium sulfate",278
,,,1.97,37.42,"VAPOR DIFFUSION, HANGING DROP",,"50 mM Tris pH 8, 2.5 M ammonium sulfate",278
"6B09",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION",9.5,"PEG 8000, CHES",293,"10.1038/s41598-019-39491-w",,"6B09",44.78,"3.2","3.2","Crystal structure of HsNUDT16 in complex with diADPR (soaked)","MAGARRLELGEALALGSGWRHVCHALLYAPDPGMLFGRIPLRYAILMQMRFDGRLGFPGGFVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLKIPAHH","Homo sapiens","NUDT16","U8 snoRNA-decapping enzyme","1","6B09"
"6B0F",,"X-RAY DIFFRACTION",2.11,41.66,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M TRIS-HCL (PH 8.5), 22% PEG 3350, 0.20 M MAGNESIUM CHLORIDE",294,"10.1021/acs.jmedchem.7b01682","C6V","6B0F",59.01,"2.86","2.86","ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH LSZ102","GSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6B0F"
"6B0T",,"X-RAY DIFFRACTION",2.75,55.32,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG 4000, 50mM Tris HCL (pH 8), 3.3% glycerol, 142mM NaCl, 5mM MgCl2, 10mM CaCl2 and 0.004% NaN3",292,"10.1016/j.jmb.2018.03.009",,"6B0T",326.56,"2.8","2.8","Structural Insights into the Induced-fit Inhibition of Fascin by a Small Molecule","AEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FSCN1, FAN1, HSN, SNL","Fascin","1","6B0T"
"6B0V",,"X-RAY DIFFRACTION",2.02,39,"VAPOR DIFFUSION, HANGING DROP",8.5,"29% PEG 4000, 0.2 M CaCl2, 0.1 M Tris pH=8.5",293,"10.1038/s41594-018-0061-5",,"6B0V",40.58,"1.29","1.29","Crystal Structure of small molecule ARS-107 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6B0V"
"6B0W",,"X-RAY DIFFRACTION",2.71,54.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"17 % (w/v) PEG 400, 15 % (v/v) glycerol, 8.5 % (v/v) isopropanol and 85 mM HEPES pH 7.5",294,"10.1084/jem.20170869",,"6B0W",47.48,"1.9","1.9","Crystal structure of the anti-circumsporozoite protein 1710 antibody","SAYELTQPPSVSVSPGQTASITCSGDKLGDKYACWYQQKPGQSPVVVIYQDTKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"1710 antibody, light chain","1","6B0W"
,,,,,,,,,,,,,,,,"EVQLQESGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSITSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDPGIAAADNHWFDPWGQGTLVTVSSASTKGPSVFPLAPSSSSKSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"1710 antibody, heavy chain","2","6B0W"
"6B0Y",,"X-RAY DIFFRACTION",2.01,38.68,"VAPOR DIFFUSION, HANGING DROP",8.5,"27% PEG 4000, 0.2 M CaCl2, 0.1 M Tris pH=8.5",293,"10.1038/s41594-018-0061-5",,"6B0Y",40.83,"1.43","1.43","Crystal Structure of small molecule ARS-917 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6B0Y"
"6B0Z",,"X-RAY DIFFRACTION",2.75,55.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"co-crystallization of protein (20-24mG/mL) /compound complex at 1/1.5 molar ratio;

reservoir solution: 1.5-1.8M Tri Ammonium Citrate, 0.1M Bis-Tris pH6.5",294,"10.1021/acsmedchemlett.7b00342","C81","6B0Z",194.33,"2.334","2.334","IDH1 R132H mutant in complex with IDH305","GPGMSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6B0Z"
"6B16",,"X-RAY DIFFRACTION",2.44,49.58,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 3500, 0.2M Ammonium Sulfate and 0.1M Tris pH 8",292,"10.1016/j.bmcl.2016.06.031","C7Y","6B16",67.96,"2.285","2.285","P21-activated kinase 1 in complex with a 4-azaindole inhibitor","GSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNHGNS","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","6B16"
"6B1C",,"X-RAY DIFFRACTION",3.73,67.04,"VAPOR DIFFUSION, SITTING DROP",7,"2.6 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7, 3% ISOPROPANOL, 2% DMSO",293.15,"10.1021/acsmedchemlett.7b00384","C9J","6B1C",38.12,"2.163","2.163","Macrophage Migration Inhibitory Factor in complex with a Naphthyridinone Inhibitor (4a)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6B1C"
"6B1E",,"X-RAY DIFFRACTION",3.01,59.18,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 4000, SODIUM ACETATE, TRIS, pH 8.0",293,"10.1002/edm2.2","LF7","6B1E",173.66,"1.77","1.77","The structure of DPP4 in complex with Vildagliptin","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","6B1E"
"6B1G",,"SOLUTION NMR",,,,,,,"10.15252/embj.201797452",,"6B1G",18.44,,,"Solution structure of TDP-43 N-terminal domain dimer.","GHMMSERIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVSQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKD","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43, Y4R Mutant","2","6B1G"
,,,,,,,,,,,,,,,,"GHMMSEYIRVTEDENDEPIEIPSEDDGTVLLSTVTAQFPGACGLRYRNPVEQCMRGVRLVEGILHAPDAGWGNLVYVVNYPKD","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43, S48E Mutant","1","6B1G"
"6B1I",,"X-RAY DIFFRACTION",2.48,50.4,"VAPOR DIFFUSION, HANGING DROP",,"NaCl, Tris, PEG 3350, MgCl2, ATP",293.15,"10.1021/acs.biochem.7b01005","ADP","6B1I",89.47,"2.3","2.3","Disrupted hydrogen bond network impairs ATPase activity in an Hsc70 cysteine mutant","MGSSHHHHHHSSGLVPRGSHMASPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILS","Homo sapiens","HSPA8, HSC70, HSP73, HSPA10","Heat shock protein family A (Hsp70) member 8","1","6B1I"
"6B1K",,"X-RAY DIFFRACTION",2.3,47,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.1 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7.5, 3% ISOPROPANOL, 1.4% DMSO",293.15,"10.1021/acsmedchemlett.7b00384","C9G","6B1K",38.5,"1.17","1.17","Macrophage Migration Inhibitory Factor in Complex with a Naphthyridinone Inhibitor (3a)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6B1K"
"6B1M",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION, HANGING DROP",,"NaCl, Tris, PEG 3350, MgCl2, AppNHp",293.15,"10.1021/acs.biochem.7b01005",,"6B1M",89.51,"1.9","1.9","Disrupted hydrogen bond network impairs ATPase activity in an Hsc70 cysteine mutant","MGSSHHHHHHSSGLVPRGSHMASPAVGIDLGTTYSWVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILS","Homo sapiens","HSPA8, HSC70, HSP73, HSPA10","Heat shock protein family A (Hsp70) member 8","1","6B1M"
"6B1N",,"X-RAY DIFFRACTION",2.53,51.36,"VAPOR DIFFUSION, HANGING DROP",,"NaCl, Tris, PEG 3350, MgCl2, ADP",293.15,"10.1021/acs.biochem.7b01005","ADP","6B1N",89.82,"1.8","1.8","Disrupted hydrogen bond network impairs ATPase activity in an Hsc70 cysteine mutant","MGSSHHHHHHSSGLVPRGSHMASPAVGIDLGTTYSWVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILS","Homo sapiens","HSPA8, HSC70, HSP73, HSPA10","Heat shock protein family A (Hsp70) member 8","1","6B1N"
"6B1O",,"X-RAY DIFFRACTION",2.86,56.94,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 4000, SODIUM ACETATE, TRIS, pH 8.0",293,"10.1002/edm2.2",,"6B1O",174.11,"1.91","1.91","The structure of DPP4 in complex with Vildagliptin Analog","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","6B1O"
"6B25",,"X-RAY DIFFRACTION",2.2,43.99,"VAPOR DIFFUSION",7.5,"0.1M sodium-HEPES, 25% PEG1000",298.15,"10.1073/pnas.1708852114",,"6B25",13.92,"2.39","2.39","Crystal structure of human STAC1 Tandem SH3 Domains (288-402)","SNANTYVALYKFVPQENEDLEMRPGDIITLLEDSNEDWWKGKIQDRIGFFPANFVQRLQQNEKIFRCVRTFIGCKEQGQITLKENQICVSSEEEQDGFIRVLSGKKKGLIPLDVLENI","Homo sapiens","STAC, STAC1","SH3 and cysteine-rich domain-containing protein","1","6B25"
"6B26",,"X-RAY DIFFRACTION",2.47,50.11,"MICRODIALYSIS",7.4,"150mM KCl, 10mM HEPES, 2mM TCEP",277.15,"10.1073/pnas.1708852114",,"6B26",13.47,"1.2","1.2","Crystal structure of human STAC2 Tandem SH3 Domains (296-411)","SNANSYVALYKFLPQENNDLALQPGDRIMLVDDSNEDWWKGKIGDRVGFFPANFVQRVRPGENVWRCCQPFSGNKEQGYMSLKENQICVGVGRSKDADGFIRVSSGKKRGLVPVDALTEI","Homo sapiens","STAC2","SH3 and cysteine-rich domain-containing protein 2","1","6B26"
"6B28",,"X-RAY DIFFRACTION",3.07,59.94,"VAPOR DIFFUSION",6.4,"0.1M Bis-Tris, 0.2M lithium sulfate, 35% PEG3350",277.15,"10.1073/pnas.1708852114",,"6B28",13.46,"2.55","2.55","Crystal structure of human STAC2 Tandem SH3 Domains Q347I (296-411)","SNANSYVALYKFLPQENNDLALQPGDRIMLVDDSNEDWWKGKIGDRVGFFPANFVIRVRPGENVWRCCQPFSGNKEQGYMSLKENQICVGVGRSKDADGFIRVSSGKKRGLVPVDALTEI","Homo sapiens","STAC2","SH3 and cysteine-rich domain-containing protein 2","1","6B28"
"6B29",,"X-RAY DIFFRACTION",2.12,42.02,"VAPOR DIFFUSION",6.5,"0.1M Bis-Tris, 22.5% PEG3350 and 0.2M ammonium acetate",298,"10.1073/pnas.1708852114",,"6B29",26.53,"1.3","1.3","Crystal structure of the second SH3 domain of STAC3 (309-364)","SNARVHRVTRSFVGNREIGQITLKKDQIVVQKGDEAGGYVKVYTGRKVGLFPTDFLEEI","Homo sapiens","STAC3","SH3 and cysteine-rich domain-containing protein 3","1","6B29"
"6B2C",,"X-RAY DIFFRACTION",3.99,68.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.1 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7.5, 3% ISOPROPANOL, 2% DMSO",293.15,"10.1021/acsmedchemlett.7b00384","C9Y","6B2C",37.54,"2","2","Macrophage Migration Inhibitory Factor in Complex with a Naphthyridinone Inhibitor (4b)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6B2C"
"6B30",,"X-RAY DIFFRACTION",3.59,65.73,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Formate, 3% MPD, and 100 mM HEPES (pH 7.5)",291,"10.1016/j.bmc.2017.12.006",,"6B30",50.91,"2.69","2.69","Structure of RORgt in complex with a novel inverse agonist 1","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQH","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6B30"
"6B31",,"X-RAY DIFFRACTION",3.3,62.72,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Formate, 3% MPD, and 100 mM HEPES (pH 7.5)",291,"10.1016/j.bmc.2017.12.039","CFJ","6B31",54.22,"3.18","3.18","Structure of RORgt in complex with a novel inverse agonist 2","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPI","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6B31"
"6B33",,"X-RAY DIFFRACTION",3.53,65.2,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Formate, 3% MPD, and 100 mM HEPES (pH 7.5)",291,"10.1002/cmdc.201900416",,"6B33",51.9,"2.48","2.48","Structure of RORgt in complex with a novel inverse agonist 3","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVER","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6B33"
"6B3D",,"X-RAY DIFFRACTION",2.93,58.02,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.085 M HEPES pH 7.5, 8.5% isopropanol, 10% ethylene glycol, 15% glycerol, and 17% PEG 4000",293.15,"10.1038/s41467-017-01640-y",,"6B3D",50.01,"2.271","2.271","Crystal structure of anti-HIV antibody PGT128 in complex with a bacterially derived synthetic mimetic of Man9.","QPQLQESGPTLVEASETLSLTCAVSGDSTAACNSFWGWVRQPPGKGLEWVGSLSHCASYWNRGWTYHNPSLKSRLTLALDTPKNLVFLKLNSVTAADTATYYCARFGGEVLRYTDWPKPAWVDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCD","Homo sapiens",,"PGT128 Fab heavy chain","2","6B3D"
,,,,,,,,,,,,,,,,"QSALTQPPSASGSPGQSITISCTGTSNNFVSWYQQHAGKAPKLVIYDVNKRPSGVPDRFSGSKSGNTASLTVSGLQTDDEAVYYCGSLVGNWDVIFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"PGT128 Fab light chain","1","6B3D"
"6B3I",,"X-RAY DIFFRACTION",3.5,64.8,"VAPOR DIFFUSION, HANGING DROP",,"100 mM NaAcetate, 40 mM 1,2-butanediol, 0.8% PEG 8000",293,"10.1074/jbc.RA118.004571",,"6B3I",116.85,"2.6","2.6","Annexin A13a","MSYYHHHHHHDYDIPTTENLYFQGAMEMGNRHAKASSPQGFDVDRDAKKLNKACKGMGTNEAAIIEILSGRTSDERQQIKQKYKATYGKELEEVLKSELSGNFEKTALALLDHPSEYAARQLQKAMKGLGTDESVLIEVLCTRTNKEIIAIKEAYQRLFDRSLESDVKGDTSGNLKKILVSLLQANRNEGDDVDKDLAGQDAKDLYDAGEGRWGTDELAFNEVLAKRSYKQLRATFQAYQILIGKDIEEAIEEETSGDLQKAYLTLVRCAQDCEDYFAERLYKSMKGAGTDEETLIRIIVTRAEVDLQGIKAKFQEKYQKSLSDMVRSDTSGDFRKLLVALLH","Homo sapiens","ANXA13, ANX13","Annexin","1","6B3I"
"6B3V",,"X-RAY DIFFRACTION",2.32,46.87,"VAPOR DIFFUSION, SITTING DROP",5.6,"PEG 4000, ammonium acetate, citrate",291.15,"10.1038/s41467-018-06703-2","7DQ","6B3V",43.13,"1.601","1.601","PANK3 complex with compound PZ-2891","MGSSHHHHHHSSGLVPRGSPWFGMDIGGTLVKLSYFEPIDITAEEEQEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLFGRRGNLHFIRFPTQDLPTFIQMGRDKNFSTLQTVLCATGGGAYKFEKDFRTIGNLHLHKLDELDCLVKGLLYIDSVSFNGQAECYYFANASEPERCQKMPFNLDDPYPLLVVNIGSGVSILAVHSKDNYKRVTGTSLGGGTFLGLCSLLTGCESFEEALEMASKGDSTQADKLVRDIYGGDYERFGLPGWAVASSFGNMIYKEKRESVSKEDLARATLVTITNNIGSVARMCAVNEKINRVVFVGNFLRVNTLSMKLLAYALDYWSKGQLKALFLEHEGYFGAVGALLGLPNFSDD","Homo sapiens","PANK3","Pantothenate kinase 3","1","6B3V"
"6B41",,"X-RAY DIFFRACTION",3.96,68.93,"VAPOR DIFFUSION, SITTING DROP",,"1.96 M NaCl, 89 mM Bis-Tris pH 6.8, 0.178 M MgCl2 and 10.7 mM Pr Acetate",277,"10.1002/anie.201711828",,"6B41",63.07,"2.61","2.61","Menin bound to M-525","SGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGEERPGEQSQGTQSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSGTVAGTARGPEGGSTAQVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVSTPSDYTLSFLKRQRKGL","Homo sapiens","MEN1, SCG2","Menin","1","6B41"
"6B42",,"X-RAY DIFFRACTION",1.98,37.76,"VAPOR DIFFUSION, HANGING DROP",6.7,"100 MM MES, 33% PEG 8000",293,"10.1021/acs.molpharmaceut.7b00664",,"6B42",14.43,"1.13","1.13","Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) 2'-deoxy-AMP complex at 1.13A resolution","SNAMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6B42"
"6B4D",,"X-RAY DIFFRACTION",2.13,42.26,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50mM Tris HCl",298,"10.1021/acsmedchemlett.7b00229","53X","6B4D",29.52,"1.196","1.196","Crystal structure of human carbonic anhydrase II in complex with a heteroaryl-pyrazole carboxylic acid derivative.","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6B4D"
"6B4K",,"X-RAY DIFFRACTION",2.45,49.85,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MIB buffer pH 5.0 (malonate, imidazole, borate), 13 % (w/v) PEG 1500",277,"10.1038/s41467-018-04459-3",,"6B4K",98.68,"2.2","2.2","Crystal structure of human DDX19B(AMPPNP)","GPHMEDRAAQSLLNKLIRSNLVDNTNQVEVLQRDPNSPLYSVKSFEELRLKPQLLQGVYAMGFNRPSKIQENALPLMLAEPPQNLIAQSQSGTGKTAAFVLAMLSQVEPANKYPQCLCLSPTYELALQTGKVIEQMGKFYPELKLAYAVRGNKLERGQKISEQIVIGTPGTVLDWCSKLKFIDPKKIKVFVLDEADVMIATQGHQDQSIRIQRMLPRNCQMLLFSATFEDSVWKFAQKVVPDPNVIKLKREEETLDTIKQYYVLCSSRDEKFQALCNLYGAITIAQAMIFCHTRKTASWLAAELSKEGHQVALLSGEMMVEQRAAVIERFREGKEKVLVTTNVCARGIDVEQVSVVINFDLPVDKDGNPDNETYLHRIGRTGRFGKRGLAVNMVDSKHSMNILNRIQEHFNKKIERLDTDDLDEIEKIAN","Homo sapiens","DDX19B, DBP5, DDX19, TDBP","ATP-dependent RNA helicase DDX19B","1","6B4K"
"6B4L",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, HANGING DROP",9.5,"18%(w/v)PEG 8000, 0.1M CHES pH 9.5, 4%(v/v) 2,2,2 trifluoroethanol",277,"10.1021/jm501258m","CJY","6B4L",36.46,"2.25","2.25","Crystal structure of MCL-1 in complex with a BIM competitive inhibitor","GSMDLYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6B4L"
"6B4U",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, HANGING DROP",9.5,"18%(w/v)PEG 8000, 0.1M CHES pH 9.5, 4%(v/v)1,1,1,3,3,3 hexafluor-2-propanol",277,"10.1021/jm501258m","CN7","6B4U",18.43,"1.95","1.95","Crystal structure of MCL-1 in complex with a BIM competitive inhibitor","GSMDLYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6B4U"
"6B4W",,"X-RAY DIFFRACTION",3.21,61.64,"VAPOR DIFFUSION, SITTING DROP",7,"100mM Sodium Cacodylate, 200mM Potassium Thiocyanate, 15% PEG 4K",277,"10.1021/acs.jmedchem.7b01223","CQ7","6B4W",35.52,"2.9","2.9","TTK in Complex with Inhibitor","MGSSHHHHHHSSGLVPRGSHNECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTLE","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","6B4W"
"6B57",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, SITTING DROP",,"20% (w/v) PEG-3350, 0.2 M ammonium formate",293,"10.1073/pnas.1711486114",,"6B57",51.33,"1.93","1.93","tudor in complex with ligand","MHHHHHHSSGRENLYFQGEVYVSASEHPNHFWIQIVGSRSLQLDKLVNEMTQHYENSVPEDLTVHVGDIVAAPLPTNGSWYRARVLGTLENGNLDLYFVDFGDNGDCPLKDLRALRSDFLSLPFQAIECSLARIAPSGDQWEEEALDEFDRLTHCADWKPLVAKISSYVQTGISTWPKIYLYDTSNGKKLDIGLELVHKGYAIELPEGSAGSAGSAGSATGRARARARGRA","Homo sapiens","TDRKH, TDRD2","Tudor and KH domain-containing protein","1","6B57"
"6B59",,"X-RAY DIFFRACTION",2.16,43.12,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate
50mM Tris-HCl",298,"10.1021/acsmedchemlett.7b00399","CQS","6B59",29.54,"1.638","1.638","Carbonic anhydrase II in complex with nitrogenous base-bearing benezenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6B59"
"6B5A",,"X-RAY DIFFRACTION",2.09,41.28,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate
50mM Tris-HCl",298,"10.1021/acsmedchemlett.7b00399","CQS","6B5A",29.29,"1.622","1.622","Carbonic anhydrase IX-mimic in complex with nitrogenous base-bearing benezenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6B5A"
"6B5C",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M TRIS pH 8.0 and 18% PEG 8000",293,"10.1074/jbc.RA117.001215",,"6B5C",34.82,"2.4","2.4","Structural Basis for Katanin Self-Assembly","AGYDKDLVEALERDIVSRNPSIHWDDIADLEEAKKLLREAVVLPMWMPDFFKGIRRPWKGVLMVGPPGTGKTMLAKAVATECGTTFFNVSSSTLTSKYRGESEKLVRLLFEMARFYAPTTIFIDQIDSICSRRGTSDEHEASRRVKSELLIQMDGVGGALENDDPSKMVMVLAATNFPWDIDEALRRRLEKRIYIPLPTAKGRAELLKINLREVELDPDIQLEDIAEKIEGYSGADITNVCRDASLMAMRRRINGLSPEEIRALSKEELQMPVTKGDFELALKKIAKSVSAADLEKYEKWMVEFGSA","Homo sapiens","KATNAL1","Katanin p60 ATPase-containing subunit A-like 1","1","6B5C"
"6B5G",,"X-RAY DIFFRACTION",2.26,45.52,"VAPOR DIFFUSION, HANGING DROP",,"40 mg/mL ALDH1A2, 0.2 M sodium citrate tribasic dehydrate, 20% w/v PEG3350, 1.3 mM 6-118, 4 mM NAD, 10% DMSO",291,"10.1021/acschembio.7b00685","CQY","6B5G",221.06,"2.2","2.2","ALDH1A2 liganded with NAD and (3-ethoxythiophen-2-yl){4-[4-nitro-3-(pyrrolidin-1-yl)phenyl]piperazin-1-yl}methanone (compound 6-118)","LPSPTPNLEIKYTKIFINNEWQNSESGRVFPVYNPATGEQVCEVQEADKADIDKAVQAARLAFSLGSVWRRMDASERGRLLDKLADLVERDRAVLATMESLNGGKPFLQAFYVDLQGVIKTFRYYAGWADKIHGMTIPVDGDYFTFTRHEPIGVCGQIIPWNFPLLMFAWKIAPALCCGNTVVIKPAEQTPLSALYMGALIKEAGFPPGVINILPGYGPTAGAAIASHIGIDKIAFTGSTEVGKLIQEAAGRSNLKRVTLELGGKSPNIIFADADLDYAVEQAHQGVFFNQGQCCTAGSRIFVEESIYEEFVRRSVERAKRRVVGSPFDPTTEQGPQIDKKQYNKILELIQSGVAEGAKLECGGKGLGRKGFFIEPTVFSNVTDDMRIAKEEIFGPVQEILRFKTMDEVIERANNSDFGLVAAVFTNDINKALTVSSAMQAGTVWINCYNALNAQSPFGGFKMSGNGREMGEFGLREYSEVKTVTVKIPQKNS","Homo sapiens","ALDH1A2, RALDH2","Retinal dehydrogenase 2","1","6B5G"
"6B5H",,"X-RAY DIFFRACTION",2.29,46.24,"VAPOR DIFFUSION, HANGING DROP",,"40 mg/mL ALDH1A2, 0.2 M sodium citrate tribasic dehydrate, 25% w/v PEG3350, 1.3 mM CM121, 10% DMSO",291,"10.1021/acschembio.7b00685","CU4","6B5H",221.18,"2.3","2.3","ALDH1A2 liganded with NAD and 1-(4-cyanophenyl)-N-(3-fluorophenyl)-3-[4-(methylsulfonyl)phenyl]-1H-pyrazole-4-carboxamide (compound CM121)","LPSPTPNLEIKYTKIFINNEWQNSESGRVFPVYNPATGEQVCEVQEADKADIDKAVQAARLAFSLGSVWRRMDASERGRLLDKLADLVERDRAVLATMESLNGGKPFLQAFYVDLQGVIKTFRYYAGWADKIHGMTIPVDGDYFTFTRHEPIGVCGQIIPWNFPLLMFAWKIAPALCCGNTVVIKPAEQTPLSALYMGALIKEAGFPPGVINILPGYGPTAGAAIASHIGIDKIAFTGSTEVGKLIQEAAGRSNLKRVTLELGGKSPNIIFADADLDYAVEQAHQGVFFNQGQCCTAGSRIFVEESIYEEFVRRSVERAKRRVVGSPFDPTTEQGPQIDKKQYNKILELIQSGVAEGAKLECGGKGLGRKGFFIEPTVFSNVTDDMRIAKEEIFGPVQEILRFKTMDEVIERANNSDFGLVAAVFTNDINKALTVSSAMQAGTVWINCYNALNAQSPFGGFKMSGNGREMGEFGLREYSEVKTVTVKIPQKNS","Homo sapiens","ALDH1A2, RALDH2","Retinal dehydrogenase 2","1","6B5H"
"6B5I",,"X-RAY DIFFRACTION",2.23,44.74,"VAPOR DIFFUSION, HANGING DROP",,"40 mg/mL ALDH1A2, 0.2 M sodium citrate tribasic dehydrate, 25% w/v PEG3350, 1.3 mM CM121, 10% DMSO",291,"10.1021/acschembio.7b00685",,"6B5I",218.52,"2.6","2.6","ALDH1A2 liganded with 1-(4-cyanophenyl)-N-(3-fluorophenyl)-3-[4-(methylsulfonyl)phenyl]-1H-pyrazole-4-carboxamide (compound CM121)","LPSPTPNLEIKYTKIFINNEWQNSESGRVFPVYNPATGEQVCEVQEADKADIDKAVQAARLAFSLGSVWRRMDASERGRLLDKLADLVERDRAVLATMESLNGGKPFLQAFYVDLQGVIKTFRYYAGWADKIHGMTIPVDGDYFTFTRHEPIGVCGQIIPWNFPLLMFAWKIAPALCCGNTVVIKPAEQTPLSALYMGALIKEAGFPPGVINILPGYGPTAGAAIASHIGIDKIAFTGSTEVGKLIQEAAGRSNLKRVTLELGGKSPNIIFADADLDYAVEQAHQGVFFNQGQCCTAGSRIFVEESIYEEFVRRSVERAKRRVVGSPFDPTTEQGPQIDKKQYNKILELIQSGVAEGAKLECGGKGLGRKGFFIEPTVFSNVTDDMRIAKEEIFGPVQEILRFKTMDEVIERANNSDFGLVAAVFTNDINKALTVSSAMQAGTVWINCYNALNAQSPFGGFKMSGNGREMGEFGLREYSEVKTVTVKIPQKNS","Homo sapiens","ALDH1A2, RALDH2","Retinal dehydrogenase 2","1","6B5I"
"6B5J",,"X-RAY DIFFRACTION",3.06,59.84,"VAPOR DIFFUSION, HANGING DROP",7,"15% tascimate, 0.1M Hepes pH 7, 2% PEG3350",283,"10.1021/acs.jmedchem.8b00125","CV4","6B5J",141.25,"2.97","2.97","TNNI3K complexed with a 4,6-diaminopyrimidine","GGDGSYVSVPSPLGKIKSMTKEKADILLLRAGLPSHFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCQLNHPCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLHNLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAPEVFTQCTRYTIKADVFSYALCLWEILTGEIPFAHLKPAAAAADMAYHHIRPPIGYSIPKPISSLLIRGWNACPEGRPEFSEVVMKLEECLCNIELMS","Homo sapiens","TNNI3K, CARK","Serine/threonine-protein kinase TNNI3K","1","6B5J"
"6B6U",,"X-RAY DIFFRACTION",2.45,49.74,"VAPOR DIFFUSION, SITTING DROP",8,"Bis-Tris propane, Sodium thicynate, PEG3350",293,"10.1021/acs.biochem.7b01013",,"6B6U",116.5,"1.35","1.35","Pyruvate Kinase M2 mutant - S437Y","EAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRYAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6B6U"
"6B6Z",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, SITTING DROP",,"180 mM Zinc Acetate, 90 mM imidazole, pH 8.0, 27% PEG 3000, 10 mM Chromium (III) chloride hexahydrate",288,,,"6B6Z",97.46,"2.112","2.112","Crystal structure of the Apo Antibody fragment (Fab) raised against C-terminal domain of Ebola nucleoprotein (EBOV, TAFV, BDBV strains)","SDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYSYSLVTFGQGTKVEIKRTVAAPSVFIFPPSDSQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Apo Fab Light Chain","1","6B6Z"
,,,,,,,,,,,,,,,,"EISEVQLVESGGGLVQPGGSLRLSCAASGFNVYYYYIHWVRQAPGKGLEWVASISPYYGYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARWSYDQSMSYKSGMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"Apo Fab Heavy Chain","2","6B6Z"
"6B74",,"X-RAY DIFFRACTION",3.32,63,"VAPOR DIFFUSION, SITTING DROP",7,"30 mM HEPES, 0.2 M NH4I, 0.2 M AmSO4",291,"10.1182/bloodadvances.2018016337",,"6B74",28.33,"2.323","2.323","Structures of the two-chain human plasma Factor XIIa co-crystallized with potent inhibitors","NGPLSCGQR","Homo sapiens","F12","Coagulation factor XII","1","6B74"
,,,,,,,,,,,,,,,,"VVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS","Homo sapiens","F12","Coagulation factor XII","2","6B74"
"6B75",,"X-RAY DIFFRACTION",2.2,44.19,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM Tris/HCl pH 8.0, 23 % (w/v) PEG 3350, 200 mM NaCl",293,,,"6B75",229.15,"2.53","2.53","Crystal Structure of human NAMPT in complex with NVP-LOQ594","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6B75"
"6B76",,"X-RAY DIFFRACTION",2.37,48.14,"VAPOR DIFFUSION, SITTING DROP",8,"25 % (w/v) PEG 3350, 
200 mM NaCl, 
100 mM Tris/HCl pH 8.0",293,,,"6B76",230.16,"2.44","2.44","Crystal Structure of human NAMPT in complex with NVP-LVR596","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHLEHHHHHHHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6B76"
"6B77",,"X-RAY DIFFRACTION",3.27,62,"VAPOR DIFFUSION, SITTING DROP",7,"30 mM HEPES, 0.2 M NH4I, 0.2 M NH4S04",291,"10.1182/bloodadvances.2018016337",,"6B77",28.38,"2.37","2.37","Structures of the two-chain human plasma factor XIIa co-crystallized with potent inhibitors","VVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS","Homo sapiens","F12","Coagulation factor XII","2","6B77"
,,,,,,,,,,,,,,,,"NGPLSCGQR","Homo sapiens","F12","Coagulation factor XII","1","6B77"
"6B79",,"X-RAY DIFFRACTION",2.12,42.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"HEPES pH 7.5, Sodium citrate, 2-Methyl-2,4-pentanediol",298,"10.1002/pro.3391",,"6B79",3.2,"1.8","1.8","Curved pair of sheets formed from SOD1 residues 28-38 with familial mutation G37R.","KXKVWGSIKRL","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6B79"
"6B7H",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION",5.5,"100 mM Bis-Tris, pH 5.5, 17% PEG10000, 100 mM ammonium acetate",298,"10.1021/acs.jmedchem.7b01481","CWY","6B7H",60.22,"2.82","2.82","Structure of mGluR3 with an agonist","MALKMLTRLQVLTLALFSKGFLLSLGDHNFLRREIKIEGDLVLGGLFPINEKGTGTEECGRINEDRGIQRLEAMLFAIDEINKDDYLLPGVKLGVHILDTCSRDTYALEQSLEFVRASLTKVDEAEYMCPDGSYAIQENIPLLIAGVIGGSYSSVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFYQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFEQEARLRNISIATAEKVGRSNIRKSYDSVIRELLQKPNARVVVLFMRSDDSRELIAAASRANASFTWVASDGWGAQESIIKGSEHVAYGAITLELASQPVRQFDRYFQSLNPYNNHRNPWFRDFWEQKFQCSLQNKRNHRRVCDKHLAIDSSNYEQESKIMFVVNAVYAMAHALHKMQRTLCPNTTKLCDAMKILDGKKLYKDYLLKINFTAPFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKYSYLKVGHWAETLSLDVNSIHWSRNSVPTSEGHHHHHH","Homo sapiens","GRM3, GPRC1C, MGLUR3","Metabotropic glutamate receptor 3","1","6B7H"
"6B7Y","6.5","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.33572",,"6B7Y",223.73,"6.5",,"Cryo-EM structure of human insulin degrading enzyme","AIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSCPVVGEFPCQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPH","Homo sapiens","IDE","Insulin-degrading enzyme","1","6B7Y"
"6B8E",,"X-RAY DIFFRACTION",3.41,63.88,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 16% PEG 8000, 2% ethanol, 10% glycerol",277,"10.7554/eLife.36307",,"6B8E",37.84,"1.82","1.82","Multiconformer model of apo WT PTP1B with glycerol at 180 K","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6B8E"
"6B8F",,"X-RAY DIFFRACTION",3.03,59.38,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir: 500 uL of 25 mM HEPES pH 7.0 with 10 mM CaCl2
Well: 2 uL of reservoir solution and 2 uL of 2.5 uM ferritin (by 24-mer) in 15 mM TRIS pH 7.4 with 150 mM NaCl
After crystals formed, a crystal was harvested and soaked in a buffered solution comprised of 25 mM HEPES pH 7.0, 30 mM CaCl2, 8.6 % (w/v) sodium acrylate, 2.5 % (w/v) acrylamide, and 0.2 % (w/v) Bis-acrylamide overnight. 
Crystal was transferred to a solution containing 1 % APS and 1% TEMED with 4 M NaCl for 5 min. Crystal was then transferred to a clean slide and soaked in 30 uL H2O for 5 min. This solution was removed and the crystal was soaked in 1 M CaCl2 for 2 min. The crystal was removed, cryoprotected in perfluoro polyether, and frozen in liquid N2.",293,"10.1038/s41586-018-0057-7",,"6B8F",21.64,"1.06","1.06","Contracted Human Heavy-Chain Ferritin Crystal-Hydrogel Hybrid","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6B8F"
"6B8G",,"X-RAY DIFFRACTION",3.02,59.31,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir: 500 uL of 25 mM HEPES pH 7.0 with 10 mM CaCl2
Well: 2 uL of reservoir solution and 2 uL of 2.5 uM ferritin (by 24-mer) in 15 mM TRIS pH 7.4 with 150 mM NaCl
After crystals formed, a crystal was harvested and soaked in a buffered solution comprised of 25 mM HEPES pH 7.0, 30 mM CaCl2, 8.6 % (w/v) sodium acrylate, 2.5 % (w/v) acrylamide, and 0.2 % (w/v) Bis-acrylamide overnight. 
Crystal was transferred to a solution containing 1 % APS and 1% TEMED with 4 M NaCl for 5 min. Crystal was then transferred to a clean slide and soaked in 30 uL H2O for 5 min. The H2O was removed the crystal was soaked in 4 M NaCl for 2 min. The crystal was removed, and soaked in 30 uL H2O for 5 min. This solution was removed and the crystal was soaked in 1 M CaCl2 for 2 min. The crystal was removed, cryoprotected in perfluoro polyether, and frozen in liquid N2.",293,"10.1038/s41586-018-0057-7",,"6B8G",21.64,"1.13","1.13","Twice-Contracted Human Heavy-Chain Ferritin Crystal-Hydrogel Hybrid","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLATDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6B8G"
"6B8K",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",,"31% PEG6000, 100 mM magnesium chloride, 8 mM BME, 100 mM Tris-HCl, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/cbdd.13348",,"6B8K",16.21,"1.28","1.28","Crystal structure of Human galectin-3 CRD in complex with Lactulose","GPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6B8K"
"6B8O",,"X-RAY DIFFRACTION",2.41,49.01,"VAPOR DIFFUSION",,"0.2 M NaI, 1.6 M ammonium sulfate, 50 mM Tris 8.5",293,"10.1074/jbc.RA118.002352",,"6B8O",120.09,"2.2","2.2","WT Ig-like V Domain with Phosphatidylserine","HDTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSENLYFQGHHHHHH","Homo sapiens","TREM2","Triggering receptor expressed on myeloid cells 2","1","6B8O"
"6B8T",,"X-RAY DIFFRACTION",3.52,65.01,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 16% PEG 8000, 2% ethanol, 10% glycerol",277,"10.7554/eLife.36307",,"6B8T",37.74,"1.85","1.85","Multiconformer model of apo WT PTP1B with glycerol at 240 K","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6B8T"
"6B8U",,"X-RAY DIFFRACTION",2.82,56.38,"VAPOR DIFFUSION, HANGING DROP",4.7,"10% PEG8000, 0.1 M sodium citrate pH 4.7, and 0.2 M sodium chloride",277,"10.1016/j.bmcl.2017.10.047","8EN","6B8U",64.73,"2.68","2.68","Crystals Structure of B-Raf kinase domain in complex with an Imidazopyridinyl benzamide inhibitor","GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6B8U"
"6B8X",,"X-RAY DIFFRACTION",3.54,65.27,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 16% PEG 8000, 2% ethanol, 10% glycerol",277,"10.7554/eLife.36307",,"6B8X",37.71,"1.74","1.74","Multiconformer model of apo WT PTP1B with glycerol at 278 K","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6B8X"
"6B8Y",,"X-RAY DIFFRACTION",1.97,37.58,"VAPOR DIFFUSION, HANGING DROP",5.6,"23%(w/v) PEG3350, 3%(v/v) glcyerol",277,"10.1016/j.bmc.2018.01.014","D0A","6B8Y",35.54,"1.65","1.65","TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-(3-fluoropyridin-4-yl)-2-[6-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine","GHMTIARDIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","6B8Y"
"6B8Z",,"X-RAY DIFFRACTION",3.63,66.16,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307","FRJ","6B8Z",38.09,"1.8","1.8","Multiconformer model of WT PTP1B with BB3 at 273 K","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6B8Z"
"6B90",,"X-RAY DIFFRACTION",3.36,63.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"well solution: PEG 8000, magnesium acetate, Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.7554/eLife.36307",,"6B90",37.95,"1.95","1.95","Multiconformer model of apo WT PTP1B with glycerol at 100 K (ALTERNATIVE REFINEMENT OF PDB 1SUG showing conformational heterogeneity)","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6B90"
"6B91",,"X-RAY DIFFRACTION",4.66,73.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.3 M K2HPO4, 45 mM NaH2PO4; drop contained 4 uL of protein solution (27 mg/mL) and 2 uL of reservoir solution, 25% ethylene glycol was used for cryo-protection",293,"10.1038/s41598-018-23608-8",,"6B91",33.83,"1.94","1.94","Crystal structure of the N-terminal domain of human METTL16","SNAMALSKSMHARNRYKDKPPDFAYLASKYPDFKQHVQINLNGRVSLNFKDPEAVRALTCTLLREDFGLSIDIPLERLIPTVPLRLNYIHWVEDLIGHQDSDKSTLRRGIDIGTGASCIYPLLGATLNGWYFLATEVDDMCFNYAKKNVEQNNLSDLIKVVKVPQKTLLMDALKEESEIIYDFCMCNPPFFANQLEAKGVNSRNPRRPPPSSVNTGGITEIMAEGGELEFVKRIIHDSLQLKKRLRWYSCMLGKKCSLAPLKEELRIQGVPKVTYTEFCQGRTMRWALAWSFYD","Homo sapiens","METTL16, METT10D","U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase","1","6B91"
"6B92",,"X-RAY DIFFRACTION",4.77,74.23,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.3 M K2HPO4, 45 mM NaH2PO4; drop contained 4 uL of protein solution (27 mg/mL) and 2 uL of reservoir solution; 0.2 uL of 200 mM SAM solution (buffered in 50 mM Hepes pH7.5) was added to the drop with mature crystals. 25% ethylene glycol was used for cryo-protection",293,"10.1038/s41598-018-23608-8",,"6B92",34.25,"2.1","2.1","Crystal Structure of the N-terminal domain of human METTL16 in complex with SAH","SNAMALSKSMHARNRYKDKPPDFAYLASKYPDFKQHVQINLNGRVSLNFKDPEAVRALTCTLLREDFGLSIDIPLERLIPTVPLRLNYIHWVEDLIGHQDSDKSTLRRGIDIGTGASCIYPLLGATLNGWYFLATEVDDMCFNYAKKNVEQNNLSDLIKVVKVPQKTLLMDALKEESEIIYDFCMCNPPFFANQLEAKGVNSRNPRRPPPSSVNTGGITEIMAEGGELEFVKRIIHDSLQLKKRLRWYSCMLGKKCSLAPLKEELRIQGVPKVTYTEFCQGRTMRWALAWSFYD","Homo sapiens","METTL16, METT10D","U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase","1","6B92"
"6B94",,"X-RAY DIFFRACTION",2.41,48.9,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium sulfate, 25% w/v PEG4000, 0.1 M sodium acetate trihydrate, pH 6.2",293,"10.1111/cbdd.13348",,"6B94",30.8,"1.8","1.8","Crystal structure of Human galectin-1 in complex with Lactulose","ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","6B94"
"6B95",,"X-RAY DIFFRACTION",3.13,60.71,"VAPOR DIFFUSION",7.5,"well solution: 0.2 M magnesium acetate tetrahydrate, 20% PEG 3350",277,"10.7554/eLife.36307",,"6B95",37.74,"1.95","1.95","Multiconformer model of K197C PTP1B tethered to compound 2 at 100 K","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFCVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6B95"
"6B96",,"X-RAY DIFFRACTION",2.05,39.95,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH7.5, 12% PEG8000",293,"10.1016/j.bmcl.2017.10.054","CZV","6B96",88.4,"1.88","1.88","Crystal Structure of PDE2 in complex with compound 16","MHHHHHHENLYFQGELSTSLYKKAGFDDDDKSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6B96"
"6B97",,"X-RAY DIFFRACTION",2.03,39.32,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Hepes pH7.5, 12% PEG8000",293,"10.1016/j.bmcl.2017.10.054","CZY","6B97",88.4,"1.76","1.76","Crystal structure of PDE2 in complex with complex 9","MHHHHHHENLYFQGELSTSLYKKAGFDDDDKSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6B97"
"6B98",,"X-RAY DIFFRACTION",1.99,38.19,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG8000, 0.1M Hepes pH7.5,  1mM TCEP",293,"10.1016/j.bmcl.2017.10.054","D07","6B98",87.96,"1.97","1.97","PDE2 in complex with compound 1","MHHHHHHENLYFQGELSTSLYKKAGFDDDDKSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6B98"
"6B99",,"X-RAY DIFFRACTION",2.49,50.52,"VAPOR DIFFUSION, HANGING DROP",6.4,"Bis Tris Propane pH 6.4, MgCl2, PEG 2000 MME. Soak with NECA",277,,,"6B99",29.08,"1.60237722156","1.60237722156","Hsp90-alpha N-domain bound to NECA","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6B99"
"6B9A",,"X-RAY DIFFRACTION",2.48,50.5,"VAPOR DIFFUSION, HANGING DROP",6.4,"Bis-Tris Propane pH 6.4, MgCl2, PEG 2000 MME. Soak crystals with NPCA",277,,,"6B9A",57.87,"1.65381","1.65381","Hsp90-alpha N-domain bound to NPCA","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6B9A"
"6B9D",,"X-RAY DIFFRACTION",2.27,45.83,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium malonate pH 6, 20% PEG3350, 1 mM GDP, 2 mM MgCl2",293.15,"10.1074/jbc.RA117.000380",,"6B9D",106.49,"1.95","1.95","Human ATL1 mutant - R77A bound to GDP","SMAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFAKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARAAALEHHHHHH","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","6B9D"
"6B9E",,"X-RAY DIFFRACTION",2.31,46.87,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 5.5, 0.2 M ammonium sulfate, 22% PEG3350, 1 mM GDP, 2 mM MgCl2",293.15,"10.1074/jbc.RA117.000380",,"6B9E",105.92,"1.99","1.99","Human ATL1 mutant - R77A / F151S bound to GDP","SMAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFAKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTSDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARAAALEHHHHHH","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","6B9E"
"6B9F",,"X-RAY DIFFRACTION",2.52,51.23,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M ammonium citrate tribasic pH 7, 0.1 M imidazole pH7, 20% PEG monomethyl ether 2,000, 1 mM GDP, 2 mM MgCl2, 2 mM AlCl2, 20 mM NaF",293.15,"10.1074/jbc.RA117.000380",,"6B9F",106.76,"1.9","1.9","Human ATL1 mutant - F151S bound to GDPAlF4-","MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTSDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAARAAALEHHHHHH","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","6B9F"
"6B9G",,"X-RAY DIFFRACTION",3.9,68.44,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M DL-malic acid pH 7, 20% PEG3350, 1 mM GDP, 2 mM MgCl2",293.15,"10.1074/jbc.RA117.000380",,"6B9G",158.08,"3","3","human ATL1 GTPase domain bound to GDP","SMAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGE","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","6B9G"
"6BA2",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION, HANGING DROP",7,"2 M NaCl, 0.1 M Tris pH 7.0, 0.22 M MgCl2",293,"10.1038/s41586-018-0387-5",,"6BA2",35.4,"1.85003821102","1.85003821102","Crystal structure of MYST acetyltransferase domain in complex with inhibitor","MGSSHHHHHHSSGLVPRGSTKVKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPPK","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6BA2"
"6BA4",,"X-RAY DIFFRACTION",2.34,47.45,"VAPOR DIFFUSION, HANGING DROP",7,"2 M NaCl, 0.1 M Tris pH 7.0, 0.22 M MgCl2",292,"10.1038/s41586-018-0387-5",,"6BA4",36.19,"1.949","1.949","Crystal structure of MYST acetyltransferase domain in complex with Acetyl-CoA cofactor","MGSSHHHHHHSSGLVPRGSTKVKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSSVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPPK","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6BA4"
"6BAD",,"X-RAY DIFFRACTION",2.11,41.81,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, sodium malonate",291,,,"6BAD",153.31,"2.1","2.1","Lactate Dehydrogenase in complex with inhibitor (R)-3-((2-chlorophenyl)thio)-6-(3-((4-fluorophenyl)amino)phenyl)-4-hydroxy-6-(thiophen-3-yl)-5,6-dihydro-2H-pyran-2-one","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6BAD"
"6BAG",,"X-RAY DIFFRACTION",2.22,44.47,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium malonate",291,,,"6BAG",152.26,"2.4","2.4","Lactate Dehydrogenase in complex with inhibitor (R)-5-((2-chlorophenyl)thio)-6'-((4-fluorophenyl)amino)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro-[2,2'-bipyridin]-6(1H)-one","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6BAG"
"6BAI",,"X-RAY DIFFRACTION",3.07,59.88,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 10-26% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"6BAI",37.44,"1.95","1.95","Multiconformer model of apo K197C PTP1B at 100 K","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFCVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6BAI"
"6BAX",,"X-RAY DIFFRACTION",2.24,45.04,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium malonate",291,,,"6BAX",151.69,"2.05","2.05","Lactate Dehydrogenase in complex with inhibitor 6-(3-aminophenyl)-3-((2-chlorophenyl)thio)-4-hydroxy-6-(thiophen-3-yl)-5,6-dihydro-2H-pyran-2-one","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6BAX"
"6BAZ",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium malonate",291,,,"6BAZ",151.11,"2.7","2.7","Lactate Dehydrogenase in complex with inhibitor (S)-5-((2-chlorophenyl)thio)-6'-((4-fluorophenyl)amino)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro-[2,2'-bipyridin]-6(1H)-one","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6BAZ"
"6BB0",,"X-RAY DIFFRACTION",2.21,44.25,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium malonate",291,,,"6BB0",151.53,"1.95","1.95","Lactate Dehydrogenase in complex with inhibitor (R)-3-((2-chlorophenyl)thio)-6-(3-((4-fluorophenyl)amino)phenyl)-4-hydroxy-6-(thiophen-3-yl)-5,6-dihydro-2H-pyran-2-one","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6BB0"
"6BB1",,"X-RAY DIFFRACTION",2.2,44.21,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium malonate",291,,,"6BB1",302.14,"2.3","2.3","Lactate Dehydrogenase in complex with inhibitor (R)-5-((2-chlorophenyl)thio)-6'-(4-fluorophenoxy)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro-[2,2'-bipyridin]-6(1H)-one","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6BB1"
"6BB2",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium malonate",291,,,"6BB2",300.74,"2.47","2.47","Lactate Dehydrogenase in complex with inhibitor (S)-5-((2-chlorophenyl)thio)-6'-(4-fluorophenoxy)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro-[2,2'-bipyridin]-6(1H)-one","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6BB2"
"6BB3",,"X-RAY DIFFRACTION",2.11,41.68,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium malonate",291,,,"6BB3",151.84,"2.4","2.4","Lactate Dehydrogenase in complex with inhibitor 3-((2-chlorophenyl)thio)-6-(6-((4-fluorophenyl)amino)pyridin-2-yl)-4-hydroxy-6-(thiophen-3-yl)-5,6-dihydro-2H-pyran-2-one","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","6BB3"
"6BBS",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION, SITTING DROP",8,"1.6 M sodium citrate, 50 mM TRIS pH 8.0",290,"10.1016/j.str.2018.01.006","BZ1","6BBS",29.74,"2","2","Joint X-ray/neutron structure of human carbonic anhydrase II in complex with brinzolamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6BBS"
"6BBU",,"X-RAY DIFFRACTION",2.05,40.15,"VAPOR DIFFUSION, HANGING DROP",,"250mM NaCl, 5mM TCEP, 10 mM ATP, 10 mM MgCl2, 30% PEG1500, 8% MPD, 0.1M Tris pH 9.0",281,"10.1021/acs.jmedchem.7b01598","D7D","6BBU",36.74,"2.08","2.08","Crystal Structure of JAK1 in complex with compound 25","GSIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6BBU"
"6BBV",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, HANGING DROP",,"28% PEG-3350, 0.1 M sodium acetate, 0.1M Hepes, pH 7.5",293,"10.1021/acs.jmedchem.7b01598","D7D","6BBV",35.2,"1.8","1.8","Crystal Structure of JAK2 in complex with compound 25","GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6BBV"
"6BC9",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M sodium citrate, 50 mM TRIS pH 8.0",293,"10.1016/j.str.2018.01.006","ETS","6BC9",29.68,"1.8",1.8,"Joint X-ray/neutron structure of human carbonic anhydrase II in complex with dorzolamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6BC9"

"6BCC",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.15,42.77,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M sodium citrate, 50 mM TRIS pH 8.0",293,"10.1016/j.str.2018.01.006","EZL","6BCC",29.61,"1.8","1.8","Joint X-ray/neutron structure of human carbonic anhydrase II in complex with ethoxzolamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6BCC"
"6BCS",,"X-RAY DIFFRACTION",1.87,34.07,"VAPOR DIFFUSION, HANGING DROP",5.53,"1.03 M Ammonium sulfate, 0.1 M Bis-Tris pH 5.53, 2.76% PEG 3350, 1.4% w/v benzamidine",298,"10.1038/s41557-018-0147-z",,"6BCS",22.77,"2.1","2.1","LilrB2 D1D2 domains complexed with benzamidine","MGTIPKPTLWAEPDSVITQGSPVTLSCQGSLEAQEYRLYREKKSASWITRIRPELVKNGQFHIPSITWEHTGRYGCQYYSRARWSELSDPLVLVMTGAYPKPTLSAQPSPVVTSGGRVTLQCESQVAFGGFILCKEGEDEHPQCLNSQPHARGSSRAIFSVGPVSPNRRWSHRCYGYDLNSPYVWSSPSDLLELLVPG","Homo sapiens","LILRB2, ILT4, LIR2, MIR10","Leukocyte immunoglobulin-like receptor subfamily B member 2","1","6BCS"
"6BCZ",,"X-RAY DIFFRACTION",2.25,45.27,"MICROBATCH",7,"PEG3350, malonate",283,"10.1021/acs.molpharmaceut.7b00957",,"6BCZ",56.77,"2.23","2.23","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BCZ"
"6BD5",,"X-RAY DIFFRACTION",2.29,46.21,"MICROBATCH",6.5,"PEG 3350, malonate",283,"10.1021/acs.molpharmaceut.7b00957",,"6BD5",56.8,"2.5","2.5","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BD5"
"6BD6",,"X-RAY DIFFRACTION",2.23,44.95,"MICROBATCH",7,"PEG 3350, malonate",293,"10.1021/acs.molpharmaceut.7b00957",,"6BD6",56.8,"2.5","2.5","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BD6"
"6BD7",,"X-RAY DIFFRACTION",2.3,46.48,"MICROBATCH",6.7,"PEG 3350, malonate",293,,,"6BD7",56.86,"2.42","2.42","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BD7"
"6BD8",,"X-RAY DIFFRACTION",2.13,42.14,"MICROBATCH",6.5,"PEG3350, malonate",293,,,"6BD8",56.89,"2.38","2.38","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BD8"
"6BDH",,"X-RAY DIFFRACTION",2.15,42.88,"MICROBATCH",7,"PEG 3350, malonate",293,,,"6BDH",56.89,"2.25","2.25","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BDH"
"6BDI",,"X-RAY DIFFRACTION",2.28,45.98,"MICROBATCH",6.8,"PEG 3350, malonate",293,,,"6BDI",56.9,"2.57","2.57","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BDI"
"6BDK",,"X-RAY DIFFRACTION",2.27,45.87,"MICROBATCH",6.5,"PEG 3350, malonate",293,"10.1021/acs.molpharmaceut.7b00957",,"6BDK",56.93,"2.67","2.67","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BDK"
"6BDL",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M PCTP, pH6.0, 25% w/v PEG1500",295,,,"6BDL",79.09,"1.96","1.96","Crystal structure of cGMP-dependent protein kinase Ialpha (PKG Ialpha) catalytic domain in apo state","GSGLDDVSNKAYEDAEAKAKYEAEAAFFANLKLSDFNIIDTLGVGGFGRVELVQLKSEESKTFAMKILKKRHIVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKIGFGKKTWTFCGTPEYVAPEIILNKGHDISADYWSLGILMYELLTGSPPFSGPDPMKTYNIILRGIDMIEFPKKIAKNAANLIKKLCRDNPSERLGNLKNGVKDIQKHKWFEGFNWEGLRKGTLTPPIIPSVASPTDTSNFDSFPEDNDEPPPDDNSGWDIDF","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent protein kinase 1","1","6BDL"
"6BDM",,"X-RAY DIFFRACTION",2.24,45.04,"MICROBATCH",6.7,"PEG 3350, malonate",293,,,"6BDM",56.93,"2.6","2.6","Crystal structure of human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6BDM"
"6BDN",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, HANGING DROP",,"Drops: 1.8 uL protein + 1.0 uL well solution, protein solution: 6.5 mg/mL TAO3K in 0.7 mM ADP, 5 mM magnesium chloride, 100 mM sodium chloride, 25 mM Tris, pH 8.0, 2 mM BME, 0.3 mM EDTA, well solution: 20% PEG3350, 0.2 M ammonium sulfate, 0.1 M Bis-Tris, pH 6.5, cryoprotectant: 20% PEG1500",279.15,,,"6BDN",37.04,"1.5","1.5","Crystal structure of human TAO3 kinase binding ADP","PLGSMAAGVLKDPEIADLFYKDDPEELFIGLHEIGHGSFGAVYFATNAHTSEVVAIKKMSYSGKQTHEKWQDILKEVKFLRQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALHGLAYLHSHALIHRDIKAGNILLTEPGQVKLADFGSASMASPANSFVGTPYWMAPEVILAMDEGQYDGKVDIWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRRFVDYCLQKIPQERPTSAELLRHDFVRRDRPLRVLIDLIQRTKDAVRELDNLQYRKMKKILFQET","Homo sapiens","TAOK3, DPK, JIK, KDS, MAP3K18","Serine/threonine-protein kinase TAO3","1","6BDN"
"6BDT",,"X-RAY DIFFRACTION",2,38.37,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, MES, calcium chloride",295.15,"10.1074/jbc.RA117.001097",,"6BDT",178.22,"2.3","2.3","Crystal Structure of Human Calpain-3 Protease Core Mutant-C129S","IISRNFPIIGVKEKTFEQLHKKCLEKKVLYVDPEFPPDETSLFYSQKFPIQFVWKRPPEICENPRFIIDGANRTDICQGELGDSWFLAAIACLTLNQHLLFRVIPHDQSFIENYAGIFHFQFWRYGEWVDVVIDDCLPTYNNQLVFTKSNHRNEFWSALLEKAYAKLHGSYEALKGGNTTEAMEDFTGGVAEFFEIRDAPSDMYKIMKKAIERGSLMGCSIDDGTNMTYGTSPSGLNMGELIARMVRNMDNSLLQDSDLDPRGSDERPTRTIIPVQYETRMACGLVRGHAYSVTGLDEVPFKGEKVKLVRLRNPWGQVEWNGSWSDRWKDWSFVDKDEKARLQHQVTEDGEFWMSYEDFIYHFTKLEICNLTADLEHHHHHH","Homo sapiens","CAPN3, CANP3, CANPL3, NCL1","Calpain-3","1","6BDT"
"6BE2",,"X-RAY DIFFRACTION",2.55,51.73,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 4000, 20% iso-propanol, 0.1 M sodium citrate pH5.6",291,"10.1074/jbc.RA117.001170",,"6BE2",47.3,"1.7","1.7","Crystal structure of a polysaccharide-binding human Fab (F598)","QLVLTQSPSASASLGASVKLTCTLSSGHSNYAIAWHQQQPGKGPRYLMKVNRDGSHIRGDGIPDRFSGSTSGAERYLTISSLQSEDEADYYCQTWGAGIRVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab (F598) Light Chain","2","6BE2"
,,,,,,,,,,,,,,,,"QVQLQESGPGLVKPSETLSLTCTVSGGSISGYYWSWIRQPPGKGLEWIGYIHYSRSTNSNPALKSRVTISSDTSKNQLSLRLSSVTAADTAVYYCARDTYYYDSGDYEDAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKAEPKSC","Homo sapiens",,"Fab (F598) Heavy Chain","1","6BE2"
"6BE3",,"X-RAY DIFFRACTION",2.58,52.27,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 4000, 20% iso-propanol, 0.1 M sodium citrate pH 5.6",291,"10.1074/jbc.RA117.001170",,"6BE3",47.52,"1.6","1.6","Crystal structure of a polysaccharide-binding human Fab (F598) in complex with N-acetyl-D-glucosamine (GlcNAc)","QLVLTQSPSASASLGASVKLTCTLSSGHSNYAIAWHQQQPGKGPRYLMKVNRDGSHIRGDGIPDRFSGSTSGAERYLTISSLQSEDEADYYCQTWGAGIRVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab (F598) Light Chain","2","6BE3"
,,,,,,,,,,,,,,,,"QVQLQESGPGLVKPSETLSLTCTVSGGSISGYYWSWIRQPPGKGLEWIGYIHYSRSTNSNPALKSRVTISSDTSKNQLSLRLSSVTAADTAVYYCARDTYYYDSGDYEDAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKAEPKSC","Homo sapiens",,"Fab (F598) Heavy Chain","1","6BE3"
"6BE4",,"X-RAY DIFFRACTION",2.68,54.16,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 4000, 20% iso-propanol, 0.1 M sodium citrate pH 5.6",291,"10.1074/jbc.RA117.001170",,"6BE4",48.33,"1.9","1.9","Crystal structure of a polysaccharide-binding human Fab (F598) in complex with nona-N-acetyl-D-glucosamine (9NAc)","QLVLTQSPSASASLGASVKLTCTLSSGHSNYAIAWHQQQPGKGPRYLMKVNRDGSHIRGDGIPDRFSGSTSGAERYLTISSLQSEDEADYYCQTWGAGIRVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab(F598) Light Chain","2","6BE4"
,,,,,,,,,,,,,,,,"QVQLQESGPGLVKPSETLSLTCTVSGGSISGYYWSWIRQPPGKGLEWIGYIHYSRSTNSNPALKSRVTISSDTSKNQLSLRLSSVTAADTAVYYCARDTYYYDSGDYEDAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKAEPKSC","Homo sapiens",,"Fab (F598) Heavy Chain","1","6BE4"
"6BE6",,"X-RAY DIFFRACTION",2.65,53.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.26M Ammonium Sulfate
100mM HEPES pH 7.5
21.75 % PEG8000",295,"10.1016/j.cell.2017.11.014",,"6BE6",203.8,"2.8","2.8","ADAM10 Extracellular Domain","TTSAEKNTCQLYIQTDHLFFKYYGTREAVIAQISSHVKAIDTIYQTTDFSGIRQISFMVKRIRINTTADEKDPTNPFRFPNIGVEKFLELNSEQNHDDYCLAYVFTDRDFDDGVLGLAWVGAPSGSSGGICEKSKLYSDGKKKSLNTGIITVQNYGSHVPPKVSHITFAHEVGHNFGSPHDSGTECTPGESKNLGQKENGNYIMYARATSGDKLNNNKFSLCSIRQISQVLEKKRNNCFVESGQPICGNGMVEQGEECDCGYSDQCKDECCFDANQPEGRKCKLKPGKQCSPSQGPCCTAQCAFKSKSEKCRDDSDCAREGICNGFTALCPASDPKPQFTDCNRHTQVCINGQCAGSICEKYGLEECTCASSDGKDDKELCHVCCMKKMDPSTCASTGSVQWSRHFSGRTITLQPGSPCNDFRGYCDVFMRCRLVDADGPLGGHHHHHH","Homo sapiens","ADAM10, KUZ, MADM","Disintegrin and metalloproteinase domain-containing protein 10","1","6BE6"
"6BE7",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BE7",0.96,,,"Solution structure of de novo macrocycle Design8.1","DDPTPRQQ","Homo sapiens",,"DDPT(DPR)(DAR)Q(DGN)","1","6BE7"
"6BE9",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BE9",0.79,,,"Solution structure of de novo macrocycle design7.1","TKNDTNP","Homo sapiens",,"T(DLY)NDT(DSG)(DPR)","1","6BE9"
"6BEN",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BEN",1.04,,,"Solution structure of de novo macrocycle design8.2","RQPQREPQ","Homo sapiens",,"(DAR)Q(DPR)(DGN)R(DGL)PQ","1","6BEN"
"6BEO",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BEO",1.1,,,"Solution structure of de novo macrocycle design9.1","PPYHPKDLQ","Homo sapiens",,"(DPR)PY(DHI)PKDL(DGN)","1","6BEO"
"6BEQ",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BEQ",1.11,,,"Solution structure of de novo macrocycle design10.1","AARVPRLTPE","Homo sapiens",,"AAR(DVA)(DPR)R(DLE)(DTH)PE","1","6BEQ"
"6BER",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BER",1.11,,,"Solution structure of de novo macrocycle design10.2","EVDPEHPNAP","Homo sapiens",,"E(DVA)DP(DGL)(DHI)(DPR)N(DAL)(DPR)","1","6BER"
"6BES",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BES",1.2,,,"Solution structure of de novo macrocycle design11_ss","AQPCKDSYCPS","Homo sapiens",,"(DAL)Q(DPR)(DCY)(DLY)DS(DTY)(DCY)P(DSN)","1","6BES"
"6BET",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BET",1.35,,,"Solution structure of de novo macrocycle design12_ss","HPVCIPPEKVCE","Homo sapiens",,"H(DPR)(DVA)CIP(DPR)E(DLY)VC(DGL)","1","6BET"
"6BEU",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BEU",1.61,,,"Solution structure of de novo macrocycle design14_ss","CNVPDVYCPNKYVP","Homo sapiens",,"(DCY)N(DVA)(DPR)DVYC(DPR)(DSG)KY(DVA)(DPR)","1","6BEU"
"6BEV",,"X-RAY DIFFRACTION",1.94,36.6,"VAPOR DIFFUSION, SITTING DROP",,"0.09 M sodium cacodylate, pH 6.5, 0.1 M sodium citrate",293.15,"10.1074/jbc.RA117.000826",,"6BEV",29.43,"1.043","1.043","Human Single Domain Sulfurtranferase TSTD1","MGSSHHHHHHSSGLVPRGSHMAGAPTVSLPELRSLLASGRARLFDVRSREEAAAGTIPGALNIPVSELESALQMEPAAFQALYSAEKPKLEDEHLVFFCQMGKRGLQATQLARSLGYTGARNYAGAYREWLEKES","Homo sapiens","TSTD1, KAT","Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1","1","6BEV"
"6BEW",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BEW",0.81,,,"Solution structure of de novo macrocycle design7.2","HPDQSEP","Homo sapiens",,"(DHI)P(DAS)(DGN)(DSN)(DGL)P","1","6BEW"
"6BF2",,"SOLUTION NMR",,,,,,,"10.1038/s41589-018-0011-x",,"6BF2",23.71,,,"Solution structure of a Bcl-xL S62E mutant","GHSMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADEPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6BF2"
"6BF3",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BF3",0.8,,,"Solution structure of de novo macrocycle design7.3a","QDPPKTD","Homo sapiens",,"QDP(DPR)K(2TL)(DAS)","1","6BF3"
"6BF5",,"SOLUTION NMR",,,,,,,"10.1126/science.aap7577",,"6BF5",0.8,,,"Solution structure of de novo macrocycle design7.3a","QDPPKTD","Homo sapiens",,"QDP(DPR)K(DTH)(DAS)","1","6BF5"
"6BF6","6.5","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.33572",,"6BF6",223.73,"6.5",,"Cryo-EM structure of human insulin degrading enzyme","AIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSCPVVGEFPCQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPH","Homo sapiens","IDE","Insulin-degrading enzyme","1","6BF6"
"6BF8","4.2","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.33572",,"6BF8",223.73,"4.2",,"Cryo-EM structure of human insulin degrading enzyme in complex with insulin","AIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSCPVVGEFPCQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPH","Homo sapiens","IDE","Insulin-degrading enzyme","1","6BF8"
"6BFD",,"X-RAY DIFFRACTION",2.59,52.57,"VAPOR DIFFUSION, HANGING DROP",,"16% PEG8000, 0.2 M ammonium sulfate, 0.1 M sodium cacodylate, pH 7.4",276,"10.1021/acs.jmedchem.7b01304","DJS","6BFD",99.26,"1.62","1.62","BACE crystal structure with hydroxy pyrrolidine inhibitor","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6BFD"
"6BFE",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, HANGING DROP",,"17% PEG 8000, 0.2M ammonium sulfate, 0.1% cacodylate, pH 7.4",276,"10.1021/acs.jmedchem.7b01304","DJV","6BFE",99.22,"1.51","1.51","BACE crystal structure with hydroxy pyrrolidine inhibitor","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6BFE"
"6BFN",,"X-RAY DIFFRACTION",2.27,45.84,"EVAPORATION",,"20% PEG3350, 0.2 M calcium chloride, 0.1 M HEPES, pH 7.0",289,"10.1073/pnas.1714386114","DL1","6BFN",76.31,"2.26","2.26","Crystal structure of human IRAK1","GAMGSRPFPFCWPLCEISRGTHNFSEELKIGEGGFGCVYRAVMRNTVYAVKRLKENADLEWTAVKQSFLTEVEQLSRFRHPNIVDFAGYCAQNGFYCLVYGFLPNGSLEDRLHCQTQACPPLSWPQRLDILLGTARAIQFLHQDSPSLIHGDIKSSNVLLDERLTPKLGDFGLARFSRFAGSSPSQSSMVARTQTVRGTLAYLPEEYIKTGRLAVDTDTFSFGVVVLETLAGQRAVKTHGARTKYLKDLVEEEAEEAGVALRSTQSTLQAGLAADAWAAPIAMQIYKKHLDPRPGPCPPELGLGLGQLACCCLHRRAKRRPPMTQVYERLEKLQAVVAGVPG","Homo sapiens","IRAK1, IRAK","Interleukin-1 receptor-associated kinase 1","1","6BFN"
"6BFW",,"X-RAY DIFFRACTION",2.56,52.05,"VAPOR DIFFUSION, HANGING DROP",,"17% PEG 8000, 0.2M ammonium sulfate, 0.1M sodium cacodylate, pH 7.4",277,"10.1021/acs.jmedchem.7b01304","DK7","6BFW",99.07,"1.84","1.84","BACE crystal structure with hydroxy morpholine inhibitor","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6BFW"
"6BFX",,"X-RAY DIFFRACTION",2.65,53.5,"VAPOR DIFFUSION, HANGING DROP",,"17% PEG 8000, 0.2M ammonium sulfate, 0.1M sodium cacodylate",277,"10.1021/acs.jmedchem.7b01304","DKJ","6BFX",98.95,"1.99","1.99","BACE crystal structure with hydroxy pyrrolidine inhibitor","MAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6BFX"
"6BG2",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION, HANGING DROP",8,"23.2% PEG1500, 0.08 M PCTP, pH8.0, 0.5% w/v polyvinylpyrrolidone K15",295,,,"6BG2",160.36,"1.83","1.83","Crystal structure of cGMP-dependent protein kinase Ialpha (PKG Ialpha) catalytic domain in AMP-PNP bound state","GSGLDDVSNKAYEDAEAKAKYEAEAAFFANLKLSDFNIIDTLGVGGFGRVELVQLKSEESKTFAMKILKKRHIVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKIGFGKKTWTFCGTPEYVAPEIILNKGHDISADYWSLGILMYELLTGSPPFSGPDPMKTYNIILRGIDMIEFPKKIAKNAANLIKKLCRDNPSERLGNLKNGVKDIQKHKWFEGFNWEGLRKGTLTPPIIPSVASPTDTSNFDSFPEDNDEPPPDDNSGWDIDF","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent protein kinase 1","1","6BG2"
"6BG6",,"X-RAY DIFFRACTION",2.73,54.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M Ammonium Sulphate, 3% 2-propanol, 100 mM Tris.HCl, pH 7.5",293,"10.1002/anie.201803191",,"6BG6",37.94,"1.52","1.52","Crystal structure of S111A mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNATFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6BG6"
"6BG7",,"X-RAY DIFFRACTION",3.71,66.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,"10.1002/anie.201803191",,"6BG7",37.86,"2.54","2.54","Crystal structure of G107A mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVAWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6BG7"
"6BG9","9","ELECTRON MICROSCOPY, SOLUTION NMR",,,,,,,"10.1016/j.str.2018.01.001",,"6BG9",30.72,"9",,"HYBRID NMR/CRYO-EM STRUCTURE OF THE HIV-1 RNA DIMERIZATION SIGNAL","GGCAGGACUCGGCUUGCUGAAGCGCGCACGGCAAGAGGCGAGGGGCC","Homo sapiens",,"RNA dimerization signal","1","6BG9"
"6BGF",,"X-RAY DIFFRACTION",3.71,66.85,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6BGF",23.87,"2.251","2.251","Crystal structure of cysteine-bound ferrous form of the crosslinked human cysteine dioxygenase","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLYSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BGF"
"6BGM",,"X-RAY DIFFRACTION",3.74,67.12,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6BGM",23.47,"2.206","2.206","Crystal structure of ferrous form of the crosslinked human cysteine dioxygenase","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLYSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BGM"
"6BGP",,"X-RAY DIFFRACTION",2.03,39.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, MES, calcium chloride",295.15,"10.1074/jbc.RA117.001097",,"6BGP",178.16,"2.75","2.75","Crystal Structure of Human Calpain-3 Protease Core Mutant-C129A","IISRNFPIIGVKEKTFEQLHKKCLEKKVLYVDPEFPPDETSLFYSQKFPIQFVWKRPPEICENPRFIIDGANRTDICQGELGDAWFLAAIACLTLNQHLLFRVIPHDQSFIENYAGIFHFQFWRYGEWVDVVIDDCLPTYNNQLVFTKSNHRNEFWSALLEKAYAKLHGSYEALKGGNTTEAMEDFTGGVAEFFEIRDAPSDMYKIMKKAIERGSLMGCSIDDGTNMTYGTSPSGLNMGELIARMVRNMDNSLLQDSDLDPRGSDERPTRTIIPVQYETRMACGLVRGHAYSVTGLDEVPFKGEKVKLVRLRNPWGQVEWNGSWSDRWKDWSFVDKDEKARLQHQVTEDGEFWMSYEDFIYHFTKLEICNLTADLEHHHHHH","Homo sapiens","CAPN3, CANP3, CANPL3, NCL1","Calpain-3","1","6BGP"
"6BGU",,"X-RAY DIFFRACTION",2.22,44.63,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DKP","6BGU",38.95,"1.684","1.684","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(propoxy)methyl)-1H-pyrrolo[3,2-b]pyridine (Compound N9)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A, linked KDM5A JMJ domain","1","6BGU"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BGV",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DQG","6BGV",39.19,"1.592","1.592","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)-1l2-pyrrolo[3,2-b]pyridine-7-carboxylic acid (Compound N40)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A, linked KDM5A JMJ domain","1","6BGV"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BGW",,"X-RAY DIFFRACTION",2.22,44.56,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DKS","6BGW",38.99,"1.644","1.644","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(4,4-difluoropiperidin-1-yl)ethoxy)methyl)-1H-pyrrolo[3,2-b]pyridine-7-carboxylic acid(Compound N41)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A, linked KDM5A JMJ domain","1","6BGW"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BGX",,"X-RAY DIFFRACTION",2.19,43.74,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DKV","6BGX",38.74,"1.882","1.882","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)((4,4-difluorocyclohexyl)methoxy)methyl)-1H-pyrrolo[3,2-b]pyridine-7-carboxylic acid(Compound N42)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A, linked KDM5A JMJ domain","1","6BGX"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BGY",,"X-RAY DIFFRACTION",2.22,44.71,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DLJ","6BGY",38.91,"1.22","1.22","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2-yl)ethoxy)methyl)-1H-pyrrolo[3,2-b]pyridine-7-carboxylic acid(Compound 46)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A,linked KDM5A JMJ domain","1","6BGY"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BGZ",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DNV","6BGZ",38.59,"1.688","1.688","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(2-(1-methyl-1H-imidazol-2-yl)ethoxy)methyl)-1H-pyrrolo[3,2-b]pyridine-7-carboxylic acid (Compound N47)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A, linked KDM5A JMJ domain","1","6BGZ"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BH0",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DO1","6BH0",38.49,"1.985","1.985","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (R)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)-1l2-pyrrolo[3,2-b]pyridine-7-carboxylic acid (Compound N51)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A,  linked KDM5A JMJ domain","1","6BH0"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BH1",,"X-RAY DIFFRACTION",2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DQG","6BH1",38.62,"1.932","1.932","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (S)-2-((2-chlorophenyl)(2-(piperidin-1-yl)ethoxy)methyl)-1l2-pyrrolo[3,2-b]pyridine-7-carboxylic acid (Compound N52)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A,  linked KDM5A JMJ domain","1","6BH1"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BH2",,"X-RAY DIFFRACTION",2.26,45.58,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","90V","6BH2",38.78,"1.447","1.447","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (R)-N-(1-(3-isopropyl-1H-pyrazole-5-carbonyl)pyrrolidin-3-yl)cyclopropanecarboxamide (Compound N54)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A,  linked KDM5A JMJ domain","1","6BH2"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BH3",,"X-RAY DIFFRACTION",2.24,45.17,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DQJ","6BH3",38.86,"1.701","1.701","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (S)-N-(1-(3-isopropyl-1H-pyrazole-5-carbonyl)pyrrolidin-3-yl)cyclopropanecarboxamide (Compound N55)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A, linked KDM5A JMJ domain","1","6BH3"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BH4",,"X-RAY DIFFRACTION",2.25,45.39,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DQS","6BH4",38.85,"2.047","2.047","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 5-(1-(tert-butyl)-1H-pyrazol-4-yl)-6-isopropyl-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile (Compound N75/CPI-48)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A,  linked KDM5A JMJ domain","1","6BH4"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BH5",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2), 0-20% glycerol, 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b00261","DNY","6BH5",38.83,"1.651","1.651","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-chlorophenyl)(3-(piperidin-1-yl)propoxy)methyl)-1H-pyrrolo[3,2-b]pyridine-7-carboxylic acid (Compound N48)","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A, linked KDM5A JMJ domain","1","6BH5"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6BH8",,"X-RAY DIFFRACTION",4.64,73.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"Glycerol, Ammonium Sulfate, PEG 3350, Hepes/NaOH pH 7.5",277,"10.1107/S2059798318003431",,"6BH8",113.26,"3.85","3.85","Crystal structure of ZMPSTE24 in complex with phosphoramidon","MGMWASLDALWEMPAEKRIFGAVLLFSWTVYLWETFLAQRQRRIYKTTTHVPPELGQIMDSETFEKSRLYQLDKSTFSFWSGLYSETEGTLILLFGGIPYLWRLSGRFCGYAGFGPEYEITQSLVFLLLATLFSALAGLPWSLYNTFVIEEKHGFNQQTLGFFMKDAIKKFVVTQCILLPVSSLLLYIIKIGGDYFFIYAWLFTLVVSLVLVTIYADYIAPLFDKFTPLPEGKLKEEIEVMAKSIDFPLTKVYVVEGSKRSSHSNAYFYGFFKNKRIVLFDTLLEEYSVLNKDIQEDSGMEPRNEEEGNSEEIKAKVKNKKQGCKNEEVLAVLGHELGHWKLGHTVKNIIISQMNSFLCFFLFAVLIGRKELFAAFGFYDSQPTLIGLLIIFQFIFSPYNEVLSFCLTVLSRRFEFQADAFAKKLGKAKDLYSALIKLNKDNLGFPVSDWLFSMWHYSHPPLLERLQALKTMKQHSGLEVLFQ","Homo sapiens","ZMPSTE24, FACE1, STE24","CAAX prenyl protease 1 homolog","1","6BH8"
"6BHC",,"X-RAY DIFFRACTION",2.26,45.66,"VAPOR DIFFUSION, HANGING DROP",6.8,"100 mM N-(2-Acetamido) iminodiacetic acid (ADA) pH 6.8, 11 % (v/v) PEG 3350",294,"10.1074/jbc.RA117.000751",,"6BHC",50.15,"2.3","2.3","Crystal structure of pseduokinase PEAK1 (Sugen Kinase 269)","MQRQALYRGLENREEVVGKIRSLHTDALKKLAVKCEDLFMAGQKDQLRFGVDSWSDFRLTSDKPCCEAGDAVYYTASYAKDPLNNYAVKICKSKAKESQQYYHSLAVRQSLAVHFNIQQDCGHFLAEVPNRLLPWEDPSKKQRSHVVVITREVPCLTVADFVRDSLAQHGKSPDLYERQVCLLLLQLCSGLEHLKPYHVTHCDLRLENLLLVHYQPGGTAQGFGPAEPTPTSSYPTRLIVSNFSQAKQKSHLVDPEILRDQSRLAPEIITATQYKKCDEFQTGILIYEMLHLPNPFDENPELKEREYTRADLPRIPFRSPYSRGLQQLASCLLNPNPSERILISDAKGILQCLLWGPREDLFQTFTACPSLVQRNTLLQNWLDIKRTLLMIKFAEKSLDREGGISLEDWLCAQYLAFATTDSLSCIVKILLEHHHHHH","Homo sapiens","PEAK1, KIAA2002","Pseudopodium-enriched atypical kinase 1","1","6BHC"
"6BHV",,"X-RAY DIFFRACTION",2.15,42.72,"VAPOR DIFFUSION, SITTING DROP",,"PARP-1 CATdeltaHD (30 mg/ml) was crystallized in the presence of 1.6 mM BAD in 24 to 29% PEG 3350, 0.2 M NaCl, 0.1 M Bis-Tris pH 5.5",293,"10.1038/s41467-018-03234-8","DQV","6BHV",122.66,"2.3","2.3","Human PARP-1 bound to NAD+ analog benzamide adenine dinucleotide (BAD)","MGSSHHHHHHSSGLVPRGSHMTKSKLPKPVQDLIKMIFGSGSGSGGDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTS","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6BHV"
"6BHZ",,"X-RAY DIFFRACTION",2.45,49.86,"VAPOR DIFFUSION, SITTING DROP",,"200 mM di-Ammonium Tartrate, 20% PEG 3350",294,"10.1002/cbic.201700611",,"6BHZ",95.07,"1.75","1.75","Trastuzumab Fab D185A (Light Chain) Mutant.","EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"Trastuzumab Anti-HER2 Fab Heavy Chain","1","6BHZ"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKAAYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Trastuzumab Anti-HER2 Fab Light Chain D185A","2","6BHZ"
"6BI0",,"X-RAY DIFFRACTION",2.46,50.04,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM Tris-HCl, pH 7.0, 20% PEGMME 2000",277,"10.1002/cbic.201700611",,"6BI0",94.99,"2.057","2.057","Trastuzumab Fab N158A, D185A, K190A (Light Chain) Triple Mutant.","EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"Trastuzumab anti-HER2 Fab Heavy Chain","1","6BI0"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGASQESVTEQDSKDSTYSLSSTLTLSKAAYEKHAVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Trastuzumab anti-HER2 Fab Light Chain","2","6BI0"
"6BI2",,"X-RAY DIFFRACTION",2.38,48.34,"VAPOR DIFFUSION, SITTING DROP",7,"1.0% trptone, 20% PEG 3350, 100 mM HEPES pH 7.0",294,"10.1002/cbic.201700611",,"6BI2",95.74,"1.801","1.801","Trastuzumab Fab D185A (Light Chain) Mutant Biotin Conjugation.","EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"Trastuzumab Anti-HER2 Fab Heavy Chain","1","6BI2"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKAAYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Trastuzumab Anti-HER2 Fab Light Chain","2","6BI2"
"6BIK",,"X-RAY DIFFRACTION",2.07,40.65,"VAPOR DIFFUSION",7,"PEG 10000, Li2SO4, pH 7.0",277,"10.1007/s10822-019-00187-y",,"6BIK",34.86,"1.901","1.901","BTK complex with compound 7","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYFQGEEYMPTEHHHHHHHH","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6BIK"
"6BJD",,"X-RAY DIFFRACTION",2.01,38.87,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 8000, MES, calcium chloride",295.15,"10.1074/jbc.RA117.001097",,"6BJD",179.91,"2.8","2.8","Crystal Structure of Human Calpain-3 Protease Core in Complex with E-64","IISRNFPIIGVKEKTFEQLHKKCLEKKVLYVDPEFPPDETSLFYSQKFPIQFVWKRPPEICENPRFIIDGANRTDICQGELGDCWFLAAIACLTLNQHLLFRVIPHDQSFIENYAGIFHFQFWRYGEWVDVVIDDCLPTYNNQLVFTKSNHRNEFWSALLEKAYAKLHGSYEALKGGNTTEAMEDFTGGVAEFFEIRDAPSDMYKIMKKAIERGSLMGCSIDDGTNMTYGTSPSGLNMGELIARMVRNMDNSLLQDSDLDPRGSDERPTRTIIPVQYETRMACGLVRGHAYSVTGLDEVPFKGEKVKLVRLRNPWGQVEWNGSWSDRWKDWSFVDKDEKARLQHQVTEDGEFWMSYEDFIYHFTKLEICNLTADLEHHHHHH","Homo sapiens","CAPN3, CANP3, CANPL3, NCL1","Calpain-3","1","6BJD"
"6BJE",,"X-RAY DIFFRACTION",2.2,44.05,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M NaCitric pH 5.6, 15% PEG-3350",293,"10.1194/jlr.M087890",,"6BJE",48.03,"2.7","2.7","Crystal Structure of Lysophospholipase A2 Conjugated with Phenylmethylsulfonyl Fluoride","LLTDAATVSGAERETAAVIFLHGLGDTGHSWADALSTIRLPHVKYICPHAPRIPVTLNMKMVMPSWFDLMGLSPDAPEDEAGIKKAAENIKALIEHEMKNGIPANRIVLGGFSQGGALSLYTALTCPHPLAGIVALSCWLPLHRAFPQAANGSAKDLAILQCHGELDPMVPVRFGALTAEKLRSVVTPARVQFKTYPGVMHSSCPQEMAAVKEFLEKLLPPV","Homo sapiens","LYPLA2, APT2","Acyl-protein thioesterase 2","1","6BJE"
"6BJF",,"SOLUTION NMR",,,,,,,"10.1016/j.bbamem.2018.07.014",,"6BJF",1.62,,,"NMR Structural and biophysical functional analysis of intracellular loop 5 of the NHE1 isoform of the Na+/H+ exchanger.","GLTWFINKFRIVK","Homo sapiens","SLC9A1, APNH1, NHE1","GLY-LEU-THR-TRP-PHE-ILE-ASN-LYS-PHE-ARG-ILE-VAL-LYS","1","6BJF"
"6BJI",,"X-RAY DIFFRACTION",2.28,46.04,"SMALL TUBES",,"Spontaneous crystals were recovered from concentrated stocks of GTA/D302C (95-100 mg/mL) stored in 50 mM MOPS, pH 7.00, 0.1 M sodium chloride, 1 mM DTT, 5 mM manganese chloride, and kept at 277 K.",277,"10.1093/glycob/cwy051",,"6BJI",34.4,"1.54","1.54","Human ABO(H) blood group glycosyltransferase GTA D302C mutant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYLGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHCESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","6BJI"
"6BJJ",,"X-RAY DIFFRACTION",2.28,46.14,"SMALL TUBES",,"Spontaneous crystals were recovered from concentrated stocks of GTB/D302A (68 mg/mL) stored in 50 mM MOPS, pH 7.00, 0.1 M sodium chloride, 1 mM DTT, 5 mM manganese chloride, and kept at 277 K.",277,"10.1093/glycob/cwy051",,"6BJJ",34.24,"1.45","1.45","Human ABO(H) blood group glycosyltransferase GTB D302A mutant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHAESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","ABO blood group (Transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6BJJ"
"6BJK",,"X-RAY DIFFRACTION",2.25,45.4,"SMALL TUBES",,"Spontaneous crystals were recovered from concentrated stocks of GTB/D302C (55 mg/mL) stored in 50 mM MOPS, pH 7.00, 0.1 M sodium chloride, 1 mM DTT, 5 mM manganese chloride, and kept at 277 K.",277,"10.1093/glycob/cwy051",,"6BJK",34.37,"2.12","2.12","Human ABO(H) blood group glycosyltransferase GTB D302C mutant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHCESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNPE","Homo sapiens","ABO","ABO blood group (Transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6BJK"
"6BJL",,"X-RAY DIFFRACTION",2.27,45.78,"SMALL TUBES",,"Spontaneous crystals were recovered from concentrated stocks of GTB/D302L (40-50 mg/mL) stored in 50 mM MOPS, pH 7.00, 0.1 M sodium chloride, 1 mM DTT, 5 mM manganese chloride, and kept at 277 K.",277,"10.1093/glycob/cwy051",,"6BJL",33.02,"1.69","1.69","Human ABO(H) blood group glycosyltransferase GTB D302L mutant","VSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHLESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVP","Homo sapiens","ABO","ABO blood group (Transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6BJL"
"6BJM",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION, HANGING DROP",,"GTB/R188K crystals were obtained by hanging drop vapor diffusion at 4 degrees C, where 3 uL of concentrated stock (66-68 mg/mL) was mixed with 1 uL of reservoir solution containing 0.3 M sodium acetate and 0.3 M sodium chloride.",277,"10.1093/glycob/cwy051",,"6BJM",33.17,"1.45","1.45","Human ABO(H) blood group glycosyltransferase GTB R188K mutant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRKMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVP","Homo sapiens","ABO","ABO blood group (Transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6BJM"
"6BJN",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, SITTING DROP",,"0.1M BisTRIS pH 5.5 and 25% PEG3350",289,"10.1002/pro.3361",,"6BJN",27.08,"2.43","2.43","PICK1 PDZ domain in complex with the class I PDZ binding motif QSAV","MGHHHHHHHHLVPRGSMFADLDYDIEEDKLGIPTVPGKVTLQKDAQNLIGISIGGGAQYCPCLYIVQVFDNTPAALDGTVAAGDEITGVNGRSIKGKTKVEVAKMIQEVKGEVTIHYNKLQQSAV","Homo sapiens","PICK1, PRKCABP","PRKCA-binding protein","1","6BJN"
"6BJO",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, SITTING DROP",,"0.1M BisTRIS pH 5.5
25% PEG3350",280,"10.1002/pro.3361","DUY","6BJO",28.29,"1.75","1.75","PICK1 PDZ domain in complex with the small molecule inhibitor BIO124.","MGHHHHHHHHLVPRGSMFADLDYDIEEDKLGIPTVPGKVTLQKDAQNLIGISIGGGAQYCPCLYIVQVFDNTPAALDGTVAAGDEITGVNGRSIKGKTKVEVAKMIQEVKGEVTIHYNKLQQSAV","Homo sapiens","PICK1, PRKCABP","PRKCA-binding protein","1","6BJO"
"6BJR",,"X-RAY DIFFRACTION",4.18,70.6,"VAPOR DIFFUSION",8.5,"100 mM Bicine, pH 8.5 and 16% PEG3350",277,"10.1038/s41598-018-21304-1",,"6BJR",67.06,"6","6","Crystal structure of prothrombin mutant S101C/A470C","ANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINCTTHPGADLQENFCRNPDSSTMGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTCNVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGEYLE","Homo sapiens","F2","Prothrombin","1","6BJR"
"6BJZ",,"X-RAY DIFFRACTION",2.05,40.05,"VAPOR DIFFUSION, SITTING DROP",3.3,"27% PEG 3350, 0.1 M Citric Acid/Sodium Citrate pH 3.3",298,"10.1021/acs.biochem.0c00474",,"6BJZ",48.09,"1.45","1.45","Crystal Structure of the Fab fragment of humanized 5c8 antibody containing the fluorescent non-canonical amino acid L-(7-hydroxycoumarin-4-yl)ethylglycine at pH 5.5","QVQLVQSGAEVVKPGASVKLSCKASGYIFTSYYMYWVKQAPGQGLEWIGEINPSNGDTNFNEKFKSKATLTVDKSASTAYMELSSLRSEDTAVYYCTRSDGRNDMDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"5c8 Fab Heavy chain","1","6BJZ"
,,,,,,,,,,,,,,,,"DIVLTQSPATLSVSPGERATISCRASQRVSSSTYSYMHWYQQKPGQPPKLLIKYASNLESGVPARFSGSGSGTDFTLTISSVEPEDFATYYCQHSWEXPPTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"5c8 Fab Light chain","2","6BJZ"
"6BKE",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION",,"30% PEG 300, Li2SO4, pH 7.0",277,"10.1007/s10822-019-00187-y",,"6BKE",34.71,"1.95","1.95","BTK complex with compound 10","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYFQGEEYMPTEHHHHHHHH","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6BKE"
"6BKH",,"X-RAY DIFFRACTION",2.09,41.01,"VAPOR DIFFUSION",7,"PEG 10000, Li2SO4, pH 7.0",277,"10.1007/s10822-019-00187-y",,"6BKH",34.79,"1.792","1.792","BTK complex with compound 11","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYFQGEEYMPTEHHHHHHHH","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6BKH"
"6BKU",,"X-RAY DIFFRACTION",2.4,48.69,"VAPOR DIFFUSION, SITTING DROP",6.2,"20% PEG smear medium, 0.2M sodium formate, 0.1M sodium-potassium phosphate, 10% glycerol",293,,"DXV","6BKU",33.56,"2","2","Crystal Structure of the Human CAMKK2B bound to GSK650394","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","6BKU"
"6BKW",,"X-RAY DIFFRACTION",2.11,41.7,"VAPOR DIFFUSION",7,"PEG 10000, Li2SO4, pH 7.0",277,"10.1007/s10822-019-00187-y",,"6BKW",35.12,"1.499","1.499","BTK complex with compound 12","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYFQGEEYMPTEHHHHHHHH","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6BKW"
"6BKX",,"X-RAY DIFFRACTION",2.72,54.77,"VAPOR DIFFUSION",7.4,"20% PEG 3350, 0.2M Potassium/Sodium tartrate",290,"10.1021/acs.jmedchem.8b00305",,"6BKX",146.2,"1.65","1.65","Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd1","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6BKX"
"6BKY",,"X-RAY DIFFRACTION",2.82,56.39,"VAPOR DIFFUSION",7,"20% PEG3350, 0.15M D,L-Malic acid pH 7.0",290,"10.1021/acs.jmedchem.8b00305","K32","6BKY",290.78,"2.17","2.17","Novel Binding Modes of Inhibition of Wild-Type IDH1: Allosteric Inhibition with Cmpd2","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6BKY"
"6BKZ",,"X-RAY DIFFRACTION",2.71,54.54,"VAPOR DIFFUSION",,"18% PEG8K, 0.2M Calcium Acetate, 0.1M Na Cacodylate pH6.5",290,"10.1021/acs.jmedchem.8b00305","DWM","6BKZ",98.8,"2.01","2.01","Novel Modes of Inhibition of Wild-Type IDH1: Non-equivalent Allosteric Inhibition with Cmpd3","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6BKZ"
"6BL0",,"X-RAY DIFFRACTION",2.68,54.14,"VAPOR DIFFUSION",,"20% PEG 1500, 0.2M Sodium Chloride, 5% Ethylene Glycol, 0.1M HEPES pH 7.5",290,"10.1021/acs.jmedchem.8b00305",,"6BL0",147.01,"2.17","2.17","Novel Modes of Inhibition of Wild-Type IDH1:Direct Covalent Modification of His315 with Cmpd11","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6BL0"
"6BL1",,"X-RAY DIFFRACTION",2.68,54.13,"VAPOR DIFFUSION",7.4,"2% PEG3350, 0.2M Potassium/Sodium tartrate",290,"10.1021/acs.jmedchem.8b00305","DWG","6BL1",146.39,"2.02","2.02","Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd13","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6BL1"
"6BL2",,"X-RAY DIFFRACTION",2.64,53.38,"VAPOR DIFFUSION",,"15% PEG3350, 0.1M Succinic acid pH 7.0",290,"10.1021/acs.jmedchem.8b00305",,"6BL2",146.52,"1.92","1.92","Novel Modes of Inhibition of Wild-Type IDH1: Direct Covalent Modification of His315 with Cmpd15","MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGRHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKLSLEHHHHHHHH","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","6BL2"
"6BL8",,"X-RAY DIFFRACTION",3.16,61.13,"VAPOR DIFFUSION",,"100 mM sodium citrate, pH 5.6, 1850 mM ammonium sulfate, 140 mM potassium sodium tartrate",295,"10.1021/acs.jctc.7b01170",,"6BL8",64.08,"2.5","2.5","Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models","DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","6BL8"
"6BLA",,"X-RAY DIFFRACTION",2.52,51.18,"VAPOR DIFFUSION, HANGING DROP",,"16.75% PEG 400, 13.4% PEG 3350, 0.1M MgCl2, 0.1M Tris pH 8.5",293,"10.1016/j.immuni.2018.03.026",,"6BLA",49.05,"1.55","1.55","Structure of AMM01 Fab, an anti EBV gH/gL neutralizing antibody","EVQLVQSGADVKKPGASVKVSCKASGYTFIHFGISWVRQAPGQGLEWMGWIDTNNGNTNYAQSLQGRVTMTTDTSTGTAYMELRSLSTDDTAVYFCARALEMGHRSGFPFDYWGQGVLVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCD","Homo sapiens",,"AMM01 Fab Heavy chain","1","6BLA"
,,,,,,,,,,,,,,,,"SYELTQPPSVSVAPGQRATITCGGHNIGAKNVHWYQQKPGQAPVLVIQYDSDRPSGIPERFSGSNSGSTATLTISRVEAGDEADYYCQVWDSGRGHPLYVFGGGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"AMM01 Fab Light chain","2","6BLA"
"6BLE",,"X-RAY DIFFRACTION",2.24,45.15,"VAPOR DIFFUSION, SITTING DROP",5.5,"28% PEG 3350; 0.07 M Ammonium Acetate; 0.1M SBG buffer pH 5.5 
cryo - 30% glycerol",293,,,"6BLE",33.64,"1.9","1.9","Crystal Structure of the Human CAMKK2B in complex with CP673451","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","6BLE"
"6BLF",,"X-RAY DIFFRACTION",2.06,40.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 15% PEG 8000, 2% Ethylene Glycol, 10 mM TCEP",293,,,"6BLF",88.56,"2.11","2.11","PDE2 complexed with 2-[6-fluoro-8-methylsulfonyl-9-[(1R)-1-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid","MHHHHHHENLYFQGELSTSLYKKAGFDDDDKSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6BLF"
"6BLN",,"X-RAY DIFFRACTION",2.07,40.68,"VAPOR DIFFUSION",,"PEG 10000, Li2SO4, pH 7.0",277,"10.1007/s10822-019-00187-y",,"6BLN",34.76,"1.3","1.3","BTK complex with compound 13","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYFQGEEYMPTEHHHHHHHH","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6BLN"
"6BML",,"X-RAY DIFFRACTION",3.33,63.1,"LIPIDIC CUBIC PHASE",,"0.1M HEPES, pH 7.03, 50mM KH2PO4, 31% PEG 300, 50mM DTT, and 2.5% 2,5-hexanediol",293,"10.1126/science.aao6326",,"6BML",70.67,"2.95","2.95","Structure of human DHHC20 palmitoyltransferase, irreversibly inhibited by 2-bromopalmitate","TLWRCCQRVVGWVPVLFITFVVVWSYYAYVVELCVFTIFGNEENGKTVVYLVAFHLFFVMFVWSYWMTIFTSPASPSKEFYLSNSEKERYEKEFSQERQQEILRRAARALPIYTTSASKTIRYCEKCQLIKPDRAHHCSACDSCILKMDHHCPWVNNCVGFSNYKFFLLFLLYSLLYCLFVAATVLEYFIKFWTNELTDTRAKFHVLFLFFVSAMFFISVLSLFSYHCWLVGKNRTTIESFRAPTFSYGPDGNGFSLGASKNWRQVFGDEKKYWLLPIFSSLGDGCSFPTRLVGM","Homo sapiens","ZDHHC20","human DHHC20 palmitoyltransferase","1","6BML"
"6BMM",,"X-RAY DIFFRACTION",3.1,60.31,"LIPIDIC CUBIC PHASE",,"50mM MES, pH 6.5, 50mM NaH2PO4, 30.3% PEG 300, 50mM DTT, 2.5% 2,5-hexanediol",293,"10.1126/science.aao6326",,"6BMM",70.86,"2.35","2.35","Structure of human DHHC20 palmitoyltransferase, space group P21","WRCCQRVVGWVPVLFITFVVVWSYYAYVVELCVFTIFGNEENGKTVVYLVAFHLFFVMFVWSYWMTIFTSPASPSKEFYLSNSEKERYEKEFSQERQQEILRRAARALPIYTTSASKTIRYCEKCQLIKPDRAHHCSACDSCILKMDHHCPWVNNCVGFSNYKFFLLFLLYSLLYCLFVAATVLEYFIKFWTNELTDTRAKFHVLFLFFVSAMFFISVLSLFSYHCWLVGKNRTTIESFRAPTFSYGPDGNGFSLGCSKNWRQVFGDEKKYWLLPIFSSLGDGCSFPTRLVGM","Homo sapiens","ZDHHC20","human DHHC20 palmitoyltransferase","1","6BMM"
"6BMN",,"X-RAY DIFFRACTION",3.27,62.43,"LIPIDIC CUBIC PHASE",,"50mM MES, pH5.8, 50mM KH2PO4, 27.7% PEG 300, 25mM DTT, 1.25% 2,5-Hexanediol after 3.5 months.",293,"10.1126/science.aao6326",,"6BMN",70.39,"2.25","2.25","Structure of human DHHC20 palmitoyltransferase, space group P63","TLWRCCQRVVGWVPVLFITFVVVWSYYAYVVELCVFTIFGNEENGKTVVYLVAFHLFFVMFVWSYWMTIFTSPASPSKEFYLSNSEKERYEKEFSQERQQEILRRAARALPIYTTSASKTIRYCEKCQLIKPDRAHHCSACDSCILKMDHHCPWVNNCVGFSNYKFFLLFLLYSLLYCLFVAATVLEYFIKFWTNELTDTRAKFHVLFLFFVSAMFFISVLSLFSYHCWLVGKNRTTIESFRAPTFSYGPDGNGFSLGCSKNWRQVFGDEKKYWLLPIFSSLGDGCSFPTRLVGM","Homo sapiens","ZDHHC20","human DHHC20 palmitoyltransferase","1","6BMN"
,,,,,,,,,,,,,,,,"TLWRCCQRVVGWVPVLFITFVVVWSYYAYVVELCVFTIFGNEENGKTVVYLVAFHLFFVMFVWSYWMTIFTSPASPSKEFYLSNSEKERYEKEFSQERQQEILRRAARALPIYTTSASKTIRYCEKCQLIKPDRAHHCSACDSCILKMDHHCPWVNNCVGFSNYKFFLLFLLYSLLYCLFVAATVLEYFIKFWTNELTDTRAKFHVLFLFFVSAMFFISVLSLFSYHCWLVGKNRTTIESFRAPTFSYGPDGNGFSLGCSKNWRQVFGDEKKYWLLPIFSSLGDGCSFPTRLVGM","Homo sapiens","ZDHHC20","human DHHC20 palmitoyltransferase","2","6BMN"
"6BMR",,"X-RAY DIFFRACTION",2.29,46.22,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acschembio.7b00980",,"6BMR",122.39,"2.205","2.205","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP244","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6BMR"
"6BMU",,"X-RAY DIFFRACTION",2.27,45.73,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acschembio.7b00980","5OD","6BMU",122.71,"2.12","2.12","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitors SHP099 and SHP244","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6BMU"
"6BMV",,"X-RAY DIFFRACTION",2.31,46.78,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acschembio.7b00980",,"6BMV",121.94,"2.053","2.053","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP504","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6BMV"
"6BMW",,"X-RAY DIFFRACTION",2.28,46.16,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acschembio.7b00980","5OD","6BMW",122.74,"2.1","2.1","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitors SHP099 and SHP504","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6BMW"
"6BMX",,"X-RAY DIFFRACTION",2.29,46.23,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acschembio.7b00980",,"6BMX",122.29,"2.424","2.424","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor SHP844","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6BMX"
"6BMY",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG3350, 200MM AMMONIUM PHOSPHATE",277,"10.1021/acschembio.7b00980","5OD","6BMY",123.09,"2.09","2.09","Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitors SHP099 and SHP844","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6BMY"
"6BN5",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, HANGING DROP",8.6,"100 mM Tris pH 8.6, 20% PEG 3350, 1 mM TCEP",298.15,"10.1016/j.bmc.2017.10.025",,"6BN5",121.24,"2.22","2.22","Non-receptor Protein Tyrosine Phosphatase SHP2 F285S in Complex with Allosteric Inhibitor JLR-2","SMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPSDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6BN5"
"6BN6",,"X-RAY DIFFRACTION",2.96,58.44,"VAPOR DIFFUSION, HANGING DROP",,,273,"10.1016/j.bmcl.2017.12.006","XGH","6BN6",62.92,"2.4","2.4","IDENTIFICATION OF BICYCLIC HEXAFLUOROISOPROPYL ALCOHOL SULFONAMIDES AS RORGT/RORC INVERSE AGONISTS","MGSSHHHHHHSSGLVPRGSHMASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFST","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6BN6"
"6BNJ",,"X-RAY DIFFRACTION",2.31,46.71,"VAPOR DIFFUSION, HANGING DROP",,"0.3 M sodium acetate, 17.5% PEG 3350 and, for 5, 0.2 M sodium acetate, 20% PEG 3350.",290,"10.1021/acschembio.7b00916","WPG","6BNJ",100.37,"1.909","1.909","Human hypoxanthine guanine phosphoribosyltransferase in complex with [3R,4R]-4-guanin-9-yl-3-((R)-2-hydroxy-2-phosphonoethyl)oxy-1-N-(phosphonopropionyl)pyrrolidine","MATRSPGVVISDDEPGYDLDLFAIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVAVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","6BNJ"
"6BNM",,"X-RAY DIFFRACTION",2.36,47.85,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M Sodium Acetate pH 5, 3.325 M Sodium Chloride",295,,,"6BNM",19.21,"1.9","1.9","Crystal Structure of the P-Rex2 PH domain","GEFEKLEVLEEWQSHIEGWEGSNITDTCTEMLMCGVLLKISSGNIQERVFFLFDNLLVYCKRKHRRLKNSKASTDGHRYLFRGRINTEVMEVENVDDGTADFHSSGHIVVNGWKIHNTAKNKWFVCMAKTPEEKHEWFEAILKERERRKGLKLGMEQDTWVM","Homo sapiens","PREX2, DEPDC2","Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein","1","6BNM"
"6BNY",,"X-RAY DIFFRACTION",2.94,58.17,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 4% PEG 8000",293,"10.1124/mol.118.112185","E0M","6BNY",76.35,"3.341","3.341","TBK1 in complex with tetrazole analog of amlexanox","SNAMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6BNY"
"6BO8","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/nature25182",,"6BO8",340.68,"3.6",,"Cryo-EM structure of human TRPV6 in nanodiscs","MGLSLPKEKGLILCLWSKFCRWFQRRESWAQSRDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHGDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGSEDLDKDSVEKLELGCPFSPHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGIINRGLEDGESWEYQILVPRGSAAAWSHPQFEK","Homo sapiens","TRPV6, ECAC2","Transient receptor potential cation channel subfamily V member 6","1","6BO8"
"6BO9","4","ELECTRON MICROSCOPY",,,,,,,"10.1038/nature25182",,"6BO9",340.68,"4",,"Cryo-EM structure of human TRPV6 in amphipols","MGLSLPKEKGLILCLWSKFCRWFQRRESWAQSRDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHGDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMYFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGSEDLDKDSVEKLELGCPFSPHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGIINRGLEDGESWEYQILVPRGSAAAWSHPQFEK","Homo sapiens","TRPV6, ECAC2","Transient receptor potential cation channel subfamily V member 6","1","6BO9"
"6BOA","4.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/nature25182",,"6BOA",340.56,"4.2",,"Cryo-EM structure of human TRPV6-R470E in amphipols","MGLSLPKEKGLILCLWSKFCRWFQRRESWAQSRDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHGDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMYFAEGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGSEDLDKDSVEKLELGCPFSPHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGIINRGLEDGESWEYQILVPRGSAAAWSHPQFEK","Homo sapiens","TRPV6, ECAC2","Transient receptor potential cation channel subfamily V member 6","1","6BOA"
"6BOD",,"X-RAY DIFFRACTION",2.92,57.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 4% PEG 8000",293,"10.1124/mol.118.112185","E0P","6BOD",76.35,"3.197","3.197","TBK1 in complex with ethyl ester analog of amlexanox","SNAMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6BOD"
"6BOE",,"X-RAY DIFFRACTION",2.93,57.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 5% PEG 8000",293,"10.1124/mol.118.112185","E0S","6BOE",76.39,"3.598","3.598","TBK1 in complex with amide-coupled tetrazole analog of amlexanox","SNAMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6BOE"
"6BOF",,"X-RAY DIFFRACTION",2.56,51.96,"VAPOR DIFFUSION, HANGING DROP",7,"1.4 M sodium malonate, pH 7.0, 0.1 M Bis-Tris propane, pH 7.0",293,"10.1158/2159-8290.CD-18-1220",,"6BOF",39.23,"1.401","1.401","Crystal structure of KRAS A146T-GDP demonstrating open switch 1 conformation","TEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSTKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6BOF"
"6BOZ",,"X-RAY DIFFRACTION",1.55,20.87,"VAPOR DIFFUSION",7,"20% (w/v) PEG 6,000, 0.2 M MgCl, 0.1 M HEPES (pH 7.0)",290,"10.7554/eLife.45403",,"6BOZ",44.39,"2.4","2.4","Structure of human SETD8 in complex with covalent inhibitor MS4138","MSYYHHHHHHDYDIPTTENLYFQGAMGSRKSKAELQSEERKRIDELIESGKEEGMKIDLIDGKGRGVIATKQFSRGDFVVEYHGDLIEITDAKKREALYAQDPSTGCYMYYFQYLSKTYCVDATRETNRLGRLINHSKSGNCQTKLHDIDGVPHLILIASRDIAAGEELLYDYGDRSKASIEAHPWLKH","Homo sapiens","KMT5A, PRSET7, SET07, SET8, SETD8","N-lysine methyltransferase KMT5A","1","6BOZ"
"6BP0",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, SITTING DROP",7,"22% PEG3350; 0.02M Lithium Sulfate; 0.1M Buffer system SBG pH 7.0",293,,,"6BP0",166.11,"1.9","1.9","Crystal Structure of the Human vaccinia-related kinase 1 bound to (R)-2-phenylaminopteridinone inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6BP0"
"6BP1",,"X-RAY DIFFRACTION",1.9,35.28,"VAPOR DIFFUSION, HANGING DROP",3.5,"4% MPD, 0.1 M citric acid, pH 3.5, 20% PEG1500",293,"10.1021/acs.biochem.7b00974",,"6BP1",19.78,"2.001","2.001","Crystal structure of human KRAS A59G mutant in complex with GCP","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTGGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6BP1"
"6BP6",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M HEPES (pH 7.0), 6% Jeffamine M-600",293,"10.7554/eLife.35898",,"6BP6",21.14,"2.17","2.17","Crystal structure of Commd9 COMM domain","MANQISLPRLVDLDWRVDIKTSSDSISRMAVPTCLLQMKIQEDPSLCGDKPSISAVTVELSKETLDTMLDGLGRIRDQLSAVASKLEHHHHHH","Homo sapiens","COMMD9, HSPC166","COMM domain-containing protein 9","1","6BP6"
"6BP9",,"SOLUTION NMR",,,,,,,,,"6BP9",20.2,,,"HSPB5 alpha-crystallin domain mutant R120G-ACD","GLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHGKYRIPADVDPLTITSSLSSDGVLTVNGPRKQV","Homo sapiens","CRYAB, CRYA2, HSPB5","Alpha-crystallin B chain","1","6BP9"
"6BPH",,"X-RAY DIFFRACTION",2.17,43.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG 3350, 0.2M magnesium chloride, 0.1M HEPES, pH 7.5",293,"10.1016/j.bbrc.2018.02.016",,"6BPH",8.07,"1.85","1.85","Crystal structure of the chromodomain of RBBP1","GEDMEPCLTGTKVKVKYGRGKTQKIYEASIKSTEIDDGEVLYLVHYYGWNVRYDEWVKADRIIWPLDKG","Homo sapiens","ARID4A, RBBP1, RBP1","AT-rich interactive domain-containing protein 4A","1","6BPH"
"6BPR",,"X-RAY DIFFRACTION",3.7,66.76,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1021/acs.biochem.9b00006",,"6BPR",24.12,"1.96","1.96","Crystal structure of cysteine, nitric oxide-bound ferrous form of the uncrosslinked F2-Tyr157 human cysteine dioxygenase","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BPR"
"6BPS",,"X-RAY DIFFRACTION",3.69,66.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6BPS",23.82,"2.1","2.1","Crystal structure of cysteine-bound ferrous form of the uncrosslinked F2-Tyr157 human cysteine dioxygenase","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BPS"
"6BPT",,"X-RAY DIFFRACTION",3.74,67.14,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6BPT",23.7,"2.402","2.402","Crystal structure of ferrous form of the uncrosslinked F2-Tyr157 human cysteine dioxygenase","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BPT"
"6BPU",,"X-RAY DIFFRACTION",3.71,66.87,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6BPU",23.69,"1.8","1.8","Crystal structure of ferrous form of the F2-Tyr157 human cysteine dioxygenase with both uncrosslinked and crosslinked cofactor","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BPU"
"6BPV",,"X-RAY DIFFRACTION",3.71,66.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6BPV",23.45,"1.95","1.95","Crystal structure of cysteine-bound ferrous form of the matured F2-Tyr157 human cysteine dioxygenase","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BPV"
"6BPW",,"X-RAY DIFFRACTION",3.7,66.72,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6BPW",23.91,"2.43","2.43","Crystal structure of ferrous form of the Cl2-Tyr157 human cysteine dioxygenase with both uncrosslinked and crosslinked cofactor","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BPW"
"6BPX",,"X-RAY DIFFRACTION",3.73,67.06,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6BPX",24.03,"2.15","2.15","Crystal structure of cysteine-bound ferrous form of the matured Cl2-Tyr157 human cysteine dioxygenase","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6BPX"
"6BQ0",,"X-RAY DIFFRACTION",2.46,50.1,"VAPOR DIFFUSION, SITTING DROP",,"0.07M sodium cacodylate pH 5.1-5.9 and 33-51% MPD",298,"10.1021/acs.jmedchem.8b00070",,"6BQ0",77.29,"2","2","Structure of human monoacylglycerol lipase bound to a covalent inhibitor","MASRGSHHHHHHGAGDRGPEFPSSMPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPPLEVDLQGDHGLSAWSHPQFEK","Homo sapiens","MGLL","Monoglyceride lipase","1","6BQ0"
"6BQ8",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.19,43.96,"VAPOR DIFFUSION, SITTING DROP",4.6,"30% MPD, 20 mM SrCl2, 100 mM NaOAc pH 4.6",277,"10.1021/acs.biochem.8b00010","6FW","6BQ8",18.09,"2, 2.2","2, 2.2","Joint X-ray/neutron structure of PKG II CNB-B domain in complex with 8-pCPT-cGMP","GSTAQARDEQYRNFLRSVSLLKNLPEDKLTKIIDCLEVEYYDKGDYIIREGEEGSTFFILAKGKVKVTQSTEGHDQPQLIKTLQKGEYFGEKALISDDVRSANIIAEENDVACLVIDRETFNQTVGTFEELQKYLEGYVANLNRDDEKRHAK","Homo sapiens","PRKG2, PRKGR2","cGMP-dependent protein kinase 2","1","6BQ8"
"6BQA",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION",6.5,"0.1M Bis-Tris, pH 6.5, 20% PEG 2000 monomethylether",277,"10.1007/s10822-019-00187-y",,"6BQA",12.19,"1.031","1.031","BRD9 bromodomain in complex with 3-(6-(but-3-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide","STPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSK","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","6BQA"
"6BQD",,"X-RAY DIFFRACTION",2.81,56.28,"VAPOR DIFFUSION",5,"8% Tacsimate pH 5.0 and 20% PEG3350",277,"10.1007/s10822-019-00187-y","69G","6BQD",30.88,"2.136","2.136","TAF1-BD2 bromodomain in complex with (E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide","DDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICTAKEAALEEAE","Homo sapiens","TAF1, BA2R, CCG1, CCGS, TAF2A","Transcription initiation factor TFIID subunit 1","1","6BQD"
"6BQL",,"X-RAY DIFFRACTION",2.54,51.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"24% PEG 3350; 0.14 M Ammonium Acetate; 0.1M CHC buffer pH 7.5",293,,,"6BQL",33.83,"2","2","Crystal Structure of the Human CAMKK2B in complex with TAE-226","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","6BQL"
"6BQP",,"X-RAY DIFFRACTION",2.27,45.83,"VAPOR DIFFUSION, SITTING DROP",7,"22% PEG 3350; 0.21 M Ammonium Acetate; 0.1M CHC buffer pH 7.0",293,,,"6BQP",33.63,"1.95","1.95","Crystal Structure of the Human CAMKK2B in complex with Crenolanib","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","6BQP"
"6BQQ",,"X-RAY DIFFRACTION",2.43,49.46,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG 3350; 0.21 M Ammonium Sulphate; 0.1M CHC buffer pH 7.5",293,,"R78","6BQQ",33.83,"1.8","1.8","Crystal Structure of the Human CAMKK2B in complex with BI2526","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","6BQQ"
"6BQR","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aar4510",,"6BQR",491.75,"3.2",,"Human TRPM4 ion channel in lipid nanodiscs in a calcium-free state","YGELDFTGAGRKHSNFLRLSDRTDPAAVYSLVTRTWGFRAPNLVVSVLGGSGGPVLQTWLQDLLRRGLVRAAQSTGAWIVTGGLHTGIGRHVGVAVRDHQMASTGGTKVVAMGVAPWGVVRNRDTLINPKGSFPARYRWRGDPEDGVQFPLDYNYSAFFLVDDGTHGCLGGENRFRLRLESYISQQKTGVGGTGIDIPVLLLLIDGDEKMLTRIENATQAQLPCLLVAGSGGAADCLAETLEDTLAPGSGGARQGEARDRIRRFFPKGDLEVLQAQVERIMTRKELLTVYSSEDGSEEFETIVLKALVKACGSSEASAYLDELRLAVAWNRVDIAQSELFRGDIQWRSFHLEASLMDALLNDRPEFVRLLISHGLSLGHFLTPMRLAQLYSAAPSNSLIRNLLDQASHSAGTKAPALKGGAAELRPPDVGHVLRMLLGKMCAPRYPSGGAWDPHPGQGFGESMYLLSDKATSPLSLDAGLGQAPWSDLLLWALLLNRAQMAMYFWEMGSNAVSSALGACLLLRVMARLEPDAEEAARRKDLAFKFEGMGVDLFGECYRSSEVRAARLLLRRCPLWGDATCLQLAMQADARAFFAQDGVQSLLTQKWWGDMASTTPIWALVLAFFCPPLIYTRLITFRKSEEEPTREELEFDMDSVINGEGPVGTADPAEKTPLGVPRQSGRPGCCGGRCGGRRCLRRWFHFWGAPVTIFMGNVVSYLLFLLLFSRVLLVDFQPAPPGSLELLLYFWAFTLLCEELRQGLSGGGGSLASGGPGPGHASLSQRLRLYLADSWNQCDLVALTCFLLGVGCRLTPGLYHLGRTVLCIDFMVFTVRLLHIFTVNKQLGPKIVIVSKMMKDVFFFLFFLGVWLVAYGVATEGLLRPRDSDFPSILRRVFYRPYLQIFGQIPQEDMDVALMEHSNCSSEPGFWAHPPGAQAGTCVSQYANWLVVLLLVIFLLVANILLVNLLIAMFSYTFGKVQGNSDLYWKAQRYRLIREFHSRPALAPPFIVISHLRLLLRQLCRRPRSPQPSSPALEHFRVYLSKEAERKLLTWESVHKENFLLARARDKRESDSERLKRTSQKVDLALKQLGHIREY","Homo sapiens","TRPM4, LTRPC4","Transient receptor potential cation channel subfamily M member 4","1","6BQR"
"6BQV","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aar4510",,"6BQV",545.08,"3.1",,"Human TRPM4 ion channel in lipid nanodiscs in a calcium-bound state","SGRSGVVPEKEQSWIPKIFKKKTCTTFIVDSTDPGGTLCQCGRPRTAHPAVAMEDAFGAAVVTVWDSDAHTTEKPTDAYGELDFTGAGRKHSNFLRLSDRTDPAAVYSLVTRTWGFRAPNLVVSVLGGSGGPVLQTWLQDLLRRGLVRAAQSTGAWIVTGGLHTGIGRHVGVAVRDHQMASTGGTKVVAMGVAPWGVVRNRDTLINPKGSFPARYRWRGDPEDGVQFPLDYNYSAFFLVDDGTHGCLGGENRFRLRLESYISQQKTGVGGTGIDIPVLLLLIDGDEKMLTRIENATQAQLPCLLVAGSGGAADCLAETLEDTLAPGSGGARQGEARDRIRRFFPKGDLEVLQAQVERIMTRKELLTVYSSEDGSEEFETIVLKALVKACGSSEASAYLDELRLAVAWNRVDIAQSELFRGDIQWRSFHLEASLMDALLNDRPEFVRLLISHGLSLGHFLTPMRLAQLYSAAPSNSLIRNLLDQASHSAGTKAPALKGGAAELRPPDVGHVLRMLLGKMCAPRYPSGGAWDPHPGQGFGESMYLLSDKATSPLSLDAGLGQAPWSDLLLWALLLNRAQMAMYFWEMGSNAVSSALGACLLLRVMARLEPDAEEAARRKDLAFKFEGMGVDLFGECYRSSEVRAARLLLRRCPLWGDATCLQLAMQADARAFFAQDGVQSLLTQKWWGDMASTTPIWALVLAFFCPPLIYTRLITFRKSEEEPTREELEFDMDSVINGEGPVGTADPAEKTPLGVPRQSGRPGCCGGRCGGRRCLRRWFHFWGAPVTIFMGNVVSYLLFLLLFSRVLLVDFQPAPPGSLELLLYFWAFTLLCEELRQGLSGGGGSLASGGPGPGHASLSQRLRLYLADSWNQCDLVALTCFLLGVGCRLTPGLYHLGRTVLCIDFMVFTVRLLHIFTVNKQLGPKIVIVSKMMKDVFFFLFFLGVWLVAYGVATEGLLRPRDSDFPSILRRVFYRPYLQIFGQIPQEDMDVALMEHSNCSSEPGFWAHPPGAQAGTCVSQYANWLVVLLLVIFLLVANILLVNLLIAMFSYTFGKVQGNSDLYWKAQRYRLIREFHSRPALAPPFIVISHLRLLLRQLCRRPRSPQPSSPALEHFRVYLSKEAERKLLTWESVHKENFLLARARDKRESDSERLKRTSQKVDLALKQLGHIREYEQRLKVLEREVQQCSRVLGWVAEALSRSALLPPGGPPPPDLPGSKD","Homo sapiens","TRPM4, LTRPC4","Transient receptor potential cation channel subfamily M member 4","1","6BQV"
"6BR2",,"X-RAY DIFFRACTION",3.61,65.94,"VAPOR DIFFUSION, SITTING DROP",,"2%MPD, 1.2M NaFormate, 0.1M Hepes 7.5",291,"10.1021/acs.jmedchem.8b00061",,"6BR2",51.2,"3.18","3.18","Structure of RORgt in complex with a novel isoquinoline inverse agonist.","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQH","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6BR2"
"6BR3",,"X-RAY DIFFRACTION",3.63,66.14,"VAPOR DIFFUSION, SITTING DROP",,"3%MDP, 1.6M NaFormate, 0.1M HEPES pH 7.5",291,"10.1021/acs.jmedchem.8b00061",,"6BR3",51.45,"3","3","Structure of RORgt in complex with a novel inverse agonist TAK-828.","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHV","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6BR3"
"6BRC",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, SITTING DROP",6,"26% PEG 3350, 0.2 M Ammonium Sulphate, 0.1M sbg buffer pH 6.0",293,,,"6BRC",67.34,"2.2","2.2","Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","6BRC"
"6BRJ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.5,"18% PEG 3350 and 0.1 M Bis-Tris pH 5.5",298,"10.1016/j.chembiol.2018.11.005","VX6","6BRJ",97.75,"2.231","2.231","DDR1 bound to VX-680","MGPEALSSLLLLLLVASGDADMKGHFDPAKCRYALGMQDRTIPDSDISASSSWSDSTAARHSRLESSDGDGAWCPAGSVFPKEEEYLQVDLQRLHLVALVGTQGRHAGGLGKEFSRSYRLRYSRDGRRWMGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLRVELYGCLWRDGLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLGQLADGVVGLDDFRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMRHNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVVNNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAILIGCLVAIILLLLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDTILINNRPGPREPPPYQEPRPRGNPPHSAPCVPNGSAYSGDYMEPEKPGAPLLPPPPQNSVPHYAEADIVTLQGVTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6BRJ"
"6BRU",,"X-RAY DIFFRACTION",3.07,59.88,"VAPOR DIFFUSION, SITTING DROP",7,"22% PEG3350, 0.02M Lithium Sulfate, 0.1M Buffer system SBG pH 7.0",293,,,"6BRU",166.15,"1.8","1.8","Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6BRU"
"6BRW",,"X-RAY DIFFRACTION",2.17,43.32,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,,,"6BRW",33.69,"2.031","2.031","JAK2 JH2 in complex with XMU-MP-1","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6BRW"
"6BS0",,"X-RAY DIFFRACTION",2.21,44.23,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,,,"6BS0",33.62,"1.541","1.541","JAK2 JH2 in complex with 63552444","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6BS0"
"6BSB",,"X-RAY DIFFRACTION",1.78,27.41,"VAPOR DIFFUSION, HANGING DROP",4.6,"Native crystals (see related entry) were used as seeds in a drop of 1:1 mix of the SeMet-derivative (9 mg/ml in 10 mM Tris-Cl, pH 7.4) and reservoir solution (0.1 M sodium acetate trihydrate pH 4.6, 1.75 M sodium chloride, 0.2 M ammonium sulfate).",293,"10.1016/j.bbapap.2020.140361",,"6BSB",12.93,"1.6","1.6","Crystal structure of the Mucin-1 SEA domain, L1105M mutant, Selenium-derivative","SFFFLSFHISNLQFNSSLEDPSTDYYQELQRDISEMFLQIYKQGGFLGLSNIKFRPG","Homo sapiens","MUC1, PUM","Mucin-1","1","6BSB"
,,,,,,,,,,,,,,,,"SVVVQLTMAFREGTINVHDVETQFNQYKTEAASRYNLTISDVSVSDVPFPFSAQS","Homo sapiens","MUC1, PUM","Mucin-1","2","6BSB"
"6BSC",,"X-RAY DIFFRACTION",1.78,31.06,"VAPOR DIFFUSION, HANGING DROP",4.6,"Drop was a 1:1 mix of protein (10 mg/ml in 10 mM Tris-Cl, pH 7.4) and reservoir solution (0.1 M sodium acetate trihydrate pH 4.6, 2.0 M sodium chloride)",293,"10.1016/j.bbapap.2020.140361",,"6BSC",12.82,"1.303","1.303","Crystal structure of the Mucin-1 SEA domain","SFFFLSFHISNLQFNSSLEDPSTDYYQELQRDISEMFLQIYKQGGFLGLSNIKFRPG","Homo sapiens","MUC1, PUM","Mucin-1","1","6BSC"
,,,,,,,,,,,,,,,,"SVVVQLTLAFREGTINVHDVETQFNQYKTEAASRYNLTISDVSVSDVPFPFSAQS","Homo sapiens","MUC1, PUM","Mucin-1","2","6BSC"
"6BSD",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.5,"18% PEG 3350 and 0.1 M Bis-Tris pH 5.5",298,"10.1016/j.chembiol.2018.11.005","1N1","6BSD",97.77,"2.606","2.606","DDR1 bound to Dasatinib","MGPEALSSLLLLLLVASGDADMKGHFDPAKCRYALGMQDRTIPDSDISASSSWSDSTAARHSRLESSDGDGAWCPAGSVFPKEEEYLQVDLQRLHLVALVGTQGRHAGGLGKEFSRSYRLRYSRDGRRWMGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLRVELYGCLWRDGLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLGQLADGVVGLDDFRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMRHNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVVNNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAILIGCLVAIILLLLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDTILINNRPGPREPPPYQEPRPRGNPPHSAPCVPNGSAYSGDYMEPEKPGAPLLPPPPQNSVPHYAEADIVTLQGVTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6BSD"
"6BSK",,"X-RAY DIFFRACTION",3.46,64.41,"VAPOR DIFFUSION, HANGING DROP",7.3,"18% PEG 3350, 0.2 M Na2SO4, 6% ethylene glycol, 0.1 M Tris, pH 7.3",293,"10.1016/j.bmcl.2018.03.018",,"6BSK",32.72,"2.573","2.573","Human PIM1 kinase in complex with compound 12b","EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","6BSK"
"6BSL",,"X-RAY DIFFRACTION",2.67,53.98,"VAPOR DIFFUSION",,"8-12% PEG3350, 150-200 KSCN, 10mM spermadine",277,"10.1021/acsmedchemlett.8b00173","EVV","6BSL",47.12,"1.45","1.45","BMP1 complexed with a reverse hydroxymate - compound 22","XAATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCPA","Homo sapiens","BMP1, PCOLC","Bone morphogenetic protein 1","1","6BSL"
"6BSM",,"X-RAY DIFFRACTION",3.83,67.92,"VAPOR DIFFUSION",,"5% PEG3350, 200 mM KSCN, 10mM spermadine",277,"10.1021/acsmedchemlett.8b00173","E7D","6BSM",23.46,"2.33","2.33","BMP1 complexed with a reverse hydroxamate - compound 4","XAATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCP","Homo sapiens","BMP1, PCOLC","Bone morphogenetic protein 1","1","6BSM"
"6BSS",,"X-RAY DIFFRACTION",2.19,43.74,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,,,"6BSS",33.62,"2.1","2.1","JAK2 JH2 in complex with NU6102","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6BSS"
"6BSX",,"X-RAY DIFFRACTION",2.1,41.51,"EVAPORATION",8.8,"28% PEG4000, 0.2M SODIUM ACETATE, 0.1M TRIS-HCL, PH 8.8, SITTING DROP, TEMPERATURE 293K",293,"10.1038/s41467-018-03035-z",,"6BSX",84,"1.65","1.65","CRYSTAL STRUCTURE OF RHEB IN COMPLEX WITH COMPOUND 1 AT 1.65A RESOLUTION","SMPQSKSRKIAILGYRSVGKSSLTIQFVEGQFVDSYDPTIENTFTKLITVNGQEYHLQLVDTAGQDEYSIFPQTYSIDINGYILVYSVTSIKSFEVIKVIHGKLLDMVGKVQIPIMLVGNKKDLHMERVISYEEGKALAESWNAAFLESSAKENQTAVDVFRRIILEAEKLEHHHHHH","Homo sapiens","RHEB, RHEB2","GTP-binding protein Rheb","1","6BSX"
"6BSZ",,"X-RAY DIFFRACTION",4.67,73.66,"VAPOR DIFFUSION, SITTING DROP",,"100 mM sodium citrate pH 6, 1.6 M ammonium sulfate, 0.2 M sodium potassium tartrate, and 5 mM L-glutamate.",298,"10.1016/j.bmcl.2018.01.037","GGL","6BSZ",108.16,"2.65","2.65","Human mGlu8 Receptor complexed with glutamate","AHSIRVDGDIILGGLFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDSYQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIGGVSIAQSQKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLQQSGHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTLANNRRNVWFAEFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEGKVQFVIDAVYSMAYALHNMHKDLCPGYIGLCPRMSTIDGKELLGYIRAVNFNGSAGTPVTFNENGDAPGRYDIFQYQITNKSTEYKVIGHWTNQLHLKVEDMQWAHREHTHPASE","Homo sapiens","GRM8, GPRC1H, MGLUR8","Metabotropic glutamate receptor 8","1","6BSZ"
"6BT0",,"X-RAY DIFFRACTION",2.12,42.08,"VAPOR DIFFUSION, HANGING DROP",,"19% PEG 1500, 0.1M Na acetate pH 5.0",295,"10.1038/s41467-018-03035-z",,"6BT0",83.39,"2.6","2.6","CRYSTAL STRUCTURE OF RHEB IN COMPLEX WITH COMPOUND NR1","SMPQSKSRKIAILGYRSVGKSSLTIQFVEGQFVDSYDPTIENTFTKLITVNGQEYHLQLVDTAGQDEYSIFPQTYSIDINGYILVYSVTSIKSFEVIKVIHGKLLDMVGKVQIPIMLVGNKKDLHMERVISYEEGKALAESWNAAFLESSAKENQTAVDVFRRIILEAEKLEHHHHHH","Homo sapiens","RHEB, RHEB2","GTP-binding protein Rheb","1","6BT0"
"6BT1",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"3', 5' Adenosine Diphosphate, Magnesium Chloride, Tris, Sodium Citrate, PEG 4000",294,"10.1093/nar/gky412",,"6BT1",35.73,"1.48","1.48","Structure of the human Nocturnin catalytic domain","STRPPRFQRDFVDLRTDCPSTHPPIRVMQWNILAQALGEGKDNFVQCPVEALKWEERKCLILEEILAYQPDILCLQEVDHYFDTFQPLLSRLGYQGTFFPKPWSPCLDVEHNNGPDGCALFFLQNRFKLVNSANIRLTAMTLKTNQVAIAQTLECKESGRQFCIAVTHLKARTGWERFRSAQGCDLLQNLQNITQGAKIPLIVCGDFNAEPTEEVYKHFASSSLNLNSAYKLLSADGQSEPPYTTWKIRTSGECRHTLDYIWYSKHALNVRSALDLLTEEQIGPNRLPSFNYPSDHLSLVCDFSFTEESDGLS","Homo sapiens","NOCT, CCR4, CCRN4L, NOC","Nocturnin","1","6BT1"
"6BT2",,"X-RAY DIFFRACTION",2.32,47.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"Adenosine 5' Monophosphate, Magnesium Chloride, HEPES, Isopropanol, Sodium Acetate, PEG 4000",295,"10.1093/nar/gky412",,"6BT2",71.65,"2.411","2.411","Structure of the human Nocturnin catalytic domain with bound sulfate anion","STRPPRFQRDFVDLRTDCPSTHPPIRVMQWNILAQALGEGKDNFVQCPVEALKWEERKCLILEEILAYQPDILCLQEVDHYFDTFQPLLSRLGYQGTFFPKPWSPCLDVEHNNGPDGCALFFLQNRFKLVNSANIRLTAMTLKTNQVAIAQTLECKESGRQFCIAVTHLKARTGWERFRSAQGCDLLQNLQNITQGAKIPLIVCGDFNAEPTEEVYKHFASSSLNLNSAYKLLSADGQSEPPYTTWKIRTSGECRHTLDYIWYSKHALNVRSALDLLTEEQIGPNRLPSFNYPSDHLSLVCDFSFTEESDGLS","Homo sapiens","NOCT, CCR4, CCRN4L, NOC","Nocturnin","1","6BT2"
"6BT5",,"X-RAY DIFFRACTION",4.67,73.66,"VAPOR DIFFUSION, SITTING DROP",,"3.3 M sodium formate, pH 7.0 and 5 mM L-AP4",295,"10.1016/j.bmcl.2018.01.037","E7P","6BT5",107.82,"2.92","2.92","Human mGlu8 Receptor complexed with L-AP4","AHSIRVDGDIILGGLFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDSYQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIGGVSIAQSQKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQSGHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTLANNRRNVWFAEFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEGKVQFVIDAVYSMAYALHNMHKDLCPGYIGLCPRMSTIDGKELLGYIRAVNFNGSAGTPVTFNENGDAPGRYDIFQYQITNKSTEYKVIGHWTNQLHLKVEDMQWAHREHTHPASE","Homo sapiens","GRM8, GPRC1H, MGLUR8","Metabotropic glutamate receptor 8","1","6BT5"
"6BTA",,"X-RAY DIFFRACTION",2.79,55.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 MM HEPES PH 7.5, 22% PEG 3350",291,"10.1038/s41467-018-03562-9",,"6BTA",18.03,"1.5","1.5","CypA Mutant - S99T C115S","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILTMANAGPNTNGSQFFISTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6BTA"
"6BTH",,"X-RAY DIFFRACTION",2.64,53.38,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris HCl, PEG 3350 22-28%",295,"10.1126/sciadv.aay8937",,"6BTH",33.47,"1.35","1.35","Crystal structure of human cellular retinol binding protein 2 (CRBP2) in complex with 2-arachidonoylglycerol (2-AG)","MTRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKKLVPR","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6BTH"
"6BTI",,"X-RAY DIFFRACTION",2.65,53.62,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M TrisHCl, PEG 3350 22-28%.",293,"10.1126/sciadv.aay8937",,"6BTI",33.3,"1.45","1.45","Crystal structure of human cellular retinol binding protein 2 (CRBP2) in complex with N-arachidonoylethanolamine (AEA)","MTRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKQWIEGDKLYLELTCGDQVCRQVFKKKLVPR","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6BTI"
"6BTN",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION",,"8-12% PEG 3350 150-200mM KSCN 10mM spermidine",277,"10.1021/acsmedchemlett.8b00173",,"6BTN",46.65,"2.05","2.05","BMP1 complexed with a reverse hydroxymate - compound 1","XAATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCPA","Homo sapiens","BMP1, PCOLC","Bone morphogenetic protein 1","1","6BTN"
"6BTO",,"X-RAY DIFFRACTION",2.68,54.12,"VAPOR DIFFUSION",,"8-12% PEG 3350 150-200mM KSCN 10mM spermidine",277,"10.1021/acsmedchemlett.8b00173",,"6BTO",47.04,"2.05","2.05","BMP1 complexed with (2~{S})-2-[[(1~{R},3~{S},4~{S})-2-[(2~{R})-2-[2-(oxidanylamino)-2-oxidanylidene-ethyl]heptanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]carbonylamino]-2-phenyl-ethanoic acid","MAATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCPA","Homo sapiens","BMP1, PCOLC","Bone morphogenetic protein 1","1","6BTO"
"6BTP",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION",,"8-12% PEG 3350 150-200mM KSCN 10mM spermidine",277,"10.1021/acsmedchemlett.8b00173",,"6BTP",46.71,"1.93","1.93","BMP1 complexed with a hydroxamate","XAATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCP","Homo sapiens","BMP1, PCOLC","Bone morphogenetic protein 1","1","6BTP"
"6BTQ",,"X-RAY DIFFRACTION",2.67,54,"VAPOR DIFFUSION",,"8-12% PEG 3350 150-200mM KSCN 10mM spermidine",277,"10.1021/acsmedchemlett.8b00173","E8S","6BTQ",47.22,"1.75","1.75","BMP1 complexed with a hydroxamate - compound 2","XAATSRPERVWPDGVIPFVIGGNFTGSQRAVFRQAMRHWEKHTCVTFLERTDEDSYIVFTYRPCGCCSYVGRRGGGPQAISIGKNCDKFGIVVHELGHVVGFWHEHTRPDRDRHVSIVRENIQPGQEYNFLKMEPQEVESLGETYDFDSIMHYARNTFSRGIFLDTIVPKYEVNGVKPPIGQRTRLSKGDIAQARKLYKCPA","Homo sapiens","BMP1, PCOLC","Bone morphogenetic protein 1","1","6BTQ"
"6BTW",,"X-RAY DIFFRACTION",2.65,53.62,"VAPOR DIFFUSION, SITTING DROP",7,"22% PEG3350, 0.02M Lithium Sulfate, 0.1M Buffer system SBG pH 7.0",293,,,"6BTW",166.26,"1.9","1.9","Crystal Structure of the Human vaccinia-related kinase bound to a phenyl-pteridinone inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6BTW"
"6BTY",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350",295,"10.1016/j.str.2018.08.010",,"6BTY",30.15,"1.678","1.678","Crystal structure of the PI3KC2alpha C2 domain in space group P41212","SNAIGGAVKLSISYRNGTLFIMVMHIKDLVTEDGADPNPYVKTYLLPDNHKTSKRKTKISRKTRNPTFNEMLVYSGYSKETLRQRELQLSVLSAESLRENFFLGGVTLPLKDFNLSKETVKWYQLTAATYL","Homo sapiens","PIK3C2A","Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha","1","6BTY"
"6BTZ",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 400, (NH4)2SO4",295,"10.1016/j.str.2018.08.010",,"6BTZ",63.54,"1.85","1.85","Crystal structure of the PI3KC2alpha C2 domain in space group C121","SNAIGGAVKLSISYRNGTLFIMVMHIKDLVTEDGADPNPYVKTYLLPDNHKTSKRKTKISRKTRNPTFNEMLVYSGYSKETLRQRELQLSVLSAESLRENFFLGGVTLPLKDFNLSKETVKWYQLTAATYL","Homo sapiens","PIK3C2A","Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha","1","6BTZ"
"6BU0",,"X-RAY DIFFRACTION",2.52,51.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 8000",295,"10.1016/j.str.2018.08.010",,"6BU0",47.75,"2.427","2.427","Crystal structure of the PI3KC2alpha C2 domain in complex with IP6","SNAIGGAVKLSISYRNGTLFIMVMHIKDLVTEDGADPNPYVKTYLLPDNHKTSKRKTKISRKTRNPTFNEMLVYSGYSKETLRQRELQLSVLSAESLRGNFFLGGVTLPLKDFNLSKETVKWYQLTAATYL","Homo sapiens","PIK3C2A","Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha","1","6BU0"
"6BU6",,"X-RAY DIFFRACTION",2.99,58.81,"VAPOR DIFFUSION, SITTING DROP",7,"22% PEG3350; 0.02M Lithium Sulfate; 0.1M Buffer system SBG pH 7.0",293,,,"6BU6",166.39,"1.8","1.8","Crystal Structure of the Human vaccinia-related kinase bound to a bis-difluorophenol-aminopyridine inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6BU6"
"6BUB",,"X-RAY DIFFRACTION",3.92,68.6,"VAPOR DIFFUSION, HANGING DROP",8,"(NH4)2SO4",295,"10.1016/j.str.2018.08.010",,"6BUB",16.93,"2.604","2.604","Crystal structure of the PI3KC2alpha PX domain in space group P432","SNADEPILSFSPKTYSFRQDGRIKEVSVFTYHKKYNPDKHYIYVVRILREGQIEPSFVFRTFDEFQELHNKLSIIFPLWKLPGFPNRMVLGRTHIKDVAAKRKIELNSYLQSLMNASTDVAECDLVCTFFHPLLRDEKAEGIA","Homo sapiens","PIK3C2A","Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha","1","6BUB"
"6BVZ",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M sodium nitrate, 0.1 M bis-tris propane pH 6.5, 25% w/v PEG3350",293,"10.1038/s41467-018-05928-5",,"6BVZ",50.33,"2.3","2.3","Importin alpha 3 in cargo free state","SGDYRVQNTSLEAIVQNASSDNQGIQLSAVQAARKLLSSDRNPPIDDLIKSGILPILVHCLERDDNPSLQFEAAWALTNIASGTSEQTQAVVQSNAVPLFLRLLHSPHQNVCEQAVWALGNIIGDGPQCRDYVISLGVVKPLLSFISPSIPITFLRNVTWVMVNLCRHKDPPPPMETIQEILPALCVLIHHTDVNILVDTVWALSYLTDAGNEQIQMVIDSGIVPHLVPLLSHQEVKVQTAALRAVGNIVTGTDEQTQVVLNCDALSHFPALLTHPKEKINKEAVWFLSNITAGNQQQVQAVIDANLVPMIIHLLDKGDFGTQKEAAWAISNLTISGRKDQVAYLIQQNVIPPFCNLLTVKDAQVVQVVLDGLSNILKMAEDEAETIGNLIEECGGLEKIEQLQNHENEDIYKLAYEIIDQFFSSDDIDEDPSLVPEAIQGGTFGFNSSANVPTEGFQF","Homo sapiens","KPNA4, QIP1","Importin subunit alpha-3","1","6BVZ"
"6BW2",,"X-RAY DIFFRACTION",3.54,65.29,"VAPOR DIFFUSION, HANGING DROP",,"20%-30% PEG 3350, Magnesium chloride, Bis-Tris",291,"10.1021/acs.jmedchem.7b01155","ECY","6BW2",74.47,"2.75","2.75","Mcl-1 complexed with small molecules","ADDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6BW2"
"6BW5",,"X-RAY DIFFRACTION",4.41,72.09,"VAPOR DIFFUSION, SITTING DROP",,"PEG400, calcium chloride",290,"10.1038/s41594-018-0031-y",,"6BW5",194.91,"3.1","3.1","Human GPT (DPAGT1) in complex with tunicamycin","MWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDVTNSLEVLFQ","Homo sapiens","DPAGT1, DPAGT2","UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase","1","6BW5"
"6BW6",,"X-RAY DIFFRACTION",4.33,71.56,"VAPOR DIFFUSION, SITTING DROP",,"PEG400, calcium chloride",290,"10.1038/s41594-018-0031-y",,"6BW6",195.07,"2.95","2.95","Human GPT (DPAGT1) H129 variant in complex with tunicamycin","MWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLHTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDVTNSLEVLFQ","Homo sapiens","DPAGT1, DPAGT2","UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase","1","6BW6"
"6BW8",,"X-RAY DIFFRACTION",3.74,67.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"20%-30% PEG3350, Magnesium chloride, Bis-Tris",291,"10.1021/acs.jmedchem.7b01155","ECM","6BW8",74.77,"2.9","2.9","Mcl-1 complexed with small molecules","ADDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6BW8"
"6BWI","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1722038115",,"6BWI",430.78,"3.7",,"3.7 angstrom cryoEM structure of full length human TRPM4","XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXDELRLAVAWNRVDIAQSELFRGDIQWRSFHLEASLMDALLNDRPEFVRLLISHGLSLGHFLTPMRLAQLYSAAPSNSLIRNLLDQASHSAGTKAPALKGGAAELRPPDVGHVLRMLLGKMCAPRYPSGGAWDPHPGQGFGESMYLLSDKATSPLSLDAGLGQAPWSDLLLWALLLNRAQMAMYFWEMGSNAVSSALGACLLLRVMARLEPDAEEAARRKDLAFKFEGMGVDLFGECYRSSEVRAARLLLRRCPLWGDATCLQLAMQADARAFFAQDGVQSLLTQKWWGDMASTTPIWALVLAFFCPPLIYTRLITFRKSEEEPTREELEFDMDSVINGEGPVGTADPAEKTPLGVPRQSGRPGCCGGRCGGRRCLRRWFHFWGAPVTIFMGNVVSYLLFLLLFSRVLLVDFQPAPPGSLELLLYFWAFTLLCEELRQGLSGGGGSLASGGPGPGHASLSQRLRLYLADSWNQCDLVALTCFLLGVGCRLTPGLYHLGRTVLCIDFMVFTVRLLHIFTVNKQLGPKIVIVSKMMKDVFFFLFFLGVWLVAYGVATEGLLRPRDSDFPSILRRVFYRPYLQIFGQIPQEDMDVALMEHSNCSSEPGFWAHPPGAQAGTCVSQYANWLVVLLLVIFLLVANILLVNLLIAMFSYTFGKVQGNSDLYWKAQRYRLIREFHSRPALAPPFIVISHLRLLLRQLCRRPRSPQPSSPALEHFRVYLSKEAERKLLTWESVHKENFLLARARDKRESDSERLKRTSQKVDLALKQLGHIREYEQRLKVLE","Homo sapiens","TRPM4, LTRPC4","Transient receptor potential cation channel subfamily M member 4","1","6BWI"
"6BWK",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",,"5% w/v polyethylene glycol 8000, 20% v/v polyethylene glycol 300, 0.1M Tris chloride pH 8.5, 10% v/v glycerol",293,"10.1038/s41467-018-04714-7",,"6BWK",33.18,"2.79","2.79","Crystal structure of the human MLKL pseudokinase domain T357E/S358E mutant","GAMGSQEQIKEIKKEQLSGSPWILLRENEVSTLYKGEYHRAPVAIKVFKKLQAGSIAIVRQTFNKEIKTMKKFESPNILRIFGICIDETVTPPQFSIVMEYCELGTLRELLDREKDLTLGKRMVLVLGAARGLYRLHHSEAPELHGKIRSSNFLVTQGYQVKLAGFELRKTQEEMSLGTTREKTDRVKSTAYLSPQELEDVFYQYDVKSEIYSFGIVLWEIATGDIPFQGCNSEKIRKLVAVKRQQEPLGEDCPSELREIIDECRAHDPSVRPSVDEILKKLSTFSK","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","6BWK"
"6BWZ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M Bis-Tris pH 6.0, 0.2M Magnesium Formate Dihydrate",298,"10.1126/science.aan6398",,"6BWZ",0.66,"1.1","1.1","SYSGYS from low-complexity domain of FUS, residues 37-42","SYSGYS","Homo sapiens","FUS, TLS","SYSGYS peptide  from low-complexity domain of FUS","1","6BWZ"
"6BX6",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, HANGING DROP",9.5,"9-14 % ethanol, 5 mM magnesium chloride, 3-7 mM manganese chloride, 10 mM TCEP and 0.1 M Tris, pH 9.5.",293,"10.1074/jbc.RA118.003547",,"6BX6",32.07,"2.9","2.9","AMP-Activated protein kinase (AMPK) inhibition by SBI-0206965: alpha 2 kinase domain bound to SBI-0206965","GPKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE","Homo sapiens","PRKAA2, AMPK, AMPK2","5'-AMP-activated protein kinase catalytic subunit alpha-2","1","6BX6"
"6BX7",,"X-RAY DIFFRACTION",4.63,73.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M Calcium Chloride, 0.1 M HEPES Sodium Salt pH 7.5, 15% PEG 400 + 15% Glycerol",277,"10.1038/s42003-019-0586-0",,"6BX7",50.48,"2.85","2.85","Crystal Structure of Human Protocadherin-1 EC1-4","MTRVVYKVPEEQPPNTLIGSLAADYGFPDVGHLYKLEVGAPYLRVDGKTGDIFTTETSIDREGLRECQNQLPGDPCILEFEVSITDLVQNGSPRLLEGQIEVQDINDNTPNFASPVITLAIPENTNIGSLFPIPLASDRDAGPNGVASYELQAGPEAQELFGLQVAEDQEEKQPQLIVMGNLDRERWDSYDLTIKVQDGGSPPRASSALLRVTVLDTNDNAPKFERPSYEAELSENSPIGHSVIQVKANDSDQGANAEIEYTFHQAPEVVRRLLRLDRNTGLITVQGPVDREDLSTLRFSVLAKDRGTNPKSARAQVVVTVKDMNDNAPTIEIRGIGLVTHQDGMANISEDVAEETAVALVQVSDRDEGENAAVTCVVAGDVPFQLRQASETGSDSKKKYFLQTTTPLDYEKVKDYTIEIVAVDSGNPPLSSTNSLKVQVVDVNDNALEHHHHHH","Homo sapiens","PCDH1","Protocadherin-1","1","6BX7"
"6BXH",,"X-RAY DIFFRACTION",2.16,37.37,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium acetate, 0.1 M HEPES and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl, 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen",283,,"EE7","6BXH",57.46,"2.445","2.445","Menin in complex with MI-853","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPAASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","6BXH"
"6BXI",,"X-RAY DIFFRACTION",3.48,64.62,"VAPOR DIFFUSION, HANGING DROP",,"4 M ammonium acetate, 0.1 M Bis-Tris propane pH 7",298,"10.1016/j.str.2018.05.014",,"6BXI",78.57,"2.2","2.2","X-ray crystal structure of NDR1 kinase domain","TRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFP","Homo sapiens","STK38, NDR1","Serine/threonine-protein kinase 38","1","6BXI"
"6BXV",,"X-RAY DIFFRACTION",1.47,16.15,"VAPOR DIFFUSION, HANGING DROP",7,"0.5M ammonium tartrate dibasic pH 7.0",298,"10.1126/science.aan6398",,"6BXV",0.88,"1.1","1.1","SYSSYGQS from low-complexity domain of FUS, residues 54-61","SYSSYGQS","Homo sapiens","FUS, TLS","FUS","1","6BXV"
"6BXX",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M sodium cacodylate pH 6.5, 30% (v/v) MPD",298,"10.1126/science.aan6398",,"6BXX",0.61,"1.1","1.1","GYNGFG from low-complexity domain of hnRNPA1, residues 243-248","GYNGFG","Homo sapiens","HNRNPA1, HNRPA1","hnRNPA1","1","6BXX"
"6BXY",,"X-RAY DIFFRACTION",2,38.84,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium acetate, 0.1 M HEPES and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl, 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen",283,"10.1021/acs.jmedchem.8b00071","EEV","6BXY",56.14,"1.82","1.82","Menin in complex with MI-1481","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPAASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","6BXY"
"6BY8",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium acetate, 0.1 M HEPES and 25% w/v PEG 3,350. This solution was mixed 1:1 with 2.5mg/mL protein in 50mM Tris-HCl, 50mM NaCl, and 1mM TCEP. Prior to data collection, crystals were transferred into a cryo-solution containing 20% PEG550 MME and flash-frozen in liquid nitrogen",283,"10.1021/acs.jmedchem.8b00071","FNV","6BY8",56.15,"1.9","1.9","Menin in complex with MI-1482","GGSSSMGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVS","Homo sapiens","MEN1, SCG2","Menin","1","6BY8"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
"6BY9",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BIS-TRIS pH6.5,3.0M NaCl",298,,,"6BY9",35.63,"2.3","2.3","Crystal structure of EHMT1","GSAAGPPLSEDDKLQGAASHVPEGFDPTGPAGLGRPTPGLSQGPGKETLESALIALDSEKPKKLRFHPKQLYFSARQGELQKVLLMLVDGIDPNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQDSA","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Histone-lysine N-methyltransferase EHMT1","1","6BY9"
"6BYB",,"X-RAY DIFFRACTION",3.1,60.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 400, 0.2 M Magnesium chloride hexahydrate, 0.1 M Sodium HEPES pH7.5",295,,,"6BYB",37.92,"1.74","1.74","Crystal structure of L3MBTL1 MBT Domain with MBK14970","GEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPRE","Homo sapiens","L3MBTL1, KIAA0681, L3MBT, L3MBTL","Lethal(3)malignant brain tumor-like protein 1","1","6BYB"
"6BYV",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.8b00349",,"6BYV",13.3,,,"Solution NMR structure of cysteine-rich calcium bound domains of very low density lipoprotein receptor","KTCAESDFVCNNGQCVPSRWKCDGDPDCEDGSDESPEQCHMRTCRIHEISCGAHSTQCIPVSWRCDGENDCDSGEDEENCGNITCSPDEFTCSSGRCISRNFVCNGQDDCSDGSDELDCAP","Homo sapiens","VLDLR","Very low-density lipoprotein receptor","1","6BYV"
"6BZ4",,"X-RAY DIFFRACTION",2.87,57.2,"VAPOR DIFFUSION, HANGING DROP",,"PEG 6000, 0.1 M MES, 25% V/V ETHYLENE GLYCOL",291,"10.1042/BCJ20180139",,"6BZ4",49.59,"2.4","2.4","Human IgG1 lacking complement-dependent cytotoxicity: hu3S193 Fc mutant K322A","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCAVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","6BZ4"
"6BZE","4","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1721967115",,"6BZE",100.92,"4",,"Cryo-EM structure of BCL10 CARD filament","EEDLTEVKKDALENLRVYLCEKIIAERHFDHLRAKKILSREDTEEISCRTSSRKRAGKLLDYLQENPKGLDTLVESIRREKTQNFLIQKITDEVLKLRNIKLEHLK","Homo sapiens","BCL10, CIPER, CLAP","B-cell lymphoma/leukemia 10","1","6BZE"
"6BZM","0.9","ELECTRON CRYSTALLOGRAPHY",1.45,15.41,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.1 M CHES, pH 9.5, 10% ethanol",298,"10.1126/science.aan6398",,"6BZM",1.57,"0.9, 0.9","0.9","GFGNFGTS from low-complexity/FG repeat domain of Nup98, residues 116-123","GFGNFGTS","Homo sapiens","NUP98, ADAR2","Nuclear pore complex protein Nup98-Nup96","1","6BZM"
"6BZP","1.1","ELECTRON CRYSTALLOGRAPHY",1.6,23.22,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1 M sodium acetate, pH 4.6, 0.15 M ammonium sulfate, 25% w/v PEG2000 MME",298,"10.1126/science.aan6398",,"6BZP",1.25,"1.1, 1.1","1.1","STGGYG from low-complexity domain of FUS, residues 77-82","STGGYG","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","6BZP"
"6BZR",,"X-RAY DIFFRACTION",2.85,56.77,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.1 M Sodium Citrate pH 6.2, 
12.5% PEG 4000,
18% propanol",277.15,,,"6BZR",55.5,"2.79999446301","2.79999446301","Human ABCC6 NBD2 in ADP-bound state","SAAQPPWPQGGQIEFRDFGLRYRPELPLAVQGVSFKIHAGEKVGIVGRTGAGKSSLASGLLRLQEAAEGGIWIDGVPIAHVGLHTLRSRISIIPQDPILFPGSLRMNLDLLQEHSDEAIWAALETVQLKALVASLPGQLQYKCADRGEDLSVGQKQLLCLARALLRKTQILILDEATAAVDPGTELQMQAMLGSWFAQCTVLLIAHRLRSVMDCARVLVMDKGQVAESGSPAQLLAQKGLFYRLAQESGLV","Homo sapiens","ABCC6, ARA, MRP6","Multidrug resistance-associated protein 6","1","6BZR"
"6BZS",,"X-RAY DIFFRACTION",2.34,47.47,"VAPOR DIFFUSION, SITTING DROP",,"2.1-2.4M Ammonium Sulfate
0.1M HEPES pH 6.8-8.2",277.15,"10.1074/jbc.RA118.004806",,"6BZS",25.4,"2.29990463032","2.29990463032","Human ABCC6 NBD1 in Apo state","SAAGKDCITIHSATFAWSQESPPCLHRINLTVPQGCLLAVVGPVGAGKSSLLSALLGELSKVEGFVSIEGAVAYVPQEAWVQNTSVVENVCFGQELDPPWLERVLEACALQPDVDSFPEGIHTSIGEQGMNLSGGQKQRLSLARAVYRKAAVYLLDDPLAALDAHVGQHVFNQVIGPGGLLQGTTRILVTHALHILPQADWIIVLANGAIAEMGSYQELLQRKGALVCLLDQARQPGD","Homo sapiens","ABCC6, ARA, MRP6","Multidrug resistance-associated protein 6","1","6BZS"
"6C01",,"X-RAY DIFFRACTION",2.79,55.87,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M buffer PCB (QIAGEN PACT suite), 25% PEG 1500",293,"10.1111/febs.14489",,"6C01",203.61,"2.3","2.3","Human ectonucleotide pyrophosphatase / phosphodiesterase 3 (ENPP3, NPP3, CD203c)","DRHHHHHHKLLEKQGSCRKKCFDASFRGLENCRCDVACKDRGDCCWDFEDTCVESTRIWMCNKFRCGETRLEASLCSCSDDCLQRKDCCADYKSVCQGETSWLEENCDTAQQSQCPEGFDLPPVILFSMDGFRAEYLYTWDTLMPNINKLKTCGIHSKYMRAMYPTKTFPNHYTIVTGLYPESHGIIDNNMYDVNLNKNFSLSSKEQNNPAWWHGQPMWLTAMYQGLKAATYFWPGSEVAINGSFPSIYMPYNGSVPFEERISTLLKWLDLPKAERPRFYTMYFEEPDSSGHAGGPVSARVIKALQVVDHAFGMLMEGLKQRNLHNCVNIILLADHGMDQTYCNKMEYMTDYFPRINFFYMYEGPAPRIRAHNIPHDFFSFNSEEIVRNLSCRKPDQHFKPYLTPDLPKRLHYAKNVRIDKVHLFVDQQWLAVRSKSNTNCGGGNHGYNNEFRSMEAIFLAHGPSFKEKTEVEPFENIEVYNLMCDLLRIQPAPNNGTHGSLNHLLKVPFYEPSHAEEVSKFSVCGFANPLPTESLDCFCPHLQNSTQLEQVNQMLNLTQEEITATVKVNLPFGRPRVLQKNVDHCLLYHREYVSGFGKAMRMPMWSSYTVPQLGDTSPLPPTVPDCLRADVRVPPSESQKCSFYLADKNITHGFLYPPASNRTSDSQYDALITSNLVPMYEEFRKMWDYFHSVLLIKHATERNGVNVVSGPIFDYNYDGHFDAPDEITKHLANTDVPIPTHYFVVLTSCKNKSHTPENCPGWLDVLPFIIPHRPTNVESCPEGKPEALWVEERFTAHIARVRDVELLTGLDFYQDKVQPVSEILQLKTYLPTFETTI","Homo sapiens","ENPP3, PDNP3","Ectonucleotide pyrophosphatase/phosphodiesterase family member 3","1","6C01"
"6C02",,"X-RAY DIFFRACTION",2.65,53.61,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES pH 7, 8% PEG 8000",293,"10.1111/febs.14489",,"6C02",200.54,"1.942","1.942","Human ectonucleotide pyrophosphatase / phosphodiesterase 3 (ENPP3, NPP3, CD203c), inactive (T205A), N594S, with alpha,beta-methylene-ATP (AMPCPP)","DRHHHHHHKLLEKQGSCRKKCFDASFRGLENCRCDVACKDRGDCCWDFEDTCVESTRIWMCNKFRCGETRLEASLCSCSDDCLQRKDCCADYKSVCQGETSWLEENCDTAQQSQCPEGFDLPPVILFSMDGFRAEYLYTWDTLMPNINKLKTCGIHSKYMRAMYPTKAFPNHYTIVTGLYPESHGIIDNNMYDVNLNKNFSLSSKEQNNPAWWHGQPMWLTAMYQGLKAATYFWPGSEVAINGSFPSIYMPYNGSVPFEERISTLLKWLDLPKAERPRFYTMYFEEPDSSGHAGGPVSARVIKALQVVDHAFGMLMEGLKQRNLHNCVNIILLADHGMDQTYCNKMEYMTDYFPRINFFYMYEGPAPRIRAHNIPHDFFSFNSEEIVRNLSCRKPDQHFKPYLTPDLPKRLHYAKNVRIDKVHLFVDQQWLAVRSKSNTNCGGGNHGYNNEFRSMEAIFLAHGPSFKEKTEVEPFENIEVYNLMCDLLRIQPAPNNGTHGSLNHLLKVPFYEPSHAEEVSKFSVCGFANPLPTESLDCFCPHLQNSTQLEQVNQMLSLTQEEITATVKVNLPFGRPRVLQKNVDHCLLYHREYVSGFGKAMRMPMWSSYTVPQLGDTSPLPPTVPDCLRADVRVPPSESQKCSFYLADKNITHGFLYPPASNRTSDSQYDALITSNLVPMYEEFRKMWDYFHSVLLIKHATERNGVNVVSGPIFDYNYDGHFDAPDEITKHLANTDVPIPTHYFVVLTSCKNKSHTPENCPGWLDVLPFIIPHRPTNVESCPEGKPEALWVEERFTAHIARVRDVELLTGLDFYQDKVQPVSEILQLKTYLPTFETTI","Homo sapiens","ENPP3, PDNP3","Ectonucleotide pyrophosphatase/phosphodiesterase family member 3","1","6C02"
"6C0S",,"X-RAY DIFFRACTION",3.59,65.75,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% w/v MEPEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% w/v  MEPEG2000, 200 mM ammonium sulfate",277,"10.1016/j.bmcl.2018.02.049","EEJ","6C0S",29.11,"2.35","2.35","Factor XIA in complex with the inhibitor methyl (4-{6-[(1S)-2-[(3R)-1-acetylpiperidin-3-yl]-1-({(2E)-3-[5-chloro-2- (1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)ethyl]-3-chloropyridazin-4-yl}phenyl) carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","6C0S"
"6C0T",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, HANGING DROP",7.5,"24%w/v PEG1500, 20%v/v glycerol, 3% w/v Trimethylamine N-oxide dihydrate",295,"10.1074/jbc.RA118.002427","EE4","6C0T",40.26,"1.98","1.98","Crystal structure of cGMP-dependent protein kinase Ialpha (PKG Ialpha) catalytic domain bound with N46","GSGLDDVSNKAYEDAEAKAKYEAEAAFFANLKLSDFNIIDTLGVGGFGRVELVQLKSEESKTFAMKILKKRHIVDTRQQEHIRSEKQIMQGAHSDFIVRLYRTFKDSKYLYMLMEACLGGELWTILRDRGSFEDSTTRFYTACVVEAFAYLHSKGIIYRDLKPENLILDHRGYAKLVDFGFAKKIGFGKKTWTFCGTPEYVAPEIILNKGHDISADYWSLGILMYELLTGSPPFSGPDPMKTYNIILRGIDMIEFPKKIAKNAANLIKKLCRDNPSERLGNLKNGVKDIQKHKWFEGFNWEGLRKGTLTPPIIPSVASPTDTSNFDSFPEDNDEPPPDDNSGWDIDF","Homo sapiens","PRKG1, PRKG1B, PRKGR1A, PRKGR1B","cGMP-dependent protein kinase 1","1","6C0T"
"6C0U",,"X-RAY DIFFRACTION",4.09,69.94,"VAPOR DIFFUSION, HANGING DROP",7.5,"16% (w/v) PEG8000, 0.04 M potassium phosphate (monobasic), 20% (v/v) glycerol",295,"10.1074/jbc.RA118.002427",,"6C0U",41.98,"2.65","2.65","Crystal structure of cAMP-dependent protein kinase Calpha subunit bound with N46","GSHMGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF","Homo sapiens","PRKACA, PKACA","cAMP-dependent protein kinase catalytic subunit alpha","1","6C0U"
"6C0V","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aar7389",,"6C0V",143.72,"3.4, 3.4",,"Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation","MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAIIHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSGIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVSKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFTDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIGAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARGAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSGQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLFATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIAIARALVRNPKILLLDQATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAGFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRSSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAIINGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKAGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNIANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEAIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFGAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDSYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVVQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVVSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLDQATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQLLAQKGIYFSMVSVQAGTKRQSNSLEVLFQ","Homo sapiens","ABCB1, MDR1, PGY1","Multidrug resistance protein 1","1","6C0V"
"6C18",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION, HANGING DROP",,"20% MPEG 5000, 0.1 M sodium cacodylate pH 7.5, 0.2 M ammonium sulfate",291,,,"6C18",71.99,"2.3","2.3","FGFR1 kinase complex with inhibitor SN37115","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6C18"
"6C19",,"X-RAY DIFFRACTION",2.24,45.19,"VAPOR DIFFUSION, HANGING DROP",,"20% MPEG 5000, 0.1 M sodium cacodylate pH 7.5, 0.2 M ammonium sulfate",291,,"YY7","6C19",71.93,"2.12","2.12","FGFR1 kinase complex with inhibitor SN36985","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6C19"
"6C1B",,"X-RAY DIFFRACTION",2.48,50.38,"VAPOR DIFFUSION, HANGING DROP",,"20% MPEG 5000, 0.1 M sodium cacodylate pH 7.5, 0.2 M ammonium sulfate",291,,,"6C1B",71.96,"2","2","FGFR1 kinase complex with inhibitor SN37118","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6C1B"
"6C1C",,"X-RAY DIFFRACTION",2.48,50.35,"VAPOR DIFFUSION, HANGING DROP",,"20% MPEG 5000, 0.1 M sodium cacodylate pH 7.5, 0.2 M ammonium sulfate",291,,,"6C1C",72.07,"2.15","2.15","FGFR1 kinase complex with inhibitor SN37116","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6C1C"
"6C1I",,"X-RAY DIFFRACTION",2.65,53.62,"VAPOR DIFFUSION",6.5,"0.1 M MOPS, pH 6.5, 0.8 M sodium citrate",298,"10.1038/s41467-018-07133-w","EEY","6C1I",63.56,"2.26","2.26","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with T0070907","GQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6C1I"
"6C1O",,"X-RAY DIFFRACTION",2.36,47.98,"VAPOR DIFFUSION, HANGING DROP",,"20% MPEG 5000, 0.1 M sodium cacodylate pH 7.5, 0.2 M ammonium sulfate",291,,,"6C1O",72.12,"2.29","2.29","FGFR1 kinase domain complexed with FIIN-1","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","6C1O"
"6C1S",,"X-RAY DIFFRACTION",2.35,47.69,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG3350, 200MM Lithium Sulfate, 10 MM DTT, 10 MM EDTA, 100 MM Tris",298,"10.1021/acs.jmedchem.8b00085","EFV","6C1S",112.03,"2.31","2.31","Phosphoinositide 3-Kinase gamma bound to an pyrrolopyridinone Inhibitor","MPMASEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSALEHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6C1S"
"6C2G",,"X-RAY DIFFRACTION",2.55,51.83,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Magnesium chloride hexahydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% w/v Polyethylene glycol 4,000.",293.15,"10.1016/j.bbagen.2018.03.019",,"6C2G",106.93,"2.3","2.3","Human triosephosphate isomerase mutant V231M","MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLMGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","Triosephosphate isomerase","1","6C2G"
"6C2I",,"X-RAY DIFFRACTION",2.82,56.36,"VAPOR DIFFUSION, HANGING DROP",,"20 % (w/v) PEG 5000 monomethylethyl ether (MME), 200 mM sodium citrate (pH 6.6) and 200 mM sodium iodide",293,"10.1016/j.bmcl.2018.01.056","EJ7","6C2I",46.85,"1.95","1.95","Structure of Bace-1 (Beta-Secretase) in complex with : N-(3-((1R,5S,6R)-3-amino-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-5-yl)-4-fluorophenyl)-5-methoxypyrazine-2-carboxamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6C2I"
"6C2R",,"X-RAY DIFFRACTION",2.12,41.87,"VAPOR DIFFUSION, SITTING DROP",4.6,"100mM MES pH 4.6, 23% PEG 3350, 150mM Ammonium Sulfate",294,"10.1158/2159-8290.CD-18-0469","EG7","6C2R",32.22,"1.96","1.96","Aurora A ligand complex","GAMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6C2R"
"6C2T",,"X-RAY DIFFRACTION",2.07,40.63,"VAPOR DIFFUSION, SITTING DROP",4.8,"100mM MES pH 4.8, 25% PEG 3350,  150mM Ammonium Sulfate",294,"10.1158/2159-8290.CD-18-0469",,"6C2T",32.14,"1.73","1.73","Aurora A ligand complex","GAMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6C2T"
"6C2W",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",9,"100 mM Bicine, pH 9.0 and 11% PEG 3350",277,"10.1038/s41598-018-21304-1",,"6C2W",134.12,"4.12","4.12","Crystal structure of human prothrombin mutant S101C/A470C","ANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINCTTHPGADLQENFCRNPDSSTMGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTCNVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGEYLE","Homo sapiens","F2","Prothrombin","1","6C2W"
"6C3E",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION",7,"0.25 M ammonium iodide, 0.03 M glycyl-glycyl-glycine and polyethylene glycol (PEG) 3350",277,"10.1021/acs.jmedchem.7b01647","EJY","6C3E",67.7,"2.6","2.6","CRYSTAL STRUCTURE OF RIP1 KINASE BOUND TO INHIBITOR","GGSGQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDLTEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6C3E"
"6C3F",,"X-RAY DIFFRACTION",1.47,16.55,"VAPOR DIFFUSION, HANGING DROP",,"1.5 M NaCl, 10 % v/v ethanol, 25% Glycerol",298,"10.1002/pro.3420",,"6C3F",1.64,"1.499","1.499","AMYLOID FORMING PEPTIDE IYKVEI FROM TRANSTHYRETIN","IYKVEI","Homo sapiens",,"ILE-TYR-LYS-VAL-GLU-ILE","1","6C3F"
"6C3G",,"X-RAY DIFFRACTION",1.53,19.71,"VAPOR DIFFUSION, HANGING DROP",3.5,"0.1 M Citric acid pH 3.5, 2.0 M Ammonium sulfate, 25% Glycerol",298,"10.1002/pro.3420",,"6C3G",1.37,"1.601","1.601","AMYLOID FORMING PEPTIDE KALGIS FROM TRANSTHYRETIN","KALGIS","Homo sapiens",,"LYS-ALA-LEU-GLY-ILE-SER","1","6C3G"
"6C3L",,"X-RAY DIFFRACTION",2.09,41.28,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium acetate pH 4.5, 27% (w/v) PEG-3,350",277,"10.1021/acs.jmedchem.8b00040","EGP","6C3L",30.98,"1.46092157578","1.46092157578","Crystal structure of BCL6 BTB domain with compound 15f","GSMASPADSQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLRVGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6C3L"
"6C3N",,"X-RAY DIFFRACTION",3.02,59.28,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M ammonium formate, .1 M Tris, pH 7.5",277,"10.1021/acs.jmedchem.8b00040","EHY","6C3N",30.35,"2.53170577659","2.53170577659","Crystal structure of BCL6 BTB domain in complex with compound 7CC5","GSMASPADSQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLRVGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6C3N"
"6C3S",,"X-RAY DIFFRACTION",1.54,20.38,"VAPOR DIFFUSION, HANGING DROP",5.5,"YTIAAL crystals were grown from a solution containing 10mg/mL peptide. The reservoir contained 100mM Bis-Tris pH 5.5 and 3 M sodium chloride. Crystals were soaked on 25% Glycerol, prior to diffraction",298,"10.1002/pro.3420",,"6C3S",0.65,"1.602","1.602","AMYLOID FORMING PEPTIDE YTIAAL FROM TRANSTHYRETIN","YTIAAL","Homo sapiens",,"TYR-THR-ILE-ALA-ALA-LEU","1","6C3S"
"6C3T",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"AADTWE crystals were grown from a solution containing 100 mg/ml peptide. The reservoir contained 0.2 M Ammonium phosphate monobasic, 0.1 M Tris pH 8.5, and 50 % v/v MPD. Crystals were soaked on 25% Glycerol prior to diffraction",298,"10.1002/pro.3420",,"6C3T",1.38,"1","1","AMYLOID FORMING PEPTIDE AADTWE FROM TRANSTHYRETIN WITH ATTR-D38A MUTATION ASSOCIATED WITH A FAMILIAL FORM OF TRANSTHYRETIN AMYLOIDOSIS","AADTWE","Homo sapiens",,"ALA-ALA-ASP-THR-TRP-GLU","1","6C3T"
"6C42",,"X-RAY DIFFRACTION",2.25,45.35,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 3,350, HEPES pH 6.5, 200 mM MgCl2",298.15,"10.1038/s41467-018-04413-3",,"6C42",57.6,"1.997","1.997","Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1156","LALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6C42"
"6C45",,"X-RAY DIFFRACTION",2.85,56.78,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG3350, 100 mM Bis-Tris, pH 7.5, 200 mM potassium bromide, 10% v/v glycerol",293,,,"6C45",130.82,"2.388","2.388","Crystal structure of human inorganic pyrophosphatase in the P212121 space group","MSGFSTEERAAPFSLEYRVFLKNEKGQYISPFHDIPIYADKDVFHMVVEVPRWSNAKMEIATKDPLNPIKQDVKKGKLRYVANLFPYKGYIWNYGAIPQTWEDPGHNDKHTGCCGDNDPIDVCEIGSKVCARGEIIGVKVLGILAMIDEGETDWKVIAINVDDPDAANYNDINDVKRLKPGYLEATVDWFRRYKVPDGKPENEFAFNAEFKDKDFAIDIIKSTHDHWKALVTKKTNGKGISCMNTTLSESPFKCDPDAARAIVDALPPPCESACTVPTDVDKWFHHQKN","Homo sapiens","PPA1, IOPPP, PP","Inorganic pyrophosphatase","1","6C45"
"6C4D",,"X-RAY DIFFRACTION",2.24,45.18,"VAPOR DIFFUSION",7.2,"0.25 M ammonium iodide, 0.03 M glycyl-glycyl-glycine and polyethylene glycol (PEG) 3350 15-25%",277,"10.1021/acs.jmedchem.7b01647","EJP","6C4D",136.23,"2.52","2.52","Structure based design of RIP1 kinase inhibitors","GGSGQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","6C4D"
"6C4J",,"X-RAY DIFFRACTION",3.14,60.77,"VAPOR DIFFUSION, HANGING DROP",,"3 mM UDP-Glc, 5mM NADH, PEG 3350, Ammonium Sulfate, NaCl, 1,2 propanediol, Tris pH (8.6)",293,"10.1021/acs.biochem.8b00497",,"6C4J",678.07,"2.53","2.53","Ligand bound full length hUGDH with A104L substitution","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRALDLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","6C4J"
"6C4K",,"X-RAY DIFFRACTION",2.68,54.07,"VAPOR DIFFUSION, HANGING DROP",7.6,"16% PEG 3350, 0.5M NaCl, 0.1M Tris (pH 7.6)",293,"10.1021/acs.biochem.8b00497",,"6C4K",165.72,"2.65","2.65","Full length hUGDH with A104L substitution in the absence of ligand","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRALDLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","6C4K"
"6C4O",,"X-RAY DIFFRACTION",1.5,18.08,"VAPOR DIFFUSION, HANGING DROP",,"TIAALLS crystals were grown from 5mg/mL peptide and 10% acetonitrile. The reservoir contained 100mM Tris pH 8.5 and 0.3 M magnesium formate dihydrate. Crystals were soaked on 25% Glycerol prior to diffraction",298,"10.1002/pro.3420",,"6C4O",1.38,"1.79","1.79","AMYLOID FORMING PEPTIDE TIAALLS FROM TRANSTHYRETIN","TIAALLS","Homo sapiens",,"THR-ILE-ALA-ALA-LEU-LEU-SER","1","6C4O"
"6C56",,"X-RAY DIFFRACTION",3.3,62.68,"VAPOR DIFFUSION, SITTING DROP",,"0.26 M ammonium phosphate, 35% glycerol",295,"10.1021/acs.jmedchem.8b00886",,"6C56",75.25,"2.8","2.8","Crystal structure of mutant human geranylgeranyl pyrophosphate synthase (Y246D) in its Apo form","MHHHHHHSSGVDLGTENLYFQSMEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIIIEVTEMLHNASLLIDDIEDNSKLRRGFPVAHSIYGIPSVINSANYVYFLGLEKVLTLDHPDAVKLFTRQLLELHQGQGLDIYWRDNYTCPTEEEYKAMVLQKTGGLFGLAVGLMQLFSDYKEDLKPLLNTLGLFFQIRDDYANLHSKEYSENKSFCEDLTEGKFSFPTIHAIWSRPESTQVQNILRQRTENIDIKKDCVHYLEDVGSFEYTRNTLKELEAKAYKQIDARGGNPELVALVKHLSKMFKEENE","Homo sapiens","GGPS1","Geranylgeranyl pyrophosphate synthase","1","6C56"
"6C57",,"X-RAY DIFFRACTION",3.28,62.49,"VAPOR DIFFUSION, SITTING DROP",,"1.7 M ammonium sulfate, 4.25% isopropanol, 15% glycerol",295,"10.1021/acs.jmedchem.8b00886",,"6C57",75.39,"3.5","3.5","Crystal structure of mutant human geranylgeranyl pyrophosphate synthase (Y246D) in complex with bisphosphonate inhibitor FV0109","MHHHHHHSSGVDLGTENLYFQSMEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIIIEVTEMLHNASLLIDDIEDNSKLRRGFPVAHSIYGIPSVINSANYVYFLGLEKVLTLDHPDAVKLFTRQLLELHQGQGLDIYWRDNYTCPTEEEYKAMVLQKTGGLFGLAVGLMQLFSDYKEDLKPLLNTLGLFFQIRDDYANLHSKEYSENKSFCEDLTEGKFSFPTIHAIWSRPESTQVQNILRQRTENIDIKKDCVHYLEDVGSFEYTRNTLKELEAKAYKQIDARGGNPELVALVKHLSKMFKEENE","Homo sapiens","GGPS1","Geranylgeranyl pyrophosphate synthase","1","6C57"
"6C58",,"X-RAY DIFFRACTION",2.82,56.44,"VAPOR DIFFUSION, HANGING DROP",7.4,"10% PEG3350, 16% 1,5-pentanediol, 100 mM HEPES",293,,,"6C58",336.29,"2.198","2.198","Human UDP-Glucose Dehydrogenase A225L substitutuion with UDP-xylose bound","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANLFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","6C58"
"6C5A",,"X-RAY DIFFRACTION",2.89,57.49,"VAPOR DIFFUSION, HANGING DROP",8.5,"13% PEG3350; 50 mM dipotassium phosphate, 100 mM Tris",293,,,"6C5A",338.27,"2.3","2.3","Human UDP-Glucose Dehydrogenase with UDP- Glc and NADH bound","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","6C5A"
"6C5F",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, HANGING DROP",5.8,"28% - 34% PEG 4000, 0.1 M sodium citrate tribasic dihydrate, pH 5.8, 0.2 M Ammonium acetate",293,"10.1021/acs.biochem.8b00344","7L9","6C5F",38.07,"1.4","1.4","Human D-Dopachrome tautomerase (D-DT)/ macrophage migration inhibitory factor 2 (MIF2) complexed with the selective inhibitor 4-CPPC","PFLELDTNLPANRVPAGLEKRLCAAAASILGKPADRVNVTVRPGLAMALSGSTEPCAQLSISSIGVVGTAEDNRSHSAHFFEFLTKELALGQDRILIRFFPLESWQIGKIGTVMTFL","Homo sapiens","DDT","D-dopachrome decarboxylase","1","6C5F"
"6C5Q",,"X-RAY DIFFRACTION",3.5,64.89,"VAPOR DIFFUSION, SITTING DROP",7,"4M ammonium acetate, O.1M bis-tris propane 7.0",298,"10.1016/j.isci.2018.06.012","EKS","6C5Q",33.34,"2.404","2.404","PPARg LBD bound to SR10171","HHHHHHGSHMESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6C5Q"
"6C5T",,"X-RAY DIFFRACTION",3.4,63.81,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG 3350 + 0.2M ammonium citrate 7.0",289,"10.1016/j.isci.2018.06.012",,"6C5T",32.07,"2.75","2.75","PPARg LBD bound to SR11023","HGSHMESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6C5T"
"6C5Z",,"X-RAY DIFFRACTION",2.84,56.74,"VAPOR DIFFUSION, HANGING DROP",8.8,"20% PEG3350, 50 mM dipotassium phosphate, 100 mM sodium glycine",293,,,"6C5Z",337.54,"2.95","2.95","Human UDP-Glucose Dehydrogenase A225L substitutuion with UDP-glucose and NADH bound","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANLFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","6C5Z"
"6C6D",,"X-RAY DIFFRACTION",5.07,75.73,"VAPOR DIFFUSION, HANGING DROP",,"10% (v/v) 2-propanol, 0.1M HEPES pH 7.5, 0.2M NaCl",303.15,,,"6C6D",150.29,"5.5","5.5","20mer crystal structure of CC chemokine 5 (CCL5)","SSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS","Homo sapiens","CCL5, D17S136E, SCYA5","C-C motif chemokine 5","1","6C6D"
"6C6M",,"X-RAY DIFFRACTION",3.22,61.78,"VAPOR DIFFUSION, SITTING DROP",,"200mM ammonium dihydrogen phosphate, 20% PEG3350",277,"10.1038/s41591-019-0393-7",,"6C6M",34.9,"2.5","2.5","IgCam3 of human MLCK1","MEGQRDSAFPKFESKPQSQEVKENQTVKFRCEVSGIPKPEVAWFLEGTPVRRQEGSIEVYEDAGSHYLCLLKARTRDSGTYSCTASNAQGQLSCSWTLQVERL","Homo sapiens","MYLK, MLCK, MLCK1, MYLK1","Myosin light chain kinase, smooth muscle","1","6C6M"
"6C6N",,"X-RAY DIFFRACTION",3.86,68.13,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2 M ammonium sulfate, 0.1 M tri-sodium citrate pH 5.6, 15-18 %(w/v) PEG 4000, 0.02 M hexammine cobalt(III) chloride",293,"10.1038/s41467-018-07928-x","EKV","6C6N",109.12,"2.3","2.3","Human squalene epoxidase (SQLE, squalene monooxygenase) structure with FAD and Cmpd-4""","GTSSQNDPEVIIVGAGVLGSALAAVLSRDGRKVTVIERDLKEPDRIVGEFLQPGGYHVLKDLGLGDTVEGLDAQVVNGYMIHDQESKSEVQIPYPLSENNQVQSGRAFHHGRFIMSLRKAAMAEPNAKFIEGVVLQLLEEDDVVMGVQYKDKETGDIKELHAPLTVVADGLFSKFRKSLVSNKVSVSSHFVGFLMKNAPQFKANHAELILANPSPVLIYQISSSETRVLVDIRGEMPRNLREYMVEKIYPQIPDHLKEPFLEATDNSHLRSMPASFLPPSSVKKRGVLLLGDAYNMRHPLTGGGMTVAFKDIKLWRKLLKGIPDLYDDAAIFEAKKSFYWARKTSHSFVVNILAQALYELFSATDDSLHQLRKACFLYFKLGGECVAGPVGLLSVLSPNPLVLIGHFFAVAIYAVYFCFKSEPWITKPRALLSSGAVLYKACSVIFPLIYSEMKYMVH","Homo sapiens","SQLE, ERG1","Squalene monooxygenase","1","6C6N"
"6C6P",,"X-RAY DIFFRACTION",3.9,68.46,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2 M Ammonium sulfate, 0.1 M tri-Sodium citrate pH 5.6, 15 %(w/v) PEG 4000, 0.02 M Hexammine cobalt(III) chloride",293,"10.1038/s41467-018-07928-x","EMV","6C6P",108.57,"2.5","2.5","Human squalene epoxidase (SQLE, squalene monooxygenase) structure with FAD and NB-598","GTSSQNDPEVIIVGAGVLGSALAAVLSRDGRKVTVIERDLKEPDRIVGEFLQPGGYHVLKDLGLGDTVEGLDAQVVNGYMIHDQESKSEVQIPYPLSENNQVQSGRAFHHGRFIMSLRKAAMAEPNAKFIEGVVLQLLEEDDVVMGVQYKDKETGDIKELHAPLTVVADGLFSKFRKSLVSNKVSVSSHFVGFLMKNAPQFKANHAELILANPSPVLIYQISSSETRVLVDIRGEMPRNLREYMVEKIYPQIPDHLKEPFLEATDNSHLRSMPASFLPPSSVKKRGVLLLGDAYNMRHPLTGGGMTVAFKDIKLWRKLLKGIPDLYDDAAIFEAKKSFYWARKTSHSFVVNILAQALYELFSATDDSLHQLRKACFLYFKLGGECVAGPVGLLSVLSPNPLVLIGHFFAVAIYAVYFCFKSEPWITKPRALLSSGAVLYKACSVIFPLIYSEMKYMVH","Homo sapiens","SQLE, ERG1","Squalene monooxygenase","1","6C6P"
"6C6R",,"X-RAY DIFFRACTION",3.81,67.74,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2 M Ammonium sulfate, 0.1 M tri-Sodium citrate pH 5.6, 15 %(w/v) PEG 4000, 0.02 M Hexammine cobalt(III) chloride",293,"10.1038/s41467-018-07928-x",,"6C6R",107.88,"3","3","Human Squalene Epoxidase (SQLE, Squalene Monooxygenase) structure with FAD","GTSSQNDPEVIIVGAGVLGSALAAVLSRDGRKVTVIERDLKEPDRIVGEFLQPGGYHVLKDLGLGDTVEGLDAQVVNGYMIHDQESKSEVQIPYPLSENNQVQSGRAFHHGRFIMSLRKAAMAEPNAKFIEGVVLQLLEEDDVVMGVQYKDKETGDIKELHAPLTVVADGLFSKFRKSLVSNKVSVSSHFVGFLMKNAPQFKANHAELILANPSPVLIYQISSSETRVLVDIRGEMPRNLREYMVEKIYPQIPDHLKEPFLEATDNSHLRSMPASFLPPSSVKKRGVLLLGDAYNMRHPLTGGGMTVAFKDIKLWRKLLKGIPDLYDDAAIFEAKKSFYWARKTSHSFVVNILAQALYELFSATDDSLHQLRKACFLYFKLGGECVAGPVGLLSVLSPNPLVLIGHFFAVAIYAVYFCFKSEPWITKPRALLSSGAVLYKACSVIFPLIYSEMKYMVH","Homo sapiens","SQLE, ERG1","Squalene monooxygenase","1","6C6R"
"6C7D",,"X-RAY DIFFRACTION",2.21,44.47,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2 M magnesium chloride, 0.1 M Tris, pH 8.4",293,"10.1021/acs.jmedchem.8b00713","EOJ","6C7D",161.89,"1.79","1.79","Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chlorophenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLD","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6C7D"
"6C7E",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2 M magnesium chloride, 0.1 M Tris, pH 8.4",293,"10.1021/acs.jmedchem.8b00713","EOG","6C7E",161.41,"1.43","1.43","Crystal structure of human phosphodiesterase 2A with 1-(2-chlorophenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLD","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6C7E"
"6C7F",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2 M magnesium chloride, 0.1 M Tris, pH 8.4",293,"10.1021/acs.jmedchem.8b00713","EOS","6C7F",121.27,"1.82","1.82","Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-isobutoxy-phenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLD","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6C7F"
"6C7G",,"X-RAY DIFFRACTION",2.26,45.46,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2 M magnesium chloride, 0.1 M Tris, pH 8.4",293,"10.1021/acs.jmedchem.8b00713","EOY","6C7G",162.17,"1.68","1.68","Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chloro-5-isobutoxy-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLD","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6C7G"
"6C7I",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2 M magnesium chloride, 0.1 M Tris, pH 8.4",293,"10.1021/acs.jmedchem.8b00713","EP7","6C7I",161.69,"1.713","1.713","Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-methoxy-phenyl)-N-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLD","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6C7I"
"6C7J",,"X-RAY DIFFRACTION",2.21,44.38,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2 M magnesium chloride, 0.1 M Tris, pH 8.4",293,"10.1021/acs.jmedchem.8b00713","EPV","6C7J",161.86,"1.85","1.85","Crystal structure of human phosphodiesterase 2A with 1-(5-tert-butoxy-2-chloro-phenyl)-N-isobutyl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLD","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6C7J"
"6C7Q",,"X-RAY DIFFRACTION",2,38.5,"VAPOR DIFFUSION, SITTING DROP",8,"50-75% peg 400, 0.1M Imidizole, pH 8.0",293,"10.1021/acs.jmedchem.8b00483","EO1","6C7Q",15.72,"1.51","1.51","BRD4 BD2 in complex with compound CE277","SNAKDVPDSQQHPAPEKSSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6C7Q"
"6C7R",,"X-RAY DIFFRACTION",2.04,39.57,"VAPOR DIFFUSION, SITTING DROP",,"20% peg 3350, 0.2M Potassium Chloride",293.15,"10.1021/acs.jmedchem.8b00483","EO4","6C7R",15.24,"1.5","1.5","BRD4 BD1 in complex with compound CF53","SNANPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELP","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6C7R"
"6C7W",,"X-RAY DIFFRACTION",2.1,41.3,"VAPOR DIFFUSION, SITTING DROP",8,"Protein was at 10 mg/mL and was set up in 250 plus 250 nL drops with a reservoir of 50 mM Tris pH 8.0, 2.8 M ammonium sulfate",281,"10.1016/j.bmcl.2018.04.038","LMS","6C7W",29.72,"1.28","1.28","Carbonic anhydrase 2 in complex with [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDRO-2-FURANYL]METHYL SULFAMATE inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6C7W"
"6C7X",,"X-RAY DIFFRACTION",2.1,41.37,"VAPOR DIFFUSION, SITTING DROP",8,"Protein was at 10 mg/mL and was set up in 250 plus 250 nL drops with a reservoir of 50 mM Tris pH 8.0, 2.8 M ammonium sulfate at 8C",281,"10.1016/j.bmcl.2018.04.038","EO7","6C7X",29.76,"1.5","1.5","Carbonic anhydrase 2 in complex with 2-chloro-5'-O-sulfamoyladenosine","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6C7X"
"6C7Z",,"X-RAY DIFFRACTION",2.02,39.14,"VAPOR DIFFUSION, HANGING DROP",4.5,"30% PEG 4000, 0.1M Ammonium Acetate, 0.1 M Sodium Acetate pH=4.5",298,"10.1002/cbic.201800050",,"6C7Z",31.79,"1.42","1.42","Crystal structure of the Q108K:K40L:T51V:R58F mutant of human Cellular Retinol Binding Protein II in complex with synthetic Ligand Julolidine","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKVKTTSTFFNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6C7Z"
"6C88",,"X-RAY DIFFRACTION",1.6,23.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"10mg/ml peptide solution. Reservoir contained 0.2 M Magnesium chloride hexahydrate, 0.1 M HEPES sodium pH 7.5, 30% v/v 2-Propanol. Crystals were soaked in 25% glycerol prior to diffraction",298,"10.1002/pro.3420",,"6C88",1.44,"1.851","1.851","STRUCTURE OF THE AMYLOID FORMING PEPTIDE VAVHVF FROM TRANSTHYRETIN","VAVHVF","Homo sapiens",,"VAL-ALA-VAL-HIS-VAL-PHE","1","6C88"
"6C8U",,"SOLUTION NMR",,,,,,,"10.1002/prot.25836",,"6C8U",13.15,,,"Solution structure of Musashi2 RRM1","MHHHHHHSTSVDLGTENLYFQSNAGKMFIGGLSWQTSPDSLRDYFSKFGEIRECMVMRDPTTKRSRGFGFVTFADPASVDKVLGQPHHELDSKTIDPKVAFPRRAQPKMVTRTKK","Homo sapiens","MSI2","RNA-binding protein Musashi homolog 2","1","6C8U"
"6C9D",,"X-RAY DIFFRACTION",2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",,"6-8% PEG8000, 0.2-0.3 M imidazole, pH 8.0-8.5",293,"10.1016/j.str.2018.05.008",,"6C9D",105.87,"2.499","2.499","Crystal structure of KA1-autoinhibited MARK1 kinase","MHHHHHHNSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVLNPIKRGSLEQIMKDRWMNVGHEEEELKPYTEPDPDFNDTKRIDIMVTMGFARDEINDALINQKYDEVMATYILLGRKPPEFEGGESLSGEPKERDKEEGKDSKPRSLRFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCSLPSLSLNGVRFKRISGTSIAFKNIASKIANELKL","Homo sapiens","MARK1, KIAA1477, MARK","Serine/threonine-protein kinase MARK1,Serine/threonine-protein kinase MARK1","1","6C9D"
,,,,,,,,,,,,,,,,,"Homo sapiens","MARK1, KIAA1477, MARK"
"6C9L",,"X-RAY DIFFRACTION",2.02,39.16,"VAPOR DIFFUSION, HANGING DROP",,"0.4 M NaCl, 0.1 M Bis-Tris pH 5.5, 20% PEG3350",295,"10.1021/acs.biochem.8b00439",,"6C9L",66.23,"2.3","2.3","MEF2B Apo Protein Structure","MGRKKIQISRILDQRNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNSANRLFQYASTDMDRVLLKYTEYSEPHESRTNTDILETLKRRGI","Homo sapiens","MEF2B, XMEF2","Myocyte-specific enhancer factor 2B","1","6C9L"
"6CA2",,"X-RAY DIFFRACTION",2.14,42.59,,,,,"10.1021/bi00110a008",,"6CA2",29.6,"2.5","2.5","ENGINEERING THE HYDROPHOBIC POCKET OF CARBONIC ANHYDRASE II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAFLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE II","1","6CA2"
"6CA6",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, SITTING DROP",,"0.17M sodium acetate, 0.085M Tris pH 8.5, 15% glycerol and 25.5% PEG 4000",293.15,"10.1016/j.celrep.2018.05.046",,"6CA6",98.72,"2.43","2.43","Crystal structure of PCT64_35S, a broadly neutralizing anti-HIV antibody.","EIVLTQSPGTLSLSPGDRATLSCRATQSVGGDYFAWYQQRPGQSPRLLIYGTSRRAAGIPDRFSGSGSGTDFTLTIDRLEPEDFAVYYCRQYETSFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PCT64_35S light chain","1","6CA6"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKPGGSLRLACVGSEFTFSEAWMTWVRQAPGKGLEWVGHMRPTTEGGAKDYAAAVRGRFTIARDDSKSTLYLQMNSLKIEDTGVYYCMTGVERGDFWSDDYSQHYNTYLIDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCD","Homo sapiens",,"PCT64_35S heavy chain","2","6CA6"
"6CA7",,"X-RAY DIFFRACTION",2.37,48.12,"VAPOR DIFFUSION, SITTING DROP",,"10% 2-propanol, 10% glycerol, 0.1 HEPES pH 7.5, and 20% PEG 2000",293.15,"10.1016/j.celrep.2018.05.046",,"6CA7",48.98,"1.643","1.643","Crystal structure of PCT64_13C, a strain specific anti-HIV antibody","EIVLTQSPGTLSLSPGERATLSCRASQSVSNNYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQSARSFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PCT64_13C light chain","1","6CA7"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKPGGSLRLSCAASGFTFTNAWLDWVRQAPGKGLEWVGRIKSKTDGGTTDHAAPVKGRFTISRDDSKNTVYLQMNSLKIEDTAVYYCTTGVETYDFWSGYDDHYYDYYFKDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCD","Homo sapiens",,"PCT64_13C heavy chain","2","6CA7"
"6CA9",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris (pH 8), 1 M lithium chloride, 10% w/v PEG 6000, cryoprotected with 30% glycerol",293,"10.1016/j.celrep.2018.05.046",,"6CA9",98.22,"2.702","2.702","Crystal structure of Fab PCT64_LMCA (SAR), the least mutated common ancestor of the HIV-1 broadly neutralizing antibody lineage PCT64","EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQSARSFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"PCT64_LMCA Fab light chain","1","6CA9"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKPGGSLRLSCAASGFTFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTGVETYDFWSGYDDHYYDYYFRDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD","Homo sapiens",,"PCT64_LMCA Fab heavy chain","2","6CA9"
"6CAA","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-03271-3",,"6CAA",232.34,"3.9",,"CryoEM structure of human SLC4A4 sodium-coupled acid-base transporter NBCe1","MSTENVEGKPSNLGERGRARSSTFLRVVQPMFNHSIFTSAVSPAAERIRFILGEEDDSPAPPQLFTELDELLAVDGQEMEWKETARWIKFEEKVEQGGERWSKPHVATLSLHSLFELRTCMEKGSIMLDREASSLPQLVEMIVDHQIETGLLKPELKDKVTYTLLRKHRHQTKKSNLRSLADIGKTVSSASRMFTNPDNGSPAMTHRNLTSSSLNDISDKPEKDQLKNKFMKKLPRDAEASNVLVGEVDFLDTPFIAFVRLQQAVMLGALTEVPVPTRFLFILLGPKGKAKSYHEIGRAIATLMSDEVFHDIAYKAKDRHDLIAGIDEFLDEVIVLPPGEWDPAIRIEPPKSLPSSDKRKNMYSGGENVQMNGDTPHDGGHGGGGHGDCEELQRTGRFCGGLIKDIKRKAPFFASDFYDALNIQALSAILFIYLATVTNAITFGGLLGDATDNMQGVLESFLGTAVSGAIFCLFAGQPLTILSSTGPVLVFERLLFNFSKDNNFDYLEFRLWIGLWSAFLCLILVATDASFLVQYFTRFTEEGFSSLISFIFIYDAFKKMIKLADYYPINSNFKVGYNTLFSCTCVPPDPANISISNDTTLAPEYLPTMSSTDMYHNTTFDWAFLSKKECSKYGGNLVGNNCNFVPDITLMSFILFLGTYTSSMALKKFKTSPYFPTTARKLISDFAIILSILIFCVIDALVGVDTPKLIVPSEFKPTSPNRGWFVPPFGENPWWVCLAAAIPALLVTILIFMDQQITAVIVNRKEHKLKKGAGYHLDLFWVAILMVICSLMALPWYVAATVISIAHIDSLKMETETSAPGEQPKFLGVREQRVTGTLVFILTGLSVFMAPILKFIPMPVLYGVFLYMGVASLNGVQFMDRLKLLLMPLKHQPDFIYLRHVPLRRVHLFTFLQVLCLALLWILKSTVAAIIFPVMILALVAVRKGMDYLFSQHDLSFLDDVIPEKDKKKKEDEKKKKKKKGSLDSDNDDSDCPYSEKVPSIKIPMDIMEQQPFLSDSKPSDRERSPTFLERHTSC","Homo sapiens","SLC4A4, NBC, NBC1, NBCE1","Electrogenic sodium bicarbonate cotransporter 1","1","6CAA"
"6CAD",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG 3350, 0.1M Bis-Tris Propane pH 6.5, 0.2M Sodium Nitrate",293,"10.1016/j.ejmech.2018.01.053","EU4","6CAD",65.44,"2.55","2.55","Crystal structure of RAF kinase domain bound to the inhibitor 2a","GAMDRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","6CAD"
"6CB5",,"X-RAY DIFFRACTION",2.84,56.69,"VAPOR DIFFUSION, SITTING DROP",7,"2.0 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7.0, 3% ISOPROPANOL",293.15,"10.1002/cmdc.201800158","EV7","6CB5",38.25,"1.78","1.78","Macrophage Migration Inhibitory Factor in complex with a Pyrazole Inhibitor (8g)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6CB5"
"6CB9",,"X-RAY DIFFRACTION",1.41,12.75,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.01 M Nickel Chloride hexahydrate, 0.1 M Tris pH 8.5, 20% (w/v) PEG 2000",298,"10.1038/s41594-018-0064-2",,"6CB9",0.58,"1.1","1.1","Segment AALQSS from the low complexity domain of TDP-43, residues 328-333","AALQSS","Homo sapiens",,"AALQSS","1","6CB9"
"6CBF",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.4M ammonium sulfate, 3% isopropanol, 0.1M Tris pH 6.5",293,"10.1002/cmdc.201800158","EWD","6CBF",37.91,"2.3","2.3","Macrophage Migration Inhibitory Factor in Complex with a Pyrazole Inhibitor (6a)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6CBF"
"6CBG",,"X-RAY DIFFRACTION",2.73,54.93,"VAPOR DIFFUSION, HANGING DROP",8,"2.4M ammonium sulfate, 3% isopropanol, 0.1M Tris pH 7",293.15,"10.1002/cmdc.201800158","EWG","6CBG",38.85,"2","2","Macrophage Migration Inhibitory Factor in Complex with a Pyrazole Inhibitor (5)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6CBG"
"6CBH",,"X-RAY DIFFRACTION",2.79,55.93,"VAPOR DIFFUSION, HANGING DROP",7,"2.4M ammonium sulfate, 3% isopropanol, 0.1M Tris pH 7",293,"10.1002/cmdc.201800158","EWJ","6CBH",38.29,"2","2","Macrophage Migration Inhibitory Factor in Complex with a Pyrazole Inhibitor (8m)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6CBH"
"6CBJ",,"X-RAY DIFFRACTION",3.88,68.31,"VAPOR DIFFUSION, HANGING DROP",5.6,"1 M sodium/potassium phosphate, pH 5.6",293,"10.1038/s41467-018-03565-6",,"6CBJ",50.53,"2.85","2.85","Crystal Structure of DH270.3 Fab in complex with Man9","QVQLVQSGAELKKPGASVKVSCKASGYTLSDYYVHWLRQAPGQGLEWVAWINPTSGRTISPRKFQGRVTMTTDTSMNVAYMELRGLRSDDTAVYFCARGGWISLYVDYSYYPNFDSWGQGTLVSVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"DH270.3 Fab heavy chain","1","6CBJ"
,,,,,,,,,,,,,,,,,"Homo sapiens"
,,,,,,,,,,,,,,,,"QPVLTQPASVSGSPGQSITISCTGSSSDVGSYNLVSWYQQHPGKAPKLMIYEVNKWASGVSDRFAGSKSGNTASLTISRLQAEDEANYFCSSSTNSATVIFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"DH270.3 Fab light chain","2","6CBJ"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"6CBU",,"X-RAY DIFFRACTION",2.16,43.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% PEG 3350, 200 mM Bis-tris, pH 6.5, 200 mM LiSO4",293,"10.1038/s41467-019-08876-w",,"6CBU",11.4,"1.2","1.2","Crystal structure of C4S3: A computationally designed immunogen to target Carbohydrate-Occluded Epitopes on the HIV envelope","GMAEGNTLISVDYEIFGKVQGVFFRKHTQAEGKKLGLVGWVQNTDRGTVQGQLQGPISKVRHMQEWLETRGSPKSHIDKANFNNEKLIEELDYSDFQIVA","Homo sapiens","ACYP1, ACYPE","Acylphosphatase-1","1","6CBU"
"6CBX",,"X-RAY DIFFRACTION",2.19,43.85,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2 M NH4SO4",291,,,"6CBX",101.47,"1.94","1.94","Crystal structure of human SET and MYND Domain Containing protein 2 with MTF1497","GMRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLEFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","6CBX"
"6CBY",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 0.2 M NH4SO4",291,,,"6CBY",101.17,"2.55","2.55","Crystal structure of human SET and MYND Domain Containing protein 2 with MTF9975","GMRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLEFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","6CBY"
"6CCF",,"X-RAY DIFFRACTION",2.49,50.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"33% PEG2000 MME, 0.1 M potassium thiocyanate, 0.1 M CHC buffer, pH 7.5, cryoprotectant: 30% polyethylene glycol",280,,,"6CCF",66.56,"2.1","2.1","Crystal Structure of the Human CAMKK1A in complex with Hesperadin","SMQLNQYKLQSEIGKGAYGVVRLAYNESEDRHYAMKVLSKKKLLKQYGFPRRPPPRGSQAAQGGPAKQLLPLERVYQEIAILKKLDHVNVVKLIEVLDDPAEDNLYLVFDLLRKGPVMEVPCDKPFSEEQARLYLRDVILGLEYLHCQKIVHRDIKPSNLLLGDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEAISDSGQSFSGKALDVWATGVTLYCFVYGKCPFIDDFILALHRKIKNEPVVFPEEPEISEELKDLILKMLDKNPETRIGVPDIKLHPWVTK","Homo sapiens","CAMKK1, CAMKKA","Calcium/calmodulin-dependent protein kinase kinase 1","1","6CCF"
"6CCR",,"X-RAY DIFFRACTION",1.97,37.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"10% 2-propanol, 20% PEG4K and 0.1M Na-HEPES",291,"10.1038/s41589-018-0036-1",,"6CCR",21.79,"1.6","1.6","Selenomethionyl derivative of a GID4 fragment","GGVATSLLYSGSKFRGHQKSKGNSYDVEVVLQHVDTGNSYLCGYLKIKGLTEEYPTLTTFFEGEIISKKHPFLTRKWDADEDVDRKHWGKFLAFYQYAKSFNSDDFDYEELKNGDYVFMRWKEQFLVPDHTIKDISGASFAGFYYICFQKSAASIEGYYYHRSSEWYQSLNLTHVPEHSAPIYEFR","Homo sapiens","GID4, C17orf39, VID24","Glucose-induced degradation protein 4 homolog","1","6CCR"
"6CCW",,"SOLUTION NMR",,,,,,,"10.1002/anie.201804667",,"6CCW",8.54,,,"Hybrid-2 form Human Telomeric G Quadruplex in Complex with Epiberberine","TTAGGGTTAGGGTTAGGGTTAGGGTT","Homo sapiens",,"DNA (26-MER)","1","6CCW"
"6CD4",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION",,"100mM Sodium Nitrate, 5% Ethylene Glycol, 18% (w/v) PEG3350",295,"10.1021/acschembio.7b00638","EX1","6CD4",15.85,"1.23","1.23","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG046","STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CD4"
"6CD5",,"X-RAY DIFFRACTION",2.38,48.4,"VAPOR DIFFUSION",,"100mM Sodium Nitrate, 5% Ethylene Glycol, 18% (w/v) PEG3350",295,"10.1021/acschembio.7b00638",,"6CD5",15.97,"1.58","1.58","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor XMD17-26","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CD5"
"6CD6",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"33.75% PEG2000 MME, 0.15 M potassium thiocyanate, 0.1 M CHC buffer, pH 7.0, cryoprotectant: 30% polyethylene glycol",280,,,"6CD6",132.48,"2.2","2.2","Crystal Structure of the Human CAMKK1A in complex with GSK650394","SMQLNQYKLQSEIGKGAYGVVRLAYNESEDRHYAMKVLSKKKLLKQYGFPRRPPPRGSQAAQGGPAKQLLPLERVYQEIAILKKLDHVNVVKLIEVLDDPAEDNLYLVFDLLRKGPVMEVPCDKPFSEEQARLYLRDVILGLEYLHCQKIVHRDIKPSNLLLGDDGHVKIADFGVSNQFEGNDAQLSSTAGTPAFMAPEAISDSGQSFSGKALDVWATGVTLYCFVYGKCPFIDDFILALHRKIKNEPVVFPEEPEISEELKDLILKMLDKNPETRIGVPDIKLHPWVTK","Homo sapiens","CAMKK1, CAMKKA","Calcium/calmodulin-dependent protein kinase kinase 1","1","6CD6"
"6CDF",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"5% PEG400, 140 mM calcium chloride",293,"10.1074/jbc.RA118.002514",,"6CDF",41.65,"2.6","2.6","Human CtBP1 (28-378)","MGSSHHHHHHSSGLVPRGSHMPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQEIHEKVLNEAVGALMYHTITLTREDLEKFKALRIIVRIGSGFDNIDIKSAGDLGIAVCNVPAASVEETADSTLCHILNLYRRATWLHQALREGTRVQSVEQIREVASGAARIRGETLGIIGLGRVGQAVALRAKAFGFNVLFYDPYLSDGVERALGLQRVSTLQDLLFHSDCVTLHCGLNEHNHHLINDFTVKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFSQGPLKDAPNLICTPHAAWYSEQASIEMREEAAREIRRAITGRIPDSLKNCVNKDHLTAATHWASMDPAVVHPELNGAAY","Homo sapiens","CTBP1, CTBP","C-terminal-binding protein 1","1","6CDF"
"6CDH",,"X-RAY DIFFRACTION",3.71,66.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6CDH",23.51,"1.821","1.821","Crystal structure of ferrous form of the Cl-Tyr157 human cysteine dioxygenase with both uncrosslinked and crosslinked cofactor","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6CDH"
"6CDN",,"X-RAY DIFFRACTION",3.69,66.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1038/s41589-018-0085-5",,"6CDN",23.63,"2.055","2.055","Crystal structure of cysteine-bound ferrous form of the crosslinked Cl-Tyr157 human cysteine dioxygenase","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLXSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6CDN"
"6CDR",,"X-RAY DIFFRACTION",2.31,46.64,"VAPOR DIFFUSION",7.5,"100 mM HEPES, 80 mM magnesium chloride, 4% PEG400",293,"10.1074/jbc.RA118.002514",,"6CDR",41.96,"2.399","2.399","Human CtBP1 (28-378)","MGSSHHHHHHSSGLVPRGSHMPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQEIHEKVLNEAVGALMYHTITLTREDLEKFKALRIIVRIGSGFDNIDIKSAGDLGIAVCNVPAVSVEETADSTLCHILNLYRRATWLHQALREGTRVQSVEQIREVASGAARIRGETLGIIGLGRVGQAVALRAKAFGFNVLFYDPYLSDGVERALGLQRVSTLQDLLFHSDCVTLHCGLNEHNHHLINDFTVKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFSQGPLKDAPNLICTPHAAWYSEQASIEMREEAAREIRRAITGRIPDSLKNCVNKDHLTAATHWASMDPAVVHPELNGAAY","Homo sapiens","CTBP1, CTBP","C-terminal-binding protein 1","1","6CDR"
"6CDS",,"X-RAY DIFFRACTION",2.7,54.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES (pH 7.5), 50 mM MgCl2(H2O)6, 35 % PEG 550 monomethyl ether",293.15,"10.1038/s41467-018-03648-4",,"6CDS",82.35,"2.62","2.62","Human neurofibromin 2/merlin/schwannomin residues 1-339 in complex with PIP2","MAGAIASRMSFSSLKRKQPKTFTVRIVTMDAEMEFNCEMKWKGKDLFDLVCRTLGLRETWFFGLQYTIKDTVAWLKMDKKVLDHDVSKEEPVTFHFLAKFYPENAEEELVQEITQHLFFLQVKKQILDEKIYCPPEASVLLASYAVQAKYGDYDPSVHKRGFLAQEELLPKRVINLYQMTPEMWEERITAWYAEHRGRARDEAEMEYLKIAQDLEMYGVNYFAIRNKKGTELLLGVDALGLHIYDPENRLTPKISFPWNEIRNISYSDKEFTIKPLDKKIDVFKFNSSKLRVNKLILQLCIENHDLFMRRRKADSLEVQQMKAQAREEKARKQMERQRL","Homo sapiens","NF2, SCH","Merlin","1","6CDS"
"6CDT",,"X-RAY DIFFRACTION",2.12,42.01,"VAPOR DIFFUSION, HANGING DROP",,"crystallized by the hanging drop vapor diffusion method at 13 degrees Celsius by mixing equal volumes of a purified protein (11-15 mg/mL) solution with a crystallization solution containing 0.15 M ammonium sulfate, 9 - 10.5% (w/v) monomethylether polyethylene glycol (MW 5 K) and 0.1 M MES buffer in a pH range of 5.3-5.6.",286,"10.1021/acsmedchemlett.8b00348",,"6CDT",36.91,"1.8","1.8","Structure of Human Anaplastic Lymphoma Kinase Domain","MAHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","6CDT"
"6CDY",,"X-RAY DIFFRACTION",2.45,49.81,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1 M Hepes, pH 7.2,
2.4 M sodium formate.",293,"10.1016/j.stem.2020.03.002",,"6CDY",55.72,"2.32","2.32","Crystal structure of TEAD complexed with its inhibitor","MAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRDVEHHHHHH","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6CDY"
"6CE1",,"X-RAY DIFFRACTION",2.75,55.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"Sodium HEPES + MOPS (acid)
Ethylene glycols
PEG 8000",291,,,"6CE1",77.53,"2.8","2.8","Crystal structure of Peptidyl Arginine Deiminase Type III (PADI3)","MSYYHHHHHHLESTSLYKKAGFMSLQRIVRVSLEHPTSAVCVAGVETLVDIYGSVPEGTEMFEVYGTPGVDIYISPNMERGRERADTRRWRFDATLEIIVVMNSPSNDLNDSHVQISYHSSHEPLPLAYAVLYLTCVDISLDCDLNCEGRQDRNFVDKRQWVWGPSGYGGILLVNCDRDDPSCDVQDNCDQHVHCLQDLEDMSVMVLRTQGPAALFDDHKLVLHTSSYDAKRAQVFHICGPEDVCEAYRHVLGQDKVSYEVPRLHGDEERFFVEGLSFPDAGFTGLISFHVTLLDDSNEDFSASPIFTDTVVFRVAPWIMTPSTLPPLEVYVCRVRNNTCFVDAVAELARKAGCKLTICPQAENRNDRWIQDEMELGYVQAPHKTLPVVFDSPRNGELQDFPYKRILGPDFGYVTREPRDRSVSGLDSFGNLEVSPPVVANGKEYPLGRILIGGNLPGSSGRRVTQVVRDFLHAQKVQPPVELFVDWLAVGHVDEFLSFVPAPDGKGFRMLLASPGACFKLFQEKQKCGHGRALLFQGVVDDEQVKTISINQVLSNKDLINYNKFVQSCIDWNREVLKRELGLAECDIIDIPQLFKTERKKATAFFPDLVNMLVLGKHLGIPKPFGPIINGCCCLEEKVRSLLEPLGLHCTFIDDFTPYHMLHGEVHCGTNVCRKPFSFKWWNMVP","Homo sapiens","PADI3, PAD3, PDI3","Protein-arginine deiminase type-3","1","6CE1"
"6CE6",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"2 M Na-formate, 0.2 M Na-acetate pH4.6, 5 % ethylene glycol",291,"10.1021/acs.jmedchem.8b00258","EYP","6CE6",12.47,"1.6","1.6","Structure of HDAC6 zinc-finger ubiquitin binding domain soaked with 3,3'-(benzo[1,2-d:5,4-d']bis(thiazole)-2,6-diyl)dipropionic acid","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","6CE6"
"6CE8",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"2 M Na-formate, 0.2 M Na-acetate pH4.6, 5 % ethylene glycol",291,"10.1021/acs.jmedchem.8b00258","EYV","6CE8",12.32,"1.55","1.55","Crystal structure of fragment 2-(Benzo[d]thiazol-2-yl)acetic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","6CE8"
"6CEA",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"2 M Na-formate, 0.2 M Na-acetate pH4.6, 5 % ethylene glycol",291,"10.1021/acs.jmedchem.8b00258","EYY","6CEA",12.33,"1.6","1.6","Crystal structure of fragment 3-(quinolin-2-yl)propanoic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","6CEA"
"6CEC",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"2 M Na-formate, 0.2 M Na-acetate pH4.6, 5 % ethylene glycol",291,"10.1021/acs.jmedchem.8b00258","EY7","6CEC",12.36,"1.55","1.55","Crystal structure of fragment 3-(3-Methoxy-2-quinoxalinyl)propanoic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","6CEC"
"6CED",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"2 M Na-formate, 0.2 M Na-acetate pH4.6, 5 % ethylene glycol",291,"10.1021/acs.jmedchem.8b00258","EYA","6CED",12.36,"1.7","1.7","Crystal structure of fragment 3-(3-Methyl-4-oxo-3,4-dihydroquinazolin-2-yl)propanoic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","6CED"
"6CEE",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"2 M Na-formate, 0.2 M Na-acetate pH4.6, 5 % ethylene glycol",291,"10.1021/acs.jmedchem.8b00258","EYM","6CEE",12.36,"1.55","1.55","Crystal structure of fragment 3-(1-Methyl-2-oxo-1,2-dihydroquinoxalin-3-yl)propionic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","6CEE"
"6CEF",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"2 M Na-formate, 0.2 M Na-acetate pH4.6, 5 % ethylene glycol",291,"10.1021/acs.jmedchem.8b00258","EYJ","6CEF",12.34,"1.8","1.8","Crystal structure of fragment 3-(1,3-Benzothiazol-2-yl)propanoic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","6CEF"
"6CEH",,"X-RAY DIFFRACTION",2.11,41.68,"VAPOR DIFFUSION, SITTING DROP",,"200 nL 7 mg/mL protein + 200 nL reservoir solution (2.9 M ammonium sulfate, 100 mM Tris buffer, pH 8.3), equilibriated at 281K",281,"10.1021/acsmedchemlett.8b00076","EZ1, SO4","6CEH",30.06,"1.43","1.43","Design, Synthesis, X-ray and Biological Activities of Selenides Bearing the Benzenesulfonamide Moiety as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6CEH"
"6CEJ",,"SOLUTION NMR",,,,,,,"10.1002/chem.201801734",,"6CEJ",1.79,,,"Solution structure of a 14mer fragment of the p21 protein","GRKRRQTSMTDFYH","Homo sapiens","CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1","Cyclin-dependent kinase inhibitor 1","1","6CEJ"
"6CEO",,"X-RAY DIFFRACTION",2.53,51.32,"VAPOR DIFFUSION, HANGING DROP",,"PEG 2000 MME, MgCl2",277,"10.1021/acs.jmedchem.7b01608","D57","6CEO",29.39,"1.896","1.896","Structure of Hsp90 NTD with a GRP94-selective resorcinylic inhibitor.","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6CEO"
"6CEW",,"X-RAY DIFFRACTION",1.43,,"VAPOR DIFFUSION, HANGING DROP",6.3,"1.3 M ammonium phosphate, 0.1 M sodium acetate pH 6.3",298,"10.1038/s41594-018-0064-2",,"6CEW",1.13,"1.2","1.2","Segment AMMAAA from the low complexity domain of TDP-43, residues 321-326","AMMAAA","Homo sapiens",,"AMMAAA","1","6CEW"
"6CF4",,"ELECTRON CRYSTALLOGRAPHY",,,"Batch",7.5,"1X PBS 7.5",310,"10.1038/s41594-018-0064-2",,"6CF4",0.75,"0.75","0.75","Segment NFGTFS, with familial mutation A315T and phosphorylated threonine, from the low complexity domain of TDP-43, residues 312-317","NFGTFS","Homo sapiens","TARDBP, TDP43","NFGTFS","1","6CF4"
"6CFE",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"16% PEG 20000, 100 mM MES pH 6.5",277,"10.1038/s41467-019-08876-w",,"6CFE",18.64,"1.994","1.994","Crystal structure of C2S5: A computationally designed immunogen to target Carbohydrate-Occluded Epitopes on the HIV envelope","MGHHHHHHGSENLYFQGSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVETKLNKLMQRTMEELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLATHLNKLRQRLLEDADDLQKRLAVYQ","Homo sapiens",,"Mutant of Apolipoprotein E3 (APO-E3)","1","6CFE"
"6CFF",,"X-RAY DIFFRACTION",2.04,39.8,"VAPOR DIFFUSION, SITTING DROP",8.2,"Sodium citrate tribasic, PEG 3350, pH 8.2",285,"10.1016/j.cell.2019.05.036",,"6CFF",27.78,"2.396","2.396","Stimulator of Interferon Genes Human","LAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","6CFF"
"6CFH",,"ELECTRON CRYSTALLOGRAPHY",,,"Batch",7.5,"phosphate buffered saline, shaken for 80 hours",303,"10.1038/s41594-018-0064-2",,"6CFH",2.4,"1.5","1.5","SWGMMGMLASQ segment from the low complexity domain of TDP-43","SWGMMGMLASQ","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","6CFH"
"6CFM",,"X-RAY DIFFRACTION",3,59.01,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG3350, 0.02M Lithium Sulfate, 0.1M Buffer system SBG pH 7.0",293,,,"6CFM",165.97,"2.45","2.45","Crystal Structure of the Human vaccinia-related kinase bound to a propynyl-pteridinone inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6CFM"
"6CFN",,"X-RAY DIFFRACTION",3.2,61,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG3350, 50 mM Tris pH8.5, and 200 mM di-sodium tartrate",291,"10.1038/s41598-018-31812-9",,"6CFN",81.09,"2.5","2.5","Crystal Structure of the DNA-free Glucocorticoid Receptor DNA Binding Domain","SPKLCLVCSDEASGCHYGVLTCGSCKVFFKRAVEGQHNYLCAGRNDCIIDKIRRKNCPACRYRKCLQAGMNLEARKTKKKIKGIQQATTG","Homo sapiens","NR3C1, GRL","Glucocorticoid receptor","1","6CFN"
"6CFR",,"X-RAY DIFFRACTION",2.45,49.74,"VAPOR DIFFUSION, HANGING DROP",,"20% polyethylene glycol 3350, 0.15 M DL-malate, pH 7.0, 50 mM MgCl2, and 8 mM beta-mercaptoethanol",290,"10.1021/acs.biochem.8b00223",,"6CFR",29.79,"2.07","2.07","Structure of Human alpha-Phosphomannomutase 1 containing mutation R183I","MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGVVGGSDYCKIAEQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHLGEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEERIEFSELDKKEKIREKFVEALKTEFAGKGLRFSIGGMISFDVFPEGWDKRYCLDSLDQDSFDTIHFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRCREIFFPETAHEA","Homo sapiens","PMM1, PMMH22","Phosphomannomutase 1","1","6CFR"
"6CFS",,"X-RAY DIFFRACTION",2.32,47.02,"VAPOR DIFFUSION, HANGING DROP",,"20% polyethylene glycol 3350, 0.15 M DL-malate, pH 7.0, 50 mM MgCl2, and 8 mM beta-mercaptoethanol",290,"10.1021/acs.biochem.8b00223",,"6CFS",29.83,"2.07","2.07","Structure of Human alpha-Phosphomannomutase 1 containing mutation M186Q","MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGVVGGSDYCKIAEQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHLGEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEERIEFSELDKKEKIREKFVEALKTEFAGKGLRFSRGGQISFDVFPEGWDKRYCLDSLDQDSFDTIHFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRCREIFFPETAHEA","Homo sapiens","PMM1, PMMH22","Phosphomannomutase 1","1","6CFS"
"6CFT",,"X-RAY DIFFRACTION",2.38,48.34,"VAPOR DIFFUSION, HANGING DROP",,"20% polyethylene glycol 3350, 0.15 M DL-malate, pH 7.0, 50 mM MgCl2, 0.05 M L-lysine and 8 mM  beta-mercaptoethanol",290,"10.1021/acs.biochem.8b00223",,"6CFT",29.74,"2.43","2.43","Structure of Human alpha-Phosphomannomutase 1 containing mutations R180T and R183I","MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGVVGGSDYCKIAEQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHLGEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEERIEFSELDKKEKIREKFVEALKTEFAGKGLTFSIGGMISFDVFPEGWDKRYCLDSLDQDSFDTIHFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRCREIFFPETAHEA","Homo sapiens","PMM1, PMMH22","Phosphomannomutase 1","1","6CFT"
"6CFU",,"X-RAY DIFFRACTION",2.3,46.56,"VAPOR DIFFUSION, HANGING DROP",,"20% polyethylene glycol 3350, 0.15 M DL-malate, pH 7.0, 50 mM MgCl2, and 8 mM  beta-mercaptoethanol",290,"10.1021/acs.biochem.8b00223",,"6CFU",29.78,"2.244","2.244","Structure of Human alpha-Phosphomannomutase 1 containing mutations R180K and R183K","MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGVVGGSDYCKIAEQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHLGEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEERIEFSELDKKEKIREKFVEALKTEFAGKGLKFSKGGMISFDVFPEGWDKRYCLDSLDQDSFDTIHFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRCREIFFPETAHEA","Homo sapiens","PMM1, PMMH22","Phosphomannomutase 1","1","6CFU"
"6CFV",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION, HANGING DROP",,"20% polyethylene glycol 3350, 0.15 M DL-malate, pH 7.0, 50 mM MgCl2, and 8 mM beta-mercaptoethanol",290,"10.1021/acs.biochem.8b00223",,"6CFV",30.18,"1.918","1.918","Structure of Human alpha-Phosphomannomutase 1 in complex with Inosine Monophosphate","MAVTAQAARRKERVLCLFDVDGTLTPARQKIDPEVAAFLQKLRSRVQIGVVGGSDYCKIAEQLGDGDEVIEKFDYVFAENGTVQYKHGRLLSKQTIQNHLGEELLQDLINFCLSYMALLRLPKKRGTFIEFRNGMLNISPIGRSCTLEERIEFSELDKKEKIREKFVEALKTEFAGKGLRFSRGGMISFDVFPEGWDKRYCLDSLDQDSFDTIHFFGNETSPGGNDFEIFADPRTVGHSVVSPQDTVQRCREIFFPETAHEA","Homo sapiens","PMM1, PMMH22","Phosphomannomutase 1","1","6CFV"
"6CG1",,"X-RAY DIFFRACTION",2.52,51.19,"VAPOR DIFFUSION",,"20% PEG4K, 150mM NaCl, 50mMHEPES pH 7.3",293,"10.1016/j.bmcl.2018.03.083",,"6CG1",164.53,"2.16","2.16","Crystal Structure of KDM4A with Compound 14","SETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6CG1"
"6CG2",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG4K, 150mM NaCl, 50mM HEPES pH 7.3",293,"10.1016/j.bmcl.2018.03.083","QC2","6CG2",164.67,"2.34","2.34","Crystal Structure of KDM4A with Compound 8","SETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6CG2"
"6CGC",,"X-RAY DIFFRACTION",1.86,34,"EVAPORATION",,"PEG 8000, potassium phosphate monobasic",300,"10.1021/acs.jpclett.8b02225",,"6CGC",72.34,"2.1","2.1","Crystal structure of human 17beta-HSD type 1 in ternary complex with 2-MeO-CC-156 and NADP+","MARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVRMLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHLSLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGGAGPGAEDEAGRGAVGDPELGDPPAAPQ","Homo sapiens","HSD17B1, E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1","Estradiol 17-beta-dehydrogenase 1","1","6CGC"
"6CGE",,"X-RAY DIFFRACTION",1.94,36.57,"EVAPORATION",,"PEG 8000, potassium phosphate monobasic",300,"10.1021/acs.jpclett.8b02225","F0D","6CGE",72.46,"2.2","2.2","Crystal structure of human 17beta-HSD type 1 in ternary complex with PBRM and NADP+","MARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVRMLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHLSLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGGAGPGAEDEAGRGAVGDPELGDPPAAPQ","Homo sapiens","HSD17B1, E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1","Estradiol 17-beta-dehydrogenase 1","1","6CGE"
"6CGH",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0217098",,"6CGH",10.4,,,"Solution structure of the four-helix bundle region of human J-protein Zuotin, a component of ribosome-associated complex (RAC)","GSKKAIKKERQKLRNSCKTWNHFSDNEAERVKMMEEVEKLCDRLELASLQCLNETLTSCTKEVGKAALEKQIEEINEQIRKEKEEAEAR","Homo sapiens","DNAJC2, MPHOSPH11, MPP11, ZRF1","DnaJ homolog subfamily C member 2","1","6CGH"
"6CHD",,"X-RAY DIFFRACTION",2.5,50.86,"VAPOR DIFFUSION, SITTING DROP",5.5,"Human KRS at 35.6 mg/ml, incubated with 5 mM L-Lysylsulfamoyl Adenosine, then mixed 1:1 with Top96(c3): 25% (w/v) PEG-3350, 0.2 M lithium sulfate, 0.1 M bis-Tris:HCl, pH = 5.5: cryoprotected with 20% ethylene glycol.  Tray: 297612c3, puck: KYY0-11",290,,,"6CHD",138.45,"2.5","2.5","Crystal Structure of Human Lysyl-tRNA Synthetase complexed with L-Lysylsulfamoyl Adenosine","MAAVQAAEVKVDGSEPKLSKNELKRRLKAEKKVAEKEAKQKELSEKQLSQATAAATNHTTDNGVGPEEESVDPNQYYKIRSQAIHQLKVNGEDPYPHKFHVDISLTDFIQKYSHLQPGDHLTDITLKVAGRIHAKRASGGKLIFYDLRGEGVKLQVMANSRNYKSEEEFIHINNKLRRGDIIGVQGNPGKTKKGELSIIPYEITLLSPCLHMLPHLHFGLKDKETRYRQRYLDLILNDFVRQKFIIRSKIITYIRSFLDELGFLEIETPMMNIIPGGAVAKPFITYHNELDMNLYMRIAPELYHKMLVVGGIDRVYEIGRQFRNEGIDLTHNPEFTTCEFYMAYADYHDLMEITEKMVSGMVKHITGSYKVTYHPDGPEGQAYDVDFTPPFRRINMVEELEKALGMKLPETNLFETEETRKILDDICVAKAVECPPPRTTARLLDKLVGEFLEVTCINPTFICDHPQIMSPLAKWHRSKEGLTERFELFVMKKEICNAYTELNDPMRQRQLFEEQAKAKAAGDDEAMFIDENFCTALEYGLPPTAGWGMGIDRVAMFLTDSNNIKEVLLFPAMKPEDKKENVATTDTLESTTVGTSV","Homo sapiens","KARS, KIAA0070, KARS1","Lysine--tRNA ligase","1","6CHD"
"6CHF",,"X-RAY DIFFRACTION",2.56,51.91,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG MME 5,000
0.1 M Bis-Tris pH 6.5",294,"10.1016/j.str.2020.03.001",,"6CHF",51.23,"2.4","2.4","Crystal structure of a Fc fragment LALA mutant (L234A, L235A) of human IgG1 (crystal form 1)","AAGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","DKFZp686C11235","Uncharacterized protein DKFZp686C11235","1","6CHF"
"6CHH",,"X-RAY DIFFRACTION",2.28,46.09,"VAPOR DIFFUSION, HANGING DROP",7.2,"1.5 ammonium sulfate, 0.1 M HEPES pH 7.2",290.15,"10.1021/acs.jmedchem.7b01422","F0P","6CHH",128.1,"2.3","2.3","Structure of human NNMT in complex with bisubstrate inhibitor MS2756","MGSSHHHHHHSSGLVPRGSMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT","Nicotinamide N-methyltransferase","1","6CHH"
"6CHI",,"X-RAY DIFFRACTION",2.59,52.59,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.175 M Tris, pH 8.5 containing 35% PEG 3350, 3% glycerol, and 0.250-0.275 M lithium sulfate",277,"10.1021/acs.jmedchem.8b00419","3NX","6CHI",227,"2.698","2.698","Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 amide","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17A1, CYP17, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","6CHI"
"6CHW",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION, SITTING DROP",,"6-12% PEG 3350, 50-150 mM MgCL2, 0.1 M imidazole pH 7.1",293,"10.1158/2159-8290.CD-17-1229",,"6CHW",28.8,"1.89","1.89","Estrogen Receptor Alpha Y537S covalently bound to antagonist H3B-5942.","LALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLSDLLLEMLDAHRLHA","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6CHW"
"6CHZ",,"X-RAY DIFFRACTION",2.44,49.65,"VAPOR DIFFUSION, SITTING DROP",,"6-12% PEG 3350, 50-150 mM MgCl2, 0.1 M imidazole pH 7.1",296,"10.1158/2159-8290.CD-17-1229",,"6CHZ",30.69,"1.68","1.68","Estrogen Receptor Alpha Y537S bound to antagonist H3B-9224.","MGHHHHHHENLYFQLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLSDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6CHZ"
"6CIC",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.biochem.8b00895","7R2","6CIC",100.22,"1.752","1.752","Structure of the human nitric oxide synthase R354A/G357D mutant heme domain in complex with N-(1-(2-(Ethyl(methyl)amino)ethyl)-1,2,3,4-tetrahydroquino-lin-6-yl)thiophene-2-carboximidamide","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6CIC"
"6CID",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.biochem.8b00895",,"6CID",100.18,"1.75","1.75","Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with N-(1-(Piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","6CID"
"6CIE",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.biochem.8b00895","7R2","6CIE",205.57,"1.95","1.95","Structure of human endothelial nitric oxide synthase heme domain in complex with N-(1-(2-(Ethyl(methyl)amino)ethyl)-1,2,3,4-tetrahydroquino-lin-6-yl)thiophene-2-carboximidamide","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6CIE"
"6CIF",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.biochem.8b00895",,"6CIF",205.5,"2.2","2.2","Structure of the human endothelial nitric oxide synthase heme domain in complex with N-(1-(Piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","6CIF"
"6CIR",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.175 M Tris, pH 8.5 containing 30% PEG 3350, 3% glycerol, and 0.250-0.275 M lithium sulfate",293,"10.1021/acs.jmedchem.8b00419","3NQ","6CIR",226.95,"2.648","2.648","Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 oxime","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17A1, CYP17, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","6CIR"
"6CIS",,"X-RAY DIFFRACTION",2.46,50.05,"VAPOR DIFFUSION, HANGING DROP",,"100mM Sodium Nitrate, 5% Ethylene Glycol, 18% (w/v) PEG3350",295,"10.1021/acschembio.7b00638","X26","6CIS",15.74,"1.51","1.51","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG047","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CIS"
"6CIV",,"SOLUTION NMR",,,,,,,"10.1002/chem.201801734",,"6CIV",1.8,,,"Lactam cyclised mimetic of a fragment of p21","GRKRRQASMTEFYH","Homo sapiens","CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1","p21","1","6CIV"
"6CIX",,"SOLUTION NMR",,,,,,,"10.1002/chem.201801734",,"6CIX",1.83,,,"Lactam cyclised mimetic of a fragment of p21","GRKRRQKSMTEFYH","Homo sapiens","CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1","p21","1","6CIX"
"6CIY",,"X-RAY DIFFRACTION",2.38,48.32,"VAPOR DIFFUSION, HANGING DROP",,"100mM Sodium Nitrate, 5% Ethylene Glycol, 18% (w/v) PEG3350",295,"10.1021/acschembio.7b00638","F3J","6CIY",15.9,"1.68","1.68","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG069","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CIY"
"6CIZ",,"X-RAY DIFFRACTION",2.6,52.77,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.175 M Tris, pH 8.5 containing 35% PEG 3350, 3% glycerol, and 0.250-0.275 M lithium sulfate",277,"10.1021/acs.jmedchem.8b00419","3NR","6CIZ",226.92,"2.601","2.601","Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 nitrile","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17A1, CYP17, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","6CIZ"
"6CJ1",,"X-RAY DIFFRACTION",2.42,49.15,"VAPOR DIFFUSION, HANGING DROP",,"100mM Sodium Nitrate, 5% Ethylene Glycol, 18% (w/v) PEG3350",295,"10.1021/acschembio.7b00638","FND","6CJ1",16.38,"1.53","1.53","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG071","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CJ1"
"6CJ2",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",,"100mM Sodium Nitrate, 5% Ethylene Glycol, 18% (w/v) PEG3350",295,"10.1021/acschembio.7b00638",,"6CJ2",15.3,"1.47","1.47","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG056","STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CJ2"
"6CJ5",,"X-RAY DIFFRACTION",3.26,62.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"20-30% (w/v) polyacrylic acid 5100, 1-5% PEG 400, and 50 mM Hepes (pH 7.5)",300.15,"10.1021/acs.jmedchem.7b01795",,"6CJ5",35.91,"2.8","2.8","Crystal Structure of Mnk2-D228G in Complex With Inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6CJ5"
"6CJC",,"X-RAY DIFFRACTION",2.83,56.47,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG MME 5,000
0.1 M Bis-Tris. pH 6.5",294,"10.1016/j.str.2020.03.001",,"6CJC",51.26,"2.575","2.575","CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 3)","AAGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","DKFZp686C11235","Uncharacterized protein DKFZp686C11235","1","6CJC"
"6CJE",,"X-RAY DIFFRACTION",3.3,62.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"20-30% (w/v) polyacrylic acid 5100, 1-5% PEG 400, and 50 mM Hepes (pH 7.5)",300.15,"10.1021/acs.jmedchem.7b01795",,"6CJE",35.92,"3.36","3.36","Crystal Structure of Mnk2-D228G in complex with Inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6CJE"
"6CJF",,"X-RAY DIFFRACTION",2.01,38.75,"VAPOR DIFFUSION, SITTING DROP",,"1.72 M ammonium sulfate, 1.4 M sodium chloride, 0.1 M sodium acetate pH 5.3, 10 mM DTT",293,"10.1021/acs.jmedchem.7b01862","F54","6CJF",84.47,"1.63","1.63","Human dihydroorotate dehydrogenase bound to 4-quinoline carboxylic acid inhibitor 43","GDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRRLEAGHHHHHH","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6CJF"
"6CJG",,"X-RAY DIFFRACTION",3.54,65.27,"VAPOR DIFFUSION, SITTING DROP",,"2.2 M Ammonium Acetate, 1.5 M sodium chloride, 0.1 M sodium cacodylate pH 5.3, 10 mM DTT",293,"10.1021/acs.jmedchem.7b01862","F51","6CJG",42.2,"2.851","2.851","Human dihydroorotate dehydrogenase bound to napthyridine inhibitor 46","GDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRRLEAGHHHHHH","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6CJG"
"6CJH",,"X-RAY DIFFRACTION",3.3,62.75,"VAPOR DIFFUSION, SITTING DROP",7.5,"20-30% (w/v) polyacrylic acid 5100, 1-5% PEG 400, and 50 mM Hepes (pH 7.5)",300.15,"10.1021/acs.jmedchem.7b01795",,"6CJH",35.94,"3.6","3.6","Co-crystal structure of MNK2 in complex with an inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6CJH"
"6CJV",,"X-RAY DIFFRACTION",2.09,41.22,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate, 50mM Tris-HCl",298,"10.1021/acsmedchemlett.8b00100",,"6CJV",29.31,"1.547","1.547","Carbonic anhydrase IX-mimic in complex with sucralose","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6CJV"
"6CJW",,"X-RAY DIFFRACTION",3.33,63.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"20-30% (w/v) polyacrylic acid 5100, 4% PEG 400, 50 mM Hepes, pH7.5.",300,"10.1021/acs.jmedchem.7b01795",,"6CJW",35.87,"3.38","3.38","Crystal Structure of Mnk2-D228G in Complex With Inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6CJW"
"6CJX",,"X-RAY DIFFRACTION",2.77,55.54,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG 3,350
0.1 M Bus-Tris pH 6.5",294,"10.1016/j.str.2020.03.001",,"6CJX",51.23,"2.44","2.44","Crystal structure of a Fc fragment LALA mutant (L234A, L235A) of human IgG1 (crystal form 2)","AAGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","DKFZp686C11235","Fc fragment of human IgG1","1","6CJX"
"6CJY",,"X-RAY DIFFRACTION",3.24,62.02,"VAPOR DIFFUSION, SITTING DROP",,"20-30% (w/v) polyacrylic acid 5100, 1-5% PEG 400, and 50 mM Hepes (pH 7.5)",300.15,"10.1021/acs.jmedchem.7b01795",,"6CJY",35.93,"3.05","3.05","Crystal Structure of Mnk2-D228G in complex with Inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6CJY"
"6CK2",,"X-RAY DIFFRACTION",1.98,37.75,"VAPOR DIFFUSION, HANGING DROP",8,"Crystals were obtained by hanging-drop vapor diffusion at room temperature in the presence of a 1:1.7 ratio of Zn2+ to protein monomer and a 3.5:1 ratio of phenol to protein monomer in Tris-HCl",298,"10.1074/jbc.RA118.003650",,"6CK2",11.91,"2.25","2.25","Insulin analog containing a YB26W mutation","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","6CK2"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFWTPAT","Homo sapiens","INS","Insulin B chain","2","6CK2"
"6CK3",,"X-RAY DIFFRACTION",3.22,61.79,"VAPOR DIFFUSION, SITTING DROP",,"20-30% (w/v) polyacrylic acid 5100, 1-5% PEG 400, and 50 mM Hepes (pH 7.5)",300.11,"10.1021/acs.jmedchem.7b01795","F67","6CK3",35.95,"2.9","2.9","Co-crytsal Structure of MNK2 in Complex With an Inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6CK3"
"6CK6",,"X-RAY DIFFRACTION",3.26,62.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"20-30% (w/v) polyacrylic acid 5100, 1-5% PEG 400, and 50 mM Hepes (pH 7.5)",300.15,"10.1021/acs.jmedchem.7b01795","N45","6CK6",36.01,"3.32","3.32","Crystal Structure of Mnk2-D228G in complex with Inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6CK6"
"6CKI",,"X-RAY DIFFRACTION",3.15,60.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"20-30% (w/v) polyacrylic acid 5100, 1-5% PEG 400, and 50 mM Hepes (pH 7.5)",300.15,"10.1021/acs.jmedchem.7b01795","FZJ","6CKI",35.94,"2.95","2.95","Co-crystal structure of MNK2 in Complex With Inhibitor","GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR","Homo sapiens","MKNK2, GPRK7, MNK2","MAP kinase-interacting serine/threonine-protein kinase 2","1","6CKI"
"6CKN",,"X-RAY DIFFRACTION",2.36,47.83,"VAPOR DIFFUSION, SITTING DROP",,"This crystal's crystallization record is incomplete. We attempted to reconstruct the condition through reference to records from related crystals: 20% PEG-3350, 0.2 M magnesium nitrate. Additive: 1,6-hexanediol",291,"10.1101/gad.311639.118",,"6CKN",17.58,"2.49","2.49","Crystal structure of an AF10 fragment","GSSLENLPPVAASIEQLLERQWSEGQQFLLEQGTPSDILGMLKSLHQLQVENRRLEEQIKNLTAKKERLQLLNAQLS","Homo sapiens","MLLT10, AF10","Protein AF-10","1","6CKN"
"6CKR",,"X-RAY DIFFRACTION",2.31,46.86,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG3350, 50 mM HEPES, pH 7.5",293,"10.1016/j.bmcl.2018.04.016","F5V","6CKR",30.84,"1.62","1.62","Crystal Structure of BRD4 with QC4956","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CKR"
"6CKS",,"X-RAY DIFFRACTION",1.94,36.57,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG6000, 50 mM TRIS, pH 7.7, 5% ethylene glycol",293,"10.1016/j.bmcl.2018.04.016","F5Y","6CKS",15.45,"1.72","1.72","Crystal Structure of BRD4 with QC4956","MNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CKS"
"6CKV",,"SOLUTION NMR",,,,,,,"10.1016/j.celrep.2018.04.060",,"6CKV",17.19,,,"Solution NMR structure of human BOK","MSPTDKELVAQAKALGREYVHARLLRAGLSWSAPERAAPVPGRLAEVAAVLLRLGDELEMIRPSVYRNVARQLHISLQSERVVTDAFLAVAGHIFSAGITWGKVVSLYAVAAGLAVDAVRQAQPAMVHALVDALGEFVRKTLATWLRRRGGWTDVLKC","Homo sapiens","BOK, BCL2L9","Bcl-2-related ovarian killer protein","1","6CKV"
"6CM2",,"X-RAY DIFFRACTION",2.41,48.94,"BATCH MODE",,"SPG buffer, PEG 1500",298,"10.1038/s41467-019-11413-4",,"6CM2",244.37,"2.14","2.14","SAMHD1 HD domain bound to decitabine triphosphate","DTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6CM2"
"6CMJ",,"X-RAY DIFFRACTION",2.88,57.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"4 M sodium formate, 3% PEG8000, 20 mM ammonium sulfate",298,"10.1016/j.bmcl.2018.03.034","F6J","6CMJ",74.63,"2.4","2.4","Human CAMKK2 with GSK650393","MNAHHHHHHGSAENLYFQGHHVSITGMQDCVQLDQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRHGAEPLPSEDENCTLVE","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","6CMJ"
"6CMM",,"X-RAY DIFFRACTION",2.58,52.37,"VAPOR DIFFUSION, SITTING DROP",6.5,"30.25% PEG3350, 200 mM LiSO4, 0.1M SBG buffer pH 6.5",293,,,"6CMM",166.47,"2.1","2.1","Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6CMM"
"6CMP",,"X-RAY DIFFRACTION",2.16,39.04,"VAPOR DIFFUSION, SITTING DROP",,"200 mM lithium nitrate, 20% PEG 3,350",291,"10.1038/s41467-018-06814-w",,"6CMP",122.06,"1.8","1.8","Closed structure of inactive SHP2 mutant C459E","GSGMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHESAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRI","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6CMP"
"6CMQ",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, SITTING DROP",,"100 mM ammonium formate, 22% PEG 3,350 and 1.5% xylitol",291,"10.1038/s41467-018-06814-w",,"6CMQ",196.53,"2.9","2.9","Structure of human SHP2 without N-SH2 domain","GSGDPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRI","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6CMQ"
"6CMR",,"X-RAY DIFFRACTION",2.17,43.19,"VAPOR DIFFUSION, SITTING DROP",,"15% PEG 20,000 and 10 mM potassium hydrogen tartrate",291,"10.1038/s41467-018-06814-w","5OD","6CMR",61.34,"2.21","2.21","Closed structure of active SHP2 mutant E76D bound to SHP099 inhibitor","GSGMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLADLVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRI","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6CMR"
"6CMS",,"X-RAY DIFFRACTION",2.11,37.78,"VAPOR DIFFUSION, SITTING DROP",9,"100 mM bicine pH 9, 100 mM NaCl, 19 % PEG MME 550",291,"10.1038/s41467-018-06814-w","5OD","6CMS",61.36,"2.68","2.68","Closed structure of active SHP2 mutant E76K bound to SHP099 inhibitor","GSGMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAKLVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRI","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6CMS"
"6CMX","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2018.03.036",,"6CMX",227.47,"3.1",,"Human Teneurin 2 extra-cellular region","HHHHHHHHASDTYKLVIVLNGTTFTYTTEAVDAATAEKVFKQYANDAGVDGEWTYDAATKTFTVTEASENLYFQSGSTSCADNKDNEGDGLVDCLDPDCCLQSACQNSLLCRGSRDPLDIIQQGQTDWPAVKSFYDRIKLLAGKDSTHIIPGENPFNSSLVSLIRGQVVTTDGTPLVGVNVSFVKYPKYGYTITRQDGTFDLIANGGASLTLHFERAPFMSQERTVWLPWNSFYAMDTLVMKTEENSIPSCDLSGFVRPDPIIISSPLSTFFSAAPGQNPIVPETQVLHEEIELPGSNVKLRYLSSRTAGYKSLLKITMTQSTVPLNLIRVHLMVAVEGHLFQKSFQASPNLAYTFIWDKTDAYGQRVYGLSDAVVSVGFEYETCPSLILWEKRTALLQGFELDPSNLGGWSLDKHHILNVKSGILHKGTGENQFLTQQPAIITSIMGNGRRRSISCPSCNGLAEGNKLLAPVALAVGIDGSLYVGDFNYIRRIFPSRNVTSILELRNNPAHKYYLAVDPVSGSLYVSDTNSRRIYRVKSLSGTKDLAGNSEVVAGTGEQCLPFDEARCGDGGKAIDATLMSPRGIAVDKNGLMYFVDATMIRKVDQNGIISTLLGSNDLTAVRPLSCDSSMDVAQVRLEWPTDLAVNPMDNSLYVLENNVILRITENHQVSIIAGRPMHCQVPGIDYSLSKLAIHSALESASAIAISHTGVLYITETDEKKINRLRQVTTNGEICLLAGAASDCDCKNDVNCNCYSGDDAYATDAILNSPSSLAVAPDGTIYIADLGNIRIRAVSKNKPVLNAFNQYEAASPGEQELYVFNADGIHQYTVSLVTGEYLYNFTYSTDNDVTELIDNNGNSLKIRRDSSGMPRHLLMPDNQIITLTVGTNGGLKVVSTQNLELGLMTYDGNTGLLATKSDETGWTTFYDYDHEGRLTNVTRPTGVVTSLHREMEKSITIDIENSNRDDDVTVITNLSSVEASYTVVQDQVRNSYQLCNNGTLRVMYANGMGISFHSEPHVLAGTITPTIGRCNISLPMENGLNSIEWRLRKEQIKGKVTIFGRKLRVHGRNLLSIDYDRSIRTEKIYDDHRKFTLRIIYDQVGRPFLWLPSSGLAAVNVSYFFNGRLAGLQRGAMSERTDIDKQGRIVSRMFADGKVWSYSYLDKSMVLLLQSQRQYIFEYDSSDRLLAVTMPSVARHSMSTHTSIGYIRNIYNPPESNASVIFDYSDDGRILKTSFLGTGRQVFYKYGKLSKLSEIVYDSTAVTFGYDETTGVLKMVNLQSGGFSCTIRYRKIGPLVDKQIYRFSEEGMVNARFDYTYHDNSFRIASIKPVISETPLPVDLYRYDEISGKVEHFGKFGVIYYDINQIITTAVMTLSKHFDTHGRIKEVQYEMFRSLMYWMTVQYDSMGRVIKRELKLGPYANTTKYTYDYDGDGQLQSVAVNDRPTWRYSYDLNGNLHLLNPGNSVRLMPLRYDLRDRITRLGDVQYKIDDDGYLCQRGSDIFEYNSKGLLTRAYNKASGWSVQYRYDGVGRRASYKTNLGHHLQYFYSDLHNPTRITHVYNHSNSEITSLYYDLQGHLFAMESSSGEEYYVASDNTGTPLAVFSINGLMIKQLQYTAYGEIYYDSNPDFQMVIGFHGGLYDPLTKLVHFTQRDYDVLAGRWTSPDYTMWKNVGKEPAPFNLYMFKSNNPLSSELGLKNYVTDVKSWLVMFGFQLSNIIPGFPRAKMYFVPPPYELSESQASENGQLITGVQQKTERHNQAFMALEGQVITKKLHASIREKAGHWFATTTPIIGKGIMFAIKEGRVTTGVSSIASEDSRKVASVLNNAYYLDKMHYSIEGKDTHYFVKIGSADGDLVTLGTTIGRKVLESGVNVTVSQPTLLVNGRTRRFTNIEFQYSTLLLSIRYGLTPDTLDEEKARVLDQARQRALGTAWAKEQQKARDGREGSRLWTEGEKQQLLSTGRVQGYEGYYVLPVEQYPELADSSSNIQFLRQNEMGKR","Homo sapiens","TENM2, KIAA1127, ODZ2, TNM2","Teneurin-2","1","6CMX"
"6CN5",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION",7.5,"1.8-2.5M Na formate, 0.1 MTris-HCl pH 7.5-8.0, 3% methyl pentane diol",298,"10.1021/acs.jmedchem.8b00392","F7M","6CN5",61.44,"2.3","2.3","HUMAN RETENOID-RELATED ORPHAN RECEPTOR-GAMMA LIGAND- BINDING DOMAIN IN COMPLEX WITH INDOLE LIGAND CP9b IN INVERSE AGONIST CONFORMATION","GPTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6CN5"
"6CN6",,"X-RAY DIFFRACTION",2.75,55.28,"VAPOR DIFFUSION",8.7,"0.1 M Tris pH 8.7, 27% ethanol",298,"10.1021/acs.jmedchem.8b00392","F7J","6CN6",30.4,"2.45","2.45","RORC2 LBD complexed with compound 34","TPEAPYASLTEIEHLVQSVSKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELSQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6CN6"
"6CNH",,"X-RAY DIFFRACTION",2.69,54.19,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG Smear High, 0.1 M N-(2-acetamido)iminodiacetic acid, 0.2 M ammonium sulfate",293,,,"6CNH",41.82,"2","2","Human PRPF4B in complex with Rebastinib","SMDFKENPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARANQEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLLRHFYHKQHLCLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASHVADNDITPYLFSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQE","Homo sapiens","PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K","Serine/threonine-protein kinase PRP4 homolog","1","6CNH"
"6CNI",,"X-RAY DIFFRACTION",2.06,40.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5
0.2 M MgCl2
30% PEG 400",293,"10.1038/s41467-019-08393-w",,"6CNI",51.14,"1.7","1.7","Crystal structure of H105A PGAM5 dimer","MHHHHHHSSGVDLGTENLYFQSMDHYKAKATRHIFLIRASQYHVDGSLEKDRTLTPLGREQAELTGLRLASLGLKFNKIVHSSMTRAIETTDIISRHLPGVCKVSTDLLREGAPIEPDPPVSHWKPEAVQYYEDGARIEAAFRNYIHRADARQEEDSYEIFICHANVIRYIVCRALQFPPEGWLRLSLNNGSITHLVIRPNGRVALRTLGDTGFMPPDKITRS","Homo sapiens","PGAM5","Serine/threonine-protein phosphatase PGAM5, mitochondrial","1","6CNI"
"6CNX",,"X-RAY DIFFRACTION",2.81,56.27,"VAPOR DIFFUSION, SITTING DROP",6.5,"30.25% PEG3350, 30mM LiSO4, 0.1M SBG (Sodium-tartrate, Bis-Tris, Glycylglycine)",293.15,,,"6CNX",167.52,"2","2","Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6CNX"
"6COY","3.36","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.36629",,"6COY",217.61,"3.36",,"Human CLC-1 chloride ion channel, transmembrane domain","MEQSRSQQRGGEQSWWGSDPQYQYMPFEHCTSYGLPSENGGLQHRLRKDAGPRHNVHPTQIYGHHKEQFSDREQDIGMPKKTGSSSTVDSKDEDHYSKCQDCIHRLGQVVRRKLGEDGIFLVLLGLLMALVSWSMDYVSAKSLQAYKWSYAQMQPSLPLQFLVWVTFPLVLILFSALFCHLISPQAVGSGIPEMKTILRGVVLKEYLTMKAFVAKVVALTAGLGSGIPVGKEGPFVHIASICAAVLSKFMSVFCGVYEQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFFAATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGLPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL","Homo sapiens","CLCN1, CLC1","Chloride channel protein 1","1","6COY"
"6COZ","3.36","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.36629",,"6COZ",217.47,"3.36",,"Human CLC-1 chloride ion channel, C-terminal cytosolic domain","MEQSRSQQRGGEQSWWGSDPQYQYMPFEHCTSYGLPSENGGLQHRLRKDAGPRHNVHPTQIYGHHKEQFSDREQDIGMPKKTGSSSTVDSKDEDHYSKCQDCIHRLGQVVRRKLGEDGIFLVLLGLLMALVSWSMDYVSAKSLQAYKWSYAQMQPSLPLQFLVWVTFPLVLILFSALFCHLISPQAVGSGIPEMKTILRGVVLKEYLTMKAFVAKVVALTAGLGSGIPVGKEGPFVHIASICAAVLSKFMSVFCGVYEQPYYYSDILTVGCAVGVGCCFGTPLGGVLFSIEVTSTYFAVRNYWRGFFAATFSAFVFRVLAVWNKDAVTITALFRTNFRMDFPFDLKELPAFAAIGICCGLLGAVFVYLHRQVMLGVRKHKALSQFLAKHRLLYPGIVTFVIASFTFPPGMGQFMAGELMPREAISTLFDNNTWVKHAGDPESLGQSAVWIHPRVNVVIIIFLFFVMKFWMSIVATTMPIPCGGFMPVFVLGAAFGRLVGEIMAMLFPDGILFDDIIYKILPGGYAVIGAAALTGAVSHTVSTAVICFELTGQIAHILPMMVAVILANMVAQSLQPSLYDSIIQVKKLPYLPDLGWNQLSKYTIFVEDIMVRDVKFVSASYTYGELRTLLQTTTVKTLPLVDSKDSMILLGSVERSELQALLQRHLCPERRLRAAQEMARKLSELPYDGKARLAGEGLPGAPPGRPESFAFVDEDEDEDLSGKSELPPSLALHPSTTAPLSPEEPNGPLPGHKQQPEAPEPAGQRPSIFQSLLHCLLGRARPTKKKTTQDSTDLVDNMSPEEIEAWEQEQLSQPVCFDSCCIDQSPFQLVEQTTLHKTHTLFSLLGLHLAYVTSMGKLRGVLALEELQKAIEGHTKSGVQLRPPLASFRNTTSTRKSTGAPPSSAENWNLPEDRPGATGTGDVIAASPETPVPSPSPEPPLSLAPGKVEGELEELELVESPGLEEELADILQGPSLRSTDEEDEDELIL","Homo sapiens","CLCN1, CLC1","Chloride channel protein 1","1","6COZ"
"6CPE",,"X-RAY DIFFRACTION",2.41,48.96,"VAPOR DIFFUSION, SITTING DROP",7.4,"A 1:1 ratio protein:mother liquor was obtained by mixing 0.5 uL Aurora A (300  uM; 10 mg/mL) in 50 mM HEPES, pH 7.3, 500 mM ammonium acetate, 1 mM MgCl2, 5 mM TCEP) with 0.5  uL of 0.15 M Tris-HCl, pH 7.5, 0.15 M ammonium sulfate, 35% (w/v) PEG-3350",291.15,"10.7554/eLife.36656",,"6CPE",33.15,"2.45","2.45","Structure of apo, dephosphorylated Aurora A (122-403) in an active conformation","SVDESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6CPE"
"6CPF",,"X-RAY DIFFRACTION",2.78,55.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystals were obtained by mixing 570 uM  Aurora A (18 mg/mL) in buffer (20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 20 mM MgCl2, 1 mM TCEP) in a 2:1 ratio with mother liquor (0.2 M Tris-HCl, pH 7.5, 0.2 M ammonium sulfate, 30% (w/v) PEG-3350).",291.15,"10.7554/eLife.36656",,"6CPF",33.52,"2.3","2.3","Structure of dephosphorylated Aurora A (122-403) bound to AMPPCP in an active conformation","SVDESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6CPF"
"6CPI",,"SOLUTION NMR",,,,,,,"10.1002/1873-3468.13209",,"6CPI",6.63,,,"Solution structure of SH3 domain from Shank1","MVPGRSFMAVKSYQAQAEGEISLSKGEKIKVLSIGEGGFWEGQVKGRVGWFPSDCLEEVAN","Homo sapiens","SHANK1","SH3 and multiple ankyrin repeat domains protein 1","1","6CPI"
"6CPK",,"SOLUTION NMR",,,,,,,"10.1002/1873-3468.13209",,"6CPK",6.62,,,"Solution structure of SH3 domain from Shank3","MVPGRKFIAVKAHSPQGEGEIPLHRGEAVKVLSIGEGGFWEGTVKGRTGWFPADCVEEVQM","Homo sapiens","SHANK3, KIAA1650, PROSAP2, PSAP2","SH3 and multiple ankyrin repeat domains protein 3","1","6CPK"
"6CPS",,"X-RAY DIFFRACTION",4.07,69.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES sodium, pH 7.5, 1.6 M lithium sulfate",277,"10.1002/prot.25636",,"6CPS",15.93,"1.93","1.93","Crystal structure of the bromodomain of human ATAD2 with a disulfide bridge","GPLQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6CPS"
"6CQ0",,"X-RAY DIFFRACTION",2.95,58.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 4% PEG 8000, 10% DMSO",293,"10.1016/j.bmc.2018.09.020","F8M","6CQ0",76.37,"3.19","3.19","TBK1 in Complex with Dimethyl Amino Analog of Amlexanox","SNAMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6CQ0"
"6CQ1",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, HANGING DROP",,".2 M NaCl, .1 M sodium cacodylate pH 6.0, 8% (w/v) PEG-8,000",277,"10.1021/acs.jmedchem.8b00040","F8J","6CQ1",30.92,"1.69921037793","1.69921037793","BCL6 BTB domain in complex with 15a","GSMASPADSQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLRVGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6CQ1"
"6CQ4",,"X-RAY DIFFRACTION",2.91,57.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 4% PEG 8000, 10% DMSO",293,"10.1016/j.bmc.2018.09.020","F8P","6CQ4",76.4,"3.2","3.2","TBK1 in Complex with Cyclohexyl Analog of Amlexanox","SNAMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6CQ4"
"6CQ5",,"X-RAY DIFFRACTION",2.94,58.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES pH 7.5, 4% PEG 8000, 10% DMSO",293,"10.1016/j.bmc.2018.09.020","F8S","6CQ5",76.41,"3.354","3.354","TBK1 in Complex with Sulfone Analog of Amlexanox","SNAMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","6CQ5"
"6CQD",,"X-RAY DIFFRACTION",2.38,48.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 12% PEG8000",292,"10.1016/j.str.2018.10.025",,"6CQD",67.5,"2.12","2.12","Crystal structure of HPK1 in complex with ATP analogue (AMPPNP)","GSDVVDPDIFNRDPRDHYDLLQRLGGGTYGEVFKARDKVSGDLVALKMVKMEPDDDVSTLQKEILILKTCRHANIVAYHGSYLWLQKLWICMEFCGAGSLQDIYQVTGSLSELQISYVCREVLQGLAYLHSQKKIHRDIKGANILINDAGEVRLADFGISAQIGAELARRLEFIGTPYWMAPEVAAVALKGGYNELCDIWSLGITAIELAELQPPLFDVHPLRVLFLMTKSGYQPPRLKEKGKWSAAFHNFIKVTLTKSPKKRPSATKMLSHQLVSQPGLNRGLILDLLDKLKNGNS","Homo sapiens","MAP4K1, HPK1","Mitogen-activated protein kinase kinase kinase kinase 1","1","6CQD"
"6CQE",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl, pH 8.5, 0.25 M sodium tartrate, 12% PEG8000",292,"10.1016/j.str.2018.10.025",,"6CQE",65.95,"1.886","1.886","Crystal structure of HPK1 kinase domain S171A mutant","GSDVVDPDIFNRDPRDHYDLLQRLGGGTYGEVFKARDKVSGDLVALKMVKMEPDDDVSTLQKEILILKTCRHANIVAYHGSYLWLQKLWICMEFCGAGSLQDIYQVTGSLSELQISYVCREVLQGLAYLHSQKKIHRDIKGANILINDAGEVRLADFGISAQIGATLARRLAFIGTPYWMAPEVAAVALKGGYNELCDIWSLGITAIELAELQPPLFDVHPLRVLFLMTKSGYQPPRLKEKGKWSAAFHNFIKVTLTKSPKKRPSATKMLSHQLVSQPGLNRGLILDLLDKLKNN","Homo sapiens","MAP4K1, HPK1","Mitogen-activated protein kinase kinase kinase kinase 1","1","6CQE"
"6CQF",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl, pH 8.5, 0.25 M sodium tartrate, 12% PEG8000",292,"10.1016/j.str.2018.10.025","F97","6CQF",33.55,"2.246","2.246","Crystal structure of HPK1 in complex an inhibitor G1858","GSDVVDPDIFNRDPRDHYDLLQRLGGGTYGEVFKARDKVSGDLVALKMVKMEPDDDVSTLQKEILILKTCRHANIVAYHGSYLWLQKLWICMEFCGAGSLQDIYQVTGSLSELQISYVCREVLQGLAYLHSQKKIHRDIKGANILINDAGEVRLADFGISAQIGATLARRLAFIGTPYWMAPEVAAVALKGGYNELCDIWSLGITAIELAELQPPLFDVHPLRVLFLMTKSGYQPPRLKEKGKWSAAFHNFIKVTLTKSPKKRPSATKMLSHQLVSQPGLNRGLILDLLDKLKNGNS","Homo sapiens","MAP4K1, HPK1","Mitogen-activated protein kinase kinase kinase kinase 1","1","6CQF"
"6CQH",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, SITTING DROP",6,"25% PEG3350, 300 mM LiSO4, 0.1M SBG, pH 6.0, 30% glycerol",293,,,"6CQH",166.99,"2.15","2.15","Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6CQH"
"6CQT",,"X-RAY DIFFRACTION",4.27,71.22,"VAPOR DIFFUSION, SITTING DROP",7,"1:1:1 ratio of DMSO, glycerol, and ethylene glycol, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acs.chemrestox.8b00294",,"6CQT",121.35,"2.273","2.273","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by (-) Stereoisomer of VX","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6CQT"
"6CQU",,"X-RAY DIFFRACTION",4.35,71.72,"VAPOR DIFFUSION, SITTING DROP",7,"15-21% PEG 3350, 0.17-0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acs.chemrestox.8b00294","HI6","6CQU",121.71,"2.308","2.308","Crystal Structure of Recombinant Human Acetylcholinesterase with Reactivator HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6CQU"
"6CQV",,"X-RAY DIFFRACTION",4.28,71.26,"VAPOR DIFFUSION, SITTING DROP",7,"15 to 21% PEG 3350, 0.17-0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acs.chemrestox.8b00294","HI6","6CQV",121.51,"2.601","2.601","Crystal Structure of Recombinant Human Acetylcholinesterase in Complex with VX(+) and HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6CQV"
"6CQW",,"X-RAY DIFFRACTION",4.35,71.71,"VAPOR DIFFUSION, SITTING DROP",7,"15 to 21% PEG 3350, 0.17 - 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acs.chemrestox.8b00294","HI6","6CQW",121.52,"2.278","2.278","Crystal Structure of Recombinant Human Acetylcholinesterase in Complex with VX(-) and HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6CQW"
"6CQX",,"X-RAY DIFFRACTION",4.33,71.59,"VAPOR DIFFUSION, SITTING DROP",7,"15 to 21% PEG 3350, 0.17 - 0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acs.chemrestox.8b00294",,"6CQX",121.39,"2.4","2.4","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by VX(+)","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6CQX"
"6CQY",,"X-RAY DIFFRACTION",4.35,71.75,"VAPOR DIFFUSION, SITTING DROP",7,"15 to 21% PEG 3350, 0.17 - 0.21M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acs.chemrestox.8b00294","HI6","6CQY",121.3,"2.449","2.449","Crystal Structure of Recombinant Human Acetylcholinesterase in Complex with EMPA and HI-6","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6CQY"
"6CQZ",,"X-RAY DIFFRACTION",4.3,71.4,"VAPOR DIFFUSION, SITTING DROP",7,"12 to 18% PEG 3350, 0.2M potassium nitrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/acs.chemrestox.8b00294",,"6CQZ",120.5,"2.216","2.216","Crystal Structure of Recombinant Human Acetylcholinesterase Inhibited by VX","GREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6CQZ"
"6CR1",,"X-RAY DIFFRACTION",3.1,60.34,"VAPOR DIFFUSION, SITTING DROP",7.2,"15% PEG 3350 and 0.25M potassium nitrate",273,"10.1080/19420862.2018.1519631",,"6CR1",48.52,"1.521","1.521","adalimumab EFab","EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSSASTKGPTVKILQSICDGGGHFPPTIQLLCLVSGYTPGTIQITWLEDGQVMDVDLSTASTTQEGELASTQSELTLSQKHWLSDRTYTCQVTYQGHTFEDSTKKCAHHHHHH","Homo sapiens",,"Heavy chain of adalimumab EFab (VH-IgE CH2)","2","6CR1"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIKRTVAAPTVKILQSSCDGGGHFPPTIQLLCLVSGYTPGTIQITWLEDGQVMDVDLSTASTTQEGELASTQSELTLSQKHWLSDRTYTCQVTYQGHTFEDSGKKCA","Homo sapiens",,"Light chain of adalimumab EFab (VL-IgE CH2)","1","6CR1"
"6CRF",,"X-RAY DIFFRACTION",2.69,54.28,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES pH 6.5, 12% PEG 20,000, and 5% Sucrose",293.15,"10.1038/s41467-018-06823-9",,"6CRF",120.7,"2.62","2.62","Crystal Structure of Shp2 E76K GOF Mutant in the Open Conformation","GMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAKLVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6CRF"
"6CRG",,"X-RAY DIFFRACTION",2.23,44.81,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 8.5, 30% PEG 4000, and 0.2 M LiSO4",293.15,"10.1038/s41467-018-06823-9","5OD","6CRG",122.18,"2.75","2.75","Crystal Structure of Shp2 E76K GOF Mutant in complex with SHP099","GMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAKLVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETL","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","6CRG"
"6CS9",,"X-RAY DIFFRACTION",1.92,35.92,"VAPOR DIFFUSION, SITTING DROP",8.38,"0.697M Sodium-malonate-malonic acid, 0.1M glycine-glycine, pH 8.38",293.15,"10.1126/sciadv.aat0979","PIO","6CS9",10.18,"1.85","1.85","Crystal structure of human beta-defensin 2 in complex with PIP2","GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP","Homo sapiens","DEFB4A, DEFB102, DEFB2, DEFB4, DEFB4B","Beta-defensin 4A","1","6CS9"
"6CSB",,"X-RAY DIFFRACTION",3.23,61.89,"VAPOR DIFFUSION, HANGING DROP",,"mixing 1.5 ul of the protein solution, 0.25 ul 70 mM HEGA-10, and 0.3 ul of the reservoir solution containing 10-20% of PEG 400, 0.1 M cacodylate, pH 7.0, 2 mM ZnSO4, and 200 mM MgAc2",293,,,"6CSB",222.35,"2.394","2.394","V308E mutant of cytochrome P450 2D6 complexed with thioridazine","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMETTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","6CSB"
"6CSD",,"X-RAY DIFFRACTION",3.25,62.16,"VAPOR DIFFUSION, HANGING DROP",,"mixing 1.5 ul of protein solution, 0.25 ul 70 mM HEGA-10, and 0.3 ul of the reservoir solution containing 10-20% of PEG400, 0.1 M cacodylate, pH 7.0, 2 mM ZnSO4, and 200 mM MgAc2",293,,,"6CSD",111.22,"2.391","2.391","V308E mutant of cytochrome P450 2D6 complexed with prinomastat","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMETTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","6CSD"
"6CSW",,"X-RAY DIFFRACTION",2.59,52.57,"VAPOR DIFFUSION, SITTING DROP",7,"27.5% PEG3350; 300 mM LiSO4; 0.1M SBG pH 7.0",293,,,"6CSW",168.61,"2.25","2.25","Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6CSW"
"6CT0","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1021/acs.biochem.8b00357",,"6CT0",69.07,"3.1",,"Atomic Structure of the E2 Inner Core of Human Pyruvate Dehydrogenase Complex","MWRVCARRAQNVAPWAGLEARWTALQEVPGTPRVTSRSGPAPARRNSVTTGYGGVRALCGWTPSSGATPRNRLLLQLLGSPGRRYYSLPPHQKVPLPSLSPTMQAGTIARWEKKEGDKINEGDLIAEVETDKATVGFESLEECYMAKILVAEGTRDVPIGAIICITVGKPEDIEAFKNYTLDSSAAPTPQAAPAPTPAATASPPTPSAQAPGSSYPPHMQVLLPALSPTMTMGTVQRWEKKVGEKLSEGDLLAEIETDKATIGFEVQEEGYLAKILVPEGTRDVPLGTPLCIIVEKEADISAFADYRPTEVTDLKPQVPPPTPPPVAAVPPTPQPLAPTPSAPCPATPAGPKGRVFVSPLAKKLAVEKGIDLTQVKGTGPDGRITKKDIDSFVPSKVAPAPAAVVPPTGPGMAPVPTGVFTDIPISNIRRVIAQRLMQSKQTIPHYYLSIDVNMGEVLLVRKELNKILEGRSKISVNDFIIKASALACLKVPEANSSWMDTVIRQNHVVDVSVAVSTPAGLITPIVFNAHIKGVETIANDVVSLATKAREGKLQPHEFQGGTFTISNLGMFGIKNFSAIINPPQACILAIGASEDKLVPADNEKGFDVASMMSVTLSCDHRVVDGAVGAQWLAEFRKYLEKPITMLL","Homo sapiens","DLAT, DLTA","Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial","1","6CT0"
"6CT2",,"X-RAY DIFFRACTION",2.25,45.4,"VAPOR DIFFUSION, SITTING DROP",,"0.196 M MgCl2, 19.5 % PEG 3350, and 0.1 M bis-tris chloride at pH 5.5",281,"10.1038/s41586-018-0387-5",,"6CT2",35.01,"2.128","2.128","MYST histone acetyltransferase KAT6A/B in complex with WM-1119","MGSSHHHHHHSSGLVPRGSTKVKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVSCIMILPPYQRRGYGRFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPPK","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","6CT2"
"6CTC",,"X-RAY DIFFRACTION",2.46,49.97,"VAPOR DIFFUSION, SITTING DROP",6.5,"Apo human transferrin (ProSpec pro-325 purified by Q-sepharose) at 56 mg/mL (0.76 mM) against Morpheus screen condition D4 12.5% PEG 1000, 12.5% PEG3350, 12.5% MPD, 0.02 M each 1,6-hexanediol, 1-butanol, RS-1,2-propanediol, 2-propanol, 1,4-butanediol, 1,3-propanediol, 0.1 M MES/imidazole pH 6.5, crystal tracking ID 246352d4, unique puck ID suv0-5",291,"10.1007/s10534-018-0142-2",,"6CTC",75.65,"2.6","2.6","Crystal structure of human transferrin bound to Triferic FPC iron pyrophosphate","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","6CTC"
"6CU6",,"X-RAY DIFFRACTION",1.97,37.56,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.1 M Sodium Malonate pH 7.5, 40 mM  Dimethyloctylphosphine oxide",293,"10.1158/2159-8290.CD-19-1006",,"6CU6",60.02,"1.5","1.5","Crystal structure of GMPPNP-bound G12R mutant of human KRAS4b","GMTEYKLVVVGARGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6CU6"
"6CU7","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-05971-2",,"6CU7",144.76,"3.5",,"Alpha Synuclein fibril formed by full length protein - Rod Polymorph","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6CU7"
"6CU8","3.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-05971-2",,"6CU8",144.76,"3.6",,"Alpha Synuclein fibril formed by full length protein - Twister Polymorph","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6CU8"
"6CUD","3.3","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.36852",,"6CUD",374.45,"3.3",,"Structure of the human TRPC3 in a lipid-occupied, closed state","MREKGRRQAVRGPAFMFNDRGTSLTAEEERFLDAAEYGNIPVVRKMLEESKTLNVNCVDYMGQNALQLAVGNEHLEVTELLLKKENLARIGDALLLAISKGYVRIVEAILNHPGFAASKRLTLSPCEQELQDDDFYAYDEDGTRFSPDITPIILAAHCQKYEVVHMLLMKGARIERPHDYFCKCGDCMEKQRHDSFSHSRSRINAYKGLASPAYLSLSSEDPVLTALELSNELAKLANIEKEFKNDYRKLSMQCKDFVVGVLDLCRDSEEVEAILNGDLESAEPLEVHRHKASLSRVKLAIKYEVKKFVAHPNCQQQLLTIWYENLSGLREQTIAIKCLVVLVVALGLPFLAIGYWIAPCSRLGKILRSPFMKFVAHAASFIIFLGLLVFNASDRFEGITTLPNITVTDYPKQIFRVKTTQFTWTEMLIMVWVLGMMWSECKELWLEGPREYILQLWNVLDFGMLSIFIAAFTARFLAFLQATKAQQYVDSYVQESDLSEVTLPPEIQYFTYARDKWLPSDPQIISEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTVKDIFKFMVLFIMVFFAFMIGMFILYSYYLGAKVNAAFTTVEESFKTLFWSIFGLSEVTSVVLKYDHKFIENIGYVLYGIYNVTMVVVLLNMLIAMINSSYQEIEDDSDVEWKFARSKLWLSYFDDGKTLPPPFSLVPSPKSFVYFIMRIVNFPKCRRRRLQKDIEMGMGNSKSRLNLFTQSNSRVFESHSFNSILNQPTRYQQIMKRLIKRYVLKAQVDKENDEVNEGELKEIKQDISSLRYEL","Homo sapiens","TRPC3, TRP3","Short transient receptor potential channel 3","1","6CUD"
"6CUH",,"X-RAY DIFFRACTION",2.27,45.88,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, Potassium-sodium tartrate tetrahydrate",293,"10.1038/s41467-018-07898-0",,"6CUH",50.65,"2.01","2.01","Crystal structure of the unliganded BC8B TCR","GNSVTQMEGPVTLSEEAFLTINCTYTATGYPSLFWYVQYPGEGLQLLLKATKADDKGSNKGFEATYRKETTSFHLEKGSVQVSDSAVYFCALTPSGGYQKVTFGTGTKLQVIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"T-cell Receptor alpha variable, TRAV 9-2. BC8B TCR","1","6CUH"
,,,,,,,,,,,,,,,,"NAGVTQTPKFRVLKTGQSMTLLCAQDMNHEYMYWYRQDPGMGLRLIHYSVGEGTTAKGEVPDGYNVSRLKKQNFLLGLESAAPSQTSVYFCASSMPGLRSSYEQYFGPGTRLTVTEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"T-cell Receptor beta variable, TRBV 6-2. BC8B TCR","2","6CUH"
"6CUI",,"SOLUTION NMR",,,,,,,,,"6CUI",15.28,,,"Solution structure of the Extraterminal (ET) Domain of BRD2","SMKTAPPALPTGYDSEEEEESRPMSYDEKRQLSLDINKLPGEKLGRVVHIIQAREPSLRDSNPEEIEIDFETLKPSTLRELERYVLSCLRKKPRKPYTIKKPVGKTKEELALEKKRELEKRLQDVSGQLNST","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6CUI"
"6CVH",,"X-RAY DIFFRACTION",3.31,62.79,"VAPOR DIFFUSION, SITTING DROP",,"1.35M NaFormate, 0.1M Hepes pH7, 3%MPD",293,"10.1016/j.bmcl.2018.03.093",,"6CVH",27.03,"3.5","3.5","Identification and biological evaluation of thiazole-based inverse agonists of RORgt","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLPA","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6CVH"
"6CVZ",,"X-RAY DIFFRACTION",2.32,47.08,"VAPOR DIFFUSION, HANGING DROP",8,"16% PEG 3500, 0.2 M Magnesium Chloride, 0.1 M Tris pH8.0",295,"10.1002/prot.25805",,"6CVZ",116.47,"1.8","1.8","Crystal structure of the WD40-repeat of RFWD3","GSPSSQGQHKHKYHFQKTFTVSQAGNCRIMAYCDALSCLVISQPSPQASFLPGFGVKMLSTANMKSSQYIPMHGKQIRGLAFSSYLRGLLLSASLDNTIKLTSLETNTVVQTYNAGRPVWSCCWCLDEANYIYAGLANGSILVYDVRNTSSHVQELVAQKARCPLVSLSYMPRAASAAFPYGGVLAGTLEDASFWEQKMDFSHWPHVLPLEPGGCIDFQTENSSRHCLVTYRPDKNHTTIRSVLMEMSYRLDDTGNPICSCQPVHTFFGGPTCKLLTKNAIFQSPENDGNILVCTGDEAANSALLWDAASGSLLQDLQTDQPVLDICPFEVNRNSYLATLTEKMVHIYKWE","Homo sapiens","RFWD3, RNF201","E3 ubiquitin-protein ligase RFWD3","1","6CVZ"
"6CWA",,"X-RAY DIFFRACTION",2.29,46.22,"VAPOR DIFFUSION, SITTING DROP",6.5,"100 MM IMIDAZOLE PH 6.5, 20% PEG
 3350, 100 MM MAGNESIUM CHLORIDE, 2M NACL, 1MM NADH; SOAK
 OVERNIGHT IN CRYSTALLIZATION SOLUTION PLUS 5 MM 3-
 PHOSPHOGLYCERATE; 20% EG CRYO, VAPOR DIFFUSION, TEMPERATURE
 289K",289,"10.1021/acs.jmedchem.9b00718",,"6CWA",71.81,"1.77","1.77","CRYSTAL STRUCTURE PHGDH IN COMPLEX WITH NADH AND 3-PHOSPHOGLYCERATE AT 1.77 A RESOLUTION","SGVDLGTENLYFQSMANLRKVLISDSLDPCCRKILQDGGLQVVEKQNLSKEELIAELQDCEGLIVRSATKVTADVINAAEKLQVVGRAGTGVDNVDLEAATRKGILVMNTPNGNSLSAAELTCGMIMCLARQIPQATASMKDGKWERKKFMGTELNGKTLGILGLGRIGREVATRMQSFGMKTIGYDPIISPEVSASFGVQQLPLEEIWPLCDFITVHTPLLPSTTGLLNDNTFAQCKKGVRVVNCARGGIVDEGALLRALQSGQCAGAALDVFTEEPPRDRALVDHENVISCPHLGASTKEAQSRCGEEIAVQFVDMVKGKSLTGV","Homo sapiens","PHGDH, PGDH3","D-3-phosphoglycerate dehydrogenase","1","6CWA"
"6CWS",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2018.06.001",,"6CWS",12.39,,,"The NMR solution structure of CCL28","SEAILPIASSCCTEVSHHISRRLLERVNMCRIQRADGDCDLAAVILHVKRRRICVSPHNHTVKQWMKVQAAKKNGKGNVCHRKKHHGKRNSNRAHQGKHETYGHKTPY","Homo sapiens","CCL28, SCYA28","C-C motif chemokine 28","1","6CWS"
"6CWU",,"X-RAY DIFFRACTION",3.16,66.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, 200 mM magnesium acetate, and 14% polyethylene glycol 8000, pH 7.5",277.15,"10.1021/acs.biochem.8b00656",,"6CWU",38.48,"2.08","2.08","Protein Tyrosine Phosphatase 1B F135Y mutant","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIYEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHNLEHHHHHH","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6CWU"
"6CWV",,"X-RAY DIFFRACTION",3.17,66.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, 200 mM magnesium acetate, and 14% polyethylene glycol 8000, pH 7.5",277.15,"10.1021/acs.biochem.8b00656",,"6CWV",38.48,"1.98002287694","1.98002287694","Protein Tyrosine Phosphatase 1B A122S mutant","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCSQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHNLEHHHHHH","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","6CWV"
"6CXL",,"X-RAY DIFFRACTION",3.97,68.98,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M lithium sulfate, 17.5% Peg400, 0.1M tris",295,"10.1021/acscentsci.8b00588",,"6CXL",97.05,"3.586","3.586","anti-HIV-1 Fab 2G12 in complex with glycopeptide 10F5","AVVMTQSPSTLSASVGDTITITCRASQSIETWLAWYQQKPGKAPKLLIYKASTLKTGVPSRFSGSGSGTEFTLTISGLQFDDFATYHCQHYAGYSATFGQGTRVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"anti-HIV-1 Fab 2G12 light chain","1","6CXL"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVKAGGSLILSCGVSNFRISAHTMNWVRRVPGGGLEWVASISTSSTYRDYADAVKGRFTVSRDDLEDFVYLQMHKMRVEDTAIYYCARKGSDRLSDNDPFDAWGPGTVVTVSPASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"anti-HIV-1 Fab 2G12 heavy chain","2","6CXL"
"6CXU",,"X-RAY DIFFRACTION",2.88,57.24,"BATCH MODE",10,"0.1 M sodium thiosulfate, 0.1 M CAPS, pH 10, 20% PEG8000",277,"10.1021/jacs.8b03691",,"6CXU",97.38,"2.49","2.49","Structure of the S167H mutant of human indoleamine 2,3 dioxygenase in complex with tryptophan and cyanide","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVHLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6CXU"
"6CXV",,"X-RAY DIFFRACTION",2.88,57.29,"BATCH MODE",10,"0.1 M sodium thiosulfate, 0.1 M CAPS, pH 10, 20% PEG8000",277,"10.1021/jacs.8b03691",,"6CXV",97.7,"2.6","2.6","Structure of the S167H mutant of human indoleamine 2,3 dioxygenase in complex with tryptophan and cyanide","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVHLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6CXV"
"6CY7",,"X-RAY DIFFRACTION",2.03,39.32,"VAPOR DIFFUSION, SITTING DROP",7,"ammonium citrate tribasic, imidazole, PEG5000 MME",285,"10.1016/j.cell.2019.05.036",,"6CY7",27.96,"2.2","2.2","Human Stimulator of Interferon Genes","LAPAEISAVCEKGNFNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTADRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTVGSLKTSAVPSTSTMSQEPELLISGMEKPLPLRTDFS","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","6CY7"
"6CYB",,"X-RAY DIFFRACTION",2.04,39.66,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG8000, 0.1M Hepes pH7.5, 1mM TCEP",293,"10.1021/acsmedchemlett.8b00214","FKV","6CYB",88.88,"1.62","1.62","PDE2 in complex with compound 7","MHHHHHHENLYFQGELSTSLYKKAGFDDDDKSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6CYB"
"6CYC",,"X-RAY DIFFRACTION",2.03,39.28,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG8000, 0.1M Hepes pH7.5, 1mM TCEP",293,"10.1021/acsmedchemlett.8b00214","FKJ","6CYC",88.96,"1.54","1.54","PDE2 in complex with compound 5","MHHHHHHENLYFQGELSTSLYKKAGFDDDDKSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6CYC"
"6CYD",,"X-RAY DIFFRACTION",1.94,36.7,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG8000, 0.1M Hepes pH7.5, 1mM TCEP",293,"10.1021/acsmedchemlett.8b00214","FKG","6CYD",88.46,"1.69","1.69","PDE2 in complex with compound 7","MHHHHHHENLYFQGELSTSLYKKAGFDDDDKSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6CYD"
"6CYG",,"X-RAY DIFFRACTION",2.47,50.29,"VAPOR DIFFUSION, HANGING DROP",6.4,"Bis-Tris Propane pH 6.4, MgCl2, PEG 2000 MME. Soak crystals with NEOCA",277,"10.1074/jbc.RA119.009960","N5O","6CYG",57.92,"1.50392199595","1.50392199595","Hsp90-alpha N-domain bound to NEOCA","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6CYG"
"6CYH",,"X-RAY DIFFRACTION",2.46,50.05,"VAPOR DIFFUSION, HANGING DROP",6.4,"Bis-Tris Propane pH 6.4, MgCl2, PEG 2000 MME. Soak crystals with NEACA",277,"10.1074/jbc.RA119.009960","N5A","6CYH",57.92,"1.49","1.49","Hsp90-alpha N-domain bound to NEACA","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6CYH"
"6CYM",,"X-RAY DIFFRACTION",2.52,51.22,"BATCH MODE",,"For complex formation, 2 mg human alpha-thrombin (7.1 mg/mL in 50% v/v glycerol) were mixed with 0.5 mM Compound 1 in DMSO and dialyzed overnight into a solution of 20 mM sodium citrate and 1.3 mM Na2SO4 (pH 5.8). After dialysis, another 0.5 mM compound were added and left to incubate at room temperature for 1 h. The protein was centrifuged for 5 min at 4 deg C and 8000x RCF. The pellet, including about 120 uL of buffer, was mixed with 100 uL of a solution containing 50 mM sodium phosphate (pH 7.3), 190 mM sodium chloride, and 0.2 mM Compound 1. The crystal used for data collection was grown from the JCSG+ screen in well A10. The crystal was grown at 20 deg C using a MRC 3-well plate and in a 150 + 150 nL drop with a reservoir of 0.2 M potassium formate and 20% w/v PEG-3350.",294,"10.1371/journal.pone.0201377",,"6CYM",66.74,"2.9","2.9","Reversible Covalent Direct Thrombin Inhibitors","IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","1","6CYM"
,,,,,,,,,,,,,,,,"ADCGLRPLFEKKSLEDKTERELLESYID","Homo sapiens","F2","Prothrombin","2","6CYM"
"6CYO",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, SITTING DROP",,"50 mM di-Sodium succinate pH 7.0 and 12-14% PEG 3350",291,"10.1038/s41589-018-0177-2",,"6CYO",17.61,"1.85","1.85","Crystal structure of human UBE2A (RAD6A)","GSHMSTPARRRLMRDFKRLQEDPPAGVSGAPSENNIMVWNAVIFGPEGTPFEDGTFKLTIEFTEEYPNKPPTVRFVSKMFHPNVYADGSICLDILQNRWSPTYDVSSILTSIQSLLDEPNPNSPANSQAAQLYQENKREYEKRVSAIVEQSWRDC","Homo sapiens","UBE2A, RAD6A","Ubiquitin-conjugating enzyme E2 A","1","6CYO"
"6CYR",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, SITTING DROP",,"50 mM di-Sodium succinate pH 7.0 and 12-14% PEG 3350",291,"10.1038/s41589-018-0177-2",,"6CYR",17.62,"2.2","2.2","Crystal structure of the UBE2A variant Q93E","GSHMSTPARRRLMRDFKRLQEDPPAGVSGAPSENNIMVWNAVIFGPEGTPFEDGTFKLTIEFTEEYPNKPPTVRFVSKMFHPNVYADGSICLDILENRWSPTYDVSSILTSIQSLLDEPNPNSPANSQAAQLYQENKREYEKRVSAIVEQSWRDC","Homo sapiens","UBE2A, RAD6A","Ubiquitin-conjugating enzyme E2 A","1","6CYR"
"6CZ1",,"X-RAY DIFFRACTION",2.09,41.26,"VAPOR DIFFUSION, HANGING DROP",8.5,"24-26% PEG3350, 0.1 M Tris-HCl, 0.2 M sodium chloride",289,,"3FD","6CZ1",85.47,"1.68","1.68","Crystal structure of ATPase domain of Human GRP78 bound to Ver155008","DVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSG","Homo sapiens","HSPA5, GRP78","Endoplasmic reticulum chaperone BiP","1","6CZ1"
"6CZ2",,"X-RAY DIFFRACTION",3.14,60.88,"VAPOR DIFFUSION, SITTING DROP",8,"3.3 M Potassium acetate, 0.1 M bicine, pH 8, 13oC",288,"10.1371/journal.pone.0198374",,"6CZ2",30.33,"2.5","2.5","Structure of the PTK6 kinase domain","GSDDAERPREEFTLCRKLGSGYFGEVFEGLWKDRVQVAIKVISRDNLLHQQMLQSEIQAMKKLRHKHILALYAVVSVGDPVYIITELMAKGSLLELLRDSDEKVLPVSELLDIAWQVAEGMCYLESQNYIHRDLAARNILVGENTLCKVGDFGLARLIKEDVYLSHDHNIPYKWTAPEALSRGHYSTKSDVWSFGILLHEMFSRGQVPYPGMSNHEAFLRVDAGYRMPCPLECPPSVHKLMLTCWCRDPEQRPCFKALRERLSS","Homo sapiens","PTK6, BRK","Protein-tyrosine kinase 6","1","6CZ2"
"6CZ3",,"X-RAY DIFFRACTION",3.14,60.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"3.4 M Potassium acetate, 0.1 M bicine, pH 7.5, 13oC",288,"10.1371/journal.pone.0198374","FLJ","6CZ3",31.16,"1.8","1.8","Structure of the PTK6 kinase domain bound to a type I inhibitor (3-fluoro-4-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}phenyl)(morpholin-4-yl)methanone","GSDDAERPREEFTLCRKLGSGYFGEVFEGLWKDRVQVAIKVISRDNLLHQQMLQSEIQAMKKLRHKHILALYAVVSVGDPVYIITELMAKGSLLELLRDSDEKVLPVSELLDIAWQVAEGMCYLESQNYIHRDLAARNILVGENTLCKVGDFGLARLIKEDVYLSHDHNIPYKWTAPEALSRGHYSTKSDVWSFGILLHEMFSRGQVPYPGMSNHEAFLRVDAGYRMPCPLECPPSVHKLMLTCWCRDPEQRPCFKALRERLSS","Homo sapiens","PTK6, BRK","Protein-tyrosine kinase 6","1","6CZ3"
"6CZ4",,"X-RAY DIFFRACTION",2.31,46.87,"VAPOR DIFFUSION, SITTING DROP",,"1.25 M Sodium dihydrogen phosphate, 0.89 M di-Potassium hydrogen phosphate, 0.2 M Lithium sulfate, 0.1 M CHES, pH 9.8, 13o C",286,"10.1371/journal.pone.0198374","FKY","6CZ4",30.77,"1.5","1.5","Structure of the PTK6 kinase domain bound to a type II inhibitor 2-{[(3R,4S)-3-fluoro-1-{[4-(trifluoromethoxy)phenyl]acetyl}piperidin-4-yl]oxy}-5-(1-methyl-1H-imidazol-4-yl)pyridine-3-carboxamide","GSDDAERPREEFTLCRKLGSGYFGEVFEGLWKDRVQVAIKVISRDNLLHQQMLQSEIQAMKKLRHKHILALYAVVSVGDPVYIITELMAKGSLLELLRDSDEKVLPVSELLDIAWQVAEGMCYLESQNYIHRDLAARNILVGENTLCKVGDFGLARLIKEDVYLSHDHNIPYKWTAPEALSRGHYSTKSDVWSFGILLHEMFSRGQVPYPGMSNHEAFLRVDAGYRMPCPLECPPSVHKLMLTCWCRDPEQRPCFKALRERLSS","Homo sapiens","PTK6, BRK","Protein-tyrosine kinase 6","1","6CZ4"
"6CZ5",,"X-RAY DIFFRACTION",2.88,57.32,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM sodium citrate, 8% PEG3000",291,"10.1093/nar/gky706",,"6CZ5",54.51,"3","3","Crystal structure of small molecule AMP-acrylamide covalently bound to DDX3 S228C","GSFTDEDDWSKPLPPSERLEQELFSGGNTGINFEKYDDIPVEATGNNCPPHIESFSDVEMGEIIMGNIELTRYTRPTPVQKHAIPIIKEKRDLMACAQTGCGKTAAFLLPILSQIYSDGPGEALRAMKENGRYGRRKQYPISLVLAPTRELAVQIYEEARKFSYRSRVRPCVVYGGADIGQQIRDLERGCHLLVATPGRLVDMMERGKIGLDFCKYLVLDEADRMLDMGFEPQIRRIVEQDTMPPKGVRHTMMFSATFPKEIQMLARDFLDEYIFLAVGRVGSTSENITQKVVWVEESDKRSFLLDLLNATGKDSLTLVFVETKKGADSLEDFLYHEGYACTSIHGDRSQRDREEALHQFRSGKSPILVATAVAARGLDISNVKHVINFDLPSDIEEYVHRIGRTGRVGNLGLATSFFNERNINITKDLLDLLVEAKQEVPSWLENMAYEHHYKGSSRGRSKSSRFSGGFGARDYRQSSG","Homo sapiens","DDX3X, DBX, DDX3","ATP-dependent RNA helicase DDX3X","1","6CZ5"
"6CZK",,"X-RAY DIFFRACTION",3.93,68.73,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1 M sodium phosphate dibasic, citric acid, pH 4.2, 2.0 M ammonium sulfate",293,"10.1371/journal.pone.0200374",,"6CZK",39.45,"2.001","2.001","Crystal structure of wild-type human pro-cathepsin H","MWATLPLLCAGAWLLGVPVCGAAELCVNSLEKFHFKSWMSKHRKTYSTEEYHHRLQTFASNWRKINAHNNGNHTFKMALNQFSDMSFAEIKHKYLWSEPQNCSATKSNYLRGTGPYPPSVDWRKKGNFVSPVKNQGACGSCWTFSTTGALESAIAIATGKMLSLAEQQLVDCAQDFNNHGCQGGLPSQAFEYILYNKGIMGEDTYPYQGKDGYCKFQPGKAIGFVKDVANITIYDEEAMVEAVALYNPVSFAFEVTQDFMMYRTGIYSSTSCHKTPDKVNHAVLAVGYGEKNGIPYWIVKNSWGPQWGMNGYFLIERGKNMCGLAACASYPIPLV","Homo sapiens","CTSH, CPSB","Pro-cathepsin H","1","6CZK"
"6CZS",,"X-RAY DIFFRACTION",3.97,69,"VAPOR DIFFUSION, SITTING DROP",4.2,"0.1 M sodium phosphate dibasic / citric acid, pH 4.2, 2.0 M ammonium sulfate",293,"10.1371/journal.pone.0200374",,"6CZS",39.79,"1.66","1.66","Crystal structure of human pro-cathepsin H C26S mutant","MWATLPLLCAGAWLLGVPVCGAAELCVNSLEKFHFKSWMSKHRKTYSTEEYHHRLQTFASNWRKINAHNNGNHTFKMALNQFSDMSFAEIKHKYLWSEPQNCSATKSNYLRGTGPYPPSVDWRKKGNFVSPVKNQGACGSSWTFSTTGALESAIAIATGKMLSLAEQQLVDCAQDFNNHGCQGGLPSQAFEYILYNKGIMGEDTYPYQGKDGYCKFQPGKAIGFVKDVANITIYDEEAMVEAVALYNPVSFAFEVTQDFMMYRTGIYSSTSCHKTPDKVNHAVLAVGYGEKNGIPYWIVKNSWGPQWGMNGYFLIERGKNMCGLAACASYPIPLV","Homo sapiens","CTSH, CPSB","Pro-cathepsin H","1","6CZS"
"6CZU",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M Ammonium Sulfate, 0.1 M Bis-Tris pH 6.5, 25% PEG 3350",297,"10.1021/acs.jmedchem.8b00666",,"6CZU",16.17,"1.47","1.47","BRD4(BD1) complexed with 3219","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CZU"
"6CZV",,"X-RAY DIFFRACTION",2.17,43.27,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Potassium Fluoride, 8% (w/v) PEG 3,350",297,"10.1021/acs.jmedchem.8b00666","FOY","6CZV",15.73,"1.88","1.88","BRD4(BD1) complexed with 2759","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6CZV"
"6D0A",,"X-RAY DIFFRACTION",2.37,48.05,"VAPOR DIFFUSION, HANGING DROP",,"Protein 10 mg/mL was mixed with an equal volume of a reservoir solution containing 200 mM NaCl, 0.1 M NaCitrate pH 5.6, 24% PEG4K and equilibrated against 1 mL of a reservoir solution.",293,,,"6D0A",48.23,"1.46809418277","1.46809418277","Crystal structure of Kynurenine Aminotransferase-II in apo-form, at 1.47 A resolution","HHHHHHMNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","6D0A"
"6D0L",,"X-RAY DIFFRACTION",1.86,34.03,"VAPOR DIFFUSION, HANGING DROP",,"0.06 M citric acid, 0.04 M Bis-Tris-Propane, pH 4.1, 16% PEG 3,350; Cryoprotection in 25% PEG 3,350",295,"10.1038/s41594-018-0083-z",,"6D0L",46.08,"1.97","1.97","Structure of human TIRR","MVPELKQISRVEAMRLGPGWSHSCHAMLYAANPGQLFGRIPMRFSVLMQMRFDGLLGFPGGFVDRRFWSLEDGLNRVLGLGLGCLRLTEADYLSSHLTEGPHRVVAHLYARQLTLEQLHAVEISAVHSRDHGLEVLGLVRVPLYTQKDRVGGFPNFLSNAFVSTAKCQLLFALKVLNMMPEEKLVEALAAATEKQKKALEKLLPASS","Homo sapiens","NUDT16L1, SDOS, TIRR","Tudor-interacting repair regulator protein","1","6D0L"
"6D0S",,"X-RAY DIFFRACTION",2.29,46.27,"VAPOR DIFFUSION",6.3,"1.4 M ammonium sulfate, 0.1 M Bis-Tris, 0.001 M DTT, 1:100 chymotrypsin",291,,,"6D0S",41.87,"2.3","2.3","RabGAP domain of human TBC1D22B","MHHHHHHSSGRENLYFQGMTVREKTRLEKFRQLLSSQNTDLDELRKCSWPGVPREVRPITWRLLSGYLPANTERRKLTLQRKREEYFGFIEQYYDSRNEEHHQDTYRQIHIDIPRTNPLIPLFQQPLVQEIFERILFIWAIRHPASGYVQGINDLVTPFFVVFLSEYVEEDVENFDVTNLSQDMLRSIEADSFWCMSKLLDGIQDNYTFAQPGIQKKVKALEELVSRIDEQVHNHFRRYEVEYLQFAFRWMNNLLMRELPLRCTIRLWDTYQSEPEGFSHFHLYVCAAFLIKWRKEILDEEDFQGLLMLLQNLPTIHWGNEEIGLLLAEAYRLKYMFADAPNHYRR","Homo sapiens","TBC1D22B, C6orf197","TBC1 domain family member 22B","1","6D0S"
"6D0W",,"X-RAY DIFFRACTION",2.41,44.48,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES, pH 5.5, PEG 4K, 150 mM AmSO4",293,,,"6D0W",28.14,"1.7","1.7","Structure of human transthyretin complex with analgesic inhibitor","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEQFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6D0W"
"6D1L",,"X-RAY DIFFRACTION",2.09,41.01,"VAPOR DIFFUSION, SITTING DROP",8.6,"200 nL 7 mg/mL protein + 200 nL reservoir (2.8 M ammonium sulfate, 100 mM Tris, pH 8.6)",281,"10.1016/j.ejmech.2018.05.026","FQV","6D1L",30.02,"1.4","1.4","Design, synthesis, and X-ray of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6D1L"
"6D1M",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION, SITTING DROP",8.6,"200 nL 7 mg/mL protein + 200 nL reservoir (2.8 M ammonium sulfate, 100 mM Tris, pH 8.6)",281,"10.1016/j.ejmech.2018.05.026","FQY","6D1M",30.08,"1.21","1.21","Design, synthesis, and X-ray of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6D1M"
"6D1W","3.54","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-04586-x",,"6D1W",342.64,"3.54",,"human PKD2 F604P mutant","EIEMQRIRQAAARDPPAGAAASPSPPLSSCSRQAWSRDNPGFEAEEEEEEVEGEEGGMVVEMDVEWRPGSRRSAASSAVSSVGARSRGLGGYHGAGHPSGRRRRREDQGPPCPSPVGGGDPLHRHLPLEGQPPRVAWAERLVRGLRGLWGTRLMEESSTNREKYLKSVLRELVTYLLFLIVLCILTYGMMSSNVYYYTRMMSQLFLDTPVSKTEKTNFKTLSSMEDFWKFTEGSLLDGLYWKMQPSNQTEADNRSFIFYENLLLGVPRIRQLRVRNGSCSIPQDLRDEIKECYDVYSVSSEDRAPFGPRNGTAWIYTSEKDLNGSSHWGIIATYSGAGYYLDLSRTREETAAQVASLKKNVWLDRGTRATFIDFSVYNANINLFCVVRLLVEFPATGGVIPSWQFQPLKLIRYVTTFDFFLAACEIIFCFFIFYYVVEEILEIRIHKLHYFRSFWNCLDVVIVVLSVVAIGINIYRTSNVEVLLQFLEDQNTFPNFEHLAYWQIQFNNIAAVTVFFVWIKLFKFINFNRTMSQLSTTMSRCAKDLFGFAIMPFIIFLAYAQLAYLVFGTQVDDFSTFQECIFTQFRIILGDINFAEIEEANRVLGPIYFTTFVFFMFFILLNMFLAIINDTYSEVKSDLAQQKAEMELSDLIRKGYHKALVKLKLKKNTVDDISESLRQGGGKLNFDELRQDLKGKGHTDAEIEAIFTKYDQDGDQELTEHEHQQMRDDLEKEREDLDLD","Homo sapiens","PKD2, TRPP2","Polycystin-2","1","6D1W"
"6D1Y",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, SITTING DROP",6.5,"Well volume: 25.0 uL
Well Ingredients:
Buffer: 0.1 M (5.0 uL of stock 0.5 M) ADA (pH 6.50)
Salt: 3.0 M (9.375 uL of stock 8.0 M) lithium nitrate

Plate setup temperature: 13 C
Plate incubation temperature: 4 C

Drop volume from well: 0.1 uL
Drop protein volume: 0.1 uL

Protein Formulation Composition:
Protein: (5.0 mg/mL) (0.14 mM)
Compound:  (3.00 mM)",277,"10.1021/acs.jmedchem.8b00280",,"6D1Y",36.46,"1.93","1.93","Crystal structure of Tyrosine-protein kinase receptor in complex with 2,4-dichloro-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)benzamide Inhibitor","GSTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6D1Y"
"6D1Z",,"X-RAY DIFFRACTION",2.26,45.5,"VAPOR DIFFUSION, HANGING DROP",7.63,"Well volume: 30.0 uL
Well Ingredients:
Salt: 0.2571428571 M (1.9285714282 uL of stock 4.0 M) potassium formate
Precipitant: 20.0 %w/v (12.0 uL of stock 50.0 %w/v) PEG 3350
Buffer: 0.1 M (3.0 uL of stock 1.0 M) Tris (pH 7.63)
Plate setup temperature: 13 C
Plate incubation temperature: 21 C
Drop volume from well: 0.1 uL
Drop protein volume: 0.3 uL
Protein: 6.00 mg/mL (0.17 mM)
Compound1: small molecule to aid crystallization (1.20 mM)
Soak of 10mM compound 3 for > 1h into co-crystals of TrkA + compound1",294,"10.1021/acs.jmedchem.8b00280",,"6D1Z",36.88,"1.87","1.87","Crystal structure of Tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one Inhibitor","GSTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6D1Z"
"6D20",,"X-RAY DIFFRACTION",2.29,46.35,"VAPOR DIFFUSION, HANGING DROP",8,"Well volume: 30.0 uL

Well Ingredients:
Polymer: 10.0 %w/v (6.0 uL of stock 50.0 %w/v) PEG 3350
Buffer: 16.0 %v/v (4.8 uL of stock 100.0 %v/v) tacsimate (pH 8.00)
Organic (non-volatile): 10.0 %v/v (3.0 uL of stock 100.0 %v/v) Ethylene glycol
Additive: 0.025 M (1.5 uL of stock 0.5 M) TCEP hydrochloride

Plate setup temperature: 13 C
Plate incubation temperature: 21 C

Drop volume from well: 0.2 uL
Drop protein volume: 0.4 uL

Protein: 6.30 mg/mL (0.17 mM)
Compound1: 1.00 mM (to aid crystallization).
Compound23 (allostric inhibitor): 1.3ul 50mM compound23 DMSO stock in 133ul protein  (0.50 mM)",294,"10.1021/acs.jmedchem.8b00280","FQG","6D20",36.88,"1.94","1.94","Crystal structure of Tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4(3H)-one and 5-{[2,4-dichloro-5-(pyridin-2-yl)benzene-1-carbonyl]amino}-N-(2-hydroxy-2-methylpropyl)-1-phenyl-1H-pyrazole-3-carboxamide Inhibitors","GSTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6D20"
"6D22",,"X-RAY DIFFRACTION",3.1,60.32,"VAPOR DIFFUSION",,"0.1M tri-Sodium citrate + 20% PEG3K",294,"10.1021/acs.jmedchem.8b00280",,"6D22",34.97,"2.46","2.46","Crystal structure of Tyrosine-protein kinase receptor","HHHHHHLVPRGSVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","Tyrosine-protein kinase receptor","1","6D22"
"6D2I",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8, 0.1M MgAcetate and 24% w/v PEG4000",277,"10.1021/acschembio.8b00722","35R","6D2I",63.3,"3.192","3.192","JAK2 Pseudokinase V617F in complex with AT9283","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL","Homo sapiens","JAK2","Tyrosine-protein kinase","1","6D2I"
"6D2L",,"X-RAY DIFFRACTION",2.35,47.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG 3350, 0.2 M NH4SO4, 0.1 M HEPES pH7.5",291,,,"6D2L",237.96,"2","2","Crystal structure of human CARM1 with (S)-SKI-72","AVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTTPSPPPGSHY","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6D2L"
"6D2P",,"X-RAY DIFFRACTION",2.7,54.48,"VAPOR DIFFUSION, SITTING DROP",,"pH 5.0 of 20% w/v PEG6000, 0.1M citric acid (pH 4.0)",293.15,"10.1126/scitranslmed.aat0381",,"6D2P",66.47,"2.6","2.6","Crystal structure of IOMA-class CLK31 Fab from an HIV-1 naive donor in complex with a germline-targeting gp120 engineered outer domain eOD-GT8 at 2.6 A","TGDTITLPCRPAPPPHCSSNITGLILTRQGGYSNANTVIFRPSGGDWRDIARCQIAGTVVSTQLFLNGSLAEEEVVIRSEDWRDNAKSICVQLATSVEIACTGAGHCAISRAKWANTLKQIASKLREQYGAKTIIFKPSSGGDPEFVNHSFNCGGEFFYCASTQLFASTWFASTGTKHHHHHH","Homo sapiens",,"Germline-targeting HIV-1 gp120 engineered outer domain eOD-GT8","1","6D2P"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARSLGRDWFDPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"IOMAclass naive CLK31 Fab heavy chain","2","6D2P"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"IOMAclass naive CLK31 Fab light chain","3","6D2P"
"6D31",,"X-RAY DIFFRACTION",2.09,41.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM bis-tris, 25% SOKALAN CP 42, 0.9% tetrahydrofuran",289,"10.1093/nar/gky812",,"6D31",22.66,"1.2","1.2","Structure of human Usb1 with adenosine 5'-monophosphate","GAHMGNWATHVYVPYEAKEEFLDLLDVLLPHAQTYVPRLVRMKVFHLSLSQSVVLRHHWILPFVQALKARMTSFHRFFFTANQVKIYTNQEKTRTFIGLEVTSGHAQFLDLVSEVDRVMEEFNLTTFYQDPSFHLSLAWCVGDARLQLEGQCLQELQAIVDGFEDAEVLLRVHTEQVRCKSGNKFFSMPLK","Homo sapiens","USB1, C16orf57, Mpn1","U6 snRNA phosphodiesterase","1","6D31"
"6D36",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, HANGING DROP",,"22% PEG4000, 0.1 M sodium acetate pH 4.5, and 0.1 M MgSO4",295,"10.1074/jbc.RA118.003586",,"6D36",159.54,"1.7","1.7","Structure of human ARH3 bound to ADP-ribose and magnesium","GPHMAAAAMAAAAGGGAGAARSLSRFRGCLAGALLGDCVGSFYEAHDTVDLTSVLRHVQSLEPDPGTPGSERTEALYYTDDTAMARALVQSLLAKEAFDEVDMAHRFAQEYKKDPDRGYGAGVVTVFKKLLNPKCRDVFEPARAQFNGKGSYGNGGAMRVAGISLAYSSVQDVQKFARLSAQLTHASSLGYNGAILQALAVHLALQGESSSEHFLKQLLGHMEDLEGDAQSVLDARELGMEERPYSSRLKKIGELLDQASVTREEVVSELGNGIAAFESVPTAIYCFLRCMEPDPEIPSAFNSLQRTLIYSISLGGDTDTIATMAGAIAGAYYGMDQVPESWQQSCEGYEETDILAQSLHRVFQKS","Homo sapiens","ADPRHL2, ARH3, ADPRS","Poly(ADP-ribose) glycohydrolase ARH3","1","6D36"
"6D3A",,"X-RAY DIFFRACTION",2.26,45.61,"VAPOR DIFFUSION, HANGING DROP",,"22% PEG4000, 0.1 M sodium acetate pH 4.5, and 0.1 M MgSO4",295,"10.1074/jbc.RA118.003586",,"6D3A",159.5,"1.60001013785","1.60001013785","Structure of human ARH3 D314E bound to ADP-ribose and magnesium","GPHMAAAAMAAAAGGGAGAARSLSRFRGCLAGALLGDCVGSFYEAHDTVDLTSVLRHVQSLEPDPGTPGSERTEALYYTDDTAMARALVQSLLAKEAFDEVDMAHRFAQEYKKDPDRGYGAGVVTVFKKLLNPKCRDVFEPARAQFNGKGSYGNGGAMRVAGISLAYSSVQDVQKFARLSAQLTHASSLGYNGAILQALAVHLALQGESSSEHFLKQLLGHMEDLEGDAQSVLDARELGMEERPYSSRLKKIGELLDQASVTREEVVSELGNGIAAFESVPTAIYCFLRCMEPDPEIPSAFNSLQRTLIYSISLGGETDTIATMAGAIAGAYYGMDQVPESWQQSCEGYEETDILAQSLHRVFQKS","Homo sapiens","ADPRHL2, ARH3, ADPRS","Poly(ADP-ribose) glycohydrolase ARH3","1","6D3A"
"6D3E",,"X-RAY DIFFRACTION",2.7,54.48,"VAPOR DIFFUSION, HANGING DROP",,"1.2M sodium citrate",289,"10.11131/2018/101350","FT7","6D3E",64.58,"2.395","2.395","PPARg LBD in Complex with SR1988","HHHHHHGSHMESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6D3E"
"6D3F",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Bicine/Trizma base pH 8.5, 0.03 mM diethylene glycol, 0.03 M triethylene glycol, 0.03 M tetraethylne glycol, 0.03 M pentaethylene glycol, 10% (w/v) polyethylene glycol 4000, 20% (v/v) glycerol",292,"10.1107/S2059798318011919",,"6D3F",64.67,"2.271","2.271","Crystal Structure of the PTP epsilon D2 domain","GGGGLEEEFRKLTNVRIMKENMRTGNLPANMKKARVIQIIPYDFNRVILSMKRGQEYTDYINASFIDGYRQKDYFIATQGPLAHTVEDFWRMIWEWKSHTIVMLTEVQEREQDKCYQYWPTEGSVTHGEITIEIKNDTLSEAISIRDFLVTLNQPQARQEEQVRVVRQFHFHGWPEIGIPAEGKGMIDLIAAVQKQQQQTGNHPITVHCSAGAGRTGTFIALSNILERVKAEGLLDVFQAVKSLRLQRPHMVQTLEQYEFCYKVVQDFIDIFSDYANFK","Homo sapiens","PTPRE","Receptor-type tyrosine-protein phosphatase epsilon","1","6D3F"
"6D3K",,"X-RAY DIFFRACTION",3.27,62.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 6% v/v PEG400, 2.0 M ammonium sulfate, protein was complexed with AMP-PNP and Mg2+ prior to crystallization",293,"10.1021/acs.biochem.9b00161",,"6D3K",114.74,"2.6","2.6","Crystal structure of unphosphorylated human PKR kinase domain in complex with ADP","MNGLRNNQRKAKRSLAPRFDLPDMKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC","Homo sapiens","EIF2AK2, PKR, PRKR","Interferon-induced, double-stranded RNA-activated protein kinase","1","6D3K"
"6D3L",,"X-RAY DIFFRACTION",2.04,39.76,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Bis-Tris, pH 5.5, 2.0 M ammonium sulfate, 1:3 molar ratio of dp8 (heparin) was added to protein prior to crystallization",293,"10.1021/acs.biochem.9b00161",,"6D3L",37.45,"3.1","3.1","Crystal structure of unphosphorylated human PKR","MNGLRNNQRKAKRSLAPRFDLPDMKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC","Homo sapiens","EIF2AK2, PKR, PRKR","Interferon-induced, double-stranded RNA-activated protein kinase","1","6D3L"
"6D3N",,"X-RAY DIFFRACTION",2.29,46.27,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.085M tri- Na citrate, pH 5.6,
25.5% PEG 4000
0.17M Amm acetate
15% glycerol",295,"10.1074/jbc.RA118.003176",,"6D3N",18.41,"2.7","2.7","Crystal structure of h4-1BB ligand","DPAGLLDLRQGMFAQLVAQNVLLIDGPLSWYSDPGLAGVSLTGGLSYKEDTKELVVAKAGVYYVFFQLELRRVVAGEGSGSVSLALHLQPLRSAAGAAALALTVDLPPASSEARNSAFGFQGRLLHLSAGQRLGVHLHTEARARHAWQLTQGATVLGLFRVTPEIHHHHHH","Homo sapiens","TNFSF9","Tumor necrosis factor ligand superfamily member 9","1","6D3N"
"6D42",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M imidazole, pH 6.5
1.0 M sodium acetate",290,"10.1371/journal.pone.0199942",,"6D42",9.26,"1.75013644453","1.75013644453","Crystal structure of the KCa3.1 C-terminal four-helix bundle (with copper)","GSMILYDLQQNLSSSHRALEKQIDTLAGKLDALTELLSTALG","Homo sapiens","KCNN4, IK1, IKCA1, KCA4, SK4","Intermediate conductance calcium-activated potassium channel protein 4","1","6D42"
"6D43",,"X-RAY DIFFRACTION",2.13,42.33,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES pH 7.5, 20% PEG 4000, and 10% 2-propanol",283,"10.1016/j.niox.2018.04.004",,"6D43",52.89,"2.04","2.04","CHARACTERIZATION OF HUMAN TRIOSEPHOSPHATE ISOMERASE S-NITROSYLATION","SRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","Triosephosphate isomerase","1","6D43"
,,,,,,,,,,,,,,,,"SRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","Triosephosphate isomerase","2","6D43"
"6D48",,"X-RAY DIFFRACTION",2.38,48.31,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG 4000
100 mM Tris-HCl pH 8.5
10% Glycerol",293,"10.1016/j.isci.2019.07.023",,"6D48",58.59,"1.776","1.776","Cell Surface Receptor","GDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAIISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSYFFRMERGSTKYSYKSPQLSVHVTDLTH","Homo sapiens","CD33, SIGLEC3","Myeloid cell surface antigen CD33","1","6D48"
"6D49",,"X-RAY DIFFRACTION",2.52,51.16,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES pH 6.5
0.6 M NaCl
18% PEG 4000",293,"10.1016/j.isci.2019.07.023","FVP","6D49",32.07,"1.801","1.801","Cell Surface Receptor in Complex with Ligand at 1.80-A Resolution","GDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAIISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSYFFRMERGSTKYSYKSPQLSVHVTDLTH","Homo sapiens","CD33, SIGLEC3","Myeloid cell surface antigen CD33","1","6D49"
"6D4A",,"X-RAY DIFFRACTION",2.51,50.94,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES pH 6.5
0.6 M NaCl
18% PEG 4000",293,"10.1016/j.isci.2019.07.023","FVP","6D4A",31.52,"1.751","1.751","Cell Surface Receptor with Bound Ligand at 1.75-A Resolution","GDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAIISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDNGSYFFRMERGSTKYSYKSPQLSVHVTDLTH","Homo sapiens","CD33, SIGLEC3","Myeloid cell surface antigen CD33","1","6D4A"
"6D4D",,"X-RAY DIFFRACTION",2.12,41.85,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl pH 8.5, 0.2 M sodium chloride, 22% (w/v) polyethylene glycol 3350",292,"10.1107/S2059798318011919",,"6D4D",67.83,"1.765","1.765","Crystal structure of the PTP epsilon D1 domain","SGPKKYFPIPVEHLEEEIRIRSADDCKQFREEFNSLPSGHIQGTFELANKEENREKNRYPNILPNDHSRVILSQLDGIPCSDYINASYIDGYKEKNKFIAAQGPKQETVNDFWRMVWEQKSATIVMLTNLKERKEEKCHQYWPDQGCWTYGNIRVCVEDCVVLVDYTIRKFCIQPQLPDGCKAPRLVSQLHFTSWPDFGVPFTPIGMLKFLKKVKTLNPVHAGPIVVHCSAGVGRTGTFIVIDAMMAMMHAEQKVDVFEFVSRIRNQRPQMVQTDMQYTFIYQALLEYYLYG","Homo sapiens","PTPRE","Receptor-type tyrosine-protein phosphatase epsilon","1","6D4D"
"6D4F",,"X-RAY DIFFRACTION",2.63,53.32,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M imidazole pH 8.0, 0.2 M calcium acetate hydrate, 20% (w/v) polyethylene glycol 1000",292,"10.1107/S2059798318011919",,"6D4F",32.67,"1.909","1.909","Crystal structure of PTP epsilon D2 domain (A455N/V457Y/E597D)","GGGGLEEEFRKLTNVRIMKENMRTGNLPANMKKNRYIQIIPYDFNRVILSMKRGQEYTDYINASFIDGYRQKDYFIATQGPLAHTVEDFWRMIWEWKSHTIVMLTEVQEREQDKCYQYWPTEGSVTHGEITIEIKNDTLSEAISIRDFLVTLNQPQARQEEQVRVVRQFHFHGWPDIGIPAEGKGMIDLIAAVQKQQQQTGNHPITVHCSAGAGRTGTFIALSNILERVKAEGLLDVFQAVKSLRLQRPHMVQTLEQYEFCYKVVQDFIDIFSDYANFK","Homo sapiens","PTPRE","Receptor-type tyrosine-protein phosphatase epsilon","1","6D4F"
"6D58",,"X-RAY DIFFRACTION",2.8,56.07,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG MME 5,000
0.1 M Bis-Tris pH 6.5",294,,,"6D58",51.43,"2.39","2.39","Crystal structure of a Fc fragment of Human IgG3","LLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFKWYVDGVEVHNAKTKPREEQYNSTFRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESSGQPENNYNTTPPMLDSDGSFFLYSKLTVDKSRWQQGNIFSCSVMHEALHNHFTQKSLSLSPGK","Homo sapiens","IGHG3","Immunoglobulin heavy constant gamma 3","1","6D58"
"6D5K",,"X-RAY DIFFRACTION",3.29,62.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"19% PEG 3350, 0.2 M MgSO4, 10 % glycerol",293,"10.1021/jacs.8b08659",,"6D5K",69.7,"2.85","2.85","Structure of Human ATP:Cobalamin Adenosyltransferase bound to ATP, and Adenosylcobalamin","MPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL","Homo sapiens","MMAB","Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial","1","6D5K"
"6D5X",,"X-RAY DIFFRACTION",3.32,62.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"19% PEG 3350, 0.2 M MgSO4, 10 % glycerol",293,"10.1021/jacs.8b08659",,"6D5X",69.64,"2.4","2.4","Structure of Human ATP:Cobalamin Adenosyltransferase bound to ATP, Adenosylcobalamin, and Triphosphate","MPKIYTKTGDKGFSSTFTGERRPKDDQVFEAVGTTDELSSAIGFALELVTEKGHTFAEELQKIQCTLQDVGSALATPCSSAREAHLKYTTFKAGPILELEQWIDKYTSQLPPLTAFILPSGGKISSALHFCRAVCRRAERRVVPLVQMGETDANVAKFLNRLSDYLFTLARYAAMKEGNQEKIYMKNDPSAESEGL","Homo sapiens","MMAB","Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial","1","6D5X"
"6D5Y",,"X-RAY DIFFRACTION",2.11,41.81,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 10% isopropanol, and 0.1 M Hepes pH 7.5",277,"10.1158/1078-0432.CCR-17-3674",,"6D5Y",40.53,"2.86","2.86","Crystal structure of ERK2 G169D mutant","MVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFDLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6D5Y"
"6D71",,"X-RAY DIFFRACTION",1.89,35.08,"VAPOR DIFFUSION, SITTING DROP",5,"10 mg/mL protein + reservoir (0.6 M MMT, pH 5.0, 22% PEG1500)",298,"10.1016/j.jsb.2020.107656",,"6D71",43.71,"1.71807785325","1.71807785325","Crystal Structure of the Human Miro1 N-terminal GTPase bound to GTP","MHHHHHHKKDVRILLVGEPRVGKTSLIMSLVSEEFPEEVPPRAEEITIPADVTPERVPTHIVDYSEAEQSDEQLHQEISQANVICIVYAVNNKHSIDKVTSRWIPLINERTDKDSRLPLILVGNKSDLVEYSSMETILPIMNQYTEIETCVECSAKNLKNISELFYYAQKAVLHPTGPLYCPEEKE","Homo sapiens","RHOT1, ARHT1","Mitochondrial Rho GTPase 1","1","6D71"
"6D74",,"SOLUTION NMR",,,,,,,"10.1016/j.chembiol.2019.03.010",,"6D74",18.32,,,"Direct Activation of the Executioner Domain of MLKL by a Select Repertoire of Inositol Phosphates","GMENLKHIITLGQVIHKRCEEMKYCKKQCRRLGHRVLGLIKPLEMLQDQGKRSVPSEKLTTAMNRFKAALEEANGEIEKFSNRSNICRFLTASQDKILFKDVNRKLSDVWKELSLLLQVEQRMPVSPISQGASWAQEDQQDADEDRRAFQMLRRDNE","Homo sapiens","MLKL","Mixed lineage kinase domain-like protein","1","6D74"
"6D7L","4","ELECTRON MICROSCOPY",,,,,,,"10.1074/jbc.RA118.005066",,"6D7L",391.48,"4",,"Cytoplasmic domain of TRPC3","GAMGSMEGSPSLRRMTVMREKGRRQAVRGPAFMFNDRGTSLTAEEERFLDAAEYGNIPVVRKMLEESKTLNVNCVDYMGQNALQLAVGNEHLEVTELLLKKENLARIGDALLLAISKGYVRIVEAILNHPGFAASKRLTLSPCEQELQDDDFYAYDEDGTRFSPDITPIILAAHCQKYEVVHMLLMKGARIERPHDYFCKCGDCMEKQRHDSFSHSRSRINAYKGLASPAYLSLSSEDPVLTALELSNELAKLANIEKEFKNDYRKLSMQCKDFVVGVLDLCRDSEEVEAILNGDLESAEPLEVHRHKASLSRVKLAIKYEVKKFVAHPNCQQQLLTIWYENLSGLREQTIAIKCLVVLVVALGLPFLAIGYWIAPCSRLGKILRSPFMKFVAHAASFIIFLGLLVFNASDRFEGITTLPNITVTDYPKQIFRVKTTQFTWTEMLIMVWVLGMMWSECKELWLEGPREYILQLWNVLDFGMLSIFIAAFTARFLAFLQATKAQQYVDSYVQESDLSEVTLPPEIQYFTYARDKWLPSDPQIISEGLYAIAVVLSFSRIAYILPANESFGPLQISLGRTVKDIFKFMVLFIMVFFAFMIGMFILYSYYLGAKVNAAFTTVEESFKTLFWSIFGLSEVTSVVLKYDHKFIENIGYVLYGIYNVTMVVVLLNMLIAMINSSYQEIEDDSDVEWKFARSKLWLSYFDDGKTLPPPFSLVPSPKSFVYFIMRIVNFPKCRRRRLQKDIEMGMGNSKSRLNLFTQSNSRVFESHSFNSILNQPTRYQQIMKRLIKRYVLKAQVDKENDEVNEGELKEIKQDISSLRYELLEDKSQATEELAILIHKLSEKLNPSMLRCE","Homo sapiens","TRPC3, TRP3","Short transient receptor potential channel 3","1","6D7L"
"6D7S","4.34","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-04828-y",,"6D7S",340.31,"4.34",,"Cryo-EM structure of human TRPV6-Y467A in amphipols","MGLSLPKEKGLILCLWSKFCRWFQRRESWAQSRDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHGDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMAFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGSEDLDKDSVEKLELGCPFSPHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGIINRGLEDGESWEYQILVPRGSAAAWSHPQFEK","Homo sapiens","TRPV6, ECAC2","Transient receptor potential cation channel subfamily V member 6","1","6D7S"
"6D7T","4.44","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-04828-y",,"6D7T",341.29,"4.44",,"Cryo-EM structure of human TRPV6-Y467A in complex with 2-Aminoethoxydiphenyl borate (2-APB)","MGLSLPKEKGLILCLWSKFCRWFQRRESWAQSRDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVVNQNMNLVRALLARRASVSARATGTAFRRSPCNLIYFGEHPLSFAACVNSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDRHGDHLQPLDLVPNHQGLTPFKLAGVEGNTVMFQHLMQKRKHTQWTYGPLTSTLYDLTEIDSSGDEQSLLELIITTKKREARQILDQTPVKELVSLKWKRYGRPYFCMLGAIYLLYIICFTMCCIYRPLKPRTNNRTSPRDNTLLQQKLLQEAYMTPKDDIRLVGELVTVIGAIIILLVEVPDIFRMGVTRFFGQTILGGPFHVLIITYAFMVLVTMVMRLISASGEVVPMSFALVLGWCNVMAFARGFQMLGPFTIMIQKMIFGDLMRFCWLMAVVILGFASAFYIIFQTEDPEELGHFYDYPMALFSTFELFLTIIDGPANYNVDLPFMYSITYAAFAIIATLLMLNLLIAMMGDTHWRVAHERDELWRAQIVATTVMLERKLPRCLWPRSGICGREYGLGDRWFLRVEDRQDLNRQRIQRYAQAFHTRGSEDLDKDSVEKLELGCPFSPHLSLPMPSVSRSTSRSSANWERLRQGTLRRDLRGIINRGLEDGESWEYQILVPRGSAAAWSHPQFEK","Homo sapiens","TRPV6, ECAC2","Transient receptor potential cation channel subfamily V member 6","1","6D7T"
"6D8E",,"X-RAY DIFFRACTION",3.5,64.86,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES(pH 6.5),
1.0 M sodium citrate",298,"10.1002/anie.201805187",,"6D8E",37.79,"2.537","2.537","Discovery of a Highly Potent and Broadly Effective EGFR and HER2 Exon 20 Insertion Mutant Inhibitor","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6D8E"
"6D8X",,"X-RAY DIFFRACTION",2.36,47.83,"VAPOR DIFFUSION, SITTING DROP",,"200mM tri-Lithium Citrate
20% (w/v) PEG 3350",277,,"EDK","6D8X",35,"1.9","1.9","PPAR gamma LBD complexed with the agonist GW1929","MAHHHHHHVDDDDKMENLYFQGQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6D8X"
"6D8Z",,"X-RAY DIFFRACTION",2.45,49.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"14% PEG 3350, 100MM HEPES PH 7.5,
 HANGING DROP, 293K, VAPOR DIFFUSION, HANGING DROP",293,"10.1126/scisignal.aav2449",,"6D8Z",112.45,"2.65","2.65","Crystal Structure of the C-terminal Guanine Nucleotide Exchange Factor Module of Human Trio","GEFEERKSSSLKRRHYVLQELVETERDYVRDLGYVVEGYMALMKEDGVPDDMKGKDKIVFGNIHQIYDWHRDFFLGELEKCLEDPEKLGSLFVKHERRLHMYIAYCQNKPKSEHIVSEYIDTFFEDLKQRLGHRLQLTDLLIKPVQRIMKYQLLLKDFLKYSKKASLDTSELERAVEVMCIVPRRCNDMMNVGRLQGFDGKIVAQGKLLLQDTFLVTDQDAGLLPRCRERRIFLFEQIVIFSEPLDKKKGFSMPGFLFKNSIKVSCLCLEENVENDPCKFALTSRTGDVVETFILHSSSPSVRQTWIHEINQILENQRN","Homo sapiens","TRIO","Triple functional domain protein","1","6D8Z"
"6D9X",,"X-RAY DIFFRACTION",2,40,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1021/acs.jmedchem.8b00375","FZM","6D9X",34.6,"1.83","1.83","Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6D9X"
"6DA2",,"X-RAY DIFFRACTION",2.22,44.53,"MICROBATCH",7,"peg 3350, malonate",298,"10.1021/acs.biochem.9b00156",,"6DA2",56.97,"2.65","2.65","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DA2"
"6DA3",,"X-RAY DIFFRACTION",2.42,49.23,"MICROBATCH",7,"peg 3350, sodium malonate",293,"10.1021/acs.biochem.9b00156","G0D","6DA3",56.88,"2.37","2.37","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DA3"
"6DA4",,"X-RAY DIFFRACTION",2.15,42.73,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 3350, 0.2M (NH4)2SO4, 2% phenylurea",298,"10.1021/acs.jmedchem.8b01308",,"6DA4",36.92,"2.9","2.9","JAK3 with Cyanamide CP10","MGHHHHHHQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6DA4"
"6DA5",,"X-RAY DIFFRACTION",2.19,43.74,"MICROBATCH",,"peg 3350, sodium malonate",293,"10.1021/acs.biochem.9b00156","G1J","6DA5",56.88,"2.25","2.25","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DA5"
"6DA8",,"X-RAY DIFFRACTION",2.19,43.94,"MICROBATCH",,"peg 3500, sodium malonate",293,"10.1021/acs.biochem.9b00156",,"6DA8",56.86,"2.802","2.802","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DA8"
"6DAA",,"X-RAY DIFFRACTION",2.22,44.53,"MICROBATCH",,"peg 3350, sodium malonate",293,"10.1021/acs.biochem.9b00156","G0M","6DAA",56.88,"2.15","2.15","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DAA"
"6DAB",,"X-RAY DIFFRACTION",2.21,44.24,"MICROBATCH",7,"peg 3350, malonate",293,"10.1021/acs.biochem.9b00156","G0V","6DAB",56.99,"2.35","2.35","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DAB"
"6DAC",,"X-RAY DIFFRACTION",2.2,44.11,"MICROBATCH",7,"peg 3350, malonate",293,"10.1021/acs.biochem.9b00156",,"6DAC",56.89,"2.55","2.55","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DAC"
"6DAG",,"X-RAY DIFFRACTION",2.21,44.4,"MICROBATCH",,"PEG 3350, sodium malonate",293,"10.1021/acs.biochem.9b00156",,"6DAG",56.89,"2.8","2.8","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DAG"
"6DAH",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG3350, 0.1 M Bis-Tris, pH 6.5",277,"10.1073/pnas.1808733115",,"6DAH",68.72,"2.502","2.502","2.5 Angstrom crystal structure of the N97S CaM mutant","GHMADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGSGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin-1","1","6DAH"
"6DAI",,"X-RAY DIFFRACTION",2,40,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1021/acs.jmedchem.8b00375","G2V","6DAI",35.03,"1.63","1.63","Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6DAI"
"6DAJ",,"X-RAY DIFFRACTION",2.2,44.09,"MICROBATCH",7,"PEG 3350, malonate",293,"10.1021/acs.biochem.9b00156","FZV","6DAJ",57.13,"2.45","2.45","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DAJ"
"6DAK",,"X-RAY DIFFRACTION",2,40,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1021/acs.jmedchem.8b00375","G1Y","6DAK",34.79,"1.6","1.6","Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6DAK"
"6DAL",,"X-RAY DIFFRACTION",2.22,44.53,"MICROBATCH",7,"PEG 3350, malonate",293,"10.1021/acs.biochem.9b00156",,"6DAL",56.97,"2.65","2.65","Human CYP3A4 bound to an inhibitor","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","6DAL"
"6DAR",,"X-RAY DIFFRACTION",2.28,46.17,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1021/acs.jmedchem.8b00375","G2J","6DAR",35.14,"1.88","1.88","Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6DAR"
"6DAS",,"X-RAY DIFFRACTION",2,40,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1021/acs.jmedchem.8b00375","G2D","6DAS",69.56,"1.8","1.8","Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6DAS"
"6DAV",,"X-RAY DIFFRACTION",2.24,45,"VAPOR DIFFUSION, SITTING DROP",8.5,"Wizard 3/4 H10 (296175h10): 100 mM Tris base/ Hydrochloric acid pH 8.5, 30% (w/v) PEG3350, 30% (v/v) 2-propanol, protein conc. 28.74 mg/mL, protein batch ID XP819, 10 mM NADP, 3.75 mM BSI108214, seeded from 293949g10, cryoprotected with 20% eg, puck izs6-6",290,,,"6DAV",45.58,"1.55","1.55","Crystal Structure of Human DHFR complexed with NADP and N10formyltetrahydrofolate","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","6DAV"
"6DB0",,"X-RAY DIFFRACTION",2.24,45.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, ammonium sulfate, HEPES",291.15,,,"6DB0",49.61,"1.7","1.7","N-Terminal bromodomain of Human BRD2 with a Tetrahydroquinoline analogue","GSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6DB0"
"6DB3",,"X-RAY DIFFRACTION",2.25,45.41,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 3350, 0.2M (NH4)2SO4, 2% phenylurea",298,"10.1021/acs.jmedchem.8b01308","G54","6DB3",36.83,"1.97","1.97","JAK3 with Cyanamide CP23","MGHHHHHHQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6DB3"
"6DB4",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 3350, 0.2M (NH4)2SO4, 2% phenylurea",298,"10.1021/acs.jmedchem.8b01308",,"6DB4",36.9,"1.662","1.662","JAK3 with Cyanamide CP34","MGHHHHHHQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6DB4"
"6DBC",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, Potassium thicyanate",291.15,,,"6DBC",14.34,"1.05","1.05","Second bromodomain of Human BRD2 with a Tetrahydroquinoline analogue","GSHMQDPEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6DBC"
"6DBH",,"X-RAY DIFFRACTION",2.48,50.39,"VAPOR DIFFUSION, HANGING DROP",7,"1.0M Sodium citrate",293,,,"6DBH",69.21,"2.597","2.597","Crystal structure of PPAR gamma in complex with NMP422","MAHHHHHHVDDDDKMENLYFQGQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6DBH"
"6DBK",,"X-RAY DIFFRACTION",1.89,34.87,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M bis-tris pH 5.5, 0.25 M NaCl, 10 mM TCEP, 27-33% PEG-3350",298,"10.1021/acs.jmedchem.8b00917","G5D","6DBK",36.96,"2","2","Tyk2 with compound 8","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6DBK"
"6DBM",,"X-RAY DIFFRACTION",1.85,33.42,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M bis-tris pH 5.5, 0.25 M NaCl, 10 mM TCEP, 27-33% PEG-3350",298,"10.1021/acs.jmedchem.8b00917","G4J","6DBM",36.94,"2.368","2.368","Tyk2 with compound 23","MAHHHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","6DBM"
"6DBN",,"X-RAY DIFFRACTION",2.03,39.5,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris pH 8.5, 6-9% MPD, 24-29% PEG-1500",298,"10.1021/acs.jmedchem.8b00917","G4J","6DBN",36.81,"2.48","2.48","Jak1 with compound 23","GSIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6DBN"
"6DBP",,"X-RAY DIFFRACTION",1.85,33.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1mM DTT, pH 7.5",293,"10.1038/s41467-019-10523-3",,"6DBP",19.19,"1.603","1.603","RNA-recognition motif 1 of human MSI2","MKMFIGGLSWQTSPDSLRDYFSKFGEIRECMVMRDPTTKRSRGFGFVTFADPASVDKVLGQPHHELDSKTIDPKVAFPRRAQPK","Homo sapiens","MSI2","RNA-binding protein Musashi homolog 2","1","6DBP"
"6DCE",,"X-RAY DIFFRACTION",2.38,48.24,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 7.4, 2 M Ammonium sulfate",292,"10.1016/j.molcel.2019.01.035",,"6DCE",11.91,"1.56","1.56","X-ray structure of FIP200 claw domain","EKIAIRDFQVGDLVLIILDERHDNYVLFTVSPTLYFLHSESLPALDLKPGEGASGASRRPWVLGKVMEKEYCQAKKAQNRFKVPLGTKFYRVKAVSWNKKV","Homo sapiens","RB1CC1, KIAA0203, RBICC","RB1-inducible coiled-coil protein 1","1","6DCE"
"6DCM",,"X-RAY DIFFRACTION",1.78,30.91,"EVAPORATION",,"PEG 4000, Sodium acetate, Ammonium acetate",298,,"ACA","6DCM",9.93,"1.031","1.031","The atomic resolution crystal structure of Kringle 2 variant bound with EACA","EFSEECMHGSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDNDPQGPWCFTTDPNKRWEYCDIPRCA","Homo sapiens","PLG","Plasminogen","1","6DCM"
"6DCU",,"X-RAY DIFFRACTION",2.4,48.74,"VAPOR DIFFUSION",,"0.2 M Potassium thiocyanate
20%(w/v) PEG 3350",293,,"NZA","6DCU",70.09,"2.95","2.95","Crystal structure of PPAR gamma co-crystallized with nTZDpa","MAHHHHHHVDDDDKMENLYFQGQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLYLVPR","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6DCU"
"6DD3",,"X-RAY DIFFRACTION",3,58,"MICROBATCH",,"2 M Ammonium sulfate and 5% 2-propanol",293,"10.1016/j.ccell.2018.06.003",,"6DD3",62.57,"1.98","1.98","Crystal structure of the double mutant (D52N/D407A) of NT5C2-537X in the active state","MSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLASSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DD3"
"6DD4",,"X-RAY DIFFRACTION",2.57,52.1,"VAPOR DIFFUSION, SITTING DROP",7,"27.5% PEG3350, 200 mM LiSO4, 0.1M SBG, pH 7.0",293,,,"6DD4",166.79,"2.1","2.1","Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","6DD4"
"6DDA",,"X-RAY DIFFRACTION",2.3,46.51,"VAPOR DIFFUSION, HANGING DROP",,"100mM HEPES, 202.9mM potassium bromide, 18.45% PEG 3350",298,"10.1016/j.chembiol.2019.02.002",,"6DDA",93.24,"3.2","3.2","Nurr1 Covalently Modified by a Dopamine Metabolite","SMVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSPPVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF","Homo sapiens","NR4A2, NOT, NURR1, TINUR","Nuclear receptor subfamily 4 group A member 2","1","6DDA"
,,,,,,,,,,,,,,,,"SMVKEVVRTDSLKGRRGRLPSKPKSPQEPSPPSPPVSLISALVRAHVDSNPAMTSLDYSRFQANPDYQMSGDDTQHIQQFYDLLTGSMEIIRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRSNPVEGKLIFCNGVVLHRLQCVRGFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTERHGLKEPKRVEELQNKIVNCLKDHVTFNNGGLNRPNYLSKLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPAIIDKLFLDTLPF","Homo sapiens","NR4A2, NOT, NURR1, TINUR","Nuclear receptor subfamily 4 group A member 2","2","6DDA"
"6DDB",,"X-RAY DIFFRACTION",3.3,61.5,"MICROBATCH",4.6,"100 mM sodium acetate trihydrate, 30% (v/v) 2-Methyl-2, 4-pentanediol, 20 mM calcium chloride dihydrate, and 5 mM MnCl2",293,"10.1016/j.ccell.2018.06.003",,"6DDB",128.35,"2.8","2.8","Crystal structure of the double mutant (D52N/R367Q) of NT5C2-537X in the basal state, Northeast Structural Genomics Consortium Target","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWQTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDB"
"6DDC",,"X-RAY DIFFRACTION",3.2,61.5,"MICROBATCH",4.6,"100 mM sodium acetate trihydrate (pH 4.6) and 2 M ammonium sulfate",293,"10.1016/j.ccell.2018.06.003",,"6DDC",128.34,"2.91","2.91","Crystal structure of the single mutant (D52N) of NT5C2-537X in the basal state, Northeast Structural Genomics Consortium Target","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDC"
"6DDH",,"X-RAY DIFFRACTION",3,58,"MICROBATCH",7.5,"0.1 M HEPES (pH 7.5), 20% (w/v) PEG 1000, and 0.1 M ammonium nitrate, 5 mM ATP, 5 mM IMP, 5 mM MgCl2",293,"10.1016/j.ccell.2018.06.003",,"6DDH",64.28,"2.35","2.35","Crystal structure of the double mutant (D52N/R367Q) of NT5C2-537X in the active state, Northeast Structural Genomics Target","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWQTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDH"
"6DDI",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, ammonium sulfate, HEPES",291.15,"10.1158/0008-5472.CAN-19-3934",,"6DDI",49.95,"1.5","1.5","Crystal Structure of the human BRD2 BD1 bromodomain in complex with a Tetrahydroquinoline analogue","GSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6DDI"
"6DDJ",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"HEHPES, PEG3000",291.15,"10.1158/0008-5472.CAN-19-3934",,"6DDJ",14.21,"1.05","1.05","Crystal Structure of the human BRD2 BD2 bromodimain in complex with a Tetrahydroquinoline analogue","GSHMQDPEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6DDJ"
"6DDK",,"X-RAY DIFFRACTION",2.4,47,"MICROBATCH",7.5,"100 mM HEPES (pH 7.5), 10% (w/v) PEG 3350, and 200 mM L-proline",293,"10.1016/j.ccell.2018.06.003",,"6DDK",134.04,"2.5","2.5","Crystal structure of the double mutant (D52N/R367Q) of the full-length NT5C2 in the basal state","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWQTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDK"
"6DDL",,"X-RAY DIFFRACTION",2.93,57.16,"MICROBATCH",4.6,"sodium acetate trihydrate (pH 4.6) and 30% (v/v) 2-Methyl-2, 4-pentanediol (MPD), 20 mM calcium chloride dihydrate",293,"10.1016/j.ccell.2018.06.003",,"6DDL",125.39,"2.26","2.26","Crystal structure of the single mutant (D52N) of NT5C2-Q523X in the basal state","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQ","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDL"
"6DDO",,"X-RAY DIFFRACTION",2.4,47,"MICROBATCH",7.5,"100 mM HEPES (pH 7.5), 10% (w/v) PEG 3350, and 200 mM L-proline",293,"10.1016/j.ccell.2018.06.003",,"6DDO",134.29,"2.48","2.48","Crystal structure of the single mutant (D52N) of the full-length NT5C2 in the basal state","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDO"
"6DDQ",,"X-RAY DIFFRACTION",2.4,47,"MICROBATCH",7.5,"100 mM HEPES (pH 7.5), 10% (w/v) PEG 3350, and 200 mM L-proline",293,"10.1016/j.ccell.2018.06.003",,"6DDQ",134.36,"2.31","2.31","Crystal structure of the double mutant (R39Q/D52N) of the full-length NT5C2 in the basal state","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNQSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDQ"
"6DDX",,"X-RAY DIFFRACTION",3,58.85,"MICROBATCH",7,"1.8 M ammonium citrate tribasic (pH 7)",293,"10.1016/j.ccell.2018.06.003",,"6DDX",64.09,"2.901","2.901","Crystal structure of the double mutant (D52N/L375F) of NT5C2-537X in the active state, Northeast Structural Genomics Target","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPEFAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDX"
"6DDY",,"X-RAY DIFFRACTION",3,57,"MICROBATCH",7.5,"0.1 M HEPES (pH 7.5), 20% (w/v) PEG 1000, 0.1 M ammonium bromide, 5 mM ATP, 5 mM IMP, and 5 mM MgCl2",293,"10.1016/j.ccell.2018.06.003",,"6DDY",64.14,"1.803","1.803","Crystal structure of the double mutant (D52N/K359Q) of NT5C2-537X in the active state, Northeast Structural Genomics Target","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILQSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDY"
"6DDZ",,"X-RAY DIFFRACTION",3,57,"MICROBATCH",7,"35% (w/v) tascimate (pH 7)",293,"10.1016/j.ccell.2018.06.003",,"6DDZ",64.82,"1.97","1.97","Crystal structure of the double mutant (D52N/R238W) of NT5C2-537X in the active state, Northeast Structural Genomics Target","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSWMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DDZ"
"6DE0",,"X-RAY DIFFRACTION",3,57,"MICROBATCH",7,"2M ammonium sulfate and 5% (v/v) 2-proponal",293,"10.1016/j.ccell.2018.06.003",,"6DE0",62.98,"2.05","2.05","Crystal structure of the single mutant (D52N) of NT5C2-Q523X in the active state","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQ","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DE0"
"6DE1",,"X-RAY DIFFRACTION",3,57,"MICROBATCH",7.5,"0.1 M HEPES (pH 7.5), and 20% (w/v) PEG 1000, 0.1 M ammonium nitrate, 5 mM ATP, 5 mM IMP, 5 mM MgCl2",293,"10.1016/j.ccell.2018.06.003",,"6DE1",67.43,"2.151","2.151","Crystal structure of the single mutant (D52N) of the full-length NT5C2 in the active state","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DE1"
"6DE2",,"X-RAY DIFFRACTION",3,57,"MICROBATCH",,"2M ammonium sulfate and 5% (v/v) 2-proponal, 5 mM ATP, 5 mM IMP, and 5 mM MgCl2",293,"10.1016/j.ccell.2018.06.003",,"6DE2",67.8,"2.1","2.1","Crystal structure of the double mutant (D52N/L375F) of the full-length NT5C2 in the active state","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPEFAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DE2"
"6DE3",,"X-RAY DIFFRACTION",3,57,"MICROBATCH",7.5,"100 mM HEPES (pH 7.5), 12% (w/v) PEG 3350, 5 mM ATP, 5 mM IMP, and 5 mM MgCl2",293,"10.1016/j.ccell.2018.06.003",,"6DE3",67.55,"3.06","3.06","Crystal structure of the double mutant (R39Q/D52N) of the full-length NT5C2 in the active state","GSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNQSLAMEKIKCFGFNMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6DE3"
"6DE4",,"X-RAY DIFFRACTION",4.63,73.41,"VAPOR DIFFUSION",,"0.1M Tris Ph 7.6,0.2M LiSo4, 15mM CaCl2, 6% EtOH, 15% Ethylene glycol",277,"10.1016/j.chembiol.2019.02.013","G6Y","6DE4",45.73,"2.411","2.411","Homo sapiens dihydrofolate reductase complexed with beta-NADPH and 3'-[(2R)-4-(2,4-diamino-6-ethylphenyl)but-3-yn-2-yl]-5'-methoxy-[1,1'-biphenyl]-4-carboxylic acid","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","6DE4"
"6DE9",,"X-RAY DIFFRACTION",4.34,71.63,"VAPOR DIFFUSION, SITTING DROP",7,"60% v/v Tacsimate TM, pH 7.0",295,"10.1038/s42004-019-0172-x","FUN","6DE9",9.69,"1.95","1.95","mitoNEET bound to furosemide","TKRFYVKDHRNKAMINLHIQKDNPKIVHAFDMEDLGDKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKET","Homo sapiens","CISD1, C10orf70, ZCD1, MDS029","CDGSH iron-sulfur domain-containing protein 1","1","6DE9"
"6DED",,"X-RAY DIFFRACTION",2.12,42,"VAPOR DIFFUSION, HANGING DROP",7.5,"50 mM Tris, pH 7.5, 700 mM sodium potassium tartrate",293,"10.15252/embj.2018100005",,"6DED",84.58,"2.204","2.204","Crystal structure of the C-terminal ARM domain of Homo sapiens SPIN90 (SH3-protein interacting with Nck), residues 351-722","SPVMEQVLLSLVEGKDLSMALPSGQVCHDQQRLEVIFADLARRKDDAQQRSWALYEDEGVIRCYLEELLHILTDADPEVCKKMCKRNEFESVLALVAYYQMEHRASLRLLLLKCFGAMCSLDAAIISTLVSSVLPVELARDMQTDTQDHQKLCYSALILAMVFSMGEAVPYAHYEHLGTPFAQFLLNIVEDGLPLDTTEQLPDLCVNLLLALNLHLPAADQNVIMAALSKHANVKIFSEKLLLLLNRGDDPVRIFKHEPQPPHSVLKFLQDVFGSPATAAIFYHTDMMALIDITVRHIADLSPGDKLRMEYLSLMHAIVRTTPYLQHRHRLPDLQAILRRILNEEETSPQCQMDRMIVREMCKEFLVLGEAPS","Homo sapiens","NCKIPSD, AF3P21, SPIN90","NCK-interacting protein with SH3 domain","1","6DED"
"6DEE",,"X-RAY DIFFRACTION",2.1,41.43,"VAPOR DIFFUSION, HANGING DROP",6,"50 mM MES, pH 6, 100 mM magnesium sulfate, 1.5% PEG6000",293,"10.15252/embj.2018100005",,"6DEE",46.97,"3.04","3.04","Crystal structure of the C-terminus of Homo sapiens SPIN90 (SH3-protein interacting with Nck), residues 306-722","SAAVPRTIGAELMELVRRNTGLSHELCRVAIGIIVGHIQASVPASSPVMEQVLLSLVEGKDLSMALPSGQVCHDQQRLEVIFADLARRKDDAQQRSWALYEDEGVIRCYLEELLHILTDADPEVCKKMCKRNEFESVLALVAYYQMEHRASLRLLLLKCFGAMCSLDAAIISTLVSSVLPVELARDMQTDTQDHQKLCYSALILAMVFSMGEAVPYAHYEHLGTPFAQFLLNIVEDGLPLDTTEQLPDLCVNLLLALNLHLPAADQNVIMAALSKHANVKIFSEKLLLLLNRGDDPVRIFKHEPQPPHSVLKFLQDVFGSPATAAIFYHTDMMALIDITVRHIADLSPGDKLRMEYLSLMHAIVRTTPYLQHRHRLPDLQAILRRILNEEETSPQCQMDRMIVREMCKEFLVLGEAPS","Homo sapiens","NCKIPSD, AF3P21, SPIN90","NCK-interacting protein with SH3 domain","1","6DEE"
"6DEU",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.6,"100 mM sodium acetate pH 4.6, 2 M sodium chloride",293,"10.1038/s41598-019-41930-7",,"6DEU",69.06,"2.796","2.796","Human caspase-6 A109T","MASSASGLRRGHPAGGEENMTETDAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHTDADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNLEHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","6DEU"
"6DEV",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",4.6,"100 mM sodium acetate pH 4.6, 2 M sodium chloride",293,"10.1038/s41598-019-41930-7",,"6DEV",138.01,"2.348","2.348","Human caspase-6 E35K","MASSASGLRRGHPAGGEENMTETDAFYKREMFDPAKKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNLEHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","6DEV"
"6DEW",,"X-RAY DIFFRACTION",2.91,57.75,"MICROBATCH",8.5,"Crystals were grown by seeded micro batch in a glass depression plate, on glass coverslips. The experiment was sealed with FOMBLIN oil. 2 microliters of protein saturated with geranylgeraniol was mixed with 1 microliter of seed stock and two microliters of reservoir solution. The reservoir solution was composed of 1.2 molar ammonium sulfate and 0.1 molar TrisHCl buffer at pH 8.5. The reservoir was saturated with geranylgeraniol by adding several microliters of neat geranylgeraniol.",293,"10.1016/j.molcel.2018.11.033",,"6DEW",147.28,"2","2","Structure of human COQ9 protein with bound isoprene.","SHMPPRYTDQGGEEEEDYESEEQLQHRILTAALEFVPAHGWTAEAIAEGAQSLGLSSAAASMFGKDGSELILHFVTQCNTRLTRVLEEEQKLVQLGQAEKRKTDQFLRDAVETRLRMLIPYIEHWPRALSILMLPHNIPSSLSLLTSMVDDMWHYAGDQSTDFNWYTRRAMLAAIYNTTELVMMQDSSPDFEDTWRFLENRVNDAMNMGHTA","Homo sapiens","COQ9, C16orf49, HSPC326, PSEC0129","Ubiquinone biosynthesis protein COQ9, mitochondrial","1","6DEW"
"6DF6",,"X-RAY DIFFRACTION",1.99,38.14,"VAPOR DIFFUSION, HANGING DROP",,"grid of PEG 3350 vs. MgCl2 with a buffer of Bis-TRIS at pH 6-6.5",292,"10.1016/j.bmcl.2019.01.036","G8Y","6DF6",130.06,"2.5","2.5","Crystal structure of estrogen receptor alpha in complex with receptor degrader 16ab","MHHHHHHSSGVDLGTENLYFQSNAIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6DF6"
"6DFD",,"X-RAY DIFFRACTION",1.68,26.84,"VAPOR DIFFUSION, HANGING DROP",7,"0.8 M succinic acid",295,"10.1074/jbc.RA118.005672",,"6DFD",58.8,"1.901","1.901","Crystal structure of CNNM3 cyclic nucleotide-binding homology domain","GPLGSSEDYRDTVVKRKPASLMAPLKRKEEFSLFKVSDDEYKVTISPQLLLATQRFLSREVDVFSPLRMSEKVLLHLLKHPSVNQEVRFDESNRLATHHYLYQRSQPVDYFILILQGRVEVEIGKEGLKFENGAFTYYGVSALMVPSSVHQSPVSSLQPIRHDLQPDPGDGTHSSMYCPDYTVRALSDLQLIKVTRLQYLNALMATRAQNLPQSPENTDLQMMPGSQTRLLGEKTTTAAGSSHSRPGVPVEGSPGRNPGV","Homo sapiens","CNNM3, ACDP3","Metal transporter CNNM3","1","6DFD"
"6DFM",,"X-RAY DIFFRACTION",2.18,43.54,"VAPOR DIFFUSION, SITTING DROP",8.5,"Triclinic crystals of apo GRP78 were observed in 0.1 M Tris-HCl, 25% PEG3350, 0.1 M sodium/potassium tartrate. Initial crystals were then microseeded in 25% PEG3350, 0.1 M Tris-HCl, 0.2 M sodium chloride. These new apo monoclinic crystals were soaked with 5 mM 8-aminoadenosine for one week.",298,,"3BH","6DFM",84.88,"2.14","2.14","Crystal structure of human GRP78 in complex with 8-aminoadenosine","DVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSG","Homo sapiens","HSPA5, GRP78","Endoplasmic reticulum chaperone BiP","1","6DFM"
"6DFN",,"X-RAY DIFFRACTION",1.99,38.23,"VAPOR DIFFUSION, HANGING DROP",,"Grid of PEG 3350 vs. MgCl2 with a buffer of Bis-TRIS at pH 6-6.5",292,"10.1016/j.bmcl.2019.01.036","G91","6DFN",131.06,"2.1","2.1","Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa","MHHHHHHSSGVDLGTENLYFQSNAIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","6DFN"
"6DFO",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, SITTING DROP",8.5,"Triclinic crystals of apo GRP78 were observed in 0.1 M Tris-HCl, 25% PEG3350, 0.1 M sodium/potassium tartrate. Initial crystals were then microseeded in 25% PEG3350, 0.1 M Tris-HCl, 0.2 M sodium chloride. These new apo monoclinic crystals were soaked with 5 mM 8-bromoadenosine for one week.",298,,,"6DFO",85,"2.54","2.54","Crystal structure of human GRP78 in complex with 8-bromoadenosine","DVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSG","Homo sapiens","HSPA5, GRP78","Endoplasmic reticulum chaperone BiP","1","6DFO"
"6DG1",,"SOLUTION NMR",,,,,,,"10.1021/jacs.8b05366",,"6DG1",11.79,,,"NMR structure of the second qRRM2 domain of human hnRNP H","SNAMDWVLKHTGPNSPDTANDGFVRLRGLPFGCSKEEIVQFFSGLEIVPNGITLPVDFQGRSTGEAFVQFASQEIAEKALKKHKERIGHRYIEIFKSSRAEVRTH","Homo sapiens","HNRNPH2, FTP3, HNRPH2","qRRM2 domain of Heterogeneous nuclear ribonucleoprotein H2","1","6DG1"
"6DGE",,"X-RAY DIFFRACTION",2.03,39.42,"VAPOR DIFFUSION, SITTING DROP",7.3,"20% PEG 3350
0.2 M NaCl",277,"10.1021/acs.biochem.8b00554",,"6DGE",33.85,"1.91","1.91","Crystal structure of the dimethylarginine dimethylaminohydrolase adduct with N5-(1-imino-2-chloroethyl)-L-lysine","MGSSHHHHHHSSGLVPRGSHMASMAGLGHPAAFGRATHAVVRALPESLGQHALRSAKGEEVDVARAERQHQLYVGVLGSKLGLQVVELPADESLPDCVFVEDVAVVCEETALITRPGAPSRRKEVDMMKEALEKLQLNIVEMKDENATLDGGDVLFTGREFFVGLSKRTNQRGAEILADTFKDYAVSTVPVADGLHLKSFCSMAGPNLIAIGSSESAQKALKIMQQMSDHRYDKLTVPDDIAANCIYLNIPNKGHVLLHRTPEEYPESAKVYEKLKDHMLIPVSMSELEKVDGLLTCCSVLINKKVDS","Homo sapiens","DDAH1, DDAH","N(G),N(G)-dimethylarginine dimethylaminohydrolase 1","1","6DGE"
"6DGL",,"X-RAY DIFFRACTION",2.67,53.85,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.8M SODIUM CITRATE, 100mM MOPS, pH 7.6",293,"10.1073/pnas.1909016116",,"6DGL",63.85,"1.95","1.95","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Darglitazone","GQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6DGL"
"6DGO",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.8M SODIUM CITRATE, 100mM MOPS, pH 7.6",293,"10.1073/pnas.1909016116","TDZ","6DGO",63.34,"3.1","3.1","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Troglitazone","QLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6DGO"
"6DGQ",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, SITTING DROP",,"0.8M SODIUM CITRATE, 100mM Tris, pH 7.6",293,"10.1073/pnas.1909016116",,"6DGQ",63.47,"2.45","2.45","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10506","GQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6DGQ"
"6DGR",,"X-RAY DIFFRACTION",2.36,47.88,"VAPOR DIFFUSION, SITTING DROP",,"0.8M SODIUM CITRATE, 100mM TRIS, pH 7.6",293,"10.1073/pnas.1909016116",,"6DGR",68.64,"2.15","2.15","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10638","MAHHHHHHVDDDDKMENLYFQGQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6DGR"
"6DH9",,"X-RAY DIFFRACTION",2.56,51.89,"VAPOR DIFFUSION, SITTING DROP",,"0.8M SODIUM CITRATE, 100mM MOPS, pH 7.6",293,,"GH1","6DH9",62.52,"2.7","2.7","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with MSDC-0602","ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6DH9"
"6DHA",,"X-RAY DIFFRACTION",2.67,53.95,"VAPOR DIFFUSION, SITTING DROP",,"0.8M SODIUM CITRATE, 100mM TRIS, pH 7.6",293,"10.1021/acs.jmedchem.8b01573","GFV","6DHA",63.06,"1.88","1.88","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Hydroxy Pioglitazone (M-IV)","ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6DHA"
"6DHB",,"X-RAY DIFFRACTION",1.93,36.23,"VAPOR DIFFUSION, SITTING DROP",8.5,"Tris, PEG",298,"10.1038/s41598-018-35754-0",,"6DHB",12.5,"1.7","1.7","Crystal structure of the human TIM-3 with bound Calcium","MVEYRAEVGQNAYLPCFYTPAAPGNLVPVCWGKGACPVFECGNVVLRTDERDVNYWTSRYWLNGDFRKGDVSLTIENVTLADSGIYCCRIQIPGIMNDEKFNLKLVIK","Homo sapiens","HAVCR2, TIM3, TIMD3","Hepatitis A virus cellular receptor 2","1","6DHB"
"6DHC",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M MgSO4, 0.1 M Na citrate (pH varied from 5.0 to 6.0) and 16 % to 22 % PEG4000",298,"10.1016/j.bmcl.2018.06.045",,"6DHC",149.53,"2.85","2.85","X-ray structure of BACE1 in complex with a bicyclic isoxazoline carboxamide as the P3 ligand","AGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6DHC"
"6DHS",,"X-RAY DIFFRACTION",4.37,71.84,"VAPOR DIFFUSION",,"30-50% peg 400 and 0.1M phosphate-citrate, pH 4.2",293,"10.1021/jacs.8b05366",,"6DHS",85.59,"3.5","3.5","Structure of hnRNP H qRRM1,2","SNAGFVVKVRGLPWSCSADEVQRFFSDCKIQNGAQGIRFIYTREGRPSGEAFVELESEDEVKLALKKDRETMGHRYVEVFKSNNVEMDWVLKHTGPNSPDTANDGFVRLRGLPFGCSKEEIVQFFSGLEIVPNGITLPVDFQGRSTGEAFVQFASQEIAEKALKKHKERIGHRYIEIFKSSRAEVRTH","Homo sapiens","HNRNPH1, HNRPH, HNRPH1","Heterogeneous nuclear ribonucleoprotein H","1","6DHS"
"6DHU",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03 M sodium fluoride
0.03 M sodium bromide
0.03 M sodium iodide",292,"10.1093/nar/gkz515",,"6DHU",105.29,"1.63","1.63","Crystal structure of Tdp1 catalytic domain in complex with Zenobia fragment ZT0911 from cocktail soak","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DHU"
"6DHW",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM TRIS-HCl pH 8.5, 400 mM LiSO4, 18% PEG3350",289,"10.1371/journal.pone.0209345",,"6DHW",45.45,"2.013","2.013","Crystal structure of primase iron-sulfur domain (266-457)","GNVGKISLDQIDLLSTKSFPPCMRQLHKALRENHHLRHGGRMQYGLFLKGIGLTLEQALQFWKQEFIKGKMDPDKFDKGYSYNIRHSFGKEGKRTDYTPFSCLKIILSNPPSQGDYHGCPFRHSDPELLKQKLQSYKISPGGISQILDLVKGTHYQVACQKYFEMIHNVDDCGFSLNHPNQFFCESQRILNG","Homo sapiens","PRIM2, PRIM2A","DNA primase large subunit","1","6DHW"
"6DI0",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION, HANGING DROP",6.9,"ID : MSC2267302.1",294,"10.1016/j.bmcl.2018.09.033","GJG","6DI0",31.82,"1.3","1.3","CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH FRAGMENT LIGAND","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6DI0"
"6DI1",,"X-RAY DIFFRACTION",2.27,45.81,"VAPOR DIFFUSION, HANGING DROP",,"RESERVOIR SOLUTION : 25% PEG 3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES pH 6.9, 3% GLYCEROL                      
PROTEIN SOLUTION   : 10 mg/mL IN 20 mM TRIS, 50 mM NACL, 3 mM DTT, pH 8.0",294,"10.1016/j.bmcl.2018.09.033",,"6DI1",31.88,"1.1","1.1","CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT FRAGMENT LIGAND","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6DI1"
"6DI3",,"X-RAY DIFFRACTION",2.36,47.89,"VAPOR DIFFUSION, HANGING DROP",,"RESERVOIR SOLUTION : 25% PEG 3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES pH 6.9, 3% GLYCEROL                      
PROTEIN SOLUTION   : 10 mg/mL IN 20 mM TRIS, 50 mM NaCL, 3 mM       
DTT, pH 8.0",294,"10.1016/j.bmcl.2018.07.008","GJA","6DI3",32.04,"2","2","CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH FRAGMENT LIGAND","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6DI3"
"6DI5",,"X-RAY DIFFRACTION",2.48,50.41,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES pH 6.9, 3% GLYCEROL 
PROTEIN SOLUTION   : 10 mg/mL IN 20 mM TRIS, 50 mM NaCl, 3 mM DTT, pH 8.0",294,"10.1016/j.bmcl.2018.07.008",,"6DI5",32.13,"1.42","1.42","CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT INHIBITOR","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6DI5"
"6DI9",,"X-RAY DIFFRACTION",2.41,48.87,"VAPOR DIFFUSION, HANGING DROP",,"RESERVOIR SOLUTION : 25% PEG 3350, 0.2M AMMONIUM ACETATE, 0.1M HEPES pH 6.9, 3% GLYCEROL                      
PROTEIN SOLUTION   : 10 mg/mL IN 20 mM TRIS, 50 mM NaCl, 3 mM  DTT, pH 8.0",294,"10.1016/j.bmcl.2018.07.008","GJJ","6DI9",32.13,"1.25","1.25","CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT INHIBITOR","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6DI9"
"6DIE",,"X-RAY DIFFRACTION",2.46,50.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515","GHM","6DIE",104.92,"1.78","1.78","Crystal structure of Tdp1 catalytic domain in complex with Zenobia fragment benzene-1,2,4-tricarboxylic acid from single soak","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tdp1 catalytic domain (residues 149-609)","1","6DIE"
"6DIH",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515","GJS","6DIH",104.8,"1.78","1.78","Crystal structure of Tdp1 catalytic domain in complex with Sigma Aldrich compound PH004941","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DIH"
"6DIM",,"X-RAY DIFFRACTION",2.47,50.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515",,"6DIM",105,"1.81","1.81","Crystal structure of Tdp1 catalytic domain in complex with Zenobia fragment ZT1982 from cocktail soak","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DIM"
"6DIX",,"X-RAY DIFFRACTION",1.46,15.72,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Imidazole, 20% PEG 3000, 0.2 M Zinc Acetate",293,"10.1074/jbc.RA118.004142",,"6DIX",2.74,"1","1","NFVFGT segment from Human Immunoglobulin Light-Chain Variable Domain, Residues 98-103, assembled as an amyloid fibril","NFVFGT","Homo sapiens",,"NFVFGT Immunoglobulin Light-Chain Variable Domain","1","6DIX"
"6DIY",,"X-RAY DIFFRACTION",1.31,6.44,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M Bis-Tris propane, 2.8 M Sodium Acetate",293,"10.1074/jbc.RA118.004142",,"6DIY",0.61,"0.9","0.9","YTFGQ segment from Human Immunoglobulin Light-Chain Variable Domain, Residues 96-100, assembled as an amyloid fibril","YTFGQ","Homo sapiens",,"YTFGQ segment Light-Chain Variable Domain Kappa AL09","1","6DIY"
"6DJ0",,"X-RAY DIFFRACTION",1.42,13.36,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M Malic Acid, MES:Tris buffer, 25% PEG 1500",293,"10.1074/jbc.RA118.004142",,"6DJ0",1.15,"1.3","1.3","ASLTVS segment from Human Immunoglobulin Light-Chain Variable Domain, Residues 73-78, assembled as an amyloid fibril","ASLTVS","Homo sapiens",,"ASLTVS segment from Light-Chain Variable Domain, Lambda Mcg","1","6DJ0"
"6DJ3",,"X-RAY DIFFRACTION",3.29,62.56,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Bis-Tris pH 6.0, 0.5 M Na Citrate pH 7.0",293,"10.1074/jbc.RA118.005672",,"6DJ3",45.64,"2.6","2.6","Crystal structure of CNNM2 cyclic nucleotide-binding homology domain","GPLGSTDLYTDNRTKKKVAHRERKQDFSAFKQTDSEMKVKISPQLLLAMHRFLATEVEAFSPSQMSEKILLRLLKHPNVIQELKYDEKNKKAPEYYLYQRNKPVDYFVLILQGKVEVEAGKEGMKFEASAFSYYGVMALTASPVIDAVTPTLGSSNNQLNSSLLQVYIPDYSVRALSDLQFVKISRQQYQNALMASRMD","Homo sapiens","CNNM2, ACDP2","Metal transporter CNNM2","1","6DJ3"
,,,,,,,,,,,,,,,,,"Homo sapiens","CNNM2, ACDP2"
"6DJB","4.4","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.38461",,"6DJB",565.91,"4.4",,"Structure of human Volume Regulated Anion Channel composed of SWELL1 (LRRC8A)","MIPVTELRYFADTQPAYRILKPWWDVFTDYISIVMLMIAVFGGTLQVTQDKMICLPCKWVTKDSCNDSFRGWAAPGPEPTYPNSTILPTPDTGPTGIKYDLDRHQYNYVDAVCYENRLHWFAKYFPYLVLLHTLIFLACSNFWFKFPRTSSKLEHFVSILLKCFDSPWTTRALSETVVEESDPKPAFSKMNGSMDKKSSTVSEDVEATVPMLQRTKSRIEQGIVDRSETGVLDKKEGEQAKALFEKVKKFRTHVEEGDIVYRLYMRQTIIKVIKFILIICYTVYYVHNIKFDVDCTVDIESLTGYRTYRCAHPLATLFKILASFYISLVIFYGLICMYTLWWMLRRSLKKYSFESIREESSYSDIPDVKNDFAFMLHLIDQYDPLYSKRFAVFLSEVSENKLRQLNLNNEWTLDKLRQRLTKNAQDKLELHLFMLSGIPDTVFDLVELEVLKLELIPDVTIPPSIAQLTGLKELWLYHTAAKIEAPALAFLRENLRALHIKFTDIKEIPLWIYSLKTLEELHLTGNLSAENNRYIVIDGLRELKRLKVLRLKSNLSKLPQVVTDVGVHLQKLSINNEGTKLIVLNSLKKMANLTELELIRCDLERIPHSIFSLHNLQEIDLKDNNLKTIEEIISFQHLHRLTCLKLWYNHIAYIPIQIGNLTNLERLYLNRNKIEKIPTQLFYCRKLRYLDLSHNNLTFLPADIGLLQNLQNLAITANRIETLPPELFQCRKLRALHLGNNVLQSLPSRVGELTNLTQIELRGNRLECLPVELGECPLLKRSGLVVEEDLFNTLPPEVKERLWRADKEQA","Homo sapiens","LRRC8A, KIAA1437, LRRC8, SWELL1, UNQ221/PRO247","Volume-regulated anion channel subunit LRRC8A","1","6DJB"
"6DJC",,"X-RAY DIFFRACTION",2.47,50.26,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Ammonium sulfate, 0.1M Bis-Tris pH6.5, 25% w/v Polyethylene glycol 3350",291,"10.1073/pnas.1720000115","CF6","6DJC",32.81,"1.46","1.46","Crystal structure of human Bromodomain-containing protein 4 (BRD4) bromodomain with MS645","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMI","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6DJC"
"6DJD",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515","GJP","6DJD",104.88,"1.777","1.777","Crystal structure of Tdp1 catalytic domain in complex with Zenobia fragment ZT1982 (single soak)","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DJD"
"6DJE",,"X-RAY DIFFRACTION",2.46,50.02,"VAPOR DIFFUSION, HANGING DROP",7.5,".1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515",,"6DJE",104.96,"1.705","1.705","Crystal structure of Tdp1 catalytic domain in complex with Sigma Aldrich compound CDS010292","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DJE"
"6DJF",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515",,"6DJF",104.97,"1.67","1.67","Crystal structure of Tdp1 catalytic domain in complex with compound XZ502","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DJF"
"6DJG",,"X-RAY DIFFRACTION",2.42,49.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515",,"6DJG",104.92,"1.88","1.88","Crystal structure of Tdp1 catalytic domain in complex with compound XZ503","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DJG"
"6DJH",,"X-RAY DIFFRACTION",2.46,49.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515",,"6DJH",104.98,"1.918","1.918","Crystal structure of Tdp1 catalytic domain in complex with compound XZ515","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DJH"
"6DJI",,"X-RAY DIFFRACTION",2.43,49.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515","GOG","6DJI",104.99,"1.75","1.75","Crystal structure of Tdp1 catalytic domain in complex with compound XZ522","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DJI"
"6DJJ",,"X-RAY DIFFRACTION",2.43,49.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M MOPS/HEPES-Na pH 7.5
10% w/v PEG 8000
20% v/v ethylene glycol
0.03M sodium fluoride
0.03M sodium bromide
0.03M sodium iodide",292,"10.1093/nar/gkz515","GM7","6DJJ",105.05,"1.741","1.741","Crystal structure of Tdp1 catalytic domain in complex with compound XZ532","SGEGQDIWDMLDKGNPFQFYLTRVSGVKPKYNSGALHIKDILSPLFGTLVSSAQFNYCFDVDWLVKQYPPEFRKKPILLVHGDKREAKAHLHAQAKPYENISLCQAKLDIAFGTHHTKMMLLLYEEGLRVVIHTSNLIHADWHQKTQGIWLSPLYPRIADGTHKSGESPTHFKADLISYLMAYNAPSLKEWIDVIHKHDLSETNVYLIGSTPGRFQGSQKDNWGHFRLKKLLKDHASSMPNAESWPVVGQFSSVGSLGADESKWLCSEFKESMLTLGKESKTPGKSSVPLYLIYPSVENVRTSLEGYPAGGSLPYSIQTAEKQNWLHSYFHKWSAETSGRSNAMPHIKTYMRPSPDFSKIAWFLVTSANLSKAAWGALEKNGTQLMIRSYELGVLFLPSAFGLDSFKVKQKFFAGSQEPMATFPVPYDLPPELYGSKDRPWIWNIPYVKAPDTHGNMWVPS","Homo sapiens","TDP1","Tyrosyl-DNA phosphodiesterase 1","1","6DJJ"
"6DJR","5.8","ELECTRON MICROSCOPY",,,,,,,"10.1074/jbc.RA118.005066",,"6DJR",166.88,"5.8",,"Full-length human TRPC3 in GDN","XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX","Homo sapiens",,"Transient Receptor Potential Cation Channel Subfamily C Member 3","1","6DJR"
"6DJZ",,"X-RAY DIFFRACTION",3.87,68.25,"LIPIDIC CUBIC PHASE",6.4,"Protein was reconstituted in cubic phase by mixing with a 1:1.5 (w:w) protein:lipid ratio. Lipid used was a 10:1 (w:w) mix of monoolein with cholesterol. Crystals were grown in 500 mM lithium sulfate, 42% PEG 300, 1% hexanediol, 100 mM MES pH 6.4",293,"10.1038/s41594-018-0137-2","GMJ","6DJZ",81.87,"3.084","3.084","Human sigma-1 receptor bound to haloperidol","GPGSMQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP","Homo sapiens","SIGMAR1, OPRS1, SRBP, AAG8","Sigma non-opioid intracellular receptor 1","1","6DJZ"
"6DK0",,"X-RAY DIFFRACTION",3.87,68.25,"LIPIDIC CUBIC PHASE",,"Protein was reconstituted in cubic phase by mixing with a 1:1.5 (w:w) protein:lipid ratio. Lipid used was a 10:1 (w:w) mix of monoolein with cholesterol. Crystals were grown in 400-500 mM lithium sulfate, 30-40% PEG 300, 1% hexanediol, 0.1 M MES pH 5.8-6.0",293,"10.1038/s41594-018-0137-2","GKY","6DK0",81.88,"2.9","2.9","Human sigma-1 receptor bound to NE-100","GPGSMQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP","Homo sapiens","SIGMAR1, OPRS1, SRBP, AAG8","Sigma non-opioid intracellular receptor 1","1","6DK0"
"6DK1",,"X-RAY DIFFRACTION",3.9,68.46,"LIPIDIC CUBIC PHASE",6,"Protein was reconstituted in cubic phase by mixing with a 1:1.5 (w:w) protein:lipid ratio. Lipid used was a 10:1 (w:w) mix of monoolein with cholesterol. The crystal was grown in 240 mM lithium sulfate, 42% PEG 300, 1% hexanediol, and 0.1M MES pH 6.0",293,"10.1038/s41594-018-0137-2","GM4","6DK1",82.84,"3.12","3.12","Human sigma-1 receptor bound to (+)-pentazocine","GPGSMQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP","Homo sapiens","SIGMAR1, OPRS1, SRBP, AAG8","Sigma non-opioid intracellular receptor 1","1","6DK1"
"6DK3",,"X-RAY DIFFRACTION",2.35,47.59,"VAPOR DIFFUSION, HANGING DROP",8,"5% PEG 8000, 0.1 M Tris-HCL pH8.0",297,,,"6DK3",54.11,"2.04","2.04","HUMAN MITOCHONDRIAL SERINE HYDROXYMETHYLTRANSFERASe 2","GQLVRMAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGTRSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","1","6DK3"
"6DK5",,"X-RAY DIFFRACTION",1.71,29.16,"VAPOR DIFFUSION, SITTING DROP",6.5,"4 uL 15 mg/mL aqueous endothelin + 6 uL reservoir solution (20-25% MPD, 0.2 M MES, pH 6.5) + 2 uL 0.2 M MES, pH 6.5",310,"10.1107/S2053230X18016011",,"6DK5",5,"1.85","1.85","The X-ray crystal structure of human endothelin-1, a polypeptide hormone regulator of blood pressure","CSCSSLMDKECVYFCHLDIIW","Homo sapiens","EDN1","Endothelin-1","1","6DK5"
"6DKB",,"X-RAY DIFFRACTION",2.29,46.23,"VAPOR DIFFUSION, SITTING DROP",8,"Well volume: 30.0 uL
Drop volume from well: 0.2 uL
Drop protein volume: 0.4 uL

Well Ingredients:
Polymer: 10.0 %w/v (6.0 uL of stock 50.0 %w/v) PEG 3350
Buffer: 16.0 %v/v (4.8 uL of stock 100.0 %v/v) tacsimate (pH 8.00)
Organic (non-volatile): 10.0 %v/v (3.0 uL of stock 100.0 %v/v) Ethylene glycol
Additive: 0.025 M (1.5 uL of stock 0.5 M) TCEP hydrochloride

Plate setup temperature: 13 C
Plate incubation temperature: 21 C",294,"10.1021/acs.jmedchem.8b00633","FKY","6DKB",36.63,"2.68","2.68","Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 10b.","GSTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6DKB"
"6DKG",,"X-RAY DIFFRACTION",2.25,45.28,"VAPOR DIFFUSION, SITTING DROP",,"Compound 13b soaked for 30 min into preformed crystals of TrkA.
Well volume: 50.0 uL
Well Ingredients:
Polymer: 9.0 %w/v (9.0 uL of stock 50.0 %w/v) PEG 3350
Buffer: 15.8 %v/v (7.9 uL of stock 100.0 %v/v) tacsimate (pH 8.00)
Additive: 0.025 M (12.5 uL of stock 0.1 M) TCEP hydrochloride

Plate setup temperature: 13 C
Plate incubation temperature: 21 C

Drop volume from well: 0.0050 uL
Drop protein volume: 0.34 uL",294,"10.1021/acs.jmedchem.8b00633","GO7","6DKG",36.87,"2.53","2.53","Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 13b.","GSTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6DKG"
"6DKI",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, SITTING DROP",8,"Well volume: 20.0 uL

Well Ingredients:
Polymer: 9.0 %w/v (3.6 uL of stock 50.0 %w/v) PEG 3350
Buffer: 15.8 %v/v (3.16 uL of stock 100.0 %v/v) tacsimate (pH 8.00)
Additive: 0.025 M (5.0 uL of stock 0.1 M) TCEP hydrochloride

Plate setup temperature: 13 C
Plate incubation temperature: 21 C

Drop volume from well: 0.01 uL
Drop protein volume: 0.2 uL
Protein: 6.30 mg/mL",294,"10.1021/acs.jmedchem.8b00633","GOD","6DKI",36.81,"2.11","2.11","Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 19.","GSTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","High affinity nerve growth factor receptor","1","6DKI"
"6DKW",,"X-RAY DIFFRACTION",2.92,57.81,"VAPOR DIFFUSION, SITTING DROP",,"not available",294,"10.1021/acs.jmedchem.8b00633","GXA","6DKW",71.21,"2.91","2.91","Crystal structure of Trk-A in complex with the Pan-Trk Kinase Inhibitor, compound 3.","MHHHHHHLVPRGSVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","Tyrosine-protein kinase receptor","1","6DKW"
"6DL2",,"X-RAY DIFFRACTION",2.12,41.89,"VAPOR DIFFUSION, SITTING DROP",,"16% Peg 3350, 0.2 M Potassium Chloride",293,"10.1021/acs.jmedchem.8b00506","GUJ","6DL2",15.53,"1.47","1.47","BRD4 bromodomain 1 in complex with HYB157","SNANPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6DL2"
"6DL4",,"SOLUTION NMR",,,,,,,"10.2174/0929866525666181004102031",,"6DL4",13.97,,,"Human Titin ZIg10","RMAHEGALTGVTTDQKEKQKPDIVLYPEPVRVLEGETARFRCRVTGYPQPKVNWYLNGQLIRKSKRFRVRYDGIHYLDIVDCKSYDTGEVKVTAENPEGVIEHKVKLEIQQLEHHHHHH","Homo sapiens","TTN","Titin","1","6DL4"
"6DL7",,"X-RAY DIFFRACTION",3,58.96,"VAPOR DIFFUSION, HANGING DROP",5.2,"5%(w/v) PEG 4,000, 100mM KCl, 100mM NaAc (pH5.2)",277,"10.1016/j.ccell.2019.03.014",,"6DL7",171.95,"2","2","Human mitochondrial ClpP in complex with ONC201 (TIC10)","SLIPIVVEQTGRGERAYDIYSRLLRERIVCVMGPIDDSVASLVIAQLLFLQSESNKKPIHMYINSPGGVVTAGLAIYDTMQYILNPICTWCVGQAASMGSLLLAAGTPGMRHSLPNSRIMIHQPSGGARGQATDIAIQAEEIMKLKKQLYNIYAKHTKQSLQVIESAMERDRYMSPMEAQEFGILDKVLVHPPQDGEDEPTLVQKEPVEAAPAAEPVPAST","Homo sapiens","CLPP","ATP-dependent Clp protease proteolytic subunit, mitochondrial","1","6DL7"
"6DL8",,"X-RAY DIFFRACTION",3.29,62.64,"EVAPORATION",,"15% v/v IPA, 0.1M NaCit pH 5.0, 10% PEG 10000",291.16,"10.1016/j.str.2020.07.012",,"6DL8",94.73,"3.805","3.805","Crystal Structure of an influenza A hemagglutinin antibody Fab variant CH67:1203d4 chimera","SALTQPPSVSVAPGQTATITCGGNNIGRKRVDWFQQKPGQAPVLVVYEDSDRPSGIPERFSDSNSGTTATLTISRVEAGDEADYYCQVWDSDSDHVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CH67:1203d4 FAB light chain","1","6DL8"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVRKPGASVKVSCKASGYTFTDNYIHWVRQAPGQGLEWMGWIHPNSGATKYAQKFEGWVTMTRDTSISTVYMELSRSRSDDTAVYYCARAGLHPTTTEYYYYGMDVWGQGTAVTVSSASFKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Ch67:1203d4 FAB heavy chain","2","6DL8"
"6DLA",,"X-RAY DIFFRACTION",2.68,54.13,"EVAPORATION",,"AmSO4 1.8-2.2M, Bis-Tris 100 mM pH 6.5",291.16,"10.1016/j.str.2020.07.012",,"6DLA",47.43,"2.004","2.004","Crystal structures of an influenza A hemagglutinin antibody Fab CH65:7969d2","QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYHINWVRQAPGQGLEWMGWIHPNSGDTNYAQKFQGWVTMTRDTAISTAYMEVNGLKSDDTAVYYCARAGLHPTTTDYYYYGMDVWGQGTTVTVSSASFKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"CH65:7969d2 Fab heavy chain","1","6DLA"
,,,,,,,,,,,,,,,,"QSVLTQPPAVSVAPGQTARITCGGNDIGRKSVHWNQQKPGQAPVLVVCYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVIFGGGTKLTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CH65:7969d2 Fab light chain","2","6DLA"
"6DLB",,"X-RAY DIFFRACTION",2.67,53.96,"EVAPORATION",,"AmSO4 1.8-2.2M, Tris 100 mM pH 8.3",291.16,"10.1016/j.str.2020.07.012",,"6DLB",47.46,"2.2","2.2","Crystal Structure of an influenza A hemagglutinin antibody Fab CH65:1203d4 chimera","QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYHINWVRQAPGQGLEWMGWIHPNSGDTNYAQKFQGWVTMTRDTAISTAYMEVNGLKSDDTAVYYCARAGLHPTTTEYYYYGMDVWGQGTTVTVSSASFKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"CH65:1203d4 Fab heavy chain","1","6DLB"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSVAPGQTARITCGGNDIGRKSVHWNQQKPGQAPVLVVCYDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHVIFGGGTKLTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"CH65:1203d4 Fab light chain","2","6DLB"
"6DLE",,"X-RAY DIFFRACTION",4.94,75.09,"VAPOR DIFFUSION, HANGING DROP",,"Na,K-Tartrate, BTP pH 7.0",293.15,,,"6DLE",69.06,"3.994","3.994","Crystal structure of IgLON5 homodimer","DYKDDDDKAAAQSLEFNSPADNYTVCEGDNATLSCFIDEHVTRVAWLNRSNILYAGNDRWTSDPRVRLLINTPEEFSILITEVGLGDEGLYTCSFQTRHQPYTTQVYLIVHVPARIVNISSPVTVNEGGNVNLLCLAVGRPEPTVTWRQLRDGFTSEGEILEISDIQRGQAGEYECVTHNGVNSAPDSRRVLVTVNYPPTITDVTSARTALGRAALLRCEAMAVPPADFQWYKDDRLLSSGTAEGLKVQTERTRSMLLFANVSARHYGNYTCRAANRLGASSASMRLLRPGSLENSALEVLFQ","Homo sapiens","IGLON5","IgLON family member 5","1","6DLE"
"6DLF",,"X-RAY DIFFRACTION",3.87,68.23,"VAPOR DIFFUSION, HANGING DROP",,"Na,K-Tartrate, Tris-HCl pH 8.5",293.15,,,"6DLF",68.85,"3.446","3.446","Crystal structure of NTRI homodimer","DYKDDDDKAAAGDATFPKAMDNVTVRQGESATLRCTIDNRVTRVAWLNRSTILYAGNDKWCLDPRVVLLSNTQTQYSIEIQNVDVYDEGPYTCSVQTDNHPKTSRVHLIVQVSPKIVEISSDISINEGNNISLTCIATGRPEPTVTWRHISPKAVGFVSEDEYLEIQGITREQSGDYECSASNDVAAPVVRRVKVTVNYPPYISEAKGTGVPVGQKGTLQCEASAVPSAEFQWYKDDKRLIEGKKGVKVENRPFLSKLIFFNVSEHDYGNYTCVASNKLGHTNASIMLFGPGAVSEVSNGLEVLFQ","Homo sapiens","NTM, IGLON2, NT, UNQ297/PRO337","Neurotrimin","1","6DLF"
"6DLO",,"X-RAY DIFFRACTION",2.65,53.57,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris-HCl at pH 8.5, 1 M LiCl, 16% polyethylene glycol (PEG) 6000, and 10% additive of 30% galactose",289,"10.1073/pnas.1817889116",,"6DLO",87.34,"2.7","2.7","Crystal structure of LRRK2 WD40 domain dimer","GGSRRILLPKNVIVECMVATHHNSRNASIWLGCGHTDRGQLSFLDLNTEGYTSEEVADSRILCLALVHLPVEKESWIVSGTQSGTLLVINTEDGKKRHTLEKMTDSVTCLYCNSFSKQSKQKNFLLVGTADGKLAIFEDKTVKLKGAAPLKILNIGNVSTPLMCLSESTNSTERNVMWGGCGTKIFSFSNDFTIQKLIETRTSQLFSYAAFSDSNIITVVVDTALYIAKQNSPVVEVWDKKTEKLCGLIDCVHFLREVMVKENKESKHKMSYSGRVKTLCLQKNTALWIGTGGGHILLLDLSTRRLIRVIYNFCNSVRVMMTAQLGSLKNVMLVLGYNRKNTEGTQKQKEIQSCLTVWDINLPHEVQNLEKHIEVRKELAEKMRRTSVE","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6DLO"
"6DLP",,"X-RAY DIFFRACTION",2.65,53.57,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris-HCl at pH 8.5, 1 M LiCl, 16% polyethylene glycol (PEG) 6000, and 10% additive of 30% galactose. The crystal was soaked in 1 mM trans-platinum (II) diammine dichloride for 1.5 hours",289,"10.1073/pnas.1817889116",,"6DLP",88.51,"4","4","Crystal structure of LRRK2 WD40 domain dimer","GGSRRILLPKNVIVECMVATHHNSRNASIWLGCGHTDRGQLSFLDLNTEGYTSEEVADSRILCLALVHLPVEKESWIVSGTQSGTLLVINTEDGKKRHTLEKMTDSVTCLYCNSFSKQSKQKNFLLVGTADGKLAIFEDKTVKLKGAAPLKILNIGNVSTPLMCLSESTNSTERNVMWGGCGTKIFSFSNDFTIQKLIETRTSQLFSYAAFSDSNIITVVVDTALYIAKQNSPVVEVWDKKTEKLCGLIDCVHFLREVMVKENKESKHKMSYSGRVKTLCLQKNTALWIGTGGGHILLLDLSTRRLIRVIYNFCNSVRVMMTAQLGSLKNVMLVLGYNRKNTEGTQKQKEIQSCLTVWDINLPHEVQNLEKHIEVRKELAEKMRRTSVE","Homo sapiens","LRRK2, PARK8","Leucine-rich repeat serine/threonine-protein kinase 2","1","6DLP"
"6DLU","3.75","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-018-0378-6",,"6DLU",172.81,"3.75",,"Cryo-EM of the GMPPCP-bound human dynamin-1 polymer assembled on the membrane in the constricted state","MGNRGMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPARKTKALLQMVQQFAVDFEKRIEGSGDQIDTYELSGGARINRIFHERFPFELVKMEFDEKELRREISYAIKNIHGIRTGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKKLQQYPRLREEMERIVTTHIREREGRTKEQVMLLIDIELAYMNTNHEDFIGFANAQQRSNQMNKKKTSGNQDEILVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLKLRDVEKGFMSSKHIFALFNTEQRNVYKDYRQLELACETQEEVDSWKASFLRAGVYPERVGDKEKASETEENGSDSFMHSMDPQLERQVETIRNLVDSYMAIVNKTVRDLMPKTIMHLMINNTKEFIFSELLANLYSCGDQNTLMEESAEQAQRRDEMLRMYHALKEALSIIGDINTT","Homo sapiens","DNM1, DNM","Dynamin-1","1","6DLU"
"6DLV","10.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-018-0378-6",,"6DLV",343.44,"10.1",,"Cryo-EM of the GTP-bound human dynamin-1 polymer assembled on the membrane in the super constricted state","MGNRGMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPARKTKALLQMVQQFAVDFEKRIEGSGDQIDTYELSGGARINRIFHERFPFELVKMEFDEKELRREISYAIKNIHGIRTGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKKLQQYPRLREEMERIVTTHIREREGRTKEQVMLLIDIELAYMNTNHEDFIGFANAQQRSNQMNKKKTSGNQDEILVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKKYMLSVDNLKLRDVEKGFMSSKHIFALFNTEQRNVYKDYRQLELACETQEEVDSWKASFLRAGVYPERVGDKEKASETEENGSDSFMHSMDPQLERQVETIRNLVDSYMAIVNKTVRDLMPKTIMHLMINNTKEFIFSELLANLYSCGDQNTLMEESAEQAQRRDEMLRMYHALKEALSIIGDINTT","Homo sapiens","DNM1, DNM","Dynamin-1","1","6DLV"
"6DLW","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-05717-0",,"6DLW",1352.08,"3.9",,"Complement component polyC9","QYTTSYDPELTESSGSASHIDCRMSPWSEWSQCDPCLRQMFRSRSIEVFGQFNGKRCTDAVGDRRQCVPTEPCEDAEDDCGNDFQCSTGRCIKMRLRCNGDNDCGDFSDEDDCESEPRPPCRDRVVEESELARTAGYGINILGMDPLSTPFDNEFYNGLCNRDRDGNTLTYYRRPWNVASLIYETKGEKNFRTEHYEEQIEAFKSIIQEKTSNFNAAISLKFTPTETNKAEQCCEETASSISLHGKGSFRFSYSKNETYQLFLSYSSKKEKMFLHVKGEIHLGRFVMRNRDVVLTTTFVDDIKALPTTYEKGEYFAFLETYGTHYSSSGSLGGLYELIYVLDKASMKRKGVELKDIKRCLGYHLDVSLAFSEISVGAEFNKDDCVKRGEGRAVNITSENLIDDVVSLIRGGTRKYAFELKEKLLRGTVIDVTDFVNWASSINDAPVLISQKLSPIYNLVPVKMKNAHLKKQNLERAIEDYINEFSVRKCHTCQNGGTVILMDGKCLCACPFKFEGIACEISKQKISEGLPALEFPNEK","Homo sapiens","C9","Complement component C9","1","6DLW"
"6DM7",,"SOLUTION NMR",,,,,,,,,"6DM7",5.48,,,"NMR structure for Sp1 transcription factor duplex 5'-d(GGGGCGGGG)","GGGGCGGGG","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*GP*CP*GP*GP*GP*G)-3')","1","6DM7"
,,,,,,,,,,,,,,,,"CCCCGCCCC","Homo sapiens",,"DNA (5'-D(*CP*CP*CP*CP*GP*CP*CP*CP*C)-3')","2","6DM7"
"6DMB","3.9","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aas8935",,"6DMB",152.69,"3.9",,"Cryo-EM structure of human Ptch1","MADYKDDDDKSGPDEVDASGRMASAGNAAEPQDRGGGGSGCIGAPGRPAGGGRRRRTGGLRRAAAPDRDYLHRPSYCDAAFALEQISKGKATGRKAPLWLRAKFQRLLFKLGCYIQKNCGKFLVVGLLIFGAFAVGLKAANLETNVEELWVEVGGRVSRELNYTRQKIGEEAMFNPQLMIQTPKEEGANVLTTEALLQHLDSALQASRVHVYMYNRQWKLEHLCYKSGELITETGYMDQIIEYLYPCLIITPLDCFWEGAKLQSGTAYLLGKPPLRWTNFDPLEFLEELKKINYQVDSWEEMLNKAEVGHGYMDRPCLNPADPDCPATAPNKNSTKPLDMALVLNGGCHGLSRKYMHWQEELIVGGTVKNSTGKLVSAHALQTMFQLMTPKQMYEHFKGYEYVSHINWNEDKAAAILEAWQRTYVEVVHQSVAQNSTQKVLSFTTTTLDDILKSFSDVSVIRVASGYLLMLAYACLTMLRWDCSKSQGAVGLAGVLLVALSVAAGLGLCSLIGISFNAATTQVLPFLALGVGVDDVFLLAHAFSETGQNKRIPFEDRTGECLKRTGASVALTSISNVTAFFMAALIPIPALRAFSLQAAVVVVFNFAMVLLIFPAILSMDLYRREDRRLDIFCCFTSPCVSRVIQVEPQAYTDTHDNTRYSPPPPYSSHSFAHETQITMQSTVQLRTEYDPHTHVYYTTAEPRSEISVQPVTVTQDTLSCQSPESTSSTRDLLSQFSDSSLHCLEPPCTKWTLSSFAEKHYAPFLLKPKAKVVVIFLFLGLLGVSLYGTTRVRDGLDLTDIVPRETREYDFIAAQFKYFSFYNMYIVTQKADYPNIQHLLYDLHRSFSNVKYVMLEENKQLPKMWLHYFRDWLQGLQDAFDSDWETGKIMPNNYKNGSDDGVLAYKLLVQTGSRDKPIDISQLTKQRLVDADGIINPSAFYIYLTAWVSNDPVAYAASQANIRPHRPEWVHDKADYMPETRLRIPAAEPIEYAQFPFYLNGLRDTSDFVEAIEKVRTICSNYTSLGLSSYPNGYPFLFWEQYIGLRHWLLLFISVVLACTFLVCAVFLLNPWTAGIIVMVLALMTVELFGMMGLIGIKLSAVPVVILIASVGIGVEFTVHVALAFLTAIGDKNRRAVLALEHMFAPVLDGAVSTLLGVLMLAGSEFDFIVRYFFAVLAILTILGVLNGLVLLPVLLSFFGPYPEVSPANGLNRLPTPSPEPPPSVVRFAMPPGHTHSGSDSSDSEYSSQTTVSGLSEELRHYEAQQGAGGPAHQVIVEATENPVFAHSTVVHPESRHHPPSNPRQQPHLDSGSLPPGRQGQQPRRDLEGSDEVDAVEGSHHHHHHHHHH","Homo sapiens","PTCH1, PTCH","Protein patched homolog 1","1","6DMB"
"6DMG",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION",6.5,"100 mM MES buffer, pH 6.5, 26-28% PEG-MME 2000, 200 mM ammonium sulfate and 20 mM 2-mercaptoethanol, vapor diffusion, temperature 298K",298,"10.1021/acs.jmedchem.8b01292",,"6DMG",41.42,"2.2","2.2","A multiconformer ligand model of EK6 bound to ERK2","PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6DMG"
"6DMI",,"X-RAY DIFFRACTION",2.96,58.38,"VAPOR DIFFUSION, HANGING DROP",,"2.5M SODIUM FORMATE, 100MM HEPES",293,"10.1021/acs.jmedchem.8b01292",,"6DMI",43.94,"1.9","1.9","A multiconformer ligand model of 5T5 bound to BACE-1","RGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6DMI"
"6DMJ",,"X-RAY DIFFRACTION",1.89,34.79,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350",293,"10.1021/acs.jmedchem.8b01292","53W","6DMJ",15.56,"1.15","1.15","A multiconformer ligand model of inhibitor 53W bound to CREB binding protein bromodomain","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6DMJ"
"6DMK",,"X-RAY DIFFRACTION",2.13,42.14,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20M NaNO3, 20.0% PEG 3350, 10.0% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/acs.jmedchem.8b01292","2LL","6DMK",14.1,"1.66","1.66","A multiconformer ligand model of an isoxazolyl-benzimidazole ligand bound to the bromodomain of human CREBBP","KIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQS","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6DMK"
"6DML",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG3350, 0.2M NANO3, 0.1M BIS-TRIS-PROPANE PH8.5",277,"10.1021/acs.jmedchem.8b01292",,"6DML",15.73,"1.5","1.5","A multiconformer ligand model of 3,5 dimethylisoxaxole bound to the bromodomain of human BRD4","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6DML"
"6DMM",,"X-RAY DIFFRACTION",1.9,35.21,"VAPOR DIFFUSION, SITTING DROP",5.5,"30% isopropanol
10% PEG 1500
200 mM lithium sulfate
100 mM sodium acetate pH 5.5",294,"10.1016/j.bbamem.2019.01.007",,"6DMM",47.16,"1.67","1.67","Crystal structure of the G23A mutant of human alpha defensin HNP4.","VCSCRLVFCRRTELRVGNCLIGAVSFTYCCTRV","Homo sapiens","DEFA4, DEF4","Neutrophil defensin 4","1","6DMM"
"6DMO","4.1","ELECTRON MICROSCOPY",,,,,,,"10.1126/science.aas8935",,"6DMO",151.8,"4.1",,"Cryo-EM structure of human Ptch1 with three mutations L282Q/T500F/P504L","MADYKDDDDKSGPDEVDASGRMASAGNAAEPQDRGGGGSGCIGAPGRPAGGGRRRRTGGLRRAAAPDRDYLHRPSYCDAAFALEQISKGKATGRKAPLWLRAKFQRLLFKLGCYIQKNCGKFLVVGLLIFGAFAVGLKAANLETNVEELWVEVGGRVSRELNYTRQKIGEEAMFNPQLMIQTPKEEGANVLTTEALLQHLDSALQASRVHVYMYNRQWKLEHLCYKSGELITETGYMDQIIEYLYPCLIITPLDCFWEGAKLQSGTAYLLGKPPLRWTNFDPLEFLEELKKINYQVDSWEEMQNKAEVGHGYMDRPCLNPADPDCPATAPNKNSTKPLDMALVLNGGCHGLSRKYMHWQEELIVGGTVKNSTGKLVSAHALQTMFQLMTPKQMYEHFKGYEYVSHINWNEDKAAAILEAWQRTYVEVVHQSVAQNSTQKVLSFTTTTLDDILKSFSDVSVIRVASGYLLMLAYACLTMLRWDCSKSQGAVGLAGVLLVALSVAAGLGLCSLIGISFNAATFQVLLFLALGVGVDDVFLLAHAFSETGQNKRIPFEDRTGECLKRTGASVALTSISNVTAFFMAALIPIPALRAFSLQAAVVVVFNFAMVLLIFPAILSMDLYRREDRRLDIFCCFTSPCVSRVIQVEPQAYTDTHDNTRYSPPPPYSSHSFAHETQITMQSTVQLRTEYDPHTHVYYTTAEPRSEISVQPVTVTQDTLSCQSPESTSSTRDLLSQFSDSSLHCLEPPCTKWTLSSFAEKHYAPFLLKPKAKVVVIFLFLGLLGVSLYGTTRVRDGLDLTDIVPRETREYDFIAAQFKYFSFYNMYIVTQKADYPNIQHLLYDLHRSFSNVKYVMLEENKQLPKMWLHYFRDWLQGLQDAFDSDWETGKIMPNNYKNGSDDGVLAYKLLVQTGSRDKPIDISQLTKQRLVDADGIINPSAFYIYLTAWVSNDPVAYAASQANIRPHRPEWVHDKADYMPETRLRIPAAEPIEYAQFPFYLNGLRDTSDFVEAIEKVRTICSNYTSLGLSSYPNGYPFLFWEQYIGLRHWLLLFISVVLACTFLVCAVFLLNPWTAGIIVMVLALMTVELFGMMGLIGIKLSAVPVVILIASVGIGVEFTVHVALAFLTAIGDKNRRAVLALEHMFAPVLDGAVSTLLGVLMLAGSEFDFIVRYFFAVLAILTILGVLNGLVLLPVLLSFFGPYPEVSPANGLNRLPTPSPEPPPSVVRFAMPPGHTHSGSDSSDSEYSSQTTVSGLSEELRHYEAQQGAGGPAHQVIVEATENPVFAHSTVVHPESRHHPPSNPRQQPHLDSGSLPPGRQGQQPRRDLEGSDEVDAVEGSHHHHHHHHHH","Homo sapiens","PTCH1, PTCH","Protein patched homolog 1","1","6DMO"
"6DMQ",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, SITTING DROP",5.5,"30% MPD
15% PEG 8000
100 mM sodium acetate pH 5.5
100 mM calcium chloride",294,"10.1016/j.bbamem.2019.01.007",,"6DMQ",29.64,"1.7","1.7","Crystal structure of the T27A mutant of human alpha defensin HNP4.","VCSCRLVFCRRTELRVGNCLIGGVSFAYCCTRV","Homo sapiens","DEFA4, DEF4","Neutrophil defensin 4","1","6DMQ"
"6DN0",,"X-RAY DIFFRACTION",2.84,56.76,"VAPOR DIFFUSION, SITTING DROP",4.6,"Equal volumes of protein (8.0 mg/mL in 25 mM Tris (pH 8.0)) were combined with an equal volume of well solution (3.5 M sodium formate, 100 mM sodium acetate (pH 4.6)",293,,,"6DN0",51.68,"2","2","Retrofitted antibodies with stabilizing mutations: Herceptin scFv mutant with VH K30D and VL S52D.","EVQLVESGGGLVQPGGSLRLSCAASGFNIDDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDVWGQGTLVTVSSGGGGSGGGGSGGGGST","Homo sapiens",,"Human Variable Heavy Chain of Herceptin containing VH mutation K30D","1","6DN0"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSADFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEI","Homo sapiens",,"Human Variable Light Chain of Herceptin containing VL mutation S52D","2","6DN0"
"6DNA",,"X-RAY DIFFRACTION",2.94,58.13,"VAPOR DIFFUSION, SITTING DROP",,"25%  w/v PEG 3,350, 0.1 M HEPES pH 7.5",294,"10.1021/acs.biochem.8b00914",,"6DNA",276.78,"3","3","Crystal structure of T110A mutant human Glutamate oxaloacetate transaminase 1 (GOT1)","VFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKIANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGAGALRIGADFLARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLENAPEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWAIRYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPPAQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWNHITDQIGMFSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ","Homo sapiens","GOT1","Aspartate aminotransferase, cytoplasmic","1","6DNA"
"6DNB",,"X-RAY DIFFRACTION",2.32,47.04,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 8.5, 20% w/v/ PEG MME 2,000, 0.2 M Trimethylamine N-oxide dehydrate",298,"10.1021/acs.biochem.8b00914",,"6DNB",46.81,"1.7","1.7","Crystal structure of T110A:S256A mutant human Glutamate oxaloacetate transaminase 1 (GOT1)","PPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKIANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGAGALRIGADFLARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLENAPEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWAIRYFVSEGFEFFCAQAFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPPAQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWIHITDQIGMFSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ","Homo sapiens","GOT1","Aspartate aminotransferase, cytoplasmic","1","6DNB"
"6DND",,"X-RAY DIFFRACTION",2.35,47.64,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Sodium Acetate Trihydrate pH 4.5, 25% w/v PEG 3,350",298,"10.1021/acs.biochem.8b00914",,"6DND",93.08,"2.1","2.1","Crystal structure of wild-type (WT) human Glutamate oxaloacetate transaminase 1 (GOT1)","PPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKIANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGTGALRIGADFLARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLENAPEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWAIRYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPPAQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWNHITDQIGMFSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ","Homo sapiens","GOT1","Aspartate aminotransferase, cytoplasmic","1","6DND"
"6DNE",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG 4000
0.1M TrisHCl pH8.5
0.2M Mg Chloride",291,"10.1073/pnas.1720000115",,"6DNE",98.4,"2.958","2.958","Crystal structure of human Bromodomain-containing protein 4 (BRD4) bromodomain with MS660","NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQAKGRGRGRKETGTAKPGVSTVPNTTQASTPPQTQTPQPNPPPVQATPHPFPAVTPDLIVQTPVMTVVPPQPLQTPPPVPPQPQPPPAPAPQPVQSHPPIIAATPQPVKTKKGVKRKADTTTPTTIDPIHEPPSLPPEPKTTKLGQRRESSRPVKPPKKDVPDSQQHPAPEKSSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDEPEEPVVAVSSPAVPPPT","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6DNE"
"6DNK",,"X-RAY DIFFRACTION",2.7,54.45,"VAPOR DIFFUSION, SITTING DROP",6.7,"Sodium sulfate, PEG 3350",285,"10.1016/j.cell.2019.05.036",,"6DNK",21.77,"1.95","1.95","Human Stimulator of Interferon Genes","NVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTADRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEE","Homo sapiens","TMEM173, ERIS, MITA, STING, STING1","Stimulator of interferon genes protein","1","6DNK"
"6DO2",,"X-RAY DIFFRACTION",2.18,43.53,"VAPOR DIFFUSION, SITTING DROP",,"24 to 26% PEG 3350, 0.1 M Tris-HCl and 0.2 M NaCl (by microseeding with the initial crystals from 0.1 M Tris- HCl pH 8.5, 25% PEG 3350 and 0.1 M Na/K tartrate)",298,,,"6DO2",84.87,"1.7","1.7","Crystal structure of human GRP78 in complex with 7-deaza-2'-C-methyladenosine","DVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSG","Homo sapiens","HSPA5, GRP78","Endoplasmic reticulum chaperone BiP","1","6DO2"
"6DO6",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA118.006848",,"6DO6",15.23,,,"NMR solution structure of wild type apo hFABP1 at 308 K","HHHHHHVAMSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRI","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","6DO6"
"6DO7",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA118.006848",,"6DO7",15.23,,,"NMR solution structure of wild type hFABP1 with GW7647","HHHHHHVAMSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRI","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","6DO7"
"6DPQ",,"X-RAY DIFFRACTION",3.01,59.1,"MICROBATCH",10,"100 mM sodium thiosulfate, 100 mM CAPS, pH 10.0, 200 mM sodium chloride, 20% w/v PEG8000",277,"10.1021/jacs.8b07994","H7P","6DPQ",97.16,"2.94","2.94","Mapping the binding trajectory of a suicide inhibitor in human indoleamine 2,3-dioxygenase 1","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6DPQ"
"6DPR",,"X-RAY DIFFRACTION",3.01,59.1,"MICROBATCH",10,"100 mM sodium thiosulfate, 100 mM CAPS, pH 10.0, 200 mM sodium chloride, 20% w/v PEG8000",277,"10.1021/jacs.8b07994","H7P","6DPR",97.22,"3.2","3.2","Mapping the binding trajectory of a suicide inhibitor in human indoleamine 2,3-dioxygenase 1","MKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6DPR"
"6DQ4",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b01219","K0I","6DQ4",39.29,"1.392","1.392","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR GSK-J1","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQ4"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQ5",,"X-RAY DIFFRACTION",2.23,44.74,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b01219","H6G","6DQ5",38.4,"1.89","1.89","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N43 i.e. 3-((6-(4-acryloyl-1,4-diazepan-1-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQ5"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQ6",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b01219","H6J","6DQ6",38.6,"1.587","1.587","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N44 i.e. 3-((2-(pyridin-2-yl)-6-(4-(vinylsulfonyl)-1,4-diazepan-1-yl)pyrimidin-4-yl)amino)propanoic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQ6"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQ7",,"X-RAY DIFFRACTION",2.25,45.35,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,,,"6DQ7",38.55,"1.852","1.852","LINKED KDM5A JMJ DOMAIN BOUND TO THE POTENTIAL HYDROLYSIS PRODUCT OF INHIBITOR N45 i.e. 3-((6-(4-(2-cyano-3-methylbut-2-enoyl)-1,4-diazepan-1-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQ7"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQ8",,"X-RAY DIFFRACTION",2.23,44.77,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b01219","H6S, H6T","6DQ8",39.18,"1.46","1.46","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N49 i.e. 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQ8"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQ9",,"X-RAY DIFFRACTION",2.24,45.13,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b01219",,"6DQ9",38.84,"1.748","1.748","Linked KDM5A JMJ Domain Bound to the Covalent Inhibitor N69 i.e. [2-((3-acrylamidophenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid]","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQ9"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQA",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b01219","H6V","6DQA",38.78,"1.888","1.888","Linked KDM5A JMJ Domain Bound to Inhibitor N70 i.e.[2-((3-aminophenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid]","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQA"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQB",,"X-RAY DIFFRACTION",2.24,45.2,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,"10.1021/acs.jmedchem.8b01219",,"6DQB",39.91,"1.791","1.791","LINKED KDM5A JMJ DOMAIN FORMING COVALENT BOND TO INHIBITOR N71 i.e. 2-((3-(4-(dimethylamino)but-2-enamido)phenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQB"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQC",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,,,"6DQC",38.7,"1.755","1.755","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N50 i.e. 2-(4-((2-(dimethylamino)ethyl)(ethyl)carbamoyl)-5-(4-methoxyphenyl)-1H-pyrazol-1-yl)isonicotinic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQC"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQD",,"X-RAY DIFFRACTION",2.22,44.52,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,,,"6DQD",38.84,"1.987","1.987","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N53 i.e. 2-(5-([1,1'-biphenyl]-3-yl)-4-(1-(2-(piperidin-1-yl)ethoxy)ethyl)-1H-pyrazol-1-yl)isonicotinic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQD"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQE",,"X-RAY DIFFRACTION",2.22,44.66,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,,,"6DQE",38.81,"1.689","1.689","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N67 i.e. 2-(5-phenyl-4-(phenyl(2-(piperidin-1-yl)ethoxy)methyl)-1H-pyrazol-1-yl)isonicotinic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQE"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQF",,"X-RAY DIFFRACTION",2.22,44.66,"VAPOR DIFFUSION, SITTING DROP",,"1.2-1.35 M (NH4)2SO4, 0.1 M Tris-HCl (pH 8.6-9.2) 0-20% glycerol 25 mM (Na/K) dibasic/monobasic phosphate",289,,,"6DQF",38.41,"1.688","1.688","LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N68 i.e. 2-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazol-2-yl)thieno[3,2-b]pyridine-7-carboxylic acid","HNMAGVGPGGYAAEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCT","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Linked KDM5A Jmj Domain","1","6DQF"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2"
"6DQG",,"X-RAY DIFFRACTION",2.91,57.68,"VAPOR DIFFUSION, SITTING DROP",6.8,"Reservoir: 10% w/v PEG8000, 0.1 M sodium chloride, 1.3% w/v octyl-b-glucopyranoside, 7.5% v/v MPD, 0.1 M sodium phosphate, pH 6.8, 1 mM sodium azide",295,"10.1002/prot.25620",,"6DQG",332.24,"2.7","2.7","Human glutamate dehydrogenase, H454Y mutant","DPNFFKMVEGFFDRGASIVEDKLVEDLRTRESEEQKRNRVRGILRIIKPCNHVLSLSFPIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFGGAKAGVKINPKNYTDNELEKITRRFTMELAKKGFIGPGIDVPAPDMSTGEREMSWIADTYASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFGDKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILGFPKAKPYEGSILEADCDILIPAASEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLERNIMVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLMSVQESLERKFGKHGGTIPIVPTAEFQDRISGASEKDIVYSGLAYTMERSARQIMRTAMKYNLGLDLRTAAYVNAIEKVFKVYNEAGVTFT","Homo sapiens","GLUD1, GLUD","Glutamate dehydrogenase 1, mitochondrial","1","6DQG"
"6DQJ","3.49","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6",,"6DQJ",1218.22,"3.49",,"Human type 3 1,4,5-inositol trisphosphate receptor in a ligand-free state","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DQJ"
"6DQN","3.33","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6","I3P","6DQN",1219.9,"3.33",,"Class 1 IP3-bound human type 3 1,4,5-inositol trisphosphate receptor","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DQN"
"6DQS","4.12","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6","I3P","6DQS",1219.9,"4.12",,"Class 3 IP3-bound human type 3 1,4,5-inositol trisphosphate receptor","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DQS"
"6DQV","3.82","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6","I3P","6DQV",1219.9,"3.82",,"Class 2 IP3-bound human type 3 1,4,5-inositol trisphosphate receptor","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DQV"
"6DQZ","6.01","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6","I3P","6DQZ",1219.9,"6.01",,"Class 4 IP3-bound human type 3 1,4,5-inositol trisphosphate receptor","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DQZ"
"6DR0","4.47","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6","I3P","6DR0",1219.9,"4.47",,"Class 5 IP3-bound human type 3 1,4,5-inositol trisphosphate receptor","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DR0"
"6DR2","4.33","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6",,"6DR2",1218.54,"4.33",,"Ca2+-bound human type 3 1,4,5-inositol trisphosphate receptor","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DR2"
"6DR4",,"X-RAY DIFFRACTION",3.21,61.68,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M tirs pH 9.0, 0.2 M magnesium chloride, 2.7 M 1,6-hexanediol",296.15,"10.1021/jacs.8b06568",,"6DR4",7.44,"2.105","2.105","X-ray crystallographic structure of a covalent trimer derived from A-beta 17_36 containing the I31V point mutation","ACVFFCEDAAVIGLAV","Homo sapiens",,"ORN-CYS-VAL-PHE-MEA-CYS-GLU-ASP-ORN-ALA-VAL-ILE-GLY-LEU-ORN-VAL","1","6DR4"
"6DR5",,"X-RAY DIFFRACTION",2.75,55.23,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium acetate, 0.1 M bis-tris pH 5, 47% (v/v) 2-methyl-2,4-pentanediol",296,"10.1021/jacs.8b06568",,"6DR5",11.22,"2.079","2.079","X-ray crystallographic structure of a covalent trimer derived from A-beta 17_36 containing the I31Chg point mutation","ACVFFCEDAAXIGLAV","Homo sapiens",,"ORT-CYS-VAL-PHE-MEA-CYS-GLU-ASP-ORT-ALA-CHG-ILE-GLY-LEU-ORA-VAL","1","6DR5"
"6DR6",,"X-RAY DIFFRACTION",3.25,62.11,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M tris pH 7.5, ).2 M magnesium chloride, 3.9 M 1,6-hexanediol",296.15,"10.1021/jacs.8b06568",,"6DR6",7.16,"2.608","2.608","X-ray crystallographic structure of a covalent trimer derived from A-beta 17_36 containing the F20Cha point mutation","ACVFACEDAAIIGLAV","Homo sapiens",,"ORT-CYS-VAL-PHE-XXX-CYS-GLU-ASP-ORT-ALA-ILE-ILE-GLY-LEU-ORA-VAL","1","6DR6"
"6DRA","3.96","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6",,"6DRA",1218.54,"3.96",,"Low IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DRA"
"6DRC","3.92","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0089-6","I3P","6DRC",1220.22,"3.92",,"High IP3 Ca2+ human type 3 1,4,5-inositol trisphosphate receptor","MSEMSSFLHIGDIVSLYAEGSVNGFISTLGLVDDRCVVEPAAGDLDNPPKKFRDCLFKVCPMNRYSAQKQYWKAKQTKQDKEKIADVVLLQKLQHAAQMEQKQNDTENKKVHGDVVKYGSVIQLLHMKSNKYLTVNKRLPALLEKNAMRVTLDATGNEGSWLFIQPFWKLRSNGDNVVVGDKVILNPVNAGQPLHASNYELSDNAGCKEVNSVNCNTSWKINLFMQFRDHLEEVLKGGDVVRLFHAEQEKFLTCDEYKGKLQVFLRTTLRQSATSATSSNALWEVEVVHHDPCRGGAGHWNGLYRFKHLATGNYLAAEENPSYKGDASDPKAAGMGAQGRTGRRNAGEKIKYCLVAVPHGNDIASLFELDPTTLQKTDSFVPRNSYVRLRHLCTNTWIQSTNVPIDIEEERPIRLMLGTCPTKEDKEAFAIVSVPVSEIRDLDFANDASSMLASAVEKLNEGFISQNDRRFVIQLLEDLVFFVSDVPNNGQNVLDIMVTKPNRERQKLMREQNILKQVFGILKAPFREKGGEGPLVRLEELSDQKNAPYQHMFRLCYRVLRHSQEDYRKNQEHIAKQFGMMQSQIGYDILAEDTITALLHNNRKLLEKHITKTEVETFVSLVRKNREPRFLDYLSDLCVSNHIAIPVTQELICKCVLDPKNSDILIRTELRPVKEMAQSHEYLSIEYSEEEVWLTWTDKNNEHHEKSVRQLAQEARAGNAHDENVLSYYRYQLKLFARMCLDRQYLAIDEISQQLGVDLIFLCMADEMLPFDLRASFCHLMLHVHVDRDPQELVTPVKFARLWTEIPTAITIKDYDSNLNASRDDKKNKFANTMEFVEDYLNNVVSEAVPFANEEKNKLTFEVVSLAHNLIYFGFYSFSELLRLTRTLLGIIDCVQGPPAMLQAYEDPGGKNVRRSIQGVGHMMSTMVLSRKQSVFSAPSLSAGASAAEPLDRSKFEENEDIVVMETKLKILEILQFILNVRLDYRISYLLSVFKKEFVEVFPMQDSGADGTAPAFDSTTANMNLDRIGEQAEAMFGVGKTSSMLEVDDEGGRMFLRVLIHLTMHDYAPLVSGALQLLFKHFSQRQEAMHTFKQVQLLISAQDVENYKVIKSELDRLRTMVEKSELWVDKKGSGKGEEVEAGAAKDKKERPTDEEGFLHPPGEKSSENYQIVKGILERLNKMCGVGEQMRKKQQRLLKNMDAHKVMLDLLQIPYDKGDAKMMEILRYTHQFLQKFCAGNPGNQALLHKHLHLFLTPGLLEAETMQHIFLNNYQLCSEISEPVLQHFVHLLATHGRHVQYLDFLHTVIKAEGKYVKKCQDMIMTELTNAGDDVVVFYNDKASLAHLLDMMKAARDGVEDHSPLMYHISLVDLLAACAEGKNVYTEIKCTSLLPLEDVVSVVTHEDCITEVKMAYVNFVNHCYVDTEVEMKEIYTSNHIWTLFENFTLDMARVCSKREKRVADPTLEKYVLSVVLDTINAFFSSPFSENSTSLQTHQTIVVQLLQSTTRLLECPWLQQQHKGSVEACIRTLAMVAKGRAILLPMDLDAHISSMLSSGASCAAAAQRNASSYKATTRAFPRVTPTANQWDYKNIIEKLQDIITALEERLKPLVQAELSVLVDVLHWPELLFLEGSEAYQRCESGGFLSKLIQHTKDLMESEEKLCIKVLRTLQQMLLKKTKYGDRGNQLRKMLLQNYLQNRKSTSRGDLPDPIGTGLDPDWSAIAATQCRLDKEGATKLVCDLITSTKNEKIFQESIGLAIHLLDGGNTEIQKSFHNLMMSDKKSERFFKVLHDRMKRAQQETKSTVAVNMNDLGSQPHEDREPVDPTTKGRVASFSIPGSSSRYSLGPSLRRGHEVSERVQSSEMGTSVLIMQPILRFLQLLCENHNRDLQNFLRCQNNKTNYNLVCETLQFLDIMCGSTTGGLGLLGLYINEDNVGLVIQTLETLTEYCQGPCHENQTCIVTHESNGIDIITALILNDISPLCKYRMDLVLQLKDNASKLLLALMESRHDSENAERILISLRPQELVDVIKKAYLQEEERENSEVSPREVGHNIYILALQLSRHNKQLQHLLKPVKRIQEEEAEGISSMLSLNNKQLSQMLKSSAPAQEEEEDPLAYYENHTSQIEIVRQDRSMEQIVFPVPGICQFLTEETKHRLFTTTEQDEQGSKVSDFFDQSSFLHNEMEWQRKLRSMPLIYWFSRRMTLWGSISFNLAVFINIIIAFFYPYMEGASTGVLDSPLISLLFWILICFSIAALFTKRYSIRPLIVALILRSIYYLGIGPTLNILGALNLTNKIVFVVSFVGNRGTFIRGYKAMVMDMEFLYHVGYILTSVLGLFAHELFYSILLFDLIYREETLFNVIKSVTRNGRSILLTALLALILVYLFSIVGFLFLKDDFILEVDRLPNNHSTASPLGMPHGAAAFVDTCSGDKMDCVSGLSVPEVLEEDRELDSTERACDTLLMCIVTVMNHGLRNGGGVGDILRKPSKDESLFPARVVYDLLFFFIVIIIVLNLIFGVIIDTFADLRSEKQKKEEILKTTCFICGLERDKFDNKTVSFEEHIKLEHNMWNYLYFIVLVRVKNKTDYTGPESYVAQMIKNKNLDWFPRMRAMSLVSNEGEGEQNEIRILQDKLNSTMKLVSHLTAQLNELKEQMTEQRKRRQRLGFVDVQNCISR","Homo sapiens","ITPR3","Inositol 1,4,5-trisphosphate receptor type 3","1","6DRC"
"6DRF",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA118.006106",,"6DRF",16.6,,,"Structure of human Retinal Degeneration 3(RD3) Protein","ARSPAEMVLETLMMELTGQMREAERQQRERSNAVRKVCTGVDYSWLASTPDSTYDLSPIERLQLEDVCVKIHPSYCGPAILRFRQLLAEQEPEVQEVSQLFRSVLQEVLERMKQEEEAHKLTRQWSLRPRGSLATFETEAEID","Homo sapiens","RD3, C1orf36","Protein RD3","1","6DRF"
"6DRG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA118.006848",,"6DRG",15.73,,,"NMR solution structure of wild type hFABP1 with GW7647","HHHHHHVAMSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRI","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","6DRG"
"6DRM",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION, HANGING DROP",8,"6% PEG8000, 0.1M Tris-HCl pH 8.0, 150 mM NaCl",293,"10.1016/j.str.2019.03.022",,"6DRM",32.73,"2.06","2.06","OTU domain of Fam105A","GAMGSNLSVEAEVDLLSYCAREWKGETPRNKLMRKAYEELFWRHHIKCVRQVRRDNYDALRSVLFQIFSQGISFPSWMKEKDIVKLPEKLLFSQGCNWIQQYSFGPEKYTGSNVFGKLRKYVELLKTQWTEFNGIRDYHKRGSMCNTLFSDAILEYKLYEALKFIMLYQVTEVYEQMKTKKVIPSLFRLLFSRETSSDPLSFMMNHLNSVGDTCGLEQIDMFILGYSLEVKIKVFRLFKFNSRDFEVCYPEEPLRDWPEISLLTENDRHYHIPVF","Homo sapiens","FAM105A, OTULINL","Inactive ubiquitin thioesterase FAM105A","1","6DRM"
"6DRW",,"X-RAY DIFFRACTION",2.46,50.01,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Glycyl-glycine pH 8.0
2.5 M Sodium Malonate pH 6.0",295,,"SKE","6DRW",37.79,"2.303","2.303","JAK2 JH1 in complex with JNJ-7706621 (Crystal Form 2)","SYYHHHHHHDYDIPTTENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","6DRW"
"6DS5","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.devcel.2018.09.010",,"6DS5",508.18,"3.8",,"Cryo EM structure of human SEIPIN","MSGRWSHPQFEKVNDPPVPALLWAQEVGQVLAGRARRLLLQFGVLFCTILLLLWVSVFLYGSFYYSYMPTVSHLSPVHFYYRTDCDSSTTSLCSFPVANVSLTKGGRDRVLMYGQPYRVTLELELPESPVNQDLGMFLVTISCYTRGGRIISTSSRSVMLHYRSDLLQMLDTLVFSSLLLFGFAEQKQLLEVELYADYRENSYVPTTGAIIEIHSKRIQLYGAYLRIHAHFTGLRYLLYNFPMTCAFIGVASNFTFLSVIVLFSYMQWVWGGIWPRHRFSLQVNIRKRDNSRKEVQRRISAHQPGPEGQEESTPQSDVTEDGESPEDPSGTEGQLSEEEKPDQQPLSGEEELEPEASDGSGSWEDAALLTEANLPAPAPASASAPVLETLGSSEPAGGALRQRPTCSSS","Homo sapiens","BSCL2","Seipin","1","6DS5"
"6DSI",,"X-RAY DIFFRACTION",3.53,65.15,"VAPOR DIFFUSION, HANGING DROP",9,"Equal volumes (2 microlitres) of protein solution (5 mg/mL in 15 mM Tris (pH 7.5) and 50 mM NaCl) were combined with well solution (2% (v/v) Dioxane, 100 mM Bicine (pH 9.0) and 10% (w/v) PEG4000)",293,,,"6DSI",25.56,"2.49","2.49","Anti recombinant prolactin receptor scFv","EVQLLESGGGLVQPGGSLRLSCAASGFRFYAEDMGWVRQAPGKGLEWVSSIYGPSGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRGYGSGAFDYWGQGTLVTVSSGGGGSGGGGSGGGGSTDIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYGASNLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQDSYLPYTFGQGTKVEIK","Homo sapiens",,"Anti-TN-C scFv","1","6DSI"
"6DTK",,"X-RAY DIFFRACTION",3.65,66.27,"VAPOR DIFFUSION, SITTING DROP",,"2-3 M Ammonium sulfate or Sodium malonate",298,,,"6DTK",165.02,"2","2","Heterodimers of FALS mutant SOD enzyme","MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGSLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQGAAASGGGGGSGGGGSATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGSLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase C111S/D83S-C111S HETERODIMER","1","6DTK"
,,,,,,,,,,,,,,,,,"Homo sapiens","SOD1"
"6DTP",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"MgCl2, PEG4000",295,,,"6DTP",71.69,"2","2","CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 COMPLEXED WITH EM139","MARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVRMLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHLSLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGGAGPGAEDEAGRGAVGDPELGDPPAAPQ","Homo sapiens","HSD17B1, E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1","Estradiol 17-beta-dehydrogenase 1","1","6DTP"
"6DU8","3.11","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.36931",,"6DU8",369.17,"3.11",,"Human Polycsytin 2-l1","MNAVGSPEGQELQKLGSGAWDNPAYSGPPSPHGTLRVCTISSTGPLQPQPKKPEDEPQETAYRTQVSSCCLHICQGIRGLWGTTLTENTAENRELYIKTTLRELLVYIVFLVDICLLTYGMTSSSAYYYTKVMSELFLHTPSDTGVSFQAISSMADFWDFAQGPLLDSLYWTKWYNNQSLGHGSHSFIYYENMLLGVPRLRQLKVRNDSCVVHEDFREDILSCYDVYSPDKEEQLPFGPFNGTAWTYHSQDELGGFSHWGRLTSYSGGGYYLDLPGSRQGSAEALRALQEGLWLDRGTRVVFIDFSVYNANINLFCVLRLVVEFPATGGAIPSWQIRTVKLIRYVSNWDFFIVGCEVIFCVFIFYYVVEEILELHIHRLRYLSSIWNILDLVVILLSIVAVGFHIFRTLEVNRLMGKLLQQPNTYADFEFLAFWQTQYNNMNAVNLFFAWIKIFKYISFNKTMTQLSSTLARCAKDILGFAVMFFIVFFAYAQLGYLLFGTQVENFSTFIKCIFTQFRIILGDFDYNAIDNANRILGPAYFVTYVFFVFFVLLNMFLAIINDTYSEVKEELAGQKDELQLSDLLKQGYNKTLLRLRLRKERVSDVQKVLQGGEQEIQFEDFTNTLRELGHAEHEITELTATFTKFDRDGNRILDEKEQEKMRQDLEEERVALNTEIEKLGRSIVSSPQGKSGPEAARAGGWVSGEEFYMLTRRVLQLETVLEGVVSQIDAVGSKLKMLERKGWLAPSPGVKEQAIWKHPQPAPAVTPDPWGVQGGQESEVPYKREEEALEERRLSRGEIPTLQRS","Homo sapiens","PKD2L1, PKD2L, PKDL, TRPP3","Polycystic kidney disease 2-like 1 protein","1","6DU8"
"6DU9",,"X-RAY DIFFRACTION",3.22,61.82,"VAPOR DIFFUSION, HANGING DROP",7.6,"0.1 M Tris pH 7.6
15 mM CdCl2
2.5 M NaCl
10% Glycerol",298,,,"6DU9",16.45,"2.33","2.33","Crystal Structure of Human Prion Protein 90-231","GQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGS","Homo sapiens","PRNP, ALTPRP, PRIP, PRP","Major prion protein","1","6DU9"
"6DUD",,"X-RAY DIFFRACTION",2.21,44.34,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 3350, 0.2M (NH4)2SO4, 2% phenylurea",298,"10.1021/acs.jmedchem.8b01308",,"6DUD",36.92,"1.66","1.66","JAK3 with cyanamide CP12","MGHHHHHHQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6DUD"
"6DUJ",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium citrate pH 5.5, 40%(w/v) PEG 600",293.15,"10.1021/acs.jpcb.9b05869",,"6DUJ",24.57,"1.82202726164","1.82202726164","Crystal structure of A51V variant of Human Cytochrome c","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAVNKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","Cytochrome c","1","6DUJ"
"6DUK",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris, 22% PEG3350, 150 mM NaCl",293,"10.1158/2159-8290.CD-18-0903",,"6DUK",232.79,"2.2","2.2","EGFR with an allosteric inhibitor","GSTSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","6DUK"
"6DUM",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Bis-Tris, pH 6.2-6.5, 200 mM sodium chloride, 5 mM ytterbium chloride, 6-11% PEG3350",300,"10.1021/acs.jmedchem.8b00930","A5Y","6DUM",56.57,"2","2","ALDH1A1 N121S in complex with 6-{[(3-fluorophenyl)methyl]sulfanyl}-2-(oxetan-3-yl)-5-phenyl-2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (compound 13g)","MSSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVDKAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLSDLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIGPALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQCCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESGKKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRANNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEYGFHEYTEVKTVTVKISQKNS","Homo sapiens","ALDH1A1, ALDC, ALDH1, PUMB1","Retinal dehydrogenase 1","1","6DUM"
"6DUN",,"X-RAY DIFFRACTION",1.98,37.8,"VAPOR DIFFUSION, SITTING DROP",6.5,"2 M ammonium citrate, pH 6.5",298,"10.1038/s41467-018-05402-2",,"6DUN",27.46,"1.59","1.59","Crystal Structure Analysis of PIN1","GSHMKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEQITRTQEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","6DUN"
"6DUP",,"X-RAY DIFFRACTION",3.04,59.52,"VAPOR DIFFUSION",8,"imidazole 100mM, NaCl 100M, Jeffamine M-600 5%,isopropanol 20%, pH8",278,"10.1016/j.bmcl.2018.08.022",,"6DUP",78.76,"2.3","2.3","CRYSTAL STRUCTURE OF PXR IN COMPLEX WITH COMPOUND 7","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGSGGSGGSSHSSLTERHKILHRLLQEGSPS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","6DUP"
"6DUV",,"X-RAY DIFFRACTION",3.43,64.16,"VAPOR DIFFUSION",10.5,"2.0 Ammonium Sulfate, 0.2 M Lithium Sulfate, CAPS pH10.5",290,,"0S6","6DUV",27.75,"1.8","1.8","Crystal structure of the second bromodomain of human BRD4 in complex with MS417 inhibitor","SSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMP","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6DUV"
"6DUW",,"X-RAY DIFFRACTION",4.03,69.49,"VAPOR DIFFUSION, SITTING DROP",,"2.0 M ammonium sulfate, 10 mM cobalt chloride",277,"10.1038/s41467-018-07481-7",,"6DUW",28.12,"2.2","2.2","Crystal structure of the alpha-N-catenin actin-binding domain H1 mutant","GSSRTSVQTEDDQLIAGQSAGSGSAQLPQEEKAKIAEQVEIFHQEKSKLDAEVAKWDDSGNDIIVLAKQMCMIMMEMTDFTRGKGPLKNTSDVINAAKKIAEAGSRMDKLARAVADQCPDSACKQDLLAYLQRIALYCHQLNICSKVKAEVQNLGGELIVSGLDSATSLIQAAKNLMNAVVLTVKASYVASTKYQKVYGTAAVNSPVVSWKMKAPEKKPLVKREKPEEFQTRVRRGSQKKHISPVQALSEFKAMDSF","Homo sapiens","CTNNA2, CAPR","Catenin alpha-2","1","6DUW"
"6DV5",,"X-RAY DIFFRACTION",3.68,66.61,"VAPOR DIFFUSION, SITTING DROP",,"0.5 M ammonium phosphate monobasic and 40 % tert-butanol.",294.15,,,"6DV5",547.45,"3.58","3.58","Oligomeric complex of a Hsp27 24-mer at 3.6 A resolution","MTERRVPFSLLRGPSWDPFRDWYPHSRLFDQAFGLPRLPEEWSQWLGGSSWPGYVRPLPPAAIESPAVAAPAYSRALSRQLSSGVSEIRHTADRWRVSLDVNHFAPDELTVKTKDGVVEITGKHEERQDEHGYISRCFTRKYTLPPGVDPTQVSSSLSPEGTLTVEAPMPKLATQSNEITIPVTFESRAQLGGPEAAKSDETAAK","Homo sapiens","HSPB1, HSP27, HSP28","Heat shock protein beta-1","1","6DV5"
"6DVR",,"X-RAY DIFFRACTION",2.44,49.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG 3350, 0.2 M NH4SO4, 0.1 M HEPES pH7.5",291,,,"6DVR",79.78,"1.54","1.54","Crystal structure of human CARM1 with (R)-SKI-72","AVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTTPSPPPGSHY","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","6DVR"
"6DVT",,"SOLUTION NMR",,,,,,,,,"6DVT",5.47,,,"NMR structure for Sp1 transcription factor duplex 5'-d(GGGGCGGGA)","GGGGCGGGA","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*GP*CP*GP*GP*GP*A)-3')","1","6DVT"
,,,,,,,,,,,,,,,,"TCCCGCCCC","Homo sapiens",,"DNA (5'-D(*TP*CP*CP*CP*GP*CP*CP*CP*C)-3')","2","6DVT"
"6DVU",,"X-RAY DIFFRACTION",1.87,34,"VAPOR DIFFUSION, SITTING DROP",8,"Crystallized in Cryschem sitting drop plates with reservoirs of 16%-18% 2-methyl-2,4-pentanediol (MPD), 0.1 M sodium acetate and 0.25% octyl-beta-s-1-thioglucopyanoside. The drops were composed of equal amounts of 8 mg/ml protein in 0.02 ammonium bicarbonate and reservoir.",298,"10.1194/jlr.M089441",,"6DVU",18.69,"1.8","1.8","Structure of the Monoclinic-1 (Monocl-1) Crystal Form of Human Apolipoprotein C1","MRLFLSLPVLVVVLSIVLEGPAPAQGTPDVSSALDKLKEFGNTLEDKARELISRIKQSELSAKMREWFSETFQKVKEKLKIDS","Homo sapiens","APOC1","Apolipoprotein C-I","1","6DVU"
"6DW2",,"X-RAY DIFFRACTION",2.7,54.45,"VAPOR DIFFUSION, SITTING DROP",,"1.9 M sodium malonate",292,"10.1080/19420862.2018.1501252",,"6DW2",53.74,"1.7","1.7","Structure of the 6078 Antibody Fab fragment bound to a Staphylococcus aureus wall techoic acid analog","MKKNIAFLLASMFVFSIATNAYADIVMTQSPSILSASVGDRVTITCRASQTISGWLAWYQQKPAEAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFGIYYCQQYKSYSFNFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"6078 Fab light chain","1","6DW2"
,,,,,,,,,,,,,,,,"MKKNIAFLLASMFVFSIATNAYAEVQLVQSGAEVKKPGASVKVSCEASGYTLTSYDINWVRQATGQGPEWMGWMNANSGNTGYAQKFQGRVTLTGDTSISTAYMELSSLRSEDTAVYYCARSSILVRGALGRYFDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"6078 Fab heavy chain","2","6DW2"
"6DW3",,"X-RAY DIFFRACTION",2.27,45.85,"MICROBATCH",,"100 MM BIS-TRIS PH 6.7 AND 25% (W/V) PEG1500",298,"10.1073/pnas.1805593115",,"6DW3",259.89,"2.2","2.2","SAMHD1 Bound to Cytarabine-TP in the Catalytic Pocket","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6DW3"
"6DW4",,"X-RAY DIFFRACTION",2.02,39.23,"MICROBATCH",,"100 MM BIS-TRIS PH 6.7 AND 25% (W/V) PEG1500",298,"10.1073/pnas.1805593115",,"6DW4",260.06,"1.99","1.99","SAMHD1 Bound to Cladribine-TP in the Catalytic Pocket and Allosteric Pocket","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6DW4"
"6DW5",,"X-RAY DIFFRACTION",2.05,40.13,"MICROBATCH",,"100 MM BIS-TRIS PH 6.7 AND 25% (W/V) PEG1500",298,"10.1073/pnas.1805593115",,"6DW5",260.17,"1.93","1.93","SAMHD1 Bound to Gemcitabine-TP in the Catalytic Pocket","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6DW5"
"6DW7",,"X-RAY DIFFRACTION",2.21,44.34,"MICROBATCH",,"100 MM BIS-TRIS PH 6.7 AND 25% (W/V) PEG1500",298,"10.1073/pnas.1805593115",,"6DW7",258.17,"2.5","2.5","SAMHD1 without Catalytic Nucleotides","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6DW7"
"6DWA",,"X-RAY DIFFRACTION",2.73,54.89,"VAPOR DIFFUSION, SITTING DROP",,"0.16M Calcium Acetate, 0.08 M Sodium Cacodylate, pH 6.5, 14.4% PEG8000, and 20% glycerol",292,"10.1080/19420862.2018.1501252",,"6DWA",105.35,"1.922","1.922","Structure of the 4497 Antibody Fab fragment bound to a Staphylococcus aureus wall techoic acid analog","MGWSCIILFLVATATGVHSDIQLTQSPDSLAVSLGERATINCKSSQSIFRTSRNKNLLNWYQQRPGQPPRLLIHWASTRKSGVPDRFSGSGFGTDFTLTITSLQAEDVAIYYCQQYFSPPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4497 Fab Light Chain","1","6DWA"
,,,,,,,,,,,,,,,,"MGWSCIILFLVATATGVHSEVQLVESGGGLVQPGGSLRLSCSASGFSFNSFWMHWVRQVPGKGLVWISFTNNEGTTTAYADSVRGRFIISRDNAKNTLYLEMNNLRGEDTAVYYCARGDGGLDDWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"4497 Fab Heavy Chain","2","6DWA"
"6DWC",,"X-RAY DIFFRACTION",2.65,53.54,"VAPOR DIFFUSION, SITTING DROP",,"0.16M Calcium Acetate, 0.08 M Sodium Cacodylate, pH 6.5, 14.4% PEG8000, and 20% glycerol",292,"10.1080/19420862.2018.1501252",,"6DWC",104.69,"2.27","2.27","Structure of the apo 4497 antibody Fab fragment","MGWSCIILFLVATATGVHSDIQLTQSPDSLAVSLGERATINCKSSQSIFRTSRNKNLLNWYQQRPGQPPRLLIHWASTRKSGVPDRFSGSGFGTDFTLTITSLQAEDVAIYYCQQYFSPPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4497 Fab Light Chain","1","6DWC"
,,,,,,,,,,,,,,,,"MGWSCIILFLVATATGVHSEVQLVESGGGLVQPGGSLRLSCSASGFSFNSFWMHWVRQVPGKGLVWISFTNNEGTTTAYADSVRGRFIISRDNAKNTLYLEMNNLRGEDTAVYYCARGDGGLDDWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"4497 Fab Heavy Chain","2","6DWC"
"6DWD",,"X-RAY DIFFRACTION",2.03,39.54,"MICROBATCH",,"100 MM BIS-TRIS PH 6.7 AND 25% (W/V) PEG1500",298,"10.1073/pnas.1805593115",,"6DWD",261.86,"1.7","1.7","SAMHD1 Bound to Clofarabine-TP in the Catalytic Pocket and Allosteric Pocket","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6DWD"
"6DWI",,"X-RAY DIFFRACTION",2.19,43.86,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Citric Acid, pH 3.5 containing 25% PEG3350",292,"10.1080/19420862.2018.1501252",,"6DWI",411.76,"2.39","2.39","Structure of the 4462 Antibody Fab fragment bound to a Staphylococcus aureus wall techoic acid analog","MGWSCIILFLVATATGVHSDIQMTQSPATLSVSPGETVTLSCRASQSVRTNVAWYRHKAGQAPMILVSGASTRASGAPARFSGSGYGTEFTLTITSLQSEDFAVYYCLQYNTWPRTFGQGTKVEVKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"4462 Fab Light Chain","1","6DWI"
,,,,,,,,,,,,,,,,"MGWSCIILFLVATATGVHSQVQLQHSGGGLEQPGGSLRISCAASGFTFNTNDMSWVRQAPGKGLQWVSTIIGIDDTTHYADSVRGRFTVSRDTSKNMVYLQMNSLRVEDTALYYCVKNSGIYSFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"4462 Fab Heavy chain","2","6DWI"
"6DWJ",,"X-RAY DIFFRACTION",2.28,45.99,"MICROBATCH",,"100 MM BIS-TRIS PH 6.7 AND 25% (W/V) PEG1500",298,"10.1073/pnas.1805593115",,"6DWJ",260.6,"2.5","2.5","SAMHD1 Bound to Vidarabine-TP in the Catalytic Pocket","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6DWJ"
"6DWK",,"X-RAY DIFFRACTION",2.29,46.19,"MICROBATCH",,"100 MM BIS-TRIS PH 6.7 AND 25% (W/V) PEG1500",298,"10.1073/pnas.1805593115",,"6DWK",261.85,"2.3","2.3","SAMHD1 Bound to Fludarabine-TP in the Catalytic Pocket","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRDPNSDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCRNLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","SAMHD1, MOP5","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1","1","6DWK"
"6DWM",,"X-RAY DIFFRACTION",3.48,64.63,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M potassium phosphate dibasic, 20% PEG3350, 15% glycerol",277.15,"10.1074/jbc.RA118.005588",,"6DWM",229.01,"2.85","2.85","Structure of Human Cytochrome P450 1A1 with Bergamottin","MAKKTSSKGLKNPPGPWGWPLIGHMLTLGKNPHLALSRMSQQYGDVLQIRIGSTPVVVLSGLDTIRQALVRQGDDFKGRPDLYTFTLISNGQSMSFSPDSGPVWAARRRLAQNGLKSFSIASDPASSTSCYLEEHVSKEAEVLISTLQELMAGPGHFNPYRYVVVSVTNVICAICFGRRYDHNHQELLSLVNLNNNFGEVVGSGNPADFIPILRYLPNPSLNAFKDLNEKFYSFMQKMVKEHYKTFEKGHIRDITDSLIEHCQEKQLDENANVQLSDEKIINIVLDLFGAGFDTVTTAISWSLMYLVMNPRVQRKIQEELDTVIGRSRRPRLSDRSHLPYMEAFILETFRHSSFVPFTIPHSTTRDTSLKGFYIPKGRCVFVNQWQINHDQKLWVNPSEFLPERFLTPDGAIDKVLSEKVIIFGMGKRKCIGETIARWEVFLFLAILLQRVEFSVPLGVKVDMTPIYGLTMKHACCEHFQMQLRSHHHHHH","Homo sapiens","CYP1A1","Cytochrome P450 1A1","1","6DWM"
"6DWN",,"X-RAY DIFFRACTION",3.52,65.01,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M potassium phosphate dibasic, 20% PEG3350, 10% glycerol, 0.5% n-dodecyl-N,N-dimethylamine-N-oxide",277.15,"10.1074/jbc.RA118.005588",,"6DWN",229.05,"3","3","Structure of Human Cytochrome P450 1A1 with Erlotinib","MAKKTSSKGLKNPPGPWGWPLIGHMLTLGKNPHLALSRMSQQYGDVLQIRIGSTPVVVLSGLDTIRQALVRQGDDFKGRPDLYTFTLISNGQSMSFSPDSGPVWAARRRLAQNGLKSFSIASDPASSTSCYLEEHVSKEAEVLISTLQELMAGPGHFNPYRYVVVSVTNVICAICFGRRYDHNHQELLSLVNLNNNFGEVVGSGNPADFIPILRYLPNPSLNAFKDLNEKFYSFMQKMVKEHYKTFEKGHIRDITDSLIEHCQEKQLDENANVQLSDEKIINIVLDLFGAGFDTVTTAISWSLMYLVMNPRVQRKIQEELDTVIGRSRRPRLSDRSHLPYMEAFILETFRHSSFVPFTIPHSTTRDTSLKGFYIPKGRCVFVNQWQINHDQKLWVNPSEFLPERFLTPDGAIDKVLSEKVIIFGMGKRKCIGETIARWEVFLFLAILLQRVEFSVPLGVKVDMTPIYGLTMKHACCEHFQMQLRSHHHHHH","Homo sapiens","CYP1A1","Cytochrome P450 1A1","1","6DWN"
"6DWS",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, SITTING DROP",,"24 to 26% PEG 3350, 0.1 M Tris-HCl and 0.2 M NaCl (by microseeding with the initial crystals from 0.1 M Tris- HCl pH 8.5, 25% PEG 3350 and 0.1 M Na/K tartrate)",298.15,,,"6DWS",85.17,"1.9","1.9","Crystal structure of human GRP78 in complex with (2R,3R,4S,5R)-2-(6-amino-8-((2-chlorobenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol","DVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSG","Homo sapiens","HSPA5, GRP78","Endoplasmic reticulum chaperone BiP","1","6DWS"
"6DXG",,"X-RAY DIFFRACTION",3.12,60.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"13-15% PEG8000, 0.07M cacodylate, pH 6.8, 0.8M calcium acetate, and 20% glycerol",298,"10.1038/s41586-018-0705-y","HGJ","6DXG",22.39,"1.905","1.905","amidobenzimidazole (ABZI) STING agonists","FNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6DXG"
"6DXH",,"X-RAY DIFFRACTION",3.58,65.62,"VAPOR DIFFUSION, SITTING DROP",7,"1.5 M ammonium sulfate, 0.1 M bis-tris pH 7.0, 25% ethylene glycol (v/v), 2.25% DMSO (v/v)",291,"10.1021/acs.jmedchem.9b00988",,"6DXH",13.83,"2","2","Structure of USP5 zinc-finger ubiquitin binding domain co-crystallized with 4-(4-tert-butylphenyl)-4-oxobutanoate","GGEVRQVSKHAFSLKQLDNPARIPPCGWKCSKCDMRENLWLNLTDGSILCGRRYFDGSGGNNHAVEHYRETGYPLAVKLGTITPDGADVYSYDEDDMVLDPSLAEHLSHFGIDMLKMQKTD","Homo sapiens","USP5, ISOT","Ubiquitin carboxyl-terminal hydrolase 5","1","6DXH"
"6DXK",,"X-RAY DIFFRACTION",3.53,65.18,"VAPOR DIFFUSION",,"pH 6.75",293,"10.1021/acs.jmedchem.8b00743","HJ4","6DXK",60.28,"3.05","3.05","Glucocorticoid Receptor in complex with Compound 11","SSPATSPQSTPTLVSALETIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPDMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQALFDAIRMTYIKELGKAIVKREGNSSQNSQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK","Homo sapiens","NR3C1, GRL","Glucocorticoid receptor","1","6DXK"
"6DXL",,"X-RAY DIFFRACTION",3,59.04,"VAPOR DIFFUSION, SITTING DROP",6.8,"13-15% PEG8000, 0.07M cacodylate, pH 6.8, 0.8M calcium acetate, and 20% glycerol",298,"10.1038/s41586-018-0705-y","HG4","6DXL",44.59,"2.45","2.45","Linked amidobenzimidazole STING agonist","FNVAHGLAWSYYIGYLRLILPELQARIRTYNQHYNNLLRGAVSQRLYILLPLDCGVPDNLSMADPNIRFLDKLPQQTGDRAGIKDRVYSNSIYELLENGQRAGTCVLEYATPLQTLFAMSQYSQAGFSREDRLEQAKLFCRTLEDILADAPESQNNCRLIAYQEPADDSSFSLSQEVLRHLRQEEKEEVTV","Homo sapiens","STING, LOC340061, hCG_1782396, STING1, ERIS, MITA, TMEM173","Stimulator of interferon protein","1","6DXL"
"6DXM",,"SOLUTION NMR",,,,,,,,,"6DXM",5.47,,,"NMR structure for Sp1 transcription factor duplex 5'-d(TGGGCGGGG)","TGGGCGGGG","Homo sapiens",,"DNA (5'-D(*TP*GP*GP*GP*CP*GP*GP*GP*G)-3')","1","6DXM"
,,,,,,,,,,,,,,,,"CCCCGCCCA","Homo sapiens",,"DNA (5'-D(*CP*CP*CP*CP*GP*CP*CP*CP*A)-3')","2","6DXM"
"6DXR",,"X-RAY DIFFRACTION",1.64,25,"VAPOR DIFFUSION, SITTING DROP",6,"20% PEG",298,"10.1194/jlr.M089441",,"6DXR",18.93,"2","2","Structure of the Monoclinic-2 (Monocl-2) Crystal Form of Human Apolipoprotein C1","MRLFLSLPVLVVVLSIVLEGPAPAQGTPDVSSALDKLKEFGNTLEDKARELISRIKQSELSAKMREWFSETFQKVKEKLKIDS","Homo sapiens","APOC1","Apolipoprotein C-I","1","6DXR"
"6DXT",,"X-RAY DIFFRACTION",2.83,56.59,"VAPOR DIFFUSION, SITTING DROP",7,"1.5 M ammonium sulfate, 0.1 M bis-tris pH 7.0, 25% ethylene glycol (v/v), 1.1% DMSO (v/v)",291,"10.1021/acs.jmedchem.9b00988",,"6DXT",27.67,"1.95","1.95","Structure of USP5 zinc-finger ubiquitin binding domain co-crystallized with 3-(5-phenyl-1,3,4-oxadiazol-2-yl)propanoate","GGEVRQVSKHAFSLKQLDNPARIPPCGWKCSKCDMRENLWLNLTDGSILCGRRYFDGSGGNNHAVEHYRETGYPLAVKLGTITPDGADVYSYDEDDMVLDPSLAEHLSHFGIDMLKMQKTD","Homo sapiens","USP5, ISOT","Ubiquitin carboxyl-terminal hydrolase 5","1","6DXT"
"6DXW",,"X-RAY DIFFRACTION",3.25,62.18,"VAPOR DIFFUSION",,"1 M LiCl, 0.1 M MES pH 6 and 10 % PEG 6000",293,"10.1073/pnas.1811759115",,"6DXW",158.17,"2.3","2.3","Human N-acylethanolamine-hydrolyzing acid amidase (NAAA) precursor (C126A)","DRHHHHHHKLSPPAAPRFNVSLDSVPELRWLPVLRHYDLDLVRAAMAQVIGDRVPKWVHVLIGKVVLELERFLPQPFTGEIRGMCDFMNLSLADALLVNLAYESSVFATSIVAQDSRGHIYHGRNLDYPFGNVLRKLTVDVQFLKNGQIAFTGTTFIGYVGLWTGQSPHKFTVSGDERDKGWWWENAIAALFRRHIPVSWLIRATLSESENFEAAVGKLAKTPLIADVYYIVGGTSPREGVVITRNRDGPADIWPLDPLNGAWFRVETNYDHWKPAPKEDDRRTSAIKALNATGQANLSLEALFQILSVVPVYNNFTIYTTVMSAGSPDKYMTRIRNPSRK","Homo sapiens","NAAA, ASAHL, PLT","N-acylethanolamine-hydrolyzing acid amidase","1","6DXW"
"6DXX",,"X-RAY DIFFRACTION",3.04,59.54,"VAPOR DIFFUSION",,"0.2 M NaSCN and 20 % PEG 3350",293,"10.1073/pnas.1811759115","WTF","6DXX",120.49,"2.7","2.7","Human N-acylethanolamine-hydrolyzing acid amidase (NAAA) in complex with non-covalent benzothiazole-piperazine inhibitor ARN19702, in presence of Triton X-100","DRHHHHHHKLSPPAAPRFNVSLDSVPELRWLPVLRHYDLDLVRAAMAQVIGDRVPKWVHVLIGKVVLELERFLPQPFTGEIRGMCDFMNLSLADCLLVNLAYESSVF","Homo sapiens","NAAA, ASAHL, PLT","N-acylethanolamine-hydrolyzing acid amidase subunit alpha","1","6DXX"
,,,,,,,,,,,,,,,,"CTSIVAQDSRGHIYHGRNLDYPFGNVLRKLTVDVQFLKNGQIAFTGTTFIGYVGLWTGQSPHKFTVSGDERDKGWWWENAIAALFRRHIPVSWLIRATLSESENFEAAVGKLAKTPLIADVYYIVGGTSPREGVVITRNRDGPADIWPLDPLNGAWFRVETNYDHWKPAPKEDDRRTSAIKALNATGQANLSLEALFQILSVVPVYNNFTIYTTVMSAGSPDKYMTRIRNPSRK","Homo sapiens","NAAA, ASAHL, PLT","N-acylethanolamine-hydrolyzing acid amidase subunit beta","2","6DXX"
"6DY7",,"X-RAY DIFFRACTION",2.12,42.03,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1016/j.celrep.2019.02.047","HH7","6DY7",33.95,"1.9","1.9","WDR5 in complex with a WIN site inhibitor","VKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6DY7"
"6DYA",,"X-RAY DIFFRACTION",2.22,44.63,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 6.0, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1016/j.celrep.2019.02.047",,"6DYA",34.2,"2.56","2.56","WDR5 in complex with a WIN site inhibitor","PVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6DYA"
"6DYZ",,"X-RAY DIFFRACTION",2.9,58.07,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM HEPES, pH 7.0, 10% w/v PEG6000",295,"10.1021/acs.jmedchem.8b01642","OS2","6DYZ",33.79,"1.62","1.62","Crystal structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase in complex with (3R,4S)-1-((4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4-((prop-2-yn-1-ylthio)methyl)pyrrolidin-3-ol","MHHHHHHENLYFQSMASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","6DYZ"
"6DZ0",,"X-RAY DIFFRACTION",2.9,57.13,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM HEPES, pH 7.0, 10% w/v PEG6000",295,"10.1021/acs.jmedchem.8b01642","OS3","6DZ0",33.91,"1.62","1.62","Crystal structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase in complex with (3R,4S)-1-((4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4-((pent-4-yn-1-ylthio)methyl)pyrrolidin-3-ol","MHHHHHHENLYFQSMASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","6DZ0"
"6DZ2",,"X-RAY DIFFRACTION",2.2,42.86,"VAPOR DIFFUSION, SITTING DROP",4.6,"100 mM sodium acetate trihydrate, pH 4.6, 2.0 M sodium chloride",295,"10.1021/acs.jmedchem.8b01642","OS5","6DZ2",101.62,"1.99","1.99","Crystal structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase in complex with (3R,4S)-1-((4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4-(((3-(1-benzyl-1H-1,2,3-triazol-4-yl)propyl)thio)methyl)pyrrolidin-3-ol","MHHHHHHENLYFQSMASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","6DZ2"
"6DZ3",,"X-RAY DIFFRACTION",2.2,42.61,"VAPOR DIFFUSION, SITTING DROP",4.6,"100 mM sodium acetate trihydrate, pH 4.6, 2.0 M sodium chloride",295,"10.1021/acs.jmedchem.8b01642","OS6","6DZ3",101.36,"1.91","1.91","Crystal structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase in complex with (3R,4S)-1-((4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4-(((3-(1-butyl-1H-1,2,3-triazol-4-yl)propyl)thio)methyl)pyrrolidin-3-ol","MHHHHHHENLYFQSMASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","6DZ3"
"6DZ6",,"X-RAY DIFFRACTION",1.76,30.2,"VAPOR DIFFUSION",6,"16% MPD - 18% MPD",298,"10.1194/jlr.M089441",,"6DZ6",18.69,"3","3","Structure of the Orthorhombic (Orthrhmb) Crystal Form of Human Apolipoprotein C1","MRLFLSLPVLVVVLSIVLEGPAPAQGTPDVSSALDKLKEFGNTLEDKARELISRIKQSELSAKMREWFSETFQKVKEKLKIDS","Homo sapiens","APOC1","Apolipoprotein C-I","1","6DZ6"
"6DZH",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7.5,"5.9% stabilization buffer (20 mM HEPES, 50 mM NaCl, 20 mM MgCl2, pH 7.5)
188.2 mM Calcium Acetate
18.8% PEG 3350
Crystals were grown in 2uL by 2uL drops of mother liquor to protein (7.7mg/mL)
Cryoprotectant for crystal diffraction: 70% mother liquor and 30% glycerol",291.15,"10.1016/j.celrep.2019.07.026",,"6DZH",58.55,"1.95","1.95","HRAS G13D bound to GDP (H13GDP)","MTEYKLVVVGAGDVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","6DZH"
"6DZN",,"X-RAY DIFFRACTION",2.29,46.24,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M citric acid pH 5.0, 1 M LiCl and 20% (w/v) polyethylene glycol 6000",277.15,"10.1016/j.celrep.2018.08.009",,"6DZN",47.66,"2.1","2.1","Pan-ebolavirus human antibody ADI-15878 Fab","DIVLTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGEAPKLLISDASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYYSSPIFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGEC","Homo sapiens",,"Antibody ADI-15878, light chain","1","6DZN"
,,,,,,,,,,,,,,,,"QVQLVQSGVTLVQPGGSLRVSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGLGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDHRVWAAGYHFDYWGQGALVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD","Homo sapiens",,"Antibody ADI-15878, heavy chain","2","6DZN"
"6DZR",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 200 mM Ammonium Acetate, 40 mM Ammonium Sulfate",278,"10.1016/j.chembiol.2019.05.010",,"6DZR",48.05,"2.4","2.4","Crystal structure of h38C2 K99R mutation","EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMSWVRQSPEKGLEWVSEIRLRSDNYATHYAESVKGRFTISRDNSKNTLYLQMNSLRAEDTGIYYCRTYFYSFSYWGQGTLVTVSSASTKGPSVFPLAPSSKATSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKS","Homo sapiens",,"h38c2 heavy chain","1","6DZR"
,,,,,,,,,,,,,,,,"ELQMTQSPSSLSASVGDRVTITCRSSQSLLHTYGSPYLNWYLQKPGQSPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFAVYFCSQGTHLPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"h38c2 light chain","2","6DZR"
"6E07",,"X-RAY DIFFRACTION",2.9,57.5,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M AMMONIUM CITRATE TRIBASIC 20%
 W/V PEG 3350 0.5 MM AG1, PH 7.0, VAPOR DIFFUSION, SITTING DROP,
 TEMPERATURE 293K",293,"10.1038/s41467-018-06447-z",,"6E07",483.69,"2.6","2.6","Crystal structure of Canton G6PD in complex with structural NADP","MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELLEAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","6E07"
"6E08",,"X-RAY DIFFRACTION",2.39,48.52,"VAPOR DIFFUSION, SITTING DROP",7.3,"20% w/v PEG 3350, 0.2 M potassium formate",293,"10.1038/s41467-018-06447-z",,"6E08",60.54,"1.9","1.9","Crystal structure of G6PD in complex with structural NADP","MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","6E08"
"6E0E",,"X-RAY DIFFRACTION",2.91,57.74,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes pH7.0, 27% PEG1500",293,"10.1016/j.bmc.2019.115232",,"6E0E",50.75,"2.7","2.7","Crystal structure of Glucokinase in complex with compound 6","TLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKAC","Homo sapiens","GCK","Glucokinase","1","6E0E"
"6E0I",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH7.5, 28% PEG3350",293,"10.1016/j.bmc.2019.115232",,"6E0I",52.3,"1.9","1.9","Crystal structure of Glucokinase in complex with compound 72","MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACK","Homo sapiens","GCK","Glucokinase","1","6E0I"
"6E0R",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION",,"16.75% PEG 3350, 2.% Tacsimate pH 7.0, 0.1M Tris Cl",293,"10.1021/acs.jmedchem.8b01630","HKJ","6E0R",36.5,"2.303","2.303","hALK in complex with compound 7 N-((1S)-1-(5-fluoropyridin-2-yl)ethyl)-1-(5-methyl-1H-pyrazol-3-yl)-3-(oxetan-3-ylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-6-amine","GAMGSTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVE","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","6E0R"
"6E1A",,"X-RAY DIFFRACTION",4.02,69.42,"VAPOR DIFFUSION, SITTING DROP",6.5,"2.0 M sodium chloride, 90.9 M Bis-Tris pH 6.5, 0.182 M Magnesium chloride, 9 mM Praseodymium Acetate",277,"10.1021/acs.jmedchem.9b00021",,"6E1A",63.31,"3.1","3.1","Menin bound to M-89","SGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGEERPGEQSQGTQSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSGTVAGTARGPEGGSTAQVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVSTPSDYTLSFLKRQRKGL","Homo sapiens","MEN1, SCG2","Menin","1","6E1A"
"6E1F",,"X-RAY DIFFRACTION",1.7,27.75,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris, pH 6.5, 0.1 M potassium chloride, 1.5 M ammonium sulfate",293,,,"6E1F",41.13,"1.16","1.16","Crystal structure of the SWIRM domain of human histone lysine-specific demethylase LSD1","GPGSLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIY","Homo sapiens","KDM1A, AOF2, KDM1, KIAA0601, LSD1","Lysine-specific histone demethylase 1A","1","6E1F"
"6E1Y",,"X-RAY DIFFRACTION",2.36,47.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Bis-Tris pH 6.0 or Hepes pH 7.5, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1016/j.celrep.2019.02.047","HLM","6E1Y",69.5,"1.219","1.219","Discovery of Potent 2-Aryl-6,7-Dihydro-5HPyrrolo[ 1,2-a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6E1Y"
"6E1Z",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes pH 7.5, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1016/j.celrep.2019.02.047","HLP","6E1Z",69.17,"1.1","1.1","Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with picomolar affinity","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6E1Z"
"6E22",,"X-RAY DIFFRACTION",2.15,43.05,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 6.0 or Hepes pH 7.5, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1016/j.celrep.2019.02.047","HLS","6E22",69.75,"1.6","1.6","Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with picomolar affinity","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6E22"
"6E23",,"X-RAY DIFFRACTION",2.15,42.9,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris pH 6.0 or Hepes pH 7.5, 0.2 M ammonium acetate, 28% to 32% PEG3350",293,"10.1016/j.celrep.2019.02.047","HLJ","6E23",70.02,"1.66","1.66","Displacement of WDR5 from chromatin by a pharmacological WIN site inhibitor with picomolar affinity","SATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","6E23"
"6E25",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA118.004821",,"6E25",11.33,,,"NMR solution structure of the CARD9 CARD bound to zinc","MSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGK","Homo sapiens","CARD9","Caspase recruitment domain-containing protein 9","1","6E25"
"6E26",,"SOLUTION NMR",,,,,,,"10.1074/jbc.RA118.004821",,"6E26",11.26,,,"NMR solution structure of the CARD9 CARD","MSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGK","Homo sapiens","CARD9","Caspase recruitment domain-containing protein 9","1","6E26"
"6E27",,"X-RAY DIFFRACTION",2.15,42.89,"VAPOR DIFFUSION, SITTING DROP",7,"5% v/v Tacsimate, 0.1 M HEPES pH 7.0, 10% w/v Polyethylene glycol monomethyl ether 5,000",292,"10.1074/jbc.RA118.004821",,"6E27",22.45,"1.811","1.811","The CARD9 CARD domain-swapped dimer with a zinc ion bound to one of the two zinc binding sites","GSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGK","Homo sapiens","CARD9","Caspase recruitment domain-containing protein 9","1","6E27"
"6E28",,"X-RAY DIFFRACTION",2.06,40.31,"VAPOR DIFFUSION, SITTING DROP",7,"1.1 M Ammonium tartrate dibasic, pH 7.0",292,"10.1074/jbc.RA118.004821",,"6E28",22.38,"1.36","1.36","The CARD9 CARD domain-swapped dimer","GSDYENDDECWSVLEGFRVTLTSVIDPSRITPYLRQCKVLNPDDEEQVLSDPNLVIRKRKVGVLLDILQRTGHKGYVAFLESLELYYPQLYKKVTGK","Homo sapiens","CARD9","Caspase recruitment domain-containing protein 9","1","6E28"
"6E2M",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG 400, 3% PPG 400, 100mM Bis-Tris pH 7.5, 10mM TCEP",293,"10.1172/JCI99768","KK7","6E2M",66.97,"2.253","2.253","ASK1 kinase domain complex with inhibitor","GSRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","6E2M"
"6E2N",,"X-RAY DIFFRACTION",2.51,51.09,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG 400, 100mM Bis-Tris pH 7.5, 3% PPG 400, 10mM TCEP",293,"10.1172/JCI99768","KK8","6E2N",67.17,"2.098","2.098","ASK1 kinase domain complex with inhibitor","GSRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","6E2N"
"6E2O",,"X-RAY DIFFRACTION",2.56,52.04,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG 400, 3% PPE 400, 100mM Bis-Tris pH 7.5, 10mM TCEP",293,"10.1172/JCI99768","S0L","6E2O",67.23,"2.389","2.389","ASK1 kinase domain complex with inhibitor","GSRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","6E2O"
"6E35",,"X-RAY DIFFRACTION",2.9,56,"MICROBATCH",5,"Protein solution: IDO1 (45 mg/ml), 10 mM IDE, 1.5 mM L-Trp, 5 mM KCN in 10 mM MES (pH 6.5), and 25 mM NaCl.

Precipitation Reagent: 20% (W/V) PEG 4000, 0.1 M Sodium Acetate (pH 5), and 0.1 M Ammonium chloride.",277,,,"6E35",97.44,"2.411","2.411","Crystal structure of human indoleamime 2,3-dioxygenase (IDO1) in complex with L-Trp and cyanide, Northeast Structural Genomics Target HR6160","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6E35"
"6E3E",,"X-RAY DIFFRACTION",3.56,65.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"2%MPD, 1.2M NaFormate, 0.1M Hepes 7.5",291,"10.1021/acs.jmedchem.8b01181",,"6E3E",51.85,"2.47","2.47","Structure of RORgt in complex with a novel inverse agonist.","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVE","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6E3E"
"6E3Z",,"X-RAY DIFFRACTION",2.52,51.13,"VAPOR DIFFUSION",6.25,"17% PEG-4000, 0.1 M MES",293,,,"6E3Z",146.19,"1.94","1.94","Structure of Bace-1 in complex with Ligand 8","MHHHHHHTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGTTGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6E3Z"
"6E40",,"X-RAY DIFFRACTION",2.53,51.35,"EVAPORATION",6.2,"0.1 M phosphate (pH 6.2), and 15% (w/v) PEG3350",298,"10.1107/S2053230X18012955","BBJ","6E40",184.98,"2.306","2.306","Crystal structure of the indoleamine 2,3-dioxygenase 1 (IDO1) in complexed with ferric heme and Epacadostat","MGSSHHHHHHSSGSAAYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSAALELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6E40"
"6E41",,"X-RAY DIFFRACTION",2.57,52.12,"EVAPORATION",6.2,"0.1 M phosphate (pH 6.2), and 15% (w/v) PEG3350",298,"10.1107/S2053230X18012955","HQS","6E41",186.4,"2.291","2.291","CRYSTAL STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) in complex with ferric heme and an Epacadostat analog","MGSSHHHHHHSSGSAAYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSAALELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6E41"
"6E42",,"X-RAY DIFFRACTION",2.44,49.65,"EVAPORATION",6.2,"0.1 M phosphate (pH 6.2), and 15% (w/v) PEG3350",298,"10.1107/S2053230X18012955",,"6E42",186.62,"2.103","2.103","CRYSTAL STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) in complex with ferric heme and 4-Chlorophenyl imidazole","MGSSHHHHHHSSGSAAYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSAALELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6E42"
"6E43",,"X-RAY DIFFRACTION",2.55,51.7,"EVAPORATION",6.2,"0.1 M phosphate (pH 6.2), and 15% (w/v) PEG3350",298,"10.1107/S2053230X18012955",,"6E43",183.55,"1.705","1.705","Crystal structure of human indoleamine 2,3-dioxygenase 1 (IDO1) in complex with a BMS-978587 analog","MGSSHHHHHHSSGSAAYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSAALELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6E43"
"6E44",,"X-RAY DIFFRACTION",2.51,51.04,"EVAPORATION",6.2,"0.1 M phosphate (pH 6.2), and 15% (w/v) PEG3350",298,"10.1107/S2053230X18012955",,"6E44",183.95,"1.903","1.903","CRYSTAL STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) free enzyme in the ferric state","MGSSHHHHHHSSGSAAYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSAALELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6E44"
"6E45",,"X-RAY DIFFRACTION",2.5,50.84,"EVAPORATION",6.2,"0.1 M phosphate (pH 6.2), and 15% (w/v) PEG3350",298,"10.1107/S2053230X18012955",,"6E45",184.41,"2","2","CRYSTAL STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) free enzyme in the ferrous state","MGSSHHHHHHSSGSAAYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSAALELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6E45"
"6E46",,"X-RAY DIFFRACTION",2.48,50.46,"EVAPORATION",6.2,"0.1 M phosphate (pH 6.2), and 15% (w/v) PEG3350",298,"10.1107/S2053230X18012955",,"6E46",184.68,"2.09","2.09","CRYSTAL STRUCTURE OF HUMAN INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) in complex with ferrous heme and tryptophan","MGSSHHHHHHSSGSAAYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSAALELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6E46"
"6E4A",,"X-RAY DIFFRACTION",1.93,36.11,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM TrisHCl pH 8.5, 25% PEG 3350",297,"10.1016/j.bmcl.2018.08.039","HRY","6E4A",32,"1.26","1.26","Crystal structure of human BRD4(1) in complex with CN750","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6E4A"
"6E4F",,"X-RAY DIFFRACTION",2.14,42.4,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M imidazole pH 7.0
16% (w/v) PEG 4000
12.5% ethylene glycol",277,"10.1158/2159-8290.CD-17-1409","HRA","6E4F",34.45,"1.15","1.15","Crystal structure of ARQ 531 in complex with the kinase domain of BTK","MHHHHHHGGGENLYFQGTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6E4F"
"6E4L",,"X-RAY DIFFRACTION",2.71,54.69,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG 3350, 150 MM POTASSIUM ACETATE, 0.1 M TRIS, pH 8.0",291,"10.1038/s41589-019-0262-1",,"6E4L",41.97,"1.6","1.6","The structure of the N-terminal domain of human clathrin heavy chain 1 (nTD) in complex with ES9","GSPEFMAQILPIRFQEHLQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASKVIALKAGKTLQIFNIEMKSKMKAHTMTDDVTFWKWISLNTVALVTDNAVYHWSMEGESQPVKMFDRHSSLAGCQIINYRTDAKQKWLLLTGISAQQNRVVGAMQLYSVDRKVSQPIEGHAASFAQFKMEGNAEESTLFCFAVRGQAGGKLHIIEVGTPPTGNQPFPKKAVDVFFPPEAQNDFPVAMQISEKHDVVFLITKYGYIHLYDLETGTCIYMNRISGETIFVTAPHEATAGIIGVNRKGQVLSVCVEEENIIPYITNVLQNPDLALRMAVRNNLAGAEELF","Homo sapiens","CLTC, CLH17, CLTCL2, KIAA0034","Clathrin heavy chain 1","1","6E4L"
"6E50",,"X-RAY DIFFRACTION",2.26,45.49,"EVAPORATION",,"PEG 4000, sodium acetate, Ammonium acetate",298,"10.1021/jacs.9b04664",,"6E50",15.75,"1.965","1.965","Crystal structure of the apo domain-swapped dimer Q108K:K40L:T51F mutant of human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKFKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6E50"
"6E51",,"X-RAY DIFFRACTION",2.29,46.34,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, ammonium acetate, Sodium acetate",298,"10.1021/jacs.9b04664",,"6E51",15.67,"2.256","2.256","Crystal structure of the apo domain-swapped dimer Q108K:K40L:T51W mutant of human cellular retinol binding protein II","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKWKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6E51"
"6E5A",,"X-RAY DIFFRACTION",2.62,52.97,"VAPOR DIFFUSION, SITTING DROP",8,"1 M Na Citrate",289,"10.1016/j.ejmech.2019.02.034",,"6E5A",63.12,"2.4","2.4","PPARg in complex with compound 4b","NPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6E5A"
"6E5E",,"X-RAY DIFFRACTION",2.26,45.69,"VAPOR DIFFUSION, HANGING DROP",,"4000 PEG, sodium acetate, ammonium acetate",298,"10.1021/jacs.9b04664",,"6E5E",15.85,"1.696","1.696","Crystal structure of the apo domain-swapped dimer Q108K:T51D mutant of human cellular retinol binding protein II","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6E5E"
"6E5G",,"X-RAY DIFFRACTION",2.53,51.31,"VAPOR DIFFUSION, HANGING DROP",,"2.4-2.8 M sodium formate, HEPES, pH 7.2- 7.4",294,"10.1016/j.chembiol.2018.11.010",,"6E5G",53.99,"2.43","2.43","Crystal structure of human TEAD2-Yap binding domain covalently bound to an allosteric regulator","GSHMAWQARGLGTARLQLVEFSAFVEPPDAVDSYQRHLFVHISQHCPSPGAPPLESVDVRQIYDKFPEKKGGLRELYDRGPPHAFFLVKFWADLNWGPSGEEAGAGGSISSGGFYGVSSQYESLEHMTLTCSSKVCSFGKQVVEKVETERAQLEDGRFVYRLLRSPMCEYLVNFLHKLRQLPERYMMNSVLENFTILQVVTNRDTQELLLCTAYVFEVSTSERGAQHHIYRLVRD","Homo sapiens","TEAD2, TEF4","Transcriptional enhancer factor TEF-4","1","6E5G"
"6E5L",,"X-RAY DIFFRACTION",2.12,41.87,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M BisTris, pH 5.5, and 25% PEG 3350",295,"10.1021/acschembio.8b01070","HVD","6E5L",16.88,"1.17","1.17","Crystal structure of human cellular retinol binding protein 1 in complex with abnormal-cannabidiol (abn-CBD)","PVDFTGYWKMLVNENFEEYLRALDVNVALRKIANLLKPDKEIVQDGDHMIIRTLSTFRNYIMDFQVGKEFEEDLTGIDDRKCMTTVSWDGDKLQCVQKGEKEGRGWTQWIEGDELHLEMRVEGVVCKQVFKKVQHHHHHH","Homo sapiens","RBP1, CRBP1","Retinol-binding protein 1","1","6E5L"
"6E5Q",,"X-RAY DIFFRACTION",2.24,45.02,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, sodium acetate, ammonium acetete",298,"10.1021/jacs.9b04664",,"6E5Q",15.92,"1.99","1.99","Crystal structure of the apo domain-swapped dimer Q108K:T51D:A28H mutant of human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFHTRKIAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6E5Q"
"6E5R",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, ammonium acetate, sodium acetate",298,"10.1021/jacs.9b04664",,"6E5R",31.93,"2.592","2.592","Crystal structure of the apo domain-swapped dimer Q108K:T51D:A28C mutant of human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFCTRKIAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6E5R"
"6E5S",,"X-RAY DIFFRACTION",2.3,46.61,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, sodium acetate, Ammonium acetate",298,"10.1021/jacs.9b04664",,"6E5S",189.34,"2.061","2.061","Crystal structure of holo retinal-bound domain-swapped dimer Q108K:T51D mutant of human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6E5S"
"6E5T",,"X-RAY DIFFRACTION",2.11,41.77,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 m BisTris, pH 5.5, 25% PEG 3350",297,"10.1021/acschembio.8b01070","HVJ","6E5T",16.83,"1.55","1.55","Crystal structure of human cellular retinol binding protein 1 in complex with abnormal-cannabidiorcin (Abn-CBDO)","PVDFTGYWKMLVNENFEEYLRALDVNVALRKIANLLKPDKEIVQDGDHMIIRTLSTFRNYIMDFQVGKEFEEDLTGIDDRKCMTTVSWDGDKLQCVQKGEKEGRGWTQWIEGDELHLEMRVEGVVCKQVFKKVQHHHHHH","Homo sapiens","RBP1, CRBP1","Retinol-binding protein 1","1","6E5T"
"6E5V",,"X-RAY DIFFRACTION",2.21,44.44,"VAPOR DIFFUSION, SITTING DROP",,"100mM Bis-Tris, pH 6.5, 27% PEG 3350, 200mM Sodium Acetate",294,"10.1021/acs.jmedchem.8b01120","HVG","6E5V",118.21,"2.95","2.95","human mGlu8 receptor amino terminal domain in complex with (S)-3,4-Dicarboxyphenylglycine (DCPG)","MALVCEGKRSASCPCFFLLTAKFYWILTMMRTHSQEYAHSIRVDGDIILGGLFPVHAKGERGVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFVQALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFKIPQISYASTAPELSDNTRYDFFSRVVPPDSYQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISREIGGVSIAQSQKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQSGHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTLANNRRNVWFAEFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEGKVQFVIDAVYSMAYALHNMHKDLCPGYIGLCPRMSTIDGKELLGYIRAVNFNGSAGTPVTFNENGDAPGRYDIFQYQITNKSTEYKVIGHWTNQLHLKVEDMQWAHRENLYFQGEGHHHHHH","Homo sapiens","GRM8, GPRC1H, MGLUR8","Metabotropic glutamate receptor 8","1","6E5V"
"6E5W",,"X-RAY DIFFRACTION",2.91,57.78,"VAPOR DIFFUSION, SITTING DROP",5,"0.2M sodium malonate, pH 5.0 20% PEG 3350",297,"10.1021/acschembio.8b01070",,"6E5W",67.31,"2.5","2.5","Crystal structure of human cellular retinol binding protein 3 in complex with abnormal-cannabidiol (abn-CBD)","MPPNLTGYYRFVSQKNMEDYLQALNISLAVRKIALLLKPDKEIEHQGNHMTVRTLSTFRNYTVQFDVGVEFEEDLRSVDGRKCQTIVTWEEEHLVCVQKGEVPNRGWRHWLEGEMLYLELTARDAVCEQVFRKVRLVPR","Homo sapiens","RBP5","Retinol-binding protein 5","1","6E5W"
"6E5Z",,"X-RAY DIFFRACTION",3.06,59.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES-Na, 1.5M Tri-sodium citrate dihydrate pH=7.5",298,"10.1016/j.bbrc.2018.08.190",,"6E5Z",20.17,"1.35","1.35","Crystal structure of human DJ-1 with a natural modification on Cys-106","GAMASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein/nucleic acid deglycase DJ-1","1","6E5Z"
"6E65",,"X-RAY DIFFRACTION",2.42,49.08,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES, pH 7.5, 10% (v/v) 2-propanol, 20% (w/v) PEG 4000",293,"10.1038/s41467-018-06742-9",,"6E65",47.01,"1.5","1.5","Crystal structure of malaria transmission-blocking antibody TB31F","NFMLTQPHSVSESPGKTVTISCTRSTGNIGSNYVSWYQQRPGSSPTTVIYRDDQRPSGVPDRFSGSIDRSSNSASLTISGLKTEDEADYYCHSYSTGMYIFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTEC","Homo sapiens",,"TB31F Fab light chain","1","6E65"
,,,,,,,,,,,,,,,,"EVQLVQSGGGLVQPGGSLRLSCAASGFTFNNYWMSWVRQAPGKGLEWVSSISNIGGTIYYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCTRDLRMSDYFDYWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"TB31F Fab heavy chain","2","6E65"
"6E68",,"X-RAY DIFFRACTION",2.47,50.3,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Sodium phosphate, pH 9.0, 28% polyethylene glycol 3350, 0.2 M NaCl",292,,,"6E68",109.99,"1.5","1.5","NAMPT co-crystal with inhibitor compound 2","EFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELE","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","6E68"
"6E69",,"X-RAY DIFFRACTION",2.94,58.15,"VAPOR DIFFUSION, SITTING DROP",5,"0.3 M ammonium citrate, pH 5.0, 14% w/v PEG3350",295,"10.1073/pnas.1909972116",,"6E69",98.01,"2.33","2.33","Ortho-substituted phenyl sulfonyl fluoride and fluorosulfate as potent elastase inhibitory fragments","IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ","Homo sapiens","ELANE, ELA2","Neutrophil elastase","1","6E69"
"6E6C",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7.5,"128 mM Calcium acetate, 20.8% PEG 3350, 20% stabilization buffer (20 mM HEPES, 50 mM NaCl, 20 mM MgCl2, at pH 7.5), Crystals were grown in 2uL by 2 uL drops of mother liquor to protein (22 mg/mL), Cryoprotectant: 70% glycerol and 30% mother liquor",291.15,"10.1016/j.celrep.2019.07.026",,"6E6C",19.52,"1.9","1.9","HRAS G13D bound to GppNHp (H13GNP)","MTEYKLVVVGAGDVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","6E6C"
"6E6E",,"X-RAY DIFFRACTION",2.53,51.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Magnesium Formate Dihydrate; 15% PEG3350",293,"10.3389/fmolb.2020.00081",,"6E6E",258.04,"2.15","2.15","DGY-06-116, a novel and selective covalent inhibitor of SRC kinase","DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL","Homo sapiens","SRC, SRC1","Proto-oncogene tyrosine-protein kinase Src","1","6E6E"
"6E6F",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION, HANGING DROP",5.6,"5 mM Sodium acetate, 91 mM sodium citrate tribasic, 183 mM Ammonium acetate, 27.2% PEG 4000, 4.3% stabilization buffer (20 mM HEPES, 50 mM NaCl, 20 mM MgCl2, at pH 7.5), crystals grown 1uL by 1uL mother liquor to protein (22mg/mL), No cryoprotectant was used for diffraction",291.15,"10.1016/j.celrep.2019.07.026",,"6E6F",38.95,"3.401","3.401","KRAS G13D bound to GppNHp (K13GNP)","MTEYKLVVVGAGDVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKH","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6E6F"
"6E6G",,"X-RAY DIFFRACTION",1.81,31.86,"VAPOR DIFFUSION, HANGING DROP",5.6,"27.5% PEG 3350, 125 mM Na(OAc), 122 mM sodium citrate, 4.0% stabilization buffer (20 mM HEPES, 50 mM NaCl, 20 mM MgCl2, at pH 7.5), Crystals grown in 1uL by 1uL drops of mother liquor to protein (18 mg/mL), No cryoprotectant used for diffraction",291.15,"10.1016/j.celrep.2019.07.026",,"6E6G",19.45,"1.93","1.93","KRAS G13D bound to GDP (K13GDP)","MTEYKLVVVGAGDVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKH","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6E6G"
"6E6H",,"X-RAY DIFFRACTION",1.95,36.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"9% 2-propanol, 72 mM HEPES, 20% PEG 4000, 15% stabilization buffer (20 mM HEPES, 50 mM NaCl, 20 mM MgCl2, at pH 7.5), Crystals were grown in 1uL by 1uL drops of mother liquor to protein (12.2 mg/mL)
No cryoprotectant used for diffraction",291.15,"10.1016/j.celrep.2019.07.026",,"6E6H",19.4,"1.99","1.99","NRAS G13D bound to GppNHp (N13GNP)","MTEYKLVVVGAGDVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKCDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQY","Homo sapiens","NRAS, HRAS1","GTPase NRas","1","6E6H"
"6E6J",,"X-RAY DIFFRACTION",3.29,62.67,"VAPOR DIFFUSION, SITTING DROP",,"Protein Buffer: 10 mM HEPES, pH 7.5, 300 mM NaCl, 0.5mM TCEP
Reservoir: 20% PEG 8000, 0.2 M NaCl, 0.1 Cacodylate, pH 5.5",290,"10.1038/s41586-020-1930-8",,"6E6J",82.05,"2.44","2.44","BRD2_Bromodomain2 complex with inhibitor 744","GSHMEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6E6J"
"6E6K",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M NaCl, 0.1 M BisTris, pH 6.5, 25% PEG3350",295,"10.1021/acschembio.8b01070",,"6E6K",16.21,"1.3","1.3","Crystal structure of human cellular retinol-binding protein 4 in complex with abnormal-cannabidiol (abn-CBD)","PADLSGTWTLLSSDNFEGYMLALGIDFATRKIAKLLKPQKVIEQNGDSFTIHTNSSLRNYFVKFKVGEEFDEDNRGLDNRKCKSLVIWDNDRLTCIQKGEKKNRGWTHWIEGDKLHLEMFCEGQVCKQTFQRALVPR","Homo sapiens","RBP7","Retinoid-binding protein 7","1","6E6K"
"6E6L",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, sodium acetate,  Ammonium acetate",298,"10.1021/jacs.9b04664",,"6E6L",15.88,"2.08","2.08","Crystal structure of the holo retinal-bound domain-swapped dimer Q108K:K40L:T51F:Y60A mutant of human cellular retinol binding protein II","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTLVIDQDGDNFKFKTTSTFRNADVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6E6L"
"6E6M",,"X-RAY DIFFRACTION",2.09,41.05,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 m BisTris, pH 5.5, 25% PEG 3350",295,"10.1021/acschembio.8b01070","8CB","6E6M",50.48,"1.55","1.55","Crystal structure of human cellular retinol-binding protein 1 in complex with cannabidiorcin (CBDO)","PVDFTGYWKMLVNENFEEYLRALDVNVALRKIANLLKPDKEIVQDGDHMIIRTLSTFRNYIMDFQVGKEFEEDLTGIDDRKCMTTVSWDGDKLQCVQKGEKEGRGWTQWIEGDELHLEMRVEGVVCKQVFKKVQHHHHHH","Homo sapiens","RBP1, CRBP1","Retinol-binding protein 1","1","6E6M"
"6E6P",,"X-RAY DIFFRACTION",1.94,36.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"152 mM Calcium Acetate, 22.8% PEG 3350, 9.5% stabilization buffer (20 mM HEPES pH 7.5, 50 mM NaCl, 20 mM MgCl2), Crystals were grown in 2uL by 2 uL drops of mother liquor to protein (22 mg/mL), Cryoprotectant: 70% glycerol and 30% mother liquor",291.15,"10.1016/j.celrep.2019.07.026",,"6E6P",58.91,"1.93","1.93","HRAS G13D bound to GppNHp (Ha,b,c13GNP)","MTEYKLVVVGAGDVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","6E6P"
"6E6Z",,"X-RAY DIFFRACTION",2.19,43.72,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,,"3MI","6E6Z",25.83,"1.75","1.75","Structure of Wild Type Human Transthyretin in Complex with Tafamidis","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E6Z"
"6E70",,"X-RAY DIFFRACTION",2.29,46.27,"VAPOR DIFFUSION, HANGING DROP",,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,,"1FL","6E70",25.79,"1.992","1.992","Structure of Wild Type Human Transthyretin in Complex with Diflunisal","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E70"
"6E71",,"X-RAY DIFFRACTION",2.35,47.73,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Lithium Sulfate, 0.1M Tris, 30% (w/v) PEG 4000",298,,,"6E71",25.44,"1.5","1.5","Structure of Human Transthyretin Val30Met/Thr119Met Mutant","CPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTMAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E71"
"6E72",,"X-RAY DIFFRACTION",2.31,46.74,"VAPOR DIFFUSION, HANGING DROP",6,"0.2M Lithium Sulfate Monohydrate, 20% (w/v) PEG 3350",298,,"3MI","6E72",25.99,"1.45","1.45","Structure of Human Transthyretin Val30Met Mutant in Complex with Tafamidis","CPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E72"
"6E73",,"X-RAY DIFFRACTION",2.32,47.01,"VAPOR DIFFUSION, HANGING DROP",8,"20% (W/V) PEG-1000, 0.1M Imidazole, 0.2M Calcium Acetate",298,,"1FL","6E73",25.84,"1.797","1.797","Structure of Human Transthyretin Val30Met Mutant in Complex with Diflunisal","CPLMVKVLDAVRGSPAINVAMHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E73"
"6E74",,"X-RAY DIFFRACTION",2.35,47.59,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.05 M calcium chloride dihydrate, 0.1 M Bis-Tris, 30% PEG monomethyl ether 550",298,,"3MI","6E74",25.8,"1.6","1.6","Structure of Human Transthyretin Leu55Pro Mutant in Complex with Tafamidis","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGEPHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E74"
"6E75",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION, HANGING DROP",4.5,"30% (v/v) PEG 400, 100 mM Sodium acetate, 200 mM Calcium acetate",298,,,"6E75",25.18,"1.5","1.5","Structure of Human Transthyretin Asp38Ala Mutant","CPLMVKVLDAVRGSPAINVAVHVFRKAAADTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E75"
"6E76",,"X-RAY DIFFRACTION",2.32,47.03,"VAPOR DIFFUSION, HANGING DROP",4.5,"50% (w/v) PEG-400, 0.2M Lithium Sulfate, 0.1M Sodium Acetate",298,,,"6E76",25.68,"1.6","1.6","Structure of Human Transthyretin Asp38Ala/Thr119Met Mutant","CPLMVKVLDAVRGSPAINVAVHVFRKAAADTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTMAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E76"
"6E77",,"X-RAY DIFFRACTION",2.32,46.95,"VAPOR DIFFUSION, HANGING DROP",5.6,"2.0M Ammonium sulfate, 0.1M Sodium citrate, 0.2M Potassium sodium tartrate tetrahydrate",298,,"3MI","6E77",25.74,"1.6","1.6","Structure of Human Transthyretin Asp38Ala Mutant in Complex with Tafamidis","CPLMVKVLDAVRGSPAINVAVHVFRKAAADTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E77"
"6E78",,"X-RAY DIFFRACTION",2.35,47.61,"VAPOR DIFFUSION, HANGING DROP",4.5,"30% (W/V) PEG-400, 0.1M Sodium Acetate, 0.2M Calcium Acetate",298,,"1FL","6E78",25.72,"1.499","1.499","Structure of Human Transthyretin Asp38Ala Mutant in Complex with Diflunisal","CPLMVKVLDAVRGSPAINVAVHVFRKAAADTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6E78"
"6E7F",,"X-RAY DIFFRACTION",3.05,65.17,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium citrate, pH 3.5, 0.8 M (NH4)2 SO4, 1 mM AMPPNP, 1 mM MnCl2, 0.73 mM Inositol (1,3,4,6)tetra phosphate (IP4)",298,"10.1038/s41598-018-34941-3",,"6E7F",64.02,"2.5","2.5","Crystal Structure of Human Inositol Polyphosphate Multikinase (IPMK) Catalytic Core Domain","MHHHHHHENLYFQGMDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQPTTTKLNDRTLAEKFLSGGGGSGGGGSQEIAEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase","1","6E7F"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"6E7M",,"X-RAY DIFFRACTION",2.19,43.82,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, ammonium acetate, sodium acetate",298,"10.1021/jacs.9b04664",,"6E7M",64.01,"2.7","2.7","Crystal structure of the holo retinal-bound domain-swapped dimer Q108K:T51D:A28C mutant of human Cellular Retinol Binding Protein II","TRDQNGTWEMESNENFEGYMKALDIDFCTRKIAVRLTQTKVIDQDGDNFKDKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","6E7M"
"6E7O",,"X-RAY DIFFRACTION",2.36,48,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M lithium sulfate, 0.1 M sodium acetate pH 4.5, 30% PEG8000, 4% propanediol",293,"10.1038/s42003-018-0262-9",,"6E7O",90.67,"3","3","Crystal structure of deglycosylated human EPDR1","SAPRPCQAPQQWEGRQVMYQQSSGRNSRALLSYDGLNQRVRVLDERKALIPCKRLFEYILLYKDGVMFQIDQATKQCSKMTLTQPWDPLDIPQNSTFEDQYSIGGPQEQITVQEWSDRKSARSYETWIGIYTVKDCYPVQETFTINYSVILSTRFFDIQLGIKDPSVFTPPSTCQMAQLEKMSEDCSWHHHHHH","Homo sapiens","EPDR1, MERP1, UCC1","Mammalian ependymin-related protein 1","1","6E7O"
"6E7P","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-06493-7",,"6E7P",263.34,"3.5, 3.5",,"cryo-EM structure of human TRPML1 with PI35P2","MTAPAGPRGSETERLLTPNPGYGTQAGPSPAPPTPPEEEDLRRRLKYFFMSPCDKFRAKGRKPCKLMLQVVKILVVTVQLILFGLSNQLAVTFREENTIAFRHLFLLGYSDGADDTFAAYTREQLYQAIFHAVDQYLALPDVSLGRYAYVRGGGDPWTNGSGLALCQRYYHRGHVDPANDTFDIDPMVVTDCIQVDPPERPPPPPSDDLTLLESSSSYKNLTLKFHKLVNVTIHFRLKTINLQSLINNEIPDCYTFSVLITFDNKAHSGRIPISLETQAHIQECKHPSVFQHGDNSFRLLFDVVVILTCSLSFLLCARSLLRGFLLQNEFVGFMWRQRGRVISLWERLEFVNGWYILLVTSDVLTISGTIMKIGIEAKNLASYDVCSILLGTSTLLVWVGVIRYLTFFHNYNILIATLRVALPSVMRFCCCVAVIYLGYCFCGWIVLGPYHVKFRSLSMVSECLFSLINGDDMFVTFAAMQAQQGRSSLVWLFSQLYLYSFISLFIYMVLSLFIALITGAYDTIKHPGGAGAEESELQAYIAQCQDSPTSGKFRRGSGSACSLLCCCGRDPSEEHSLLVN","Homo sapiens","MCOLN1, ML4, MSTP080, TRPML1","Mucolipin-1","1","6E7P"
"6E7Y","3.57","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-06493-7",,"6E7Y",263.33,"3.57, 3.57",,"cryo-EM structure of human TRPML1 with PI45P2","MTAPAGPRGSETERLLTPNPGYGTQAGPSPAPPTPPEEEDLRRRLKYFFMSPCDKFRAKGRKPCKLMLQVVKILVVTVQLILFGLSNQLAVTFREENTIAFRHLFLLGYSDGADDTFAAYTREQLYQAIFHAVDQYLALPDVSLGRYAYVRGGGDPWTNGSGLALCQRYYHRGHVDPANDTFDIDPMVVTDCIQVDPPERPPPPPSDDLTLLESSSSYKNLTLKFHKLVNVTIHFRLKTINLQSLINNEIPDCYTFSVLITFDNKAHSGRIPISLETQAHIQECKHPSVFQHGDNSFRLLFDVVVILTCSLSFLLCARSLLRGFLLQNEFVGFMWRQRGRVISLWERLEFVNGWYILLVTSDVLTISGTIMKIGIEAKNLASYDVCSILLGTSTLLVWVGVIRYLTFFHNYNILIATLRVALPSVMRFCCCVAVIYLGYCFCGWIVLGPYHVKFRSLSMVSECLFSLINGDDMFVTFAAMQAQQGRSSLVWLFSQLYLYSFISLFIYMVLSLFIALITGAYDTIKHPGGAGAEESELQAYIAQCQDSPTSGKFRRGSGSACSLLCCCGRDPSEEHSLLVN","Homo sapiens","MCOLN1, ML4, MSTP080, TRPML1","Mucolipin-1","1","6E7Y"
"6E7Z","3.73","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-06493-7",,"6E7Z",264.79,"3.73, 3.73",,"cryo-EM structure of human TRPML1 with ML-SA1 and PI35P2","MTAPAGPRGSETERLLTPNPGYGTQAGPSPAPPTPPEEEDLRRRLKYFFMSPCDKFRAKGRKPCKLMLQVVKILVVTVQLILFGLSNQLAVTFREENTIAFRHLFLLGYSDGADDTFAAYTREQLYQAIFHAVDQYLALPDVSLGRYAYVRGGGDPWTNGSGLALCQRYYHRGHVDPANDTFDIDPMVVTDCIQVDPPERPPPPPSDDLTLLESSSSYKNLTLKFHKLVNVTIHFRLKTINLQSLINNEIPDCYTFSVLITFDNKAHSGRIPISLETQAHIQECKHPSVFQHGDNSFRLLFDVVVILTCSLSFLLCARSLLRGFLLQNEFVGFMWRQRGRVISLWERLEFVNGWYILLVTSDVLTISGTIMKIGIEAKNLASYDVCSILLGTSTLLVWVGVIRYLTFFHNYNILIATLRVALPSVMRFCCCVAVIYLGYCFCGWIVLGPYHVKFRSLSMVSECLFSLINGDDMFVTFAAMQAQQGRSSLVWLFSQLYLYSFISLFIYMVLSLFIALITGAYDTIKHPGGAGAEESELQAYIAQCQDSPTSGKFRRGSGSACSLLCCCGRDPSEEHSLLVN","Homo sapiens","MCOLN1, ML4, MSTP080, TRPML1","Mucolipin-1","1","6E7Z"
"6E87",,"X-RAY DIFFRACTION",3.75,67.16,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES, 2 M ammonium sulfate, 2% PEG400",295,"10.1021/acs.biochem.9b00006",,"6E87",23.66,"1.952","1.952","Crystal structure of ferrous form of the crosslinked human cysteine dioxygenase in the anaerobic condition","SEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSVGLHRVENISHTEPAVSLHLYSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN","Homo sapiens","CDO1","Cysteine dioxygenase type 1","1","6E87"
"6E8F",,"X-RAY DIFFRACTION",5.14,76.06,"VAPOR DIFFUSION, SITTING DROP",,"40% MPD, 0.2 M Lithium Chloride, 0.01 M Adenosine triphosphate disodium",277,"10.1073/pnas.1920444117",,"6E8F",121.79,"2.99","2.99","Crystal Structure of Human Protocadherin-15 EC3-5 CD2-1","MPMFLPCVLVPNTRDCRPLTYQAAIPELRTPEELNPIIVTPPIQAIDQDRNIQPPSDRPGILYSILVGTPEDYPRFFHMHPRTAELSLLEPVNRDFHQKFDLVIKAEQDNGHPLPAFAGLHIEILDENNQSPYFTMPSYQGYILESAPVGATISDSLNLTSPLRIVALDKDIEDVPPSGVPTKDPELHLFLNDYTSVFTVTQTGITRYLTLLQPVDREEQQTYTFSITAFDGVQESEPVIVNIQVMDANDNTPTFPEISYDVYVYTDMRPGDSVIQLTAVDADEGSNGEITYEILVGAQGDFIINKTTGLITIAPGVEMIVGRTYALTVQAADNAPPAERRNSICTVYIEVLPPLEHHHHHH","Homo sapiens","PCDH15, USH1F","Protocadherin-15","1","6E8F"
"6E8N",,"X-RAY DIFFRACTION",3.07,60,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M zinc acetate",293,"10.1038/s42003-018-0262-9",,"6E8N",46.17,"3.2","3.2","Crystal structure of glycosylated human EPDR1","SAPRPCQAPQQWEGRQVMYQQSSGRNSRALLSYDGLNQRVRVLDERKALIPCKRLFEYILLYKDGVMFQIDQATKQCSKMTLTQPWDPLDIPQNSTFEDQYSIGGPQEQITVQEWSDRKSARSYETWIGIYTVKDCYPVQETFTINYSVILSTRFFDIQLGIKDPSVFTPPSTCQMAQLEKMSEDCSWHHHHHH","Homo sapiens","EPDR1, MERP1, UCC1","Mammalian ependymin-related protein 1","1","6E8N"
"6E8P",,"X-RAY DIFFRACTION",2.17,43.33,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate
50mM Tris",298,"10.1021/acs.jmedchem.8b01990",,"6E8P",29.34,"1.9","1.9","CA IX mimic Complexed with Steroidal Sulfamate Compound STX 49","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6E8P"
"6E8X",,"X-RAY DIFFRACTION",2.17,43.25,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate
50mM Tris",298,"10.1021/acs.jmedchem.8b01990","J0A","6E8X",29.36,"1.6","1.6","CA IX mimic Complexed with Steroidal Sulfamate Compound STX 140","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6E8X"
"6E8Y",,"X-RAY DIFFRACTION",2.05,40.13,"VAPOR DIFFUSION, HANGING DROP",7,"175 mM potassium chloride, 23% PEG 20000, 0.1M bis-tris propane pH 7.0; 10 mg/mL",287,"10.1021/acs.biochem.8b01103",,"6E8Y",75.53,"1.85","1.85","Unliganded Human Glycerol 3-Phosphate Dehydrogenase","MASKKVCIVGSGNWGSAIAKIVGGNAAQLAQFDPRVTMWVFEEDIGGKKLTEIINTQHENVKYLPGHKLPPNVVAVPDVVQAAEDADILIFVVPHQFIGKICDQLKGHLKANATGISLIKGVDEGPNGLKLISEVIGERLGIPMSVLMGANIASEVADEKFCETTIGCKDPAQGQLLKELMQTPNFRITVVQEVDTVEICGALKNVVAVGAGFCDGLGFGDNTKAAVIRLGLMEMIAFAKLFCSGPVSSATFLESCGVADLITTCYGGRNRKVAEAFARTGKSIEQLEKELLNGQKLQGPETARELYSILQHKGLVDKFPLFMAVYKVCYEGQPVGEFIHCLQNHPEHM","Homo sapiens","GPD1","Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic","1","6E8Y"
"6E8Z",,"X-RAY DIFFRACTION",2.23,44.89,"VAPOR DIFFUSION, HANGING DROP",7,"200 mM potassium chloride, 23% PEG 20000, 0.1 M bis-tris propane pH 7.0, 10 mM NAD; 10 mg/mL",287,"10.1021/acs.biochem.8b01103","NAD","6E8Z",77.06,"2.1","2.1","Binary complex of Human glycerol 3-phosphate dehydrogenase with NAD","MASKKVCIVGSGNWGSAIAKIVGGNAAQLAQFDPRVTMWVFEEDIGGKKLTEIINTQHENVKYLPGHKLPPNVVAVPDVVQAAEDADILIFVVPHQFIGKICDQLKGHLKANATGISLIKGVDEGPNGLKLISEVIGERLGIPMSVLMGANIASEVADEKFCETTIGCKDPAQGQLLKELMQTPNFRITVVQEVDTVEICGALKNVVAVGAGFCDGLGFGDNTKAAVIRLGLMEMIAFAKLFCSGPVSSATFLESCGVADLITTCYGGRNRKVAEAFARTGKSIEQLEKELLNGQKLQGPETARELYSILQHKGLVDKFPLFMAVYKVCYEGQPVGEFIHCLQNHPEHM","Homo sapiens","GPD1","Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic","1","6E8Z"
"6E90",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M calcium chloride, 5% MPD, 20% PEG 8000, 50 mM bis-Tris propane pH 7.0, 2 mM NAD, 1 mM dihydroxyacetone phosphate; 10 mg/mL",287,"10.1021/acs.biochem.8b01103",,"6E90",153.27,"2.05","2.05","Ternary complex of human glycerol 3-phosphate dehydrogenase","MASKKVCIVGSGNWGSAIAKIVGGNAAQLAQFDPRVTMWVFEEDIGGKKLTEIINTQHENVKYLPGHKLPPNVVAVPDVVQAAEDADILIFVVPHQFIGKICDQLKGHLKANATGISLIKGVDEGPNGLKLISEVIGERLGIPMSVLMGANIASEVADEKFCETTIGCKDPAQGQLLKELMQTPNFRITVVQEVDTVEICGALKNVVAVGAGFCDGLGFGDNTKAAVIRLGLMEMIAFAKLFCSGPVSSATFLESCGVADLITTCYGGRNRKVAEAFARTGKSIEQLEKELLNGQKLQGPETARELYSILQHKGLVDKFPLFMAVYKVCYEGQPVGEFIHCLQNHPEHM","Homo sapiens","GPD1","Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic","1","6E90"
"6E91",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate
50mM Tris",298,"10.1021/acs.jmedchem.8b01990","J04","6E91",29.35,"1.8","1.8","CA IX mimic Complexed with Steroidal Sulfamate Compound STX 2484","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6E91"
"6E92",,"X-RAY DIFFRACTION",2.17,43.19,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M NaCitrate
50mM Tris",298,"10.1021/acs.jmedchem.8b01990","HZY","6E92",29.32,"1.772","1.772","CA IX mimic Complexed with Steroidal Sulfamate Compound STX 2845","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6E92"
"6E9W",,"X-RAY DIFFRACTION",4.13,73.46,"VAPOR DIFFUSION, HANGING DROP",,"1-1.5 M lithium sulfate, 0.1 M sodium citrate pH 6.2 to 6.6, 0.5 M ammonium sulfate",296,"10.1021/acs.jmedchem.8b01098",,"6E9W",103.7,"2.96","2.96","Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMDPLVPRGSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","6E9W"
"6EA4",,"X-RAY DIFFRACTION",3.19,61.38,"VAPOR DIFFUSION, SITTING DROP",6.5,"10% PEG 8000, 20% ethylene glycol, 61 mM MES, 39 mM imidazole, 20 mM sodium-L-glutamate, 20 mM D-L-alanine, 20 mM glycine, 20 mM D-L-lysine, 20 mM D-L-serine (Morpheus H2)",297,,,"6EA4",218.81,"2.45","2.45","ERAP2 bound to Aryl Sulfonamide Uncompetitive Inhibitor","FPVATNGERFPWQELRLPSVVIPLHYDLFVHPNLTSLDFVASEKIEVLVSNATQFIILHSKDLEITNATLQSEEDSRYMKPGKELKVLSYPAHEQIALLVPEKLTPHLKYYVAMDFQAKLGDGFEGFYKSTYRTLGGETRILAVTDFEPTQARMAFPCFDEPLFKANFSIKIRRESRHIALSNMPKVKTIELEGGLLEDHFETTVKMSTYLVAYIVCDFHSLSGFTSSGVKVSIYASPDKRNQTHYALQASLKLLDFYEKYFDIYYPLSKLDLIAIPDFAPGAMENWGLITYRETSLLFDPKTSSASDKLWVTRVIAHELAHQWFGNLVTMEWWNDIWLNEGFAKYMELIAVNATYPELQFDDYFLNVCFEVITKDSLNSSRPISKPAETPTQIQEMFDEVSYNKGACILNMLKDFLGEEKFQKGIIQYLKKFSYRNAKNDDLWSSLSNSCLESDFTSGGVCHSDPKMTSNMLAFLGENAEVKEMMTTWTLQKGIPLLVVKQDGCSLRLQQERFLQGVFQEDPEWRALQERYLWHIPLTYSTSSSNVIHRHILKSKTDTLDLPEKTSWVKFNVDSNGYYIVHYEGHGWDQLITQLNQNHTLLRPKDRVGLIHDVFQLVGAGRLTLDKALDMTYYLQHETSSPALLEGLSYLESFYHMMDRRNISDISENLKRYLLQYFKPVIDRQSWSDKGSVWDRMLRSALLKLACDLNHAPCIQKAAELFSQWMESSGKLNIPTDVLKIVYSVGAQTTAGWNYLLEQYELSMSSAEQNKILYALSTSKHQEKLLKLIELGMEGKVIKTQNLAALLHAIARRPKGQQLAWDFVRENWTHLLKKFDLGSYDIRMIISGTTAHFSSKDKLQEVKLFFESLEAQGSHLDIFQTVLETITKNIKWLEKNLPTLRTWLMVNTRHH","Homo sapiens","ERAP2, LRAP","Endoplasmic reticulum aminopeptidase 2","1","6EA4"
"6EB5",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.1 M MES pH 5.9, 0.15 M MgCl2, 32% PEG 400",277,"10.1073/pnas.1920444117",,"6EB5",59.02,"2.6","2.6","Crystal Structure of Human Protocadherin-15 EC2-3 V250N","MASNSPTFKHESYYATVNELTPVGTTIFTGFSGDNGATDIDDGPNGQIEYVIQYNPDDPTSNDTFEIPLMLTGNIVLRKRLNYEDKTRYFVIIQANDRAQNLNERRTTTTTLTVDVLDGDDLGPMFLPCVLNPNTRDCRPLTYQAAIPELRTPEELNPIIVTPPIQAIDQDRNIQPPSDRPGILYSILVGTPEDYPRFFHMHPRTAELSLLEPVNRDFHQKFDLVIKAEQDNGHPLPAFAGLHIEILDENNLEHHHHHH","Homo sapiens","PCDH15, USH1F","Protocadherin-15","1","6EB5"
"6EB6",,"X-RAY DIFFRACTION",2.25,45.24,"VAPOR DIFFUSION, SITTING DROP",,"Sodium formate, TCEP",293,"10.1016/j.celrep.2019.03.040",,"6EB6",21.27,"2.023","2.023","Crystal structure of BAX W139A monomer","MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSECLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALCTKVPELIRTIMGATLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQTVTIFVAGVLTASLTIWKKMG","Homo sapiens","BAX, BCL2L4","Apoptosis regulator BAX","1","6EB6"
"6EBE",,"X-RAY DIFFRACTION",2.19,43.72,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium citrate, 50 mM Tris-HCl, pH 7.8",298,"10.1021/acs.jmedchem.8b01504","J3V","6EBE",29.42,"1.88","1.88","Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII and show hypoxia-enhanced cytotoxicity against human cancer cell lines.","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6EBE"
"6EBT",,"X-RAY DIFFRACTION",2.93,58.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M HEPES
16% (m/v) PEG 10000",294,,,"6EBT",100.71,"2.3","2.3","Crystal structure of recombinant mutant N107T of human fumarase","ASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVTQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK","Homo sapiens","FH","Fumarate hydratase, mitochondrial","1","6EBT"
"6EBW",,"X-RAY DIFFRACTION",2.13,42.35,"VAPOR DIFFUSION",,"14.25% PEG 3350, 2.% Tacsimate pH 7.0, 0.1M Tris Cl",293,"10.1021/acs.jmedchem.8b01630","J3Y","6EBW",36.49,"2.455","2.455","hALK in complex with compound 9 (6-(((1S)-1-(5-Fluoropyridin-2-yl)ethyl)amino)-1-(3-methyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)(morpholin-4-yl)methanone","GAMGSTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVE","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","6EBW"
"6ECJ",,"X-RAY DIFFRACTION",3.09,60.14,"VAPOR DIFFUSION, HANGING DROP",8.5,"Hanging drops of 1 microL of 30.1 mg/mL of reduced protein and 1 microL reservoir buffer were allowed to equilibrate above the reservoir buffer (30% (w/v) polyethylene glycol 5000, 60 mM lithiumsulfate, 50 mM Tris-HCl pH 8.5). The protein solution was 26 mM sodium phosphate, 37 mM sodium chloride, 14 mM sodium dithionite (pH 7.6).",291,"10.1042/BCJ20200793",,"6ECJ",98.43,"2.7","2.7","Human cytochrome c G41T","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTTQAPGYSYTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","Cytochrome c","1","6ECJ"
"6ECM",,"X-RAY DIFFRACTION",2.05,40.01,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris (pH 8.5) 200 mM LiSO4, 24% PEG4000, 10% glycerol",293,"10.1038/s41467-019-09355-y",,"6ECM",15.23,"2.353","2.353","Crystal Structure of SNX15 PX domain in domain swapped conformation","GSMSRQAKDDFLRHYTVSDPRTHPKGYTEYKVTAQFISKKDPEDVKEVVVWKRYSDFRKLHGDLAYTHRNLFRRLEEFPAFPRAQVFGRFEASVIEERRKGAEDLLRFTVHIPALNNSPQLKEFFRGG","Homo sapiens","SNX15","Sorting nexin-15","1","6ECM"
"6ECP",,"X-RAY DIFFRACTION",2.2,44.1,"VAPOR DIFFUSION, HANGING DROP",5.2,"PEG 3350, GLYCEROL, SODIUM CITRATE, AMMONIUM ACETATE, pH 5.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 20K",293,"10.1107/S2053230X18018083",,"6ECP",69.05,"2.2","2.2","The human methylenetetrahydrofolate dehydrogenase/cyclohydrolase (FolD) complexed with NADP and inhibitor LY249543","MAPAEILNGKEISAQIRARLKNQVTQLKEQVPGFTPRLAILQVGNRDDSNLYINVKLKAAEEIGIKATHIKLPRTTTESEVMKYITSLNEDSTVHGFLVQLPLDSENSINTEEVINAIAPEKDVDGLTSINAGRLARGDLNDCFIPCTPKGCLELIKETGVPIAGRHAVVVGRSKIVGAPMHDLLLWNNATVTTCHSKTAHLDEEVNKGDILVVATGQPEMVKGEWIKPGAIVIDCGINYVPDDKKPNGRKVVGDVAYDEAKERASFITPVPGGVGPMTVAMLMQSTVESAKRFLEKFKPGKWMIQ","Homo sapiens","MTHFD1, MTHFC, MTHFD","Methylenetetrahydrofolate dehydrogenase cyclohydrolase","1","6ECP"
"6ECQ",,"X-RAY DIFFRACTION",2.2,44.1,"VAPOR DIFFUSION, HANGING DROP",5.2,"PEG 3350, GLYCEROL, SODIUM CITRATE, AMMONIUM ACETATE, pH 5.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 20K.",293,"10.1107/S2053230X18018083",,"6ECQ",66.14,"2.7","2.7","The human methylenetetrahydrofolate dehydrogenase/cyclohydrolase (FolD) complexed with NADP and inhibitor LY345899","MAPAEILNGKEISAQIRARLKNQVTQLKEQVPGFTPRLAILQVGNRDDSNLYINVKLKAAEEIGIKATHIKLPRTTTESEVMKYITSLNEDSTVHGFLVQLPLDSENSINTEEVINAIAPEKDVDGLTSINAGRLARGDLNDCFIPCTPKGCLELIKETGVPIAGRHAVVVGRSKIVGAPMHDLLLWNNATVTTCHSKTAHLDEEVNKGDILVVATGQPEMVKGEWIKPGAIVIDCGINYVPDDKKPNGRKVVGDVAYDEAKERASFITPVPGGVGPMTVAMLMQSTVESAKRFLE","Homo sapiens","MTHFD1, MTHFC, MTHFD","METHYLENETETRAHYDROFOLATE DEHYDROGENASE CYCLOHYDROLASE","1","6ECQ"
"6ECR",,"X-RAY DIFFRACTION",2.22,44.63,"VAPOR DIFFUSION, HANGING DROP",5.2,"PEG 3350, GLYCEROL, SODIUM CITRATE, AMMONIUM ACETATE, pH 5.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 20K.",293,"10.1107/S2053230X18018083",,"6ECR",65.73,"2.2","2.2","The human methylenetetrahydrofolate dehydrogenase/cyclohydrolase (FolD) complexed with NADP","MAPAEILNGKEISAQIRARLKNQVTQLKEQVPGFTPRLAILQVGNRDDSNLYINVKLKAAEEIGIKATHIKLPRTTTESEVMKYITSLNEDSTVHGFLVQLPLDSENSINTEEVINAIAPEKDVDGLTSINAGRLARGDLNDCFIPCTPKGCLELIKETGVPIAGRHAVVVGRSKIVGAPMHDLLLWNNATVTTCHSKTAHLDEEVNKGDILVVATGQPEMVKGEWIKPGAIVIDCGINYVPDDKKPNGRKVVGDVAYDEAKERASFITPVPGGVGPMTVAMLMQSTVESAKRFLE","Homo sapiens","MTHFD1, MTHFC, MTHFD","methylenetetrahydrofolate dehydrogenase cyclohydrolase","1","6ECR"
"6ECZ",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium citrate, 50 mM Tris-HCl",298,"10.1021/acs.jmedchem.8b01504","J4D","6ECZ",29.47,"2.21","2.21","Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII and show hypoxia-enhanced cytotoxicity against human cancer cell lines.","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6ECZ"
"6ED6",,"X-RAY DIFFRACTION",3.04,59.55,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.0 M ammonium sulfate, 0.1 M Bis-Tris pH 5.5",290,"10.1021/acs.jmedchem.8b01098",,"6ED6",96.81,"2.86","2.86","Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor","MSYYHHHHHHDYDIPTTENLYFQGQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR","Homo sapiens","ROCK2, KIAA0619","Rho-associated protein kinase 2","1","6ED6"
"6ED9",,"SOLUTION NMR",,,,,,,,,"6ED9",5.47,,,"NMR structure for Sp1 transcription factor duplex 5'-d(TGGGCGGGA)","TGGGCGGGA","Homo sapiens",,"DNA (5'-D(*TP*GP*GP*GP*CP*GP*GP*GP*A)-3')","1","6ED9"
,,,,,,,,,,,,,,,,"TCCCGCCCA","Homo sapiens",,"DNA (5'-D(*TP*CP*CP*CP*GP*CP*CP*CP*A)-3')","2","6ED9"
"6EDA",,"X-RAY DIFFRACTION",2.19,43.89,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium citrate, 50 mM Tris-HCl",298,"10.1021/acs.jmedchem.8b01504","J3V","6EDA",29.42,"1.879","1.879","Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII and show hypoxia-enhanced cytotoxicity against human cancer cell lines.","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6EDA"
"6EDF",,"X-RAY DIFFRACTION",2,37.6,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M magnesium acetate",291,,,"6EDF",8.94,"1.4","1.4","Fragment of a tyrosine-protein kinase","GGVTLFVALYDYEARTEDDISVHKGEKVQILNSSEGDWWEVRSLTTGETGYVPSNYVAPVDGSAAMGPVLRLRAFYNGG","Homo sapiens","FYN","FYN","1","6EDF"
"6EDL",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION",,"20 mM Tris pH 8.0, 150 mM NaCl, 0.5 mM EDTA, 1 mM Benzamidine and 0.25 mM TCEP",278,"10.1021/acs.jmedchem.8b01630",,"6EDL",36.4,"2.799","2.799","hALK in complex with compound 1 (S)-N-(1-(2,4-difluorophenyl)ethyl)-3-(3-methyl-1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-6-amine","GAMGSTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVE","Homo sapiens","ALK","ALK tyrosine kinase receptor","1","6EDL"
"6EDR",,"X-RAY DIFFRACTION",2.55,51.72,"VAPOR DIFFUSION, HANGING DROP",7,"100mM HEPES pH 7.0, 14-18% PEG 4000",295,"10.1039/c8sc03899f",,"6EDR",60.89,"2.4","2.4","Crystal Structure of Human CD38 in Complex with 4'-Thioribose NAD+","SRWRQQWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFATSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1","1","6EDR"
"6EDX",,"X-RAY DIFFRACTION",2.56,52.04,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M Sodium Citrate, 2M Sodium Malonate (pH 5.0)",293,"10.1038/s41467-019-09355-y",,"6EDX",14.09,"2.009","2.009","Crystal Structure of SGK3 PX domain","GSKESCPSVSIPSSDEHREKKKRFTVYKVLVSVGRSEWFVFRRYAEFDKLYNTLKKQFPAMALKIPAKRIFGDNFDPDFIKQRRAGLNEFIQNLVRYPELYNHPDVRAFLQMDSPKHQ","Homo sapiens","SGK3, CISK, SGKL","Serine/threonine-protein kinase Sgk3","1","6EDX"
"6EE0",,"X-RAY DIFFRACTION",2.18,43.56,"VAPOR DIFFUSION, HANGING DROP",8.5,"50 mM Tris (pH 8.5), 0.2 M NaCl, 25% PEG 3350",293,"10.1038/s41467-019-09355-y",,"6EE0",46.86,"2.518","2.518","Crystal Structure of SNX23 PX domain","GSDPIKISIPRYVLCGQGKDAHFEFEVKITVLDETWTVFRRYSRFREMHKTLKLKYAELAALEFPPKKLFGNKDERVIAERRSHLEKYLRDFFSVMLQSATSPLHINKVGLTLSKHTICEFSPFFKKGVFDYS","Homo sapiens","KIF16B, C20orf23, KIAA1590, SNX23","Kinesin-like protein KIF16B","1","6EE0"
"6EEA",,"X-RAY DIFFRACTION",2.18,43.64,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sosium citrate, 50 mM Tris-HCl",298,"10.1021/acs.jmedchem.8b01504","J3V","6EEA",29.75,"1.63","1.63","Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII and show hypoxia-enhanced cytotoxicity against human cancer cell lines.","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6EEA"
"6EEB",,"X-RAY DIFFRACTION",2.38,48.35,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris pH 8.5, 0.2 M MgCl2, 20% (w/v) PEG 8000",293,"10.1073/pnas.1818547116","J6P","6EEB",17.75,"1.96","1.96","Calmodulin in complex with malbrancheamide","SNAMADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin-1","1","6EEB"
"6EEH",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium citrate, 50 mM Tris-HCl",298,"10.1021/acs.jmedchem.8b01504","J4D","6EEH",30.33,"1.629","1.629","Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII and show hypoxia-enhanced cytotoxicity against human cancer cell lines.","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6EEH"
"6EEL",,"X-RAY DIFFRACTION",2.17,43.27,"VAPOR DIFFUSION, HANGING DROP",,"orthorhombic shaped crystals",310,"10.1016/j.jmb.2019.04.006",,"6EEL",43.31,"1.93","1.93","Crystal Structure of Myoferlin C2A with divalent cation","AITHMLRVIVESASNIPKTKFGKPDPIVSVIFKDEKKKTKKVDNELNPVWNEILEFDLRGIPLDFSSSLGIIVKDFETIGQNKLIGTATVALKDLTGDQSRSLPYKLISLLNEKGQDTGATIDLVIGYD","Homo sapiens","MYOF, FER1L3, KIAA1207","Myoferlin","1","6EEL"
"6EEO",,"X-RAY DIFFRACTION",2.19,43.71,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M Sodium citrate, 50 mM Tris-HCl",298,"10.1021/acs.jmedchem.8b01504","J6V","6EEO",29.29,"1.719","1.719","Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII and show hypoxia-enhanced cytotoxicity against human cancer cell lines.","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6EEO"
"6EEY",,"X-RAY DIFFRACTION",1.77,30.64,"VAPOR DIFFUSION, HANGING DROP",,"21% PEG 3350, 0.25 M Ammonium Nitrate",277,"10.1038/s41598-019-50671-6",,"6EEY",9.98,"1.145","1.145","Crystal structure of human Scribble PDZ4 R1110G Mutant","SHMLRELCIQKAPGEGLGISIRGGARGHAGNPRDPTDEGIFISKVSPTGAAGRDGRLRVGLRLLEVNQQSLLGLTHGEAVQLLRSVGDTLTVLVC","Homo sapiens","SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL","Protein scribble homolog","1","6EEY"
"6EG9",,"X-RAY DIFFRACTION",3.25,62.21,"VAPOR DIFFUSION",8,"0.1M Tris-Hcl pH 8.0
1.5M-1.6M ammonium sulfate
20mM Cobalt chloride",289,"10.1074/jbc.RA118.005428","0LI","6EG9",71.14,"2.414","2.414","IRAK4 in complex with Ponatinib","GAMGSENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6EG9"
"6EGA",,"X-RAY DIFFRACTION",3.18,61.37,"VAPOR DIFFUSION",8,"0.1M Tris-Hcl pH 8.0
1.5M-1.6M ammonium sulfate
20mM Cobalt chloride",289,"10.1074/jbc.RA118.005428",,"6EGA",71.35,"2.512","2.512","IRAK4 in complex with a type II inhibitor","GAMGSENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6EGA"
"6EGD",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, HANGING DROP",,"150 mM DL-Malic acid and 20% PEG3350",277.15,"10.1074/jbc.RA118.005428",,"6EGD",68.23,"2.1","2.1","Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor","GAMGSRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRNIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6EGD"
"6EGE",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, HANGING DROP",,"150 mM DL-Malic acid and 20% PEG3350",277.15,"10.1074/jbc.RA118.005428",,"6EGE",68.19,"1.401","1.401","Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor","GAMGSRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRNIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6EGE"
"6EGF",,"X-RAY DIFFRACTION",4.95,75.13,"VAPOR DIFFUSION, HANGING DROP",7,"1.6-1.9 M ammonium sulfate, 100 mM Hepes-NaOH at pH7",293.15,"10.1074/jbc.RA118.005428",,"6EGF",34.44,"2.61","2.61","Crystal structure of the inactive unphosphorylated IRAK4 kinase domain bound to AMP-PNP","GAMGSRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRNIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6EGF"
"6EGS",,"X-RAY DIFFRACTION",2.51,51.09,"VAPOR DIFFUSION, SITTING DROP",,"PEG6000, Hepes",291,"10.1002/chem.201800701",,"6EGS",116.06,"2.7","2.7","Crystal structure of the GalNAc-T2 F104S mutant in complex with UDP-GalNAc","KREAEAKVRWPDFNQEAYVGGTMVRSGQDPYARNKSNQVESDKLRMDRAIPDTRHDQCQRKQWRVDLPATSVVITFHNEARSALLRTVVSVLKKSPPHLIKEIILVDDYSNDPEDGALLGKIEKVRVLRNDRREGLMRSRVRGADAAQAKVLTFLDSHCECNEHWLEPLLERVAEDRTRVVSPIIDVINMDNFQYVGASADLKGGFDWNLVFKWDYMTPEQRRSRQGNPVAPIKTPMIAGGLFVMDKFYFEELGKYDMMMDVWGGENLEISFRVWQCGGSLEIIPCSRVGHVFRKQHPYTFPGGSGTVFARNTRRAAEVWMDEYKNFYYAAVPSARNVPYGNIQSRLELRKKLSCKPFKWYLENVYPELRVPDHQDIAFGALQQGTNCLDTLGHFADGVVGVYECHNAGGNQEWALTKEKSVKHMDLCLTVVDRAPGSLIKLQGCRENDSRQKWEQIEGNSKLRHVGSNLCLDSRTAKSGGLSVEVCGPALSQQWKFTLNLQQ","Homo sapiens","GALNT2","Polypeptide N-acetylgalactosaminyltransferase 2","1","6EGS"
"6EH4",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 4K, 15% Glycerol, 100mM TRIS pH 8.0",291,"10.3389/fimmu.2018.00674",,"6EH4",50.45,"1.26","1.26","003 Human T-Cell Receptor specific for HIV GAG epitope SLYNTVATL carried by Human Leukocyte Antigen HLA-A*0201","KQEVTQIPAALSVPEGENLVLNCSFTDSAIYNLQWFRQDPGKGLTSLLLIQSSQREQTSGRLNASLDKSSGRSTLYIAASQPGDSATYLCAVTNFNKFYFGSGTKLNVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"Human T Cell Receptor Alpha Chain","1","6EH4"
,,,,,,,,,,,,,,,,"MKAGVTQTPRYLIKTRGQQVTLSCSPISGHRSVSWYQQTPGQGLQFLFEYFSETQRNKGNFPGRFSGRQFSNSRSEMNVSTLELGDSALYLCASSFDSGNSPLHFGNGTRLTVVEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human T Cell Receptor Beta Chain","2","6EH4"
"6EH5",,"X-RAY DIFFRACTION",2.29,46.22,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 4K, 200mM Ammonium sulfate, 100mM Sodium cacodylate pH 6.5",291,"10.3389/fimmu.2018.00674",,"6EH5",51.84,"1.29","1.29","003 Human T-Cell Receptor specific for HIV GAG epitope SLYNTVATL carried by Human Leukocyte Antigen HLA-A*0201","MKQEVTQIPAALSVPEGENLVLNCSFTDSAIYNLQWFRQDPGKGLTSLLLIQSSQREQTSGRLNASLDKSSGRSTLYIAASQPGDSATYLCAVTNFNKFYFGSGTKLNVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSP","Homo sapiens",,"Human T Cell Receptor Alpha Chain","1","6EH5"
,,,,,,,,,,,,,,,,"MKAGVTQTPRYLIKTRGQQVTLSCSPISGHRSVSWYQQTPGQGLQFLFEYFSETQRNKGNFPGRFSGRQFSNSRSEMNVSTLELGDSALYLCASSFDSGNSPLHFGNGTRLTVTEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human T Cell Receptor Beta Chain","2","6EH5"
"6EH6",,"X-RAY DIFFRACTION",2.5,50.79,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 1.5K, 100mM MMT pH 6.0",291,"10.3389/fimmu.2018.00674",,"6EH6",50.47,"1.78","1.78","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human T Cell Receptor Alpha Chain","1","6EH6"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human T Cell Receptor BetaChain","2","6EH6"
"6EH7",,"X-RAY DIFFRACTION",4.57,73.09,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 1.5K, 100mM SPG buffer pH 6.0",291,"10.3389/fimmu.2018.00674",,"6EH7",50.6,"1.89","1.89","F11 Human T-Cell Receptor specific for influenza virus haaemagglutinin epitope PKYVKQNTLKLAT carried by Human Leukocyte Antigen HLA-DR0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human T Cell Receptor Alpha Chain","1","6EH7"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human T Cell Receptor Beta Chain","2","6EH7"
"6EH8",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, SITTING DROP",,"15% PEG 4K, 15% Glycerol, 100mM MES pH 7.0",291,"10.3389/fimmu.2018.00674",,"6EH8",49.77,"2.51","2.51","HA1.7 Human T-Cell Receptor specific for Influenza virus epitope PKYVKQNTLKLAT presented by Human Leukocyte Antigen HLA-DR0101","QSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSESPFGNEKLTFGTGTRLTIIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTF","Homo sapiens",,"Human T Cell Receptor Alpha Chain","1","6EH8"
,,,,,,,,,,,,,,,,"VKVTQSSRYLVKRTGEKVFLECVQDMDHENMFWYRQDPGLGLRLIYFSYDVKMKEKGDIPEGYSVSREKKERFSLILESASTNQTSMYLCASSSTGLPYGYTFGSGTRLTVVEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA","Homo sapiens",,"Human T Cell Receptor Beta Chain","2","6EH8"
"6EH9",,"X-RAY DIFFRACTION",2.53,51.31,"VAPOR DIFFUSION, SITTING DROP",,"15% PEG 4K, 15% Glycerol, 100mM MES pH 7.0",291,"10.3389/fimmu.2018.00674",,"6EH9",49.9,"2.49","2.49","HA1.7 Human T-Cell Receptor specific for Influenza virus epitope PKYVKQNTLKLAT presented by Human Leukocyte Antigen HLA-DR0101","MQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSESPFGNEKLTFGTGTRLTIIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTF","Homo sapiens",,"Human T Cell Receptor Alpha Chain","1","6EH9"
,,,,,,,,,,,,,,,,"VKVTQSSRYLVKRTGEKVFLECVQDMDHENMFWYRQDPGLGLRLIYFSYDVKMKEKGDIPEGYSVSREKKERFSLILESASTNQTSMYLCASSSTGLPYGYTFGSGTRLTVVEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA","Homo sapiens",,"Human T Cell Receptor Beta Chain","2","6EH9"
"6EHA",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"2.08 M AmSO4 
0.9 % (v/v) 1,6-hexanediol 
0.1 M HEPES pH 7.5",293,"10.1016/j.abb.2019.07.002",,"6EHA",67.57,"2","2","Heme oxygenase 1 in complex with inhibitor","MERPQPDSMPQDLSEALKEATKEVHTQAENAEFMRNFQKGQVTRDGFKLVMASLYHIYVALEEEIERNKESPVFAPVYFPEELHRKAALEQDLAFWYGPRWQEVIPYTPAMQRYVKRLHEVGRTEPELLVAHAYTRYLGDLSGGQVLKKIAQKALDLPSSGEGLAFFTFPNIASATKFKQLYRSRMNSLEMTPAVRQRVIEEAKTAFLLNIQLFEELQELLTHDTKDQSPSRAPGLRQRASNKVQDSAPVETPRGKPPLNTRSQAPLLRWVLTLSFLVATVAVGLYAM","Homo sapiens","HMOX1, HO, HO1","Heme oxygenase 1","1","6EHA"
"6EHJ",,"X-RAY DIFFRACTION",2.32,47.02,"VAPOR DIFFUSION, SITTING DROP",,"16-18% (v/w) PEG 4K, 5 mM NiCl2, 100 mM sodium citrate pH 4.5, and 2.5% (v/v) glycerol",293,"10.1038/s41467-020-14847-3",,"6EHJ",96.19,"2.1","2.1","Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and peptide bound","GPHMEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ","Homo sapiens","NMT1, NMT","Glycylpeptide N-tetradecanoyltransferase 1","1","6EHJ"
"6EHK",,"X-RAY DIFFRACTION",1.93,36.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"112.5mM Mes pH 6.5, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1039/c7sc05122k","54G","6EHK",41.48,"1.4","1.4","The crystal structure of CK2alpha in complex with CAM4712 and compound 37","SGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6EHK"
"6EHO",,"X-RAY DIFFRACTION",3.5,64.86,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.0 Ammonium sulphate",291,"10.1016/j.str.2017.09.015",,"6EHO",82.3,"3.5","3.5","Dimer of the Sortilin Vps10p domain at low pH","QDRLDAPPPPAAPLPRWSGPIGVSWGLRAAAAGGAFPRGGRWGGSAPGEDEECGRVRDFVAKLANNTHQHVFDDLRGSVSLSWVGDSTGVILVLTTFHVPLVIMTFGQSKLYRSEDYGKNFKDITDLINNTFIRTEFGMAIGPENSGKVVLTAEVSGGSRGGRIFRSSDFAKNFVQTDLPFHPLTQMMYSPQNSDYLLALSTENGLWVSKNFGGKWEEIHKAVCLAKWGSDNTIFFTTYANGSCKADLGALELWRTSDLGKSFKTIGVKIYSFGLGGRFLFASVMADKDTTRRIHVSTDQGDTWSMAQLPSVGQEQFYSILAANDDMVFMHVDEPGDTGFGTIFTSDDRGIVYSKSLDRHLYTTTGGETDFTNVTSLRGVYITSVLSEDNSIQTMITFDQGGRWTHLRKPENSECDATAKNKNECSLHIHASYSISQKLNVPMAPLSEPNAVGIVIAHGSVGDAISVMVPDVYISDDGGYSWTKMLEGPHYYTILDSGGIIVAIEHSSRPINVIKFSTDEGQCWQTYTFTRDPIYFTGLASEPGARSMNISIWGFTESFLTSQWVSYTIDFKDILERNCEEKDYTIWLAHSTDPEDYEDGCILGYKEQFLRLRKSSMCQNGRDYVVTKQPSICLCSLEDFLCDFGYYRPENDSKCVEQPELKGHDLEFCLYGREEHLTTNGYRKIPGDKCQGGVNPVREVKDLKKKCTSNFLSPEKQNSKSNS","Homo sapiens","SORT1","Sortilin","1","6EHO"
"6EHU",,"X-RAY DIFFRACTION",2.11,41.84,"VAPOR DIFFUSION, HANGING DROP",6.5,"112.5mM Mes pH 6.5, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1039/c7sc05122k",,"6EHU",84.23,"1.95","1.95","The crystal structure of CK2alpha in complex with compound 32","SGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6EHU"
"6EHV",,"X-RAY DIFFRACTION",3.24,62.06,"VAPOR DIFFUSION",,"2M ammonium sulphate",293,,,"6EHV",27.49,"2.54","2.54","scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery","QVQLVQSGPEVKKPGASVKVSCKTSGFNFNTYAITWVRQAPGQGLEYMGWFNVYDGKTSYAWDFKDRVIMTADKSTTTAYMTLRNLRSDDTAVYYCARDSWERFFEHWGKGTLVTVSSGGGGSGGGGSGGGGSALETTLTQSPGTLSLSPGERATLSCRASQTVSGSYLAWYQQKPGQAPRLLIYGASTRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGNSPPNTFGQGTRLEIKRAAAENLYFQ","Homo sapiens",,"scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery","1","6EHV"
"6EHW",,"X-RAY DIFFRACTION",2.42,49.27,"VAPOR DIFFUSION",,"NaCl, Hepes pH 7.5",293,,,"6EHW",26.89,"2.19","2.19","scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery","EVQLVESGGGLVQPGQSLKLSCKASGYTFTSYGMHWVRQAPGKGLEWMGGIIPIFGTANYNPSVKGRFTISRDTSKNTAYLQLNNLRAEDTAVYYCARAPGYSNAYYFDYWGQGTLVTVSGGGGSGGGGSGGGGSDIQMTQSPSLLSASLGDRVTITCRASEGIYHWLAWYQQKPGQSPKLLIYKASSRASGVPDRFSGSGSGTDFTLTISSLEPEDFATYYCQQYSNYPLTFGGGTKLEIKAAAENLYFQ","Homo sapiens",,"scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery","1","6EHW"
"6EHX",,"X-RAY DIFFRACTION",3.79,67.55,"VAPOR DIFFUSION",7.5,"NaCl 1.5M, Na Hepes, pH 7.5",290,,,"6EHX",25.53,"2.2","2.2","scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery","QVQLVESGGGLVKPGASLKLSCKASGYTFTSYGMHWVRQAPGKGLEWMGGIIPIFGTANYNEKVKGRFTISRDKSKSTAYLQLSSLTSEDTAVYYCARAPGYSNAYYFDYWGQGTLVTVGGGSGGGGSGGGGSDIVMTQSPASLSASLGERVTITCRASEGIYHWLAWYQQKPGQSPKLLIYKASSLASGVPSRFSGSGSGTDFTLTISSLEPEDFATYYCQQYSNYPLTFGGGTKLEIK","Homo sapiens",,"scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery","1","6EHX"
"6EHY",,"X-RAY DIFFRACTION",1.93,36.17,"VAPOR DIFFUSION",7.5,"4.5M NaCl 100mM HEPES pH 7.5",293,,,"6EHY",53.71,"2.25","2.25","scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery","QVQLVQSGTEVKSPGSSVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARAPGYSNAYYFDYWGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSTLSASIGDRVTITCRASEGIYHWLAWYQQKPGKAPKLLIYKASSLASGAPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQYSNYPLTFGGGTKLEIKRAAAENLYFQ","Homo sapiens",,"scFv antibody fragment","1","6EHY"
"6EI5",,"X-RAY DIFFRACTION",3.24,62.02,"VAPOR DIFFUSION, HANGING DROP",,"Na-Cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","B5Q","6EI5",23.8,"2.2","2.2","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","EEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6EI5"
"6EI8",,"X-RAY DIFFRACTION",3.9,68.45,"VAPOR DIFFUSION, HANGING DROP",6,"2M ammonium sulfate
50 mM sodium cacodylate
15 mM magnesium acetate",292,"10.1021/acs.biochem.9b00111",,"6EI8",13.94,"2.25","2.25","Crystal structure of human tRNA-dihydrouridine (20) synthase dsRBD F359A mutant","MTSEQTGEPAEDTSGVIKMAVKADRRAYPAQITPKMCLLEWCRREKLAQPVYETVQRPLDRLFSSIVTVAEQKYQSTLWDKSKKLAEQAAAIVCLRSQGLPEGRLGEESPSLHKHHHHHH","Homo sapiens","DUS2, DUS2L","tRNA-dihydrouridine(20) synthase [NAD(P)+]-like","1","6EI8"
"6EIE",,"X-RAY DIFFRACTION",2.33,47.27,"VAPOR DIFFUSION, HANGING DROP",,"Protein 10.3 mg/ml in 25 mM Tris HCl, pH 7.5, 100 mM NaCl, 1 mM DTT. Reservoir 0,1 M Natriumacetat, 20% w/v PEG 3350. Cryo buffer was reservoir supplemented with 15% glycerol.",293,"10.1073/pnas.1812963116",,"6EIE",57.37,"2.72","2.72","Ras guanine nucleotide exchange factor SOS2 (Rem-cdc25), with surface mutations","GAMAEQQLRLPSPEVYRFVVKDSEENIVFEDNLQSRSGIPIIKGGTVVKLIERLTYHMYADPNFVRTFLTTYRSFCKPQELLSLLIERFEIPEPEPTDADKLAIEKGEQPISADLKRFRKEYVQPVQLRILNVFRHWVEHHFYDFERDLYLLERLESFISSVRGKAMKKWVESIAKIIRRKKQAQANGVSHNITFESPPPPIEWHISKPGHIETFDLMTLHPIEIARQLTLLESDLYRKVQPSELVGSVWTKEDKEINSPNLLKMIRHTTNLTLWFEKCIVEAENFEERVAVLSRIIEILQVFQDLNNFNGVLEIVSAVNSVSVYRLDHTFEALQERKRKILDEAVELSQDHFKKYLVKLKSINPPCVPFFGIYLTNILKTEEGNNDFLTRHGKDLINFSKRRKVAEITGEIQQYQNQPYCLRIEPDMRRFFENLNPMGSASEKEFTDYLFNKSLEIEPRNPKQPPRFPRKSTFSLKSPGIRPNTGRHGS","Homo sapiens","SOS2","Son of sevenless homolog 2","1","6EIE"
"6EIF",,"X-RAY DIFFRACTION",2.65,53.62,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.1M NaCl; 14% PEG 3350, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/acs.jmedchem.7b01847","B5T","6EIF",172.02,"2.22","2.22","DYRK1A in complex with XMD7-117","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6EIF"
"6EII",,"X-RAY DIFFRACTION",2.19,43.89,"VAPOR DIFFUSION, HANGING DROP",6.5,"112.5mM Mes pH 6.5, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1039/c7sc05122k",,"6EII",84.23,"1.935","1.935","The crystal structure of CK2alpha in complex with compound 18","GSMDIEFDDDADDDGSGSGSGSGSSGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6EII"
"6EIJ",,"X-RAY DIFFRACTION",2.63,53.24,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.05M KCl; 10% PEG 3350, pH 6.8",293,"10.1021/acs.jmedchem.7b01847","B5Z","6EIJ",172.48,"2.42","2.42","DYRK1A in complex with HG-8-60-1","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6EIJ"
"6EIL",,"X-RAY DIFFRACTION",2.58,52.37,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.1M NaCl; 16% PEG 3350, pH 6.8",293,"10.1021/acs.jmedchem.7b01847","B6B","6EIL",171.58,"2.465","2.465","DYRK1A in complex with XMD8-49","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","DYRK1A","1","6EIL"
"6EIM",,"X-RAY DIFFRACTION",2.34,47.35,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG1000, 10% PEG8000",277,,,"6EIM",69.64,"1.43","1.43","Human STK10 bound to GW683134A","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLAIAASDPPTLLTPSKWSVEFRDFLAIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","Serine/threonine-protein kinase 10","1","6EIM"
"6EIN",,"X-RAY DIFFRACTION",4.4,72.03,"VAPOR DIFFUSION",7.5,"0.1M HEPES pH 7.5, 0.8M Pottassium Phosphate-dibasic, 0.8M Sodium Phosphate monobasic",277,,,"6EIN",56.26,"2.11","2.11","Crystal structure of KDM5B in complex with S49365a.","SMFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKLGGGGARDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAESYNEWALNVNEALEAKINK","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6EIN"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6EIP",,"X-RAY DIFFRACTION",2.61,52.88,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.05M LiCl; 10% PEG 3350, pH 6.8",293,"10.1021/acs.jmedchem.7b01847","B7B","6EIP",172.3,"2.56","2.56","DYRK1A in complex with XMD8-62e","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6EIP"
"6EIQ",,"X-RAY DIFFRACTION",2.57,52.22,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.1M NaCl; 12% PEG 3350, pH 6.8",293,"10.1021/acs.jmedchem.7b01847","B6Z","6EIQ",172.31,"2.3","2.3","DYRK1A in complex with XMD14-124","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6EIQ"
"6EIR",,"X-RAY DIFFRACTION",2.57,52.23,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.1 M NaCl; 10% PEG 3350, pH 6.8",293,"10.1021/acs.jmedchem.7b01847","B6H","6EIR",172.59,"2.4","2.4","DYRK1A in complex with XMD15-27-2","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6EIR"
"6EIS",,"X-RAY DIFFRACTION",2.66,53.76,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN, 0.1M KCl, 16% PEG 3350",293,"10.1021/acs.jmedchem.7b01847","B6N","6EIS",172.31,"2.36","2.36","DYRK1A in complex with JWC-055","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6EIS"
"6EIU",,"X-RAY DIFFRACTION",4.28,71.29,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.8M Pottassium Phosphate-dibasic, 0.8M Sodium Phosphate monobasic",277,,,"6EIU",54.64,"1.88","1.88","Crystal structure of KDM5B in complex with KDOPZ29a","MFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKLGGGGARDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAES","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6EIU"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6EIV",,"X-RAY DIFFRACTION",2.66,53.78,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.05M LiCl; 10% PEG 3350, pH 6.8",293,"10.1021/acs.jmedchem.7b01847",,"6EIV",172.47,"2.68","2.68","DYRK1A in complex with JWD-065","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6EIV"
"6EIX",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES pH 6.5 -- 12%(w/v) PEG 20000",293,,"A3F","6EIX",39.43,"2.3","2.3","Crystal structure of the kinase domain of the Q207E mutant of ACVR1 (ALK2) in complex with a 2-aminopyridine inhibitor K02288","SMTTNVGDSTLADLLDHSCTSGSGSGLPFLVQRTVAREITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKIDNSLDKLKTDC","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6EIX"
"6EIY",,"X-RAY DIFFRACTION",4.19,70.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.8M Pottassium Phosphate-dibasic, 0.8M Sodium Phosphate monobasic",277,,,"6EIY",54.14,"2.15","2.15","Crystal structure of KDM5B in complex with KDOPZ000034a.","MFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKGGGGARDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAES","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6EIY"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6EJ0",,"X-RAY DIFFRACTION",4.17,70.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.8M Pottassium Phosphate-dibasic, 0.8M Sodium Phosphate monobasic",277,,,"6EJ0",53.95,"2.06","2.06","Crystal structure of KDM5B in complex with KDOPZ000049a.","MFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRGGGGRDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAES","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6EJ0"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6EJ1",,"X-RAY DIFFRACTION",4.31,71.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.8M Pottassium Phosphate-dibasic, 0.8M Sodium Phosphate monobasic",277,,,"6EJ1",53.87,"2.07","2.07","Crystal structure of KDM5B in complex with KDOPZ48a.","MFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRGGGGGRDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAES","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6EJ1"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6EJ2",,"X-RAY DIFFRACTION",2.28,46,"VAPOR DIFFUSION, SITTING DROP",,"18% PEG 5k MME, 0.2M AmI, 0.2M sodium citrate pH 6.5",293,"10.1021/acs.jmedchem.7b01716","B7E","6EJ2",56.19,"1.46","1.46","BACE1 compound 28","MAQALPWLLLWMGAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTDLMEDCGYNIPQTDESTLMTIAYVMAAICALFMLPLCLMVCQWRCLRCLRQQHDDFADDISLLK","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6EJ2"
"6EJ3",,"X-RAY DIFFRACTION",3.09,60.22,"VAPOR DIFFUSION",,"11% PEG 6k, 100mM NaOAc pH 5.0",293,"10.1021/acs.jmedchem.7b01716","B7T","6EJ3",56.19,"1.94","1.94","BACE1 compound 23","MAQALPWLLLWMGAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTLMTIAYVMAAICALFMLPLCLMVCQWRCLRCLRQQHDDFADDISLLK","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6EJ3"
"6EJ4",,"X-RAY DIFFRACTION",2.61,52.89,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M KSCN; 0.05M NaCl; 16% PEG 3350, pH 6.8",293,"10.1021/acs.jmedchem.7b01847","B7W","6EJ4",171.76,"2.88","2.88","DYRK1A in complex with XMD7-112","GASDSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS","Homo sapiens","DYRK1A, DYRK, MNB, MNBH","Dual specificity tyrosine-phosphorylation-regulated kinase 1A","1","6EJ4"
"6EJ5",,"X-RAY DIFFRACTION",3.69,66.66,"BATCH MODE",,"1.4 M sodium malonate, 50 mM sodium citrate pH 6.2",291,"10.1093/nar/gky040",,"6EJ5",71.55,"3.34","3.34","A conserved structural element in the RNA helicase UPF1 regulates its catalytic activity in an isoform-specific manner","GAADSMRYEDAYQYQNIFGPLVKLEADYDKKLKESQTQDNITVRWDLGLNKKRIAYFTLPKTDSGNEDLVIIWLRDMRLMQGDEICLRYKGDLAPLWKGIGHVIKVPDNYGDEIAIELRSSVGAPVEVTHNFQVDFVWKSTSFDRMQSALKTFAVDETSVSGYIYHKLLGHEVEDVIIKCQLPKRFTAQGLPDLNHSQVYAVKTVLQRPLSLIQGPPGTGKTVTSATIVYHLARQGNGPVLVCAPSNIAVDQLTEKIHQTGLKVVRLCAKSREAIDSPVSFLALHNQIRNMDSMPELQKLQQLKDETGELSSADEKRYRALKRTAERELLMNADVICCTCVGAGDPRLAKMQFRSILIDESTQATEPECMVPVVLGAKQLILVGDHCQLGPVVMCKKAAKAGLSQSLFERLVVLGIRPIRLQVQYRMHPALSAFPSNIFYEGSLQNGVTAADRVKKGFDFQWPQPDKPMFFYVTQGQEEIASSGTSYLNRTEAANVEKITTKLLKAGAKPDQIGIITPYEGQRSYLVQYMQFSGSLHTKLYQEVEIASVDAFQGREKDFIILSCVRANEHQGIGFLNDPRRLNVALTRARYGVIIVGNPKALSKQPLWNHLLNYYKEQKVLVEGPLNNLRESLMQFS","Homo sapiens","UPF1, KIAA0221, RENT1","Regulator of nonsense transcripts 1","1","6EJ5"
"6EK3",,"X-RAY DIFFRACTION",2.47,50.3,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M NH4Cl pH 7.5, 20% (w/v) PEG 3350",293,"10.1016/j.ejmech.2018.06.047","OUL","6EK3",51.29,"1.6","1.6","PARP15 CATALYTIC DOMAIN MUTANT (Y598L) IN COMPLEX WITH OUL35","MHHHHHHSSGVDLGTENLYFQSMNLPEHWTDMNHQLFCMVQLEPGQSEYNTIKDKFTRTCSSYAIEKIERIQNAFLWQSYQVKKRQMDIKNDHKNNERLLFHGTDADSVPYVNQHGFNRSCAGKNAVSYGKGTYFAVDASLSAKDTYSKPDSNGRKHMYVVRVLTGVFTKGRAGLVTPPPKNPHNPTDLFDSVTNNTRSPKLFVVFFDNQAYPEYLITFTA","Homo sapiens","PARP15, BAL3","Poly [ADP-ribose] polymerase 15","1","6EK3"
"6EK6",,"X-RAY DIFFRACTION",4.17,70.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.8M Pottassium Phosphate-dibasic, 0.8M Sodium Phosphate monobasic",277,,"90V","6EK6",53.94,"2.05","2.05","Crystal structure of KDM5B in complex with S49195a.","MFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVRDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAES","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6EK6"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6EKD",,"X-RAY DIFFRACTION",2.07,40.67,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Bis Tris pH 5.5, 200 mM NaCl, 29% PEG 3350, 1 mM AMP-PCP, 0.4 mM Zwittergent 3-14, 10% Ethylene glycol",293,"10.1021/acsomega.8b00668","B9K","6EKD",42.78,"2.1","2.1","Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor","GGSMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","6EKD"
"6EKN",,"X-RAY DIFFRACTION",2.16,43.15,"VAPOR DIFFUSION, SITTING DROP",10,"Protein: 1 micro-L MMP12 at 290 micro-M with 10 milli-M acetohydroxamate  + 0.1 Micro-L BE6 from 10 milii-M in 100% DMSO
Precipitant: 17% PEG 20K, 250 milli-M NaCl, 100 milii-M TRIS HCl, pH 10.0.
cryoprotectant: 40% (25 % di-ethylene glycol + 25 % glycerol + 25 % 1,2-propanediol) 10 % PEG 10K, 200 milli-M NaCl, 100 milli-M AAB (Na acetate,N-(2-Acetamido)iminodiacetic acid (ADA), Bicine)  10% acid/90% basic",293,"10.1021/acs.jmedchem.8b00096","B9N","6EKN",18.38,"1.2","1.2","Crystal structure of MMP12 in complex with inhibitor BE7.","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","6EKN"
"6EKQ",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Bis-Tris Propane pH9, 10% EG, 0.15M NaNO3, 25% PEG3350",277,"10.1016/j.ejmech.2018.05.037","B0H","6EKQ",28.23,"1.65","1.65","Crystal structure of the human BRPF1 bromodomain complexed with BZ054 in space group C2","SMEMQLTPFLILLRKTLEQLQEKDTGNIFSEPVPLSEVPDYLDHIKKPMDFFTMKQNLEAYRYLNFDDFEEDFNLIVSNCLKYNAKDTIFYRAAVRLREQGGAVLRQARRQAEKMG","Homo sapiens","BRPF1, BR140","Peregrin","1","6EKQ"
"6EL5",,"X-RAY DIFFRACTION",2.83,56.5,"VAPOR DIFFUSION, HANGING DROP",,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","PU1","6EL5",27.04,"1.67","1.67","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6EL5"
"6ELA",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, SITTING DROP",8.5,"protein solution: hMMP12 at 314 micro-M + 10 milli-M acetohydroxamate +  1 milli-M BE4, 10% DMSO
precipitant:  38% PEG 4K, 0.16 M imidazole piperidine,15% Dioxane, pH 8.5.
Cryoprotectant: 40% CM15 (12.5 % diethylene glycol + 12.5 % ethylene glycol + 12.5 % MPD + 12.5 % glycerol + 12.5 % 1,2-propanediol + 12.5 % 1,4-dioxane + 12.5 mM NDSB 201), 25% PEG 6K, 100 milli-M TRIS HCl, pH 7.0",293,"10.1021/acs.jmedchem.8b00096","B9Z","6ELA",73.43,"1.485","1.485","Crystal structure of MMP12 in complex with inhibitor BE4.","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYAYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","6ELA"
"6ELE",,"X-RAY DIFFRACTION",2.71,54.62,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M TRIS, pH 9.0, 22.5 %w/v PEG 6K",293,,,"6ELE",96.33,"1.78","1.78","FAB Fragment. AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision making in antibody drug discovery","EVQLVESGGGLVQPGGSLRLSCATSGFDFSRYWMSWVRQAPGKGLVWIGEVNPDSTSINYTPSLKDQFTISRDNAKNTLYLQMNSLRAEDTAVYYCTRPNYYGSRYHYYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"fAB heavy chain","1","6ELE"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDINNYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGSTLPFTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"fAB light chain","2","6ELE"
"6ELJ",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Na cacodylat 6.5 pH  
25 %w/v PEG 4K",293,,,"6ELJ",96.25,"1.9","1.9","FAB Fragment. AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision making in antibody drug discovery","EVQLVESGGGLVQPGGSLRLSCATSGFDFSRYWMSWVRQAPGKGLVWIGEVNPDSTSINYTPSLKDQFTISRDNAKNTLYLQMNSLRAEDTAVYYCTRPNYYGSRYHYYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"fAB heavy chain","1","6ELJ"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDINNYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGSTLPFTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"fAB light chain","2","6ELJ"
"6ELL",,"X-RAY DIFFRACTION",2.58,52.25,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M TRIS, pH 7.5
25 %w/v PEG 6K",293,,,"6ELL",96.25,"1.9","1.9","FAB Fragment. AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision making in antibody drug discovery","EVQLVESGGGLVQPGGSLRLSCATSGFDFSRYWMSWVRQAPGKGLVWIGEVNPDSTSINYTPSLKDQFTISRDNAKNTLYLQMNSLRAEDTAVYYCTRPNYYGSRYHYYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"fAB heavy chain","1","6ELL"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDINNYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGSTLPFTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"fAB light chain","2","6ELL"
"6ELM",,"X-RAY DIFFRACTION",2.06,40.3,"VAPOR DIFFUSION, SITTING DROP",8,"30% PEG1000 -- 0.1M SPG pH 8.0",293,,,"6ELM",11.34,"1.14","1.14","Crystal structure of the human WNK2 CCT1 domain","SMAEDTGVRVELAEEDHGRKSTIALRLWVEDPKKLKGKPKDNGAIEFTFDLEKETPDEVAQEMIESGFFHESDVKIVAKSIRDRVALIQWRRERIWPA","Homo sapiens","WNK2, KIAA1760, PRKWNK2, SDCCAG43, P/OKcl.13","Serine/threonine-protein kinase WNK2","1","6ELM"
"6ELN",,"X-RAY DIFFRACTION",3.18,61.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","P4A","6ELN",23.62,"1.6","1.6","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","VETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6ELN"
"6ELO",,"X-RAY DIFFRACTION",2.77,55.52,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","BAW","6ELO",26.91,"1.8","1.8","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6ELO"
"6ELP",,"X-RAY DIFFRACTION",2.87,57.08,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","BA8","6ELP",26.99,"1.85","1.85","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6ELP"
"6ELR",,"X-RAY DIFFRACTION",2.53,51.33,"VAPOR DIFFUSION, HANGING DROP",,"2mM ligand, 27% (m/v) PEG6000, 0.1 M MES/NaOH pH 6.0, 5 mM DTT",282,,"BFK","6ELR",70.27,"1.8","1.8","Human jak1 kinase domain in complex with compound 7","DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-Protein Kinase JAK1","1","6ELR"
"6ELW",,"X-RAY DIFFRACTION",1.7,27.74,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 % (w/v) PEG 1500, 10 % (v/v) isopropanol, 0.1 M calcium chloride and 0.1 M imidazole/ hydrochloric acid pH 6.5",293,"10.1016/j.bbalip.2018.06.006",,"6ELW",21.91,"1.3","1.3","High resolution structure of selenocysteine containing human GPX4","MGSSHHHHHHSSGLVPRGSHMLEAASRDDWRAARSMHEFSAKDIDGHMVNLDKYRGFVSIVTNVASQUGKTEVNYTQLVDLHARYAEAGLRILAFPSNQFGKQEPGSNEEIKEFAAGYNVKFDMFSKIAVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGAVVKRYGPMEEPLVIEKDLPHYF","Homo sapiens","GPX4","Phospholipid hydroperoxide glutathione peroxidase, mitochondrial","1","6ELW"
"6EMH",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Bis-Tris pH5.5, 200 mM NaCl, 29% PEG 3350, 1mM AMP-PCP, 0.4 mM Zwittergent 3-14, 10% Ethylene glycol",293,"10.1021/acsomega.8b00668","BGE","6EMH",172.2,"1.76","1.76","Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor","GGSMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","6EMH"
"6EMI",,"X-RAY DIFFRACTION",3.04,59.59,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, ammonium acetate",277,"10.3390/molecules22111828",,"6EMI",123.73,"2.476","2.476","Crystal structure of a variant of human butyrylcholinesterase expressed in bacteria.","GAMEDDIIITTKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQPLTKWSGIWNATKYANSCMQNIDTSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVMVWIYGGGFQTGTSSLPVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALKWVQDNIAAFGGDPNRVTLFGESAGAASVSLHLLSPGSHPLFTRAILQSGSANAPWAVMSPEEARNRTLNLAKLLGCSRENETEIIKCLRNKDPQEILDNEAFVVPYSTPLSVNFGPTVDGDFLTDMPDTLLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNDSIITRKEFQEGLKVFFPNVSEFGKESILFHYTDWEDEDRPENYRDALAEVVGDYFFICPALEFAKKYAEHGNNAYFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRLNYTKEEEILSREIMRRWANFAKYGNPNETQNNSTQWPVFKPTEQKYLTLNTESSRIMTKLRAQHCRFWNSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6EMI"
"6EMJ",,"X-RAY DIFFRACTION",2.67,53.94,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 8.5  
20 %w/v PEG 6K",293,,,"6EMJ",96.27,"2.3","2.3","FAB Fragment. AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision making in antibody drug discovery","EVQLVESGGGLVQPGGSLRLSCATSGFDFSRYWMSWVRQAPGKGLVWIGEVNPDSTSINYTPSLKDQFTISRDNAKNTLYLQMNSLRAEDTAVYYCTRPNYYGSRYHYYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"fAB heavy chain","1","6EMJ"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQDINNYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGSTLPFTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"fAb light chain","2","6EMJ"
"6EMM",,"X-RAY DIFFRACTION",3.18,61.33,"VAPOR DIFFUSION, SITTING DROP",7,"HEPES 0.1 M pH 7.00, sodium formate 3.3 M",291,,,"6EMM",29.78,"2.47","2.47","17beta-hydroxysteroid dehydrogenase 14 variant T205 in complex with Salicylic acid","GHMATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRATIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPSGS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6EMM"
"6EN5",,"X-RAY DIFFRACTION",3,59.02,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.06 M DIVALENT CATIONS, 0.1 M TRIS/BICINE PH 8.5, 30 % PEG550MME/PEG20000",289,"10.1021/acs.jmedchem.7b01478","BJ2","6EN5",304.58,"1.75","1.75","Crystal structure A of the Angiotensin-1 converting enzyme N-domain in complex with a diprolyl inhibitor.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6EN5"
"6EN6",,"X-RAY DIFFRACTION",3.03,59.39,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.06 M DIVALENT CATIONS, 0.1 M TRIS/BICINE PH 8.5, 30 % PEG550MME/PEG20000",289,"10.1021/acs.jmedchem.7b01478","BJ2","6EN6",304.45,"1.8","1.8","Crystal structure B of the Angiotensin-1 converting enzyme N-domain in complex with a diprolyl inhibitor.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPQKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6EN6"
"6ENC",,"X-RAY DIFFRACTION",2.43,49.36,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 0.1 IMIDAZOLE PH 6.8, 0.1    SODIUM ACETATE, 0.005 M YBCL3",298,"10.1038/s41598-017-13490-1","BGW","6ENC",70.42,"1.95","1.95","LTA4 hydrolase in complex with Compound11","GPGPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","6ENC"
"6END",,"X-RAY DIFFRACTION",2.43,49.36,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 0.1 IMIDAZOLE PH 6.8, 0.1 SODIUM ACETATE, 0.005 M YBCL3",298,"10.1038/s41598-017-13490-1","BGK","6END",70.31,"2.24","2.24","LTA4 hydrolase in complex with Compound15","GPGPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","6END"
"6ENM",,"X-RAY DIFFRACTION",2,38.53,"VAPOR DIFFUSION, SITTING DROP",8.5,"Drops: 1 micro-L  hMMP12 at 927 micro-M + 10 mM acetohydroxamic acid, LP168 at 1 milli-M and 1 micro-L precipitant.
Precipitant: 17% PEG 20K, 0.2 M imidazole malate, pH 8.5, 0.250 M NaCl
cryoprotectant: 27% PEG8K, 15% MPEG550, 10% glycerol, 90mM Tris-HCl, pH 8.0",293,"10.1021/acs.jmedchem.8b00096","LPW","6ENM",36.53,"1.59","1.59","Crystal structure of MMP12 in complex with hydroxamate inhibitor LP168.","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","6ENM"
"6ENP",,"X-RAY DIFFRACTION",1.79,31.16,"VAPOR DIFFUSION, HANGING DROP",4.5,"1 M ammonium phosphate, 100 mM sodium acetate pH 4.5",293,"10.1016/j.bbagen.2018.09.021",,"6ENP",15.26,"1.042","1.042","Atomic resolution structure of human RNase 6 in the presence of phosphate anions in P21 space group.","MWPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLHDSFQNVAAVCDLLSIVCKNRRHNCHQSSKPVNMTDCRLTSGKYPQCRYSAAAQYKFFIVACDPPQKSDPPYKLVPVHLDSIL","Homo sapiens","RNASE6, RNS6","Ribonuclease K6","1","6ENP"
"6ENQ",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION, HANGING DROP",,"Na Citrate 0,9 M
1,2 - propanediol 3,5 %
Hepes 0,1 M",293,"10.1021/acs.jmedchem.7b01285","BJB","6ENQ",64.85,"2.2","2.2","Structure of human PPAR gamma LBD in complex with Lanifibranor (IVA337)","EISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6ENQ"
"6EOG",,"X-RAY DIFFRACTION",2.11,41.71,"VAPOR DIFFUSION, HANGING DROP",,"19 MG/ML GALECTIN-3C, 100MM NACL, 29 % W/V PEG 4000, 0.4 M NASCN, 18 MM BETA-MERCAPTOETHANOL,0.02 % NAN3, 10 MM PHOSHATE, 100 MM MGCL2, 100 MM TRIS/HCL PH 7.5, 2.5 MM LIGAND",298,"10.1002/cmdc.201700744","BKK","6EOG",16.42,"1.2","1.2","Human galectin-3c in complex with a galactose derivative","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6EOG"
"6EOL",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, HANGING DROP",,"20 MG/ML GALECTIN-3C, 100MM NACL, 30 % W/V PEG 4000, 0.4 M NASCN, 8 MM BETA-MERCAPTOETHANOL, 10 MM PHOSHATE, 100 MM MGCL2, 100 MM TRIS/HCL PH 7.5, 1.0 MM LIGAND",,"10.1002/cmdc.201700744","BKH","6EOL",16.37,"1.5","1.5","Human galectin-3c in complex with a galactose derivative","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6EOL"
"6EOO",,"X-RAY DIFFRACTION",4.23,70.89,"VAPOR DIFFUSION, HANGING DROP",,"Na Citrate 0.46M",277,"10.1073/pnas.1717565115",,"6EOO",310.45,"2.5","2.5","DPP8 - Apo, space group 20","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","6EOO"
"6EOQ",,"X-RAY DIFFRACTION",2.84,56.64,"VAPOR DIFFUSION, HANGING DROP",,"10%PEG 8000, 25% Glycerol, 0.16M Calcium Acetate, 0.08M Caodilate pH6.25,",293,"10.1073/pnas.1717565115",,"6EOQ",396.85,"3","3","DPP9 - Apo","MATTGTPTADRGDAAATDDPAARFQVQKHSWDGLRSIIHGSRKYSGLIVNKAPHDFQFVQKTDESGPHSHRLYYLGMPYGSRENSLLYSEIPKKVRKEALLLLSWKQMLDHFQATPHHGVYSREEELLRERKRLGVFGITSYDFHSESGLFLFQASNSLFHCRDGGKNGFMVSPMKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSPGEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYLHHHHHH","Homo sapiens","DPP9, DPRP2","Dipeptidyl peptidase 9","1","6EOQ"
"6EOR",,"X-RAY DIFFRACTION",2.77,55.67,"VAPOR DIFFUSION, HANGING DROP",,"10% PEG 8000, 25% Glycerol, 0.16M Calcium Acetate, 0.08M Cacodilate pH 6.25",293,"10.1073/pnas.1717565115","9XH","6EOR",398.87,"2.9","2.9","DPP9 - 1G244","MATTGTPTADRGDAAATDDPAARFQVQKHSWDGLRSIIHGSRKYSGLIVNKAPHDFQFVQKTDESGPHSHRLYYLGMPYGSRENSLLYSEIPKKVRKEALLLLSWKQMLDHFQATPHHGVYSREEELLRERKRLGVFGITSYDFHSESGLFLFQASNSLFHCRDGGKNGFMVSPMKPLEIKTQCSGPRMDPKICPADPAFFSFINNSDLWVANIETGEERRLTFCHQGLSNVLDDPKSAGVATFVIQEEFDRFTGYWWCPTASWEGSEGLKTLRILYEEVDESEVEVIHVPSPALEERKTDSYRYPRTGSKNPKIALKLAEFQTDSQGKIVSTQEKELVQPFSSLFPKVEYIARAGWTRDGKYAWAMFLDRPQQWLQLVLLPPALFIPSTENEEQRLASARAVPRNVQPYVVYEEVTNVWINVHDIFYPFPQSEGEDELCFLRANECKTGFCHLYKVTAVLKSQGYDWSEPFSPGEDEFKCPIKEEIALTSGEWEVLARHGSKIWVNEETKLVYFQGTKDTPLEHHLYVVSYEAAGEIVRLTTPGFSHSCSMSQNFDMFVSHYSSVSTPPCVHVYKLSGPDDDPLHKQPRFWASMMEAASCPPDYVPPEIFHFHTRSDVRLYGMIYKPHALQPGKKHPTVLFVYGGPQVQLVNNSFKGIKYLRLNTLASLGYAVVVIDGRGSCQRGLRFEGALKNQMGQVEIEDQVEGLQFVAEKYGFIDLSRVAIHGWSYGGFLSLMGLIHKPQVFKVAIAGAPVTVWMAYDTGYTERYMDVPENNQHGYEAGSVALHVEKLPNEPNRLLILHGFLDENVHFFHTNFLVSQLIRAGKPYQLQIYPNERHSIRCPESGEHYEVTLLHFLQEYLHHHHHH","Homo sapiens","DPP9, DPRP2","Dipeptidyl peptidase 9","1","6EOR"
"6EOS",,"X-RAY DIFFRACTION",4.27,71.16,"VAPOR DIFFUSION, HANGING DROP",,"Na Citrate 0.46M",277,"10.1073/pnas.1717565115",,"6EOS",620.9,"3.1","3.1","DPP8 - Apo, space group 19","MWKRSEQMKIKSGKCNMAAAMETEQLGVEIFETADCEENIESQDRPKLEPFYVERYSWSQLKKLLADTRKYHGYMMAKAPHDFMFVKRNDPDGPHSDRIYYLAMSGENRENTLFYSEIPKTINRAAVLMLSWKPLLDLFQATLDYGMYSREEELLRERKRIGTVGIASYDYHQGSGTFLFQAGSGIYHVKDGGPQGFTQQPLRPNLVETSCPNIRMDPKLCPADPDWIAFIHSNDIWISNIVTREERRLTYVHNELANMEEDARSAGVATFVLQEEFDRYSGYWWCPKAETTPSGGKILRILYEENDESEVEIIHVTSPMLETRRADSFRYPKTGTANPKVTFKMSEIMIDAEGRIIDVIDKELIQPFEILFEGVEYIARAGWTPEGKYAWSILLDRSQTRLQIVLISPELFIPVEDDVMERQRLIESVPDSVTPLIIYEETTDIWINIHDIFHVFPQSHEEEIEFIFASECKTGFRHLYKITSILKESKYKRSSGGLPAPSDFKCPIKEEIAITSGEWEVLGRHGSNIQVDEVRRLVYFEGTKDSPLEHHLYVVSYVNPGEVTRLTDRGYSHSCCISQHCDFFISKYSNQKNPHCVSLYKLSSPEDDPTCKTKEFWATILDSAGPLPDYTPPEIFSFESTTGFTLYGMLYKPHDLQPGKKYPTVLFIYGGPQVQLVNNRFKGVKYFRLNTLASLGYVVVVIDNRGSCHRGLKFEGAFKYKMGQIEIDDQVEGLQYLASRYDFIDLDRVGIHGWSYGGYLSLMALMQRSDIFRVAIAGAPVTLWIFYDTGYTERYMGHPDQNEQGYYLGSVAMQAEKFPSEPNRLLLLHGFLDENVHFAHTSILLSFLVRAGKPYDLQIYPQERHSIRVPESGEHYELHLLHYLQENLGSRIAALKVI","Homo sapiens","DPP8, DPRP1, MSTP097, MSTP135, MSTP141","Dipeptidyl peptidase 8","1","6EOS"
"6EOU",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Na-HEPES and 0.1 M MOPS-HCl pH 7,5, 0.04 M diethylene glycol, 0.04 M triethylene glycol, 0.04 M tetraethylene glycol, 0.04 M pentaethylene glycol, 20 % v/v ethylene glycol and 10 % w/v PEG 4000",295.2,"10.1016/j.chembiol.2018.03.004",,"6EOU",43.54,"1.75","1.75","O-GlcNAc transferase TPR domain with the intellectual disability associated mutation L254F","GPMELAHREYQAGDFEAAERHCMQLWRQEPDNTGVLLLLSSIHFQCRRLDRSAHFSTLAIKQNPLLAEAYSNLGNVYKERGQLQEAIEHYRHALRLKPDFIDGYINLAAALVAAGDMEGAVQAYVSALQYNPDLYCVRSDLGNLLKALGRLEEAKACYLKAIETQPNFAVAWSNLGCVFNAQGEIWLAIHHFEKAVTLDPNFLDAYINLGNVLKEARIFDRAVAAYLRALSFSPNHAVVHGNLACVYYEQGLIDLAIDTYRRAIELQPHFPDAYCNLANALKEKGSVAEAEDCYNTALRLCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTLKEMQD","Homo sapiens","OGT","UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit","1","6EOU"
"6EOX",,"X-RAY DIFFRACTION",2.11,41.76,"VAPOR DIFFUSION, SITTING DROP",8.5,"Drop: 1 micro-L (hMMP-12 at 855 micro-M + 1 milli-M hydroxamic acid + 1 milli-M LP165) and 1 micro-L reservoir solution.
Precipitant: 17% PEG 20K, 0.2M imidazole malate
250mM NaCl, pH 8.5.
Cryoprotection: 40% MPEG 5K, 10% 1,2-propanediol, 10% AAB (sodium acetate, ADA, bicine: 90% basic/10% acid), pH 8.0",293,"10.1021/acs.jmedchem.8b00096","BKW","6EOX",18.25,"1.3","1.3","Crystal structure of MMP12 in complex with carboxylic inhibitor LP165.","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","6EOX"
"6EOY",,"X-RAY DIFFRACTION",2.34,47.35,"EVAPORATION",,"acetate buffer 0.2 M pH 4.8-5.4, ammonium sulfate 1.8-2.2 M, 7% glycerol",293,"10.1016/j.ejmech.2021.113847",,"6EOY",25.69,"1.38","1.38","Transthyretin in complex with 4-(1,3-Benzothiazol-2-yl)-2-methylaniline","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6EOY"
"6EP1",,"X-RAY DIFFRACTION",2.34,47.5,"EVAPORATION",,"acetate buffer 0.2 M pH 4.8-5.4, ammonium sulfate 1.8-2.2 M, 7% glycerol",293,,,"6EP1",26.04,"1.3","1.3","Transthyretin in complex with 5-(4-nitrophenylazo)-3-iodosalicylic acid","CPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","Transthyretin","1","6EP1"
"6EP4",,"X-RAY DIFFRACTION",3.36,63.39,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 MES Buffer, 2.1 M ammonium sulfate",293,"10.3390/molecules22122098","DME","6EP4",62.2,"2.30005381157","2.30005381157","Human butyrylcholinesterase in complex with decamethonium","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6EP4"
"6EP9",,"X-RAY DIFFRACTION",2.27,45.81,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES",293,"10.1007/s10822-019-00187-y",,"6EP9",33.14,"2.01","2.01","Crystal structure of BTK kinase domain complexed with N-[2-methyl-3-[4-methyl-6-[4-(4-methylpiperazine-1-carbonyl)anilino]-5-oxo-pyrazin-2-yl]phenyl]-4-(1-piperidyl)benzamide","GSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREARHAFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASAAVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","6EP9"
"6EPJ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.0 M ammonium sulfate 
0.1 M Bis-tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6EPJ",16.16,"1.652","1.652","The ATAD2 bromodomain in complex with compound 6","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6EPJ"
"6EPR",,"X-RAY DIFFRACTION",4.13,70.21,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M ammonium sulfate, 0.1M Bis-Tris pH 5.5",277,,,"6EPR",16.04,"2.053","2.053","The ATAD2 bromodomain in complex with compound UZH-DS15","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6EPR"
"6EPS",,"X-RAY DIFFRACTION",4.13,70.22,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M ammonium sulfate, 0.1M Bis-Tris pH 5.5",277,,,"6EPS",15.91,"2.081","2.081","The ATAD2 bromodomain in complex with compound UZH-DQ41","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6EPS"
"6EPT",,"X-RAY DIFFRACTION",4.13,70.25,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M ammonium sulfate, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6EPT",16.24,"1.65","1.65","The ATAD2 bromodomain in complex with compound 12","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6EPT"
"6EPU",,"X-RAY DIFFRACTION",4.06,69.68,"VAPOR DIFFUSION, HANGING DROP",5.5,"2M (NH4)2SO4, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6EPU",15.8,"1.8","1.8","The ATAD2 bromodomain in complex with compound 2","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6EPU"
"6EPV",,"X-RAY DIFFRACTION",4.07,69.79,"VAPOR DIFFUSION, HANGING DROP",,"2M ammonium sulfate, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6EPV",15.79,"1.793","1.793","The ATAD2 bromodomain in complex with compound 5","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6EPV"
"6EPW",,"X-RAY DIFFRACTION",4.08,69.86,"VAPOR DIFFUSION, HANGING DROP",,"2M ammonium sulfate, 0.1M Bis-Tris pH 5.5",277,,,"6EPW",16.28,"1.924","1.924","The ATAD2 bromodomain in complex with compound UZH-DU32","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6EPW"
"6EPX",,"X-RAY DIFFRACTION",4.09,69.9,"VAPOR DIFFUSION, HANGING DROP",,"2M ammonium sulfate, 0.1M Bis-Tris pH 5.5",277,"10.1021/acsmedchemlett.0c00080",,"6EPX",16.07,"1.84","1.84","The ATAD2 bromodomain in complex with compound 3","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6EPX"
"6EQ2",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"23 % PEG3350, 0.2 M LI2SO4, 0.1 M SODIUM ACETATE PH 4.5",293,"10.1016/j.ejmech.2019.04.037",,"6EQ2",21.24,"1.802","1.802","MTH1 in complex with fragment 6","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6EQ2"
"6EQ3",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"23 % PEG3350, 0.2 M LI2SO4, 0.1 M SODIUM ACETATE PH 4.5",293,"10.1016/j.ejmech.2019.04.037",,"6EQ3",21.43,"1.798","1.798","MTH1 in complex with fragment 9","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6EQ3"
"6EQ4",,"X-RAY DIFFRACTION",1.7,27.68,"VAPOR DIFFUSION, HANGING DROP",4.5,"23 % PEG3350, 0.2 M LI2SO4, 0.1 M SODIUM ACETATE PH 4.5",293,"10.1016/j.ejmech.2019.04.037",,"6EQ4",21.51,"1.4","1.4","MTH1 in complex with fragment 8","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6EQ4"
"6EQ5",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"23 % PEG3350, 0.2 M LI2SO4, 0.1 M SODIUM ACETATE PH4.5",293,"10.1016/j.ejmech.2019.04.037",,"6EQ5",21.33,"1.801","1.801","MTH1 in complex with fragment 4","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6EQ5"
"6EQ6",,"X-RAY DIFFRACTION",1.73,,"VAPOR DIFFUSION, HANGING DROP",4.5,"23 % PEG3350, 0.2 M LI2SO4, 0.1 M SODIUM ACETATE PH 4.5",293,"10.1016/j.ejmech.2019.04.037",,"6EQ6",21.47,"2.002","2.002","MTH1 in complex with fragment 1","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6EQ6"
"6EQ7",,"X-RAY DIFFRACTION",2.04,39.56,"VAPOR DIFFUSION, HANGING DROP",4.5,"23 % PEG3350, 0.2 M LI2SO4, 0.1 M SODIUM ACETATE PH4.5",293,"10.1016/j.ejmech.2019.04.037",,"6EQ7",21.43,"1.5","1.5","MTH1 in complex with fragment 11","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6EQ7"
"6EQ9",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Bis-Tris pH 5.5, 200 mM NaCl, 29% PEG 3350, 1 mM AMP-PCP, 0.4 mM Zwittergent 3-14, 10% Ethylene glycol",293,"10.1021/acsomega.8b00668",,"6EQ9",86.37,"1.83","1.83","Crystal structure of JNK3 in complex with AMP-PCP","GGSMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","6EQ9"
"6EQJ",,"X-RAY DIFFRACTION",2.49,50.59,"VAPOR DIFFUSION, SITTING DROP",6.2,"28% PEG smear broad, 0.1M sodium/potassium phosphate pH 6.2, 0.2M sodium chloride",293.15,"10.1038/s41586-018-0644-7",,"6EQJ",30.03,"2.18","2.18","Crystal Structure of Human Glycogenin-1 (GYG1) Tyr195pIPhe mutant, apo form","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIFSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG1, GYG","Glycogenin-1","1","6EQJ"
"6EQL",,"X-RAY DIFFRACTION",2.51,50.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"22.5% PEG Smear High, 0.2M potassium chloride",293.15,"10.1038/s41586-018-0644-7",,"6EQL",60.84,"2.38","2.38","Crystal Structure of Human Glycogenin-1 (GYG1) Tyr195pIPhe mutant complexed with manganese and UDP","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIFSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG1, GYG","Glycogenin-1","1","6EQL"
"6EQM",,"X-RAY DIFFRACTION",2.13,42.31,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% PEG 1,500 in water",292,"10.15252/emmm.201809316","BUH","6EQM",45.29,"1.35","1.35","Crystal Structure of Human BACE-1 in Complex with CNP520","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6EQM"
"6EQP",,"X-RAY DIFFRACTION",3.43,64.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 MES BUFFER, 2.1 M AMMONIUM SULFATE",293,"10.3390/molecules22122098","BUW","6EQP",62.61,"2.34941708483","2.34941708483","Human butyrylcholinesterase in complex with ethopropazine","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6EQP"
"6EQQ",,"X-RAY DIFFRACTION",3.36,63.42,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES buffer, 2.1 M Ammonium sulfate",293,"10.3390/molecules22122098",,"6EQQ",62.82,"2.40000447819","2.40000447819","Human butyrylcholinesterase in complex with huprine 19","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6EQQ"
"6EQS",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, SITTING DROP",5.5,"30% PEG3350, 0.2 M NaCl, 0.1 M Bis-Tris pH 5.5, 5% 1,3-butandiol",293,"10.1002/anie.201709050",,"6EQS",126.44,"1.32","1.32","Human Sirt5 in complex with stalled peptidylimidate intermediate of inhibitory compound 29","GIDPFTARPSSSMADFRKFFAKAKHIVIISGAGVSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRAIAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPICPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELAHCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEALA","Homo sapiens","SIRT5, SIR2L5","NAD-dependent protein deacylase sirtuin-5, mitochondrial","1","6EQS"
"6EQT",,"X-RAY DIFFRACTION",3.18,55.3,"VAPOR DIFFUSION",,"6-16% PEG3350, pH 6.6-7.2",277,"10.7554/eLife.33442",,"6EQT",52.06,"2.735","2.735","CRYSTAL STRUCTURE OF THE HUMAN KINETOCHORE PROTEIN CENP-N","MDETVAEFIKRTILKIPMNELTTILKAWDFLSENQLQTVNFRQRKESVVQHLIHLCEEKRASISDAALLDIIYMQFHQHQKVWDVFQMSKGPGEDVDLFDMKQFKNSFKKILQRALKNVTVSFRETEENAVWIRIAWGTQYTKPNQYKPTYVVYYSQTPYAFTSSSMLRRNTPLLGQALTIASKHHQIVKMDLRSRYLDSLKAIVFKQYNQTFHHHHHH","Homo sapiens","CENPN, C16orf60, ICEN32, BM-309","Centromere protein N","1","6EQT"
"6EQU",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.3 M SODIUM CITRATE, 100 mM TRIS-HCl",293,"10.1080/14756366.2017.1405263","BVE","6EQU",29.9,"1.65","1.65","X-Ray crystal structure of the human carbonic anhydrase II adduct with a membrane-impermeant inhibitor","GMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6EQU"
"6EQY",,"SOLUTION NMR",,,,,,,"10.1038/s41598-018-30042-3",,"6EQY",14.41,,,"4th KOW domain of human hSpt5","AMGSETASGVDVGGQHEWGELVQLDPQTVGVIVRLERETFQVLNMYGKVVTVRHQAVTRKKDNRFAVALDSEQNNIHVKDIVKVIDGPHSGREGEIRHLFRSFAFLHCKKLVENGGMFVCKTRHLVLAG","Homo sapiens","SUPT5H, SPT5, SPT5H","Transcription elongation factor SPT5","1","6EQY"
"6ER0",,"SOLUTION NMR",,,,,,,"10.1038/s41598-018-30042-3",,"6ER0",13.86,,,"6th KOW domain of human hSpt5","GGYNPHTPGSGIEQNSSDWVTTDIQVKVRDTYLDTQVVGQTGVIRSVTGGMCSVYLKDSEKVVSISSEHLEPITPTKNNKVKVILGEDREATGVLLSIDGEDGIVRMDLDEQLKILNLRFLGKLLEA","Homo sapiens","SUPT5H, SPT5, SPT5H","Transcription elongation factor SPT5","1","6ER0"
"6ERL",,"SOLUTION NMR",,,,,,,"10.1002/chem.201801851",,"6ERL",7.32,,,"Quadruplex with flipped tetrad formed by the c-myc promoter sequence","TGAGGGTGGGTAGGGTGGGTAA","Homo sapiens",,"cmbr-481317","1","6ERL"
"6ERO",,"X-RAY DIFFRACTION",2.26,45.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"NaCl, PEG3350, HEPES",293,"10.1016/j.cell.2017.10.036",,"6ERO",71.69,"1.75","1.75","Structure of human TFB2M","NAKASKASLDFKRYVTDRRLAETLAQIYLGKPSRPPHLLLECNPGPGILTQALLEAGAKVVALESDKTFIPHLESLGKNLDGKLRVIHCDFFKLDPRSGGVIKPPAMSSRGLFKNLGIEAVPWTADIPLKVVGMFPSRGEKRALWKLAYDLYSCTSIYKFGRIEVNMFIGEKEFQKLMADPGNPDLYHVLSVIWQLACEIKVLHMEPGSSGKLYLIQMIPRQNLFTKNLTPMNYNIFFHLLKHCFGRRSATVIDHLRSLTPLDARDILMQIGKQEDEKVVNMHPQDFKTLFETIERSKDCAYKWLYDETLEDR","Homo sapiens","TFB2M, NS5ATP5","Dimethyladenosine transferase 2, mitochondrial,Dimethyladenosine transferase 2, mitochondrial","1","6ERO"
,,,,,,,,,,,,,,,,,"Homo sapiens","TFB2M, NS5ATP5"
"6ES0",,"X-RAY DIFFRACTION",2.48,50.41,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG Smear Low -- 0.1M MES pH 6.5 -- 0.05M magnesium acetate -- 0.05M magnesium chloride",293,"10.1016/j.bmcl.2018.01.044","BW8","6ES0",73.75,"2.38","2.38","Crystal structure of the kinase domain of human RIPK2 in complex with the activation loop targeting inhibitor CS-R35","SMGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLKKTKLQSV","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6ES0"
"6ESJ",,"X-RAY DIFFRACTION",2.86,56.98,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.2 M Ammonium Sulfate, 12% Polyethylene glycol 4000",293,"10.3390/molecules22122098",,"6ESJ",123.83,"2.97984513804","2.97984513804","Human butyrylcholinesterase in complex with propidium","EDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6ESJ"
"6ESM",,"X-RAY DIFFRACTION",2.08,40.82,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein: human MMP9 E402Q  300 micro-M
Precipitant: 31.5% MPEG 5K; .14 M imidazole piperidine; pH 8.5
Cryoprotectant: 40% CM2 (25% di-ethylene glycol + 25% glycerol + 25% 1,2-propanediol), 10% PEG 10K, 200 milli-M NaCl, 100milli-M PCTP 50/50",293,"10.1021/acs.jmedchem.8b00096","B9Z","6ESM",18.66,"1.104","1.104","Crystal structure of MMP9 in complex with inhibitor BE4.","FEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVGYSLFLVAAHQFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYG","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9,Matrix metalloproteinase-9","1","6ESM"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"6ESP",,"SOLUTION NMR",,,,,,,"10.15252/msb.20178129",,"6ESP",12.22,,,"Proteome-wide analysis of phospho-regulated PDZ domain interactions","GAMGAPARIEEEELTLTILRQTGGLGISIAGGKGSTPYKGDDEGIFISRVSEEGPAARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAVQMRVWRERMVEPENAVTITPLR","Homo sapiens","SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL","Protein scribble homolog","1","6ESP"
"6ESY",,"X-RAY DIFFRACTION",2.76,55.41,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.2 M AMMONIUM SULFATE, 12% POLYETHYLENE GLYCOL 4000",293,"10.3390/molecules22122098","TFX","6ESY",124.85,"2.8","2.8","Human butyrylcholinesterase in complex with thioflavine T","EDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6ESY"
"6ET4",,"X-RAY DIFFRACTION",3.67,66.47,"VAPOR DIFFUSION, HANGING DROP",4.8,"30% glycerol, 100 mM Sodium acetate pH 4.8, 2 M Ammoniumsulphate",293,"10.1038/s41467-018-03441-3","SDV","6ET4",41.86,"1.7","1.7","HUMAN DIHYDROOROTATE DEHYDROGENASE IN COMPLEX WITH NOVEL INHIBITOR","MATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6ET4"
"6ETA",,"X-RAY DIFFRACTION",2.85,56.79,"BATCH MODE",7,"0.1M phosphate, 20mM DTT",293,"10.1016/j.bpj.2019.07.019",,"6ETA",41.4,"2.198","2.198","Crystal Structure of Human Gamma-D crystallin Mutant P23T+R36S at Room Temperature","MGKITLYEDRGFQGRHYECSSDHTNLQPYLSRCNSASVDSGCWMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNEIHSLNVLEGSWVLYELSNYRGRQYLLMPGDYRRYQDWGATNARVGSLRRVIDFS","Homo sapiens","CRYGD, CRYG4","Gamma-crystallin D","1","6ETA"
"6ETC",,"X-RAY DIFFRACTION",1.77,30.47,"BATCH MODE",7,"0.1M phosphate buffer, 20mM DTT",310,"10.1016/j.bpj.2019.07.019",,"6ETC",20.7,"1.197","1.197","Crystal Structure of Human gamma-D-crystallin Mutant P23T+R36S at 1.2 Angstroms Resolution","MGKITLYEDRGFQGRHYECSSDHTNLQPYLSRCNSASVDSGCWMLYEQPNYSGLQYFLRRGDYADHQQWMGLSDSVRSCRLIPHSGSHRIRLYEREDYRGQMIEFTEDCSCLQDRFRFNEIHSLNVLEGSWVLYELSNYRGRQYLLMPGDYRRYQDWGATNARVGSLRRVIDFS","Homo sapiens","CRYGD, CRYG4","Gamma-crystallin D","1","6ETC"
"6ETE",,"X-RAY DIFFRACTION",2.53,51.42,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6ETE",40.46,"1.468","1.468","Crystal structure of KDM4D with tetrazolhydrazide compound 5","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6ETE"
"6ETG",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,"10.1002/cmdc.201900441",,"6ETG",40.73,"1.279","1.279","Crystal structure of KDM4D with tetrazolhydrazide compound 6","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6ETG"
"6ETJ",,"X-RAY DIFFRACTION",4.01,69.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG3350, Hepes, glycerol",277,"10.1038/s41467-018-06287-x",,"6ETJ",60.94,"2.51","2.51","HUMAN PFKFB3 IN COMPLEX WITH KAN0438241","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","6ETJ"
"6ETS",,"X-RAY DIFFRACTION",2.54,51.55,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,"10.1002/cmdc.201900441",,"6ETS",40.51,"1.333","1.333","Crystal structure of KDM4D with tetrazolhydrazide compound 1","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQD","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6ETS"
"6ETT",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,"10.1002/cmdc.201900441",,"6ETT",40.8,"1.257","1.257","Crystal structure of KDM4D with tetrazole compound 4","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6ETT"
"6ETU",,"X-RAY DIFFRACTION",2.56,51.98,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,"10.1002/cmdc.201900441",,"6ETU",40.29,"1.33","1.33","Crystal structure of KDM4D with tetrazolhydrazide compound 7","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6ETU"
"6ETV",,"X-RAY DIFFRACTION",2.52,51.16,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,"10.1002/cmdc.201900441",,"6ETV",40.69,"1.18","1.18","Crystal structure of KDM4D with tetrazolhydrazide compound 2","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6ETV"
"6ETW",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,"10.1002/cmdc.201900441",,"6ETW",40.36,"1.35","1.35","Crystal structure of KDM4D with tetrazolhydrazide compound 3","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6ETW"
"6ETY",,"X-RAY DIFFRACTION",3.3,62.74,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, and 100 mM Tris-HCl, pH 8.0",293,"10.1016/j.bmc.2018.11.022",,"6ETY",83.14,"1.68","1.68","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor JHU3371","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6ETY"
"6EUA",,"X-RAY DIFFRACTION",2.02,35.14,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.2 M Magnesium chloride hexahydrate, 0.1 M BIS-Tris pH 5.5, 25 % (w/v) PEG 3350",295,"10.1038/s41598-018-25237-7",,"6EUA",80.12,"2.095","2.095","The fibrinogen-like domain of human Angptl3","MHHHHHHMIPAECTTIYNRGEHTSGMYAIRPSNSQVFHVYCDVISGSPWTLIQHRIDGSQNFNETWENYKYGFGRLDGEFWLGLEKIYSIVKQSNYVLRIELEDWKDNKHYIEYSFYLGNHETNYTLHLVAITGNVPNAIPENKDLVFSTWDHKAKGHFNCPEGYSGGWWWHDECGENNLNGKYNKPRAKSKPERRRGLSWKSQNGRLYSIKSTKMLIHPTDSESFE","Homo sapiens","ANGPTL3, ANGPT5, UNQ153/PRO179","Angiopoietin-related protein 3","1","6EUA"
"6EUB",,"X-RAY DIFFRACTION",3.37,63.49,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1 M Bis-Tris Propane pH 7.5, 0.2 M Sodium malonate, 20 % (w/v) PEG 3350",295,"10.1038/s41598-018-25237-7",,"6EUB",26.4,"2.3","2.3","The fibrinogen-like domain of human Angptl4","MHHHHHHMLPRDCQELFQVGERQSGLFEIQPQGSPPFLVNCKMTSDGGWTVIQRRHDGSVDFNRPWEAYKAGFGDPHGEFWLGLEKVHSITGDRNSRLAVQLRDWDGNAELLQFSVHLGGEDTAYSLQLTAPVAGQLGATTVPPSGLSVPFSTWDQDHDLRRDKNCAKSLSGGWWFGTCSHSNLNGQYFRSIPQQRQKLKKGIFWKTWRGRYYPLQATTMLIQPMAAEAAS","Homo sapiens","ANGPTL4, ARP4, HFARP, PGAR, PP1158, PSEC0166, UNQ171/PRO197","Angiopoietin-related protein 4","1","6EUB"
"6EUL",,"X-RAY DIFFRACTION",3.18,61.39,"VAPOR DIFFUSION",7.4,"Tris 20 mM pH 7.4
Ammonium sulfate 2.15 M",295,,,"6EUL",60.6,"2.6","2.6","Butyrylcolinesterase expressed in CHO cells co-crystallised with a rivastigmine analogue","DIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETENNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVL","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6EUL"
"6EVL",,"X-RAY DIFFRACTION",2.67,54.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"2.45 M ammonium sulphate, 10% DMSO, 100 mM MOPS, pH 6.5",277,"10.1002/pro.3450",,"6EVL",12.24,"1.87","1.87","Crystal structure of an unlignaded peptide-substrate-binding domain of human type II collagen prolyl 4-hydroxylase","MHHHHHHMLSVDDCFGMGRSAYNEGDYYHTVLWMEQVLKQLDAGEEATTTKSQVLDYLSYAVFQLGDLHRALELTRRLLSLDPSHERAGGNLRYFEQLLEEE","Homo sapiens","P4HA2, UNQ290/PRO330","Prolyl 4-hydroxylase subunit alpha-2","1","6EVL"
"6EVR",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, HANGING DROP",9,"28% PEG4000, 0.2 M Sodium acetate, Tris 100 mM",296,"10.1016/j.ejmech.2018.04.002","BZW, ACT","6EVR",58.92,"1.5","1.5","Crystal structure of human carbonic anhydrase I in complex with the 4-(4 acetyl-3-benzylpiperazine-1 carbonyl)benzene-1-sulfonamide inhibitor","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6EVR"
"6EW1",,"X-RAY DIFFRACTION",2.81,56.28,"VAPOR DIFFUSION, HANGING DROP",,"0.05 M ammonium citrate, 18 % PEG 3350",293,"10.1016/j.str.2018.09.007",,"6EW1",31.05,"2.3070081803","2.3070081803","Crystal structure of the Filamin A Ig-like domains 3-5 mutant P637Q","SMCNPSACRAVGRGLQPKGVRVKETADFKVYTKGAGSGELKVTVKGPKGEERVKQKDLGDGVYGFEYYPMVPGTYIVTITWGGQNIGRSPFEVKVGTECGNQKVRAWGPGLEGGVVGKSADFVVEAIGDDVGTLGFSVEGPSQAKIECDDKGDGSCDVRYWQQEAGEYAVHVLCNSEDIRLSPFMADIRDAPQDFHPDRVKARGPGLEKTGVAVNKPAEFTVDAKHGGKAPLRVQVQDNEGCPVEALVKDNGNGTYSCSYVPRKPVKHTAMVSWGGVSIPNSPFRVNVGAG","Homo sapiens","FLNA, FLN, FLN1","Filamin-A","1","6EW1"
"6EW2",,"X-RAY DIFFRACTION",2.22,44.49,"VAPOR DIFFUSION, SITTING DROP",,"40-42% PEG 6000",277,"10.1186/s12900-018-0087-2",,"6EW2",15.21,"1.588","1.588","Human myelin protein P2 F57A mutant, tetragonal crystal form","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTAKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6EW2"
"6EW4",,"X-RAY DIFFRACTION",2.11,41.71,"VAPOR DIFFUSION, SITTING DROP",,"40-42% PEG 6000",277,"10.1186/s12900-018-0087-2",,"6EW4",15.17,"1.271","1.271","Human myelin protein P2 F57A mutant, monoclinic crystal form","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTAKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6EW4"
"6EW5",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, SITTING DROP",,"40-42% PEG 6000",277,"10.1186/s12900-018-0087-2",,"6EW5",60.69,"1.95","1.95","Human myelin protein P2 F57A mutant, monoclinic crystal form","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTAKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","Myelin P2 protein","1","6EW5"
"6EW6",,"X-RAY DIFFRACTION",2.04,39.7,"VAPOR DIFFUSION, SITTING DROP",,"unknown",293,"10.1021/acschembio.8b00698","C0H","6EW6",14.41,"1.39","1.39","Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligand","DSQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTARKFIKAS","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6EW6"
"6EW7",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, SITTING DROP",,"unknown",310,"10.1021/acschembio.8b00698","C1W","6EW7",29.06,"1.6","1.6","Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligand","SQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKAS","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6EW7"
"6EW8",,"X-RAY DIFFRACTION",2.04,39.7,"VAPOR DIFFUSION, SITTING DROP",,"unknown",310,"10.1021/acschembio.8b00698",,"6EW8",14.82,"1.84","1.84","Crystal structure of the BCL6 BTB domain in complex with anilinopyrimidine ligand","DSQIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE","Homo sapiens","BCL6, BCL5, LAZ3, ZBTB27, ZNF51","B-cell lymphoma 6 protein","1","6EW8"
"6EX1",,"X-RAY DIFFRACTION",2.33,47.12,"VAPOR DIFFUSION, HANGING DROP",9,"28% PEG4000, 0.2 M Sodium acetate, Tris 100 mM",296,"10.1016/j.ejmech.2018.04.002","N19, ACT","6EX1",58.83,"1.6","1.6","Crystal structure of human carbonic anhydrase I in complex with the 4-[(3S)-3 benzyl-4-(4-sulfamoylbenzoyl)piperazine -1-carbonyl]benzene-1-sulfonamide inhibitor","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6EX1"
"6EXW",,"X-RAY DIFFRACTION",3.23,61.94,"EVAPORATION",5.9,"12% PEG 3350, 0.22 M MgCl2, 0.1M BISTris",293,"10.1111/febs.14616",,"6EXW",29.85,"2.2","2.2","Crystal structure of cIAP1-BIR3 in complex with a covalently bound SM","MENSLETLRFSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRYPHLLEQLLSTSLEHHHHHH","Homo sapiens","BIRC2, API1, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","6EXW"
"6EXY",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.19,44,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG 4000 OR PEG 3000, 0.1M MGCL2, 0.015M BETA MERCAPTOETHANOL, 0.1M TRIS-DCL, PD 7.9, 0.4M NaSCN. All dissolved in D2O. Crystal grown in a 15 + 15 microlitre sitting drop that was first equilibrated for 1 week. A small crystal grown at 20-28% PEG was introduced. The drop was fed with fresh protein by adding 3-4 micro litres of protein with 10 mM lactose every 3-4 days for 3 months. Then the lactose was exchanged for glycerol by dialysis for at least one month against 10% glycerol (1.37 M), 24% PEG 4000 in the same buffer. For details see Manzoni et al. (2016).",293,"10.1021/acs.jmedchem.8b00081",,"6EXY",15.92,"1.1, 1.7","1.1, 1.7","Neutron crystal structure of perdeuterated galectin-3C in complex with glycerol","MPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6EXY"
"6EY2",,"X-RAY DIFFRACTION",2.73,54.95,"EVAPORATION",7.5,"10% PEG 400, 0.2 M MgCl2, 0.1M Hepes-Na",293,"10.1111/febs.14616",,"6EY2",136.29,"2.7","2.7","Crystal structure of XIAP-BIR3 in complex with a cIAP1-selective SM","HHHHHHSSGLVPRGSHMASMTGGQQMGRGSSDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTT","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","6EY2"
"6EY3",,"SOLUTION NMR",,,,,,,,,"6EY3",1.01,,,"mf2","CRPLWTACG","Homo sapiens",,"CYS-ARG-PRO-LEU-TRP-THR-ALA-CYS-GLY","1","6EY3"
"6EY8",,"X-RAY DIFFRACTION",3.22,61.81,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Na-cacodylateNa, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","C4T","6EY8",27.18,"2.16","2.16","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6EY8"
"6EY9",,"X-RAY DIFFRACTION",2.84,56.7,"VAPOR DIFFUSION, HANGING DROP",,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","C4N","6EY9",27.12,"2","2","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6EY9"
"6EYA",,"X-RAY DIFFRACTION",2.84,56.73,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","C4K","6EYA",27.02,"2.1","2.1","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6EYA"
"6EYB",,"X-RAY DIFFRACTION",2.81,56.16,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","C3Z","6EYB",27.06,"1.9","1.9","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6EYB"
"6EYF",,"X-RAY DIFFRACTION",3.21,61.68,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris pH 8.5, 2.15 M ammonium sulfate.",298,,,"6EYF",61.11,"2.6","2.6","Butyrylcolinesterase expressed in CHO cells co-crystallised with a rivastigmine analogue","DIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6EYF"
"6EYI",,"X-RAY DIFFRACTION",2.86,56.93,"VAPOR DIFFUSION, SITTING DROP",,"0.2M CaCl2, 0.1 M Mops pH 6.2, 11-14% PEG8000, after microseeding",293,,,"6EYI",33.55,"2.04","2.04","E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand BW69669","WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA","Homo sapiens","SELE, ELAM1","E-selectin","1","6EYI"
"6EYJ",,"X-RAY DIFFRACTION",2.74,55.16,"VAPOR DIFFUSION, SITTING DROP",,"0.2M CaCl2, 0.1 M Mops pH 6.2, 11-14% PEG8000, after microseeding",293,,,"6EYJ",67.05,"2.2","2.2","E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand NV354","WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA","Homo sapiens","SELE, ELAM1","E-selectin","1","6EYJ"
"6EYK",,"X-RAY DIFFRACTION",2.85,56.92,"VAPOR DIFFUSION, SITTING DROP",,"0.2M CaCl2, 0.1 M Mops pH 6.2, 11-14% PEG8000, after microseeding",293,,,"6EYK",33.58,"2.21","2.21","E-selectin lectin, EGF-like and two SCR domains complexed with glycomimetic ligand NV355","WSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKA","Homo sapiens","SELE, ELAM1","E-selectin","1","6EYK"
"6EYM",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.19,44,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG 4000 OR PEG 3000, 0.1M MGCL2, 0.015M BETA MERCAPTOETHANOL, 0.1M TRIS-DCL, PD 7.9, 0.4M NASCN. All dissolved in D2O. Crystal grown in a 15 + 15 microlitre sitting drops that was first equilibrated for 1 week. A crystal grown at 20-28% PEG was introduced. The drop was fed with fresh protein by adding 3-4 micro litres of protein with 10 mM lactose every 3-4 days for 3 months. For details see Manzoni et al. (2016).",295,"10.1021/acs.jmedchem.8b00081",,"6EYM",16.04,"1.7, 1.1","1.7, 1.1","Neutron crystal structure of perdeuterated galectin-3C in complex with lactose","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6EYM"
,,,2.19,44,"VAPOR DIFFUSION",7.5,"12-15% PEG 4000 OR PEG 3000, 0.1M MGCL2, 0.015M BETA MERCAPTOETHANOL, 0.1M TRIS-DCL, PD 7.9, 0.4M NASCN. All dissolved in D2O. Crystal grown in a 15 + 15 microlitre sitting drops that was first equilibrated for 1 week. A crystal grown at 20-28% PEG was introduced. The drop was fed with fresh protein by adding 3-4 micro litres of protein with 10 mM lactose every 3-4 days for 3 months. For details see Manzoni et al. (2016).",293
"6EYN",,"X-RAY DIFFRACTION",3.44,64.25,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M ADA (N-(2-acetamido) iminodiacetic acid) pH6.5 and 12% (w/v) PEG 4000",291,"10.1038/s41598-018-29664-4",,"6EYN",146.05,"2.4","2.4","Structure of the 8D6 (anti-IgE) Fab","DIVLTQSPASLAVSLGQRATISCKASQSVDYDGDTYMNWYHQKPGQPPKLLIYAASNLDSGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQTNEDPWTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"8D6 Fab light chain","1","6EYN"
,,,,,,,,,,,,,,,,"QVQLQQSGAELAKPGASVMLSCKASGYTFNGYWMHWVKQRPGQDLEWIGYINPTTGHTEYNQKFKDKATLTADESSNTAYIELSSLTSDDSAVYYCARQEYRHSWFAYWGQGTLVTVSAASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKAEPKSCDKTHT","Homo sapiens",,"8D6 Fab heavy chain","2","6EYN"
"6EZ2",,"X-RAY DIFFRACTION",2.97,58.55,"VAPOR DIFFUSION, HANGING DROP",7.4,"100 mM ammonium acetate, pH 7.40, 13% polyethylene glycol 3350",298,,,"6EZ2",122.64,"2.7","2.7","Human butyrylcholinesterase carbamylated.","DIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6EZ2"
"6EZ4",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-04431-1",,"6EZ4",15.8,,,"NMR structure of the C-terminal domain of the human RPAP3 protein","GPHMAQFATTVLPPIPANSFQLESDFRQLKSSPDMLYQYLKQIEPSLYPKLFQKNLDPDVFNQIVKILHDFYIEKEKPLLIFEILQRLSELKRFDMAVMFMSETEKKIARALFNHIDKSGLKDSSVEELKKRYGG","Homo sapiens","RPAP3","RNA polymerase II-associated protein 3","1","6EZ4"
"6EZ9",,"X-RAY DIFFRACTION",3.33,63.06,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4,
2 % (w/v) PEG 3350,
100 mM Tris-HCl, pH 8.0",293,"10.1016/j.bmc.2018.11.022",,"6EZ9",83.14,"1.61","1.61","X-ray structure of human glutamate carboxypeptidase II (GCPII) - the E424M inactive mutant, in complex with a inhibitor JHU3372","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAMEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6EZ9"
"6EZA",,"X-RAY DIFFRACTION",2.45,49.86,"VAPOR DIFFUSION, HANGING DROP",5.5,"30% PEG 2000 MME
200 mM ammonium sulfate
50 mM sodium acetate",292,"10.1021/acs.biochem.8b00584",,"6EZA",75.55,"2","2","Crystal Structure of human tRNA-dihydrouridine(20) synthase catalytic domain E294K mutant","MHHHHHHLILAPMVRVGTLPMRLLALDYGADIVYCEELIDLKMIQCKRVVNEVLSTVDFVAPDDRVVFRTCEREQNRVVFQMGTSDAERALAVARLVENDVAGIDVNMGCPKQYSTKGGMGAALLSDPDKIEKILSTLVKGTRRPVTCKIRILPSLEDTLSLVKRIERTGIAAIAVHGRKREERPQHPVSCEVIKAIADTLSIPVIANGGSHDHIQQYSDIEDFRQATAASSVMVARAAMWNPSIFLKEGLRPLEEVMQKYIRYAVQYDNHYTNTKYCLCQMLREQLKSPQGRLLHAAQSSREICEAFGLGAFYEETTQELDAQQAR","Homo sapiens","DUS2, DUS2L","tRNA-dihydrouridine(20) synthase [NAD(P)+]-like","1","6EZA"
"6EZB",,"X-RAY DIFFRACTION",2.94,58.17,"VAPOR DIFFUSION, HANGING DROP",,"2.2 M ammonium sulfate",292,"10.1021/acs.biochem.8b00584",,"6EZB",37.74,"2.25","2.25","Crystal Structure of human tRNA-dihydrouridine(20) synthase catalytic domain Q305K mutant","MHHHHHHLILAPMVRVGTLPMRLLALDYGADIVYCEELIDLKMIQCKRVVNEVLSTVDFVAPDDRVVFRTCEREQNRVVFQMGTSDAERALAVARLVENDVAGIDVNMGCPKQYSTKGGMGAALLSDPDKIEKILSTLVKGTRRPVTCKIRILPSLEDTLSLVKRIERTGIAAIAVHGRKREERPQHPVSCEVIKAIADTLSIPVIANGGSHDHIQQYSDIEDFRQATAASSVMVARAAMWNPSIFLKEGLRPLEEVMQKYIRYAVQYDNHYTNTKYCLCQMLREQLESPQGRLLHAAKSSREICEAFGLGAFYEETTQELDAQQAR","Homo sapiens","DUS2, DUS2L","tRNA-dihydrouridine(20) synthase [NAD(P)+]-like","1","6EZB"
"6EZC",,"X-RAY DIFFRACTION",2.66,53.8,"VAPOR DIFFUSION, HANGING DROP",5,"30% PEG 2000 MME
200 mM ammonium sulfate
50 mM sodium acetate",292,"10.1021/acs.biochem.8b00584",,"6EZC",38.11,"2","2","Crystal Structure of human tRNA-dihydrouridine(20) synthase catalytic domain E294K Q305K double mutant","MHHHHHHLILAPMVRVGTLPMRLLALDYGADIVYCEELIDLKMIQCKRVVNEVLSTVDFVAPDDRVVFRTCEREQNRVVFQMGTSDAERALAVARLVENDVAGIDVNMGCPKQYSTKGGMGAALLSDPDKIEKILSTLVKGTRRPVTCKIRILPSLEDTLSLVKRIERTGIAAIAVHGRKREERPQHPVSCEVIKAIADTLSIPVIANGGSHDHIQQYSDIEDFRQATAASSVMVARAAMWNPSIFLKEGLRPLEEVMQKYIRYAVQYDNHYTNTKYCLCQMLREQLKSPQGRLLHAAKSSREICEAFGLGAFYEETTQELDAQQAR","Homo sapiens","DUS2, DUS2L","tRNA-dihydrouridine(20) synthase [NAD(P)+]-like","1","6EZC"
"6EZF",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",8.25,"25 % PEG4000
0.10 M Tris 8.25
0.20 M LiSO4",298,"10.1038/s41598-018-23039-5",,"6EZF",42.04,"1.5","1.5","PDE2 in complex with molecule 5","MHASDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEELEHHHHHH","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","6EZF"
"6EZP",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, SITTING DROP",3.5,"0.1 M citrate, 25% PEG3350",294,"10.1021/acs.jmedchem.7b01869","C3E","6EZP",24.83,"1.37","1.37","CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(21),6(11),7,9,14,18(22),19-heptaene-3-carboxamide","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","Cathepsin L1","1","6EZP"
"6EZQ",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, HANGING DROP",7,"Essentially defatted human serum albumin from Sigma was purified by size exclusion chromatography to obtain pure monomeric protein. The purified HSA was dissolved in 50 mM potassium phosphate, 150 mM sodium chloride (pH 7.5) and concentrated to 2 mM (140 mg/mL). The HSA solution was incubated with a six fold excess of the NBD-labelled fatty acid at 4-5 deg.C for 4 hours. The final concentration of dimethyl sulfoxide was 2% (v/v). The crystal was grown by the hanging drop vapor diffusion method using a reservoir solution containing buffer (2.5 mM potassium phosphate, 7.5 mM sodium chloride, pH 7.0), 0.3% glycerol and polyethylene glycol 3350 (~30%). For crystallization 1 uL of HSA-ligand solution was equilibrated against 1 uL of reservoir solution.",292,"10.1002/anie.201710437","C7K","6EZQ",67.33,"2.39","2.39","human Serum Albumin complexed with NBD-C12 fatty acid","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","6EZQ"
"6EZX",,"X-RAY DIFFRACTION",2.32,46.99,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.1 M Bis-Tris",294,"10.1021/acs.jmedchem.7b01869",,"6EZX",49.29,"2.34","2.34","CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-17-oxa-4-azatricyclo[16.2.2.06,11]docosa-1(21),6,8,10,14,18(22),19-heptaene-3-carboxamide","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","Cathepsin L1","1","6EZX"
"6F00",,"X-RAY DIFFRACTION",2.84,56.63,"VAPOR DIFFUSION, HANGING DROP",7,"1.6 M ammonium sulfate
100 mM sodium chloride
100 mM HEPES",292,,,"6F00",42.43,"2.163","2.163","Crystal Structure of human tRNA dihydrouridine synthase (20) dsRBD E423A mutant","MTSEQTGEPAEDTSGVIKMAVKFDRRAYPAQITPKMCLLEWCRREKLAQPVYETVQRPLDRLFSSIVTVAEQKYQSTLWDKSKKLAAQAAAIVCLRSQGLPEGRLGEESPSLHKHHHHHH","Homo sapiens","DUS2, DUS2L","tRNA-dihydrouridine(20) synthase [NAD(P)+]-like","1","6F00"
"6F02",,"X-RAY DIFFRACTION",4.22,70.83,"MICROBATCH",,"PEG3350, Salt",293,,,"6F02",91.95,"3","3","Crystal structure of human glycosylated kallistatin at 3.0 Angstrom resolution","GSPSLKIAPANADFAFRFYYLIASETPGKNIFFSPLSISAAYAMLSLGACSHSRSQILEGLGFNLTELSESDVHRGFQHLLHTLNLPGHGLETRVGSALFLSHNLKFLAKFLNDTMAVYEAKLFHTNFYDTVGTIQLINDHVKKETRGKIVDLVSELKKDVLMVLVNYIYFKALWEKPFISSRTTPKDFYVDENTTVRVPMMLQDQEHHWYLHDRYLPCSVLRMDYKGDATVFFILPNQGKMREIEEVLTPEMLMRWNNLLRKRNFYKKLELHLPKFSISGSYVLDQILPRLGFTDLFSKWADLSGITKQQKLEASKSFHKATLDVDEAGTEAAAATSFAIKFFSAQTNRHILRFNRPFLVVIFSTSTQSVLFLGKVVDPTKPHHHHHH","Homo sapiens","SERPINA4, KST, PI4","Kallistatin","1","6F02"
"6F06",,"X-RAY DIFFRACTION",1.92,35.85,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG3350, 0.05 M zinc acetate",294,"10.1021/acs.jmedchem.7b01869","C7T","6F06",50.38,"2.02","2.02","CATHEPSIN L IN COMPLEX WITH (3S,14E)-8-(azetidin-3-yl)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(21),6,8,10,14,18(22),19-heptaene-3-carboxamide","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","Cathepsin L1","1","6F06"
"6F0A",,"X-RAY DIFFRACTION",3.1,60.3,"VAPOR DIFFUSION, SITTING DROP",8.5,"27-33% PEG 8000/Ethylene glycol mix
100mM Tris/Bicine mix pH 8.5
20-40mM L-alanine",298,"10.1002/cbic.201700560","C82","6F0A",90.25,"2.26","2.26","Crystal structure of human indoleamine 2,3-dioxygenase bound to a triazole inhibitor and alanine molecule.","ISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","6F0A"
"6F1D",,"X-RAY DIFFRACTION",2.91,57.7,"VAPOR DIFFUSION, SITTING DROP",8.5,"50 mM Tris-HCl at pH 8.5 containing 25% PEG-8K, 2 mM CaCl2 and 3% 1,6-diaminohexane",298,"10.1073/pnas.1718709115",,"6F1D",13.48,"1.95","1.95","CUB2 domain of C1r","AECSSELYTEASGYISSLEYPRSYPPDLRCNYSIRVERGLTLHLKFLEPFDIEDHPEVPCPYDQLQIYANGKNIGEFCGKQRPPDLDTSSNAVDLLFFTDESGDSRGWKLRYTTEII","Homo sapiens","C1R","Complement C1r subcomponent","1","6F1D"
"6F1N",,"X-RAY DIFFRACTION",3.13,60.76,"VAPOR DIFFUSION, HANGING DROP",6.5,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,"10.1021/acs.jctc.8b00230","C8W","6F1N",27.14,"2.09","2.09","Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation","MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6F1N"
"6F1V","3.4","ELECTRON MICROSCOPY",,,,,,,"10.1038/nature25462",,"6F1V",273.57,"3.4",,"C terminal region of the dynein heavy chains in the dynein tail/dynactin/BICDR1 complex","MSEPGGGGGEDGSAGLEVSAVQNVADVSVLQKHLRKLVPLLLEDGGEAPAALEAALEEKSALEQMRKFLSDPQVHTVLVERSTLKEDVGDEGEEEKEFISYNINIDIHYGVKSNSLAFIKRTPVIDADKPVSSQLRVLTLSEDSPYETLHSFISNAVAPFFKSYIRESGKADRDGDKMAPSVEKKIAELEMGLLHLQQNIEIPEISLPIHPMITNVAKQCYERGEKPKVTDFGDKVEDPTFLNQLQSGVNRWIREIQKVTKLDRDPASGTALQEISFWLNLERALYRIQEKRESPEVLLTLDILKHGKRFHATVSFDTDTGLKQALETVNDYNPLMKDFPLNDLLSATELDKIRQALVAIFTHLRKIRNTKYPIQRALRLVEAISRDLSSQLLKVLGTRKLMHVAYEEFEKVMVACFEVFQTWDDEYEKLQVLLRDIVKRKREENLKMVWRINPAHRKLQARLDQMRKFRRQHEQLRAVIVRVLRPQVTAVAQQNQGEVPEPQDMKVAEVLFDAADANAIEEVNLAYENVKEVDGLDVSKEGTEAWEAAMKRYDERIDRVETRITARLRDQLGTAKNANEMFRIFSRFNALFVRPHIRGAIREYQTQLIQRVKDDIESLHDKFKVQYPQSQACKMSHVRDLPPVSGSIIWAKQIDRQLTAYMKRVEDVLGKGWENHVEGQKLKQDGDSFRMKLNTQEIFDDWARKVQQRNLGVSGRIFTIESTRVRGRTGNVLKLKVNFLPEIITLSKEVRNLKWLGFRVPLAIVNKAHQANQLYPFAISLIESVRTYERTCEKVEERNTISLLVAGLKKEVQALIAEGIALVWESYKLDPYVQRLAETVFNFQEKVDDLLIIEEKIDLEVRSLETCMYDHKTFSEILNRVQKAVDDLNLHSYSNLPIWVNKLDMEIERILGVRLQAGLRAWTQVLLGQAEDKAEVDMDTDAPQVSHKPGGEPKIKNVVHELRITNQVIYLNPPIEECRYKLYQEMFAWKMVVLSLPRIQSQRYQVGVHYELTEEEKFYRNALTRMPDGPVALEESYSAVMGIVSEVEQYVKVWLQYQCLWDMQAENIYNRLGEDLNKWQALLVQIRKARGTFDNAETKKEFGPVVIDYGKVQSKVNLKYDSWHKEVLSKFGQMLGSNMTEFHSQISKSRQELEQHSVDTASTSDAVTFITYVQSLKRKIKQFEKQ","Homo sapiens","DYNC1H1, DHC1, DNCH1, DNCL, DNECL, DYHC, KIAA0325","Cytoplasmic dynein 1 heavy chain 1","1","6F1V"
"6F1W",,"X-RAY DIFFRACTION",2.54,51.58,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M MES pH 5.5, 10 % (w/v) PEG 4000, 0.2 M lithium sulfate",293,"10.3390/molecules24050873","CG5","6F1W",75.52,"1.864","1.864","Crystal structure of human Casein Kinase I delta in complex with compound 31a","MGSSHHHHHHSSGLVPRGSHMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6F1W"
,,,,,,,,,,,,,,,,"MGSSHHHHHHSSGLVPRGSHMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","2","6F1W"
"6F1X",,"X-RAY DIFFRACTION",2.29,46.26,"VAPOR DIFFUSION, SITTING DROP",3.6,"26% PEG6000, 0.1M Na-acetate pH 3.6, 0.22M LiSO4",277,"10.1021/acs.jmedchem.7b01884","C9Q","6F1X",37.97,"1.9","1.9","Complex between MTH1 and compound 7 (a 7-azaindole-2-amide derivative)","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6F1X"
"6F20",,"X-RAY DIFFRACTION",2.32,47.02,"VAPOR DIFFUSION, SITTING DROP",3.6,"27% PEG6000, 0.3M Lithium sulfate, 0.1M sodium acetate pH=3.6",277,"10.1021/acs.jmedchem.7b01884","C9E","6F20",37.73,"2","2","Complex between MTH1 and compound 1 (a 7-azaindole-4-ester derivative)","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6F20"
"6F22",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG4K, 0.24M AmSO4, 12.5% glycerol",277,"10.1021/acs.jmedchem.7b01884","C9B","6F22",38.03,"1.55","1.55","Complex between MTH1 and compound 29 (a 4-amino-2,7-diazaindole derivative)","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6F22"
"6F23",,"X-RAY DIFFRACTION",2.28,46.2,"VAPOR DIFFUSION, HANGING DROP",3.6,"23% PEG 6000, 0.28M lithium sulfate, 0.1M sodium acetate pH 3.6",293,"10.1021/acs.jmedchem.7b01884","C8Z","6F23",38.28,"1.84","1.84","Complex between MTH1 and compound 16 (a 4-amino-7-azaindole derivative)","GSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6F23"
"6F25",,"X-RAY DIFFRACTION",6.33,80.58,"VAPOR DIFFUSION, HANGING DROP",7,"1.5 M LiSo4, 100 mM Hepes pH 7, 60 mM MgSo4",293,"10.1016/j.neuropharm.2019.05.025",,"6F25",123.42,"3.05199647812","3.05199647812","Crystal structure of human acetylcholinesterase in complex with C35.","DAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSAT","Homo sapiens","ACHE","Acetylcholinesterase","1","6F25"
"6F26",,"X-RAY DIFFRACTION",2.53,51.4,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M MES pH 5.5, 10 % (w/v) PEG 4000, 0.2 M lithium sulfate",293,"10.3390/molecules24050873","C9Z","6F26",75.83,"1.83","1.83","Crystal structure of human Casein Kinase I delta in complex with compound 31b","MGSSHHHHHHSSGLVPRGSHMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6F26"
"6F27",,"SOLUTION NMR",,,,,,,"10.1038/nchembio.2551",,"6F27",1.03,,,"NMR solution structure of non-bound [des-Arg10]-kallidin (DAKD)","KRPPGFSPF","Homo sapiens","KNG1, BDK, KNG","DAKD","1","6F27"
"6F2L",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, SITTING DROP",8,"0.8 M NA CITRATE, 0.15 M TRIS, PH 8.0",293,,"AXY","6F2L",69.56,"2.1","2.1","Crystal structure of the complex between PPARgamma LBD and the ligand LJ570: structure obtained from crystals of the apo-form soaked for 15 days.","MGSSHHHHHHSSGLVPRGSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6F2L"
"6F2Q",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.19,44,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG 4000 OR PEG 3000, 0.1M MGCL2, 0.015M BETA MERCAPTOETHANOL, 0.1M TRIS-DCL, PD 7.9, 0.4M NASCN. ALL DISSOLVED IN D2O. CRYSTAL GROWN IN A 15 + 15 MICROLITRE SITTING DROP THAT WAS FIRST EQUILIBRATED FOR 1 WEEK. A SMALL CRYSTAL GROWN AT 20-28% PEG WAS THEN INTRODUCED. THE DROP WAS FED WITH FRESH PROTEIN BY ADDING 3-4 MICROLITRES OF PROTEIN WITH 10 MM LACTOSE EVERY 3-4 DAYS FOR 3 MONTHS. LACTOSE WAS THEN REMOVED IN TWO STEPS, FIRST BY DIALYSING AGAINST 1M GLYCEROL FOR 1 MONTH THEN AGAINST BUFFER WITH NO GLYCEROL FOR 1 MONTH. FOR DETAILS, SEE MANZONI ET AL. (2016).",293,"10.1021/acs.jmedchem.8b00081",,"6F2Q",15.7,"1.03, 1.757","1.03, 1.757","Neutron crystal structure of perdeuterated galectin-3C in the ligand-free form","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6F2Q"
"6F2U",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION",,"100mM MES pH 6.0, 25% PEG 8000",293,"10.1016/j.ejmech.2018.03.040","CJ2","6F2U",73.89,"1.88","1.88","Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid","QCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPY","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","6F2U"
"6F2Z",,"X-RAY DIFFRACTION",3.19,61.39,"VAPOR DIFFUSION, SITTING DROP",7.4,"20% PEG3350",295,,,"6F2Z",54.05,"2.3","2.3","Structure of a Fc mutatnt","DKTHTSPPSPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLWCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSALTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Fc fragment of antiboy","1","6F2Z"
"6F39",,"X-RAY DIFFRACTION",6.95,82.31,"VAPOR DIFFUSION, SITTING DROP",,"12-18% PEG 8000, 100 mM Imidazole at pH 8.0",298,"10.1073/pnas.1718709115",,"6F39",67.59,"5.801","5.801","C1r homodimer CUB1-EGF-CUB2","PQKLFGEVTSPLFPKPYPNNFETTTVITVPTGYRVKLVFQQFDLEPSEGCFYDYVKISADKKSLGRFCGQLGSPLGNPPGKKEFMSQGNKMLLTFHTDFSNEENGTIMFYKGFLAYYQAVDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQEDTHSCQAECSSELYTEASGYISSLEYPRSYPPDLRCNYSIRVERGLTLHLKFLEPFDIDDHQQVHCPYDQLQIYANGKNIGEFCGKQRPPDLDTSSNAVDLLFFTDESGDSRGWKLRYTTEI","Homo sapiens","C1R","Complement C1r subcomponent","1","6F39"
"6F3B",,"X-RAY DIFFRACTION",2.32,47.03,"VAPOR DIFFUSION, HANGING DROP",9,"28% PEG4000, 0.2 M Sodium acetate, Tris 100 mM",296,"10.1021/acs.jmedchem.8b00770","CJK, ACT","6F3B",58.94,"1.4","1.4","Crystal structure of human carbonic anhydrase I in complex with the 1-(2-hydroxy-5-sulfamoylphenyl)-3-[(4-methylphenyl)methyl]urea inhibitor","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6F3B"
"6F3D",,"X-RAY DIFFRACTION",3.02,59.31,"VAPOR DIFFUSION",,"50 mM Hepes pH 7.5, 0.02% octylglucoside, 10% glycerol, 0.3 M NaCl, 1 mM TCEP",293,"10.1016/j.bmc.2018.01.008","CJT","6F3D",67.59,"2.38","2.38","IRAK4 IN COMPLEX WITH inhibitor","RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6F3D"
"6F3E",,"X-RAY DIFFRACTION",2.56,51.95,"VAPOR DIFFUSION",,"50 mM Hepes pH 7.5, 0.02% octylglucoside, 10% glycerol, 0.3 M NaCl, 1 mM TCEP",293,"10.1016/j.bmc.2018.01.008","CJQ","6F3E",67.56,"2.67","2.67","IRAK4 IN COMPLEX WITH inhibitor","RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6F3E"
"6F3G",,"X-RAY DIFFRACTION",2.6,52.76,"VAPOR DIFFUSION",,"50 mM Hepes pH 7.5, 0.02% octylglucoside, 10% glycerol, 0.3 M NaCl, 1 mM TCEP",293,"10.1016/j.bmc.2018.01.008","CJN","6F3G",67.41,"2.37","2.37","IRAK4 IN COMPLEX WITH inhibitor","RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6F3G"
,,,,,,,,,,,,,,,,"RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","2","6F3G"
"6F3I",,"X-RAY DIFFRACTION",2.25,45.39,"VAPOR DIFFUSION",,"50 mM Hepes pH 7.5, 0.02% octylglucoside, 10% glycerol, 0.3 M NaCl, 1 mM TCEP",293,"10.1016/j.bmc.2018.01.008","CKN","6F3I",74.01,"2.14","2.14","IRAK4 IN COMPLEX WITH inhibitor","MHHHHHHHENLYFQGENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","6F3I"
"6F3V",,"SOLID-STATE NMR",,,,,,,"10.1038/nchembio.2551",,"6F3V",1.06,,,"Backbone structure of bradykinin (BK) peptide bound to human Bradykinin 2 Receptor (B2R) determined by MAS SSNMR","RPPGFSPFR","Homo sapiens","KNG1, BDK, KNG","Bradykinin (BK)","1","6F3V"
"6F3W",,"SOLID-STATE NMR",,,,,,,"10.1038/nchembio.2551",,"6F3W",1.06,,,"Backbone structure of free bradykinin (BK) in DDM/CHS detergent micelle determined by MAS SSNMR","RPPGFSPFR","Homo sapiens","KNG1, BDK, KNG","Kininogen-1","1","6F3W"
"6F3X",,"SOLID-STATE NMR",,,,,,,"10.1038/nchembio.2551",,"6F3X",1.03,,,"Backbone structure of Des-Arg10-Kallidin (DAKD) peptide in frozen DDM/CHS detergent micelle solution determined by DNP-enhanced MAS SSNMR","KRPPGFSPF","Homo sapiens","KNG1, BDK, KNG","Kininogen-1","1","6F3X"
"6F3Y",,"SOLID-STATE NMR",,,,,,,"10.1038/nchembio.2551",,"6F3Y",1.03,,,"Backbone structure of Des-Arg10-Kallidin (DAKD) peptide bound to human Bradykinin 1 Receptor (B1R) determined by DNP-enhanced MAS SSNMR","KRPPGFSPF","Homo sapiens","KNG1, BDK, KNG","Kininogen-1","1","6F3Y"
"6F46",,"SOLUTION NMR",,,,,,,"10.1002/chem.201800812",,"6F46",3.88,,,"Structure of the transmembrane helix of BclxL in phospholipid nanodiscs","GSGESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","6F46"
"6F4M",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 22.5 % PEG3350, 0.002 M MnCl2, 300 nl sitting drops (sample:well, 1:1 ratio)",298,"10.1038/s41467-018-03410-w",,"6F4M",27.13,"1.705","1.705","Human JMJD5 in its apo form.","STVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPAMQKWSLEYIQEIAGARTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYASLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSAILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","JmjC domain-containing protein 5","1","6F4M"
"6F4N",,"X-RAY DIFFRACTION",3.19,61.48,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M Bis-Tris pH 6.0, 21.4 % PEG3350, 0.07 M MgCl2, 0.002 M MnCl2, 300 nl sitting drops (sample:well, 1:2 ratio)",298,"10.1038/s41467-018-03410-w",,"6F4N",63.12,"2.541","2.541","Human JMJD5 in complex with MN and 2OG.","ENLYFQSRPARGSLPEQPCTKKARADHGLIPDVKLEKTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","JmjC domain-containing protein 5","1","6F4N"
"6F4O",,"X-RAY DIFFRACTION",2.33,47.33,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 15.0 % PEG3350, 0.002 M MnCl2, 300 nl sitting drops (sample:well, 2:1 ratio)",298,"10.1038/s41467-018-03410-w",,"6F4O",29.9,"1.28","1.28","Human JMJD5 in complex with Mn(II) and Succinate.","HHHHHHSSGVDLGTENLYFQSTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","JmjC domain-containing protein 5","1","6F4O"
"6F4U",,"X-RAY DIFFRACTION",3.25,63,"VAPOR DIFFUSION, SITTING DROP",,"30% tertbutanal",293,,,"6F4U",44.28,"1.9","1.9","Crystal structure of reactive loop cleaved kallistatin at 1.9 angstrom resolution","GSLKIAPANADFAFRFYYLIASETPGKNIFFSPLSISAAYAMLSLGACSHSRSQILEGLGFNLTELSESDVHRGFQHLLHTLNLPGHGLETRVGSALFLSHNLKFLAKFLNDTMAVYEAKLFHTNFYDTVGTIQLINDHVKKETRGKIVDLVSELKKDVLMVLVNYIYFKALWEKPFISSRTTPKDFYVDENTTVRVPMMLQDQEHHWYLHDRYLPCSVLRMDYKGDATVFFILPNQGKMREIEEVLTPEMLMRWNNLLRKRNFYKKLELHLPKFSISGSYVLDQILPRLGFTDLFSKWADLSGITKQQKLEASKSFHKATLDVDEAGTEAAAATSFAIKF","Homo sapiens","SERPINA4, KST, PI4","Kallistatin","1","6F4U"
,,,,,,,,,,,,,,,,"FSAQTNRHILRFNRPFLVVIFSTSTQSVLFLGKVVDPTKP","Homo sapiens","SERPINA4, KST, PI4","Kallistatin","2","6F4U"
"6F4V",,"X-RAY DIFFRACTION",3.28,0.63,"VAPOR DIFFUSION, SITTING DROP",,"30% TERTBUTABOL",293,,,"6F4V",44.74,"1.8","1.8","Crystal structure of cleaved Kallistatin complexed with heparin at 1.8 Angstrom resolution","GSLKIAPANADFAFRFYYLIASETPGKNIFFSPLSISAAYAMLSLGACSHSRSQILEGLGFNLTELSESDVHRGFQHLLHTLNLPGHGLETRVGSALFLSHNLKFLAKFLNDTMAVYEAKLFHTNFYDTVGTIQLINDHVKKETRGKIVDLVSELKKDVLMVLVNYIYFKALWEKPFISSRTTPKDFYVDENTTVRVPMMLQDQEHHWYLHDRYLPCSVLRMDYKGDATVFFILPNQGKMREIEEVLTPEMLMRWNNLLRKRNFYKKLELHLPKFSISGSYVLDQILPRLGFTDLFSKWADLSGITKQQKLEASKSFHKATLDVDEAGTEAAAATSFAIKF","Homo sapiens","SERPINA4, KST, PI4","Kallistatin","1","6F4V"
,,,,,,,,,,,,,,,,"FSAQTNRHILRFNRPFLVVIFSTSTQSVLFLGKVVDPTKP","Homo sapiens","SERPINA4, KST, PI4","Kallistatin","2","6F4V"
"6F56",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION, HANGING DROP",4.6,"PEG 4000 22 %
Sodium citrate 0.1 M
Glycerol 2.5 %",293.15,"10.1021/acs.jmedchem.9b00586",,"6F56",195.22,"1.9401987668","1.9401987668","Mutant of Human N-myristoyltransferase with bound myristoyl-CoA","MGSSHHHHHHSSGLEVLFQGPHMEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCQYFHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNMVDLMENKTFVEKLKFGIGDGHLQYYLYNWKCPSMGAEKVGLVML","Homo sapiens","NMT1, NMT","Glycylpeptide N-tetradecanoyltransferase 1","1","6F56"
"6F5H",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000, Tris, Li2-Sulfate, pH 7.75",293.15,"10.1021/acsmedchemlett.7b00512","CQ5","6F5H",84.33,"2.16","2.16","Crystal structure of USP7 in complex with a 4-hydroxypiperidine based inhibitor","SKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKRKERQEHHH","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","6F5H"
"6F5L",,"X-RAY DIFFRACTION",3.28,62.49,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4
2 % (w/v) PEG 3350
100 mM Tris-HCl, pH 8.0",293,"10.1016/j.bmc.2018.11.022",,"6F5L",83.41,"1.63","1.63","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor JHU2379","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6F5L"
"6F5M",,"X-RAY DIFFRACTION",2.68,54.16,"VAPOR DIFFUSION, SITTING DROP",,"HLE from human blood was purchased from SERVA as a lyophilisate in the presence of sodium acetate puffer, pH 5.5. The lyophilisate was disolved in water so that the HLE concentration was 5 mg/ml (170 micromolar) and the acetate concentration 250 millimolar. 120 microliter dissolved HNE lysophilisate was mixed with 6 microliter inhibitor solution (10 mM in DMSO). 1 microliter of the resulting HLE/inhibitor mixture was mixed with 0.5 microliter reservoir solution which was composed of 20 % PEG MME 5000, 0.2 M potassium sulphate. Repeated seeding was necessary to get usable crystals. In the final seeding step the reservoir was composed of 20 % PEG MME 5000, 0.2 M sodium sulphate.",293,"10.1107/S2053230X1800537X",,"6F5M",51.58,"2.7","2.7","Crystal structure of highly glycosylated human leukocyte elastase in complex with a thiazolidinedione inhibitor","IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ","Homo sapiens","ELANE, ELA2","Neutrophil elastase","1","6F5M"
"6F5Q",,"X-RAY DIFFRACTION",2.61,52.9,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6F5Q",40.66,"1.43","1.43","Crystal Structure of KDM4D with GF026 ligand","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6F5Q"
"6F5R",,"X-RAY DIFFRACTION",2.63,53.17,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6F5R",38.86,"1.607","1.607","Crystal Structure of KDM4D with GF028 ligand","AQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWK","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6F5R"
"6F5S",,"X-RAY DIFFRACTION",2.61,52.85,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6F5S",40.57,"1.48","1.48","Crystal Structure of KDM4D with tetrazole ligand GF049","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6F5S"
"6F5T",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6F5T",39.47,"1.58","1.58","Crystal Structure of KDM4D with tetrazole ligand GF057","AQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQ","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6F5T"
"6F5X",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, HANGING DROP",6.2,"140 mM NaCl, 70 mM Na/K phosphate pH 6.2, 35% (v/v) PEG200; soaked in 40% (v/v) PEG200 and 100 mM NaI",293,"10.1038/s41594-018-0078-9",,"6F5X",9.57,"1.91","1.91","Crystal structure of the SYCP1 N-terminal head-to-head assembly in closed conformation","GSMGLSRVYSKLYKEAEKIKKWKVSTEAELRQKESKLQENRKIIEAQRKAIQELQFGNEKVSLKLEEGIQENKDLIKE","Homo sapiens","SYCP1, SCP1","Synaptonemal complex protein 1","1","6F5X"
"6F62",,"X-RAY DIFFRACTION",2.47,50.22,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES pH 6.0, 40% (v/v) MPD",293,"10.1038/s41594-018-0078-9",,"6F62",26.08,"2.066","2.066","Crystal structure of the SYCP1 N-terminal head-to-head assembly in open conformation","GSMGLSRVYSKLYKEAEKIKKWKVSTEAELRQKESKLQENRKIIEAQRKAIQELQFGNEKVSLKLEEGIQENKDLIKENNATRHLCNLLKETCARSAEKTKKYEYEREE","Homo sapiens","SYCP1, SCP1","Synaptonemal complex protein 1","1","6F62"
"6F63",,"X-RAY DIFFRACTION",2.39,48.63,"VAPOR DIFFUSION, HANGING DROP",7,"3.5 M sodium formate pH 7.0; soaked in 6 M sodium formate pH 7.0",293,"10.1038/s41594-018-0078-9",,"6F63",45.54,"2.154","2.154","Crystal structure of the SYCP1 C-terminal back-to-back assembly","GSMENLLEEVEKAKVIADEAVKLQKEIDKRCQHKIAEMVALMEKHKHQYDKIIEERDSELGLYKSKEQEQSSLRASLEIELSNLKAELLSVKKQLEIE","Homo sapiens","SYCP1, SCP1","Synaptonemal complex protein 1","1","6F63"
"6F64",,"X-RAY DIFFRACTION",3.02,59.25,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M sodium cacodylate pH 6.5, 1.4M sodium acetate; soaked in 0.1 M sodium cacodylate pH 6.5, 1.4 M sodium acetate, 20% PEG400",293,"10.1038/s41594-018-0078-9",,"6F64",11.44,"2.493","2.493","Crystal structure of the SYCP1 C-terminal back-to-back assembly","GSMENLLEEVEKAKVIADEAVKLQKEIDKRCQHKIAEMVALMEKHKHQYDKIIEERDSELGLYKSKEQEQSSLRASLEIELSNLKAELLSVKKQLEIE","Homo sapiens","SYCP1, SCP1","Synaptonemal complex protein 1","1","6F64"
"6F6P",,"X-RAY DIFFRACTION",2.61,56,"VAPOR DIFFUSION",7.3,"50 mM Tris pH 7.3 and 40% MPD",291,"10.1002/prot.25455",,"6F6P",47.99,"2.45","2.45","Crystal structure of tetrameric human Rabin8 GEF domain","GAASRLRSPSVLEVREKGYERLKEELAKAQRELKLKDEECERLSKVRDQLGQELEELTASLFEEAHKMVREANIKQATAEKQLKEAQGKIDVLQAEVAALKTLVLS","Homo sapiens","RAB3IP, RABIN8","Rab-3A-interacting protein","1","6F6P"
,,,,,,,,,,,,,,,,"GASSRLRSPSVLEVREKGYERLKEELAKAQRELKLKDEECERLSKVRDQLGQELEELTASLFEEAHKMVREANIKQATAEKQLKEAQGKIDVLQAEVAALKTLVLS","Homo sapiens","RAB3IP, RABIN8","Rab-3A-interacting protein","2","6F6P"
"6F6R",,"X-RAY DIFFRACTION",4.63,73.43,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES (pH7.4), 2 M (NH4)2SO4 and 25 mM DTT",277,"10.1021/acs.jmedchem.8b00067",,"6F6R",31.03,"1.8","1.8","Crystal structure of human Caspase-1 with N-{3-[1-((S)-2-Hydroxy-5-oxo-tetrahydro-furan-3-ylcarbamoyl)-ethyl]-1-methyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl}-4-(quinoxalin-2-ylamino)-benzamide","QDNPAMPTSSGSEGNVKLCSLEEAQRIWKQKSAEIYPIMDKSSRTRLALIICNEEFDSIPRRTGAEVDITGMTMLLQNLGYSVDVKKNLTASDMTTELEAFAHRPEHKTSDSTFLVFMSHGIREGICGKKHSEQVPDILQLNAIFNMLNTKNCPSLKDKPKVIIIQACRGDSPGVVWFKD","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","1","6F6R"
,,,,,,,,,,,,,,,,"AIKKAHIEKDFIAFCSSTPDNVSWRHPTMGSVFIGRLIEHMQEYACSCDVEEIFRKVRFSFEQPDGRAQMPTTERVTLTRCFYLFPGH","Homo sapiens","CASP1, IL1BC, IL1BCE","Caspase-1","2","6F6R"
"6F6U",,"X-RAY DIFFRACTION",2.42,49.14,"VAPOR DIFFUSION, HANGING DROP",,"Hepes 
PEG 3350 
Magnesium Chloride",293,"10.1021/acs.biochem.8b00288","CV8","6F6U",80.42,"1.828","1.828","Crystal structure of the PDE4D catalytic domain in complex with GEBR-7b","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6F6U"
"6F6Y",,"X-RAY DIFFRACTION",2.19,44,"VAPOR DIFFUSION, SITTING DROP",7.5,"19 mg/ml Gal3C in 10 mM sodium phosphate buffer pH 7.5, 100 mM NaCl, 10 mM beta-mercaptoethanol, 0.02 % NaN3. 3.5 microlitres Gal3C were mixed with 3.5 microlitres  100 mM galactopentaose solution and incubated on ice for one hour. Crystals were obtained in 30% w/v PEG 4000, 0.1 M Tris/HCl pH 7.5, 0.1M MgCl2, 0.4M NaSCN, 8 mM beta-mercaptoethanol. Cryoprotectant contained an additional 11% glycerol.",293,,,"6F6Y",16.08,"1.41","1.41","Crystal structure of galectin-3 CRD in complex with galactopentaose","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6F6Y"
"6F76",,"X-RAY DIFFRACTION",2.52,51.14,"VAPOR DIFFUSION, SITTING DROP",7,"8-15% w/v Polyethylene glycol 3350 and 0.2M lithium citrate",291,"10.7554/eLife.37122",,"6F76",122.95,"2.2","2.2","Antibody derived (Abd-8) small molecule binding to KRAS.","AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6F76"
"6F78",,"X-RAY DIFFRACTION",2.4,48.78,"VAPOR DIFFUSION",,"100mM MES pH 6.0, 25% PEG 8000",277,"10.1016/j.ejmech.2018.03.040","CVN","6F78",74.89,"1.3","1.3","Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid","QCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEY","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","6F78"
"6F7B",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION",7.26,"200mM MgCl2, 100mM Tris-HCl pH 7.26, 5% glycerol, 20% PEG 3350",277,"10.1158/1078-0432.CCR-18-0628",,"6F7B",42.04,"2","2","Crystal structure of the human Bub1 kinase domain in complex with BAY 1816032","GSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK","Homo sapiens","BUB1, BUB1L","Mitotic checkpoint serine/threonine-protein kinase BUB1","1","6F7B"
"6F7H",,"X-RAY DIFFRACTION",3.09,60.2,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES-monohydrate-NaOH pH 6.0
19% PEG 2k MME 
5% glycerol",291,"10.1038/s41467-018-07176-z",,"6F7H",132.59,"2.304","2.304","Crystal structure of human AQP10","MVFTQAPAEIMGHLRIRSLLARQCLAEFLGVFVLMLLTQGAVAQAVTSGETKGNFFTMFLAGSLAVTIAIYVGGNVSGAHLNPAFSLAMCIVGRLPWVKLPIYILVQLLSAFCASGATYVLYHDALQNYTGGNLTVTGPKETASIFATYPAPYLSLNNGFLDQVLGTGMLIVGLLAILDRRNKGVPAGLEPVVVGMLILALGLSMGANCGIPLNPARDLGPRLFTYVAGWGPEVFSAGNGWWWVPVVAPLVGATVGTATYQLLVALHHPEGPEPAQDLVSAQHKASELETPASAQMLECKL","Homo sapiens","AQP10","Aquaporin-10","1","6F7H"
"6F7I",,"X-RAY DIFFRACTION",2.61,52.94,"VAPOR DIFFUSION, SITTING DROP",,"12 mg/ml, 25mM HEPES pH7.5, 50mM NaCl, 1mM TCEP",294,"10.1038/s41589-018-0222-1",,"6F7I",92.55,"2.43","2.43","human MALT1(329-728) IN COMPLEX WITH MLT-747","GPGSDNKEQTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRGLGRKTCFQ","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","6F7I"
"6F7J",,"X-RAY DIFFRACTION",3,58.94,"VAPOR DIFFUSION, SITTING DROP",10.5,"Protein solution at 6 mg per ml in 20 mM HEPES, 300 mM NaCl, 2 mM tris(2-carboxyethyl)phosphine pH 7.8, mixed 1:1 with reservoir solution containing 1.2 M sodium dihydrogen phosphate, 0.8 M dipotassium hydrogen phosphate, 0.2 M lithium sulphate and 0.1 M CAPS pH 10.5.",281,"10.1038/s41467-018-04142-7",,"6F7J",53.2,"3.22","3.22","Crystal structure of Human ARS2 residues 171-270 + 408-763","RYNDYKLDFRRQQMQDFFLAHKDEEWFRSKYHPDEVGKRRQEARGALQNRLRVFLSLMETGWFDNLLLDIDKADAIVKMLDAAVIKMEGGTENDLRILEQ","Homo sapiens","SRRT, ARS2, ASR2","Serrate RNA effector molecule homolog","1","6F7J"
,,,,,,,,,,,,,,,,"GLECKPRPLHKTCSLFMRNIAPNISRAEIISLCKRYPGFMRVALSEPQPERRFFRRGWVTFDRSVNIKEICWNLQNIRLRECELSPGVNRDLTRRVRNINGITQHKQIVRNDIKLAAKLIHTLDDRTQLWASEPGTPPLPTSLPSQNPILKNITDYLIEEVSAEEEELLGSSGGAPPEEPPKEGNPAEINVERDEKLIKVLDKLLLYLRIVHSLDYYNTCEYPNEDEMPNRCGIIHVRGPMPPNRISHGEVLEWQKTFEEKLTPLLSVRESLSEEEAQKMGRKDPEQEVEKFVTSNTQELGKDKWLCPLSGKKFKGPEFVRKHIFNKHAEKIEEVKKEVAFFNNFLTDAKRPALPE","Homo sapiens","SRRT, ARS2, ASR2","Serrate RNA effector molecule homolog","2","6F7J"
"6F7M",,"SOLUTION NMR",,,,,,,"10.1016/j.bioorg.2018.07.013",,"6F7M",2.91,,,"NMR structure of EphA2-Sam stapled peptides (S13ST)","XKRIGVRLPGHQKRLAYSLLGLKDQVX","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6F7M"
"6F7N",,"SOLUTION NMR",,,,,,,"10.1016/j.bioorg.2018.07.013",,"6F7N",1.58,,,"NMR structure of EphA2-Sam stapled peptides (S13STshort)","XLPGHLKRILYSLLX","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6F7N"
"6F7O",,"SOLUTION NMR",,,,,,,"10.1016/j.bioorg.2018.07.013",,"6F7O",1.6,,,"NMR structure of an Odin-Sam1 stapled peptide","XDPQHLRKLLQAARX","Homo sapiens","ANKS1A, ANKS1, KIAA0229, ODIN","Ankyrin repeat and SAM domain-containing protein 1A","1","6F7O"
"6F7P",,"X-RAY DIFFRACTION",3.83,67.86,"VAPOR DIFFUSION, SITTING DROP",7.8,"Crystals were obtained at 4 C in 2 microlitre hanging drops with a 1:1 ratio of protein solution at 6 mg per ml in 20 mM HEPES, 300 mM NaCl, 2 mM tris(2-carboxyethyl)phosphine pH 7.8) to crystallisation solution. The crystallisation solution was 0.2 M lithium sulphate and 20% (w/v) PEG 3550.",281,"10.1038/s41467-018-04142-7",,"6F7P",111.85,"3.7","3.7","Crystal structure of Human ARS2 residues 147-270 + 408-763","PVMKTFKEFLLSLDDSVDETEAVKRYNDYKLDFRRQQMQDFFLAHKDEEWFRSKYHPDEVGKRRQEARGALQNRLRVFLSLMETGWFDNLLLDIDKADAIVKMLDAAVIKMEGGTENDLRILEQ","Homo sapiens","SRRT, ARS2, ASR2","Serrate RNA effector molecule homolog","1","6F7P"
,,,,,,,,,,,,,,,,"GLECKPRPLHKTCSLFMRNIAPNISRAEIISLCKRYPGFMRVALSEPQPERRFFRRGWVTFDRSVNIKEICWNLQNIRLRECELSPGVNRDLTRRVRNINGITQHKQIVRNDIKLAAKLIHTLDDRTQLWASEPGTPPLPTSLPSQNPILKNITDYLIEEVSAEEEELLGSSGGAPPEEPPKEGNPAEINVERDEKLIKVLDKLLLYLRIVHSLDYYNTCEYPNEDEMPNRCGIIHVRGPMPPNRISHGEVLEWQKTFEEKLTPLLSVRESLSEEEAQKMGRKDPEQEVEKFVTSNTQELGKDKWLCPLSGKKFKGPEFVRKHIFNKHAEKIEEVKKEVAFFNNFLTDAKRPALPE","Homo sapiens","SRRT, ARS2, ASR2","Serrate RNA effector molecule homolog","2","6F7P"
"6F7Q",,"X-RAY DIFFRACTION",3.45,64.38,"VAPOR DIFFUSION, HANGING DROP",8.9,"0.1 M Tris, 2.3 M ammonium sulfate",293,"10.1016/j.ejmech.2018.07.033",,"6F7Q",126.21,"2.6","2.6","Human Butyrylcholinesterase complexed with N-Propargyliperidines","EDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","Cholinesterase","1","6F7Q"
"6F7R",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, AmCitrate",298,"10.1038/s41598-019-39722-0",,"6F7R",37.03,"0.92","0.92","AKR1B1 at 0.03 MGy radiation dose.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","6F7R"
"6F7S",,"X-RAY DIFFRACTION",3.51,64.94,"VAPOR DIFFUSION, HANGING DROP",8.3,"Crystals of human ARS2 were obtained at 4 C in 2 microliter hanging drops with a 1:1 ratio of protein solution (6 mg per ml in 20 mM HEPES, 300 mM NaCl, 2 mM tris(2-carboxyethyl)phosphine, pH 7.8) to crystallisation solution. The crystallisation solution was 0.2 M potassium citrate tribasic monohydrate, 20 % (w/v) PEG 3350.",281,"10.1038/s41467-018-04142-7",,"6F7S",106.48,"3.37","3.37","Crystal structure of Human ARS2 residues 147-270 + 408-763 with deletion of loop B","PVMKTFKEFLLSLDDSVDETEAVKRYNDYKLDFRRQQMQDFFLAHKDEEWFRSKYHPDEVGKRRQEARGALQNRLRVFLSLMETGWFDNLLLDIDKADAIVKMLDAAVIKMEGGTENDLRILEQ","Homo sapiens","SRRT, ARS2, ASR2","Serrate RNA effector molecule homolog","1","6F7S"
,,,,,,,,,,,,,,,,"GLECKPRPLHKTCSLFMRNIAPNISRAEIISLCKRYPGFMRVALSEPQPERRFFRRGWVTFDRSVNIKEICWNLQNIRLRECELSPGVNRDLTRRVRNINGITQHKQIVRNDIKLAAKLIHTLDDRTQLWASEPGTPPLPTSLPSQNPILKNITDYLIEEGSGSGSERDEKLIKVLDKLLLYLRIVHSLDYYNTCEYPNEDEMPNRCGIIHVRGPMPPNRISHGEVLEWQKTFEEKLTPLLSVRESLSEEEAQKMGRKDPEQEVEKFVTSNTQELGKDKWLCPLSGKKFKGPEFVRKHIFNKHAEKIEEVKKEVAFFNNFLTDAKRPALPE","Homo sapiens","SRRT, ARS2, ASR2","Serrate RNA effector molecule homolog,Serrate RNA effector molecule homolog","2","6F7S"
,,,,,,,,,,,,,,,,,"Homo sapiens","SRRT, ARS2, ASR2"
"6F81",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, AmCitrate",298,"10.1038/s41598-019-39722-0",,"6F81",37.03,"0.97","0.97","AKR1B1 at 0.75 MGy radiation dose.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","6F81"
"6F82",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, AmCitrate",298,"10.1038/s41598-019-39722-0",,"6F82",37.03,"1.03","1.03","AKR1B1 at 1.65 MGy radiation dose.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","6F82"
"6F83",,"X-RAY DIFFRACTION",2.45,49.7,"VAPOR DIFFUSION, HANGING DROP",6.2,"4-8 microlitre drops consisting of equal volumes of protein solution (20 mM sodium potassium phosphate buffer, pH 7.0, and protein at concentration of 10 mg/mL) and reservoir solution (0.2 M ammonium sulphate, 25% w/v polyethylene glycol 4000, 0.1M sodium acetate trihydrate, pH 6.2), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"6F83",31.21,"2.2","2.2","Crystal Structure of Human Galectin-1 in Complex With Thienyl-1,2, 3-triazolyl Thiodigalactoside Inhibitor","ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","6F83"
"6F84",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, AmCitrate",298,"10.1038/s41598-019-39722-0",,"6F84",37.03,"1.09","1.09","AKR1B1 at 2.55 MGy radiation dose.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","6F84"
"6F8D",,"X-RAY DIFFRACTION",4.01,69.34,"VAPOR DIFFUSION, HANGING DROP",10.5,"Crystals of ARS2 were obtained at 4 C in 2 microlitre hanging drops with a 1:1 ratio of protein solution (6 mg/ml in 20 mM HEPES, 300 mM NaCl, 2 mM tris(2-carboxyethyl)phosphine pH 7.8) to crystallisation solution. The crystallisation solution was 1.2 M sodium dihydrogen phosphate, 0.8 M dipotassium hydrogen phosphate, 0.2 M lithium sulphate, 0.1 M  CAPS pH 10.5",277,"10.1038/s41467-018-04142-7",,"6F8D",106.39,"3.48","3.48","Crystal structure of Human ARS2 residues 171-270 + 408-763 (P65 form)","RYNDYKLDFRRQQMQDFFLAHKDEEWFRSKYHPDEVGKRRQEARGALQNRLRVFLSLMETGWFDNLLLDIDKADAIVKMLDAAVIKMEGGTENDLRILEQ","Homo sapiens","SRRT, ARS2, ASR2","Serrate RNA effector molecule homolog","1","6F8D"
,,,,,,,,,,,,,,,,"GLECKPRPLHKTCSLFMRNIAPNISRAEIISLCKRYPGFMRVALSEPQPERRFFRRGWVTFDRSVNIKEICWNLQNIRLRECELSPGVNRDLTRRVRNINGITQHKQIVRNDIKLAAKLIHTLDDRTQLWASEPGTPPLPTSLPSQNPILKNITDYLIEEVSAEEEELLGSSGGAPPEEPPKEGNPAEINVERDEKLIKVLDKLLLYLRIVHSLDYYNTCEYPNEDEMPNRCGIIHVRGPMPPNRISHGEVLEWQKTFEEKLTPLLSVRESLSEEEAQKMGRKDPEQEVEKFVTSNTQELGKDKWLCPLSGKKFKGPEFVRKHIFNKHAEKIEEVKKEVAFFNNFLTDAKRPALPE","Homo sapiens","SRRT, ARS2, ASR2","Serrate RNA effector molecule homolog","2","6F8D"
"6F8O",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, HANGING DROP",5,"PEG 6000, AmCitrate",298,"10.1038/s41598-019-39722-0",,"6F8O",36.83,"1.17","1.17","AKR1B1 at 3.45 MGy radiation dose.","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","6F8O"
"6F8R",,"X-RAY DIFFRACTION",2.48,50.43,"VAPOR DIFFUSION, HANGING DROP",,"Hepes 
PEG 3350 
Magnesium Chloride",293,"10.1021/acs.biochem.8b00288","CZK","6F8R",80.34,"1.826","1.826","Crystal structure of the PDE4D catalytic domain in complex with GEBR-54","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6F8R"
"6F8T",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION, HANGING DROP",,"Hepes 
PEG 3350 
Magnesium Chloride",293,"10.1021/acs.biochem.8b00288","CZT","6F8T",80.32,"1.8","1.8","Crystal structure of the PDE4D catalytic domain in complex with GEBR-4a","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6F8T"
"6F8U",,"X-RAY DIFFRACTION",2.41,48.93,"VAPOR DIFFUSION, HANGING DROP",,"Hepes 
PEG 3350 
Magnesium Chloride",293,"10.1021/acs.biochem.8b00288","CZQ","6F8U",80.78,"2.1","2.1","Crystal structure of the PDE4D catalytic domain in complex with GEBR-20b","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6F8U"
"6F8V",,"X-RAY DIFFRACTION",2.4,48.84,"VAPOR DIFFUSION, HANGING DROP",,"Hepes 
PEG 3350 
Magnesium Chloride",293,"10.1021/acs.biochem.8b00288","D0B","6F8V",80.33,"1.85","1.85","Crystal structure of the PDE4D catalytic domain in complex with GEBR-18b","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6F8V"
"6F8W",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, HANGING DROP",,"Hepes 
PEG 3350 
Magnesium Chloride",293,"10.1021/acs.biochem.8b00288","D0E","6F8W",80.3,"1.601","1.601","Crystal structure of the PDE4D catalytic domain in complex with GEBR-18a","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6F8W"
"6F8X",,"X-RAY DIFFRACTION",2.4,48.81,"VAPOR DIFFUSION, HANGING DROP",,"Hepes 
PEG 3350 
Magnesium Chloride",293,"10.1021/acs.biochem.8b00288","D08","6F8X",80.49,"1.95","1.95","Crystal structure of the PDE4D catalytic domain in complex with GEBR-26g","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6F8X"
"6F9R",,"X-RAY DIFFRACTION",2.76,55.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris/Bicine pH 8.5, 0.06 M Divalent Cations, 30% PEG550MME/PEG20000",289,"10.1111/febs.14421","D0W","6F9R",151.09,"1.85","1.85","Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Sampatrilat-Asp.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6F9R"
"6F9T",,"X-RAY DIFFRACTION",2.37,48.18,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M MIB Buffer pH 4.0, 5% Glycerol, 15% PEG 3350",289,"10.1111/febs.14421",,"6F9T",71.76,"1.6","1.6","Crystal structure of human testis Angiotensin-1 converting enzyme in complex with Sampatrilat.","LVTDEAEASKFVEEYDRTSQVVWNEYAGANWNYNTNITTETSKILLQKNMQIAQHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPQGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWQKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPQMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6F9T"
"6F9U",,"X-RAY DIFFRACTION",2.36,47.85,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M MIB Buffer pH 4.0, 5% Glycerol, 15% PEG 3350",289,"10.1111/febs.14421",,"6F9U",70.99,"1.9","1.9","Crystal structure of human testis Angiotensin-1 converting enzyme in complex with Sampatrilat-Asp.","LVTDEAEASKFVEEYDRTSQVVWNEYAGANWNYNTNITTETSKILLQKNMQIAQHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPQGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWQKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPQMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6F9U"
"6F9V",,"X-RAY DIFFRACTION",2.81,56.16,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris/Bicine pH 8.5, 0.06 M Divalent Cations, 30% PEG550MME/PEG20000",289,"10.1111/febs.14421","D0Z","6F9V",150.52,"1.69","1.69","Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Sampatrilat.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6F9V"
"6FA1",,"X-RAY DIFFRACTION",2.5,50.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"8-15% w/v Polyethylene glycol 3350 and 0.2M lithium citrate",277,"10.1038/s41467-018-05707-2",,"6FA1",122.03,"1.97","1.97","Antibody derived (Abd-4) small molecule binding to KRAS.","AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6FA1"
,,,,,,,,,,,,,,,,"AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","2","6FA1"
,,,,,,,,,,,,,,,,"AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","3","6FA1"
"6FA2",,"X-RAY DIFFRACTION",2.46,49.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"8-15% w/v Polyethylene glycol 3350 and 0.2M lithium citrate",277,"10.1038/s41467-018-05707-2",,"6FA2",122.03,"2.6","2.6","Antibody derived (Abd-5) small molecule binding to KRAS.","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6FA2"
,,,,,,,,,,,,,,,,"FQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","2","6FA2"
,,,,,,,,,,,,,,,,"YFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","3","6FA2"
"6FA3",,"X-RAY DIFFRACTION",2.5,50.8,"VAPOR DIFFUSION, SITTING DROP",,"8-15% w/v Polyethylene glycol 3350 and 0.2M lithium citrate",277,"10.1038/s41467-018-05707-2","D1Z","6FA3",122.9,"1.82","1.82","Antibody derived (Abd-6) small molecule binding to KRAS.","AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6FA3"
,,,,,,,,,,,,,,,,"AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","2","6FA3"
"6FA4",,"X-RAY DIFFRACTION",2.5,50.9,"VAPOR DIFFUSION, SITTING DROP",5.5,"8-15% w/v Polyethylene glycol 3350 and 0.2M Lithium citrate",277,"10.1038/s41467-018-05707-2","D1W","6FA4",123.36,"2.02","2.02","Antibody derived (Abd-7) small molecule binding to KRAS.","AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6FA4"
,,,,,,,,,,,,,,,,"AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","2","6FA4"
"6FAF",,"X-RAY DIFFRACTION",2.33,47.15,"VAPOR DIFFUSION, HANGING DROP",9,"28% PEG4000, 0.2 M Sodium acetate, Tris 100 mM",296,"10.1021/acs.jmedchem.8b00770","D3B","6FAF",59,"1.99","1.99","Crystal structure of human carbonic anhydrase I in complex with the 3-(2,5-dimethylphenyl)-1-(2-hydroxy-5-sulfamoylphenyl)urea inhibitor","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6FAF"
"6FAG",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION, HANGING DROP",9,"28% PEG4000, 0.2 M Sodium acetate, Tris 100 mM",296,"10.1021/acs.jmedchem.8b00770","EON","6FAG",58.8,"1.79","1.79","Crystal structure of human carbonic anhydrase I in complex with the 1-(2-hydroxy-5-sulfamoylphenyl)-3-(2-methoxyphenyl)urea inhibitor","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6FAG"
"6FAJ",,"X-RAY DIFFRACTION",2.13,42.3,"VAPOR DIFFUSION, HANGING DROP",7,"35% PEG600
0.1M HEPES pH7.0",298,,,"6FAJ",87.91,"1.95","1.95","The structure of Human Methionine Adenosyltransferase II in apo state","MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6FAJ"
"6FAK",,"X-RAY DIFFRACTION",2.24,45.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"30 % PEG 1000, 270 mM CH3COONH4, 3% 6-aminohexanoic acid (ACA). 1.5 uL 5 mg/mL Stock + 1.5 uL precipitant. Streak seeding followed by micro-seeding immediately after pipetting with no pre-equilibration of the drop. Controlled hydration experiment for data collection.",293,"10.1107/S2059798319013500",,"6FAK",70.7,"1.9","1.9","Human afamin orthorhombic crystal form by controlled hydration","LPTQPRDIENFNSTQKFIEDNIEYITIIAFAQYVQEATFEEMEKLVKDMVEYKDRCMADKTLPECSKLPNNVLQEKICAMEGLPQKHNFSHCCSKVDAQRRLCFFYNKKSDVGFLPPFPTLDPEEKCQAYESNRESLLNHFLYEVARRNPFVFAPTLLTVAVHFEEVAKSCCEEQNKVNCLQTRAIPVTQYLKAFSSYQKHVCGALLKFGTKVVHFIYIAILSQKFPKIEFKELISLVEDVSSNYDGCCEGDVVQCIRDTSKVMNHICSKQDSISSKIKECCEKKIPERGQCIINSNKDDRPKDLSLREGKFTDSENVCQERDADPDTFFAKFTFEYSRRHPDLSIPELLRIVQIYKDLLRNCCNTENPPGCYRYAEDKFNETTEKSLKMVQQECKHFQNLGKDGLKYHYLIRLTKIAPQLSTEELVSLGEKMVTAFTTCCTLSEEFACVDNLADLVFGELCGVNENRTINPAVDHCCKTNFAFRRPCFESLKADKTYVPPPFSQDLFTFHADMCQSQNEELQRKTDRFLVNLVKLKHELTDEELQSLFTNFANVVDKCCKAESPEVCFNEESPKIGNKGENLYFQ","Homo sapiens","AFM, ALB2, ALBA","Afamin","1","6FAK"
"6FAP",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.4 M sodium/ potassium phosphate",291,"10.1021/acschembio.7b01093",,"6FAP",27.62,"2.7","2.7","Crystal structure of human BAZ2A PHD zinc finger in complex with Fr23","HMSVNKVTCLVCRKGDNDEFLLLCDGCDRGCHIYCHRPKMEAVPEGDWFCTVCLAQQV","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FAP"
"6FB4",,"X-RAY DIFFRACTION",3.63,66.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Na HEPES, 0.8M Na dihydrogen phosphare, 0.8M K dihydrogen phosphate
5% glycerol cryoprotectant",291,"10.1074/jbc.RA118.002279",,"6FB4",29.56,"2.4156309909","2.4156309909","human KIBRA C2 domain mutant C771A","SGATRIQIALKYDEKNKQFAILIIQLSNLSALLQQQDQKVNIRVAVLPCSESTTCLFRTRPLDASDTLVFNEVFWVSMSYPALHQKTLRVDVCTTDRSHLEECLGGAQISLAEVARSGERSTRWYNLLS","Homo sapiens","WWC1, KIAA0869","Protein KIBRA","1","6FB4"
"6FBN",,"X-RAY DIFFRACTION",2.22,44.64,"VAPOR DIFFUSION, HANGING DROP",7,"30% PEG600
0.1M HEPES pH7.0",298,"10.1111/febs.14790",,"6FBN",88.59,"2.7","2.7","Human Methionine Adenosyltransferase II mutant (Q113A)","MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQASPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6FBN"
"6FBO",,"X-RAY DIFFRACTION",2.19,43.83,"VAPOR DIFFUSION, HANGING DROP",7,"30% PEG600
0.1M HEPES pH.7.0",298,"10.1111/febs.14790",,"6FBO",45.01,"1.8","1.8","Human Methionine Adenosyltransferase II mutant (S114A) in I222 crystal form","MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQAPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6FBO"
"6FBP",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, HANGING DROP",7,"30% PEG600
0.1M HEPES",298,"10.1111/febs.14790",,"6FBP",88.69,"1.65","1.65","Human Methionine Adenosyltransferase II mutant (S114A) in P22121 crystal form","MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQAPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6FBP"
"6FC8",,"X-RAY DIFFRACTION",2.38,48.43,"VAPOR DIFFUSION, HANGING DROP",,"16% Peg8k, 0.1M Caco pH 6.8, 0.15M AS",298,"10.1021/acs.jmedchem.7b01490","D4Q","6FC8",32.31,"1.61","1.61","CHK1 KINASE IN COMPLEX WITH COMPOUND 13","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","6FC8"
"6FCB",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES
35% PEG600",298,"10.1111/febs.14790",,"6FCB",44.53,"2.7","2.7","Human Methionine Adenosyltransferase II mutant (P115G)","MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSGDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6FCB"
"6FCD",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, HANGING DROP",7,"30% PEG600
0.1M HEPES pH 7.0",298,"10.1111/febs.14790",,"6FCD",44.7,"1.7","1.7","Human Methionine Adenosyltransferase II mutant (R264A)","MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGAKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6FCD"
"6FCF",,"X-RAY DIFFRACTION",2.56,51.93,"VAPOR DIFFUSION, HANGING DROP",,"16% Peg8k, 0.1M Caco pH 6.8, 0.15M AS",298,"10.1021/acs.jmedchem.7b01490","D58","6FCF",32.37,"1.85","1.85","CHK1 KINASE IN COMPLEX WITH COMPOUND 44","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","6FCF"
"6FCH",,"X-RAY DIFFRACTION",2.25,45.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"NaOAc, PEG4000, Glycerol, Tris",293,"10.1016/j.chembiol.2018.02.011",,"6FCH",39.68,"1.45","1.45","Crystal Structure of Human APRT wild type in complex with PRPP and Mg2+","DSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6FCH"
"6FCI",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, SITTING DROP",8.5,"NaOAc, PEG4000, Glycerol, Tris",293,"10.1016/j.chembiol.2018.02.011",,"6FCI",80.19,"1.94","1.94","Crystal Structure of Human APRT wild type in complex with Adenine, PRPP and Mg2+","ADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6FCI"
"6FCJ",,"X-RAY DIFFRACTION",2.84,56.66,"VAPOR DIFFUSION, HANGING DROP",,"Na-cacodylate, pH 6.5
30% PEG8000
0.2 M ammonium sulfate",277,,,"6FCJ",26,"2.49","2.49","Estimation of Protein-Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics Simulations","GDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6FCJ"
"6FCK",,"X-RAY DIFFRACTION",2.42,49.1,"VAPOR DIFFUSION, HANGING DROP",,"16% Peg8k, 0.1M Caco pH 6.8, 0.15M AS",298,"10.1021/acs.jmedchem.7b01490","D4Z","6FCK",32.27,"1.9","1.9","CHK1 KINASE IN COMPLEX WITH COMPOUND 13","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","6FCK"
"6FCL",,"X-RAY DIFFRACTION",2.31,46.64,"VAPOR DIFFUSION, SITTING DROP",8.5,"NAOAC, PEG4000, GLYCEROL, TRIS, PH
 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1016/j.chembiol.2018.02.011",,"6FCL",39.55,"1.5","1.5","Crystal Structure of Human APRT wild type in complex with AMP","DSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6FCL"
"6FCM",,"X-RAY DIFFRACTION",2.5,50.79,"VAPOR DIFFUSION, HANGING DROP",8.5,"19 to 23% PEG 3350, 0.2 to 0.3 M NaCl, 0.1 M Tris-HCl pH 8.5",293,"10.1084/jem.20180371",,"6FCM",93.29,"2.8","2.8","Crystal structure of human PCNA","MGSSHHHHHHSSGLVPRGSHMMFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS","Homo sapiens","PCNA","Proliferating cell nuclear antigen","1","6FCM"
"6FCN",,"X-RAY DIFFRACTION",2.58,52.37,"VAPOR DIFFUSION, HANGING DROP",8.5,"19 to 23% PEG 3350, 0.2 to 0.3 M NaCl, 0.1 M Tris-HCl pH 8.5
12h prior to crystal freezing, 100 uM of p47phox(106-127) peptide was added to the crystallization drop",293,"10.1084/jem.20180371",,"6FCN",93.29,"3.22","3.22","Crystal structure of human PCNA soaked with p47phox(106-127) peptide","MGSSHHHHHHSSGLVPRGSHMMFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS","Homo sapiens","PCNA","Proliferating cell nuclear antigen","1","6FCN"
"6FCX",,"X-RAY DIFFRACTION",3.24,62.08,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Sodium Citrate tribasic, 22.5% PEG4K, 5% 2-propanol",277.15,"10.1038/s41467-018-04735-2",,"6FCX",143.83,"2.5","2.5","Structure of human 5,10-methylenetetrahydrofolate reductase (MTHFR)","MDPERHERLREKMRRRLESGDKWFSLEFFPPRTAEGAVNLISRFDRMAAGGPLYIDVTWHPAGDPGSDKETSSMMIASTAVNYCGLETILHMTCCRQRLEEITGHLHKAKQLGLKNIMALRGDPIGDQWEEEEGGFNYAVDLVKHIRSEFGDYFDICVAGYPKGHPEAGSFEADLKHLKEKVSAGADFIITQLFFEADTFFRFVKACTDMGITCPIVPGIFPIQGYHSLRQLVKLSKLEVPQEIKDVIEPIKDNDAAIRNYGIELAVSLCQELLASGLVPGLHFYTLNREMATTEVLKRLGMWTEDPRRPLPWALSAHPKRREEDVRPIFWASRPKSYIYRTQEWDEFPNGRWGNSSSPAFGELKDYYLFYLKSKSPKEELLKMWGEELTSEASVFEVFVLYLSGEPNRNGHKVTCLPWNDEPLAAETSLLKEELLRVNRQGILTINSQPNINGKPSSDPIVGWGPSGGYVFQKAYLEFFTSRETAEALLQVLKKYELRVNYHLVNVKGENITNAPELQPNAVTWGIFPGREIIQPTVVDPVSFMFWKDEAFALWIEQWGKLYEEESPSRTIIQYIHDNYFLVNLVDNDFPLDNCLWQVVEDTLELLNAENLYFQ","Homo sapiens","MTHFR","Methylenetetrahydrofolate reductase","1","6FCX"
"6FD0",,"X-RAY DIFFRACTION",2.42,49.26,"VAPOR DIFFUSION, HANGING DROP",6,"0.15M ammonium sulfate, 0.1M MES pH 6.0, 15% w/v PEG4000",298,"10.1074/jbc.RA118.002279",,"6FD0",32.11,"2.64215847029","2.64215847029","Human KIBRA C2 domain mutant M734I S735A","MRGSHHHHHHGSGATRIQIALKYDEKNKQFAILIIQLSNLSALLQQQDQKVNIRVAVLPCSESTTCLFRTRPLDASDTLVFNEVFWVSIAYPALHQKTLRVDVCTTDRSHLEECLGGAQISLAEVCRSGERSTRWYNLLS","Homo sapiens","WWC1, KIAA0869","Protein KIBRA","1","6FD0"
"6FD3",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2M magnesium formate",293,"10.1042/BCJ20180867",,"6FD3",34.33,"1.52","1.52","Thiophosphorylated PAK3 kinase domain","SMTDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTALDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLDKPLSSLTPLIIAAKEAIKNSSR","Homo sapiens","PAK3, OPHN3","Serine/threonine-protein kinase PAK 3","1","6FD3"
"6FD4",,"X-RAY DIFFRACTION",2.28,46.1,"VAPOR DIFFUSION, SITTING DROP",8.5,"NAOAC, PEG4000, GLYCEROL, TRIS, PH
 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1016/j.chembiol.2018.02.011",,"6FD4",39.65,"1.5","1.5","Crystal Structure of Human APRT-Tyr105Phe variant in complex with Adenine, PRPP and Mg2+, 14 hours post crystallization","DSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEFGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6FD4"
"6FD5",,"X-RAY DIFFRACTION",2.3,46.44,"VAPOR DIFFUSION, SITTING DROP",8.5,"NAOAC, PEG4000, GLYCEROL, TRIS, PH
 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1016/j.chembiol.2018.02.011",,"6FD5",40.4,"1.55","1.55","Crystal Structure of Human APRT-Tyr105Phe variant in complex with Adenine, PRPP and Mg2+, 14 days post crystallization (with AMP and PPi products partially generated)","DSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEFGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6FD5"
"6FD6",,"X-RAY DIFFRACTION",2.28,46.13,"VAPOR DIFFUSION, SITTING DROP",8.5,"NaOAc, PEG4000, Glycerol, Tris",293,"10.1016/j.chembiol.2018.02.011",,"6FD6",39.9,"1.8","1.8","Crystal Structure of Human APRT-Tyr105Phe variant in complex with Adenine, PRPP and Mg2+, 30 days post crystallization (with AMP and PPi products fully generated)","DSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEFGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6FD6"
"6FD7",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2018.06.002",,"6FD7",14.49,,,"NMR structure of the first TPR domain of the human RPAP3 protein","GPHMALVLKEKGNKYFKQGKYDEAIDCYTKGMDADPYNPVLPTNRASAYFRLKKFAVAESDCNLAVALNRSYTKAYSRRGAARFALQKLEEAKKDYERVLELEPNNFEATNELRKISQALASKENSY","Homo sapiens","RPAP3","RNA polymerase II-associated protein 3","1","6FD7"
"6FD8",,"X-RAY DIFFRACTION",2.64,53.49,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Sodium tartrate dibasic dihydrate (pH 7.3), 20% w/v polyethylene glycol 3350",292,"10.1016/j.jmb.2018.12.005",,"6FD8",42.07,"2.1","2.1","Gamma-s crystallin dimer","MSKTGTKITFYEDKNFQGRRYDCDCDCADFHTYLSRCNSIKVEGGTWAVYERPNFAGYMYILPQGEYPEYQRWMGLNDRLSSCRAVHLPSGGQYKIQIFEKGDFSGQMYETTEDCPSIMEQFHMREIHSCKVLEGVWIFYELPNYRGRQYLLDKKEYRKPIDWGAASPAVQSFRRIVE","Homo sapiens","CRYGS, CRYG8","Beta-crystallin S","1","6FD8"
"6FDC",,"X-RAY DIFFRACTION",2.42,49.13,"VAPOR DIFFUSION, HANGING DROP",,"Hepes 
PEG 3350 
Magnesium Chloride",293,"10.1021/acs.biochem.8b00288","DD5, D5N","6FDC",80.5,"1.45","1.45","Crystal structure of the PDE4D catalytic domain in complex with GEBR-32a","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FDC"
"6FDI",,"X-RAY DIFFRACTION",2.65,53.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES",293,,,"6FDI",174.66,"1.9","1.9","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-226","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FDI"
"6FDL",,"X-RAY DIFFRACTION",2.06,40.17,"VAPOR DIFFUSION, HANGING DROP",,"12% (w/v) PEG3350, 0.2 M K3-Citrate and 0.1 M Bis-Tris propane, pH 6.5",293.15,"10.1093/nar/gky1011",,"6FDL",36.47,"1.75","1.75","Crystal structure of the NYN domain of human MARF1","GPLGSPIGVFWDIENCSVPSGRSATAVVQRIREKFFKGHREAEFMCVCDISKENKEVIQELNNCQVTVAHINATAKNAADDKLRQSLRRFANTHTAPATVVLVSTDVNFAMELSDLRHRHGFHIILVHKNQASEALLHHANELIRFEEFISDLPHHHHHH","Homo sapiens","MARF1, KIAA0430, LKAP","Meiosis regulator and mRNA stability factor 1","1","6FDL"
"6FDM",,"X-RAY DIFFRACTION",2.64,53.38,"VAPOR DIFFUSION, SITTING DROP",,"Morpheus screen D2",298,"10.1080/15476286.2019.1653679",,"6FDM",146.45,"2.1","2.1","Human Rio2 kinase structure","MGKVNVAKLRYMSRDDFRVLTAVEMGMKNHEIVPGSLIASIASLKHGGCNKVLRELVKHKLIAWERTKTVQGYRLTNAGYDYLALKTLSSRQVVESVGNQMGVGKESDIYIVANEEGQQFALKLHRLGRTSFRNLKNKRDYHKHRHNVSWLYLSRLSAMKEFAYMKALYERKFPVPKPIDYNRHAVVMELINGYPLCQIHHVEDPASVYDEAMELIVKLANHGLIHGDFNEFNLILDESDHITMIDFPQMVSTSHPNAEWYFDRDVKCIKDFFMKRFSYESELFPTFKDIRREDTLDVEVSASGYTKEMQADD","Homo sapiens","RIOK2, RIO2","Serine/threonine-protein kinase RIO2","1","6FDM"
"6FDN",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, SITTING DROP",,"Morpheus D2",298,"10.1080/15476286.2019.1653679",,"6FDN",74.22,"2.9","2.9","Rio2 structure","MGKVNVAKLRYMSRDDFRVLTAVEMGMKNHEIVPGSLIASIASLKHGGCNKVLRELVKHKLIAWERTKTVQGYRLTNAGYDYLALKTLSSRQVVESVGNQMGVGKESDIYIVANEEGQQFALKLHRLGRTSFRNLKNKRDYHKHRHNVSWLYLSRLSAMKEFAYMKALYERKFPVPKPIDYNRHAVVMELINGYPLCQIHHVEDPASVYDEAMELIVKLANHGLIHGDFNEFNLILDESDHITMIDFPQMVSTSHPNAEWYFDRDVKCIKDFFMKRFSYESELFPTFKDIRREDTLDVEVSASGYTKEMQADDELLHPLG","Homo sapiens","RIOK2, RIO2","Serine/threonine-protein kinase RIO2","1","6FDN"
"6FDO",,"X-RAY DIFFRACTION",2.52,51.27,"VAPOR DIFFUSION, SITTING DROP",,"Morpheus D2",298,"10.1080/15476286.2019.1653679",,"6FDO",81.46,"2.6","2.6","Rio2 structure","MGKVNVAKLRYMSRDDFRVLTAVEMGMKNHEIVPGSLIASIASLKHGGCNKVLRELVKHKLIAWERTKTVQGYRLTNAGYDYLALKTLSSRQVVESVGNQMGVGKESDIYIVANEEGQQFALKLHRLGRTSFRNLKNKRDYHKHRHNVSWLYLSRLSAMKEFAYMKALYERKFPVPKPIDYNRHAVVMELINGYPLCQIHHVEDPASVYDEAMELIVKLANHGLIHGDFNEFNLILDESDHITMIDFPQMVSTSHPNAEWYFDRDVKCIKDFFMKRFSYESELFPTFKDIRREDTLDVEVSASGYTKEMQADDELLHPLGPDDKNIETKEGSEFSFSDGEVAEKAEVYGSENE","Homo sapiens","RIOK2, RIO2","Serine/threonine-protein kinase RIO2","1","6FDO"
"6FDY",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris pH 8.5; 0.2 M sodium citrate; 30% PEG400",277,,"DB8","6FDY",33,"1.7","1.7","Unc-51-Like Kinase 3 (ULK3) In Complex With Bosutinib","AGPGWGPPRLDGFILTERLGSGTYATVYKAYAKKDTREVVAIKCVAKKSLNKASVENLLTEIEILKGIRHPHIVQLKDFQWDSDNIYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSMGVILYEALFGQPPFASRSFSELEEKIRSNRVIELPLRPLLSRDCRDLLQRLLERDPSRRISFQDFFAHPWVDLEHMPS","Homo sapiens","ULK3","Serine/threonine-protein kinase ULK3","1","6FDY"
"6FDZ",,"X-RAY DIFFRACTION",2.79,55.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M MgCl2, 30% 2-propanol",277,,,"6FDZ",32.35,"2.55","2.55","Unc-51-Like Kinase 3 (ULK3) In Complex With Momelotinib","AGPGWGPPRLDGFILTERLGSGTYATVYKAYAKKDTREVVAIKCVAKKSLNKASVENLLTEIEILKGIRHPHIVQLKDFQWDSDNIYLIMEFCAGGDLSRFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKPHLKLADFGFAQHMSPWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSMGVILYEALFGQPPFASRSFSELEEKIRSNRVIELPLRPLLSRDCRDLLQRLLERDPSRRISFQDFFAHPWVDLEHMPS","Homo sapiens","ULK3","Serine/threonine-protein kinase ULK3","1","6FDZ"
"6FE0",,"X-RAY DIFFRACTION",3.44,64.29,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100%  DIMETHYL SULFOXIDE)",294,"10.18632/oncotarget.25508","V90","6FE0",114.6,"1.91","1.91","Three dimensional structure of human carbonic anhydrase IX in complex with benzenesulfonamide.","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6FE0"
"6FE1",,"X-RAY DIFFRACTION",3.42,64.05,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100%  DIMETHYL SULFOXIDE)",294,"10.18632/oncotarget.25508","V14","6FE1",114.73,"1.95","1.95","Three dimensional structure of human carbonic anhydrase IX in complex with benzenesulfonamide.","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6FE1"
"6FE2",,"X-RAY DIFFRACTION",3.42,64.04,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100%  DIMETHYL SULFOXIDE)",294,"10.18632/oncotarget.25508",,"6FE2",112.95,"1.87","1.87","Three dimensional structure of human carbonic anhydrase IX","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6FE2"
"6FE5",,"X-RAY DIFFRACTION",3.34,63.12,"VAPOR DIFFUSION, HANGING DROP",8,"33 % (v/v) pentaerythritol propoxylate PO/OH 5/4
2 % (w/v) PEG 3350 
100 mM Tris-HCl, pH 8.0",293,"10.1016/j.bmc.2018.11.022","D6E","6FE5",83.3,"1.52","1.52","X-ray structure of human glutamate carboxypeptidase II (GCPII) - the E424M inactive mutant, in complex with a inhibitor JHU 2249","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAMEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6FE5"
"6FE7",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES",293,,,"6FE7",176.33,"2","2","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-356","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FE7"
"6FEB",,"X-RAY DIFFRACTION",2.51,50.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES",293,,,"6FEB",86.99,"1.93","1.93","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1086","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FEB"
"6FEK",,"X-RAY DIFFRACTION",2.36,47.84,"VAPOR DIFFUSION, SITTING DROP",4.4,"3.4 M sodium formate, and 0.1 M sodium acetate pH 4.4",289,"10.1038/s41467-018-02994-7",,"6FEK",34.71,"2.3","2.3","Oncogenic point mutation of RET receptor tyrosine kinase","GPLSLSVDAFKILAAPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDFYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRR","Homo sapiens","RET, CDHF12, CDHR16, PTC, RET51","Proto-oncogene tyrosine-protein kinase receptor Ret","1","6FEK"
"6FER",,"X-RAY DIFFRACTION",2.29,46.34,"VAPOR DIFFUSION, SITTING DROP",7,"12.6 mg/mL protein in 20mM Tris/HCl pH7.5, 0.2M NaCl, 2mM TCEP, 0.02% NaN3, 50microM target ligand mixed 1:1 in 200 nL with 1M Na citrate ; 0.1M HEPES/NaOH pH7.0",293,"10.1021/acschembio.8b00866",,"6FER",435.19,"2.87","2.87","Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide","VAVEEFPRKLLTFKEKLGEGQFGEVHLCEVEGMEKFKDKDFALDVSANQPVLVAVKMLRADANKNARNDFLKEIKIMSRLKDPNIIHLLAVCITDDPLCMITEYMENGDLNQFLSRHEPPNSSSSDVRTVSYTNLKFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQTYLPQPAICPDSVYKLMLSCWRRDTKNRPSFQEIHLLLLQQGDEHHHHHH","Homo sapiens","DDR2, NTRKR3, TKT, TYRO10","Discoidin domain-containing receptor 2","1","6FER"
"6FET",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES",293,,,"6FET",176.36,"1.88","1.88","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-1439","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FET"
"6FEW",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, SITTING DROP",5.5,"11.5 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed 3:1 in 600 nL with 0.1M Ca acetate, 12% PEG 8K, 0.1M Na cacodylate pH5.5",293,"10.1021/acschembio.8b00866","D6W","6FEW",36.95,"1.44","1.44","DDR1, 2-[8-(1H-indazole-5-carbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-N-methylacetamide, 1.440A, P1211, Rfree=24.1%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6FEW"
"6FEX",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, SITTING DROP",5.5,"11.3 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed 1.3:1 with 90mM MES/NaOH pH6.5, 0.18M potassium iodide, 0.2M Li2SO4, 22.5% PEG 4K",293,"10.1021/acschembio.8b00866","D6Z","6FEX",37.91,"1.291","1.291","DDR1, 2-[4-bromo-2-oxo-1'-(1H-pyrazolo[4,3-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide, 1.291A, P212121, Rfree=17.4%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6FEX"
"6FF8",,"X-RAY DIFFRACTION",2.27,45.78,"VAPOR DIFFUSION",,"O.2M sodium potassium tartrate, 0.1M Bis-Tris propane pH 8.5, 20% w/v PEG 3350",293,"10.1080/21541248.2019.1666623","GTP","6FF8",42.27,"2.13","2.13","Crystal structure of uncomplexed Rab32 in the active GTP-bound state at 2.13 Angstrom resolution","SMETREHLFKVLVIGELGVGKTSIIKRYVHQLFSQHYRATIGVDFALKVLNWDSRTLVRLQLWDIAGLERFGNMTRVYYKEAVGAFVVFDISRSSTFEAVLKWKSDLDSKVHLPNGSPIPAVLLANKCDQNKDSSQSPSQVDQFCKEHGFAGWFETSAKDNINIEEAARFLVEKILVNHQS","Homo sapiens","RAB32","Ras-related protein Rab-32","1","6FF8"
"6FF9",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, SITTING DROP",,"35% PEG 3350",293,"10.3390/ijms19041184",,"6FF9",87.24,"2","2","Mutant R280K of human P53","VPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGKDRRTEEENL","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6FF9"
"6FFB",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION",,"PEG 6000 20%; Hepes 0.1 M pH 7.00; DMSO 5%",291,"10.1016/j.jsbmb.2019.02.009","F45","6FFB",29.8,"1.65","1.65","17beta-hydroxysteroid dehydrogenase 14 variant S205 - mutant Q148A - in complex with a nonsteroidal inhibitor","GHMATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGAAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPSGS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6FFB"
"6FFC","3.56","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0049-1",,"6FFC",147.84,"3.56",,"Structure of an inhibitor-bound ABC transporter","DYKDDDDKGSSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS","Homo sapiens","ABCG2, ABCP, BCRP, BCRP1, MXR","ATP-binding cassette sub-family G member 2","1","6FFC"
"6FFD",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M morpheus buffer1, pH 6.5, 30% morpheus EDO_P8K, 0.12M Morpheus alchol mixture",293,,"D7T","6FFD",13.92,"1.83","1.83","Human BRD4 C-terminal bromodomain with 1-(4-(3-methylbenzyl)-3,4-dihydroquinoxalin-1(2H)-yl)ethanone","SSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDEPEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6FFD"
"6FFE",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, SITTING DROP",,"0.1M MES, pH6.5 30% PEG300",279.5,"10.1021/acs.jmedchem.7b01666",,"6FFE",14.12,"1.76","1.76","Human BRD2 C-terminal bromodomain with 2-((4-acetyl-3-cyclopropyl-3,4-dihydroquinoxalin-1(2H)-yl)methyl)benzoic acid","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6FFE"
"6FFF",,"X-RAY DIFFRACTION",2.3,46.41,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES, pH6.5 30% PEG300",293,"10.1021/acs.jmedchem.7b01666",,"6FFF",14.15,"1.67","1.67","Human BRD2 C-terminal bromodomain with (S)-5-(1-acetyl-2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-1,2,3,4-tetrahydroquinoxalin-6-yl)pyrimidine-2-carboxamide","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6FFF"
"6FFG",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION",6.5,"0.1M MES, pH6.5 30% PEG300",293,"10.1021/acs.jmedchem.7b01666",,"6FFG",14.38,"1.59","1.59","Human BRD2 C-terminal bromodomain with (S)-1-(2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-6-(1,2,3,6-tetrahydropyridin-4-yl)-3,4-dihydroquinoxalin-1(2H)-yl)ethanone","GSMGKLSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","6FFG"
"6FFJ",,"X-RAY DIFFRACTION",2.53,51.37,"VAPOR DIFFUSION, SITTING DROP",,"12.5 % w/v PEG 1000, 12.5 % w/v PEG 3350, 12.5 % v/v MPD, 0.02 M 1,6-hexandiol, 0.02 M 1-butanol, 0.02 M (RS)-1,2-propanediol, 0.02 M 2-propanol, 0.02 M 1,4-butanediol, 0.02 M 1,3-propanediol, 0.1 M bicine/tris base pH 8.5",293,"10.1038/s41598-018-28918-5",,"6FFJ",112.46,"2.2","2.2","Anti-tumor antibody 14F7-derived single chain fragment variable (scFv)","QVQLQQSGAELAKPGASMKMSCRASGYSFTSYWIHWLKQRPDQGLEWIGYIDPATAYTESNQKFKDKAILTADRSSNTAFMYLNSLTSEDSAVYYCARESPRLRRGIYYYAMDYWGQGTTVTVSSKLSGSASAPKLEEGEFSEARVDIQMTQTPSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPPTFGAGTKLELK","Homo sapiens",,"14F7-derived scFv","1","6FFJ"
"6FFK",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES, 20% PEG 3350",293,"10.1021/acsmedchemlett.8b00199","D7Z","6FFK",64.82,"1.94","1.94","Human apo-SOD1 bound to PtCl2(1R,2R-1,4-DACH","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6FFK"
"6FFM",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, HANGING DROP",,"25-28 % PEG 4000, 0.1 M Tris-HCl pH 8.0 and 0.2 M lithium sulfate",293,"10.1002/open.201800185",,"6FFM",15.41,"2.2","2.2","Crystal Structure of Human KEAP1 BTB Domain in Complex with isoxazoline-based inhibitor","GHMGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACADFLVQQLD","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","6FFM"
"6FFT",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.19,43.77,"VAPOR DIFFUSION, SITTING DROP",,"2.3M sodium malonate pD 5.9",293,"10.1038/s41467-019-08609-z","3MI","6FFT",28.71,"2, 2","2","Neutron structure of human transthyretin (TTR) S52P mutant in complex with tafamidis at room temperature to 2A resolution (quasi-Laue)","GAMGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSEPGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6FFT"
"6FG2",,"X-RAY DIFFRACTION",3.62,65.99,"VAPOR DIFFUSION, HANGING DROP",,"MES 100mM - PEG 400 35% - NaCl 200mM - MPD 4% - pH6",292,"10.1038/s41591-019-0568-2",,"6FG2",195.44,"2.788","2.788","CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84.","EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYSMSWVRQAPGKGLEWVSSISRSTPYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDLWSPDSNYYDQSAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTENLYFQ","Homo sapiens",,"HEAVY CHAIN FAB NAA84","1","6FG2"
,,,,,,,,,,,,,,,,"SSELTQDPAVSVALGQTVRITCQGDSLRSNYASWYQQKPGQAPLLVIYGKNYRPSGIPDRFSGSYSGNTASLTISGAQAEDEADYYCNSRDSSGDHPVVFGGGTNLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"LIGHT CHAIN FAB NAA84","2","6FG2"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDEAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPENLYFQ","Homo sapiens",,"HEAVY CHAIN FAB NATALIZUMAB","3","6FG2"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG","Homo sapiens",,"LIGHT CHAIN FAB NATALIZUMAB","4","6FG2"
"6FG6",,"X-RAY DIFFRACTION",3.52,65.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1002/cmdc.201800234",,"6FG6",12.58,"2.401","2.401","Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 1","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FG6"
"6FGF",,"X-RAY DIFFRACTION",3.51,64.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1002/cmdc.201800234",,"6FGF",12.71,"2.801","2.801","Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 2","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FGF"
"6FGG",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1002/cmdc.201800234","D9B","6FGG",12.87,"1.1","1.1","Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 5","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFYQ","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FGG"
"6FGH",,"X-RAY DIFFRACTION",3.5,64.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1002/cmdc.201800234",,"6FGH",12.61,"2.1","2.1","Crystal Structure of BAZ2A bromodomain in complex with 3-amino-2-methylpyridine derivative 1","MSHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FGH"
"6FGI",,"X-RAY DIFFRACTION",3.5,64.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1002/cmdc.201800234",,"6FGI",12.62,"2.551","2.551","Crystal Structure of BAZ2A bromodomain in complex with 3-amino-2-methylpyridine derivative 2","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FGI"
"6FGL",,"X-RAY DIFFRACTION",3.56,65.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1002/cmdc.201800234","UO1","6FGL",12.73,"2.1","2.1","Crystal Structure of BAZ2A bromodomain in complex with acetylindole compound UZH47","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFY","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FGL"
"6FGQ",,"X-RAY DIFFRACTION",3.59,65.77,"VAPOR DIFFUSION, HANGING DROP",7,"1.3M LiSO4 0.1M MgCl2 0.1M Hepes pH 7",273,"10.1021/acs.jmedchem.8b00783","D9N","6FGQ",62.94,"2.37","2.37","Ligand complex of RORg LBD","MHNHNHNHNHNHNGGENLYFQGASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","6FGQ"
"6FGT",,"X-RAY DIFFRACTION",4.15,70.34,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG500MME, 2% PEG1000, 2% PEG3350, 10% PEG20000, 2% MPD",277,"10.1002/cmdc.201800234",,"6FGT",13.88,"2","2","Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 3","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","6FGT"
"6FGU",,"X-RAY DIFFRACTION",4.22,70.84,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG500MME, 2% PEG1000, 2% PEG3350, 10% PEG20000, 2% MPD",277,"10.1002/cmdc.201800234",,"6FGU",13.87,"2.05","2.05","Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 4","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","6FGU"
"6FGV",,"X-RAY DIFFRACTION",3.4,63.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2 M MgCl2",277,"10.1002/cmdc.201800234",,"6FGV",12.77,"2.5","2.5","Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 3","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFYQ","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FGV"
"6FGW",,"X-RAY DIFFRACTION",3.4,63.79,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M MgCl2",277,"10.1002/cmdc.201800234",,"6FGW",12.76,"2.725","2.725","Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 4","SMHSDLTFCEIILMEMESHDAAWPFLEPVNPRLVSGYRRIIKNPMDFSTMRERLLRGGYTSSEEFAADALLVFDNCQTFNEDDSEVGKAGHIMRRFFESRWEEFYQ","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FGW"
"6FGY",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% PEG 1,500 in water",292,"10.1016/j.bmcl.2018.05.003","D9W","6FGY",44.48,"1.54","1.54","Crystal Structure of Human BACE-1 in Complex with amino-1,4-oxazine compound 4","GPFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","6FGY"
"6FH5",,"X-RAY DIFFRACTION",2.62,53.07,"VAPOR DIFFUSION, HANGING DROP",,"20 Percent PEG3350, 175 mM AmSO4, 10 mM DTT and 100 mM Hepes pH 7.4 to 7.9",293,,,"6FH5",111.09,"2.84","2.84","PI3Kg IN COMPLEX WITH Compound 7","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6FH5"
"6FH6",,"X-RAY DIFFRACTION",4.06,69.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG500MME, 2% PEG1000, 2% PEG3350, 10% PEG20000, 2% MPD",277,"10.1002/cmdc.201800234",,"6FH6",13.81,"2.082","2.082","Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 1","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","6FH6"
"6FH7",,"X-RAY DIFFRACTION",4.08,69.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG500MME, 2% PEG1000, 2% PEG3350, 10% PEG20000, 2% MPD",277,"10.1002/cmdc.201800234",,"6FH7",13.95,"2.1","2.1","Crystal Structure of BAZ2B bromodomain in complex with 1-methylpyridinone compound 2","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","6FH7"
"6FHA",,"X-RAY DIFFRACTION",2.38,48.4,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG 4000, 0.2M ammonium sulfate, 0.1M sodium sulfate",292.15,,,"6FHA",38.65,"2.3","2.3","Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289A and S308A mutations","GPMATVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAAAVNMEKFKKFAARKKWKQAVRLISLCQRLSRSFLSRSNMSVARSD","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","6FHA"
"6FHB",,"X-RAY DIFFRACTION",2.93,57.99,"VAPOR DIFFUSION, SITTING DROP",,"10% PEG 8000, 0.2M magnesium acetate",292.15,,,"6FHB",39.16,"1.75","1.75","Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289A and S308E mutations","GPMATVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAAAVNMEKFKKFAARKKWKQEVRLISLCQRLSRSFLSRSNMSVARSD","Homo sapiens","DAPK1, DAPK","Death-associated protein kinase 1","1","6FHB"
"6FHK",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Succinic acid pH 7.0, 15%
w/v Polyethylene glycol 3,350",291,"10.1126/scisignal.aao2464","ADP","6FHK",85.36,"1.657","1.657","Structure of a modified protein containing a genetically encoded phosphoserine","MAKAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVALNPQNSVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEISSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLNKSINPDEAVAYGAAVQAAILM","Homo sapiens","HSPA1A, HSP72, HSPA1, HSX70","Heat shock 70 kDa protein 1A","1","6FHK"
"6FHQ",,"X-RAY DIFFRACTION",2.19,43.79,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.2 - 2.4 M sodium/ potassium phosphate",291,"10.1021/acschembio.7b01093","DE5","6FHQ",13.51,"1.95","1.95","Crystal structure of human BAZ2B PHD zinc finger in complex with Fr 21","HMSIMKVYCQICRKGDNEELLLLCDGCDKGCHTYCHRPKITTIPDGDWFCPACIAKAS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","6FHQ"
"6FI0",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.2-2.4 M sodium/potassium phosphate",291,"10.1021/acschembio.7b01093",,"6FI0",27.86,"1.9","1.9","Crystal structure of BAZ2A PHD zinc finger in complex with Fr 19","HMSVNKVTCLVCRKGDNDEFLLLCDGCDRGCHIYCHRPKMEAVPEGDWFCTVCLAQQV","Homo sapiens","BAZ2A, KIAA0314, TIP5","Bromodomain adjacent to zinc finger domain protein 2A","1","6FI0"
"6FI1",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION, SITTING DROP",8.5,"2.2-2.4 M sodium/potassium phopsphate",291,"10.1021/acschembio.7b01093",,"6FI1",13.51,"2.7","2.7","Crystal structure of human BAZ2B PHD zinc finger in complex with Fr23","HMSIMKVYCQICRKGDNEELLLLCDGCDKGCHTYCHRPKITTIPDGDWFCPACIAKAS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","6FI1"
"6FIA",,"X-RAY DIFFRACTION",2.58,52.41,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES, 0.15M AMMONIUM SULFATE, 12% PEG 2000",291,"10.7554/eLife.34960",,"6FIA",75.73,"2.65","2.65","Structure of the human LINE-1 ORF1p coiled coil domain","GPHMSELREDIQTKGKEVENFEKNLEECITRITNTEKCLKELMELKTKARELREECRSLRSRCDQLEERVSAAEDEINEIKREGKFREKRIKRNEQSLQEIWDY","Homo sapiens","L1RE1, LRE1","LINE-1 retrotransposable element ORF1 protein","1","6FIA"
"6FIC",,"X-RAY DIFFRACTION",4.13,70.23,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 7.5, 4.2 M NaCl",293,,,"6FIC",36.24,"2.18","2.18","Bivalent Inhibitor UNC4512 Bound to the TAF1 Bromodomain Tandem","GTTVHCDYLNRPHKSIHRRRTDPMVTLSSILESIINDMRDLPNTYPFHTPVNAKVVKDYYKIITRPMDLQTLRENVRKRLYPSREEFREHLELIVKNSATYNGPKHSLTQISQSMLDLCDEKLKEKEDKLARLEKAINPLLDDDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICTAKEAALEEAELESLDPMT","Homo sapiens","TAF1, BA2R, CCG1, CCGS, TAF2A","Transcription initiation factor TFIID subunit 1","1","6FIC"
"6FIE",,"X-RAY DIFFRACTION",2.15,42.82,"VAPOR DIFFUSION, SITTING DROP",,"Sample: 41.6mg/ml Calbindin-D28k in 1mM CaCl 5mM Tris pH8.0 (HCl).
Reservoir: 0.1M Potassium thiocyanate and 30% w/v PEG 2000 MME.",293,"10.1107/S2059798318011610",,"6FIE",30.53,"1.51","1.51","Crystallographic structure of calcium loaded Calbindin-D28K.","GPHMAESHLQSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELQQARKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVLPTEENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQDGNGYIDENELDALLKDLCEKNKQDLDINNITTYKKNIMALSDGGKLYRTDLALILCAGDN","Homo sapiens","CALB1, CAB27","Calbindin","1","6FIE"
"6FIL",,"X-RAY DIFFRACTION",2.38,48.42,"VAPOR DIFFUSION, SITTING DROP",5.5,"11.3 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed 1.3:1 with 90mM MES/NaOH pH6.5, 0.18M potassium iodide, 0.2M Li2SO4, 22.5% PEG 4K",293,"10.1021/acschembio.8b00866","D6W","6FIL",37.08,"1.73","1.73","DDR1, 2-[8-(1H-indazole-5-carbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-N-methylacetamide, 1.730A, P212121, Rfree=24.5%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6FIL"
"6FIN",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION, SITTING DROP",5.5,"11.3 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed 1.3:1 with 90mM MES/NaOH pH6.5, 0.18M potassium iodide, 0.2M Li2SO4, 22.5% PEG 4K",293,"10.1021/acschembio.8b00866","DJQ","6FIN",38.02,"1.67","1.67","DDR1, 3-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]-8-(1H-indazole-5-carbonyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 1.670A, P1211, Rfree=22.8%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6FIN"
"6FIO",,"X-RAY DIFFRACTION",2.8,56.15,"VAPOR DIFFUSION, SITTING DROP",5.5,"11.3 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed 1.3:1 with 90mM MES/NaOH pH6.5, 0.18M potassium iodide, 0.2M Li2SO4, 22.5% PEG 4K",293,"10.1021/acschembio.8b00866","DJH","6FIO",37,"1.99","1.99","DDR1, 2-[1'-(1H-indazole-5-carbonyl)-4-methyl-2-oxospiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide, 1.990A, P6522, Rfree=27.7%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6FIO"
"6FIQ",,"X-RAY DIFFRACTION",2.14,42.44,"VAPOR DIFFUSION, SITTING DROP",5.5,"11.3 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed 1.3:1 with 90mM MES/NaOH pH6.5, 0.18M potassium iodide, 0.2M Li2SO4, 22.5% PEG 4K",293,"10.1021/acschembio.8b00866",,"6FIQ",37.09,"1.79","1.79","DDR1, 1-(1H-indazole-5-carbonyl)-5'-methoxy-1'-[2-oxo-2-[(2S)-2-(trifluoromethyl)pyrrolidin-1-yl]ethyl]spiro[piperidine-4,3'-pyrrolo[3,2-b]pyridine]-2'-one, 1.790A, P212121, Rfree=23.8%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6FIQ"
"6FIR",,"X-RAY DIFFRACTION",3.06,59.76,"VAPOR DIFFUSION, SITTING DROP",,"MGSO4, TRIS AND LIGAND, pH 8.5",277,"10.1016/j.ejmech.2019.02.040",,"6FIR",65.05,"2.5","2.5","Human cytosolic 5'-nucleotidase II soaked with 5mM3-Phenyl-N-(9H-purin-6-yl)benzamide","MGSSHHHHHHSSGLVPRGSMSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6FIR"
"6FIS",,"X-RAY DIFFRACTION",3.07,59.93,"VAPOR DIFFUSION, SITTING DROP",,"MGSO4, TRIS AND LIGAND, pH 8.5",277,"10.1016/j.ejmech.2019.02.040",,"6FIS",62.84,"2.3","2.3","Human cytosolic 5'-nucleotidase II soaked with 10mM 7-Benzyloxymethyl-7H-adenine","MSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6FIS"
"6FIT",,"X-RAY DIFFRACTION",2.93,58.04,,6.5,"GROWN FROM AMMONIUM SULFATE, PH 6.5",,"10.1126/science.278.5336.286",,"6FIT",17.39,"2.6","2.6","FHIT-TRANSITION STATE ANALOG","MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTFSMQDGPEAGQTVKHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ","Homo sapiens","FHIT","FRAGILE HISTIDINE TRIAD PROTEIN","1","6FIT"
"6FIU",,"X-RAY DIFFRACTION",3.04,59.48,"VAPOR DIFFUSION, SITTING DROP",,"MGSO4, TRIS AND LIGAND, pH 8.5",277,"10.1016/j.ejmech.2019.02.040",,"6FIU",63.31,"2.5","2.5","Human cytosolic 5'-nucleotidase II soaked with 10mM 2-(6-([1,1'-Biphenyl]-3-carboxamido)-9H-purin-9-yl)acetic acid","MSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6FIU"
"6FIW",,"X-RAY DIFFRACTION",3.05,59.73,"VAPOR DIFFUSION, SITTING DROP",,"MGSO4, TRIS AND LIGAND, pH 8.5",277,"10.1016/j.ejmech.2019.02.040",,"6FIW",62.55,"2.2","2.2","Human cytosolic 5'-nucleotidase II co-crystallized with 10mM Sodium ((4-(3'-((7H-purin-6-yl)carbamoyl)-[1,1'-biphenyl]-3-yl)-1H-imidazol-1-yl) methyl) phosphonate","MSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNL","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6FIW"
"6FJC",,"X-RAY DIFFRACTION",3.29,62.67,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0, 1.5M (NH4)2SO4",293,"10.1074/jbc.RA118.002279",,"6FJC",33.93,"2.598","2.598","Human KIBRA C2 domain mutant C771A in complex with phosphatidylinositol 3,4,5-trisphosphate","MRGSHHHHHHGSGATRIQIALKYDEKNKQFAILIIQLSNLSALLQQQDQKVNIRVAVLPCSESTTCLFRTRPLDASDTLVFNEVFWVSMSYPALHQKTLRVDVCTTDRSHLEECLGGAQISLAEVARSGERSTRWYNLLS","Homo sapiens","WWC1, KIAA0869","Protein KIBRA","1","6FJC"
"6FJD",,"X-RAY DIFFRACTION",3.29,62.67,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0, 1.5M (NH4)2SO4",293,"10.1074/jbc.RA118.002279",,"6FJD",33.49,"2.898","2.898","Human KIBRA C2 domain mutant C771A in complex with phosphatidylinositol 4,5-bisphosphate","MRGSHHHHHHGSGATRIQIALKYDEKNKQFAILIIQLSNLSALLQQQDQKVNIRVAVLPCSESTTCLFRTRPLDASDTLVFNEVFWVSMSYPALHQKTLRVDVCTTDRSHLEECLGGAQISLAEVARSGERSTRWYNLLS","Homo sapiens","WWC1, KIAA0869","Protein KIBRA","1","6FJD"
"6FJI",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.2 M sodium citrate
100 mM Tris pH 8.5",293,"10.1016/j.jsb.2018.12.009",,"6FJI",29.27,"1.6, 2.033","1.6, 2.033","Joint neutron and x-ray crystal structure of human carbonic anhydrase IX mimic (apo).","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6FJI"
"6FJJ",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.15,42.75,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.2 M sodium citrate, 100 mM Tris pH 8.5",293,"10.1016/j.jsb.2018.12.009","LSA","6FJJ",29.45,"1.5, 2","1.5, 2","Joint neutron and x-ray crystal structure of human carbonic anhydrase IX mimic (saccharin).","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6FJJ"
"6FK0",,"X-RAY DIFFRACTION",2.51,50.93,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 8000, 0.1 M Ches pH 9.5",293,"10.1074/jbc.RA118.002154",,"6FK0",29.85,"2.9","2.9","Xray structure of domain-swapped cystatin E dimer","MDRPQERMVGELRDLSPDDPQVQKAAQAAVASYNMGSNSIYYFRDTHIIKAQSQLVAGIKYFLTMEMGSTDCRKTRVTGDHVDLTTCPLAAGAQQEKLRCDFEVLVVPWQNSSQLLKHNCVQMLEHHHHHH","Homo sapiens","CST6","Cystatin-M","1","6FK0"
"6FK2",,"X-RAY DIFFRACTION",2.14,42.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% PEG 4K, 0.1M MgCl2, 5mM DTT, 0.4M NaSCN",289,,,"6FK2",16.05,"1.01","1.01","Galectin-3 carbohydrate recognition domain in complex with lactitol","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6FK2"
"6FL5",,"X-RAY DIFFRACTION",3.17,61.24,"VAPOR DIFFUSION, HANGING DROP",6.5,"2 microL of 80microM protein solution in: 20 mM Hepes pH7.2, 250 mM NaCl 5% glycerol + 2 microL of reservoir:0.1 M Na Cacodilate pH6.5 - 1M Na citrate",294,"10.1111/febs.14610",,"6FL5",207.91,"3.6","3.6","Structure of human SHMT1-H135N-R137A-E168N mutant at 3.6 Ang. resolution","DADLWSSHDKMLAQPLKDSDVEVYNIIKKESNRQRVGLELIASENFASRAVLEALGSCLNNKYSEGYPGQRYYGGTEFIDELETLCQKRALQAYKLDPQCWGVNVQPYSGSPANFAVYTALVEPNGAIMGLDLPDGGHLTHGFMTDKKKISATSIFFNSMPYKVNPDTGYINYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHISGLVAAGVVPSPFEHCHVVTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLINSAVFPGLQGGPHNHAIAGVAVALKQAMTLEFKVYQHQVVANCRALSEALTELGYKIVTGGSDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCPGDRSALRPSGLRLGTPALTSRGLLEKDFQKVAHFIHRGIELTLQIQSDTGVRATLKEFKERLAGDKYQAAVQALREEVESFASLFPLPGLP","Homo sapiens","SHMT1","Serine hydroxymethyltransferase, cytosolic","1","6FL5"
"6FLH",,"X-RAY DIFFRACTION",3.74,67.12,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M sodium acetate pH 4.6 and 2 M ammonium sulfate",293,"10.1021/jacs.8b08141",,"6FLH",12.08,"1.79","1.79","Monomeric Human Cu,Zn Superoxide dismutase, SOD1 7+7, apo form","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEEGAGHVGDLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKADDGAGGNAGSRLASGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6FLH"
"6FLJ",,"X-RAY DIFFRACTION",2.02,39.03,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350 and 0.2 M NaSCN",293,"10.1016/j.jsb.2018.01.009",,"6FLJ",17.36,"1.751","1.751","Crystal structure of Cep120 C2A_K76A mutant","GPMVSKSDQLLIVVSILEGRHFPKRPKHMLVVEAKFDGEQLATDPVDHTDQPEFATELAWEIDRKALHQHRLQRTPIALQCFALDPVTSAKETIGYIVLDLRTAQETKQAPKWYQLLSNKYTKFKSEIQISIALETDTKPPVDSFKAKGAPPR","Homo sapiens","CEP120, CCDC100","Centrosomal protein of 120 kDa","1","6FLJ"
"6FLK",,"X-RAY DIFFRACTION",2.39,48.55,"VAPOR DIFFUSION, SITTING DROP",,"0.03M magnesium chloride hexahydrate; 0.03M calcium chloride dehydrate, 0.1M Tris(Base)/BICINE pH 8.5, 20% v/v Ethylene glycol and 10 % w/v PEG 8000",293,"10.1016/j.jsb.2018.01.009",,"6FLK",37.07,"1.6","1.6","Crystal structure of Cep120 C2C domain","GPTSHHFCFSIDLRSIHALEIGFPINCILRYSYPFFGSAAPIMTNPPVEVRKNMEVFLPQSYCAFDFATMPHQLQDTFLRIPLLVELWHKDKMSKDLLLGIARIQLSNILSSEKTRFLGSNGEQCWRQTYSESVPVIAAQGSNNRIADLSYTVTLEDYGLVKM","Homo sapiens","CEP120, CCDC100","Cep120","1","6FLK"
"6FLM",,"X-RAY DIFFRACTION",3.41,63.94,"VAPOR DIFFUSION, SITTING DROP",6.5,"15 mg/ml protein mixed in 1:1 ratio with reservoir containing 0.1 M bis-TRIS pH 6.5 and 2M ammonium sulphate.",293,"10.1038/s41467-018-04214-8",,"6FLM",69.37,"2.009","2.009","Crystal structure of the human TRIM25 PRYSPRY domain","GMASLKAKVLETFLAKSRPELLEYYIKVILDYNTAHNKVALSECYTVASVAEMPQNYRPHPQRFTYCSQVLGLHCYKKGIHYWEVELQKNNFCGVGICYGSMNRQGPESRLGRNSASWCVEWFNTKISAWHNNVEKTLPSTKATRVGVLLNCDHGFVIFFAVADKVHLMYKFRVDFTEALYPAFWVFSAGATLSICSPK","Homo sapiens","TRIM25, EFP, RNF147, ZNF147","E3 ubiquitin/ISG15 ligase TRIM25","1","6FLM"
"6FLN",,"X-RAY DIFFRACTION",2.4,48.74,"VAPOR DIFFUSION, SITTING DROP",,"Protein at 10 mg/ml was mixed in 2:1 ratio with mother liquor containing 0.2 M sodium formate, 14% PEG 3350 and 0.1 M bis-Tris pH 6.5.",293,"10.1038/s41467-018-04214-8",,"6FLN",150.87,"3.6","3.6","Crystal structure of the human TRIM25 coiled-coil and PRYSPRY domains","GAMASLSQASADLEATLRHKLTVMYSQINGASRALDDVRNRQQDVRMTANRKVEQLQQEYTEMKALLDASETTSTRKIKEEEKRVNSKFDTIYQILLKKKSEIQTLKEEIEQSLTKRDEFEFLEKASKLRGISTKPVYIPEVELNHKLIKGIHQSTIDLKNELKQCIGRLQEPTPSSGDPGEHDPASTHKSTRPVKKVSKEEKKSKKPPPVPALPSKLPTFGAPEQLVDLKQAGLEAAAKATSSHPNSTSLKAKVLETFLAKSRPELLEYYIKVILDYNTAHNKVALSECYTVASVAEMPQNYRPHPQRFTYCSQVLGLHCYKKGIHYWEVELQKNNFCGVGICYGSMNRQGPESRLGRNSASWCVEWFNTKISAWHNNVEKTLPSTKATRVGVLLNCDHGFVIFFAVADKVHLMYKFRVDFTEALYPAFWVFSAGATLSICSPK","Homo sapiens","TRIM25, EFP, RNF147, ZNF147","E3 ubiquitin/ISG15 ligase TRIM25","1","6FLN"
"6FLT","3.42","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.36402",,"6FLT",122.43,"3.42",,"Structure of alpha-synuclein fibrils","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPD","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6FLT"
"6FM8",,"X-RAY DIFFRACTION",2.51,51,"VAPOR DIFFUSION, SITTING DROP",7,"0.5M Potassium thiocyanate, 0.1M Bis-Tris Propane pH 7.0",287,,,"6FM8",6.15,"1.78","1.78","RPAP3 c-terminus","SLYPKLFQKNLDPDVFNQIVKILHDFYIEKEKPLLIFEILQRLSELKRFD","Homo sapiens","RPAP3","RNA polymerase II-associated protein 3","1","6FM8"
"6FM9",,"X-RAY DIFFRACTION",4.06,69.72,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.05M ADA pH 6.5 -- 24%  PEG400",277,"10.1016/j.cell.2018.10.037",,"6FM9",46.96,"3.6","3.6","Crystal structure of human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1)","SMWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAVVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDV","Homo sapiens","DPAGT1, DPAGT2","UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase","1","6FM9"
"6FMC",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, HANGING DROP",,"16 % w/v PEG3350 and 200 mM ammonium chloride",277.15,"10.1021/acs.jmedchem.8b00210","DUE","6FMC",18.5,"0.9","0.9","Neuropilin1-b1 domain in complex with EG01377, 0.9 Angstrom structure","GHMFKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKIT","Homo sapiens","NRP1, NRP, VEGF165R","Neuropilin-1","1","6FMC"
"6FMD",,"X-RAY DIFFRACTION",3.37,63.47,"VAPOR DIFFUSION, HANGING DROP",5.2,"0.2M KBr, 0.2M KSCN, 0.1M NaAc pH 5.2, 25% PEG 400, 2% PGA-LM",293,"10.1021/acs.jmedchem.8b00373","DUH","6FMD",45.64,"1.58","1.58","Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors based on 2-hydroxypyrazolo[1,5-a]pyridine scaffold","MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6FMD"
"6FMF",,"X-RAY DIFFRACTION",2.01,38.92,"VAPOR DIFFUSION, HANGING DROP",,"16 % w/v PEG3350 and 200 mM ammonium chloride",293.15,"10.1021/acs.jmedchem.8b00210",,"6FMF",18.62,"2.811","2.811","Neuropilin-1 b1 domain in complex with EG01377; 2.8 Angstrom structure","GHMFKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKIT","Homo sapiens","NRP1, NRP, VEGF165R","Neuropilin-1","1","6FMF"
"6FN8",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M Sodium Chloride, 20% (w/v) PEG 6000; 0.1 M Hepes",293,"10.1371/journal.pbio.3000141",,"6FN8",32.16,"1.55","1.55","Domain II of the HUMAN COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE at 1.55 A resolution","NLGAAVAILGGPGTVQGVVRFLQLTPERCLIEGTIDGLEPGLHGLHVHQYGDLTNNCNSCGNHFNPDGASHGGPQDSDRHRGDLGNVRADADGRAIFRMEDEQLKVWDVIGRSLIIDEGEDDLGRGGHPLSKITGNSGERLACGIIARSAGL","Homo sapiens","CCS","Copper chaperone for superoxide dismutase","1","6FN8"
"6FN9",,"X-RAY DIFFRACTION",4.02,69.38,"VAPOR DIFFUSION, SITTING DROP",,"0.09 M HEPES sodium salt pH 7.5
1.26 M tri-Sodium citrate 
10 %(v/v) Glycerol",277.15,"10.1002/chem.201801074","DW8","6FN9",54.25,"2.27","2.27","Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins","MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTS","Homo sapiens","YWHAZ","14-3-3 protein zeta/delta","1","6FN9"
"6FNA",,"X-RAY DIFFRACTION",4,69.25,"VAPOR DIFFUSION, SITTING DROP",,"0.18 M Magnesium chloride
0.09 M Sodium HEPES pH 7.5
10% (v/v) Glycerol
27% (v/v) Isopropanol",277.15,"10.1002/chem.201801074",,"6FNA",55.55,"2.12","2.12","Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins","MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTS","Homo sapiens","YWHAZ","14-3-3 protein zeta/delta","1","6FNA"
"6FNB",,"X-RAY DIFFRACTION",3.98,69.12,"VAPOR DIFFUSION, SITTING DROP",,"0.09 M HEPES sodium salt pH 7.5
1.26 M tri-Sodium citrate
10 %(v/v) Glycerol",277.15,"10.1002/chem.201801074",,"6FNB",55.96,"2.3","2.3","Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins","MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTS","Homo sapiens","YWHAZ","14-3-3 protein zeta/delta","1","6FNB"
"6FNC",,"X-RAY DIFFRACTION",4.01,69.33,"VAPOR DIFFUSION, SITTING DROP",,"0.18 M Magnesium chloride, 
0.09 M Sodium HEPES pH 7.5
10%(v/v) Glycerol
27%(v/v) Isopropanol",277.15,"10.1002/chem.201801074",,"6FNC",55.06,"2.12","2.12","Mono- and bivalent 14-3-3 inhibitors for characterizing supramolecular lysine-PEG interactions in proteins","MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTS","Homo sapiens","YWHAZ","14-3-3 protein zeta/delta","1","6FNC"
"6FNE",,"X-RAY DIFFRACTION",2.52,51.13,"VAPOR DIFFUSION",,"18% PEG 20000, 0.1 M Tris pH 8.5",293,"10.1038/s41589-019-0228-3","DY5","6FNE",95.47,"2.501","2.501","Structure of human Brag2 (Sec7-PH domains) with the inhibitor Bragsin bound to the PH domain","MSYYHHHHHHDYDIPTTENLYFQGAMGSEFMSWDSPAFSNDVIRKRHYRIGLNLFNKKPEKGVQYLIERGFVPDTPVGVAHFLLQRKGLSRQMIGEFLGNRQKQFNRDVLDCVVDEMDFSTMELDEALRKFQAHIRVQGEAQKVERLIEAFSQRYCICNPGVVRQFRNPDTIFILAFAIILLNTDMYSPNVKPERKMKLEDFIKNLRGVDDGEDIPREMLMGIYERIRKRELKTNEDHVSQVQKVEKLIVGKKPIGSLHPGLGCVLSLPHRRLVCYCRLFEVPDPNKPQKLGLHQREIFLFNDLLVVTKIFQKKKNSVTYSFRQSFSLYGMQVLLFENQYYPNGIRLTSSVPGADIKVLINFNAPNPQDRKKFTDDLRESIAEVQEMEKHRIESELEKQKGVVRP","Homo sapiens","IQSEC1, ARFGEP100, BRAG2, KIAA0763","IQ motif and SEC7 domain-containing protein 1","1","6FNE"
"6FNF",,"X-RAY DIFFRACTION",1.86,33.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"37.5 % MPD/PEG1000/PEG3350 (MD), 0.1 M Amino Acids Mix (MD), 0.1 M Tris pH 7.5",291,"10.1002/cmdc.201800398","DXH","6FNF",34.97,"1.556","1.556","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with NVP-BHG712","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6FNF"
"6FNG",,"X-RAY DIFFRACTION",1.95,37,"VAPOR DIFFUSION, SITTING DROP",8.5,"37.5 % MPD/PEG1000/PEG3350 (MD), 
0.2 M Lysine, 0.1 M Buffer System 3 (MD) pH 8.5",291,"10.1002/cmdc.201800398","DWT","6FNG",35.34,"1.038","1.038","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with an isomer of NVP-BHG712","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6FNG"
"6FNH",,"X-RAY DIFFRACTION",2.75,55.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"37.5 % MPD/PEG1000/PEG3350 (MD), 0.075 M Carboxylic Acids Mix (MD), 0.1 M Buffer System 3 (MD) pH 8.5",291,"10.1002/cmdc.201800398",,"6FNH",105.12,"1.379","1.379","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6FNH"
"6FNI",,"X-RAY DIFFRACTION",2.91,57.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 % PEG5000 MME, 0.15 M MgCl2, 15 % Glycerol, 0.1 M TRIS pH 7.5",291,"10.1002/cmdc.201800398","DXH","6FNI",33.99,"1.468","1.468","Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with NVP-BHG712","GMDPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQIVSALDKMIRNPASLKIVARENG","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","Ephrin type-B receptor 4","1","6FNI"
"6FNJ",,"X-RAY DIFFRACTION",2.76,55.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"10 % PEG5000 MME, 0.15 M MgCl2, 15 % Glycerol, 0.1 M TRIS pH 7.5",291,"10.1002/cmdc.201800398","DWT","6FNJ",68.05,"1.239","1.239","Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with an isomer of NVP-BHG712","GMDPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQIVSALDKMIRNPASLKIVARENG","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","Ephrin type-B receptor 4","1","6FNJ"
"6FNK",,"X-RAY DIFFRACTION",2.03,39.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"10 % PEG5000 MME, 0.15 M MgCl2, 15 % Glycerol, 0.1 M TRIS pH 7.5",291,"10.1002/cmdc.201800398",,"6FNK",33.84,"1.049","1.049","Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712","GMDPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQIVSALDKMIRNPASLKIVARENG","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","Ephrin type-B receptor 4","1","6FNK"
"6FNL",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"25 % PEG5000 MME, 15 % Glycerol, 0.1 M TRIS pH7.5",291,"10.1002/cmdc.201800398",,"6FNL",33.49,"1.269","1.269","Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase","GMDPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQIVSALDKMIRNPASLKIVARENG","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","Ephrin type-B receptor 4","1","6FNL"
"6FNM",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"25 % PEG5000 MME, 15 % Glycerol, 0.15 M MgCl2, 0.1 M TRIS pH7.5",291,"10.1002/cmdc.201800398","1N1","6FNM",33.98,"1.157","1.157","Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with Dasatinib","GMDPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQIVSALDKMIRNPASLKIVARENG","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","Ephrin type-B receptor 4","1","6FNM"
"6FNX",,"X-RAY DIFFRACTION",2.17,43.27,"EVAPORATION",,"5mM of #F1 inhibitor (in DMSO) final concentration.
Ratio 1:1 (protein:precipitant). 
20mg/mL of BRD4(BD1) protein. 
0.25M AmSO4; 0.1M NaCl; 0,1M Tris pH 8.5; 19% (w/v) PEG3350. 
Cryoprotectant: 10 % (w/v) ethylene glycol.",292,"10.1021/acs.jmedchem.8b00653","DYZ","6FNX",15.62,"1.19","1.19","FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR F1","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6FNX"
"6FO5",,"X-RAY DIFFRACTION",2.04,39.7,"EVAPORATION",8.5,"2.5mM of #17 inhibitor (in DMSO) final concentration.
Ratio 1:1 (protein:precipitant. 
12mg/mL of BRD4(BD1) protein. 
Precipitant agent: 0.3M NaNO3; 0.1M NaCl; 22% (w/v) PEG3350; 10% (w/v) ethylene glycol. 
Cryoprotectant: 10 % (w/v) glycerol.",292,"10.1021/acs.jmedchem.8b00653","DZH","6FO5",15.68,"0.95","0.95","FIRST DOMAIN OF HUMAN BROMODOMAIN BRD4 IN COMPLEX WITH INHIBITOR #17","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6FO5"
"6FOA",,"X-RAY DIFFRACTION",2.75,55.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"55-65% precipitant mix 2 (PEG8000 and ethylene glycol), 

100 mM Bicine/Tris buffer at pH 7.5 
100 mM of a sodium nitrate/sodium phosphate/ammonium sulphate mix.",293,"10.1016/j.str.2018.03.014",,"6FOA",86.46,"1.869","1.869","Human Xylosyltransferase 1 apo structure","APLVHHHHHHALDENLYFQGALADVSRPPHARKTGGSSPETKYDQPPKCDISGKEAISALSRAKSKHCRQEIGETYCRHKLGLLMPEKVTRFCPLEGKANKNVQWDEDSVEYMPANPVRIAFVLVVHGRASRQLQRMFKAIYHKDHFYYIHVDKRSNYLHRQVLQVSRQYSNVRVTPWRMATIWGGASLLSTYLQSMRDLLEMTDWPWDFFINLSAADYPIRTNDQLVAFLSRYRDMNFLKSHGRDNARFIRKQGLDRLFLECDAHMWRLGDRRIPEGIAVDGGSDWFLLNRRFVEYVTFSTDDLVTKMKQFYSYTLLPAESFFHTVLENSPHCDTMVDNNLRITNWNRKLGCKCQYKHIVDWCGCSPNDFKPQDFHRFQQTARPTFFARKFEAVVNQEIIGQLDYYLYGNYPAGTPGLRSYWENVYDEPDGIHSLSDVTLTLYHSFARLGLRRAETSLHTDGENSCRYYPMGHPASVHLYFLADRFQGFLIKHHATNLAVSKLETLETWVMPKKVFKIASPPSDFGRLQFSEVGTDWDAKERLFRNFGGLLGPMDEPVGMQKWGKGPNVTVTVIWVDPVNVIAATYDILIESTAEFTHYKPPLNLPLRPGVWTVKILHHWVPVAETKFLVAPLTFSNRQPIKPEEALKLHNGPLRNAYMEQSFQSLNPVLSLPINPAQVEQARRNAASTGTALEGWLDSLVGGMWTAMDICATGPTACPVMQTCSQTAWSSFSPDPKSELGAVKPDGRLR","Homo sapiens","XYLT1, XT1","Xylosyltransferase 1","1","6FOA"
"6FOE",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION, SITTING DROP",6.4,"100 mM Tris/HCl, 25% (w/v) PEG 3350",293,"10.1021/acs.biochem.7b01156",,"6FOE",94.61,"2.6","2.6","BaxB01 Fab fragment","EVQLLESGGGLVQPGGSLRLSCAASGFTFSIYSMNWVRQAPGKGLEWVSSIGSSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAGSQWLYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Fab BaxB01 heavy chain","1","6FOE"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRSSQRIMTYLNWYQQKPGKAPKLLIFVASHSQSGVPSRFRGSGSETDFTLTISGLQPEDSATYYCQQSFWTPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab BaxB01 light chain","2","6FOE"
"6FOF",,"X-RAY DIFFRACTION",2.78,55.4,"VAPOR DIFFUSION, SITTING DROP",8.5,"18% PEG 8K, 100 mM Tris-HCl (pH 8.5), 200 mM lithium sulfate",295,"10.1038/s41598-018-28235-x",,"6FOF",260.93,"2.2","2.2","Crystal structure of a crystallized variant of h-Gal3: Gal-3[NTS/VII-IX]","ADNFSLHDALSGSGNPNPQGWPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3,Galectin-3","1","6FOF"
,,,,,,,,,,,,,,,,,"Homo sapiens","LGALS3, MAC2"
"6FOG",,"X-RAY DIFFRACTION",2.8,56.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG4000, 50mM MgCl2, 100mM HEPES pH7.5",291,"10.1042/BCJ20180750",,"6FOG",200.14,"1.94","1.94","X-ray structure of homo sapiens Fumarylacetoacetate hydrolase domain containing protein 1 (FAHD1) in complex with inhibitor oxalate at 1.94A resolution.","MGIMAASRPLSRFWEWGKNIVCVGRNYADHVREMRSAVLSEPVLFLKPSTAYAPEGSPILMPAYTRNLHHELELGVVMGKRCRAVPEAAAMDYVGGYALCLDMTARDVQDECKKKGLPWTLAKSFTASCPVSAFVPKEKIPDPHKLKLWLKVNGELRQEGETSSMIFSIPYIISYVSKIITLEEGDIILTGTPKGVGPVKENDEIEAGIHGLVSMTFKVEKPEY","Homo sapiens","FAHD1, C16orf36, YISKL","Acylpyruvase FAHD1, mitochondrial","1","6FOG"
"6FOH",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG4000 50mM MgCl2 100mM HEPES pH7.5",291,"10.1042/BCJ20180750",,"6FOH",49.86,"1.56","1.56","X-ray structure of homo sapiens Fumarylacetoacetate hydrolase domain containing protein 1 (FAHD1) at 1.56A resolution.","MGIMAASRPLSRFWEWGKNIVCVGRNYADHVREMRSAVLSEPVLFLKPSTAYAPEGSPILMPAYTRNLHHELELGVVMGKRCRAVPEAAAMDYVGGYALCLDMTARDVQDECKKKGLPWTLAKSFTASCPVSAFVPKEKIPDPHKLKLWLKVNGELRQEGETSSMIFSIPYIISYVSKIITLEEGDIILTGTPKGVGPVKENDEIEAGIHGLVSMTFKVEKPEY","Homo sapiens","FAHD1, C16orf36, YISKL","Acylpyruvase FAHD1, mitochondrial","1","6FOH"
"6FOI",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M Lithium sulphate
24% w/v PEG 4000
0.1 M Tris-HCl pH 8.0",293,"10.1371/journal.pbio.3000141",,"6FOI",191.19,"2","2","Human Cys57/156Ala superoxide dismutase-1 (SOD1), as isolated.","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGATSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLAAGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","6FOI"
"6FPY",,"X-RAY DIFFRACTION",2.79,55.85,"VAPOR DIFFUSION",7.5,"100mM HEPES, pH 7.5, 
100mM Sodium acetate, 
10% PEG8K, 
20% Glycerol",293,,,"6FPY",148.48,"2.339","2.339","Inter-alpha-inhibitor heavy chain 1, wild type","MAHHHHHHVGTGSNDDDDDKSPSKSSEKRQAVDTAVDGVFIRSLKVNCKVTSRFAHYVVTSQVVNTANEAREVAFDLEIPKTAFISDFAVTADGNAFIGDIKDKVTAWKQYRKAAISGENAGLVRASGRTMEQFTIHLTVNPQSKVTFQLTYEEVLKRNHMQYEIVIKVKPKQLVHHFEIDVDIFEPQGISKLDAQASFLPKELAAQTIKKSFSGKKGHVLFRPTVSQQQSCPTCSTSLLNGHFKVTYDVSRDKICDLLVANNHFAHFFAPQNLTNMNKNVVFVIDISGSMRGQKVKQTKEALLKILGDMQPGDYFDLVLFGTRVQSWKGSLVQASEANLQAAQDFVRGFSLDEATNLNGGLLRGIEILNQVQESLPELSNHASILIMLTDGDPTEGVTDRSQILKNVRNAIRGRFPLYNLGFGHNVDFNFLEVMSMENNGRAQRIYEDHDATQQLQGFYSQVAKPLLVDVDLQYPQDAVLALTQNHHKQYYEGSEIVVAGRIADNKQSSFKADVQAHGEGQEFSITCLVDEEEMKKLLRERGHMLENHVERLWAYLTIQELLAKRMKVDREERANLSSQALQMSLDYGFVTPLTSMSIRGMADQDGLKPTIDKPSEDSPPLEMLGPRRTFVLSALQPSPTHSSSNTQRLPDRVTGVDTD","Homo sapiens","ITIH1, IGHEP1","Inter-alpha-trypsin inhibitor heavy chain H1","1","6FPY"
"6FPZ",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES, pH 7.5,
100mM Sodium acetate, 
10% PEG8K, 
20% Glycerol",293,,,"6FPZ",148.68,"2.2","2.2","Inter-alpha-inhibitor heavy chain 1, D298A","MAHHHHHHVGTGSNDDDDDKSPSKSSEKRQAVDTAVDGVFIRSLKVNCKVTSRFAHYVVTSQVVNTANEAREVAFDLEIPKTAFISDFAVTADGNAFIGDIKDKVTAWKQYRKAAISGENAGLVRASGRTMEQFTIHLTVNPQSKVTFQLTYEEVLKRNHMQYEIVIKVKPKQLVHHFEIDVDIFEPQGISKLDAQASFLPKELAAQTIKKSFSGKKGHVLFRPTVSQQQSCPTCSTSLLNGHFKVTYDVSRDKICDLLVANNHFAHFFAPQNLTNMNKNVVFVIAISGSMRGQKVKQTKEALLKILGDMQPGDYFDLVLFGTRVQSWKGSLVQASEANLQAAQDFVRGFSLDEATNLNGGLLRGIEILNQVQESLPELSNHASILIMLTDGDPTEGVTDRSQILKNVRNAIRGRFPLYNLGFGHNVDFNFLEVMSMENNGRAQRIYEDHDATQQLQGFYSQVAKPLLVDVDLQYPQDAVLALTQNHHKQYYEGSEIVVAGRIADNKQSSFKADVQAHGEGQEFSITCLVDEEEMKKLLRERGHMLENHVERLWAYLTIQELLAKRMKVDREERANLSSQALQMSLDYGFVTPLTSMSIRGMADQDGLKPTIDKPSEDSPPLEMLGPRRTFVLSALQPSPTHSSSNTQRLPDRVTGVDTD","Homo sapiens","ITIH1, IGHEP1","Inter-alpha-trypsin inhibitor heavy chain H1","1","6FPZ"
"6FQ1",,"X-RAY DIFFRACTION",2.28,46,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M KNO3, 20% PEG3350",293.15,"10.1261/rna.065649.118",,"6FQ1",38.16,"1.31","1.31","Crystal structure of the RRM12 domain of IMP3","GGSMNKLYIGNLSENAAPSDLESIFKDAKIPVSGPFLVKTGYAFVDCPDESWALKAIEALSGKIELHGKPIEVEHSVPKRQRIRKLQIRNIPPHLQWEVLDSLLVQYGVVESCEQVNTDSETAVVNVTYSSKDQARQALDKLNGFQLENFTLKVAYIPDEMAAQHHHHHH","Homo sapiens","IGF2BP3, IMP3, KOC1, VICKZ3","Insulin-like growth factor 2 mRNA-binding protein 3","1","6FQ1"
"6FQF",,"X-RAY DIFFRACTION",2.13,42.16,"VAPOR DIFFUSION, HANGING DROP",7,"The crystals used in the diffraction experiments were obtained with a protein concentration of 8 mg/ml, at pH 7.0. The composition of the reservoir solution was 2.5 M ammonium sulphate and 0.26 M sodium phosphate buffer at pH 7.0.",293,"10.1016/j.bpc.2018.05.003",,"6FQF",66.03,"2.1","2.1","THE X-RAY STRUCTURE OF FERRIC-BETA4 HUMAN HEMOGLOBIN","VHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH","Homo sapiens","HBB","Hemoglobin subunit beta","1","6FQF"
"6FQO",,"X-RAY DIFFRACTION",1.97,37.58,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M KSCN, 20% PEG3350, 10% EG",277,"10.1021/acsmedchemlett.8b00286","E2T","6FQO",29.49,"1.35","1.35","Crystal structure of CREBBP bromodomain complexd with DT29","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6FQO"
"6FQT",,"X-RAY DIFFRACTION",2.05,40.12,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes, pH7.5, 0.2 M LiSO4, 25% PEG3350",277,,,"6FQT",15.08,"1.8","1.8","Crystal structure of CREBBP bromodomain complexd with DR46","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6FQT"
"6FQU",,"X-RAY DIFFRACTION",2.48,50.5,"VAPOR DIFFUSION, HANGING DROP",,"0.15 M KSCN, 20% PEG3350, 10% EG",277,"10.1021/acsmedchemlett.8b00286","E3B","6FQU",14.58,"1.43","1.43","Crystal structure of CREBBP bromodomain complexd with DR09","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6FQU"
"6FR0",,"X-RAY DIFFRACTION",2.01,38.78,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes, pH7.5, 0.2 M LiSO4, 25% PEG3350",277,"10.1021/acsmedchemlett.8b00286","E3H","6FR0",29.4,"1.5","1.5","Crystal structure of CREBBP bromodomain complexd with PB08","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6FR0"
"6FR2",,"X-RAY DIFFRACTION",2.7,54.39,"VAPOR DIFFUSION, HANGING DROP",,"1 uL protein solution Protein (5-10 mg/mL , 50 mM NaCl, 50 mM sodium phosphate, 10% glycerol (98%), 2 mM DTT at pH 7.4) was mixed in different ratios (2/1, 1/1, 1/2) with precipitant solution (23 %-28 % (w/v) polyethylenglycol (PEG) 6000, 70 mM ammonium acetat, 200 mM magnesium acetat, 100 mM sodium cacodylate at pH 6.1-6.5)",277,"10.1016/j.bioorg.2018.07.014","E3N","6FR2",40.17,"2.262","2.262","Soluble epoxide hydrolase in complex with LK864","MASLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMLLEHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","6FR2"
"6FR3",,"X-RAY DIFFRACTION",2.28,46.16,"VAPOR DIFFUSION, SITTING DROP",7,"Pact Premier solution A04:
0.1 M SPG Buffer, pH 7.0, 25% PEG w/v 1500",291,"10.3389/fimmu.2018.00674",,"6FR3",52.33,"1.35","1.35","003 TCR Study of CDR Loop Flexibility","MKQEVTQIPAALSVPEGENLVLNCSFTDSAIYNLQWFRQDPGKGLTSLLLIQSSQREQTSGRLNASLDKSSGRSTLYIAASQPGDSATYLCAVTNFNKFYFGSGTKLNVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSP","Homo sapiens",,"003 TCR Alpha Chain","1","6FR3"
,,,,,,,,,,,,,,,,"MKAGVTQTPRYLIKTRGQQVTLSCSPISGHRSVSWYQQTPGQGLQFLFEYFSETQRNKGNFPGRFSGRQFSNSRSEMNVSTLELGDSALYLCASSFDSGNSPLHFGNGTRLTVTEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"003 TCR Beta Chain","2","6FR3"
"6FR5",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M Na Citrate, 0.1M TrisHCl, 30% PEG 400",291,"10.3389/fimmu.2018.00674",,"6FR5",51.21,"1.37","1.37","HA1.7 TCR Study of CDR Loop Flexibility","MKQEVTQIPAALSVPEGENLVLNCSFTDSAIYNLQWFRQDPGKGLTSLLLIQSSQREQTSGRLNASLDKSSGRSTLYIAASQPGDSATYLCAVTNFNKFYFGSGTKLNVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSP","Homo sapiens",,"TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain","1","6FR5"
,,,,,,,,,,,,,,,,"MKAGVTQTPRYLIKTRGQQVTLSCSPISGHRSVSWYQQTPGQGLQFLFEYFSETQRNKGNFPGRFSGRQFSNSRSEMNVSTLELGDSALYLCASSFDSGNSPLHFGNGTRLTVTEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain","2","6FR5"
"6FR6",,"X-RAY DIFFRACTION",2.57,52.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 8K, 0.1 M Tris, 0.2M NH4SO4",291,"10.3389/fimmu.2018.00674",,"6FR6",50.09,"2.98","2.98","HA1.7 Human T-Cell Receptor specific for Influenza virus epitope PKYVKQNTLKLAT presented by Human Leukocyte Antigen HLA-DR0101","MQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSESPFGNEKLTFGTGTRLTIIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTF","Homo sapiens",,"Human T-Cell Receptor Alpha Chain","1","6FR6"
,,,,,,,,,,,,,,,,"VKVTQSSRYLVKRTGEKVFLECVQDMDHENMFWYRQDPGLGLRLIYFSYDVKMKEKGDIPEGYSVSREKKERFSLILESASTNQTSMYLCASSSTGLPYGYTFGSGTRLTVVEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA","Homo sapiens",,"Human T-cell Receptor Beta Chain","2","6FR6"
"6FR7",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M KSCN, 0.1M Bis-Tris, 20% PEG3350",291,"10.3389/fimmu.2018.00674",,"6FR7",50.3,"2.31","2.31","HA1.7 Human T-Cell Receptor specific for Influenza virus epitope PKYVKQNTLKLAT presented by Human Leukocyte Antigen HLA-DR0101","MQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSESPFGNEKLTFGTGTRLTIIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFF","Homo sapiens",,"T-Cell Receptor alpha chain","1","6FR7"
,,,,,,,,,,,,,,,,"VKVTQSSRYLVKRTGEKVFLECVQDMDHENMFWYRQDPGLGLRLIYFSYDVKMKEKGDIPEGYSVSREKKERFSLILESASTNQTSMYLCASSSTGLPYGYTFGSGTRLTVVEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA","Homo sapiens",,"T-cell Rceceptor beta Chain","2","6FR7"
"6FR8",,"X-RAY DIFFRACTION",2.53,51.31,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M KSCN,0.1M Bis-Tris, 20% PEG3350",291,"10.3389/fimmu.2018.00674",,"6FR8",49.99,"2.38","2.38","HA1.7 Human T-Cell Receptor specific for Influenza virus epitope PKYVKQNTLKLAT presented by Human Leukocyte Antigen HLA-DR0101","MQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSESPFGNEKLTFGTGTRLTIIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTF","Homo sapiens",,"T-Cell Receptor HA1.7 alpha Chain","1","6FR8"
,,,,,,,,,,,,,,,,"VKVTQSSRYLVKRTGEKVFLECVQDMDHENMFWYRQDPGLGLRLIYFSYDVKMKEKGDIPEGYSVSREKKERFSLILESASTNQTSMYLCASSSTGLPYGYTFGSGTRLTVVEDLNKVFPPEVAVFEPSEAEISHTQKATLVCLATGFFPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA","Homo sapiens",,"T-Cell Receptor HA1.7 beta Chain","2","6FR8"
"6FR9",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 4K, 20% 2-Propanol, 0.1M HEPES",291,"10.3389/fimmu.2018.00674",,"6FR9",50.33,"1.62","1.62","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"T-Cell Receptor F11 alpha chain","1","6FR9"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"T-Cell Receptor F11 beta chain","2","6FR9"
"6FRA",,"X-RAY DIFFRACTION",2.51,51.04,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG 8K, 0.1M MES, 0.2M Na Acetate",291,"10.3389/fimmu.2018.00674",,"6FRA",50.63,"1.73","1.73","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human T-Cell Receptor F11 alpha Chain","1","6FRA"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human T-Cell Receptor F11 beta Chain","2","6FRA"
"6FRB",,"X-RAY DIFFRACTION",2.5,50.78,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M SPG Buffer, 25%
PEG 1500",291,"10.3389/fimmu.2018.00674",,"6FRB",49.65,"1.75","1.75","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human T-Cell Receptor F11 alpha chain","1","6FRB"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human T-Cell Receptor F11 beta Chain","2","6FRB"
"6FRC",,"X-RAY DIFFRACTION",2.5,50.79,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M NaF, 0.1M Bis-Tris Propane, 20% PEG 3350",291,"10.3389/fimmu.2018.00674",,"6FRC",51.18,"1.59","1.59","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human T-Cell Receptor F11 alpha Chain","1","6FRC"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human T-Cell Receptor beta Chain","2","6FRC"
"6FRF",,"X-RAY DIFFRACTION",2.81,56.25,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Sodium Citrate, pH 5.6, 1.3 M Ammonium Sulfate",277,"10.1021/acsmedchemlett.8b00286","E3T","6FRF",58.67,"2.1","2.1","Crystal structure of CREBBP bromodomain complexd with PA10","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","6FRF"
"6FS1",,"X-RAY DIFFRACTION",2.39,48.49,"VAPOR DIFFUSION, SITTING DROP",,"22% PEG MME 5K, 2% PEG 400, 0.1M MES pH 5.6",293,"10.1038/s41467-018-07551-w","E4Q","6FS1",35.48,"1.6","1.6","MCL1 in complex with an indole acid ligand","DDLYRQSLEIISRYLREQATGSKDSKPLGEAGAAGRRALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHV","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6FS1"
"6FS2",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, SITTING DROP",,"unknown",293,"10.1038/s41467-018-07551-w",,"6FS2",36.93,"2.55","2.55","MCL1 in complex with indole acid ligand","DDLYRQSLEIISRYLREQATGSKDTKPLGEAGAAGRRALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLE","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","6FS2"
"6FSY",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, SITTING DROP",5.5,"20 % PEG 3350 and 0.1 M citrate pH 5.5",277,"10.1016/j.bmc.2018.05.003","E5Q","6FSY",15.52,"1.34","1.34","Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6FSY"
"6FT0",,"X-RAY DIFFRACTION",2.64,53.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES pH 7.5",293,,,"6FT0",174.15,"2.1","2.1","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-425","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FT0"
"6FT3",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M K(citrate)
0.1 M cacodylate pH 6.5",277,"10.1016/j.bmc.2018.05.003","E5T","6FT3",15.42,"1.28","1.28","Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6FT3"
"6FT4",,"X-RAY DIFFRACTION",2.14,42.58,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000
0.1M MMT pH 6.0",277,"10.1016/j.bmc.2018.05.003","E5W","6FT4",15.42,"1.34","1.34","Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6FT4"
"6FT7",,"X-RAY DIFFRACTION",2.98,58.68,"VAPOR DIFFUSION, SITTING DROP",7,"21% PEG3350, 0.2 M sodium iodide,  0.1 M bis-tris-propane pH 7.0, 10% ethylene glycol",277.15,"10.1371/journal.pone.0196761",,"6FT7",87.65,"2.02","2.02","Crystal structure of CLK3 in complex with compound 8a","SMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6FT7"
"6FT8",,"X-RAY DIFFRACTION",2.6,52.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.1 M sodium malonate",277.15,"10.1371/journal.pone.0196761",,"6FT8",40.27,"1.45","1.45","Crystal structure of CLK1 in complex with inhibitor 8g","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6FT8"
"6FT9",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% 1,2-propanediol, 10% glycerol, 0.1 M sodium/potassium phosphate",277.15,"10.1371/journal.pone.0196761",,"6FT9",120.77,"1.87","1.87","Crystal structure of CLK1 in complex with inhibitor 16","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6FT9"
"6FTA",,"X-RAY DIFFRACTION",2.65,53.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES pH 7.5",293,,,"6FTA",173.35,"2.34","2.34","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-3098","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FTA"
"6FTP",,"X-RAY DIFFRACTION",2.14,42.44,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M sodium thiocyanate, 20 % w/v PEG 3350",293,"10.1073/pnas.1716666115",,"6FTP",47.44,"1.8","1.8","Crystal form 1 of Alpha1-antichymotrypsin variant DBS-II-allo: an allosterically modulated drug-binding serpin for doxorubicin","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKFEMPFDPQDTHQSRFYLSKKKYVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASALFILPDQDKMEEVEAMLSQETLSRFFESLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTERSAATALEVLFQ","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6FTP"
,,,,,,,,,,,,,,,,"GPLVETRTIVRFNRPFLMIIVDNFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6FTP"
"6FTQ",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",7.75,"16% (w/v) PEG 3350
0.1 M HEPES pH 7.75
300 mM NaSCN
3 mg/ml enzyme variant",293,"10.1042/BCJ20180222",,"6FTQ",43.88,"2.08","2.08","Crystal structure of human beta-ureidopropionase (beta-alanine synthase) - mutant T299C","GIDPFTMAGAEWKSLEECLEKHLPLPDLQEVKRVLYGKELRKLDLPREAFEAASREDFELQGYAFEAAEEQLRRPRIVHVGLVQNRIPLPANAPVAEQVSALHRRIKAIVEVAAMCGVNIICFQEAWTMPFAFCTREKLPWTEFAESAEDGPTTRFCQKLAKNHDMVVVSPILERDSEHGDVLWNTAVVISNSGAVLGKTRKNHIPRVGDFNESTYYMEGNLGHPVFQTQFGRIAVNICYGRHHPLNWLMYSINGAEIIFNPSATIGALSESLWPIEARNAAIANHCFTCAINRVGTEHFPNEFCSGDGKKAHQDFGYFYGSSYVAAPDSSRTPGLSRSRDGLLVAKLDLNLCQQVNDVWNFKMTGRYEMYARELAEAVKSNYSPTIVKE","Homo sapiens","UPB1, BUP1","Beta-ureidopropionase","1","6FTQ"
"6FTV",,"X-RAY DIFFRACTION",2.99,58.86,"VAPOR DIFFUSION, HANGING DROP",,"2.0 M MgCl2, 0.1 M bicine pH 9.0",293,"10.1039/c8dt00860d",,"6FTV",21.69,"1.58","1.58","X-ray structure of human heavy chain ferritin in complex with NAMI A","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6FTV"
"6FTW",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES pH 7.5",293,"10.1016/j.bmc.2019.06.027",,"6FTW",172.64,"2.16","2.16","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-048","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FTW"
"6FTY",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, HANGING DROP",,"PEG 3350, 100 mM HEPES pH 7.5",295,"10.1021/acsmedchemlett.8b00104","E7H","6FTY",25.18,"1.67","1.67","COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 5","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASAAA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6FTY"
"6FTZ",,"X-RAY DIFFRACTION",2.11,41.71,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, 100 mM HEPES pH 7.5",295,"10.1021/acsmedchemlett.8b00104","E7E","6FTZ",25.05,"1.67","1.67","COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 6","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASAAA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6FTZ"
"6FU5",,"X-RAY DIFFRACTION",2.28,46.12,"VAPOR DIFFUSION, SITTING DROP",,"150 nL sitting drops containing 50 nL protein and 100 nL of a reservoir solution containing 0.2 M potassium formate and 20% (w/v) PEG3350",293,"10.15252/embj.201899372",,"6FU5",73.73,"3.26","3.26","Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18","SMGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLKKTKLQSV","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6FU5"
"6FUG",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 100 mM TRIS pH 8.5",293,"10.1021/acsmedchemlett.8b00104","E85","6FUG",150.52,"2.21","2.21","Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASAAA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6FUG"
"6FUH",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG3350, 100 mM TRIS pH 8.5, 200 mM NH4SO2, 2 mM inhibitor",293,"10.1021/acsmedchemlett.8b00104","E88","6FUH",25.1,"1.37","1.37","Complement factor D in complex with the inhibitor (4-((3-(aminomethyl)phenyl)amino)quinazolin-2-yl)-L-valine","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASAAA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6FUH"
"6FUI",,"X-RAY DIFFRACTION",2.12,41.95,"VAPOR DIFFUSION, SITTING DROP",,"22-25% PEG3350, 100 mM HEPES pH 7.5",293,"10.1021/acsmedchemlett.8b00104","E7W","6FUI",25.13,"1.38","1.38","Complement factor D in complex with the inhibitor 3-((3-((3-(aminomethyl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)phenol","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASAAA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6FUI"
"6FUJ",,"X-RAY DIFFRACTION",2.97,58.57,"VAPOR DIFFUSION, SITTING DROP",,"22-25% PEG3350, 100 mM HEPES pH 7.5, 2 mM inhibitor",293,"10.1021/acsmedchemlett.8b00104","E8B","6FUJ",149.28,"2.25","2.25","Complement factor D in complex with the inhibitor N-(3'-(aminomethyl)-[1,1'-biphenyl]-3-yl)-3-methylbutanamide","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASAAA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6FUJ"
"6FUK",,"X-RAY DIFFRACTION",2.58,52.33,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl (pH 8.5), Li2 SO4 (0.15-0.25 M), PEG 3350 (20-25% w/v)",277,"10.1021/acs.jcim.8b00539",,"6FUK",61.1,"2","2","Crystal structure of UTX complexed with 5-carboxy-8-hydroxyquinoline","GPGYQDPNSQIIPSMSVSIYPSSAEVLKACRNLGKNGLSNSSILLDKCPPPRPPSSPYPPLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPNNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWHCESNRSHTTIAKYAQYQASSFQESLREENEKRSHHKDHSDSESTSSDNSGRRRKGPFKTIKFGTNIDLSDDKKWKLQLHELTKLPAFVRVVSAGNLLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEGYWGVLNDFCEKNNLNFLMGSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAIGWCNNIAWNVGPLTACQYKLAVERYEWNKLQSVKSIVPMVHLSWNMARNIKVSDPKLFEMIKYCLLRTLKQCQTLREALIAAGKEIIWHGRTKEEPAHYCSICEVEVFDLLFVTNESNSRKTYIVHCQDCARKTSGNLENFVVLEQYKMEDLMQVYDQFTLAPPLPSASS","Homo sapiens","KDM6A, UTX","Lysine-specific demethylase 6A","1","6FUK"
"6FUL",,"X-RAY DIFFRACTION",2.53,51.45,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl (pH 8.5), Li2 SO4 (0.15-0.25 M), PEG 3350 (20-25% w/v)",277,"10.1021/acs.jcim.8b00539","PG0","6FUL",61.25,"1.649","1.649","Crystal structure of UTX complexed with 5-hydroxy-4-keto-1-methyl-picolinate","GPGYQDPNSQIIPSMSVSIYPSSAEVLKACRNLGKNGLSNSSILLDKCPPPRPPSSPYPPLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPNNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWHCESNRSHTTIAKYAQYQASSFQESLREENEKRSHHKDHSDSESTSSDNSGRRRKGPFKTIKFGTNIDLSDDKKWKLQLHELTKLPAFVRVVSAGNLLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEGYWGVLNDFCEKNNLNFLMGSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAIGWCNNIAWNVGPLTACQYKLAVERYEWNKLQSVKSIVPMVHLSWNMARNIKVSDPKLFEMIKYCLLRTLKQCQTLREALIAAGKEIIWHGRTKEEPAHYCSICEVEVFDLLFVTNESNSRKTYIVHCQDCARKTSGNLENFVVLEQYKMEDLMQVYDQFTLAPPLPSASS","Homo sapiens","KDM6A, UTX","Lysine-specific demethylase 6A","1","6FUL"
"6FUM",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Na/K PO4, 20% PEG 3350",291,"10.3389/fimmu.2018.00674",,"6FUM",50.15,"1.76","1.76","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human F11 T-Cell Receptor alpha chain","1","6FUM"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human F11 T-Cell Receptor beta chain","2","6FUM"
"6FUN",,"X-RAY DIFFRACTION",2.5,50.84,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Na Malonate, 20% PEG 3350",291,"10.3389/fimmu.2018.00674",,"6FUN",50.74,"1.58","1.58","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human F11 T-Cell Receptor alpha chain","1","6FUN"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human F11 T-Cell Receptor beta chain","2","6FUN"
"6FUO",,"X-RAY DIFFRACTION",2.52,51.1,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Na Acetate, 20% PEG 3350",291,"10.3389/fimmu.2018.00674",,"6FUO",51.75,"1.7","1.7","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human F11 T-Cell Receptor alpha chain","1","6FUO"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human F11 T-Cell Receptor","2","6FUO"
"6FUP",,"X-RAY DIFFRACTION",2.51,50.95,"VAPOR DIFFUSION, SITTING DROP",,"PACT Premier E08: 0.2 M Na SO4, 20% PEG 3350",291,"10.3389/fimmu.2018.00674",,"6FUP",51.8,"1.72","1.72","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human F11 T-cell Receptor alpha Chain","1","6FUP"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human F11 T-Cell Receptor beta chain","2","6FUP"
"6FUQ",,"X-RAY DIFFRACTION",2.5,50.86,"VAPOR DIFFUSION, SITTING DROP",,"PACT Premier E04: 0.2 M K SCN, 20% PEG 3350",291,"10.3389/fimmu.2018.00674",,"6FUQ",51.71,"1.6","1.6","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human F11 T-Cell Receptor","1","6FUQ"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human F11 T-Cell Receptor beta chain","2","6FUQ"
"6FUR",,"X-RAY DIFFRACTION",2.5,50.79,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M NH4 SO4, 0.1 M MES, 25% PEG 4K",291,"10.3389/fimmu.2018.00674",,"6FUR",102.13,"1.73","1.73","F11 T-Cell Receptor Recognising PKYVKQNTLKLAT Peptide Presented by HLA-DR*0101","AQSVTQLGSHVSVSEGALVLLRCNYSSSVPPYLFWYVQYPNQGLQLLLKYTSAATLVKGINGFEAEFKKSETSFHLTKPSAHMSDAAEYFCAVSEQDDKIIFGKGTRLHILPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPS","Homo sapiens",,"Human F11 T-Cell Receptor alpha chain","1","6FUR"
,,,,,,,,,,,,,,,,"ADVTQTPRNRITKTGKRIMLECSQTKGHDRMYWYRQDPGLGLRLIYYSFDVKDINKGEISDGYSVSRQAQAKFSLSLESAIPNQTALYFCATSDESYGYTFGSGTRLTVVEDLNKVSPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"Human F11 T-Cell Receptor","2","6FUR"
"6FUT",,"X-RAY DIFFRACTION",3.06,59.74,"VAPOR DIFFUSION, SITTING DROP",,"22-25% PEG3350, 100 mM HEPES pH 7.5",293,"10.1021/acsmedchemlett.8b00104","E82","6FUT",25.21,"1.5","1.5","Complement factor D in complex with the inhibitor (S)-3'-(aminomethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-[1,1'-biphenyl]-3-carboxamide","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLASAAA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","6FUT"
"6FUY",,"X-RAY DIFFRACTION",2.77,55.55,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000, calcium acetate, Tris-HOAc, 15% ethylene glycol",277.15,"10.1038/s41598-018-21006-8",,"6FUY",116.7,"3","3","Crystal structure of human full-length vinculin-T12-A974K (residues 1-1066)","MPVFHTRTIESILEPVAQQISHLVIMHEEGEVDGKAIPDLTAPVAAVQAAVSNLVRVGKETVQTTEDQILKRDMPPAFIKVENACTKLVQAAQMLQSDPYSVPARDYLIDGSRGILSGTSDLLLTFDEAEVRKIIRVCKGILEYLTVAEVVETMEDLVTYTKNLGPGMTKMAKMIDERQQELTHQEHRVMLVNSMNTVKELLPVLISAMKIFVTTKNSKNQGIEEALKNRNFTVEKMSAEINEIIRVLQLTSWDEDAWASKDTEAMKRALASIDSKLNQAKGWLRDPSASPGDAGEQAIRQILDEAGKVGELCAGKERREILGTCKMLGQMTDQVADLRARGQGSSPVAMQKAQQVSQGLDVLTAKVENAARKLEAMTNSKQSIAKKIDAAQNWLADPNGGPEGEEQIRGALAEARKIAELCDDPKERDDILRSLGEISALTSKLADLRRQGKGDSPEARALAKQVATALQNLQTKTNRAVANSRPAKAAVHLEGKIEQAQRWIDNPTVDDRGVGQAAIRGLVAEGHRLANVMMGPYRQDLLAKCDRVDQLTAQLADLAARGEGESPQARALASQLQDSLKDLKARMQEAMTQEVSDVFSDTTTPIKLLAVAATAPPDAPNREEVFDERAANFENHSGKLGATAEKAAAVGTANKSTVEGIQASVKTARELTPQVVSAARILLRNPGNQAAYEHFETMKNQWIDNVEKMTGLVDEAIDTKSLLDASEEAIKKDLDKCKVAMANIQPQMLVAGATSIARRANRILLVAKREVENSEDPKFREAVKAASDELSKTISPMVMDAKAVAGNISDPGLQKSFLDSGYRILGAVAKVREAFQPQEPDFPPPPPDLEQLRLTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQKAGEVINQPMMMAARQLHDEARKWSSKGNDIIAAAKRMALLMAEMSRLVRGGSGTKRALIQCAKDIAKASDEVTRLAKEVAKQCTKAAIATNLLQVCERIPTISTQLKILSTVKATMLGRTNISDEESEQATEMLVHNAQNLMQSVKETVREAEAASIKIRTDAGFTLRWVRKTPWYQ","Homo sapiens","VCL","Vinculin","1","6FUY"
"6FVE",,"X-RAY DIFFRACTION",1.93,36.12,"VAPOR DIFFUSION, SITTING DROP",7,"Ammonium Sulfate, 0.1M Hepes pH 7.0",298,"10.1134/S000629791806007X",,"6FVE",38.34,"1.41","1.41","Macrophage Migration Inhibitory Factor (MIF) with Covalently Bound FITC","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6FVE"
"6FVF",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, HANGING DROP",6.5,"112.5mM Mes pH 6.5, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1038/s41598-019-52141-5",,"6FVF",40.03,"1.47","1.47","The Structure of CK2alpha with CCh503 bound","SGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6FVF"
"6FVG",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, HANGING DROP",6.5,"112.5mM Mes pH 6.5, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1038/s41598-019-52141-5",,"6FVG",39.98,"1.6","1.6","The Structure of CK2alpha with CCh507 bound","SGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6FVG"
"6FVH",,"X-RAY DIFFRACTION",2.75,55.27,"VAPOR DIFFUSION, HANGING DROP",7,"Ammonium Sulfate, Hepes",293,"10.1134/S000629791806007X",,"6FVH",38.05,"1.4","1.4","Macrophage Migration Inhibitory Factor (MIF) with Covalently Bound PITC","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","6FVH"
"6FVI",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, SITTING DROP",5.5,"100 mM Na-Citrate, pH 5.5, 30 % (v/v) PEG-400, 100 mM NaCl, 100 mM MgCl2",292,,,"6FVI",16.99,"1","1","ASH / PapD-like domain of human CEP192 (PapD-like domain 7)","GPHMSVSHLVKPMTKPPSTKVEIRNKSITFPTTEPGETSESCLELENHGTTDVKWHLSSLAPPYVKGVDESGDVFRATYAAFRCSPISGLLESHGIQKVSITFLPRGRGDYAQFWDVECHPLKEPHMKHTLRFQLSGQSIEAENEPENACL","Homo sapiens","CEP192, KIAA1569, PP8407","Centrosomal protein of 192 kDa","1","6FVI"
"6FVZ",,"X-RAY DIFFRACTION",2.68,54.18,"VAPOR DIFFUSION, SITTING DROP",,"12% PEG4000, 100 mM ADA buffer pH 6.5, 70 mM lithium sulphate",277,"10.1021/acs.jmedchem.8b00357","E8Z","6FVZ",120.69,"1.8","1.8","Crystal structure of human monoamine oxidase B (MAO B) in complex with dimethylphenyl-chromone-carboxamide","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","6FVZ"
"6FW0",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, SITTING DROP",,"12% PEG4000, 100 mM ADA buffer pH 6.5, 70 mM lithium sulphate",277,"10.1021/acs.jmedchem.8b00357","E92","6FW0",120.7,"1.6","1.6","Crystal structure of human monoamine oxidase B (MAO B) in complex with chlorophenyl-chromone-carboxamide","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","6FW0"
"6FW3",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"24% PEG 3350, 30% Ethylene Glycol, 0.1 M HEPES",293,,,"6FW3",174.89,"1.78","1.78","Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-007","GSHMIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","6FW3"
"6FWB",,"X-RAY DIFFRACTION",2.21,44.39,"EVAPORATION",7.4,"35% PEG 1000, 0.1M Hepes, 50mM Li2SO4",293,"10.1016/j.ebiom.2018.12.036",,"6FWB",185.5,"1.79","1.79","Crystal structure of Mat2A at 1.79 Angstron resolution","MAHHHHHHENLYFQGSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLK","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6FWB"
"6FWC",,"X-RAY DIFFRACTION",2.68,54.13,"VAPOR DIFFUSION, SITTING DROP",,"12% PEG4000, 100 mM ADA pH 6.5, 70 mM lithium sulphate",277,"10.1021/acs.jmedchem.8b00357","E98","6FWC",120.67,"1.7","1.7","Crystal structure of human monoamine oxidase B (MAO B) in complex with fluorophenyl-chromone-carboxamide","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","6FWC"
"6FWD",,"X-RAY DIFFRACTION",2.12,41.89,"VAPOR DIFFUSION, HANGING DROP",5.5,"7% glycerol, 1.3 M sodium citrate, pH 5.5",291,,,"6FWD",27.41,"1.576","1.576","Crystal structure of human transthyretin double mutant R34G/T119M at pH 5.5","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFGKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTMAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6FWD"
"6FWN",,"SOLUTION NMR",,,,,,,"10.1182/blood-2018-04-843615",,"6FWN",9.12,,,"Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor","GSMASACEVVTGSPRGDSQSSWKSVGSQWASPENPCLINECVRVKEEVFIQQRNVSCPQLEVPVCPSGFQLSCKTSACCPSCRCE","Homo sapiens","VWF, F8VWF","von Willebrand factor","1","6FWN"
"6FWT",,"X-RAY DIFFRACTION",2.09,41.19,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Potassium Nitrate, 20% (w/v) PEG 3350",293,"10.1371/journal.pone.0205571",,"6FWT",31.98,"1.845","1.845","Crystal structure of human wild type beta-1,4-galactosyltransferase-1 (B4GalT1) in apo-open monomeric form","TTALSLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGRCRMIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, GGTB2","Beta-1,4-galactosyltransferase 1","1","6FWT"
"6FWU",,"X-RAY DIFFRACTION",1.91,35.44,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Potassium Nitrate, 20% (w/v) PEG 3350",293,"10.1371/journal.pone.0205571",,"6FWU",63.13,"2.35","2.35","Crystal structure of human wild type beta-1,4-galactosyltransferase-1 (B4GalT1) in apo-closed dimeric form","SLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGRCRMIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS","Homo sapiens","B4GALT1, GGTB2","Beta-1,4-galactosyltransferase 1","1","6FWU"
"6FWX",,"X-RAY DIFFRACTION",2.78,55.71,"VAPOR DIFFUSION, SITTING DROP",,"10% [v/v] isopropanol, 100 mM Na2HPO4 pH 4.2, 200 mM LiSO4",293,"10.1002/adma.201807521",,"6FWX",83.99,"3","3","Chimeric titin Z1Z2-Z1Z2 tandem (Z1212) functionalized with a GRGDS exogenous peptide from fibronectin","MTTQAPTFTQPLQSVVVLEGSTATFEAHISGFPVPEVSWFRDGQVISTSTLPGVQISFSDGRAKLTIPAVTKANSGRYSLKATNGSGQATSTAELLVKAETAPPNFVQRLQSMTVRQGSQVRLQVRVTGIPTPVVKFYRDGAEIQSSLDFQISQEGDLYSLLIAEAYPEDSGTYSVNATNSVGRATSTAELLVQGETTQAPTFTQPLQSVVVLEGSTATFEAHISGFPVPEVSWFRDGQVISSGRGDSSPGVQISFSDGRAKLTIPAVTKANSGRYSLKATNGSGQATSTAELLVKAETAPPNFVQRLQSMTVRQGSQVRLQVRVTGIPTPVVKFYRDGAEIQSSLDFQISQEGDLYSLLIAEAYPEDSGTYSVNATNSVGRATSTAELLVQGE","Homo sapiens","TTN","Titin,Titin,Titin","1","6FWX"
,,,,,,,,,,,,,,,,,"Homo sapiens","TTN"
,,,,,,,,,,,,,,,,,"Homo sapiens","TTN"
"6FWZ",,"X-RAY DIFFRACTION",3.91,68.59,"VAPOR DIFFUSION, SITTING DROP",9,"0.1M bicine pH 9.0 -- 0.05M sodium chloride -- 37.5% PEG300",293,"10.1016/j.cell.2018.10.037",,"6FWZ",47.55,"3.1","3.1","Crystal structure of human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1) (V264G mutant) in complex with UDP-GlcNAc","SMWAFSELPMPLLINLIVSLLGFVATVTLIPAFRGHFIAARLCGQDLNKTSRQQIPESQGVISGAVFLIILFCFIPFPFLNCFVKEQCKAFPHHEFVALIGALLAICCMIFLGFADDVLNLRWRHKLLLPTAASLPLLMVYFTNFGNTTIVVPKPFRPILGLHLDLGILYYVYMGLLAVFCTNAINILAGINGLEAGQSLVISASIIVFNLVELEGDCRDDHVFSLYFMIPFFFTTLGLLYHNWYPSRVFVGDTFCYFAGMTFAGVGILGHFSKTMLLFFMPQVFNFLYSLPQLLHIIPCPRHRIPRLNIKTGKLEMSYSKFKTKSLSFLGTFILKVAESLQLVTVHQSETEDGEFTECNNMTLINLLLKVLGPIHERNLTLLLLLLQILGSAITFSIRYQLVRLFYDV","Homo sapiens","DPAGT1, DPAGT2","UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase","1","6FWZ"
"6FX0",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"SODIUM ACETATE, PH 7.0",293,"10.1016/j.bmcl.2018.04.036","E9T","6FX0",51,"1.9","1.9","Structure-based design of Trifarotene (CD5789), a potent and selective RAR gamma agonist for the treatment of acne","MATNKERLFAAGALGPGSGYPGAGFPFAFPGALRGSPPFEMLSPSFRGLGQPDLPKEMASLSVETQSTSSEEMVPSSPSPPPPPRVYKPCFVCNDKSSGYHYGVSSCEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKEAVRNDRNKKKKEVKEEGSPDSYELSPQLEELITKVSKAHQETFPSLCQLGKYTTNSSADHRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERAITLKMEIPGPMPPLIREMLENPEMFEDDSSQPGPHPNASSEDEVPGGQGKGGLKSPA","Homo sapiens","RARG, NR1B3","Retinoic acid receptor gamma","1","6FX0"
"6FXH",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, SITTING DROP",,"MGSO4, TRIS AND LIGAND, PH 8.5",277,"10.1016/j.ejmech.2019.02.040",,"6FXH",65.95,"2.3","2.3","Human cytosolic 5'-nucleotidase II soaked with 10mM 3-Phenyl-N-(9H-purin-6-yl)benzamide","MSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE","Homo sapiens","NT5C2, NT5B, NT5CP, PNT5","Cytosolic purine 5'-nucleotidase","1","6FXH"
"6FXI",,"X-RAY DIFFRACTION",2.87,57.1,"VAPOR DIFFUSION, SITTING DROP",5,"16% PEG3350, 0.1 M Citrate-Bis-Tris-Propane, 3 mM 3-aminobenzamide",277,,,"6FXI",44.01,"2.6","2.6","Human PARP10 (ARTD10), catalytic fragment in complex with 3-aminobenzamide and citrate","SMNLERLAENTGEFQEVVRAFYDTLDAARSSIRVVRVERVSHPLLQQQYELYRERLLQRCERRPVEQVLYHGTTAPAVPDICAHGFNRSFCGRNATVYGKGVYFARRASLSVQDRYSPPNADGHKAVFVARVLTGDYGQGRRGLRAPPLRGPGHVLLRYDSAVDCICQPSIFVIFHDTQALPTHLITCEHV","Homo sapiens","PARP10","Poly [ADP-ribose] polymerase 10","1","6FXI"
"6FXK",,"X-RAY DIFFRACTION",3.1,60,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH",277,"10.1038/s41467-018-05631-5",,"6FXK",83.82,"2.7","2.7","Crystal Structure of full-length Human Lysyl Hydroxylase LH3","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6FXK"
"6FXM",,"X-RAY DIFFRACTION",3.1,60,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 0.5 mM MnCl2",277,"10.1038/s41467-018-05631-5",,"6FXM",84.11,"2.1","2.1","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Mn2+","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6FXM"
"6FXR",,"X-RAY DIFFRACTION",3.1,60,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 0.5 mM FeCl2, 0.5 mM MnCl2, 1 mM UDP-Gal",277,"10.1038/s41467-018-05631-5",,"6FXR",84.33,"2.1","2.1","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Fe2+, Mn2+, UDP-Gal","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6FXR"
"6FXT",,"X-RAY DIFFRACTION",3.1,60,"VAPOR DIFFUSION",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 0.5 mM FeCl2, 0.5 mM MnCl2, 1 mM UDP-Glc",277,"10.1038/s41467-018-05631-5",,"6FXT",84.33,"2.5","2.5","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Fe2+, Mn2+, UDP-Glc","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6FXT"
"6FXU",,"X-RAY DIFFRACTION",2.12,41.93,"VAPOR DIFFUSION, HANGING DROP",5.5,"7% glycerol, 1.3 M sodium citrate, pH 5.5.",291,,,"6FXU",27.61,"1.359","1.359","Crystal structure of human transthyretin mutant T119M at pH 5.5","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTMAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6FXU"
"6FXX",,"X-RAY DIFFRACTION",3.1,60,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 0.5 mM FeCl2, 0.5 mM MnCl2, 1 mM UDP-Glc",277,"10.1038/s41467-018-05631-5",,"6FXX",84.84,"3","3","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Fe2+, Mn2+, UDP-Gal, Hg2+ Soak","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6FXX"
"6FXY",,"X-RAY DIFFRACTION",3.1,60,"VAPOR DIFFUSION, HANGING DROP",7.8,"600 mM sodium formate, 12% PGA-LM, 100 mM HEPES/NaOH, 0.5 mM FeCl2, 0.5 mM MnCl2, 1 mM UDP-Gal",277,"10.1038/s41467-018-05631-5",,"6FXY",84.33,"2.138","2.138","Crystal Structure of full-length Human Lysyl Hydroxylase LH3 - Cocrystal with Fe2+, Mn2+, UDP-Gal - Structure from long-wavelength S-SAD","SSDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDPAAA","Homo sapiens","PLOD3","Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3","1","6FXY"
"6FY4",,"X-RAY DIFFRACTION",2.72,54.81,"VAPOR DIFFUSION",5.9,"0.2 M magnesium chloride hexahydrate, 20% w/v polyethylene glycol 3350, pH 5.9",293,"10.1002/1873-3468.13636",,"6FY4",127.08,"2.76","2.76","Structure of human NAD(P) H:quinone oxidoreductase in complex with N-(2-bromophenyl)pyrrolidine-1-sulfonamide","MVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDITGKLKDPANFQYPAESVLAYKEGHLSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGDMNVILWPIQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIWDETPLYFAPSSLFDLNFQAGFLMKKEVQDEEKNKKFGLSVGHHLGKSIPTDNQIKARK","Homo sapiens","NQO1, DIA4, NMOR1","NAD(P)H dehydrogenase [quinone] 1","1","6FY4"
"6FY5",,"X-RAY DIFFRACTION",2.34,47.49,"VAPOR DIFFUSION",6.5,"12.5% (w/v) PEG 1,000, 0.2 M sodium acetate, 0.1 M Mes pH 6.5",298,"10.15252/embr.201744445",,"6FY5",42.84,"1.65","1.65","Crystal structure of the macro domain of human macroh2a2","AGMGPGDGFTILSSKSLVLGQKLSLTQSDISHIGSMRVEGIVHPTTAEIDLKEDIGKALEKAGGKEFLETVKELRKSQGPLEVAEAAVSQSSGLAAKFVIHCHIPQWGSDKCEEQLEETIKNCLSAAEDKKLKSVAFPPFPSGRNCFPKQTAAQVTLKAISAHFDDSSASSLKNVYFLLFDSESIGIYVQEMAKLDAK","Homo sapiens","H2AFY2, MACROH2A2","Core histone macro-H2A.2","1","6FY5"
"6FYI",,"X-RAY DIFFRACTION",2.12,41.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG3350, 0.1M HEPES",298,"10.1002/cmdc.201800344","EAE","6FYI",43.64,"2.6","2.6","X-ray Structure of CLK2-KD(130-496)/TG003 at 2.6A","SMRSSSHSSRRAKSVEDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSRD","Homo sapiens","CLK2","Dual specificity protein kinase CLK2","1","6FYI"
"6FYK",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG2000, 0.2M trimethylamine n-oxide, 0.1M TRIS",298,"10.1002/cmdc.201800344","EAZ","6FYK",129.28,"2.39","2.39","X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A","GPSSRRAKSVEDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSRD","Homo sapiens","CLK2","Dual specificity protein kinase CLK2","1","6FYK"
"6FYL",,"X-RAY DIFFRACTION",2.09,41.15,"VAPOR DIFFUSION, SITTING DROP",7,"30% Jeffamine ED-2001, 0.1M HEPES",298,"10.1002/cmdc.201800344","3NG","6FYL",43.12,"1.95","1.95","X-ray structure of CLK2-KD(136-496)/CX-4945 at 1.95A","GPSSRRAKSVEDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSRD","Homo sapiens","CLK2","Dual specificity protein kinase CLK2","1","6FYL"
"6FYM",,"X-RAY DIFFRACTION",2.74,55.18,"VAPOR DIFFUSION, SITTING DROP",,"20% Poly(ethylene glycol) 3350, 0.2M sodium nitrate",277,"10.1016/j.chembiol.2018.09.011",,"6FYM",89.79,"2.15","2.15","Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK1","SMDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","6FYM"
"6FYO",,"X-RAY DIFFRACTION",2.28,46.06,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG3350,0.2M Ammonium Sulfate, 0.1M TRIS",298,"10.1002/cmdc.201800344",,"6FYO",40.25,"2.32","2.32","X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A","GPHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRRCKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6FYO"
"6FYP",,"X-RAY DIFFRACTION",2.43,49.47,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG3350,0.2M Ammonium Sulfate, 0.1M TRIS",298,"10.1002/cmdc.201800344","3NG","6FYP",42.6,"2.29","2.29","X-RAY STRUCTURE OF CLK3-KD(GP-[275-632], NON-PHOS.)/CX-4945 AT 2.29A","GPQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6FYP"
"6FYR",,"X-RAY DIFFRACTION",2.2,44.04,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG4000, 0.1M HEPES",298,"10.1002/cmdc.201800344",,"6FYR",42.62,"1.42","1.42","X-RAY STRUCTURE OF CLK3-KD(GP-[275-632], NON-PHOS.)/Cpd-2 AT 1.42A","GPQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","6FYR"
"6FYV",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% Pentaerythritol ethoxylate (15/4 EO/OH),0.05M Ammonium Sulfate, 0.05M TRIS",298,"10.1002/cmdc.201800344","3NG","6FYV",40.33,"2.46","2.46","X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A","GPHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYREAARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQIDHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYVVKYNSKMKRDERTLKNTDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFQTHDSKEHLAMMERILGPIPQHMIQKTRKRKYFHHNQLDWDEHSSAGRYVRRRCKPLKEFMLCHDEEHEKLFDLVRRMLEYDPTQRITLDEALQHPFFDLLKK","Homo sapiens","CLK4","Dual specificity protein kinase CLK4","1","6FYV"
"6FYZ",,"X-RAY DIFFRACTION",2.22,44.72,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M BisTris, 18 to 24% PEG MME 5000",293,"10.1016/j.bmcl.2018.11.009","EBE","6FYZ",129.87,"2.15","2.15","Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor","MGSTKPRFTTGLVYDTLMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRHHHHHH","Homo sapiens","HDAC4, KIAA0288","Histone deacetylase 4","1","6FYZ"
"6FZ2",,"X-RAY DIFFRACTION",2.33,47.22,"VAPOR DIFFUSION, HANGING DROP",4.5,"24% PEG 4000
5 mM NiCl2
0.1 M Na citrate
5% Glycerol",293,"10.1021/acs.jmedchem.9b00586",,"6FZ2",96.76,"2.05","2.05","Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound","MGSSHHHHHHSSGRENLYFQGRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ","Homo sapiens","NMT1, NMT","Glycylpeptide N-tetradecanoyltransferase 1","1","6FZ2"
"6FZ3",,"X-RAY DIFFRACTION",2.16,43.08,"VAPOR DIFFUSION",4.5,"24% PEG 4000
5 mM NiCl2
0.1 M Na citrate
5% Glycerol",293,"10.1021/acs.jmedchem.9b00586","EBK","6FZ3",97.04,"2","2","Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound","MGSSHHHHHHSSGRENLYFQGRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ","Homo sapiens","NMT1, NMT","Glycylpeptide N-tetradecanoyltransferase 1","1","6FZ3"
"6FZ5",,"X-RAY DIFFRACTION",2.31,46.67,"VAPOR DIFFUSION, HANGING DROP",4.5,"24% PEG 4000
5 mM NiCl2
0.1 M Na citrate
5% Glycerol",293,"10.1021/acs.jmedchem.9b00586","BXN","6FZ5",92.37,"1.89","1.89","Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound","RSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ","Homo sapiens","NMT1, NMT","Glycylpeptide N-tetradecanoyltransferase 1","1","6FZ5"
"6FZG",,"X-RAY DIFFRACTION",2.34,47.43,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG 3350, 0.2 M NaCl, 0.1 M Hepes pH 7.5",290,"10.1038/s41467-018-08157-y","EDK","6FZG",32.13,"2.1","2.1","PPAR gamma mutant complex","MQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKMKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6FZG"
"6FZL",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, HANGING DROP",5.5,"7% glycerol, 1.3 M sodium citrate, pH 5.5",291,,,"6FZL",27.56,"1.446","1.446","Crystal structure of human transthyretin double mutant K35T/T119M","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRTAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTMAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6FZL"
"6FZM",,"X-RAY DIFFRACTION",2.35,47.71,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% Poly(ethylene glycol) 3350, 0.2M sodium nitrate and 0.1M Bis-Tris-Propane",277,"10.1016/j.chembiol.2018.09.011",,"6FZM",44.97,"2.67","2.67","Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK6","SMDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","6FZM"
"6FZY",,"X-RAY DIFFRACTION",2.53,51.36,"VAPOR DIFFUSION, SITTING DROP",7,"0.5 M ammonium sulfate, 0.1 M PIPES pH7, 0.9 M disodium tartrate",290,"10.1038/s41467-018-08157-y",,"6FZY",63.79,"3.1","3.1","PPAR mutant","GSHMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVMEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","6FZY"
"6G0D",,"X-RAY DIFFRACTION",2.2,42.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M sodium fluoride, 20 % (w/v) PEG 3350, cryo protection: 20% ethylene glycol",277,,"LY2","6G0D",15.47,"1.314","1.314","BRD4 (BD1) in complex with APSC-derived ligands (e.g. LY294002)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6G0D"
"6G0E",,"X-RAY DIFFRACTION",2.1,41.7,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M sodium acetate pH 4.6, 3.5 M sodium formate, cryo protection: 20% glycero",277,,,"6G0E",15.74,"1.613","1.613","BRD4 (BD1) in complex with APSC-derived ligands","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6G0E"
"6G0F",,"X-RAY DIFFRACTION",2.2,42.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6 M Tri-sodium citrate pH 6.5, cryo protection: 20% ethylene glycol",277,,,"6G0F",15.57,"1.618","1.618","BRD4 (BD1) in complex with docking-derived ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6G0F"
"6G0G",,"X-RAY DIFFRACTION",2.2,42.7,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1 M sodium acetate anhydrous pH 4.6 and 3.5 M sodium formate, cryo protection: 25% ethylene glycol",277,,,"6G0G",15.68,"1.478","1.478","BRD4 (BD1) in complex with APSC-derived ligands (e.g. sulfasalazine)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6G0G"
"6G0H",,"X-RAY DIFFRACTION",2.1,42,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1 M sodium acetate anhydrous pH 4.6 and 3.5 M sodium formate, cryo protection: 25% ethylene glycol",277,,,"6G0H",15.65,"1.907","1.907","BRD4 (BD1) in complex with APSC-derived ligands (e.g. SSLH01 a sulfasalazine derivate)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6G0H"
"6G0I",,"X-RAY DIFFRACTION",2.54,51.63,"VAPOR DIFFUSION, SITTING DROP",8,"28% w/v PEG 3350, 0.1 M TRIS-Cl, pH 8.0 RT, 1 M Lithium Chloride
Soaked in 18 mM ascorbate.",291,"10.1002/1873-3468.13284",,"6G0I",37.96,"2","2","Active Fe-PP1","GMSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPADKNKGKYGQFSGLNPGGRPITPPRNSAKAKK","Homo sapiens","PPP1CA, PPP1A","Serine/threonine-protein phosphatase PP1-alpha catalytic subunit","1","6G0I"
"6G0J",,"X-RAY DIFFRACTION",2.57,52.15,"VAPOR DIFFUSION, SITTING DROP",8,"28% w/v PEG 3350, 0.1 M TRIS-Cl,pH 8.0 RT, 1 M Lithium Chloride.",291,"10.1002/1873-3468.13284",,"6G0J",37.96,"2.1","2.1","Inactive Fe-PP1","GMSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPADKNKGKYGQFSGLNPGGRPITPPRNSAKAKK","Homo sapiens","PPP1CA, PPP1A","Serine/threonine-protein phosphatase PP1-alpha catalytic subunit","1","6G0J"
"6G0V",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, HANGING DROP",7.5,"34% (w/v) PEG 400, 100 mM Tris-HCl (pH 7.5), 100 mM MgCl2, 8 mM B-mercaptoethanol",277,"10.1002/cmdc.201800525","EGZ","6G0V",16.27,"1.09","1.09","Human Galectin-3 in complex with a TF tumor-associated antigen mimetic","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6G0V"
"6G0W",,"X-RAY DIFFRACTION",2.89,57.49,"VAPOR DIFFUSION, SITTING DROP",6,"20% (w/v) PEG6000, 0.2M magnesium chloride, 0.1M MES",277,"10.1016/j.bmcl.2018.04.056","EGW","6G0W",45.07,"2.34","2.34","Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor MCD72","SMDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","6G0W"
"6G22",,"X-RAY DIFFRACTION",3.23,61.86,"VAPOR DIFFUSION",8,"20 mM potassium phosphate monobasic, 8% PEG8000, 10% gycerol, pH 4",291,,,"6G22",24.06,"1.85","1.85","Crystal structure of human mitochondrial 5'(3')-deoxyribonucleotidase in complex with the inhibitor PB-PEU","SNAASGGRALRVLVDMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRPC","Homo sapiens","NT5M, DNT2","5'(3')-deoxyribonucleotidase, mitochondrial","1","6G22"
"6G24",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G24",16.5,"2.1","2.1","X-ray structure of NSD3-PWWP1 in complex with compound 3","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G24"
"6G25",,"X-RAY DIFFRACTION",2.3,46.59,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G25",16.51,"1.432","1.432","X-ray structure of NSD3-PWWP1 in complex with compound 4","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G25"
"6G27",,"X-RAY DIFFRACTION",2.35,47.65,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G27",16.54,"1.65","1.65","X-ray structure of NSD3-PWWP1 in complex with compound 5","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G27"
"6G28",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, SITTING DROP",,"200 mM magnesium formate, 20 % (w/v) PEG3350",293.15,"10.1016/j.chembiol.2018.11.001",,"6G28",41.4,"1.23","1.23","Human [protein ADP-ribosylargenine] hydrolase ARH1 in complex with ADP-ribose","MGHHHHHHGGMEKYVAAMVLSAAGDALGYYNGKWEFLQDGEKIHRQLAQLGGLDALDVGRWRVSDDTVMHLATAEALVEAGKAPKLTQLYYLLAKHYQDCMEDMDGRAPGGASVHNAMQLKPGKPNGWRIPFNSHEGGCGAAMRAMCIGLRFPHHSQLDTLIQVSIESGRMTHHHPTGYLGALASALFTAYAVNSRPPLQWGKGLMELLPEAKKYIVQSGYFVEENLQHWSYFQTKWENYLKLRGILDGESAPTFPESFGVKERDQFYTSLSYSGWGGSSGHDAPMIAYDAVLAAGDSWKELAHRAFFHGGDSDSTAAIAGCWWGVMYGFKGVSPSNYEKLEYRNRLEETARALYSLGSKEDTVISL","Homo sapiens","ADPRH, ARH1","[Protein ADP-ribosylarginine] hydrolase","1","6G28"
"6G29",,"X-RAY DIFFRACTION",2.28,46.05,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G29",16.54,"1.7","1.7","X-ray structure of NSD3-PWWP1 in complex with compound 6","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G29"
"6G2A",,"X-RAY DIFFRACTION",2.04,39.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM magnesium acetate, 12 % (w/v) PEG8000, 100 mM MOPS pH 7.5",293.15,"10.1016/j.chembiol.2018.11.001",,"6G2A",41.47,"1.8","1.8","Human [protein ADP-ribosylargenine] hydrolase ARH1 in complex with ADP-HPM","MGHHHHHHGGMEKYVAAMVLSAAGDALGYYNGKWEFLQDGEKIHRQLAQLGGLDALDVGRWRVSDDTVMHLATAEALVEAGKAPKLTQLYYLLAKHYQDCMEDMDGRAPGGASVHNAMQLKPGKPNGWRIPFNSHEGGCGAAMRAMCIGLRFPHHSQLDTLIQVSIESGRMTHHHPTGYLGALASALFTAYAVNSRPPLQWGKGLMELLPEAKKYIVQSGYFVEENLQHWSYFQTKWENYLKLRGILDGESAPTFPESFGVKERDQFYTSLSYSGWGGSSGHDAPMIAYDAVLAAGDSWKELAHRAFFHGGDSDSTAAIAGCWWGVMYGFKGVSPSNYEKLEYRNRLEETARALYSLGSKEDTVISL","Homo sapiens","ADPRH, ARH1","[Protein ADP-ribosylarginine] hydrolase","1","6G2A"
"6G2B",,"X-RAY DIFFRACTION",2.24,45.21,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G2B",16.51,"1.61","1.61","X-ray structure of NSD3-PWWP1 in complex with compound 8","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G2B"
"6G2C",,"X-RAY DIFFRACTION",2.28,46.09,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G2C",16.53,"1.76","1.76","X-ray structure of NSD3-PWWP1 in complex with compound 9","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G2C"
"6G2D","5.4","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-018-0201-4",,"6G2D",1090.53,"5.4",,"Citrate-induced acetyl-CoA carboxylase (ACC-Cit) filament at 5.4 A resolution","MAHHHHHHHHHHGSTSGSGEQKLISEEDLGSTSGSGDYKDDDDKLTSLYKKAGLENLYFQGMDEPSPLAQPLELNQHSRFIIGSVSEDNSEDEISNLVKLDLLEEKEGSLSPASVGSDTLSDLGISSLQDGLALHIRSSMSGLHLVKQGRDRKKIDSQRDFTVASPAEFVTRFGGNKVIEKVLIANNGIAAVKCMRSIRRWSYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELILDIAKRIPVQAVWAGWGHASENPKLPELLLKNGIAFMGPPSQAMWALGDKIASSIVAQTAGIPTLPWSGSGLRVDWQENDFSKRILNVPQELYEKGYVKDVDDGLQAAEEVGYPVMIKASEGGGGKGIRKVNNADDFPNLFRQVQAEVPGSPIFVMRLAKQSRHLEVQILADQYGNAISLFGRDCSVQRRHQKIIEEAPATIATPAVFEHMEQCAVKLAKMVGYVSAGTVEYLYSQDGSFYFLELNPRLQVEHPCTEMVADVNLPAAQLQIAMGIPLYRIKDIRMMYGVSPWGDSPIDFEDSAHVPCPRGHVIAARITSENPDEGFKPSSGTVQELNFRSNKNVWGYFSVAAAGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLIKLLETESFQMNRIDTGWLDRLIAEKVQAERPDTMLGVVCGALHVADVSLRNSVSNFLHSLERGQVLPAHTLLNTVDVELIYEGVKYVLKVTRQSPNSYVVIMNGSCVEVDVHRLSDGGLLLSYDGSSYTTYMKEEVDRYRITIGNKTCVFEKENDPSVMRSPSAGKLIQYIVEDGGHVFAGQCYAEIEVMKMVMTLTAVESGCIHYVKRPGAALDPGCVLAKMQLDNPSKVQQAELHTGSLPRIQSTALRGEKLHRVFHYVLDNLVNVMNGYCLPDPFFSSKVKDWVERLMKTLRDPSLPLLELQDIMTSVSGRIPPNVEKSIKKEMAQYASNITSVLCQFPSQQIANILDSHAATLNRKSEREVFFMNTQSIVQLVQRYRSGIRGHMKAVVMDLLRQYLRVETQFQNGHYDKCVFALREENKSDMNTVLNYIFSHAQVTKKNLLVTMLIDQLCGRDPTLTDELLNILTELTQLSKTTNAKVALRARQVLIASHLPSYELRHNQVESIFLSAIDMYGHQFCIENLQKLILSETSIFDVLPNFFYHSNQVVRMAALEVYVRRAYIAYELNSVQHRQLKDNTCVVEFQFMLPTSHPNRGNIPTLNRMSFSSNLNHYGMTHVASVSDVLLDNSFTPPCQRMGGMVSFRTFEDFVRIFDEVMGCFSDSPPQSPTFPEAGHTSLYDEDKVPRDEPIHILNVAIKTDCDIEDDRLAAMFREFTQQNKATLVDHGIRRLTFLVAQKDFRKQVNYEVDRRFHREFPKFFTFRARDKFEEDRIYRHLEPALAFQLELNRMRNFDLTAIPCANHKMHLYLGAAKVEVGTEVTDYRFFVRAIIRHSDLVTKEASFEYLQNEGERLLLEAMDELEVAFNNTNVRTDCNHIFLNFVPTVIMDPSKIEESVRSMVMRYGSRLWKLRVLQAELKINIRLTPTGKAIPIRLFLTNESGYYLDISLYKEVTDSRTAQIMFQAYGDKQGPLHGMLINTPYVTKDLLQSKRFQAQSLGTTYIYDIPEMFRQSLIKLWESMSTQAFLPSPPLPSDMLTYTELVLDDQGQLVHMNRLPGGNEIGMVAWKMTFKSPEYPEGRDIIVIGNDITYRIGSFGPQEDLLFLRASELARAEGIPRIYVSANSGARIGLAEEIRHMFHVAWVDPEDPYKGYRYLYLTPQDYKRVSALNSVHCEHVEDEGESRYKITDIIGKEEGIGPENLRGSGMIAGESSLAYNEIITISLVTCRAIGIGAYLVRLGQRTIQVENSHLILTGAGALNKVLGREVYTSNNQLGGIQIMHNNGVTHCTVCDDFEGVFTVLHWLSYMPKSVHSSVPLLNSKDPIDRIIEFVPTKTPYDPRWMLAGRPHPTQKGQWLSGFFDYGSFSEIMQPWAQTVVVGRARLGGIPVGVVAVETRTVELSIPADPANLDSEAKIIQQAGQVWFPDSAFKTYQAIKDFNREGLPLMVFANWRGFSGGMKDMYDQVLKFGAYIVDGLRECCQPVLVYIPPQAELRGGSWVVIDSSINPRHMEMYADRESRGSVLEPEGTVEIKFRRKDLVKTMRRVDPVYIHLAERLGTPELSTAERKELENKLKEREEFLIPIYHQVAVQFADLHDTPGRMQEKGVISDILDWKTSRTFFYWRLRRLLLEDLVKKKIHNANPELTDGQIQAMLRRWFVEVEGTVKAYVWDNNKDLAEWLEKQLTEEDGVHSVIEENIKCISRDYVLKQIRSLVQANPEVAMDSIIHMTQHISPTQRAEVIRILSTMDSPST","Homo sapiens","ACACA, ACAC, ACC1, ACCA","Acetyl-CoA carboxylase 1","1","6G2D"
"6G2E",,"X-RAY DIFFRACTION",2.28,46.06,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G2E",16.56,"1.85","1.85","X-ray structure of NSD3-PWWP1 in complex with compound 13","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G2E"
"6G2F",,"X-RAY DIFFRACTION",2.31,46.69,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G2F",16.59,"1.74","1.74","X-ray structure of NSD3-PWWP1 in complex with compound 16","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G2F"
"6G2H","4.6","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-018-0201-4",,"6G2H",1635.8,"4.6",,"Filament of acetyl-CoA carboxylase and BRCT domains of BRCA1 (ACC-BRCT) core at 4.6 A resolution","MAHHHHHHHHHHGSTSGSGEQKLISEEDLGSTSGSGDYKDDDDKLTSLYKKAGLENLYFQGMDEPSPLAQPLELNQHSRFIIGSVSEDNSEDEISNLVKLDLLEEKEGSLSPASVGSDTLSDLGISSLQDGLALHIRSSMSGLHLVKQGRDRKKIDSQRDFTVASPAEFVTRFGGNKVIEKVLIANNGIAAVKCMRSIRRWSYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELILDIAKRIPVQAVWAGWGHASENPKLPELLLKNGIAFMGPPSQAMWALGDKIASSIVAQTAGIPTLPWSGSGLRVDWQENDFSKRILNVPQELYEKGYVKDVDDGLQAAEEVGYPVMIKASEGGGGKGIRKVNNADDFPNLFRQVQAEVPGSPIFVMRLAKQSRHLEVQILADQYGNAISLFGRDCSVQRRHQKIIEEAPATIATPAVFEHMEQCAVKLAKMVGYVSAGTVEYLYSQDGSFYFLELNPRLQVEHPCTEMVADVNLPAAQLQIAMGIPLYRIKDIRMMYGVSPWGDSPIDFEDSAHVPCPRGHVIAARITSENPDEGFKPSSGTVQELNFRSNKNVWGYFSVAAAGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLIKLLETESFQMNRIDTGWLDRLIAEKVQAERPDTMLGVVCGALHVADVSLRNSVSNFLHSLERGQVLPAHTLLNTVDVELIYEGVKYVLKVTRQSPNSYVVIMNGSCVEVDVHRLSDGGLLLSYDGSSYTTYMKEEVDRYRITIGNKTCVFEKENDPSVMRSPSAGKLIQYIVEDGGHVFAGQCYAEIEVMKMVMTLTAVESGCIHYVKRPGAALDPGCVLAKMQLDNPSKVQQAELHTGSLPRIQSTALRGEKLHRVFHYVLDNLVNVMNGYCLPDPFFSSKVKDWVERLMKTLRDPSLPLLELQDIMTSVSGRIPPNVEKSIKKEMAQYASNITSVLCQFPSQQIANILDSHAATLNRKSEREVFFMNTQSIVQLVQRYRSGIRGHMKAVVMDLLRQYLRVETQFQNGHYDKCVFALREENKSDMNTVLNYIFSHAQVTKKNLLVTMLIDQLCGRDPTLTDELLNILTELTQLSKTTNAKVALRARQVLIASHLPSYELRHNQVESIFLSAIDMYGHQFCIENLQKLILSETSIFDVLPNFFYHSNQVVRMAALEVYVRRAYIAYELNSVQHRQLKDNTCVVEFQFMLPTSHPNRGNIPTLNRMSFSSNLNHYGMTHVASVSDVLLDNSFTPPCQRMGGMVSFRTFEDFVRIFDEVMGCFSDSPPQSPTFPEAGHTSLYDEDKVPRDEPIHILNVAIKTDCDIEDDRLAAMFREFTQQNKATLVDHGIRRLTFLVAQKDFRKQVNYEVDRRFHREFPKFFTFRARDKFEEDRIYRHLEPALAFQLELNRMRNFDLTAIPCANHKMHLYLGAAKVEVGTEVTDYRFFVRAIIRHSDLVTKEASFEYLQNEGERLLLEAMDELEVAFNNTNVRTDCNHIFLNFVPTVIMDPSKIEESVRSMVMRYGSRLWKLRVLQAELKINIRLTPTGKAIPIRLFLTNESGYYLDISLYKEVTDSRTAQIMFQAYGDKQGPLHGMLINTPYVTKDLLQSKRFQAQSLGTTYIYDIPEMFRQSLIKLWESMSTQAFLPSPPLPSDMLTYTELVLDDQGQLVHMNRLPGGNEIGMVAWKMTFKSPEYPEGRDIIVIGNDITYRIGSFGPQEDLLFLRASELARAEGIPRIYVSANSGARIGLAEEIRHMFHVAWVDPEDPYKGYRYLYLTPQDYKRVSALNSVHCEHVEDEGESRYKITDIIGKEEGIGPENLRGSGMIAGESSLAYNEIITISLVTCRAIGIGAYLVRLGQRTIQVENSHLILTGAGALNKVLGREVYTSNNQLGGIQIMHNNGVTHCTVCDDFEGVFTVLHWLSYMPKSVHSSVPLLNSKDPIDRIIEFVPTKTPYDPRWMLAGRPHPTQKGQWLSGFFDYGSFSEIMQPWAQTVVVGRARLGGIPVGVVAVETRTVELSIPADPANLDSEAKIIQQAGQVWFPDSAFKTYQAIKDFNREGLPLMVFANWRGFSGGMKDMYDQVLKFGAYIVDGLRECCQPVLVYIPPQAELRGGSWVVIDSSINPRHMEMYADRESRGSVLEPEGTVEIKFRRKDLVKTMRRVDPVYIHLAERLGTPELSTAERKELENKLKEREEFLIPIYHQVAVQFADLHDTPGRMQEKGVISDILDWKTSRTFFYWRLRRLLLEDLVKKKIHNANPELTDGQIQAMLRRWFVEVEGTVKAYVWDNNKDLAEWLEKQLTEEDGVHSVIEENIKCISRDYVLKQIRSLVQANPEVAMDSIIHMTQHISPTQRAEVIRILSTMDSPST","Homo sapiens","ACACA, ACAC, ACC1, ACCA","Acetyl-CoA carboxylase 1","1","6G2H"
"6G2L",,"X-RAY DIFFRACTION",3.12,60.57,"VAPOR DIFFUSION",8,"20 mM potassium phosphate monobasic, 8% PEG8000, 10% gycerol, pH 4,",291,,,"6G2L",24.09,"1.48","1.48","Crystal structure of human mitochondrial 5'(3')-deoxyribonucleotidase in complex with the inhibitor PB-PMTMU","SNAASGGRALRVLVDMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRPC","Homo sapiens","NT5M, DNT2","5'(3')-deoxyribonucleotidase, mitochondrial","1","6G2L"
"6G2M",,"X-RAY DIFFRACTION",3.11,60.44,"VAPOR DIFFUSION",8,"100mM CHES, pH 9.5, 20% PEG8000",291,,,"6G2M",24.27,"1.37","1.37","Crystal structure of human mitochondrial 5'(3')-deoxyribonucleotidase in complex with the inhibitor PB-PAU","SNAASGGRALRVLVDMDGVLADFEGGFLRKFRARFPDQPFIALEDRRGFWVSEQYGRLRPGLSEKAISIWESKNFFFELEPLPGAVEAVKEMASLQNTDVFICTSPIKMFKYCPYEKYAWVEKYFGPDFLEQIVLTRDKTVVSADLLIDDRPDITGAEPTPSWEHVLFTACHNQHLQLQPPRRRLHSWADDWKAILDSKRPC","Homo sapiens","NT5M, DNT2","5'(3')-deoxyribonucleotidase, mitochondrial","1","6G2M"
"6G2N",,"X-RAY DIFFRACTION",2.16,42.99,"VAPOR DIFFUSION",8,"Morpheus H2, 0.1M MES/imidazole pH 6.5, 10% PEG 8000, 20% ethylene glycol, 0.02M of each amino acid,",291,,,"6G2N",48.82,"1.4","1.4","Crystal structure of human cytosolic 5'(3')-deoxyribonucleotidase in complex with the inhibitor PB-PAU","SNAASARSVRVLVDMDGVLADFEAGLLRGFRRRFPEEPHVPLEQRRGFLAREQYRALRPDLADKVASVYEAPGFFLDLEPIPGALDAVREMNDLPDTQVFICTSPLLKYHHCVGEKYRWVEQHLGPQFVERIILTRDKTVVLGDLLIDDKDTVRGQEETPSWEHILFTCCHNRHLVLPPTRRRLLSWSDNWREILDSKRGAAQRE","Homo sapiens","NT5C, DNT1, UMPH2","5'(3')-deoxyribonucleotidase, cytosolic type","1","6G2N"
"6G2O",,"X-RAY DIFFRACTION",2.21,44.26,"VAPOR DIFFUSION",,"100mM Morpheus Buffer 3, 30% P550MME_P20K, 10% Morpheus Ethylene glycols",277,"10.1038/s41589-019-0310-x",,"6G2O",16.63,"1.81","1.81","X-ray structure of NSD3-PWWP1 in complex with compound BI-9321","STGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G2O"
"6G2U",,"X-RAY DIFFRACTION",2.99,58.93,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 8000, MPD, NaCl, sodium phosphate",291,"10.1111/jnc.15296",,"6G2U",340.12,"2.93428699014","2.93428699014","Crystal structure of the human glutamate dehydrogenase 2 (hGDH2)","SELVADREDDPNFFKMVEGFFDRGASIVEDKLVKDLRTQESEEQKRNRVRGILRIIKPCNHVLSLSFPIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFGGAKAGVKINPKNYTENELEKITRRFTMELAKKGFIGPGVDVPAPDMNTGEREMSWIADTYASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFRDKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILGFPKAKPYEGSILEVDCDILIPAATEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLERNILVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLLSVQESLERKFGKHGGTIPIVPTAEFQDSISGASEKDIVHSALAYTMERSARQIMHTAMKYNLGLDLRTAAYVNAIEKVFKVYSEAGVTFT","Homo sapiens","GLUD2, GLUDP1","Glutamate dehydrogenase 2, mitochondrial","1","6G2U"
"6G2V",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, SITTING DROP",,"0.08M L-Na-Glutamate; 0.08M Alanine (racemic); 0.08M Glycine; 0.08M Lysine HCl (racemic); 0.08M Serine (racemic), 0.08M Tris, 0.08M BICINE, 10% v/v MPD; 10% PEG 1000; 10% w/v PEG 3350 at pH 8.5",293,"10.1002/1873-3468.13667",,"6G2V",31.94,"1.903","1.903","Crystal structure of the p97 D2 domain in a helical split-washer conformation","GPGSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTSEANVREIFDKARQAAPCVLFFDELDSIAKAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRREREVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQ","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","6G2V"
"6G2W",,"X-RAY DIFFRACTION",2.36,47.8,"VAPOR DIFFUSION, SITTING DROP",,"0.08M L-Na-Glutamate; 0.08M Alanine (racemic); 0.08M Glycine; 0.08M Lysine HCl (racemic); 0.08M Serine (racemic), 0.08M Tris, 0.08M BICINE, 10% v/v MPD; 10% PEG 1000; 10% w/v PEG 3350 at pH 8.5",293,"10.1002/1873-3468.13667",,"6G2W",35.54,"2.678","2.678","Crystal structure of the p97 D2 domain in a helical split-washer conformation","GPGSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQ","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","6G2W"
"6G2X",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, SITTING DROP",,"0.08M L-Na-Glutamate; 0.08M Alanine (racemic); 0.08M Glycine; 0.08M Lysine HCl (racemic); 0.08M Serine (racemic), 0.08M Tris, 0.08M BICINE, 10% v/v MPD; 10% PEG 1000; 10% w/v PEG 3350 at pH 8.5",293,"10.1002/1873-3468.13667",,"6G2X",35.75,"2.078","2.078","Crystal structure of the p97 D2 domain in a helical split-washer conformation","GPGSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQ","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","6G2X"
"6G2Y",,"X-RAY DIFFRACTION",2.51,51.02,"VAPOR DIFFUSION, SITTING DROP",,"0.08M L-Na-Glutamate; 0.08M Alanine (racemic); 0.08M Glycine; 0.08M Lysine HCl (racemic); 0.08M Serine (racemic), 0.08M Tris, 0.08M BICINE, 10% v/v MPD; 10% PEG 1000; 10% w/v PEG 3350 at pH 8.5",,"10.1002/1873-3468.13667",,"6G2Y",35.33,"2.153","2.153","Crystal structure of the p97 D2 domain in a helical split-washer conformation","SALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQ","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","6G2Y"
"6G2Z",,"X-RAY DIFFRACTION",2.38,48.22,"VAPOR DIFFUSION, SITTING DROP",,"0.08M L-Na-Glutamate; 0.08M Alanine (racemic); 0.08M Glycine; 0.08M Lysine HCl (racemic); 0.08M Serine (racemic), 0.08M Tris, 0.08M BICINE, 10% v/v MPD; 10% PEG 1000; 10% w/v PEG 3350 at pH 8.5",293,"10.1002/1873-3468.13667",,"6G2Z",35.48,"1.923","1.923","Crystal structure of the p97 D2 domain in a helical split-washer conformation","GPGSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQ","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","6G2Z"
"6G30",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, SITTING DROP",,"0.08M L-Na-Glutamate; 0.08M Alanine (racemic); 0.08M Glycine; 0.08M Lysine HCl (racemic); 0.08M Serine (racemic), 0.08M Tris, 0.08M BICINE, 10% v/v MPD; 10% PEG 1000; 10% w/v PEG 3350 at pH 8.5",293,"10.1002/1873-3468.13667",,"6G30",35.5,"2.418","2.418","Crystal structure of the p97 D2 domain in a helical split-washer conformation","GPGSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQ","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","6G30"
"6G31",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, SITTING DROP",,"0.18M magnesium acetate tetrahydrate, 18% w/v PEG 3350, 0.18M sodium thiocyanate",292,"10.1124/mol.118.113670","ZOL","6G31",429.95,"3","3","Crystal structure of human geranylgeranyl diphosphate synthase mutant D188Y bound to zoledronate","GSGSGSGMEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIIIEVTEMLHNASLLIDDIEDNSKLRRGFPVAHSIYGIPSVINSANYVYFLGLEKVLTLDHQDAVKLFTRQLLELHQGQGLDIYWRDNYTCPTEEEYKAMVLQKTGGLFGLAVGLMQLFSDYKEDLKPLLNTLGLFFQIRYDYANLHSKEYSENKSFCEDLTEGKFSFPTIHAIWSRPESTQVQNILRQRTENIDIKKYCVHYLEDVGSFEYTRNTLKELEAKAYKQIDARGGNPELVALVKHLSKMFKEENE","Homo sapiens","GGPS1","Geranylgeranyl pyrophosphate synthase","1","6G31"
"6G32",,"X-RAY DIFFRACTION",3.47,64.6,"VAPOR DIFFUSION, SITTING DROP",,"3.6M Sodium formate, 0.01% w/v aspartame, 0.01% w/v gly-gly-gly, 0.01% w/v pentaglycine, 0.01% w/v tyr-ala, 0.01% w/v tyr-phe, 0.0018M HEPES sodium pH 6.8",292,"10.1124/mol.118.113670",,"6G32",213.46,"3.281","3.281","Crystal structure of human geranylgeranyl diphosphate synthase mutant D188Y","GSGSGSGMEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIIIEVTEMLHNASLLIDDIEDNSKLRRGFPVAHSIYGIPSVINSANYVYFLGLEKVLTLDHQDAVKLFTRQLLELHQGQGLDIYWRDNYTCPTEEEYKAMVLQKTGGLFGLAVGLMQLFSDYKEDLKPLLNTLGLFFQIRYDYANLHSKEYSENKSFCEDLTEGKFSFPTIHAIWSRPESTQVQNILRQRTENIDIKKYCVHYLEDVGSFEYTRNTLKELEAKAYKQIDARGGNPELVALVKHLSKMFKEENE","Homo sapiens","GGPS1","Geranylgeranyl pyrophosphate synthase","1","6G32"
"6G33",,"X-RAY DIFFRACTION",2.47,50.14,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% 1,2-propanediol, 5% glycerol and 0.1 M NaKPO4",277.15,"10.1002/anie.201801666","5ID","6G33",120.56,"2.05","2.05","Crystal structure of CLK1 in complex with 5-iodotubercidin","SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","1","6G33"
,,,,,,,,,,,,,,,,"SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI","Homo sapiens","CLK1, CLK","Dual specificity protein kinase CLK1","2","6G33"
"6G34",,"X-RAY DIFFRACTION",3.03,59.4,"VAPOR DIFFUSION, SITTING DROP",,"51-63% MPD and 0.1M SPG buffer, pH 6.0-6.5",277.15,"10.1002/anie.201801666","5ID","6G34",41.56,"1.76","1.76","Crystal structure of haspin in complex with 5-iodotubercidin","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6G34"
"6G35",,"X-RAY DIFFRACTION",3,59.04,"VAPOR DIFFUSION, SITTING DROP",,"51-63% MPD and 0.1M SPG buffer, pH 6.0-6.5",277.15,"10.1002/anie.201801666","EKK","6G35",41.45,"1.55","1.55","Crystal structure of haspin in complex with 5-bromotubercidin","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6G35"
"6G36",,"X-RAY DIFFRACTION",3.01,59.09,"VAPOR DIFFUSION, SITTING DROP",,"51-63% MPD and 0.1M SPG buffer, pH 6.0-6.5",277.15,"10.1002/anie.201801666","EKH","6G36",41.61,"1.46","1.46","Crystal structure of haspin in complex with 5-chlorotubercidin","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6G36"
"6G37",,"X-RAY DIFFRACTION",3.04,59.49,"VAPOR DIFFUSION, SITTING DROP",,"51-63% MPD and 0.1M SPG buffer, pH 6.0-6.5",277.15,"10.1002/anie.201801666","FTU","6G37",41.09,"1.48","1.48","Crystal structure of haspin in complex with 5-fluorotubercidin","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6G37"
"6G38",,"X-RAY DIFFRACTION",3.04,59.54,"VAPOR DIFFUSION, SITTING DROP",,"51-63% MPD and 0.1M SPG buffer, pH 6.0-6.5",277.15,"10.1002/anie.201801666","TBN","6G38",41.39,"1.47","1.47","Crystal structure of haspin in complex with tubercidin","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6G38"
"6G39",,"X-RAY DIFFRACTION",3.04,59.54,"VAPOR DIFFUSION, SITTING DROP",,"51-63% MPD and 0.1M SPG buffer, pH 6.0-6.5",277.15,"10.1002/anie.201801666",,"6G39",41.51,"1.45","1.45","Crystal structure of haspin F605Y mutant in complex with 5-iodotubercidin","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEYEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6G39"
"6G3A",,"X-RAY DIFFRACTION",3.03,59.34,"VAPOR DIFFUSION, SITTING DROP",,"51-63% MPD and 0.1M SPG buffer, pH 6.0-6.5",277.15,"10.1002/anie.201801666",,"6G3A",41.48,"1.43","1.43","Crystal structure of haspin F605T mutant in complex with 5-iodotubercidin","MHHHHHHSSGVDLGTENLYFQSMGECSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLETEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSLFK","Homo sapiens","HASPIN, GSG2","Serine/threonine-protein kinase haspin","1","6G3A"
"6G3C",,"X-RAY DIFFRACTION",2.37,48.11,"VAPOR DIFFUSION, HANGING DROP",8,"24% PEG4000, 0.1M Magnesium Acetate, 0.1M Tris",277,"10.1021/acschembio.8b00722",,"6G3C",63.9,"1.6","1.6","Crystal Structure of JAK2-V617F pseudokinase domain in complex with Compound 2","FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL","Homo sapiens","JAK2","Tyrosine-protein kinase","1","6G3C"
"6G3O",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M TRIS, pH 9.15, 54 %(w/v) PEG 400",293,"10.1016/j.bmcl.2018.06.029","EL8","6G3O",129.53,"2.27","2.27","Crystal structure of human HDAC2 in complex with (R)-6-[3,4-Dioxo-2-(4-trifluoromethoxy-phenylamino)-cyclobut-1-enylamino]-heptanoic acid hydroxyamide","GGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPH","Homo sapiens","HDAC2","Histone deacetylase 2","1","6G3O"
"6G3P",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION",,"50 mM TRIS pH 9.0, 23% PEG3350",293,"10.1038/s41589-019-0310-x",,"6G3P",72.28,"2.8","2.8","X-ray structure of seleno-methionine labelled NSD3-PWWP1","GEAPVQPILSSVPTTEVSTGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G3P"
"6G3Q",,"X-RAY DIFFRACTION",2.09,41.19,"VAPOR DIFFUSION",8,"1.5 M sodium citrate, Tris 50 mM",296,"10.1021/acsmedchemlett.8b00334","FO9","6G3Q",29.79,"1.01","1.01","Crystal structure of human carbonic anhydrase II in complex with the inhibitor famotidine","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6G3Q"
"6G3R",,"X-RAY DIFFRACTION",2.57,52.18,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Tris pH 8.5, 25% PEG 3350",293,"10.1371/journal.pone.0199639","ADP","6G3R",44.09,"1.4","1.4","Structure of tellurium-centred Anderson-Evans polyoxotungstate (TEW) bound to the nucleotide binding domain of HSP70. Structure one of two TEW-HSP70 structures deposited.","KAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVALNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEISSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLNKSINPDEAVAYGAAVQAAILMG","Homo sapiens","HSPA1A, HSP72, HSPA1, HSX70","Heat shock 70 kDa protein 1A","1","6G3R"
"6G3S",,"X-RAY DIFFRACTION",2.94,58.17,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Bis-Tris pH 6.5, 0.2 M NaCl, 25% PEG 3350",293,"10.1371/journal.pone.0199639","ADP","6G3S",45.73,"2.3","2.3","Structure of tellurium-centred Anderson-Evans polyoxotungstate (TEW) bound to the nucleotide binding domain of HSP70. Second structure of two TEW-HSP70 structures deposited.","KAAAIGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVALNPQNTVFDAKRLIGRKFGDPVVQSDMKHWPFQVINDGDKPKVQVSYKGETKAFYPEEISSMVLTKMKEIAEAYLGYPVTNAVITVPAYFNDSQRQATKDAGVIAGLNVLRIINEPTAAAIAYGLDRTGKGERNVLIFDLGGGTFDVSILTIDDGIFEVKATAGDTHLGGEDFDNRLVNHFVEEFKRKHKKDISQNKRAVRRLRTACERAKRTLSSSTQASLEIDSLFEGIDFYTSITRARFEELCSDLFRSTLEPVEKALRDAKLDKAQIHDLVLVGGSTRIPKVQKLLQDFFNGRDLNKSINPDEAVAYGAAVQAAILMG","Homo sapiens","HSPA1A, HSP72, HSPA1, HSX70","Heat shock 70 kDa protein 1A","1","6G3S"
"6G3T",,"X-RAY DIFFRACTION",2.84,56.67,"VAPOR DIFFUSION",,"100 mM HEPES pH 7.8, 28% PEG3350, 2% PEG200, 1.5% 1,2-Butandiol",293,"10.1038/s41589-019-0310-x",,"6G3T",72.62,"2.53","2.53","X-ray structure of NSD3-PWWP1","GEAPVQPILSSVPTTEVSTGVKFQVGDLVWSKVGTYPWWPCMVSSDPQLEVHTKINTRGAREYHVQFFSNQPERAWVHEKRVREYKGHKQYEELLAEATKQASNHSEKQKIRKPRPQRERAQWDIGIAHAEKALKMTREERIEQYTFIYIDKQ","Homo sapiens","NSD3, WHSC1L1, DC28","Histone-lysine N-methyltransferase NSD3","1","6G3T"
"6G3V",,"X-RAY DIFFRACTION",2.34,47.5,"VAPOR DIFFUSION",9,"28% PEG4000, 0.2 M sodium acetate, Tris 100 mM",296,"10.1021/acsmedchemlett.8b00334","FO9","6G3V",58.9,"1.69","1.69","Crystal structure of human carbonic anhydrase I in complex with the inhibitor famotidine","MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","6G3V"
"6G4L",,"X-RAY DIFFRACTION",2.44,49.68,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 6000 50%w/v
HEPES 0.1M
DMSO 5%",291.15,,"F45","6G4L",29.59,"1.444","1.444","17beta-hydroxysteroid Dehydrogenase Type 14 Mutant Y253A in Complex With a Non-steroidal Inhibitor","MATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGAGCKASRSTPVDAPDIPS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6G4L"
"6G4T",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% (w/v) polyethylene glycol 3350, 0.1 M Tris, pH 8.5",293,"10.3390/ijms19061571",,"6G4T",30.99,"1.91","1.91","The crystal structure of uninhibited C183S/C217S mutant of human CA VII","MGMTGHHGWGYGQDDGPSHWHKLYPIAQGDRQSPINIISSQAVYSPSLQPLELSYEACMSLSITNNGHSVQVDFNDSDDRTVVTGGPLEGPYRLKQFHFHWGKKHDVGSEHTVDGKSFPSELHLVHWNAKKYSTFGEAASAPDGLAVVGVFLETGDEHPSMNRLTDALYMVRFKGTKAQFSCFNPKSLLPASRHYWTYPGSLTTPPLSESVTWIVLREPISISERQMGKFRSLLFTSEDDERIHMVNNFRPPQPLKGRVVKASFRALEHHHHHH","Homo sapiens","CA7","Carbonic anhydrase 7","1","6G4T"
"6G52",,"X-RAY DIFFRACTION",2.49,50.68,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.5 M Sodium Formate, 5 % PEG 3350, 0.1 M TRIS pH 7.2",291,"10.3390/ijms20246279",,"6G52",192.67,"3.691","3.691","CRYSTAL STRUCTURE OF THE CNMP BINDING DOMAIN OF THE MAGNESIUM TRANSPORTER CNNM4","AGMKISPQLLLAAHRFLATEVSQFSPSLISEKILLRLLKYPDVIQELKFDEHNKYYARHYLYTRNKPADYFILILQGKVEVEAGKENMKFETGAFSYYGTMALTSVPSDRSPAHPTPLSRSASLSYPDRTDVSTAATLAGSSNQFGSSVLGQYISDFSVRALVDLQYIKITRQQYQNGLLASRMENSPQ","Homo sapiens","CNNM4, ACDP4, KIAA1592","Metal transporter CNNM4","1","6G52"
"6G54",,"X-RAY DIFFRACTION",2.91,57.66,"VAPOR DIFFUSION, SITTING DROP",5.9,"0.9M Li2SO4 and 0.1M citrate 5.9",277.15,"10.1016/j.chembiol.2019.02.021",,"6G54",43.03,"2.05","2.05","Crystal structure of ERK2 covalently bound to SM1-71","SMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G54"
"6G57",,"X-RAY DIFFRACTION",2.33,47.12,"VAPOR DIFFUSION, SITTING DROP",,"50% PEG200 -- 0.2M sodium chloride -- 0.1M sodium/potassium phosphate pH 7.5",293,,,"6G57",57.75,"2.8","2.8","Structure of the H1 domain of human KCTD8","SMAQDKRSGFLTLGYRGSYTTVRDNQADAKFRRVARIMVCGRIALAKEVFGDTLNESRDPDRQPEKYTSRFYLKFTYLEQAFDRLSEAGFHMVACNSSGTAAFVNQYRDDKIWSSYTEYIFFRP","Homo sapiens","KCTD8","BTB/POZ domain-containing protein KCTD8","1","6G57"
"6G5J",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"37-45% PEG400
0.1M bis-Tris pH 5.6-5.9",295,"10.1021/acsmedchemlett.7b00507","EM8","6G5J",37.83,"1.85","1.85","Secreted phospholipase A2 type X in complex with ligand","MGPLPVCLPIMLLLLLPSLLLLLLLPGPGSGEASRILRVHRRGILELAGTVGCVGPRTPIAYMKYGCFCGLGGHGQPRDAIDWCCHGHDCCYTRAEEAGCSPKTERYSWQCVNQSVLCGPAENKCQELLCKCDQEIANCLAQTEYNLKYLFYPQFLCEPDSPKCD","Homo sapiens","PLA2G10","Group 10 secretory phospholipase A2","1","6G5J"
"6G5L",,"X-RAY DIFFRACTION",2.08,40.78,"VAPOR DIFFUSION, SITTING DROP",7.2,"Crystallization buffer: 0.1M ammonium citrate (pH 7.2), 0.2 M ammonium sulfate and 30% PEG4000",291,"10.1016/j.ejmech.2018.06.059","EM5","6G5L",122.39,"1.21","1.21","Crystal structure of human carbonic anhydrase isozyme XII with 4-chloro-2-(cyclohexylamino)-N-(2-hydroxyethyl)-5-sulfamoyl-benzamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6G5L"
"6G5N",,"X-RAY DIFFRACTION",2.76,55.38,"VAPOR DIFFUSION, SITTING DROP",6.1,"17-26% PEG20K, 0.1M MES pH 6.1, 2-4% ethylene glycol, 4 days",277.15,,,"6G5N",43.91,"1.765","1.765","Crystal structure of human SP100 in complex with bromodomain-focused fragment XS039818e 1-(3-Phenyl-1,2,4-oxadiazol-5-yl)methanamine","ENSNICEVCNKWGRLFCCDTCPRSFHEHCHIPSVEANKNPWSCIFCRIKTIQERCPESQSGHQESEVLMRQMLPEEQLKCEFLLLKVYCDSKSCFFASEPYYNREGSQGPQKPMWLNKVKTSLNEQMYTRVEGFVQDMRLIFHNHKEFYREDKFTRLGIQVQDIFEKNFRNIFAIQETSK","Homo sapiens","SP100","Nuclear autoantigen Sp-100","1","6G5N"
"6G5P",,"X-RAY DIFFRACTION",2.77,55.56,"VAPOR DIFFUSION, SITTING DROP",6.1,"17-23% PEG20K, 0.1M MES 6.1, 2-4% Ethylene glycol, 4 days",277,,,"6G5P",43.98,"1.35","1.35","Crystal structure of human SP100 in complex with bromodomain-focused fragment FM009493b 2,3-Dimethoxy-2,3-dimethyl-2,3-dihydro-1,4-benzodioxin-6-amine","ENSNICEVCNKWGRLFCCDTCPRSFHEHCHIPSVEANKNPWSCIFCRIKTIQERCPESQSGHQESEVLMRQMLPEEQLKCEFLLLKVYCDSKSCFFASEPYYNREGSQGPQKPMWLNKVKTSLNEQMYTRVEGFVQDMRLIFHNHKEFYREDKFTRLGIQVQDIFEKNFRNIFAIQETSK","Homo sapiens","SP100","Nuclear autoantigen Sp-100","1","6G5P"
"6G5U",,"X-RAY DIFFRACTION",2.22,44.2,"VAPOR DIFFUSION, SITTING DROP",5,"Crystallization buffer: 0.1M ammonium citrate (pH 5.0) and 18% PEG
4000",291,"10.1016/j.ejmech.2018.06.059","ENN","6G5U",60.39,"1.7","1.7","Crystal structure of human carbonic anhydrase isozyme XIII with N-butyl-2,4-dichloro-5-sulfamoyl-benzamide","MMSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH","Homo sapiens","CA13","Carbonic anhydrase 13","1","6G5U"
"6G5W",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION",5.5,"100mM Citrate, 10mM NiCl2, 20% PEG 3350",277,"10.1021/acs.jmedchem.1c00693",,"6G5W",84.94,"1.83","1.83","Crystal Structure of KDM4A with compound YP-03-038","MASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6G5W"
"6G5X",,"X-RAY DIFFRACTION",2.51,50.98,"VAPOR DIFFUSION",5.5,"100mM Citrate, 10mM NiCl2, 20% PEG 3350",277,"10.1021/acs.jmedchem.1c00693",,"6G5X",85.15,"1.78","1.78","Crystal Structure of KDM4A with compound YP-02-145","MASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6G5X"
"6G6R",,"X-RAY DIFFRACTION",2.21,44.14,"VAPOR DIFFUSION, HANGING DROP",7,"30% PEG600
0.1M HEPES pH 7.0",298,"10.1111/febs.14790",,"6G6R",44.95,"1.35","1.35","Human Methionine Adenosyltransferase II with SAMe and PPNP","MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","6G6R"
"6G6S",,"X-RAY DIFFRACTION",1.93,36.38,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M Ammonium acetate, 100 mM Tris-HCl pH 8.5, 25% w/v Polyethylene glycol 3350",291.15,"10.7717/peerj.5163",,"6G6S",21.35,"1.65","1.65","Crystal structure of human Acinus RNA recognition motif domain","GSGKISNIVHISNLVRPFTLGQLKELLGRTGTLVEEAFWIDKIKSHCFVTYSTVEEAVATRTALHGVKWPQSNPKFLCADYAEQDELDYHRGLLV","Homo sapiens","ACIN1, ACINUS, KIAA0670","Apoptotic chromatin condensation inducer in the nucleus","1","6G6S"
"6G6T",,"X-RAY DIFFRACTION",2.07,40.2,"VAPOR DIFFUSION, SITTING DROP",7,"Crystallization buffer: 0.1M sodium bicine (pH 9), 0.2M ammonium sulfate and 2M sodium malonate (pH 7)",291,"10.1016/j.ejmech.2018.06.059","ENN","6G6T",29.92,"1.12","1.12","Crystal structure of human carbonic anhydrase isozyme II with N-butyl-2,4-dichloro-5-sulfamoyl-benzamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6G6T"
"6G6U",,"X-RAY DIFFRACTION",2.87,57.13,"VAPOR DIFFUSION, SITTING DROP",6.5,"25.5% precipitant mix 4 [25% (v/v) MPD, 25% (w/v) PEG 1000, 25% (w/v) PEG 3350], 0.06 M NH4NO3, 0.1 buffer system 1 [imidazole and MES adjusted to pH 6.5]",292,,,"6G6U",65.92,"2.74","2.74","The dynamic nature of the VDAC1 channels in bilayers: human VDAC1 at 2.7 Angstrom resolution","MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQALEHHHHHH","Homo sapiens","VDAC1, VDAC","Voltage-dependent anion-selective channel protein 1","1","6G6U"
"6G6Y",,"X-RAY DIFFRACTION",2.42,49.14,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M HEPES pH 8.0, 12.5 % PEG3350, and 0.1 M MgCl2",291,"10.1016/j.ejmech.2018.07.006","ADP, EOK","6G6Y",41.94,"1.8","1.8","Eg5-inhibitor complex","GPMASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","6G6Y"
"6G6Z",,"X-RAY DIFFRACTION",3.45,64.38,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES, pH 5.5, 24.5% PEG 3350, 0.3 M (NH4)2SO4, 0.1 M Trimethylamine",277,"10.1016/j.ejmech.2018.07.006",,"6G6Z",41.94,"2.8","2.8","Eg5-inhibitor complex","GPMASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","Kinesin-like protein KIF11","1","6G6Z"
"6G73",,"X-RAY DIFFRACTION",3.21,61.74,"VAPOR DIFFUSION, SITTING DROP",7.5,"25.5% Precipitant mix 4 [precipitant mix 4 consists of 25% (v/v) MPD, 25% (w/v) PEG1000, 25% (w/v) PEG3350], 0.06M NaNO3, 0.08M K2HPO4, 0.1M Buffer System2 [HEPES and MOPS adjusted to pH 7.5]",292.2,,,"6G73",130.9,"3.27","3.27","The dynamic nature of the VDAC1 channels in bilayers: human VDAC1 at 3.3 Angstrom resolution","MAVPPTYADLGKSARDVFTKGYGFGLIKLDLKTKSENGLEFTSSGSANTETTKVTGSLETKYRWTEYGLTFTEKWNTDNTLGTEITVEDQLARGLKLTFDSSFSPNTGKKNAKIKTGYKREHINLGCDMDFDIAGPSIRGALVLGYEGWLAGYQMNFETAKSRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQKVNKKLETAVNLAWTAGNSNTRFGIAAKYQIDPDACFSAKVNNSSLIGLGYTQTLKPGIKLTLSALLDGKNVNAGGHKLGLGLEFQALEHHHHHH","Homo sapiens","VDAC1, VDAC","Voltage-dependent anion-selective channel protein 1","1","6G73"
"6G76",,"X-RAY DIFFRACTION",2.82,56.32,"VAPOR DIFFUSION, SITTING DROP",8,"18 % PEG 6000, 0.1 M TRIS pH8, 2 mM Zinc chloride",291,"10.1126/scitranslmed.aba4627",,"6G76",72.21,"3","3","Phosphorylated RSK4 N-terminal Kinase Domain in complex with AMP-PNP","GPLGSDEGVVKEIPITHHVKEGYEKADPAQFELLKVLGQGSFGKVFLVRKKTGPDAGQLYAMKVLKKASLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDVFTRLSKEVLFTEEDVKFYLAELALALDHLHQLGIVYRDLKPENILLDEIGHIKLTDFGLSKESVDQEKKAYSFCGTVEYMAPEVVNRRGHSQSADWWSYGVLMFEMLTGTLPFQGKDRNETMNMILKAKLGMPQFLSAEAQSLLRMLFKRNPANRLGSEGVEEIKRHLFFANIDWDKLYKREVQPPFKP","Homo sapiens","RPS6KA6, RSK4","Ribosomal protein S6 kinase alpha-6","1","6G76"
"6G77",,"X-RAY DIFFRACTION",2.71,54.56,"VAPOR DIFFUSION, SITTING DROP",8,"20 % PEG 6000, 0.1 M TRIS pH8, 2 mM Zinc chloride",291,"10.1126/scitranslmed.aba4627",,"6G77",72.62,"2.499","2.499","RSK4 N-terminal Kinase Domain in complex with AMP-PNP","GPLGSDEGVVKEIPITHHVKEGYEKADPAQFELLKVLGQGSFGKVFLVRKKTGPDAGQLYAMKVLKKASLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDVFTRLSKEVLFTEEDVKFYLAELALALDHLHQLGIVYRDLKPENILLDEIGHIKLTDFGLSKESVDQEKKAYSFCGTVEYMAPEVVNRRGHSQSADWWSYGVLMFEMLTGTLPFQGKDRNETMNMILKAKLGMPQFLSAEAQSLLRMLFKRNPANRLGSEGVEEIKRHLFFANIDWDKLYKREVQPPFKP","Homo sapiens","RPS6KA6, RSK4","Ribosomal protein S6 kinase alpha-6","1","6G77"
"6G78",,"X-RAY DIFFRACTION",2.95,58.25,"VAPOR DIFFUSION, SITTING DROP",8,"20 % PEG 6000, 0.1 M TRIS pH8, 2 mM Zinc chloride",291,"10.1126/scitranslmed.aba4627",,"6G78",71.56,"2.5","2.5","RSK4 N-terminal Kinase Domain S232E in complex with AMP-PNP","GPLGSDEGVVKEIPITHHVKEGYEKADPAQFELLKVLGQGSFGKVFLVRKKTGPDAGQLYAMKVLKKASLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDVFTRLSKEVLFTEEDVKFYLAELALALDHLHQLGIVYRDLKPENILLDEIGHIKLTDFGLSKESVDQEKKAYEFCGTVEYMAPEVVNRRGHSQSADWWSYGVLMFEMLTGTLPFQGKDRNETMNMILKAKLGMPQFLSAEAQSLLRMLFKRNPANRLGSEGVEEIKRHLFFANIDWDKLYKREVQPPFKP","Homo sapiens","RPS6KA6, RSK4","Ribosomal protein S6 kinase alpha-6","1","6G78"
"6G7A",,"X-RAY DIFFRACTION",2.06,39.9,"VAPOR DIFFUSION, SITTING DROP",7.2,"Crystallization buffer: 0.1M ammonium citrate (pH 7.2), 0.2 M ammonium sulfate and 26% PEG4000",291,"10.1016/j.ejmech.2018.06.059","EOQ","6G7A",122.21,"1.42","1.42","Crystal structure of human carbonic anhydrase isozyme XII 2-(benzylamino)-4-chloro-N-(2-hydroxyethyl)-5-sulfamoyl-benzamide","MSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQ","Homo sapiens","CA12","Carbonic anhydrase 12","1","6G7A"
"6G7W",,"X-RAY DIFFRACTION",2.14,42.62,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M Li2SO4, 0.1 M BisTris pH 5.5, 25% w/v PEG 3350",295,"10.1371/journal.pone.0202391",,"6G7W",39.11,"1.746","1.746","Crystal structure of NHL repeat containing domain of human NHLRC2","MHHHHHHMSPLLFPGKVTVDQVTDRLVIADTGHHRILVVWKNGQIQYSIGGPNPGRKDGIFSESTFNSPQGVAIMNNIIYVADTENHLIRKIDLEAEKVSTVAGIGIQGTDKEGGAKGEQQPISSPWDVVFGTSGSEVQRGDILWIAMAGTHQIWALLLDSGKLPKKNELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVADSESSTVRTVSLKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGVTWDKKRNLLYVADSYNHKIKVVDPKTKNCTTLAGTGDTNNVTSSSFTESTFNEPGGLCIGENGELLYVADTNNHQIKVMDLETKMVSVLPIF","Homo sapiens","NHLRC2","NHL repeat-containing protein 2","1","6G7W"
"6G82",,"X-RAY DIFFRACTION",4.23,70.96,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bis-Tris Propane pH 6.5, 0.2M Sodium bromide and 20% PEG 3350.",291,"10.1093/molbev/msz298",,"6G82",39.65,"2.401","2.401","Serum paraoxonase-1 by directed evolution with the L69S/H115W/F222S mutations","MAKLTALTLLGMGLALFDRQKSSFQTRFNVHREVTPVELPNCNLVKGIDNGSEDLEILPNGLAFISSGSKYPGIMSFDPDKSGKILLMDLNEKEPAVSELEIIGNTLDISSFNPWGISTFIDDDNTVYLLVVNHPGSSSTVEVFKFQEEEKSLLHLKTIRHKLLPSVNDIVAVGPEHFYATNDHYFIDPYLKSWEMHLGLAWSFVTYYSPNDVRVVAEGFDSANGINISPDGKYVYIAELLAHKIHVYEKHANWTLTPLRVLSFDTLVDNISVDPVTGDLWVGCHPNGMRIFFYDAENPPGSEVLRIQDILSEEPKVTVVYAENGTVLQGSTVAAVYKGKLLIGTVFHKALYCDL","Homo sapiens",,"Serum paraoxonase-1 by directed evolution with the L69S/H115W/F222S mutations","1","6G82"
"6G8F",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl (pH 8.5), Li2 SO4 (0.15-0.25 M), PEG 3350 (20-25% w/v)",277,"10.1021/acs.jcim.8b00539","K0I","6G8F",61.12,"2.043","2.043","Crystal structure of UTX complexed with GSK-J1","GPGYQDPNSQIIPSMSVSIYPSSAEVLKACRNLGKNGLSNSSILLDKCPPPRPPSSPYPPLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPNNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWHCESNRSHTTIAKYAQYQASSFQESLREENEKRSHHKDHSDSESTSSDNSGRRRKGPFKTIKFGTNIDLSDDKKWKLQLHELTKLPAFVRVVSAGNLLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEGYWGVLNDFCEKNNLNFLMGSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAIGWCNNIAWNVGPLTACQYKLAVERYEWNKLQSVKSIVPMVHLSWNMARNIKVSDPKLFEMIKYCLLRTLKQCQTLREALIAAGKEIIWHGRTKEEPAHYCSICEVEVFDLLFVTNESNSRKTYIVHCQDCARKTSGNLENFVVLEQYKMEDLMQVYDQFTLAPPLPSASS","Homo sapiens","KDM6A, UTX","Lysine-specific demethylase 6A","1","6G8F"
"6G8T",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, SITTING DROP",,"24% PEG1500, 20% glycerol",293.15,,,"6G8T",13.11,"2.67","2.67","Crystal Structures of the Single PDZ Domains from GRASP65 and their Interaction with the Golgin GM130","MGLGVSAEQPAGGAEGFHLHGVQENSPAQQAGLEPYFDFIITIGHSRLNKENDTLKALLKANVEKPVKLEVFNMKTMRVREVEVVPSNMWGGQGLLGASVRFCSFRRASEQVWHVLDV","Homo sapiens","GORASP1, GOLPH5, GRASP65","Golgi reassembly-stacking protein 1","1","6G8T"
"6G8W",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, SITTING DROP",,"1.4M Na/K phosphate pH 8.2",293.15,,,"6G8W",21.48,"2.12","2.12","Crystal Structures of the Single PDZ Domains from GRASP65 and their Interaction with the Golgin GM130","ASEQVWHVLDVEPSSPAALAGLRPYTDYVVGSDQILQESEDFFTLIESHEGKPLKLMVYNSKSDSCREVTVTPNAAWGGEGSLGCGIGYGYLHRIPT","Homo sapiens","GORASP1, GOLPH5, GRASP65","Golgi reassembly-stacking protein 1","1","6G8W"
"6G8X",,"X-RAY DIFFRACTION",2.32,46.87,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.1M HEPES/NaOHpH=7.2, 34.0%w/v MPEG 2000, 0.02M Mercaptoethanol, 0.2M (NH4)2SO4",293,"10.1021/acs.jmedchem.8b00421",,"6G8X",43.08,"1.76","1.76","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G8X"
"6G91",,"X-RAY DIFFRACTION",2.31,46.71,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.1M HEPES/NaOHpH=7.2, 34.0%w/v MPEG 2000, 0.02M Mercaptoethanol, 0.2M (NH4)2SO4",293,"10.1021/acs.jmedchem.8b00421","EQW","6G91",42.96,"1.8","1.8","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G91"
"6G92",,"X-RAY DIFFRACTION",2.32,46.91,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4, 0.1M HEPES/NaOHpH=7.2, 34.0%w/v MPEG 2000, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","ERZ","6G92",43.04,"1.99","1.99","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G92"
"6G93",,"X-RAY DIFFRACTION",2.31,46.84,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.1M HEPES/NaOHpH=7.2, 34.0%w/v MPEG 2000, 0.02M Mercaptoethanol, 0.2M (NH4)2SO4",293,"10.1021/acs.jmedchem.8b00421","EU2","6G93",43.38,"1.67","1.67","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G93"
"6G97",,"X-RAY DIFFRACTION",2.31,46.77,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","EQZ","6G97",43.53,"1.9","1.9","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G97"
"6G98",,"X-RAY DIFFRACTION",3.43,64.14,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100%  DIMETHYL SULFOXIDE)",294,"10.18632/oncotarget.25508","ER5","6G98",115.24,"2.47","2.47","Three dimensional structure of human carbonic anhydrase IX in complex with sulfonamide","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6G98"
"6G9A",,"X-RAY DIFFRACTION",2.3,46.53,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","ESQ","6G9A",43.3,"1.91","1.91","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G9A"
"6G9D",,"X-RAY DIFFRACTION",2.3,46.59,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","ER8","6G9D",43.49,"1.8","1.8","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G9D"
"6G9H",,"X-RAY DIFFRACTION",2.32,46.97,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","ERW","6G9H",43.41,"1.73","1.73","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G9H"
"6G9J",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.3M (NH4)2SO4, 32.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","ERK","6G9J",43.4,"1.98","1.98","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G9J"
"6G9K",,"X-RAY DIFFRACTION",2.27,45.88,"VAPOR DIFFUSION, SITTING DROP",7.2,"2M (NH4)2SO4
34% MPEG 2000
.02M Mercaptoethanol
.1M pH=7.2 HEPES/NaOH",293,"10.1021/acs.jmedchem.8b00421",,"6G9K",43.44,"1.94","1.94","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G9K"
"6G9M",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, SITTING DROP",7.2,"2M (NH4)2SO4
32% MPEG 2000
.02M Mercaptoethanol
.1M pH=7.2 HEPES/NaOH",293,"10.1021/acs.jmedchem.8b00421","ESW","6G9M",43.36,"1.86","1.86","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G9M"
"6G9N",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, SITTING DROP",7.2,"2M (NH4)2SO4
34% MPEG 2000
.02M Mercaptoethanol
.1M pH=7.2 HEPES/NaOH",293,"10.1021/acs.jmedchem.8b00421","ESN","6G9N",43.68,"1.76","1.76","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6G9N"
"6G9U",,"X-RAY DIFFRACTION",3.43,64.14,"VAPOR DIFFUSION, SITTING DROP",4.5,"1.0 M DI-AMMONIUM HYDROGEN PHOSPHATE, 0.1 M SODIUM ACETATE PH 4.5, PROTEIN 10 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100%  DIMETHYL SULFOXIDE)",294,"10.18632/oncotarget.25508","ETK","6G9U",115.02,"1.75","1.75","Three dimensional structure of human carbonic anhydrase IX in complex with sulfonamide","GPDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFSPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFP","Homo sapiens","CA9, G250, MN","Carbonic anhydrase 9","1","6G9U"
"6G9Z",,"X-RAY DIFFRACTION",2.55,51.72,"VAPOR DIFFUSION, HANGING DROP",7,"25% PEG 1500, 0.1 M MMT Buffer pH 7.0",281,,,"6G9Z",27.78,"1.43","1.43","Crystal structure of human histidine triad nucleotide-binding protein 1 (hHINT1) crystallized at P212121 space group, with visible extended fragment of N-terminus","MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","6G9Z"
"6GBI",,"X-RAY DIFFRACTION",2.81,56.24,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 Tris-HCl
2M Ammonium Sulphate",300,"10.1002/1873-3468.13212",,"6GBI",12.31,"1.25","1.25","Wnt signalling","ETGFKCFTCEKAADNYECNRWAPDIYCPRETRYCYTQHTMEVTGNSISVTKRCVPLEECLSTGCRDSEHEGHKVCTSCCEGNICNLPLPRNETDATFAGTLEVL","Homo sapiens","LYPD6, UNQ3023/PRO9821","Ly6/PLAUR domain-containing protein 6","1","6GBI"
"6GBT",,"X-RAY DIFFRACTION",2.46,50.06,"VAPOR DIFFUSION, SITTING DROP",7,"PEG6000 50% W/V
HEPES 0.1M
DMSO 5%",291.15,,"F45","6GBT",29.39,"2.1","2.1","17beta-hydroxysteroid dehydrogenase type 14 Mutant Y253A in complex with a non-steroidal inhibitor","MATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGAKASRSTPVDAPDIPS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6GBT"
"6GBX",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, 0.4 M ammonium sulfate, 0.07 M sodium chloride",277.15,"10.1007/s00775-018-1605-1","S77","6GBX",115.21,"1.72","1.72","Crystal structure of human glutaminyl cyclase variant Y115E-Y117E in complex with SEN177","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPEGERSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","6GBX"
"6GC1",,"X-RAY DIFFRACTION",2.37,48.04,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M BisTris Propane pH 6.5, 0.2 M K/Na Tartrate, 18% PEG 3350",295,"10.1371/journal.pone.0202391",,"6GC1",255.22,"2.7","2.7","Crystal structure of Trx-like and NHL repeat containing domains of human NHLRC2","MHHHHHHMAAPGGRGRSLSGLLPAQTSLEYALLDAVTQQEKDSLVYQYLQKVDGWEQDLSVPEFPEGLEWLNTEEPISVYKDLCGKIVVLDFFTYCCINCIHLLPDLHALEHTYSDKDGLLIIGVHSAKFPNEKVLDNIKSAVLRYNITHPMVNDADASLWQELEVSCWPTLVILGPRGNMLFSLIGEGHKDKLFLYTSIALKYYKDRGQIRDNKIGIKLYKDSLPPSPLLFPGKVTVDQVTDRLVIADTGHHRILVVWKNGQIQYSIGGPNPGRKDGIFSESTFNSPQGVAIMNNIIYVADTENHLIRKIDLEAEKVSTVAGIGIQGTDKEGGAKGEQQPISSPWDVVFGTSGSEVQRGDILWIAMAGTHQIWALLLDSGKLPKKNELTKGTCLRFAGSGNEENRNNAYPHKAGFAQPSGLSLASEDPWSCLFVADSESSTVRTVSLKDGAVKHLVGGERDPMNLFAFGDVDGVGINAKLQHPLGVTWDKKRNLLYVADSYNHKIKVVDPKTKNCTTLAGTGDTNNVTSSSFTESTFNEPGGLCIGENGELLYVADTNNHQIKVMDLETKMVSVLPIF","Homo sapiens","NHLRC2","NHL repeat-containing protein 2","1","6GC1"
"6GC2",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, SITTING DROP",,"0.2M Mg formate 2H2O
0.1M Na acetate 3H2O
18% PEG MME 5000",293,"10.1371/journal.pcbi.1007207",,"6GC2",51.74,"2.55","2.55","AbLIFT: Antibody stability and affinity optimization by computational design of the variable light-heavy chain interface","MGWSCIILFLVATATGVHSDIELTQSPATLSVTPGDSVSLSCRASQSISNNLHWYQQKSHEPPRLLIKYVSQSVSGIPSRFSGSGSGTDFTLSINSVETEDFGMYFCGQSNSWPRTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECMGWSCIILFLVATATGVHC","Homo sapiens",,"Light Chain","1","6GC2"
,,,,,,,,,,,,,,,,"QVQLQESGAEVMKPGASVKISCKATGYTFSTYWIEWMKQRPGGGLEYIGEILPGSGSTYYNEKFKGKATFTADTSSNTAYMQLSSLTSEDSAVYYCARGDGYYKYWGQGTTLTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDQTHHHHH","Homo sapiens",,"Heavy chain","2","6GC2"
"6GCT","3.85","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0076-y",,"6GCT",170.36,"3.85",,"cryo-EM structure of the human neutral amino acid transporter ASCT2","MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVVAVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLDPGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEVLDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIVFGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFARLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLMMKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVTATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSCTVLNVEGDALGAGLLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESVM","Homo sapiens","SLC1A5, ASCT2, M7V1, RDR, RDRC","Neutral amino acid transporter B(0)","1","6GCT"
"6GCY",,"X-RAY DIFFRACTION, NEUTRON DIFFRACTION",2.16,43.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.2 M sodium citrate, 0.1 M Tris pH 8.5 in Hampton sandwich box set-ups. Drops were 150-250 uL and we set-up in a 1:1 ratio. To get the complex with SGC ligand we did ""dry co-crystallization"".",293,"10.1016/j.jsb.2018.12.009","3QR","6GCY",29.71,"1.3, 2","1.3, 2","Joint neutron and x-ray crystal structure of human carbonic anhydrase IX mimic (saccharin-sugar conjugate complex)","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6GCY"
"6GDC",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION",7.8,"Ammoniumsulfate 2.70 M, pH=7.8, saturated with para-Chloromercurybenzoic acid",291,"10.1021/acschembio.9b00895","FB2","6GDC",31.07,"1.079","1.079","Human Carbonic Anhydrase II in complex with Benzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6GDC"
"6GDH",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION, HANGING DROP",6.5,"25 mM potassium chloride, 10 mM potassium cacodylate 50mM for magnesium chloride, 20mM for calcium chloride, MPD 32% to 38%",285,"10.1021/jacs.8b08699",,"6GDH",24.35,"2.85","2.85","Holliday Junctions formed from Telomeric DNA","CTAACCCTAA","Homo sapiens",,"DNA (5'-D(*CP*TP*AP*AP*CP*CP*CP*TP*AP*A)-3')","1","6GDH"
,,,,,,,,,,,,,,,,"TTAGGGTTAG","Homo sapiens",,"DNA (5'-D(*TP*TP*AP*GP*GP*GP*TP*TP*AP*G)-3')","2","6GDH"
"6GDK",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1808733115",,"6GDK",16.85,,,"Calcium bound form of human calmodulin mutant F141L","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEELVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin-1","1","6GDK"
"6GDL",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1808733115",,"6GDL",16.69,,,"Calmodulin mutant - F141L apo-form Unstructured C-domain","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEELVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1","Calmodulin-1","1","6GDL"
"6GDM",,"X-RAY DIFFRACTION",2.3,46.54,"VAPOR DIFFUSION, SITTING DROP",7.2,"35.0%w/v MPEG 2000, 0.2M (NH4)2SO4, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","F3Z","6GDM",43.64,"1.91","1.91","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6GDM"
"6GDN",,"X-RAY DIFFRACTION",2.75,55.28,"VAPOR DIFFUSION, HANGING DROP",6,"0.04 M Magnesium acetate tetrahydrate, 0.05 M Sodium cacodylate trihydrate, 30% v/v (+/-)-2-Methyl-2,4-pentanediol.",297,"10.1021/jacs.8b08699",,"6GDN",25.86,"3","3","Holliday Junctions formed from Telomeric DNA","GGTTAGGGTTCTTGAACCCTTGGGTTACTTGTAACCCTAACC","Homo sapiens",,"Telomere DNA (42-MER)","1","6GDN"
"6GDQ",,"X-RAY DIFFRACTION",2.31,46.73,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4, 33.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","EVK","6GDQ",43.54,"1.86","1.86","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6GDQ"
"6GDS",,"X-RAY DIFFRACTION",2.42,49.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"25 mM Potassium Chloride, 10 mM Potassium Cacodylate, 50mM Magnesium Chloride, 20mM Calcium Chloride, 35% v/v (+/-)-2-Methyl-2,4-Pentanediol.",285,"10.1021/jacs.8b08699",,"6GDS",12.18,"2.95","2.95","Holliday Junctions formed from Telomeric DNA","CTAACCCTAA","Homo sapiens",,"Telomeric DNA (5' CTAACCCTAA) 10mer","1","6GDS"
,,,,,,,,,,,,,,,,"TTAGGGTTAG","Homo sapiens",,"Telomeric DNA (5'-TTAGGGTTAG)-3') 10mer","2","6GDS"
"6GDY",,"X-RAY DIFFRACTION",2.65,47.6,"VAPOR DIFFUSION, SITTING DROP",7.8,"0.1M HEPES pH 7.8, 0.7M NaH2PO4, 0.9M KH2PO4, 3% glycerol",293,"10.1074/jbc.RA119.008693","AKG","6GDY",82.62,"2.04","2.04","Crystal structure of 2OG oxygenase JMJD6 (aa 1-343) in complex with Fe(II) and 2OG","MNHKSKKRIREAKRSARPELKDSLDWTRHNYYESFSLSPAAVADNVERADALQLSVEEFVERYERPYKPVVLLNAQEGWSAQEKWTLERLKRKYRNQKFKCGEDNDGYSVKMKMKYYIEYMESTRDDSPLYIFDSSYGEHPKRRKLLEDYKVPKFFTDDLFQYAGEKRRPPYRWFVMGPPRSGTGIHIDPLGTSAWNALVQGHKRWCLFPTSTPRELIKVTRDEGGNQQDEAITWFNVIYPRTQLPTWPPEFKPLEILQKPGETVFVPGGWWHVVLNLDTTIAITQNFASSTNFPVVWHKTVRGRPKLSRKWYRILKQEHPELAVLADSVDLQESTGIASDSS","Homo sapiens","JMJD6, KIAA0585, PTDSR, PSR","Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6","1","6GDY"
"6GE0",,"X-RAY DIFFRACTION",2.31,46.86,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.2M (NH4)2SO4, 33.0%w/v MPEG 2000, 0.1M HEPES/NaOHpH=7.2, 0.02M Mercaptoethanol",293,"10.1021/acs.jmedchem.8b00421","EVQ","6GE0",43.59,"1.82","1.82","Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6GE0"
"6GES",,"X-RAY DIFFRACTION",2.18,43.69,"VAPOR DIFFUSION, SITTING DROP",7.5,"34% PEG 4k, 0.2M Li2SO4, 0.1M tris 7.5",277.14,"10.1016/j.chembiol.2019.02.021","EWH","6GES",88.45,"2.07","2.07","Crystal structure of ERK1 covalently bound to SM1-71","SMAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP","Homo sapiens","MAPK3, ERK1, PRKM3","Mitogen-activated protein kinase 3","1","6GES"
"6GEU",,"X-RAY DIFFRACTION",2.58,52.24,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M MES, 20% PEG 3350",293,"10.1021/jacs.8b09061",,"6GEU",33.77,"1.55","1.55","Crystal structure of the C230A mutant of human IBA57","TAGAAWACFRLDGRTLLRVRGPDAAPFLLGLLTNELPLPSPAAAGAPPAARAGYAHFLNVQGRTLYDVILYGLQEHSEVSGFLLECDSSVQGALQKHLALYRIRRKVTVEPHPELRVWAVLPSSPEACGAASLQERAGAAAILIRDPRTARMGWRLLTQDEGPALVPGGRLGDLWDYHQHRYLQGVPEGVRDLPPGVALPLESNLAFMNGVSFTKGAYIGQELTARTHHMGVIRKRLFPVRFLDPLPTSGITPGATVLTASGQTVGKFRAGQGNVGLALLWSEKIKGPLHIRASEGAQVALAASVPDWWPTVSK","Homo sapiens","IBA57, C1orf69","Putative transferase CAF17, mitochondrial","1","6GEU"
"6GF1",,"X-RAY DIFFRACTION",3.89,68.36,"VAPOR DIFFUSION, SITTING DROP",5,"3.2 M Ammonium sulfate, 0.1 M Citric acid",293.15,"10.1038/s41467-018-05776-3",,"6GF1",28.88,"1.925","1.925","The structure of the ubiquitin-like modifier FAT10 reveals a novel targeting mechanism for degradation by the 26S proteasome","GASTLTVHVRSEEWDLMTFDANPYDSVKKIKEHVRSKTKVPVQDQVLLLGSKILKPRRSLSSYGIDKEKTIHLTLKVVKPSDE","Homo sapiens","UBD, FAT10","Ubiquitin D","1","6GF1"
"6GF2",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-05776-3",,"6GF2",9.26,,,"The structure of the ubiquitin-like modifier FAT10 reveals a novel targeting mechanism for degradation by the 26S proteasome","GAMGDEELPLFLVESGDEAKRHLLQVRRSSSVAQVKAMIETKTGIIPETQIVTLNGKRLEDGKMMADYGIRKGNLLFLASYSIGG","Homo sapiens","UBD, FAT10","Ubiquitin D","1","6GF2"
"6GFA",,"X-RAY DIFFRACTION",2.97,58.62,"VAPOR DIFFUSION, HANGING DROP",8,"NBDHSP110 at 4 mg/ml, 30% (w/v) PEG4000, Tris 100 mM, pH 8.5, MgCl2 0.2 M",298,"10.1038/s41418-019-0343-4",,"6GFA",42.75,"2","2","Structure of Nucleotide binding domain of HSP110, ATP and Mg2+ complexed","MSVVGLDVGSQSCYIAVARAGGIETIANEFSDRCTPSVISFGSKNRTIGVAAKNQQITHANNTVSNFKRFHGRAFNDPFIQKEKENLSYDLVPLKNGGVGIKVMYMGEEHLFSVEQITAMLLTKLKETAENSLKKPVTDCVISVPSFFTDAERRSVLDAAQIVGLNCLRLMNDMTAVALNYGIYKQDLPSLDEKPRIVVFVDMGHSAFQVSACAFNKGKLKVLGTAFDPFLGGKNFDEKLVEHFCAEFKTKYKLDAKSKIRALLRLYQECEKLKKLMSSNSTDLPLNIECFMNDKDVSGKMNRSQFEELCAELLQKIEVPLYSLLEQTHLKVEDVSAVEIVGGATRIPAVKERIAKFFGKDISTTLNADEAVARGCALQCS","Homo sapiens","HSPH1, HSP105, HSP110, KIAA0201","Heat shock protein 105 kDa","1","6GFA"
"6GFB",,"X-RAY DIFFRACTION",2.08,40.95,"VAPOR DIFFUSION, HANGING DROP",6.8,"9% PEG 8000
0.2M zinc acetate
0.1M imidazole pH 6.8",293,"10.1128/JVI.00226-18",,"6GFB",36.37,"2.08","2.08","Structure of the BTB/POZ domain of human 90K","RSTNETRSTHTLDLSRELSEALGQIFDSQRGCDLSISVNVQGEDALGFCGHTVILTANLEAQALWKEPGSNVTMSVDAECVPMVRDLLRYFYSRRIDITLSSVKCFHKLASAYGARQLQGYCASLFAILSRDDDDKAGWSHPQFEKGGGSGGGSGGGSWSHPQFEK","Homo sapiens","LGALS3BP, M2BP","Galectin-3-binding protein","1","6GFB"
"6GFE",,"X-RAY DIFFRACTION",3.04,59.54,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 % PEG 8000, 0.2 M Calcium acetate, 0.1 M imidazole",293,"10.1016/j.bpj.2019.03.036",,"6GFE",149.27,"1.8","1.8","High-resolution Structure of a therapeutic full-length anti-NPRA Antibody with exceptional Conformational Diversity","QVELQQSGPGLVKPSQTLSLTCAISGDSVSSRSASWSWIRQSPGRGLEWLGRTYYRSHWYYEYAQSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARMDVPSFRYFDVWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPPCPPCPAPEFLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK","Homo sapiens",,"Immunoglobulin gamma-4 heavy chain","1","6GFE"
,,,,,,,,,,,,,,,,"DIVLTQSPATLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASNRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQISNSPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Immunoglobulin gamma-4 light chain","2","6GFE"
"6GFK",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, HANGING DROP",5.6,"1.7M Ammonium Sulfate, 0.2M K/Na Tartrate, 0.1M Na Citrate",293,"10.1016/j.molcel.2018.08.004",,"6GFK",87.65,"2.3","2.3","delta-N METTL16 MTase domain","RVSLNFKDPEAVRALTCTLLREDFGLSIDIPLERLIPTVPLRLNYIHWVEDLIGHQDSDKSTLRRGIDIGTGASCIYPLLGATLNGWYFLATEVDDMCFNYAKKNVEQNNLSDLIKVVKVPQKTLLMDALKEESEIIYDFCMCNPPFFANQLEAKGVNSRNPRRPPPSSVNTGGITEIMAEGGELEFVKRIIHDSLQLKKRLRWYSCMLGKKCSLAPLKEELRIQGVPKVTYTEFCQGRTMRWALAWSFYD","Homo sapiens","METTL16, METT10D","U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase","1","6GFK"
"6GFN",,"X-RAY DIFFRACTION",2.9,57.6,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M di-sodium tartrate and 20% (w/v) PEG 3350",293,"10.1016/j.molcel.2018.08.004",,"6GFN",33.73,"2.86","2.86","METTL16 MTase domain","MALSKSMHARNRYKDKPPDFAYLASKYPDFKQHVQINLNGRVSLNFKDPEAVRALTCTLLREDFGLSIDIPLERLIPTVPLRLNYIHWVEDLIGHQDSDKSTLRRGIDIGTGASCIYPLLGATLNGWYFLATEVDDMCFNYAKKNVEQNNLSDLIKVVKVPQKTLLMDALKEESEIIYDFCMCNPPFFANQLEAKGVNSRNPRRPPPSSVNTGGITEIMAEGGELEFVKRIIHDSLQLKKRLRWYSCMLGKKCSLAPLKEELRIQGVPKVTYTEFCQGRTMRWALAWSFYD","Homo sapiens","METTL16, METT10D","U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase","1","6GFN"
"6GG1",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, SITTING DROP",6,"20% PEG8000, 0.2M CaCl2, 0.1M MES",293,"10.1111/febs.14945",,"6GG1",18.32,"1.3","1.3","Structure of PROSS-edited human interleukin 24","AFHFGPCRVEGVVPQELWEAFWAVRDTLQAQDNITDVRLLRAEVLQNVSDAESCYLVHQLLRFYLDTVFKNYHNKTAELRTLKSFSTLANNFVLIVSDLQPCQEQNMCSSREEAHRRFLQFQRAFEQLDVEAAATKALGEIDILLRWMQKFYQL","Homo sapiens","IL24, MDA7, ST16","Interleukin-24","1","6GG1"
"6GG3",,"X-RAY DIFFRACTION",2.7,54.41,"VAPOR DIFFUSION, HANGING DROP",,"10-16% PEG 3350, 100 mM sodium Cacodylate, 50 mM MgCl2, 100 mM KCl",290,"10.1042/BCJ20180171",,"6GG3",724.38,"3.72","3.72","Crystal structure of M2 PYK in complex with Alanine.","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6GG3"
"6GG4",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, HANGING DROP",,"10-16% PEG 3350, 100 mM sodium Cacodylate, 50 mM MgCl2, 100 mM KCl,",290,"10.1042/BCJ20180171",,"6GG4",242.39,"2.46","2.46","Crystal structure of M2 PYK in complex with Phenyalanine.","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6GG4"
"6GG5",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",,"10-16% PEG 3350, 100 mM sodium Cacodylate, 50 mM MgCl2, 100 mM KCl",290,"10.1042/BCJ20180171",,"6GG5",242.55,"3.2","3.2","Crystal structure of M2 PYK in complex with Tryptophan.","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6GG5"
"6GG6",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, HANGING DROP",,"10-16% PEG 3350, 100 mM sodium Cacodylate, 50 mM MgCl2, 100 mM KCl",290,"10.1042/BCJ20180171",,"6GG6",483.74,"2.96","2.96","Crystal structure of M2 PYK in complex with Serine.","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","Pyruvate kinase PKM","1","6GG6"
"6GGA",,"X-RAY DIFFRACTION",2.73,54.97,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT. Soaking buffer: Saturated solution of compound in 100 mm HEPES, ph 7.2, 10 mM sodium phosphate, ph 7.2, 19% (w/v) polyethylene glycol 4000, 20 % (v/v) glycerol, 150 mm KCl.",293,"10.4155/fmc-2019-0181",,"6GGA",49.83,"1.55000123008","1.55000123008","p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9284","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6GGA"
"6GGB",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT. Soaking buffer: Saturated solution of compound in 100 mm HEPES, ph 7.2, 10 mM sodium phosphate, ph 7.2, 19% (w/v) polyethylene glycol 4000, 20 % (v/v) glycerol, 150 mm KCl.",293,"10.4155/fmc-2019-0181",,"6GGB",50.26,"1.32","1.32","p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9318","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6GGB"
"6GGC",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT. Soaking buffer: Saturated solution of compound in 100 mm HEPES, ph 7.2, 10 mM sodium phosphate, ph 7.2, 19% (w/v) polyethylene glycol 4000, 20 % (v/v) glycerol, 150 mm KCl.",293,"10.4155/fmc-2019-0181",,"6GGC",50.02,"1.24","1.24","p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9320","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6GGC"
"6GGD",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT. Soaking buffer: Saturated solution of compound in 100 mm HEPES, ph 7.2, 10 mM sodium phosphate, ph 7.2, 19% (w/v) polyethylene glycol 4000, 20 % (v/v) glycerol, 150 mm KCl.",293,"10.4155/fmc-2019-0181",,"6GGD",49.9,"1.4000088608","1.4000088608","p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9324","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6GGD"
"6GGE",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm KCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT. Soaking buffer: Saturated solution of compound in 100 mm HEPES, ph 7.2, 10 mM sodium phosphate, ph 7.2, 19% (w/v) polyethylene glycol 4000, 20 % (v/v) glycerol, 150 mm KCl.",293,"10.4155/fmc-2019-0181",,"6GGE",49.86,"1.25000506704","1.25000506704","p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9327","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6GGE"
"6GGF",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"Protein solution: 6 mg/ml protein in 25 mM sodium phosphate, ph 7.2, 150 mm NaCl, 5 mm DTT. Reservoir buffer: 100 mm HEPES, pH 7.2, 19% (w/v) polyethylene glycol 4000, 5 mm DTT. Soaking buffer: Saturated solution of compound in 100 mm HEPES, ph 7.2, 10 mM sodium phosphate, ph 7.2, 19% (w/v) polyethylene glycol 4000, 20 % (v/v) glycerol, 150 mm NaCl.",293,"10.4155/fmc-2019-0181",,"6GGF",49.96,"1.32000022323","1.32000022323","Structure of the p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9328","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","6GGF"
"6GGH",,"X-RAY DIFFRACTION",2.52,51.22,"VAPOR DIFFUSION, HANGING DROP",,"27% (m/v) PEG6000, 0.1 M MES/NaOH pH 6.0 and 5 mM DTT",278,,,"6GGH",68.36,"1.7","1.7","Human jak1 kinase domain in complex with inhibitor","TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","6GGH"
"6GGN",,"X-RAY DIFFRACTION",2.17,43.34,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.5M (NH4)2SO4, 0.1M NaCitrate",298,"10.1016/j.bmcl.2018.08.027","EYH","6GGN",11.74,"2","2","In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor","GSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","6GGN"
"6GGS","3.94","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-06451-3",,"6GGS",125.72,"3.94",,"Structure of RIP2 CARD filament","LQPGIAQQWIQSKREDIVNQMTEACLNQSLDALLSRDLIMKEDYELVSTKPTRTSKVRQLLDTTDIQGEEFAKVIVQKLKDNKQMGLQPYPEILVVSRSPSLNLLQNKSM","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","6GGS"
"6GH0",,"SOLUTION NMR",,,,,,,"10.1093/nar/gky1269",,"6GH0",6.94,,,"Two-quartet kit* G-quadruplex is formed via double-stranded pre-folded structure","GGCGAGGAGGGGCGTGGCCGGC","Homo sapiens",,"DNA (5'-D(*GP*GP*CP*GP*AP*GP*GP*AP*GP*GP*GP*GP*CP*GP*TP*GP*GP*CP*CP*GP*GP*C)-3')","1","6GH0"
"6GH9",,"X-RAY DIFFRACTION",2.22,44.61,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Hepes pH 7.0, 14% MPD",293.15,"10.1074/jbc.RA118.003857",,"6GH9",84.08,"2.09","2.09","USP15 catalytic domain in complex with small molecule","MEQPGLCGLSNLGNTCFMNSAIQCLSNTPPLTEYFLNDKYQEELNFDNPLGMRGEIAKSYAELIKQMWSGKFSYVTPRAFKTQVGRFAPQFSGYQQQDCQELLAFLLDGLHEDLNRIRKKPYIQLKDADGRPDKVVAEEAWENHLKRNDSIIVDIFHGLFKSTLVCPECAKISVTFDPFCYLTLPLASTSKVKLKDCIELFTTKEKLGAEDPWYCPNCKEHQQATKKLDLWSLPPVLVVHLKRFSYSRYMRDKLDTLVDFPINDLDMSEFLINPNAGPCRYNLIAVSNHYGGMGGGHYTAFAKNKDDGKWYYFDDSSVSTASEDQIVSKAAYVLFYQRQDTFSGTGFFPLDRETAAALEHHHHHH","Homo sapiens","USP15, KIAA0529","Ubiquitin carboxyl-terminal hydrolase 15","1","6GH9"
,,,,,,,,,,,,,,,,,"Homo sapiens","USP15, KIAA0529"
"6GHA",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris-Cl pH 8.5, 20% PEG 2000",293.15,"10.1074/jbc.RA118.003857",,"6GHA",41.81,"1.98","1.98","USP15 catalytic domain structure","MEQPGLCGLSNLGNTCFMNSAIQCLSNTPPLTEYFLNDKYQEELNFDNPLGMRGEIAKSYAELIKQMWSGKFSYVTPRAFKTQVGRFAPQFSGYQQQDCQELLAFLLDGLHEDLNRIRKKPYIQLKDADGRPDKVVAEEAWENHLKRNDSIIVDIFHGLFKSTLVCPECAKISVTFDPFCYLTLPLASTSKVKLKDCIELFTTKEKLGAEDPWYCPNCKEHQQATKKLDLWSLPPVLVVHLKRFSYSRYMRDKLDTLVDFPINDLDMSEFLINPNAGPCRYNLIAVSNHYGGMGGGHYTAFAKNKDDGKWYYFDDSSVSTASEDQIVSKAAYVLFYQRQDTFSGTGFFPLDRETAAALEHHHHHH","Homo sapiens","USP15, KIAA0529","Ubiquitin carboxyl-terminal hydrolase 15,Ubiquitin carboxyl-terminal hydrolase 15","1","6GHA"
,,,,,,,,,,,,,,,,,"Homo sapiens","USP15, KIAA0529"
"6GHG",,"X-RAY DIFFRACTION",3.01,59.09,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES, pH 6.5, 20% PEG2000MME",293,"10.1093/protein/gzy021",,"6GHG",93.01,"1.88","1.88","Variable heavy - variable light domain and Fab-arm CrossMabs with charged residue exchanges","EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGSGFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVEDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDEKVEPKSC","Homo sapiens",,"Fab heavy chain","1","6GHG"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGQGTKVEIKRTVAAPSVFIFPPSDKKLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab light chain","2","6GHG"
"6GHK",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION, SITTING DROP",5.5,"22.5% PEG 3350, 0.18M ammonium sulfate,  0.09M Bis-Tris",277,,,"6GHK",81.75,"2.28","2.28","Human PARP1 (ARTD1) - Catalytic domain in complex with inhibitor ME0527","MKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKAEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTAHHHHHH","Homo sapiens","PARP1, ADPRT, PPOL","Poly [ADP-ribose] polymerase 1","1","6GHK"
"6GHV",,"X-RAY DIFFRACTION",3.15,60.9,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3350, 200mM Mg(NO3)2, 100mM MES pH6. Protein sample: 150mM NaCl, 4mM CaCl2, 25mM Tris pH8, 2% DMSO, 3.25 mM ligand and 5.54mg/mL protein.",293,"10.1002/chem.201903391","EZ8","6GHV",112.19,"2.1","2.1","Structure of a DC-SIGN CRD in complex with high affinity glycomimetic.","ERLCHPCPWEWTFFQGNCYFMSNSQRNWHDSITACKEVGAQLVVIKSAEEQNFLQLQSSRSNRFTWMGLSDLNQEGTWQWVDGSPLLPSFKQYWNRGEPNNVGEEDCAEFSGNGWNDDKCNLAKFWICKKSAASCSRDEEQFLSPAPATPNPPPA","Homo sapiens","CD209, CLEC4L","CD209 antigen","1","6GHV"
"6GI6",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.5M ammonium sulfate, 0.1M sodium chloride, 0.1M bis-tris pH 6.5",277,"10.1021/acs.jmedchem.8b00782","EZB","6GI6",35.83,"1.98","1.98","Crystal structure of the ACVR1 (ALK2) kinase in complex with a Quinazolinone based ALK2 inhibitor with a 5-methyl core.","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6GI6"
"6GID",,"X-RAY DIFFRACTION",2.35,47.71,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M potassium nitrate and 20% (w/v) PEG3350",291,"10.1016/j.jsb.2018.06.004",,"6GID",81.48,"1.9","1.9","High resolution crystal structure of substrate-free human neprilysin","GICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW","Homo sapiens","MME, EPN","Neprilysin","1","6GID"
"6GIH",,"X-RAY DIFFRACTION",2.04,39.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"112.5mM Mes pH 6.5, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1016/j.bmc.2018.05.011","EZN","6GIH",39.41,"1.96","1.96","Crystal Structure of CK2alpha with CAM187 bound","SGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVAAAKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6GIH"
"6GIN",,"X-RAY DIFFRACTION",2.4,48.82,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.6M ammonium sulfate,12% glycerol, 0.1M tris pH 8.5",277,"10.1021/acs.jmedchem.8b00782","IR2","6GIN",70.77,"2.2","2.2","Crystal structure of the ACVR1 (ALK2) kinase in complex with an Quinazolinone based ALK2 inhibitor with a 4-morpholinophenyl solvent accessible group.","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6GIN"
"6GIP",,"X-RAY DIFFRACTION",2.61,53.1,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.5M ammonium sulfate, 0.1M tris pH 8.5, 4% glycerol",293,"10.1021/acs.jmedchem.8b00782","EUN","6GIP",35.35,"2.17","2.17","Crystal structure of the ACVR1 (ALK2) kinase in complex with a Quinazolinone based ALK2 inhibitor with a 2, 5-dimethyl core.","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","6GIP"
"6GIU",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, HANGING DROP",5.5,"Equal volumes (1uL) of the enzyme-inhibitor mix and reservoir solution (0.2 M MnSO4, 0.1 M MES pH 5.5, 25 % (w/v) PEG 4000) containing seeds (diluted 1:100 in reservoir solution) were mixed.",293,"10.1107/S2059798318010380","L69","6GIU",63.11,"1.39","1.39","Human IMPase with L-690330","MADPWQECMDYAVTLARQAGEVVCEAIKNEMNVMLKSSPVDLVTATDQKVEKMLISSIKEKYPSHSFIGEESVAAGEKSILTDNPTWIIDPIDGTTNFVHRFPFVAVSIGFAVNKKIEFGVVYSCVEGKMYTARKGKGAFCNGQKLQVSQQEDITKSLLVTELGSSRTPETVRMVLSNMEKLFCIPVHGIRSVGTAAVNMCLVATGGADAYYEMGIHCWDVAGAGIIVTEAGGVLMDVTGGPFDLMSRRVIAANNRILAERIAKEIQVIPLQRDDED","Homo sapiens","IMPA1, IMPA","Inositol monophosphatase 1","1","6GIU"
"6GJ0",,"X-RAY DIFFRACTION",2.63,53.19,"VAPOR DIFFUSION, SITTING DROP",5.5,"Equal volumes (1 uL) of the protein in storage buffer (20 mg/mL) and reservoir solution (0.12 M MnSO4, 0.1 M MES pH 5.5, 24 % (w/v) PEG 4000) were mixed.",293,"10.1107/S2059798318010380",,"6GJ0",61.65,"1.73","1.73","Human IMPase with Mn","MADPWQECMDYAVTLARQAGEVVCEAIKNEMNVMLKSSPVDLVTATDQKVEKMLISSIKEKYPSHSFIGEESVAAGEKSILTDNPTWIIDPIDGTTNFVHRFPFVAVSIGFAVNKKIEFGVVYSCVEGKMYTARKGKGAFCNGQKLQVSQQEDITKSLLVTELGSSRTPETVRMVLSNMEKLFCIPVHGIRSVGTAAVNMCLVATGGADAYYEMGIHCWDVAGAGIIVTEAGGVLMDVTGGPFDLMSRRVIAANNRILAERIAKEIQVIPLQRDDED","Homo sapiens","IMPA1, IMPA","Inositol monophosphatase 1","1","6GJ0"
"6GJ5",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG3350, 0.2 M potassium acetate",298,"10.1073/pnas.1904529116","F0N","6GJ5",40.47,"1.499","1.499","CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 15","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GJ5"
"6GJ6",,"X-RAY DIFFRACTION",2.61,52.88,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG3350, 0.2M ammonium nitrate",298,"10.1073/pnas.1904529116","EZZ","6GJ6",20.32,"1.761","1.761","CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 18","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GJ6"
"6GJ7",,"X-RAY DIFFRACTION",2.89,57.38,"VAPOR DIFFUSION, HANGING DROP",,"Molecular Dimensions Morpheus Screen with 30% Precipitant Mix1, 0.1M Morpheus buffer system 2 pH 7.5 and 10% nitrate phosphate sulfate mix",298,"10.1073/pnas.1904529116",,"6GJ7",20.44,"1.67","1.67","CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 22","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GJ7"
"6GJ8",,"X-RAY DIFFRACTION",2.87,57.1,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 0.2M ammonium sulfate and 0.1M bis-TRIS buffer at pH 6",298,"10.1073/pnas.1904529116",,"6GJ8",20.32,"1.65","1.65","CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH BI 2852","GMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GJ8"
"6GJB",,"X-RAY DIFFRACTION",2.29,46.4,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.2M ammonium sulphate, 34% MPEG2000, 0.1MHepes, pH7.3, 0.02M mercaptoethanol",293,"10.1039/c8sc02754d","F0H","6GJB",43.69,"1.82","1.82","Erk2 signalling protein","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6GJB"
"6GJD",,"X-RAY DIFFRACTION",2.31,46.68,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.1M Hepes,pH7.3, 0.2M ammonium sulphate, 34% MPEG200, 0.02Mmercaptoethanol",293,"10.1039/c8sc02754d","F0E","6GJD",44.31,"1.58","1.58","Erk2 signalling protein","MAHHHHHHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","6GJD"
"6GJI",,"X-RAY DIFFRACTION",2.82,56.36,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 8000, Tris-HCl",279.15,"10.1039/c8sc03831g",,"6GJI",18.47,"1.6","1.6","Cyclophilin A complexed with the tri-vector ligand 8.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GJI"
"6GJJ",,"X-RAY DIFFRACTION",2.86,57.03,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 8000, Tris-HCl",279.15,"10.1039/c8sc03831g",,"6GJJ",18.33,"1.38","1.38","Cyclophilin A complexed with tri-vector ligand 2.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GJJ"
"6GJL",,"X-RAY DIFFRACTION",2.86,57,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, Tris-HCl",279.15,"10.1039/c8sc03831g",,"6GJL",18.37,"1.16","1.16","Cyclophilin A complexed with tri-vector ligand 10.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GJL"
"6GJM",,"X-RAY DIFFRACTION",2.81,56.24,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 8000, Tris-HCl",279.15,"10.1039/c8sc03831g",,"6GJM",18.33,"1.354","1.354","Cyclophilin A complexed with tri-vector ligand 4.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GJM"
"6GJN",,"X-RAY DIFFRACTION",2.76,55.4,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, Tris-HCl",279.15,"10.1039/c8sc03831g",,"6GJN",18.75,"1.7","1.7","Cyclophilin A complexed with tri-vector ligand 15.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GJN"
"6GJO",,"X-RAY DIFFRACTION",3.01,59.15,"VAPOR DIFFUSION",8.1,"100 mM Tris Acetate pH 8.1, 125 mM NaCl, 15-20% PEG8K",277,,,"6GJO",92.98,"2.91","2.91","Crystal Structure of Glycogen Synthase Kinase-3 beta in Complex with BI-91BS","TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","6GJO"
"6GJP",,"X-RAY DIFFRACTION",2.82,56.38,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 8000, Tris-HCl",279.15,"10.1039/c8sc03831g",,"6GJP",18.34,"1.94","1.94","Cyclophilin A complexed with tri-vector ligand 7.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GJP"
"6GJR",,"X-RAY DIFFRACTION",2.75,55.22,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 8000, Tris-HCl",279.15,"10.1039/c8sc03831g",,"6GJR",18.38,"1.69","1.69","Cyclophilin A complexed with tri-vector ligand 9.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GJR"
"6GJW",,"X-RAY DIFFRACTION",2.02,39.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"8% PEG 8000, 0.1 M Tris pH 8.5",293,"10.1002/open.201900059","F2H","6GJW",51.43,"1.9","1.9","Structure of XIAP-BIR1 domain in complex with an NF023 analog","MGSSHHHHHHSSGLVPQGSHMKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAVGRHRKVSPNCRFINGFYLE","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","6GJW"
"6GJY",,"X-RAY DIFFRACTION",2.74,55.18,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, Tris-HCl",279.15,"10.1039/c8sc03831g",,"6GJY",18.33,"1.29","1.29","Cyclophilin A complexed with tri-vector ligand 5.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GJY"
"6GK0",,"X-RAY DIFFRACTION",3.64,66.25,"VAPOR DIFFUSION, SITTING DROP",4.8,"30% glycerol, 100 mM sodium acetate pH 4.8, 1.8 M Ammoniumsulphate, 40 mM DDAO, 6.4 mM C11DAO, 2 mM L-DHO, 1 mM Tenovin",293,"10.1074/jbc.RA119.012056",,"6GK0",41.98,"1.85","1.85","HUMAN DIHYDROOROTATE DEHYDROGENASE IN COMPLEX WITH CLASS III HISTONE DEACETYLASE INHIBITOR","MATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","6GK0"
"6GK3","3.975","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-06761-6",,"6GK3",61.08,"3.9, 3.975",,"Two protofilament beta-2-microglobulin amyloid fibril","FLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHV","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","6GK3"
"6GKQ",,"X-RAY DIFFRACTION",2.71,54.55,"IN CELL",,"Data was collected from ex vivo Charcot-Leyden crystals. Sticky allergic mucin type mucus was obtained from CRSwNP patients undergoing endoscopic sinus surgery. One g of the allergic mucin was cut thoroughly in 10 ml RPMI-1640 (Sigma-Aldrich) containing antibiotics (50 IU/mL penicillin and 50 mg/mL streptomycin; One g of the allergic mucin was cut thoroughly in 10 ml RPMI-1640 (Sigma-Aldrich) containing antibiotics (50 IU/mL penicillin and 50 mg/mL streptomycin; Thermo Fisher Scientific), 0.1 percent BSA (Sigma-Aldrich) and 1 mg/ml Collagen type 2 (Worthington), and further homogenized using a GentleMACS Dissociator (Myltenyi Biotec) and subsequently incubed at 37 degrees for 45 minutes under continuous rotation. After centrifugation the pellet was dissolved in 3 ml PBS containing antibiotics, to which 6 ml Ficoll-Paque (GE Healthcare) was added.  After centrifugation at 250g and removal of the supernatant and most of the Ficoll layer, the pellet was dissolved 1:10 in PBS with antibiotics. This precipitation process was repeated 5 more times. The final pellet containing the crystals was resuspended in PBS with antibiotics.",310,"10.1126/science.aaw4295",,"6GKQ",16.59,"2.3","2.3","X-ray structure determined from ex vivo Charcot-Leyden crystal","MSLLPVPYTEAASLSTGSTVTIKGRPLVCFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6GKQ"
"6GKS",,"X-RAY DIFFRACTION",2.68,54.07,"BATCH MODE",7.4,"Upon removal of the N-terminal His-tag by TEV protease, at a protease:target protein ratio of 1:100 (w/w), recombinant galectin-10 autocrystallized in PBS buffer.",298,"10.1126/science.aaw4295",,"6GKS",16.76,"1.38","1.38","X-ray structure determined from recombinant Charcot-Leyden crystal","GHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREYGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6GKS"
"6GKT",,"X-RAY DIFFRACTION",3,58.95,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M ammonium citrate pH 5.1
20% PEG 3350",298,"10.1126/science.aaw4295",,"6GKT",101.48,"2.1","2.1","X-ray structure of a non-autocrystallizing galectin-10 variant, Gal10-Tyr69Glu","GHMSLLPVPYTEAASLSTGSTVTIKGRPLACFLNEPYLQVDFHTEMKEESDIVFHFQVCFGRRVVMNSREEGAWKQQVESKNMPFQDGQEFELSISVLPDKYQVMVNGQSSYTFDHRIKPEAVKMVQVWRDISLTKFNVSYLKR","Homo sapiens","CLC, LGALS10, LGALS10A","Galectin-10","1","6GKT"
"6GL3",,"X-RAY DIFFRACTION",2.2,44.09,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M sodium citrate, 
22% (w/v) PEG3350,
10 mM Manganese(II)chloride",293,"10.1021/acs.jmedchem.8b00521","EMW","6GL3",88.39,"2.77","2.77","Crystal structure of human Phosphatidylinositol 4-kinase III beta (PI4KIIIbeta) in complex with ligand 44","GSSPVRLAPEREFIKSLMAIGKRLATLPTKEQKTQRLISELSLLNHKLPARVWLPTAGFDHHVVRVPHTQAVVLNSKDKAPYLIYVEVLECENFDTTSVPARIPENRIRSTRSDSGDGSALKEPWQEKVRRIREGSPYGHLPNWRLLSVIVKCGDDLRQELLAFQVLKQLQSIWEQERVPLWIKPYKILVISADSGMIEPVVNAVSIHQVKKQSQLSLLDYFLQEHGSYTTEAFLSAQRNFVQSCAGYCLVCYLLQVKDRHNGNILLDAEGHIIHIDFGFILSSSPRNLGFETSAFKLTTEFVDVMGGLDGDMFNYYKMLMLQGLIAARKHMDKVVQIVEIMQQGSQLPCFHGSSTIRNLKERFHMSMTEEQLQLLVEQMVDGSMR","Homo sapiens","PI4KB, PIK4CB","Phosphatidylinositol 4-kinase beta,Phosphatidylinositol 4-kinase beta","1","6GL3"
,,,,,,,,,,,,,,,,,"Homo sapiens","PI4KB, PIK4CB"
"6GL9",,"X-RAY DIFFRACTION",1.95,36.89,"VAPOR DIFFUSION, SITTING DROP",,"24-30% PEG 3350, 0.1 M MES, pH 5.5-6.0 and 0.1-0.2 M MgCl2",277.15,"10.1021/acs.jmedchem.8b00571","F3W","6GL9",68.83,"1.7","1.7","Crystal structure of JAK3 in complex with Compound 10 (FM475)","SMQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRALAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6GL9"
"6GLA",,"X-RAY DIFFRACTION",1.93,36.35,"VAPOR DIFFUSION, SITTING DROP",,"24-30% PEG 3350, 0.1 M MES, pH 5.5-6.0 and 0.1-0.2 M MgCl2",277.15,"10.1021/acs.jmedchem.8b00571","F4B","6GLA",68.32,"1.92","1.92","Crystal structure of JAK3 in complex with Compound 11 (FM481)","SMQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRALAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6GLA"
"6GLB",,"X-RAY DIFFRACTION",1.94,36.5,"VAPOR DIFFUSION, SITTING DROP",,"24-30% PEG 3350, 0.1 M MES, pH 5.5-6.0 and 0.1-0.2 M MgCl2",277.15,"10.1021/acs.jmedchem.8b00571","F48","6GLB",68.14,"2","2","Crystal structure of JAK3 in complex with Compound 20 (FM484)","SMQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRALAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","6GLB"
"6GLE",,"X-RAY DIFFRACTION",1.71,28.15,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5, 20% DMSO, 10 mM compound",293,,,"6GLE",21.37,"1.402","1.402","Crystal structure of hMTH1 in complex with TH scaffold 1 in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLE"
"6GLF",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5",293,,,"6GLF",21.03,"2","2","Crystal structure of hMTH1 F27A in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGAGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLF"
"6GLG",,"X-RAY DIFFRACTION",1.73,28.97,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5, 20% DMSO, 10 mM compound",293,,,"6GLG",21.32,"1.313","1.313","Crystal structure of hMTH1 F27A in complex with LW14 in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGAGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLG"
"6GLH",,"X-RAY DIFFRACTION",1.72,28.54,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 0.27 M ammonium sulfate, 17% glycerol, 27% PEG4000, 20% DMSO, 10 mM compound",293,,,"6GLH",21.36,"1.201","1.201","Crystal structure of hMTH1 F27A in complex with LW14 in the absence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGAGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLH"
"6GLI",,"X-RAY DIFFRACTION",1.72,28.47,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5, 20% DMSO, 10 mM compound",293,,,"6GLI",21.2,"1.6","1.6","Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGAGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLI"
"6GLJ",,"X-RAY DIFFRACTION",1.71,28.11,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 0.27 M ammonium sulfate, 17% glycerol, 27% PEG4000, 50 mM compound",293,,,"6GLJ",21.58,"1.301","1.301","Crystal structure of hMTH1 F27A in complex with TH scaffold 1 in the absence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGAGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLJ"
"6GLK",,"X-RAY DIFFRACTION",1.7,27.84,"VAPOR DIFFUSION, HANGING DROP",4.5,"23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5",293,,,"6GLK",21.35,"1.5","1.5","Crystal structure of hMTH1 N33A in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWAGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLK"
"6GLL",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5, 20% DMSO, 10 mM compound",293,,,"6GLL",42.89,"1.395","1.395","Crystal structure of hMTH1 N33A in complex with LW14 in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWAGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLL"
"6GLM",,"X-RAY DIFFRACTION",1.71,28.19,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 0.27 M ammonium sulfate, 17% glycerol, 27% PEG4000, 20% DMSO, 10 mM compound",293,,,"6GLM",21.39,"1.6","1.6","Crystal structure of hMTH1 N33A in complex with LW14 in the absence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWAGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLM"
"6GLN",,"X-RAY DIFFRACTION",1.71,28.01,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 0.27 M ammonium sulfate, 17% glycerol, 27% PEG4000, 50 mM compound",293,,,"6GLN",21.62,"1.401","1.401","Crystal structure of hMTH1 N33A in complex with TH scaffold 1 in the absence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWAGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLN"
"6GLO",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5",293,,,"6GLO",42.58,"1.701","1.701","Crystal structure of hMTH1 N33G in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWGGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLO"
"6GLP",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5, 20% DMSO, 10 mM compound",293,,,"6GLP",42.96,"1.5","1.5","Crystal structure of hMTH1 N33G in complex with LW14 in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWGGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLP"
"6GLQ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 0.27 M ammonium sulfate, 17% glycerol, 27% PEG4000, 20% DMSO, 10 mM compound",293,,,"6GLQ",43.23,"1.601","1.601","Crystal structure of hMTH1 N33G in complex with LW14 in the absence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWGGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLQ"
"6GLR",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5, 20% DMSO, 10 mM compound",293,,,"6GLR",43.36,"1.601","1.601","Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWGGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLR"
"6GLS",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 0.27 M ammonium sulfate, 17% glycerol, 27% PEG4000, 50 mM compound",293,,,"6GLS",43.38,"1.501","1.501","Crystal structure of hMTH1 N33G in complex with TH scaffold 1 in the absence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWGGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLS"
"6GLT",,"X-RAY DIFFRACTION",1.71,28.18,"VAPOR DIFFUSION, HANGING DROP",4.5,"23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5",293,,,"6GLT",21.18,"1.596","1.596","Crystal structure of hMTH1 D120N in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDNSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLT"
"6GLU",,"X-RAY DIFFRACTION",,27.75,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5, 20% DMSO, 10 mM compound",293,,,"6GLU",21.24,"1.7","1.7","Crystal structure of hMTH1 D120N in complex with LW14 in the presence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDNSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLU"
"6GLV",,"X-RAY DIFFRACTION",,27.32,"VAPOR DIFFUSION, HANGING DROP",4.5,"crystallized in: 23-27% PEG3350, 0.2 M LiSO4, 0.1 M sodium acetate pH 4.5

soaked in: 0.27 M ammonium sulfate, 17% glycerol, 27% PEG4000, 50 mM compound",293,,,"6GLV",21.66,"1.601","1.601","Crystal structure of hMTH1 D120N in complex with TH scaffold 1 in the absence of acetate","MKHHHHHHPMSDYDIPTTENLYFQGAMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDNSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","6GLV"
"6GM9",,"X-RAY DIFFRACTION",2.06,40.44,"VAPOR DIFFUSION, HANGING DROP",7.8,"Ammoniumsulfate 2.70 M, pH = 7.8, saturated with p-Chloromercurybenzoic acid",291,"10.1021/acschembio.9b00895","4J8","6GM9",31.28,"1.089","1.089","Human Carbonic Anhydrase II in complex with 4-Methylbenzenesulfonamide","GSPEFMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6GM9"
"6GMA",,"X-RAY DIFFRACTION",2.51,50.98,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M MES pH 6.0, 1.0 M LiCl, 14% PEG 6000",293,"10.1016/j.molcel.2019.01.035",,"6GMA",96.46,"3.2","3.2","Crystal structure of the FIP200 C-terminal region","GAARIMLLERTLQLKEEENKRLNQRLMSQSMSSVSSRHSEKIAIRDFQVGDLVLIILDERHDNYVLFTVSPTLYFLHSESLPALDLKPGEGASGASRRPWVLGKVMEKEYCQAKKAQNRFKVPLGTKFYRVKAVSWNKKV","Homo sapiens","RB1CC1, KIAA0203, RBICC","RB1-inducible coiled-coil protein 1","1","6GMA"
"6GMB",,"X-RAY DIFFRACTION",2.37,48.21,"VAPOR DIFFUSION, SITTING DROP",,"30% PEG1000 -- 0.1M MIB pH 8.0",290,,,"6GMB",41.13,"1.35","1.35","Structure of human hydroxyacid oxidase 1 bound with FMN and glycolate","MLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRK","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","6GMB"
"6GMC",,"X-RAY DIFFRACTION",2.38,48.36,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350 -- 10% ethylene glycol -- 0.1M bis-tris-propane pH 7.5 -- 0.2M sodium acetate",298,,,"6GMC",41.71,"1.2","1.2","1.2 A resolution structure of human hydroxyacid oxidase 1 bound with FMN and 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1,2,3-thiadiazole","MLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","6GMC"
"6GMD",,"X-RAY DIFFRACTION",2.38,48.31,"VAPOR DIFFUSION, HANGING DROP",6.5,"112.5mM Mes pH 6.5, 35% glycerol ethoxylate, 180 mM ammonium acetate",298,"10.1016/j.bmc.2018.05.011",,"6GMD",84.97,"1.66","1.66","The crystal structure of CK2alpha in complex with compound 3","GSMDIEFDDDADDDGSGSGSGSGSSGPVPSRARVYTDVNTHRPSEYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6GMD"
"6GMU",,"X-RAY DIFFRACTION",3.99,69.2,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bis-Tris Propane pH 6.5, 0.2M Sodium Bromide and 20% PEG 3350",291,"10.1093/molbev/msz298",,"6GMU",39.96,"2.7","2.7","Serum paraoxonase-1 by directed evolution with the L69G/H134R/F222S/T332S mutations","MAKLTALTLLGMGLALFDRQKSSFQTRFNVHREVTPVELPNCNLVKGIDNGSEDLEILPNGLAFISSGGKYPGIMSFDPDKSGKILLMDLNEKEPAVSELEIIGNTLDISSFNPHGISTFIDDDNTVYLLVVNRPGSSSTVEVFKFQEEEKSLLHLKTIRHKLLPSVNDIVAVGPEHFYATNDHYFIDPYLKSWEMHLGLAWSFVTYYSPNDVRVVAEGFDSANGINISPDGKYVYIAELLAHKIHVYEKHANWTLTPLRVLSFDTLVDNISVDPVTGDLWVGCHPNGMRIFFYDAENPPGSEVLRIQDILSEEPKVTVVYAENGTVLQGSSVAAVYKGKLLIGTVFHKALYCDL","Homo sapiens",,"Serum Paraoxonase-1 by directed evolution with the L69G/H134R/F222S/T332S mutations","1","6GMU"
"6GMY",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz197",,"6GMY",6.59,,,"Tc-DNA/RNA duplex","CTCGGCTTAC","Homo sapiens",,"Tc-DNA (5'-(*(TCJ)P*(TTK)P*(TCJ)P*(TCS)P*(TCS)P*(TCJ)P*(TTK)P*(TTK)P*(TCY)P*(TCJ))-3')","1","6GMY"
,,,,,,,,,,,,,,,,"GUAAGCCGAG","Homo sapiens",,"RNA (5'-R(*GP*UP*AP*AP*GP*CP*CP*GP*AP*G)-3')","2","6GMY"
"6GN1",,"X-RAY DIFFRACTION",2.84,56.68,"VAPOR DIFFUSION, HANGING DROP",7,"reservoir 0,1 M HEPES pH 7.0, 22% v/v PEG 8000, 8% ethylenglycol, 5mg/ml GSK3B (in 25 mM TRIS, 250 mM NaCl, 10 % Glycerol, pH 8), 1ul reservoir + 1ul protein solution",293,"10.1002/anie.201804917","CL, F4N","6GN1",84.32,"2.6","2.6","Crystal Structure of Glycogen synthase kinase-3 beta (GSK3B) in Complex with PIK-75","GKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTN","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","6GN1"
"6GN4",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz197",,"6GN4",6.78,,,"tc-DNA/tc-DNA duplex","CTCGGCTTAC","Homo sapiens",,"Tc-DNA (5'-D(*(TCJ)P*(TTK)P*(TCJ)P*(TCS)P*(TCS)P*(TCJ)P*(TTK)P*(TTK)P*(TCY)P*(TCJ))-3')","1","6GN4"
,,,,,,,,,,,,,,,,"GTAAGCCGAG","Homo sapiens",,"Tc-DNA (5'-D(*(TCS)P*(TTK)P*(TCY)P*(TCY)P*(TCS)P*(TCJ)P*(TCJ)P*(TCS)P*(TCY)P*(TCS))-3')","2","6GN4"
"6GN5",,"X-RAY DIFFRACTION",2.5,43.8,"VAPOR DIFFUSION, HANGING DROP",7,"40% MPD 10% PEG8000 0.1M HEPES PH 7.0",293,"10.1038/s41589-019-0307-5",,"6GN5",23.03,"1.41","1.41","CRYSTAL STRUCTURE OF HUMAN GRAMD1C START DOMAIN","GPLGSENVPEKDLHGRLFINRIFHISADRMFELLFTSSRFMQKFASSRNIIDVVSTPWTAELGGDQLRTMTYTIVLNSPLTGKCTAATEKQTLYKESREARFYLVDSEVLTHDVPYHDYFYTVNRYCIIRSSKQKCRLRVSTDLKYRKQPWGLVKSLIEKNSWSSLEDYFKQLESDLLIEESVLNQAIEDPG","Homo sapiens","GRAMD1C, UNQ2543/PRO6095","GRAM domain-containing protein 1C","1","6GN5"
"6GNQ",,"X-RAY DIFFRACTION",2.05,39.98,"BATCH MODE",6.1,"sodium-monopotassium phosphate buffer, zinc acetate, m-cresol",298,,,"6GNQ",72.23,"2.2","2.2","Monoclinic crystalline form of human insulin, complexed with meta-cresol","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","6GNQ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","6GNQ"
"6GOD",,"X-RAY DIFFRACTION",2.35,47.74,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M TrisCl, 0.2 M NaOAc and 30-35 % PEG 4000",277,"10.1073/pnas.1811360116",,"6GOD",20.24,"1.71","1.71","KRAS full length wild-type GPPNHP","STEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMSK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GOD"
"6GOE",,"X-RAY DIFFRACTION",2.55,51.78,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M TrisCl, 0.2 M NaOAc and 30-35 % PEG 4000",277,"10.1073/pnas.1811360116",,"6GOE",20.09,"1.6","1.6","KRAS full length G12V GPPNHP","GSTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMS","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GOE"
"6GOF",,"X-RAY DIFFRACTION",2.35,47.65,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M, TrisCl, 0.2 M NaOAc and 30-35 % PEG 4000",277,"10.1073/pnas.1811360116",,"6GOF",20.2,"1.98","1.98","KRAS full length G12D GPPNHP","STEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEKMSK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GOF"
"6GOG",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, SITTING DROP",,"8-15% w/v Polyethylene glycol 3350 and 0.2 M Lithium citrate",277,"10.1073/pnas.1811360116",,"6GOG",122.52,"2.05","2.05","KRAS-169 Q61H GPPNHP","YFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GOG"
"6GOM",,"X-RAY DIFFRACTION",2.6,52.64,"VAPOR DIFFUSION, SITTING DROP",,"8-15% w/v Polyethylene glycol 3350 and 0.2 M Lithium citrate",277,"10.1073/pnas.1811360116",,"6GOM",121.8,"1.63","1.63","KRAS-169 Q61H GPPNHP + PPIN-1","AFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GOM"
"6GOT",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION",8,"1.5 M sodium citrate, Tris 100 mM",296,"10.1016/j.bioorg.2018.09.028","F6W","6GOT",29.79,"1.56","1.56","Crystal structure of human carbonic anhydrase II in complex with the inhibitor 4-(phenethylthio)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6GOT"
"6GP4",,"X-RAY DIFFRACTION",2.81,56.19,"VAPOR DIFFUSION, SITTING DROP",6.5,"25 % wt/vol PEG 2000, 200 mM MgCl2 and 100 mM sodium cacodylate, pH 6.5",291,"10.1016/j.bbapap.2018.09.005",,"6GP4",28.74,"1.7","1.7","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112A","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAASGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GP4"
"6GP8",,"X-RAY DIFFRACTION",2.11,41.77,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000,2 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112A 20 mg/mL, 10 mM AMPCPP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GP8",29.23,"1.75","1.75","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112A in complex AMPCPP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAASGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GP8"
"6GPF",,"X-RAY DIFFRACTION",2.13,42.12,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000,2 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112A 20 mg/mL, 10 mM AMPPNP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GPF",29.23,"1.55","1.55","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112A in complex with AMPPNP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAASGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GPF"
"6GPH",,"X-RAY DIFFRACTION",2.17,43.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000,2 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112A 20 mg/mL, 10 mM AMPCP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GPH",29.15,"1.56","1.56","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112A in complex with AMPCP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAASGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GPH"
"6GPI",,"SOLUTION NMR",,,,,,,"10.1093/nar/gkz197",,"6GPI",6.45,,,"Tc-DNA/DNA duplex","CTCGGCTTAC","Homo sapiens",,"tc-DNA (5'-D(*(TCJ)P*(TTK)P*(TCJ)P*(TCS)P*(TCS)P*(TCJ)P*(TTK)P*(TTK)P*(TCY)P*(TCJ))-3')","1","6GPI"
,,,,,,,,,,,,,,,,"GTAAGCCGAG","Homo sapiens",,"DNA (5'-D(*GP*TP*AP*AP*GP*CP*CP*GP*AP*G)-3')","2","6GPI"
"6GPJ",,"X-RAY DIFFRACTION",2.38,48.37,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350 -- 0.2M ammonium citrate dibasic",293,"10.1021/acscatal.9b00064",,"6GPJ",166.14,"1.94","1.94","Crystal structure of human GDP-D-mannose 4,6-dehydratase in complex with GDP-4F-Man","SMRNVALITGITGQDGSYLAEFLLEKGYEVHGIVRRSSSFNTGRIEHLYKNPQAHIEGNMKLHYGDLTDSTCLVKIINEVKPTEIYNLGAQSHVKISFDLAEYTADVDGVGTLRLLDAVKTCGLINSVKFYQASTSELYGKVQEIPQKETTPFYPRSPYGAAKLYAYWIVVNFREAYNLFAVNGILFNHESPRRGANFVTRKISRSVAKIYLGQLECFSLGNLDAKRDWGHAKDYVEAMWLMLQNDEPEDFVIATGEVHSVREFVEKSFLHIGKTIVWEGKNENEVGRCKETGKVHVTVDLKYYRPTEVDFLQGDCTKAKQKLNWKPRVAFDELVREMVHADVELMRTNPNA","Homo sapiens","GMDS","GDP-mannose 4,6 dehydratase","1","6GPJ"
"6GPK",,"X-RAY DIFFRACTION",2.21,44.34,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.15M DL- malic acid",293,"10.1021/acscatal.9b00064",,"6GPK",177.33,"1.47","1.47","Crystal structure of human GDP-D-mannose 4,6-dehydratase (E157Q) in complex with GDP-Man","MHHHHHHSSGVDLGTENLYFQSMRNVALITGITGQDGSYLAEFLLEKGYEVHGIVRRSSSFNTGRIEHLYKNPQAHIEGNMKLHYGDLTDSTCLVKIINEVKPTEIYNLGAQSHVKISFDLAEYTADVDGVGTLRLLDAVKTCGLINSVKFYQASTSQLYGKVQEIPQKETTPFYPRSPYGAAKLYAYWIVVNFREAYNLFAVNGILFNHESPRRGANFVTRKISRSVAKIYLGQLECFSLGNLDAKRDWGHAKDYVEAMWLMLQNDEPEDFVIATGEVHSVREFVEKSFLHIGKTIVWEGKNENEVGRCKETGKVHVTVDLKYYRPTEVDFLQGDCTKAKQKLNWKPRVAFDELVREMVHADVELMRTNPNA","Homo sapiens","GMDS","GDP-mannose 4,6 dehydratase","1","6GPK"
"6GPL",,"X-RAY DIFFRACTION",2.39,48.43,"VAPOR DIFFUSION, SITTING DROP",9,"20% PEG6000, 0.1M bicine pH 9.0",293,"10.1021/acscatal.9b00064",,"6GPL",166.27,"1.76","1.76","Crystal structure of human GDP-D-mannose 4,6-dehydratase in complex with GDP-4k6d-Man","SMRNVALITGITGQDGSYLAEFLLEKGYEVHGIVRRSSSFNTGRIEHLYKNPQAHIEGNMKLHYGDLTDSTCLVKIINEVKPTEIYNLGAQSHVKISFDLAEYTADVDGVGTLRLLDAVKTCGLINSVKFYQASTSELYGKVQEIPQKETTPFYPRSPYGAAKLYAYWIVVNFREAYNLFAVNGILFNHESPRRGANFVTRKISRSVAKIYLGQLECFSLGNLDAKRDWGHAKDYVEAMWLMLQNDEPEDFVIATGEVHSVREFVEKSFLHIGKTIVWEGKNENEVGRCKETGKVHVTVDLKYYRPTEVDFLQGDCTKAKQKLNWKPRVAFDELVREMVHADVELMRTNPNA","Homo sapiens","GMDS","GDP-mannose 4,6 dehydratase","1","6GPL"
"6GPO",,"X-RAY DIFFRACTION",1.94,36.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000,2 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112A 20 mg/mL, 10 mM cAMP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GPO",29.09,"1.48","1.48","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112A in complex with cAMP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAASGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GPO"
"6GPP",,"X-RAY DIFFRACTION",2.21,44.31,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112A 20 mg/mL, 10 mM ADP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GPP",29.15,"1.51","1.51","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112A in complex with ADP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAASGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GPP"
"6GPR",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD  20 mg/mL, 10 mM cAMP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GPR",29.07,"2.35","2.35","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) in complex with cAMP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GPR"
"6GPT",,"X-RAY DIFFRACTION",2,38.61,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD  20 mg/mL, 10 mM AMPCP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GPT",29.19,"2","2","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) in complex with AMPCP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GPT"
"6GPW",,"X-RAY DIFFRACTION",3.1,60.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5",291,"10.1016/j.bbapap.2018.09.005",,"6GPW",28.8,"1.6","1.6","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD)","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GPW"
"6GPY",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD 20 mg/mL, 10 mM AMPPNP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GPY",29.27,"2.25","2.25","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) in complex with AMPPNP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GPY"
"6GQ3",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M NaCl, 0.1 M sodium HEPES buffer, pH 7.5, and 12% w/v PEG 8000",290,"10.1038/s42003-019-0587-z",,"6GQ3",130,"1.85","1.85","Human asparagine synthetase (ASNS) in complex with 6-diazo-5-oxo-L-norleucine (DON) at 1.85 A resolution","MCGIWALFGSDDCLSVQCLSAMKIAHRGPDAFRFENVNGYTNCCFGFHRLAVVDPLFGMQPIRVKKYPYLWLCYNGEIYNHKKMQQHFEFEYQTKVDGEIILHLYDKGGIEQTICMLDGVFAFVLLDTANKKVFLGRDTYGVRPLFKAMTEDGFLAVCSEAKGLVTLKHSATPFLKVEPFLPGHYEVLDLKPNGKVASVEMVKYHHCRDVPLHALYDNVEKLFPGFEIETVKNNLRILFNNAVKKRLMTDRRIGCLLSGGLDSSLVAATLLKQLKEAQVQYPLQTFAIGMEDSPDLLAARKVADHIGSEHYEVLFNSEEGIQALDEVIFSLETYDITTVRASVGMYLISKYIRKNTDSVVIFSGEGSDELTQGYIYFHKAPSPEKAEEESERLLRELYLFDVLRADRTTAAHGLELRVPFLDHRFSSYYLSLPPEMRIPKNGIEKHLLRETFEDSNLIPKEILWRPKEAFSDGITSVKNSWFKILQEYVEHQVDDAMMANAAQKFPFNTPKTKEGYYYRQVFERHYPGRADWLSHYWMPKWINATDPSARTLTHYKSAVKA","Homo sapiens","ASNS, TS11","Asparagine synthetase [glutamine-hydrolyzing]","1","6GQ3"
"6GQ6",,"X-RAY DIFFRACTION",1.87,34.18,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD 20 mg/mL, 10 mM ADP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GQ6",29.19,"2.25","2.25","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) in complex with ADP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GQ6"
"6GQ7",,"X-RAY DIFFRACTION",2.63,53.18,"VAPOR DIFFUSION",,"20% PEG3350, 175 mM AmSO4, 10 mM DTT and 100 mM Hepes",293,,,"6GQ7",111.09,"2.84","2.84","PI3Kg IN COMPLEX WITH INH","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","6GQ7"
"6GQD",,"X-RAY DIFFRACTION",2.23,44.96,"VAPOR DIFFUSION, SITTING DROP",,"0.2M ammonium sulphate, 30% PEG4000",277.15,,,"6GQD",44.1,"1.523","1.523","Structure of human galactose-1-phosphate uridylyltransferase (GALT), with crystallization epitope mutations A21Y:A22T:T23P:R25L","SMSRSGTDPQQRQQASEADAAYTPFLANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWDHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA","Homo sapiens","GALT","Galactose-1-phosphate uridylyltransferase","1","6GQD"
"6GQE",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.08 M magnesium acetate, 0.05 M sodium cacodylate pH 6.5, 30% w/v Polyethylene glycol 4,000",292,"10.1038/s41467-019-09769-8",,"6GQE",18.63,"2.15","2.15","X-ray structure of KH1-2 domain of IMP3","GAMAKPCDLPLRLLVPTQFVGAIIGKEGATIRNITKQTQSKIDVHRKENAGAAEKSITILSTPEGTSAACKSILEIMHKEAQDIKFTEEIPLKILAHNNFVGRLIGDDGRNLKKIEQDTDTKITISPLQELTLYNPERTITVKGNVETCAKAEEEIMKKIRESYENDI","Homo sapiens","IGF2BP3, IMP3, KOC1, VICKZ3","Insulin-like growth factor 2 mRNA-binding protein 3","1","6GQE"
"6GQJ",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, SITTING DROP",7.5,"10 % PEG 4000, 20 % glycerol, 0.1 M HEPES-MOPS pH 7.5, 
0.02 M sodium formate, 0.02 M ammonium acetate, 0.02 M sodium citrate tribasic dihydrate, 0.02 M sodium potassium tartrate tetrahydrate, 0.02 M sodium oxamate",293,"10.1021/acs.jmedchem.8b00938",,"6GQJ",75.34,"2.33","2.33","Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 18)","GSHMPMYEVQWKVVEESNGNNYSYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAQGLIKSDAAMTVAVKMLKPSAHSTEREALMSELKVLSYLGNHENIVNLLGACTHGGPTLVITEYCCYGDLLNFLRRKRDEFVPYKVAPEDLYKDFLTLEHLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGNITKICDFGLARDIKNDSNYVDKGNARLPVKWMAPESIFNSVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMSSPEYAPAEMYDIMKTCWDADPDKRPTFKQIVQDIEKQISESTN","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","6GQJ"
"6GQK",,"X-RAY DIFFRACTION",2.74,55.1,"VAPOR DIFFUSION, SITTING DROP",8.5,"10 % PEG 8000, 20 % ethylene glycol, 0.1 M Tris-BICINE pH 8.5, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",293,"10.1021/acs.jmedchem.8b00938",,"6GQK",75.53,"2.31","2.31","Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)","GSHMPMYEVQWKVVEESNGNNYSYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAQGLIKSDAAMTVAVKMLKPSAHSTEREALMSELKVLSYLGNHENIVNLLGACTHGGPTLVITEYCCYGDLLNFLRRKRDEFVPYKVAPEDLYKDFLTLEHLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGNITKICDFGLARDIKNDSNYVDKGNARLPVKWMAPESIFNSVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMSSPEYAPAEMYDIMKTCWDADPDKRPTFKQIVQDIEKQISESTNH","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","6GQK"
,,,,,,,,,,,,,,,,,"Homo sapiens","KIT, SCFR"
"6GQL",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, SITTING DROP",6.2,"9 % PEG 3350, 18 % glycerol, 0.1 M PCTP pH 6.2, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",293,"10.1021/acs.jmedchem.8b00938",,"6GQL",75.56,"2.01","2.01","Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 35)","GSHMPMYEVQWKVVEESNGNNYSYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAQGLIKSDAAMTVAVKMLKPSAHSTEREALMSELKVLSYLGNHENIVNLLGACTHGGPTLVITEYCCYGDLLNFLRRKRDEFVPYKVAPEDLYKDFLTLEHLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGNITKICDFGLARDIKNDSNYVDKGNARLPVKWMAPESIFNSVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMSSPEYAPAEMYDIMKTCWDADPDKRPTFKQIVQDIEKQISESTNH","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","6GQL"
"6GQM",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION, SITTING DROP",6.2,"9 % PEG 8000, 18 % ethylene glycol, 0.1 M PCTP pH 6.2, 0.03 M sodium fluoride, 0.03 M sodium bromide, 0.03 M sodium iodide",293,"10.1021/acs.jmedchem.8b00938",,"6GQM",75.7,"2","2","Crystal structure of human c-KIT kinase domain in complex with a small molecule inhibitor, AZD3229","GSHMPMYEVQWKVVEESNGNNYSYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAQGLIKSDAAMTVAVKMLKPSAHSTEREALMSELKVLSYLGNHENIVNLLGACTHGGPTLVITEYCCYGDLLNFLRRKRDEFVPYKVAPEDLYKDFLTLEHLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGNITKICDFGLARDIKNDSNYVDKGNARLPVKWMAPESIFNSVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMSSPEYAPAEMYDIMKTCWDADPDKRPTFKQIVQDIEKQISESTNH","Homo sapiens","KIT, SCFR","Mast/stem cell growth factor receptor Kit","1","6GQM"
"6GQO",,"X-RAY DIFFRACTION",2.38,48.36,"VAPOR DIFFUSION, SITTING DROP",8.5,"8 % PEG 8000, 0.1 M Tris pH 8.5",293,"10.1021/acs.jmedchem.8b00938",,"6GQO",37.47,"1.87","1.87","Crystal structure of human KDR (VEGFR2) kinase domain in complex with AZD3229-analogue (compound 18)","MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDENLYFQ","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","6GQO"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1, VEGFR2"
"6GQP",,"X-RAY DIFFRACTION",2.35,47.68,"VAPOR DIFFUSION, SITTING DROP",7.8,"7 % PEG 8000, 0.1 M PCTP (sodium propionate, sodium cacodylate trihydrate, bis-tris propane) pH 7.8",293,"10.1021/acs.jmedchem.8b00938",,"6GQP",37.42,"2.09","2.09","Crystal structure of human KDR (VEGFR2) kinase domain in complex with AZD3229-analogue (compound 23)","MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDENLYFQ","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","6GQP"
"6GQQ",,"X-RAY DIFFRACTION",2.32,46.96,"VAPOR DIFFUSION, SITTING DROP",7.2,"5 % PEG 8000, 0.1 M PCTP (sodium propionate, sodium cacodylate trihydrate, bis-tris propane) pH 7.2",293,"10.1021/acs.jmedchem.8b00938",,"6GQQ",37.44,"1.52","1.52","Crystal structure of human KDR (VEGFR2) kinase domain in complex with AZD3229-analogue (compound 35)","MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDENLYFQ","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","6GQQ"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDR, FLK1, VEGFR2"
"6GQR",,"X-RAY DIFFRACTION",2.02,39.23,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD 20 mg/mL, 10 mM AMPCPP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GQR",29.27,"2.05","2.05","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) in complex with AMPCPP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GQR"
"6GQS",,"X-RAY DIFFRACTION",2.11,41.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112R 20 mg/mL, 10 mM AMPCP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GQS",29.24,"1.43","1.43","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112R in complex with AMPCP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIARSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GQS"
"6GQT",,"X-RAY DIFFRACTION",2.61,52.8,"VAPOR DIFFUSION, SITTING DROP",,"8-15% w/v Polyethylene glycol 3350 and 0.2 M Lithium citrate",277,"10.1073/pnas.1811360116",,"6GQT",122.5,"1.69","1.69","KRAS-169 Q61H GPPNHP + PPIN-2","FQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GQT"
"6GQU",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112R 20 mg/mL, 10 mM cAMP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GQU",29.09,"1.72","1.72","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112R in complex with cAMP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIARSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GQU"
"6GQW",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, SITTING DROP",,"8-15% w/v Polyethylene glycol 3350 and 0.2M Lithium citrate",277,"10.1073/pnas.1811360116",,"6GQW",121.72,"2.8","2.8","KRAS-169 Q61H GPPNHP + CH-1","YFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GQW"
,,,,,,,,,,,,,,,,"YFQGMTEYKLVVVGAGGVGKSALVIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","2","6GQW"
"6GQX",,"X-RAY DIFFRACTION",2.49,50.66,"VAPOR DIFFUSION, SITTING DROP",,"8-15% w/v polyethylene glycol 3350 and 0.2 M Lithium citrate",277,"10.1073/pnas.1811360116",,"6GQX",121.25,"2.2","2.2","KRAS-169 Q61H GPPNHP + CH-2","YFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GQX"
,,,,,,,,,,,,,,,,"FQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","2","6GQX"
"6GQY",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, SITTING DROP",,"8-15% w/v polyethylene glycol 3350 and 0.2M Lithium citrate",277,"10.1073/pnas.1811360116",,"6GQY",121.92,"2.75","2.75","KRAS-169 Q61H GPPNHP + CH-3","YFQGMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGHEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","6GQY"
"6GQZ",,"X-RAY DIFFRACTION",2.15,42.9,"VAPOR DIFFUSION, SITTING DROP",9,"1.8 M ammonium sulfate, 0.1 M bicine/NaOH",293,"10.1002/anie.201807442",,"6GQZ",40.27,"1.4","1.4","Petrobactin-binding engineered lipocalin without ligand","SDLIPAPPLSKVPLQQNFQDNQFHGKWYVVGFAENIQQREDKDPPKMIATIYELKEDKSYNVTNVASNWEKCTYRIKTFVPGSQPGEFTLGEIKSRPGMTSYLVRVVSTNYNQHAMVFFKTVVQNREKFWITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","6GQZ"
"6GR0",,"X-RAY DIFFRACTION",2.76,55.48,"VAPOR DIFFUSION, SITTING DROP",4.5,"2.5 M sodium chloride, 0.2 M lithium sulfate, 0.1 M sodium acetate",293,"10.1002/anie.201807442","F8W","6GR0",65.2,"2.5","2.5","Petrobactin-binding engineered lipocalin in complex with gallium-petrobactin","SDLIPAPPLSKVPLQQNFQDNQFHGKWYVVGFAENIQQREDKDPPKMIATIYELKEDKSYNVTNVASNWEKCTYRIKTFVPGSQPGEFTLGEIKSRPGMTSYLVRVVSTNYNQHAMVFFKTVVQNREKFWITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","6GR0"
"6GR1",,"X-RAY DIFFRACTION",2.06,40.38,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112R 20 mg/mL, 10 mM AMPCPP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GR1",29.29,"2.05","2.05","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112R in complex with AMPCPP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIARSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GR1"
"6GR2",,"X-RAY DIFFRACTION",2.51,50.97,"VAPOR DIFFUSION, SITTING DROP",,"0.1M cacodylate pH 6.3, 17.5% PEG8K -- 0.2M ammonium sulfate",298,,,"6GR2",350.16,"2.49","2.49","Structure of human galactokinase in complex with galactose and ADP","MAHHHHHHAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGAASLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL","Homo sapiens","GALK1, GALK","Galactokinase","1","6GR2"
"6GR3",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION, SITTING DROP",,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112R 20 mg/mL, 10 mM AMPPNP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GR3",29.21,"1.88","1.88","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112R in complex with AMPPNP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIARSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GR3"
"6GR4",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5",291,"10.1016/j.bbapap.2018.09.005",,"6GR4",28.82,"1.5","1.5","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112R","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIARSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GR4"
"6GR5",,"X-RAY DIFFRACTION",2.04,39.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"Precipitant: 25 % wt/vol PEG 2000, 200mM MgCl2, 100 mM sodium cacodylate, pH 6.5 
Sample: Hsp90a-NTD K112R 20 mg/mL, 10 mM ADP, 500 mM NaCl, 20 mM TRIS, pH 7.5",291,"10.1016/j.bbapap.2018.09.005",,"6GR5",29.22,"1.34","1.34","Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112R in complex with ADP","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIARSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","6GR5"
"6GR7",,"X-RAY DIFFRACTION",2.14,42.65,"VAPOR DIFFUSION, HANGING DROP",4.5,"The purified human TTR was dialyzed against 10 mM Na-phosphate buffer with 100 mM KCl (pH 7.6) and concentrated to 5 mg/mL The reservoir contained 28% PEG 4K, 0.1M NaAc pH 4.5, 0.2M AmAc. Drop size 3 plus 3 microliter.",291,"10.1021/acs.est.8b03581","F52","6GR7",28.07,"1.4","1.4","Crystal Structure Of Human Transthyretin in complex with 2,4,5-trichlorophenoxyacetic acid (2,4,5-T)","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6GR7"
"6GRA",,"X-RAY DIFFRACTION",2.6,52.76,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M potassium citrate, 0.1 M Bis-Tris propane pH 7.5, 20% PEG 3350, 10% ethylene glycol",277,,,"6GRA",33.54,"2.6","2.6","Human AURKA bound to BRD-7880","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","6GRA"
"6GRO",,"X-RAY DIFFRACTION",2.67,53.95,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M sodium/potassium tartrate, 0.1 M bis-tris-propane pH 8.5, 20% PEG3350, 10% ethylene glycol",277,,,"6GRO",39.19,"1.45","1.45","Human CSNK1G3 bound to SB-223133","SMGVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGAVQQDPALSSNREAHQHRDKMQQSKNQ","Homo sapiens","CSNK1G3","Casein kinase I isoform gamma-3","1","6GRO"
"6GRP",,"X-RAY DIFFRACTION",2.15,42.78,"VAPOR DIFFUSION, HANGING DROP",4.5,"Purified TTRwt was dialyzed against 10 mM sodiumphosphate buffer with 100 mM KCl pH 7.6 and concentrated to 5 mg per ml. TC2P was added at 5 x molar excess to the protein. The 1.65 M NaCitrate pH 5.5, 5.8-8.6 % glycerol.",291,"10.1021/acs.est.8b03581","F4Z","6GRP",28.37,"1.6","1.6","Crystal Structure Of Human Transthyretin in complex with 3,5,6-trichloro-2-pyridinol (TC2P)","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","6GRP"
"6GRU",,"X-RAY DIFFRACTION",2.6,52.68,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.2M magnesium chloride, 0.1M tris pH 8.5",293.15,,,"6GRU",92.9,"1.93","1.93","Crystal structure of human NUDT5","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","6GRU"
"6GRZ",,"X-RAY DIFFRACTION",2.44,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.02M Sodium Potassium Phosphate, 0.1M Bis-Tris Propane pH 8.5, 20% w/v PEG 3350",293.15,,,"6GRZ",46.13,"2.1","2.1","Crystal structure of the light chain dimer mH6","QSVLTQPPSVSAAPGQKVTISCSGNNSNIGKNYVSWYQQLPGRTPKLIMYENNKRSSGIPDRFSGSKSGNSATLTITGLQTGDEADYYCGVWDSSLSGGVFGGGTKVTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"mH6","1","6GRZ"
"6GS6",,"X-RAY DIFFRACTION",3.01,59.13,"VAPOR DIFFUSION, HANGING DROP",,"2.2 M Ammonium Sulfate",289.15,,,"6GS6",18.32,"1.16","1.16","Cyclophilin A single mutant D66A in complex with an inhibitor.","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGAFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","6GS6"
"6GSS",,"X-RAY DIFFRACTION",2.64,53.47,,5.4,"pH 5.4",,"10.1006/jmbi.1997.1364",,"6GSS",47.5,"1.9","1.9","HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH GLUTATHIONE","PPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GTP_HUMAN, GSTP1, FAEES3, GST3","GLUTATHIONE S-TRANSFERASE P1-1","1","6GSS"
"6GT5",,"X-RAY DIFFRACTION",2.7,54.5,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris propane, 0.2 M pottassium-sodium tartrate, 20% PEG 3350",293,"10.1016/j.molcel.2018.08.004",,"6GT5",66.69,"2.45","2.45","METTL16 MTase domain (crystal form 2)","MALSKSMHARNRYKDKPPDFAYLASKYPDFKQHVQINLNGRVSLNFKDPEAVRALTCTLLREDFGLSIDIPLERLIPTVPLRLNYIHWVEDLIGHQDSDKSTLRRGIDIGTGASCIYPLLGATLNGWYFLATEVDDMCFNYAKKNVEQNNLSDLIKVVKVPQKTLLMDALKEESEIIYDFCMCNPPFFANQLEAKGVNSRNPRRPPPSSVNTGGITEIMAEGGELEFVKRIIHDSLQLKKRLRWYSCMLGKKCSLAPLKEELRIQGVPKVTYTEFCQGRTMRWALAWSFYD","Homo sapiens","METTL16, METT10D","U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase","1","6GT5"
"6GT6",,"X-RAY DIFFRACTION",3.69,66.64,"VAPOR DIFFUSION, SITTING DROP",,"0.1M Tris.Cl pH 8.0, 1.5M AmSO4",292.15,"10.1107/S2059798319006910",,"6GT6",28.27,"2.54","2.54","Crystal structure of recombinant coagulation factor beta-XIIa","VVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVSTRTGHHHHHH","Homo sapiens","F12","Coagulation factor XII","1","6GT6"
"6GTB",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, SITTING DROP",7,"HEPES 0.1 M pH 7.00, sodium formate 3.3 M",291,,,"6GTB",29.98,"1.619","1.619","17beta-hydroxysteroid dehydrogenase 14 variant T205 in complex with FB211","GHMATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRATIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPSGS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6GTB"
"6GTT",,"X-RAY DIFFRACTION",3.11,60.5,"VAPOR DIFFUSION, SITTING DROP",6,"20% PEG6000, 10% ethylene glycol, 0.1M MES pH 6.0, 0.1M magnesium chloride",277,,"B96","6GTT",34.77,"2.25","2.25","Human STK10 bound to BIRB-796","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLAIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","Serine/threonine-protein kinase 10","1","6GTT"
"6GTU",,"X-RAY DIFFRACTION",3.16,61.08,"VAPOR DIFFUSION, SITTING DROP",7,"HEPES 0.1 M pH 7.00, sodium formate 3.3 M",291,,,"6GTU",29.75,"2.25","2.25","17beta-hydroxysteroid dehydrogenase 14 variant T205 in complex with fragment J6","GHMATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATKGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRATIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPSGS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6GTU"
"6GUH",,"X-RAY DIFFRACTION",1.97,37.62,"VAPOR DIFFUSION, HANGING DROP",,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1016/j.chembiol.2018.10.015","FB8","6GUH",35.26,"1.5","1.5","CDK2 in complex with AZD5438","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6GUH"
"6GUK",,"X-RAY DIFFRACTION",2,38.37,"VAPOR DIFFUSION, HANGING DROP",,"10MG/ML CDK2 10% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5",293,"10.1016/j.chembiol.2018.10.015","FC8","6GUK",35.15,"1.3","1.3","CDK2 in complex with CGP74514A","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","6GUK"
"6GUU",,"X-RAY DIFFRACTION",3.8,67.61,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium nitrate
20 % PEG 3350
2 % benzamidine hydrochloride",277,,,"6GUU",57.43,"2.95","2.95","Structure of CHD5 PHD2 - tandem chromodomains","GPGEDDHMEFCRVCKDGGELLCCDACPSSYHLHCLNPPLPEIPNGEWLCPRCTCPPLKGKVQRILHWRWTEPPAPFMVGLPGPDVEPSLPPPKPLEGIPEREFFVKWAGLSYWHCSWVKELQLELYHTVMYRNYQRKNDMDEPPPFDYGSGDEDGKSEKRKNKDPLYAKMEERFYRYGIKPEWMMIHRILNHSFDKKGDVHYLIKWKDLPYDQCTWEIDDIDIPYYDNLKQAYWGHRELML","Homo sapiens","CHD5, KIAA0444","Chromodomain-helicase-DNA-binding protein 5","1","6GUU"
"6GV0",,"X-RAY DIFFRACTION",1.96,37,"VAPOR DIFFUSION",,"0.2-0.4M Mg-formate 0.1M BisTris buffer",293,"10.1038/s41598-021-81251-2",,"6GV0",11.89,"1.26","1.26","Insulin glulisine","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","6GV0"
,,,,,,,,,,,,,,,,"FVKQHLCGSHLVEALYLVCGERGFFYTPET","Homo sapiens","INS","Insulin","2","6GV0"
"6GVF",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, SITTING DROP",,"NULL",293,"10.1021/acsmedchemlett.9b00401","FE5","6GVF",110.29,"2.5","2.5","Crystal structure of PI3K alpha in complex with 3-(2-Amino-benzooxazol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine","NREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGW","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","6GVF"
"6GVG",,"X-RAY DIFFRACTION",2.57,52.13,"VAPOR DIFFUSION, SITTING DROP",,"none",293,"10.1021/acsmedchemlett.9b00401",,"6GVG",112.38,"3","3","Crystal structure of PI3K alpha in complex with 3-(2-Amino-benzooxazol-5-yl)-1-isopropyl-4-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-ylamine","NREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","6GVG"
"6GVH",,"X-RAY DIFFRACTION",2.45,49.69,"VAPOR DIFFUSION, SITTING DROP",,"none",293,"10.1021/acsmedchemlett.9b00401",,"6GVH",112.4,"2.74","2.74","Crystal structure of PI3K alpha in complex with 3-(2-Amino-benzooxazol-5-yl)-4-chloro-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-6-ylamine","NREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","6GVH"
"6GVI",,"X-RAY DIFFRACTION",2.57,52.19,"VAPOR DIFFUSION, SITTING DROP",,"none",293,"10.1021/acsmedchemlett.9b00401",,"6GVI",112.38,"2.9","2.9","Crystal structure of PI3K alpha in complex with 3-(2-Amino-benzooxazol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine","NREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","6GVI"
"6GVJ",,"X-RAY DIFFRACTION",2.07,40.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M Ammonium sulfate
20% (w/v) PEG8000
0.1 M MES-buffer, pH 6.5",293,"10.1002/prot.25651",,"6GVJ",49.5,"2.41","2.41","Human Mps1 kinase domain with ordered activation loop","MAHHHHHHSAALEVLFQGPGPAASSNHWQIPELARKVNTEQKHTTFEQPVFSVSKQSPPISTSKWFDPKSICKTPSSNTLDDYMSCFRTPVVKNDFPPACQLSTPYGQPACFQQQQHQILATPLQNLQVLASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","6GVJ"
"6GVX",,"X-RAY DIFFRACTION",2.41,48.88,"VAPOR DIFFUSION, SITTING DROP",,"HEPES, PEG 3350",295,"10.1016/j.abb.2019.05.014","TAK","6GVX",80.37,"2.24","2.24","Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK) in complex with dorsomorphin (Compound C)","PLGSMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCG","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","6GVX"
"6GWE",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, SITTING DROP",,"25% ethylene glycol
100 mM MES pH 6.2
15% w/v PEG 3350",293,"10.1126/sciadv.aaw2851","ODB","6GWE",69.82,"2.3","2.3","Crystal structure of Thrombin bound to P2 macrocycle","IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","1","6GWE"
,,,,,,,,,,,,,,,,"TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","2","6GWE"
"6GWR",,"X-RAY DIFFRACTION",2.2,44.14,"VAPOR DIFFUSION, SITTING DROP",,"10% ethylene glycol -- 0.2M sodium sulfate -- 24% PEG3350 -- 0.1M bis-tris-propane pH 7.1",293,"10.1021/acs.jmedchem.8b01045","FEW","6GWR",74.14,"2.07","2.07","Structure of the kinase domain of human DDR1 in complex with a potent and selective inhibitor of DDR1 and DDR2","SMPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","6GWR"
"6GWY",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, HANGING DROP",7,"MOPS buffer, Magnesium chloride, ammonium sulfate and PEG3350",293,,,"6GWY",35.03,"1.4","1.4","Blood group synthase AAGlyB in its apo form cryoprotected with glycerol","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6GWY"
"6GWZ",,"X-RAY DIFFRACTION",2.27,45.89,"VAPOR DIFFUSION, HANGING DROP",7,"MOPS buffer, Magnesium chloride, ammonium sulfate and PEG 3350",293,,,"6GWZ",34.97,"1.65","1.65","Blood group synthase AAGlyB in its apo form cryoprotected with PEG 3350","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6GWZ"
"6GX0",,"X-RAY DIFFRACTION",2.27,45.87,"VAPOR DIFFUSION, HANGING DROP",7,"MOPS buffer, Magnesium chloride, ammonium sulfate and PEG 3350",293,,,"6GX0",35.86,"1.25","1.25","Blood group synthase AAGlyB in complex with UDP-Gal and cryoprotected with PEG 3350","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6GX0"
"6GX1",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, HANGING DROP",,"MOPS buffer, Magnesium sulfate, ammonium sulfate and PEG 3350",293,,,"6GX1",36.11,"1.6","1.6","Blood group synthase AAGlyB in complex with UDP-GalNAc and cryoprotected with PEG 3350","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6GX1"
"6GX2",,"X-RAY DIFFRACTION",2.25,45.24,"VAPOR DIFFUSION, HANGING DROP",7,"MOPS buffer, Magnesium chloride, ammonium sulfate and PEG3350",293,,,"6GX2",35.68,"1.07","1.07","Blood group synthase AAGlyB in complex with UDP-GalNAc and cryoprotected with glycerol","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase transferase B, alpha 1-3-galactosyltransferase)","1","6GX2"
"6GX5","3.2","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-018-0454-y",,"6GX5",30.41,"3.2",,"Narrow Pick Filament from Pick's disease brain","KNVKSKIGSTENLKHQPGGGKVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTF","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","6GX5"
"6GXB",,"X-RAY DIFFRACTION",2.09,41.04,"VAPOR DIFFUSION, HANGING DROP",7.8,"protein 25 mg/mL, 1.6M sodium citrate, 50mM Tris H2SO4 pH 7.8",291,,,"6GXB",29.33,"1.35","1.35","Carbonic Anhydrase CAIX mimic in complex with inhibitor JS13","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6GXB"
"6GXE",,"X-RAY DIFFRACTION",2.1,41.34,"VAPOR DIFFUSION, HANGING DROP",7.8,"Complex was prepared by adding 1-fold molar excess of inhibitor (dissolved in pure DMSO) to 25 mg/mL protein solution in water. 2 uL of complex solution were mixed with 1 uL of precipitant solution containing 1.6M sodium citrate, 50mM Tris H2SO4 pH 7.8",291,,,"6GXE",30.3,"1.3","1.3","Carbonic Anhydrase CAIX mimic in complex with inhibitor JS14","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6GXE"
"6GXK",,"X-RAY DIFFRACTION",2.38,48.32,"VAPOR DIFFUSION",,"10mM MES pH6.0, 25% PEG8000",277,"10.1021/acsmedchemlett.8b00484",,"6GXK",76.32,"1.7","1.7","Crystal structure of Aldo-Keto Reductase 1C3 (AKR1C3) complexed with inhibitor.","MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEY","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","6GXK"
"6GY4",,"X-RAY DIFFRACTION",1.88,34.48,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Lithium Sulfate, 50 % PEG 400, 0.1 M acetate pH 4.0",277,,,"6GY4",39.84,"1.986","1.986","Crystal structure of the N-terminal KH domain of human BICC1","SMSEERFRVDRKKLEAMLQAAAEGKGRSGEDFFQKIMEETNTQIAWPSKLKIGAKSKKDPHIKVSGKKEDVKEAKEMIMSVLDTKS","Homo sapiens","BICC1","Protein bicaudal C homolog 1","1","6GY4"
"6GYN","3.4","ELECTRON MICROSCOPY",,,,,,,,,"6GYN",271.46,"3.4",,"Structure of human HCN4 hyperpolarization-activated cyclic nucleotide-gated ion channel","SMLPEAEVRLGQAGFMQRQFGAMLQPGVNKFSLRMFGSQKAVEREQERVKSAGFWIIHPYSDFRFYWDLTMLLLMVGNLIIIPVGITFFKDENTTPWIVFNVVSDTFFLIDLVLNFRTGIVVEDNTEIILDPQRIKMKYLKSWFMVDFISSIPVDYIFLIVETRIDSEVYKTARALRIVRFTKILSLLRLLRLSRLIRYIHQWEEIFHMTYDLASAVVRIVNLIGMMLLLCHWDGCLQFLVPMLQDFPDDCWVSINNMVNNSWGKQYSYALFKAMSHMLCIGYGRQAPVGMSDVWLTMLSMIVGATCYAMFIGHATALIQSLDSSRRQYQEKYKQVEQYMSFHKLPPDTRQRIHDYYEHRYQGKMFDEESILGELSEPLREEIINFNCRKLVASMPLFANADPNFVTSMLTKLRFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKETKLADGSYFGEICLLTRGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVALDRLDRIGKKNS","Homo sapiens","HCN4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","1","6GYN"
"6GYO","3.4","ELECTRON MICROSCOPY",,,,,,,,,"6GYO",276.38,"3.4",,"Structure of human HCN4 hyperpolarization-activated cyclic nucleotide-gated ion channel in complex with cAMP","SMLPEAEVRLGQAGFMQRQFGAMLQPGVNKFSLRMFGSQKAVEREQERVKSAGFWIIHPYSDFRFYWDLTMLLLMVGNLIIIPVGITFFKDENTTPWIVFNVVSDTFFLIDLVLNFRTGIVVEDNTEIILDPQRIKMKYLKSWFMVDFISSIPVDYIFLIVETRIDSEVYKTARALRIVRFTKILSLLRLLRLSRLIRYIHQWEEIFHMTYDLASAVVRIVNLIGMMLLLCHWDGCLQFLVPMLQDFPDDCWVSINNMVNNSWGKQYSYALFKAMSHMLCIGYGRQAPVGMSDVWLTMLSMIVGATCYAMFIGHATALIQSLDSSRRQYQEKYKQVEQYMSFHKLPPDTRQRIHDYYEHRYQGKMFDEESILGELSEPLREEIINFNCRKLVASMPLFANADPNFVTSMLTKLRFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKETKLADGSYFGEICLLTRGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVALDRLDRIGKKNS","Homo sapiens","HCN4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","1","6GYO"
"6GYR",,"X-RAY DIFFRACTION",3.14,60.78,"VAPOR DIFFUSION",,"100 mM HEPES, pH 7.5, 18-22% polyethylene glycol 3350, 0.2 M NaCl",277,"10.1038/s41586-018-0621-1",,"6GYR",279.5,"3.1","3.1","Transcription factor dimerization activates the p300 acetyltransferase","AKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQPQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWFKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQD","Homo sapiens","EP300, P300","Histone acetyltransferase p300","1","6GYR"
"6GZ6",,"X-RAY DIFFRACTION",1.76,30.2,"VAPOR DIFFUSION, HANGING DROP",,"40% MPD, 12mM Spermine, 80mM KCl, 20mM BaCl2, 40mM NaCacodylate pH7.0",294,"10.1002/anie.201812628",,"6GZ6",8.69,"2.006","2.006","Structure of a left-handed G-quadruplex","GTGGTGGTGGTGTTGTGGTGGTGGTGT","Homo sapiens",,"DNA (27-MER)","1","6GZ6"
"6GZD",,"X-RAY DIFFRACTION",3.02,59.23,"VAPOR DIFFUSION, SITTING DROP",8,"CSNK1A1 at a concentration of 5.8 mg/ml (50 mM Tris-HCl, 300 mM NaCl, 0.25 mM TCEP, pH 8.0) was pre-incubated with 0.7 mM (4.7-fold molar excess) of Mg2+-ATP (120 mM in UPW) for 1 h. 0.1 uL of the protein solution was then mixed with 0.1 uL of reservoir solution (0.10 M MES/NaOH pH 6.8, 10.0% 2-propanol, 26.0% PEG400) and equilibrated at 4 C over 0.06mL of reservoir solution. Well diffracting crystals appeared within 4 days and grew to full size over 23 days.",277.15,"10.1016/j.cell.2018.07.045","LCI","6GZD",45.22,"2.28","2.28","Crystal structure of Human CSNK1A1 with A86","MGSSHHHHHHSSGVDLWSHPQFEKGTENLYFQGGGGRMASSSGSKAEFIVGGKYKLGRKIGSGSFGDIYLATNITNGEEVAVKLESQKARHPQLHYESKLYKILQGGVGIPHIRWYGQEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMISRIEYVHTKNFIHRDIKPDNFLMGIGRHCNKLFLIDFGLAKKYRDNRTRQHIPYREDKNLTGTARYASINAHLGIEQSRRDDMESLGYVLMYFNRTSLPWQGLKAATKKQKYEKISEKKMSTPVEVLCKGFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTMLKQKAAQQAASSSGQGQQAQTPTGKQTDKTKSNMKGF","Homo sapiens","CSNK1A1","Casein kinase I isoform alpha","1","6GZD"
"6GZM",,"X-RAY DIFFRACTION",2.29,46.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"The construct used for crystallization was that of the wild type protein with the mutation R13N. Crystals of CK1d in complex with A-86 were obtained using hanging drop vapour diffusion set-ups. CK1d at a concentration of 13.6 mg/ml (50 mM HEPES, 266 mM NaCl, 1 mM EDTA, 1 mM DTT, 5 mM B-OG, pH 7.5) was pre-incubated with 2 mM (5.1-fold molar excess) of A-86 (150 mM in DMSO) for 1 h. 1 ul of the protein solution was then mixed with 1 ul of reservoir solution (0.1 M Na3-Citrate, pH 4.9, 18 %(w/v) PEG 3350) and equilibrated at 20 C over 0.4 ml of reservoir solution. Well diffracting crystals appeared over night",293.15,"10.1016/j.cell.2018.07.045",,"6GZM",69.87,"1.59","1.59","Crystal Structure of Human CKIdelta with A86","MELRVGNRYRLGNKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","6GZM"
"6GZN",,"SOLUTION NMR",,,,,,,"10.1002/anie.201809328",,"6GZN",6.41,,,"Adenine-driven structural switch from two- to three-quartet DNA G-quadruplex","GGGTAGGGAGCGGGAGAGGG","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*TP*AP*GP*GP*GP*AP*GP*CP*GP*GP*GP*AP*GP*AP*GP*GP*G)-3')","1","6GZN"
"6GZY",,"X-RAY DIFFRACTION",2.46,50.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris HCl pH 8.5, 28% w/v PEG 4000, 0.2 M Li2SO4",291,"10.1021/jacs.8b13193",,"6GZY",52.4,"2.15","2.15","HOIP-fragment5 complex","GPGPEYQAQGLAMYLQENGIDCPKCKFSYALARGGCMHFHCTQCRHQFCSGCYNAFYAKNKCPEPNCRVKKSLHGHHPRDCLFYLRDWTALRLQKLLQDNNVMFNTEPPAGARAVPGGGCRVIEQKEVPNGLRDEACGKETPAGYAGLCQAHYKEYLVSLINAHSLDPATLYEVEELETATERYLHVRPQPLAGEDPPAYQARLLQKLTEEVPLGQSIPRRRK","Homo sapiens","RNF31, ZIBRA","E3 ubiquitin-protein ligase RNF31","1","6GZY"
"6H00",,"X-RAY DIFFRACTION",2.43,49.3,"VAPOR DIFFUSION, SITTING DROP",4.2,"20% PEG1000, 0.2 M lithium sulphate, 0.1 M citrate, pH 4.2",277.15,,,"6H00",30.99,"1.66","1.66","Crystal structure of human pyridoxine 5-phophate oxidase, R116Q variant","MTCWLRGVTATFGRPAEWPGYLSHLCGRSAAMDLGPMRKSYRGDREAFEETHLTSLDPVKQFAAWFEEAVQCPDIGEANAMCLATCTRDGKPSARMLLLKGFGKDGFRFFTNFESQKGKELDSNPFASLVFYWEPLNRQVRVEGPVKKLPEEEAECYFHSRPKSSQIGAVVSHQSSVIPDREYLRKKNEELEQLYQDQEVPKPKSWGGYVLYPQVMEFWQGQTNRLHDRIVFRRGLPTGDSPLGPMTHRGEEDWLYERLAP","Homo sapiens","PNPO","Pyridoxine-5'-phosphate oxidase","1","6H00"
"6H05","2.9","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.bbagen.2021.129889",,"6H05",45.54,"2.9",,"Cryo-electron microscopic structure of the dihydrolipoamide succinyltransferase (E2) component of the human alpha-ketoglutarate (2-oxoglutarate) dehydrogenase complex [residues 218-453]","MASWSHPQFEKGGGSGGGSGGSAWSHPQFEKLEVLFQGPGDDLVTVKTPAFAESVTEGDVRWEKAVGDTVAEDEVVCEIETDKTSVQVPSPANGVIEALLVPDGGKVEGGTPLFTLRKTGAAPAKAKPAEAPAAAAPKAEPTAAAVPPPAAPIPTQMPPVPSPSQPPSGKPVSAVKPTVAPPLAEPGAGKGLRSEHREKMNRMRQRIAQRLKEAQNTCAMLTTFNEIDMSNIQEMRARHKEAFLKKHNLKLGFMSAFVKASAFALQEQPVVNAVIDDTTKEVVYRDYIDISVAVATPRGLVVPVIRNVEAMNFADIERTITELGEKARKNELAIEDMDGGTFTISNGGVFGSLFGTPIINPPQSAILGMHGIFDRPVAIGGKVEVRPMMYVALTYDHRLIDGREAVTFLRKIKAAVEDPRVLLLDL","Homo sapiens","DLST, DLTS","Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial","1","6H05"
"6H0A",,"X-RAY DIFFRACTION",4,69.2,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bis-Tris Propane pH 6.5, 0.2M Sodium Bromide and 20% PEG 3350",291,"10.1093/molbev/msz298",,"6H0A",40.6,"2.1","2.1","Serum paraoxonase-1 by directed evolution with the L69G/H115W/H134R/F222S/T332S mutations","MAKLTALTLLGMGLALFDRQKSSFQTRFNVHREVTPVELPNCNLVKGIDNGSEDLEILPNGLAFISSGGKYPGIMSFDPDKSGKILLMDLNEKEPAVSELEIIGNTLDISSFNPWGISTFIDDDNTVYLLVVNRPGSSSTVEVFKFQEEEKSLLHLKTIRHKLLPSVNDIVAVGPEHFYATNDHYFIDPYLKSWEMHLGLAWSFVTYYSPNDVRVVAEGFDSANGINISPDGKYVYIAELLAHKIHVYEKHANWTLTPLRVLSFDTLVDNISVDPVTGDLWVGCHPNGMRIFFYDAENPPGSEVLRIQDILSEEPKVTVVYAENGTVLQGSSVAAVYKGKLLIGTVFHKALYCDL","Homo sapiens",,"Serum Paraoxonase-1 by directed evolution with the L69G/H115W/H134R/F222S/T332S mutations","1","6H0A"
"6H0M",,"X-RAY DIFFRACTION",2.43,49.47,"VAPOR DIFFUSION, SITTING DROP",7.1,"PEG 6000 20% W/V
HEPES 0.1 M
DMSO 5%",291.15,,,"6H0M",29.22,"1.25","1.25","17beta-hydroxysteroid dehydrogenase type 14 mutant K158A in complex with Nicotinamide Adenine Dinucleotide","MATGTRYAGKVVVVTGGGRGIGAGIVRAFVNSGARVVICDKDESGGRALEQELPGAVFILCDVTQEDDVKTLVSETIRRFGRLDCVVNNAGHHPPPQRPEETSAQGFRQLLELNLLGTYTLTKLALPYLRKSQGNVINISSLVGAIGQAQAVPYVATAGAVTAMTKALALDESPYGVRVNCISPGNIWTPLWEELAALMPDPRASIREGMLAQPLGRMGQPAEVGAAAVFLASEANFCTGIELLVTGGAELGYGCKASRSTPVDAPDIPS","Homo sapiens","HSD17B14, DHRS10, SDR3, SDR47C1, UNQ502/PRO474","17-beta-hydroxysteroid dehydrogenase 14","1","6H0M"
"6H0T",,"X-RAY DIFFRACTION",2.74,55.11,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, cacodylate, zinc acetate",293,"10.1016/j.tox.2018.10.015",,"6H0T",61.59,"1.9","1.9","Crystal structure of native recombinant human bile salt activated lipase","HHHHHHHHENLYFQSKLGAVYTEGGFVEGVNKKLGLLGDSVDIFKGIPFAAPTKALENPQPHPGWQGTLKAKNFKKRCLQATITQDSTYGDEDCLYLNIWVPQGRKQVSRDLPVMIWIYGGAFLMGSGHGANFLNNYLYDGEEIATRGNVIVVTFNYRVGPLGFLSTGDANLPGNYGLRDQHMAIAWVKRNIAAFGGDPDNITLFGESAGGASVSLQTLSPYNKGLIRRAISQSGVALSPWVIQKNPLFWAKKVAEKVGCPVGDAARMAQCLKVTDPRALTLAYKVPLAGLEYPMLHYVGFVPVIDGDFIPDDPINLYANAADIDYIAGTNNMDGHIFASIDMPAINKGNKKVTEEDFYKLVSEFTITKGLRGAKTTFDVYTESWAQDPSQENKKKTVVDFETDVLFLVPTEIALAQHRANAKSAKTYAYLFSHPSRMPVYPKWVGADHADDIQYVFGKPFATPTGYRPQDRTVSKAMIAYWTNFAKTGDPNMGDSAVPTHWEPYTTENSGYLEITKKMGSSSMKRSLRTNFLRYWTLTYLALPTVT","Homo sapiens","CEL, BAL","Bile salt-activated lipase","1","6H0T"
"6H0U",,"X-RAY DIFFRACTION",2.65,53.54,"VAPOR DIFFUSION, SITTING DROP",7,"GSK3beta(35-386) aliquots were concentrated to 4.4 mg/ml and used for crystallization trials. GSK3b-inhibitor co-crystals were grown using the sitting drop vapor diffusion technique in 0.2M DL-Malic acid pH 7.0, 20% PEG 3350 as reservoir solution. The protein was previously incubated with 3x molar excess of compound for 3h at 4C. Crystallization drops were prepared from 0.5ul of protein solution and 0.5ul of reservoir, and incubated for 10 days at 20C. Crystals were cryoprotected in 30% Glycerol and frozen in liquid nitrogen prior to data collection.",293,"10.1002/cmdc.201800778","CL","6H0U",94.73,"2.3","2.3","Glycogen synthase kinase-3 beta (GSK3) complex with a covalent [1,2,4]triazolo[1,5-a][1,3,5]triazine inhibitor","MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","6H0U"
"6H0V",,"X-RAY DIFFRACTION",2.55,51.83,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, cacodylate, Zinc acetate",293,"10.1016/j.tox.2018.10.015",,"6H0V",61.44,"2.2","2.2","Crystal structure of tabun surrogate NEDPA inhibited recombinant human bile salt activated lipase","HHHHHHHHENLYFQSKLGAVYTEGGFVEGVNKKLGLLGDSVDIFKGIPFAAPTKALENPQPHPGWQGTLKAKNFKKRCLQATITQDSTYGDEDCLYLNIWVPQGRKQVSRDLPVMIWIYGGAFLMGSGHGANFLNNYLYDGEEIATRGNVIVVTFNYRVGPLGFLSTGDANLPGNYGLRDQHMAIAWVKRNIAAFGGDPDNITLFGESAGGASVSLQTLSPYNKGLIRRAISQSGVALSPWVIQKNPLFWAKKVAEKVGCPVGDAARMAQCLKVTDPRALTLAYKVPLAGLEYPMLHYVGFVPVIDGDFIPDDPINLYANAADIDYIAGTNNMDGHIFASIDMPAINKGNKKVTEEDFYKLVSEFTITKGLRGAKTTFDVYTESWAQDPSQENKKKTVVDFETDVLFLVPTEIALAQHRANAKSAKTYAYLFSHPSRMPVYPKWVGADHADDIQYVFGKPFATPTGYRPQDRTVSKAMIAYWTNFAKTGDPNMGDSAVPTHWEPYTTENSGYLEITKKMGSSSMKRSLRTNFLRYWTLTYLALPTVT","Homo sapiens","CEL, BAL","Bile salt-activated lipase","1","6H0V"
"6H0W",,"X-RAY DIFFRACTION",2.53,51.32,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6H0W",40.94,"1.23","1.23","Crystal Structure of KDM4D with tetrazolylhydrazide ligand NS035","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6H0W"
"6H0X",,"X-RAY DIFFRACTION",2.57,52.1,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6H0X",40.16,"1.64","1.64","Crystal Structure of KDM4D with tetrazolylhydrazide ligand AA040","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6H0X"
"6H0Y",,"X-RAY DIFFRACTION",2.53,51.43,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6H0Y",40.59,"1.212","1.212","Crystal Structure of KDM4D with tetrazolylhydrazide ligand NS022","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6H0Y"
"6H0Z",,"X-RAY DIFFRACTION",2.56,51.92,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6H0Z",40.73,"1.34","1.34","Crystal Structure of KDM4D with tetrazolylhydrazide ligand NR067","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6H0Z"
"6H10",,"X-RAY DIFFRACTION",2.52,51.28,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6H10",41.06,"1.104","1.104","Crystal Structure of KDM4D with tetrazolylhydrazide ligand NR073","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6H10"
"6H11",,"X-RAY DIFFRACTION",2.58,52.24,"VAPOR DIFFUSION",7,"100mM HEPES, 180mM ammonium sulphate, 24% PEG 3350",293,,,"6H11",40.3,"1.516","1.516","Crystal Structure of KDM4D with tetrazolylhydrazide ligand AA028","METMKSKANCAQNPNCNIMIFHPTKEEFNDFDKYIAYMESQGAHRAGLAKIIPPKEWKARETYDNISEILIATPLQQVASGRAGVFTQYHKKKKAMTVGEYRHLANSKKYQTPPHQNFEDLERKYWKNRIYNSPIYGADISGSLFDENTKQWNLGHLGTIQDLLEKECGVVIEGVNTPYLYFGMWKTTFAWHTEDMDLYSINYLHLGEPKTWYVVPPEHGQRLERLARELFPGSSRGCGAFLRHKVALISPTVLKENGIPFNRITQEAGEFMVTFPYGYHAGFNHGFNCAEAINFATPRWIDYGKMASQCSCGEARVTFSMDAFVRILQPERYDLWKRGQDR","Homo sapiens","KDM4D, JHDM3D, JMJD2D","Lysine-specific demethylase 4D","1","6H11"
"6H18",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, cacodylate, Zinc Acetate",293,"10.1016/j.tox.2018.10.015",,"6H18",62,"1.85","1.85","Crystal structure of sarin surrogate NIMP inhibited recombinant human bile salt activated lipase","HHHHHHHHENLYFQSKLGAVYTEGGFVEGVNKKLGLLGDSVDIFKGIPFAAPTKALENPQPHPGWQGTLKAKNFKKRCLQATITQDSTYGDEDCLYLNIWVPQGRKQVSRDLPVMIWIYGGAFLMGSGHGANFLNNYLYDGEEIATRGNVIVVTFNYRVGPLGFLSTGDANLPGNYGLRDQHMAIAWVKRNIAAFGGDPDNITLFGESAGGASVSLQTLSPYNKGLIRRAISQSGVALSPWVIQKNPLFWAKKVAEKVGCPVGDAARMAQCLKVTDPRALTLAYKVPLAGLEYPMLHYVGFVPVIDGDFIPDDPINLYANAADIDYIAGTNNMDGHIFASIDMPAINKGNKKVTEEDFYKLVSEFTITKGLRGAKTTFDVYTESWAQDPSQENKKKTVVDFETDVLFLVPTEIALAQHRANAKSAKTYAYLFSHPSRMPVYPKWVGADHADDIQYVFGKPFATPTGYRPQDRTVSKAMIAYWTNFAKTGDPNMGDSAVPTHWEPYTTENSGYLEITKKMGSSSMKRSLRTNFLRYWTLTYLALPTVT","Homo sapiens","CEL, BAL","Bile salt-activated lipase","1","6H18"
"6H19",,"X-RAY DIFFRACTION",2.48,50.46,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, cacodylate, zinc acetate",293,"10.1016/j.tox.2018.10.015",,"6H19",61.97,"1.89","1.89","Crystal structure of ethyl-paraoxon inhibited recombinant human bile salt activated lipase (aged form)","HHHHHHHHENLYFQSKLGAVYTEGGFVEGVNKKLGLLGDSVDIFKGIPFAAPTKALENPQPHPGWQGTLKAKNFKKRCLQATITQDSTYGDEDCLYLNIWVPQGRKQVSRDLPVMIWIYGGAFLMGSGHGANFLNNYLYDGEEIATRGNVIVVTFNYRVGPLGFLSTGDANLPGNYGLRDQHMAIAWVKRNIAAFGGDPDNITLFGESAGGASVSLQTLSPYNKGLIRRAISQSGVALSPWVIQKNPLFWAKKVAEKVGCPVGDAARMAQCLKVTDPRALTLAYKVPLAGLEYPMLHYVGFVPVIDGDFIPDDPINLYANAADIDYIAGTNNMDGHIFASIDMPAINKGNKKVTEEDFYKLVSEFTITKGLRGAKTTFDVYTESWAQDPSQENKKKTVVDFETDVLFLVPTEIALAQHRANAKSAKTYAYLFSHPSRMPVYPKWVGADHADDIQYVFGKPFATPTGYRPQDRTVSKAMIAYWTNFAKTGDPNMGDSAVPTHWEPYTTENSGYLEITKKMGSSSMKRSLRTNFLRYWTLTYLALPTVT","Homo sapiens","CEL, BAL","Bile salt-activated lipase","1","6H19"
"6H1A",,"X-RAY DIFFRACTION",2.51,50.98,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8000, cacodylate, zinc acetate",293,"10.1016/j.tox.2018.10.015",,"6H1A",61.98,"1.75","1.75","Crystal structure of VX surrogate NEMP inhibited recombinant human bile salt activated lipase","HHHHHHHHENLYFQSKLGAVYTEGGFVEGVNKKLGLLGDSVDIFKGIPFAAPTKALENPQPHPGWQGTLKAKNFKKRCLQATITQDSTYGDEDCLYLNIWVPQGRKQVSRDLPVMIWIYGGAFLMGSGHGANFLNNYLYDGEEIATRGNVIVVTFNYRVGPLGFLSTGDANLPGNYGLRDQHMAIAWVKRNIAAFGGDPDNITLFGESAGGASVSLQTLSPYNKGLIRRAISQSGVALSPWVIQKNPLFWAKKVAEKVGCPVGDAARMAQCLKVTDPRALTLAYKVPLAGLEYPMLHYVGFVPVIDGDFIPDDPINLYANAADIDYIAGTNNMDGHIFASIDMPAINKGNKKVTEEDFYKLVSEFTITKGLRGAKTTFDVYTESWAQDPSQENKKKTVVDFETDVLFLVPTEIALAQHRANAKSAKTYAYLFSHPSRMPVYPKWVGADHADDIQYVFGKPFATPTGYRPQDRTVSKAMIAYWTNFAKTGDPNMGDSAVPTHWEPYTTENSGYLEITKKMGSSSMKRSLRTNFLRYWTLTYLALPTVT","Homo sapiens","CEL, BAL","Bile salt-activated lipase","1","6H1A"
"6H1H",,"X-RAY DIFFRACTION",2.37,48.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"1 microliter of protein 50 mg/mL and 1 microliter of reservoir solution containing 0.1 M HEPES (pH 7.5), 8 % ethylene glycol, 20 % (w/v) PEG 8,000, placed over 200 microliters of reservoir solution",277,"10.1021/acsmedchemlett.8b00364",,"6H1H",33.21,"1.54","1.54","Crystal structure of human Pirin in complex with compound 7 (PLX4720)","GSHMGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","PIR","Pirin","1","6H1H"
"6H1I",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"1 microliter of protein 50 mg/mL and 1 microliter of reservoir solution containing 0.1 M HEPES (pH 7.5), 8 % ethylene glycol, 20 % (w/v) PEG 8,000, placed over 200 microliters of reservoir solution",277,"10.1021/acsmedchemlett.8b00364","FJH","6H1I",33.23,"1.69","1.69","Crystal structure of human Pirin in complex with bisamide compound 2","GSHMGSSKKVTLSVLSREQSEGVGARVRRSIGRPELKNLDPFLLFDEFKGGRPGGFPDHPHRGFETVSYLLEGGSMAHEDFCGHTGKMNPGDLQWMTAGRGILHAEMPCSEEPAHGLQLWVNLRSSEKMVEPQYQELKSEEIPKPSKDGVTVAVISGEALGIKSKVYTRTPTLYLDFKLDPGAKHSQPIPKGWTSFIYTISGDVYIGPDDAQQKIEPHHTAVLGEGDSVQVENKDPKRSHFVLIAGEPLREPVIQHGPFVMNTNEEISQAILDFRNAKNGFERAKTWKSKIGN","Homo sapiens","PIR","Pirin","1","6H1I"
"6H23",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",6.5,"magnesium chloride, MES, PEG4000",293,"10.1002/anie.201808189",,"6H23",357.66,"3.089","3.089","Crystal structure of the hClpP Y118A mutant with an activating small molecule","PLIPIVVEQTGRGERAYDIYSRLLRERIVCVMGPIDDSVASLVIAQLLFLQSESNKKPIHMAINSPGGVVTAGLAIYDTMQYILNPICTWCVGQAASMGSLLLAAGTPGMRHSLPNSRIMIHQPSGGARGQATDIAIQAEEIMKLKKQLYNIYAKHTKQSLQVIESAMERDRYMSPMEAQEFGILDKVLVHPPQDGEDEPTLVQKEPVEAAPAAEPVPASTWSHPQFEK","Homo sapiens","CLPP","ATP-dependent Clp protease proteolytic subunit, mitochondrial","1","6H23"
"6H29",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, HANGING DROP",8,"1.3 M sodium citrate, 60 mM Tris-HCl",293,"10.1039/c8cc05755a","FK8","6H29",29.51,"1.46","1.46","HUMAN CARBONIC ANHYDRASE II IN COMPLEX WITH BENZYL CARBAMATE","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6H29"
"6H2P",,"X-RAY DIFFRACTION",2.75,55.22,"VAPOR DIFFUSION",6.9,"100mM NaCacodylate, 690-760mM NaCitrate",293,"10.1111/febs.14620",,"6H2P",109.98,"1.479","1.479","Crystal Structure of Arg184Gln mutant of Human Prolidase with Mn ions and Cacodylate ligand","MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECQVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKFTPFSGPK","Homo sapiens","PEPD, PRD","Xaa-Pro dipeptidase","1","6H2P"
"6H2Q",,"X-RAY DIFFRACTION",2.75,55.27,"VAPOR DIFFUSION, SITTING DROP",6.9,"100mM NaCacodylate, 690-760mM NaCitrate",293,"10.1111/febs.14620",,"6H2Q",110.16,"1.78","1.78","Crystal Structure of Arg184Gln mutant of Human Prolidase with Mn ions and LeuPro ligand","MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEPGCYGVIDVDTGKSTLFVPRLPASHATWMGKIHSKEHFKEKYAVDDVQYVDEIASVLTSQKPSVLLTLRGVNTDSGSVCREASFDGISKFEVNNTILHPEIVECQVFKTDMELEVLRYTNKISSEAHREVMKAVKVGMKEYELESLFEHYCYSRGGMRHSSYTCICGSGENSAVLHYGHAGAPNDRTIQNGDMCLFDMGGEYYCFASDITCSFPANGKFTADQKAVYEAVLRSSRAVMGAMKPGVWWPDMHRLADRIHLEELAHMGILSGSVDAMVQAHLGAVFMPHGLGHFLGIDVHDVGGYPEGVERIDEPGLRSLRTARHLQPGMVLTVEPGIYFIDHLLDEALADPARASFLNREVLQRFRGFGGVRIEEDVVVTDSGIELLTCVPRTVEEIEACMAGCDKAFTPFSGPK","Homo sapiens","PEPD, PRD","Xaa-Pro dipeptidase","1","6H2Q"
"6H2Z",,"X-RAY DIFFRACTION",2.05,40.05,"VAPOR DIFFUSION, HANGING DROP",8.5,"sodium citrate 1.3M, Tris-HCl 0.1 M, pH 8.5",293,"10.1016/j.ejmech.2018.11.073","FKE","6H2Z",30.07,"1.94","1.94","The crystal structure of human carbonic anhydrase II in complex with 4-(4-phenylpiperidine-1-carbonyl)benzenesulfonamide.","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6H2Z"
"6H33",,"X-RAY DIFFRACTION",2.06,40.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"sodium citrate 1.3 M, Tris-HCl 0.1 M, pH 8.5",293,"10.1016/j.ejmech.2018.11.073","FKQ","6H33",30,"1.58","1.58","The crystal structure of human carbonic anhydrase II in complex with 4-(4-phenyl)-4-hydroxy-1-piperidine-1-carbonyl)benzenesulfonamide.","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6H33"
"6H34",,"X-RAY DIFFRACTION",2.07,40.67,"VAPOR DIFFUSION, HANGING DROP",8.5,"Sodium citrate 1.3 M, Tris-HCl 0.1 M pH 8.5",293,"10.1016/j.ejmech.2018.11.073","FKK","6H34",30.01,"1.55","1.55","The crystal structure of human carbonic anhydrase II in complex with 4-[(4-fluorophenyl)methyl]-1-piperazinyl]benzenesulfonamide.","MGMSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6H34"
"6H36",,"X-RAY DIFFRACTION",2.07,40.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% v/v Peg3350, 0.2 M Ammonium acetate, 0.1 M Tris-HCl pH 8.5",293,"10.1016/j.ejmech.2018.11.073","FKE","6H36",31.34,"1.85","1.85","The crystal structure of human carbonic anhydrase VII in complex with 4-(4-phenylpiperidine-1-carbonyl)benzenesulfonamide.","MGMTGHHGWGYGQDDGPSHWHKLYPIAQGDRQSPINIISSQAVYSPSLQPLELSYEACMSLSITNNGHSVQVDFNDSDDRTVVTGGPLEGPYRLKQFHFHWGKKHDVGSEHTVDGKSFPSELHLVHWNAKKYSTFGEAASAPDGLAVVGVFLETGDEHPSMNRLTDALYMVRFKGTKAQFSCFNPKSLLPASRHYWTYPGSLTTPPLSESVTWIVLREPISISERQMGKFRSLLFTSEDDERIHMVNNFRPPQPLKGRVVKASFRALEHHHHHH","Homo sapiens","CA7","Carbonic anhydrase 7","1","6H36"
"6H37",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% v/v Peg3350, 0.2 M Ammonium acetate, 0.1 M Tris pH 8.5",293,"10.1016/j.ejmech.2018.11.073","FKQ","6H37",31.35,"1.9","1.9","The crystal structure of human carbonic anhydrase VII in complex with 4-(4-phenyl)-4-hydroxy-1-piperidine-1-carbonyl)benzenesulfonamide","MGMTGHHGWGYGQDDGPSHWHKLYPIAQGDRQSPINIISSQAVYSPSLQPLELSYEACMSLSITNNGHSVQVDFNDSDDRTVVTGGPLEGPYRLKQFHFHWGKKHDVGSEHTVDGKSFPSELHLVHWNAKKYSTFGEAASAPDGLAVVGVFLETGDEHPSMNRLTDALYMVRFKGTKAQFSCFNPKSLLPASRHYWTYPGSLTTPPLSESVTWIVLREPISISERQMGKFRSLLFTSEDDERIHMVNNFRPPQPLKGRVVKASFRALEHHHHHH","Homo sapiens","CA7","Carbonic anhydrase 7","1","6H37"
"6H38",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% v/v Peg3350, 0.2 M Ammonium acetate, 0.1 M Tris-HCl pH 8.5",293,"10.1016/j.ejmech.2018.11.073","FKK","6H38",31.55,"1.7","1.7","The crystal structure of human carbonic anhydrase VII in complex with 4-[(4-fluorophenyl)methyl]-1-piperazinyl]benzenesulfonamide.","MGMTGHHGWGYGQDDGPSHWHKLYPIAQGDRQSPINIISSQAVYSPSLQPLELSYEACMSLSITNNGHSVQVDFNDSDDRTVVTGGPLEGPYRLKQFHFHWGKKHDVGSEHTVDGKSFPSELHLVHWNAKKYSTFGEAASAPDGLAVVGVFLETGDEHPSMNRLTDALYMVRFKGTKAQFSCFNPKSLLPASRHYWTYPGSLTTPPLSESVTWIVLREPISISERQMGKFRSLLFTSEDDERIHMVNNFRPPQPLKGRVVKASFRALEHHHHHH","Homo sapiens","CA7","Carbonic anhydrase 7","1","6H38"
"6H3E",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1905105116",,"6H3E",2.26,,,"Receptor-bound Ghrelin conformation","GSDFLSPEHQRVQQRKESX","Homo sapiens","GHRL, MTLRP, UNQ524/PRO1066","Appetite-regulating hormone","1","6H3E"
"6H3K",,"X-RAY DIFFRACTION",3.43,64.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Bis-Tris propane; 
0.1 M MgCl2
0.1 M Sodium formate
18-26% PEG3350",291.15,"10.1021/acs.jmedchem.8b00690","FMW","6H3K",33,"2.48","2.48","Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.","QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","6H3K"
"6H3M",,"X-RAY DIFFRACTION",1.8,31.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.8 M NaCl, 35 mM NaCitrate, 0.5 mM ZnAcetate, 0.3 M Tris pH 7.5",293,"10.1002/chem.201900892",,"6H3M",47.29,"1.821","1.821","The crystal structure of a human seleno-insulin analog","GIVEQUCTSIUSLYQLENYCN","Homo sapiens","INS","Insulin","1","6H3M"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","6H3M"
"6H3Q",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION",8,"1.5 M sodium citrate, Tris 50 mM",296,"10.1016/j.ejmech.2018.08.096","FMH","6H3Q",29.69,"1.31","1.31","Crystal structure of human carbonic anhydrase II in complex with the 4-(5-(chloromethyl)-1,3-selenazol-2-yl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6H3Q"
"6H42",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION, SITTING DROP",,"100 mM Tris pH 7.8
200 mM KBr
200 mM KSCN
3 % (w/v) PGA-LM
5 % PEG 4000",273,"10.3390/biom8030081",,"6H42",87.26,"2.45","2.45","crystal structure of the human TGT catalytic subunit QTRT1","ESAPRIMRLVAECSRSRARAGELWLPHGTVATPVFMPVGTQATMKGITTEQLDALGCRICLGNTYHLGLRPGPELIQKANGLHGFMNWPHNLLTDSGGFQMVSLVSLSEVTEEGVRFRSPYDGNETLLSPEKSVQIQNALGSDIIMQLDDVVSSTVTGPRVEEAMYRSIRWLDRCIAAHQRPDKQNLFAIIQGGLDADLRATCLEEMTKRDVPGFAIGGLSGGESKSQFWRMVALSTSRLPKDKPRYLMGVGYATDLVVCVALGCDMFDCVFPTRTARFGSALVPTGNLQLRKKVFEKDFGPIDPECTCPTCQKHSRAFLHALLHSDNTAALHHLTVHNIAYQLQLMSAVRTSIVEKRFPDFVRDFMGAMYGDPTLCPTWATDALASVGITLG","Homo sapiens","QTRT1, TGT, TGUT","Queuine tRNA-ribosyltransferase catalytic subunit 1","1","6H42"
"6H45",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Tris pH 7.8
200 mM KBr
200 mM KSCN
3 % (w/v) PGA-LM
5 % (w/v) PEG 4000",293,"10.3390/biom8030081",,"6H45",87.64,"2.4","2.4","crystal structure of the human TGT catalytic subunit QTRT1 in complex with queuine","SAPRIMRLVAECSRSRARAGELWLPHGTVATPVFMPVGTQATMKGITTEQLDALGCRICLGNTYHLGLRPGPELIQKANGLHGFMNWPHNLLTDSGGFQMVSLVSLSEVTEEGVRFRSPYDGNETLLSPEKSVQIQNALGSDIIMQLDDVVSSTVTGPRVEEAMYRSIRWLDRCIAAHQRPDKQNLFAIIQGGLDADLRATCLEEMTKRDVPGFAIGGLSGGESKSQFWRMVALSTSRLPKDKPRYLMGVGYATDLVVCVALGCDMFDCVFPTRTARFGSALVPTGNLQLRKKVFEKDFGPIDPECTCPTCQKHSRAFLHALLHSDNTAALHHLTVHNIAYQLQLMSAVRTSIVEKRFPDFVRDFMGAMYGDPTLCPTWATDALASVGITLG","Homo sapiens","QTRT1, TGT, TGUT","Queuine tRNA-ribosyltransferase catalytic subunit 1","1","6H45"
"6H4A",,"X-RAY DIFFRACTION",2.03,39.41,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 2000
0.1M Mes pH 6.5",293,"10.1038/s41589-018-0222-1","FNB","6H4A",46.17,"2.65","2.65","Human MALT1(329-728) in complex with MLT-748","GPGSDNKEQTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRGLGRKTCFQ","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","6H4A"
"6H4I",,"X-RAY DIFFRACTION",4.17,70.47,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M citric acid pH 5.0 
0.8 M Ammonium Sulfate",293,"10.1016/j.molcel.2019.02.029",,"6H4I",131.82,"3.22","3.22","Usp28 catalytic domain apo","GPNPNDWRRVDGWPVGLKNVGNTCWFSAVIQSLFQLPEFRRLVLSYSLPQNVLENCRSHTEKRNIMFMQELQYLFALMMGSNRKFVDPSAALDLLKGAFRSSEEQQQDVSEFTHKLLDWLEDAFQLAVNVNSPRNKSENPMVQLFYGTFLTEGVREGKPFCNNETFGQYPLQVNGYRNLDECLEGAMVEGDVELLPSDHSVKYGQERWFTKLPPVLTFELSRFEFNQSLGQPEKIHNKLEFPQIIYMDRYMYRSKELIRNKRECIRKLKEEIKILQQKLERYVKYGSGPARFPLPDMLKYVIEFASTKPASESCPPESDTHMTLPLSSVHCSVSDQTSKESTSTESSSQDVESTFSSPEDSLPKSKPLTSSRSSMEMPSQPAPRTVTDEEINFVKTCLQRWRSEIEQDIQDLKTCIASTTQTIEQMYCDPLLRQVPYRLHAVLVHEGQANAGHYWAYIYNQPRQSWLKYNDISVTESSWEEVERDSYGGLRNVSAYCLMYINDKLPYFNAEAAPTESDQMSEVEALSVELKHYIQEDNWRFEQEVEEWEEEQSCKIPQME","Homo sapiens","USP28, KIAA1515","Ubiquitin carboxyl-terminal hydrolase 28","1","6H4I"
"6H4J",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes pH 7.5
12% w/v PEG4000 
0.2 M MgCl2",293,"10.1016/j.molcel.2019.02.029",,"6H4J",128.5,"3.07","3.07","Usp25 catalytic domain","GPNPYDRKRQDKAPVGLKNVGNTCWFSAVIQSLFNLLEFRRLVLNYKPPSNAQDLPRNQKEHRNLPFMRELRYLFALLVGTKRKYVDPSRAVEILKDAFKSNDSQQQDVSEFTHKLLDWLEDAFQMKAEEETDEEKPKNPMVELFYGRFLAVGVLEGKKFENTEMFGQYPLQVNGFKDLHECLEAAMIEGEIESLHSENSGKSGQEHWFTELPPVLTFELSRFEFNQALGRPEKIHNKLEFPQVLYLDRYMHRNREITRIKREEIKRLKDYLTVLQQRLERYLSYGSGPKRFPLVDVLQYALEFASSKPVCTSPVDDIDASSPPSGSIPSQTLPSTTEQQGALSSELPSTSPSSVAAISSRSVIHKPFTQSRIPPDLPMHPAPRHITEEELSVLESCLHRWRTEIENDTRDLQESISRIHRTIELMYSDKSMIQVPYRLHAVLVHEGQANAGHYWAYIFDHRESRWMKYNDIAVTKSSWEELVRDSFGGYRNASAYCLMYINDKAQFLIQEEFNKETGQPLVGIETLPPDLRDFVEEDNQRFEKELEEWDAQ","Homo sapiens","USP25, USP21","Ubiquitin carboxyl-terminal hydrolase 25","1","6H4J"
"6H4K",,"X-RAY DIFFRACTION",2.34,47.42,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Tris pH 8.5
22% w/v PEG4000
0.2M SrCl2",293,"10.1016/j.molcel.2019.02.029",,"6H4K",35.18,"2.05","2.05","Structure of the Usp25 C-terminal domain","GPSHEHEDKSPETVLQSAIKLEYARLVKLAQEDTPPETDYRLHHVVVYFIQNQAPKKIIEKTLLEQFGDRNLSFDERCHNIMKVAQAKLEMIKPEEVNLEEYEEWHQDYRKFRETTMYLIIGLENFQRESYIDSLLFLICAYQNNKELLSKGLYRGHDEELISHYRRECLLKLNEQAAELFESGEDREVNNGLIIMNEFIVPFLPLLLVDEMEEKDILAVEDMRNRWCSYLGQEMEPHLQEKLTDFLPKLLDCSMEIKSFHEPPKLPSYSTHELCERFARIMLSLSRTPADGR","Homo sapiens","USP25, USP21","Ubiquitin carboxyl-terminal hydrolase 25","1","6H4K"
"6H4L",,"X-RAY DIFFRACTION",4.42,72.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"MES pH 6.5
2M RbBr",293,"10.1371/journal.pone.0226693",,"6H4L",11.72,"1.6","1.6","Structure of Titin M4 trigonal form","GPFTLDHAPRITLRMRSHRVPCGQNTRFILNVQSKPTAEVKWYHNGVELQESSKIHYTNTSGVLTLEILDCHTDDSGTYRAVCTNYKGEASDYATLDVTGGDY","Homo sapiens","TTN","Titin","1","6H4L"
"6H4O",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",291,"10.1016/j.ejmech.2019.05.041","FQH","6H4O",170.31,"2.25","2.25","Crystal structure of human KDM4A in complex with compound 18a","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4O"
"6H4P",,"X-RAY DIFFRACTION",2.49,50.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",293,"10.1016/j.ejmech.2019.05.041","FQ5","6H4P",170.59,"2.19","2.19","Crystal structure of human KDM4A in complex with compound 16a","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4P"
"6H4Q",,"X-RAY DIFFRACTION",2.45,49.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",293,"10.1016/j.ejmech.2019.05.041","FO2","6H4Q",169.87,"2.31","2.31","Crystal structure of human KDM4A in complex with compound 34a","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4Q"
"6H4R",,"X-RAY DIFFRACTION",2.47,50.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",293,"10.1016/j.ejmech.2019.05.041","FQB","6H4R",170.13,"2.14","2.14","Crystal structure of human KDM4A in complex with compound 17f","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4R"
"6H4S",,"X-RAY DIFFRACTION",2.46,50.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",293,"10.1016/j.ejmech.2019.05.041","FQE","6H4S",170.25,"2.45","2.45","Crystal structure of human KDM4A in complex with compound 16m","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4S"
"6H4T",,"X-RAY DIFFRACTION",2.48,50.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",293,"10.1016/j.ejmech.2019.05.041","FOW","6H4T",170.35,"2.38","2.38","Crystal structure of human KDM4A in complex with compound 19a","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4T"
"6H4U",,"X-RAY DIFFRACTION",2.62,53.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",293,"10.1016/j.ejmech.2019.05.041",,"6H4U",169.9,"2.21","2.21","Crystal structure of human KDM4A in complex with compound 34b","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4U"
"6H4V",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",293,"10.1016/j.ejmech.2019.05.041","FQN","6H4V",169.97,"2.15","2.15","Crystal structure of human KDM4A in complex with compound 34g","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4V"
"6H4W",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",293,"10.1016/j.ejmech.2019.05.041",,"6H4W",170.09,"2.81","2.81","Crystal structure of human KDM4A in complex with compound 19d","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4W"
"6H4X",,"X-RAY DIFFRACTION",2.46,50.04,"VAPOR DIFFUSION, SITTING DROP",,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",291,"10.1016/j.ejmech.2019.05.041","FNQ","6H4X",170.42,"2.34","2.34","Crystal structure of human KDM4A in complex with compound 17b","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4X"
"6H4Y",,"X-RAY DIFFRACTION",2.47,50.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"Crystallisation solution is 0.1M Bis-Tris-Propane pH7.5, 12-16% PEG-4000. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",291,"10.1016/j.ejmech.2019.05.041","FO8","6H4Y",170.51,"2.38","2.38","Crystal structure of human KDM4A in complex with compound 17e","SMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","6H4Y"
"6H4Z",,"X-RAY DIFFRACTION",4.19,70.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 nL of protein is mixed with 200 nL of crystallisation solution containing 1.6 M Na/K phosphate, 0.1 M HEPES pH 7.5, and with 20 nL of seeds obtained in the same conditions. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",277,"10.1016/j.ejmech.2019.05.041","FQ5","6H4Z",57.7,"2.3","2.3","Crystal structure of human KDM5B in complex with compound 16a","SMFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKLGGGGARDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAESYNEWALNVNEALEAKINK","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6H4Z"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6H50",,"X-RAY DIFFRACTION",4.03,69.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 nL of protein is mixed with 200 nL of crystallisation solution containing 1.6 M Na/K phosphate, 0.1 M HEPES pH 7.5, and with 20 nL of seeds obtained in the same conditions. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",277,"10.1016/j.ejmech.2019.05.041","FO2","6H50",56.68,"2.19","2.19","Crystal structure of human KDM5B in complex with compound 34a","SMFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKLGGGGARDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAESYNEWALNVNEALEAKINK","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6H50"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6H51",,"X-RAY DIFFRACTION",4,69.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 nL of protein is mixed with 200 nL of crystallisation solution containing 1.6 M Na/K phosphate, 0.1 M HEPES pH 7.5, and with 20 nL of seeds obtained in the same conditions. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",277,"10.1016/j.ejmech.2019.05.041","FQK","6H51",56.86,"2.21","2.21","Crystal structure of human KDM5B in complex with compound 34f","SMFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKLGGGGARDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAESYNEWALNVNEALEAKINK","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6H51"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6H52",,"X-RAY DIFFRACTION",4.01,69.29,"VAPOR DIFFUSION",7.5,"100 nL of protein is mixed with 200 nL of crystallisation solution containing 1.6 M Na/K phosphate, 0.1 M HEPES pH 7.5, and with 20 nL of seeds obtained in the same conditions. Inhibitor is soaked in crystals by addition directly to the drops of DMSO dissolved compound",277,"10.1016/j.ejmech.2019.05.041","FQN","6H52",56.95,"2.14","2.14","Crystal structure of human KDM5B in complex with compound 34g","SMFLPPPECPVFEPSWEEFADPFAFIHKIRPIAEQTGICKVRPPPDWQPPFACDVDKLHFTPRIQRLNELEAQTRVKLGGGGARDYTLRTFGEMADAFKSDYFNMPVHMVPTELVEKEFWRLVSTIEEDVTVEYGADIASKEFGSGFPVRDGKIKLSPEEEEYLDSGWNLNNMPVMEQSVLAHITADICGMKLPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPGYAAEQLENVMKKLAPELFVSQPDLLHQLVTIMNPNTLMTHEVPVYRTNQCAGEFVITFPRAYHSGFNQGFNFAEAVNFCTVDWLPLGRQCVEHYRLLHRYCVFSHDEMICKMASKADVLDVVVASTVQKDMAIMIEDEKALRETVRKLGVIDSERMDFELLPDDERQCVKCKTTCFMSAISCSCKPGLLVCLHHVKELCSCPPYKYKLRYRYTLDDLYPMMNALKLRAESYNEWALNVNEALEAKINK","Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1","Lysine-specific demethylase 5B,Lysine-specific demethylase 5B","1","6H52"
,,,,,,,,,,,,,,,,,"Homo sapiens","KDM5B, JARID1B, PLU1, RBBP2H1"
"6H55","6","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2019.04.009",,"6H55",69.07,"6",,"core of the human pyruvate dehydrogenase (E2)","MWRVCARRAQNVAPWAGLEARWTALQEVPGTPRVTSRSGPAPARRNSVTTGYGGVRALCGWTPSSGATPRNRLLLQLLGSPGRRYYSLPPHQKVPLPSLSPTMQAGTIARWEKKEGDKINEGDLIAEVETDKATVGFESLEECYMAKILVAEGTRDVPIGAIICITVGKPEDIEAFKNYTLDSSAAPTPQAAPAPTPAATASPPTPSAQAPGSSYPPHMQVLLPALSPTMTMGTVQRWEKKVGEKLSEGDLLAEIETDKATIGFEVQEEGYLAKILVPEGTRDVPLGTPLCIIVEKEADISAFADYRPTEVTDLKPQVPPPTPPPVAAVPPTPQPLAPTPSAPCPATPAGPKGRVFVSPLAKKLAVEKGIDLTQVKGTGPDGRITKKDIDSFVPSKVAPAPAAVVPPTGPGMAPVPTGVFTDIPISNIRRVIAQRLMQSKQTIPHYYLSIDVNMGEVLLVRKELNKILEGRSKISVNDFIIKASALACLKVPEANSSWMDTVIRQNHVVDVSVAVSTPAGLITPIVFNAHIKGVETIANDVVSLATKAREGKLQPHEFQGGTFTISNLGMFGIKNFSAIINPPQACILAIGASEDKLVPADNEKGFDVASMMSVTLSCDHRVVDGAVGAQWLAEFRKYLEKPITMLL","Homo sapiens","DLAT, DLTA","Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial","1","6H55"
"6H5R",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION",6.5,"isopropanol, KCacodylate, Li2SO4, MgSO4",296,"10.1039/c8dt03607a",,"6H5R",9.65,"2","2","Structure of the complex of a human telomeric DNA with bis(1-butyl-3-methyl-imidazole-2-ylidene) gold(I)","TAGGGTTAGGGTTAGGGTTAGGGT","Homo sapiens",,"Human Telomeric DNA","1","6H5R"
"6H5T",,"X-RAY DIFFRACTION",3.11,60.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% (v/v) polyethylene glycol 550 mono-methyl ether, 100 mM MES-NaOH at pH 6.5, and 10 mM ZnSO4",291,"10.1016/j.str.2019.03.020",,"6H5T",22.53,"1.689","1.689","Intersectin SH3A short isoform","GSHMKVVYYRALYPFESRSHDEITIQPGDIVMVDESQTGEPGWLGGELKGKTGWFPANYAEKIPENEVPAPVKPVTDSTSAPAPKLALRETPAPLAVTS","Homo sapiens","ITSN1, ITSN, SH3D1A","Intersectin-1","1","6H5T"
"6H5W",,"X-RAY DIFFRACTION",2.37,48.05,"VAPOR DIFFUSION, HANGING DROP",4,"0.1 M MIB Buffer pH 4.0, 5% Glycerol, 16% PEG 3350",289,"10.1021/acs.jmedchem.8b01309","FT8","6H5W",71.73,"1.37","1.37","Crystal structure of human Angiotensin-1 converting enzyme C-domain in complex with Omapatrilat.","LVTDEAEASKFVEEYDRTSQVVWNEYAGANWNYNTNITTETSKILLQKNMQIAQHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPQGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWQKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPQMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSAR","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6H5W"
"6H5X",,"X-RAY DIFFRACTION",2.84,56.69,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris/Bicine pH 8.5, 0.06 M Divalent Cations, 30% PEG550MME?PEG20000",289,"10.1021/acs.jmedchem.8b01309","FT8","6H5X",150.87,"1.8","1.8","Crystal structure of human Angiotensin-1 converting enzyme N-domain in complex with Omapatrilat.","LDPGLQPGQFSADEAGAQLFAQSYQSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQQFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSQMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWQATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLRAGSSRPWQEVLKDMVGLDALDAQPLLKYFQLVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDL","Homo sapiens","ACE, DCP, DCP1","Angiotensin-converting enzyme","1","6H5X"
"6H60","6","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.str.2019.04.009",,"6H60",54.19,"6",,"pseudo-atomic structural model of the E3BP component of the human pyruvate dehydrogenase multienzyme complex","MAASWRLGCDPRLLRYLVGFPGRRSVGLVKGALGWSVSRGANWRWFHSTQWLRGDPIKILMPSLSPTMEEGNIVKWLKKEGEAVSAGDALCEIETDKAVVTLDASDDGILAKIVVEEGSKNIRLGSLIGLIVEEGEDWKHVEIPKDVGPPPPVSKPSEPRPSPEPQISIPVKKEHIPGTLRFRLSPAARNILEKHSLDASQGTATGPRGIFTKEDALKLVQLKQTGKITESRPTPAPTATPTAPSPLQATAGPSYPRPVIPPVSTPGQPNAVGTFTEIPASNIRRVIAKRLTESKSTVPHAYATADCDLGAVLKVRQDLVKDDIKVSVNDFIIKAAAVTLKQMPDVNVSWDGEGPKQLPFIDISVAVATDKGLLTPIIKDAAAKGIQEIADSVKALSKKARDGKLLPEEYQGGSFSISNLGMFGIDEFTAVINPPQACILAVGRFRPVLKLTEDEEGNAKLQQRQLITVTMSSDSRVVDDELATRFLKSFKANLENPIRLA","Homo sapiens","PDHX, PDX1","Pyruvate dehydrogenase protein X component, mitochondrial","1","6H60"
"6H64",,"X-RAY DIFFRACTION",2.8,56.07,"VAPOR DIFFUSION, SITTING DROP",,"1.6M magnesium sulfate, 100 mM MES at pH 6.5, 2 mM lactose",293,"10.1002/biot.201800214",,"6H64",115.94,"1.8","1.8","Crystal structure of the CRD-SAT","MSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPKMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSTSYTMISSGVDLGTENLYFQ","Homo sapiens","LGALS3, MAC2","Galectin-3","1","6H64"
"6H6B","3.4","ELECTRON MICROSCOPY",,,,,,,"10.7554/eLife.36402",,"6H6B",122.43,"3.4",,"Structure of alpha-synuclein fibrils","MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPD","Homo sapiens","SNCA, NACP, PARK1","Alpha-synuclein","1","6H6B"
"6H6Q",,"X-RAY DIFFRACTION",4.54,72.93,"VAPOR DIFFUSION, SITTING DROP",8,"3M NaCl
.1M pH=8 HEPES/NaOH",293,"10.1021/acs.jmedchem.8b00900","FUK","6H6Q",30.36,"2.63","2.63","Fragment Derived XIAP inhibitor","MGSSHHHHHHSSGLVPRGSHMNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVR","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","6H6Q"
"6H6R",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",8,"3.1M NaCl
.1M pH=8 HEPES/NaOH",293,"10.1021/acs.jmedchem.8b00900","FUE","6H6R",15.21,"2.03","2.03","Fragment Derived XIAP inhibitor","MGSSHHHHHHSSGLVPRGSHMNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVR","Homo sapiens","XIAP, API3, BIRC4, IAP3","E3 ubiquitin-protein ligase XIAP","1","6H6R"
"6H6S",,"X-RAY DIFFRACTION",2.06,40.25,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM HEPES, 2.9 M ammonium sulfate",293,"10.1007/s00775-018-1630-0",,"6H6S",58.55,"1.45","1.45","Sad phasing on nickel-substituted human carbonic anhydrase II","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6H6S"
"6H6T",,"X-RAY DIFFRACTION",3.18,61.36,"VAPOR DIFFUSION, HANGING DROP",4.5,"100 mM sodium acetate pH 4.5, 42 % propanediol",293,,,"6H6T",258.57,"1.9","1.9","Binary crystal structure of positively and negatively supercharged variants Ftn(pos) and Ftn(neg) from human heavy chain ferritin (propandiol condition, coordination number 8)","MTTASTSQVRQNYHQDSEKAINRQIRLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDKDDWESGLRAMEKALKLEKKVNQSLLELHKLATKKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPRSGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6H6T"
,,,,,,,,,,,,,,,,"MTTASTSQVRQNYHQDSEEAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEEALELEKNVNQSLLELHKLATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","2","6H6T"
"6H6U",,"X-RAY DIFFRACTION",2.84,56.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.22 M CaCl2, 0.1 M HEPES pH 7.5 M, 30% PEG 400",293,,,"6H6U",130.09,"2","2","Unitary crystal structure of the positively supercharged variant Ftn(pos) from human heavy chain ferritin (PEG 400 condition)","MTTASTSQVRQNYHQDSEKAINRQIRLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDKDDWESGLRAMEKALKLEKKVNQSLLELHKLATKKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPRSGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","6H6U"
"6H78",,"X-RAY DIFFRACTION",3.15,60.91,"VAPOR DIFFUSION, HANGING DROP",7.9,"0.2M sodium citrate tribasic dihydrate pH 7.9, 20% PEG 3350.",293.13,"10.1016/j.jmb.2018.10.007",,"6H78",545.13,"2.7","2.7","E1 enzyme for ubiquitin like protein activation.","GRVRIEKMSSEVVDSNPYSRLMALKRMGIVSDYEKIRTFAVAIVGVGGVGSVTAEMLTRCGIGKLLLFDYDKVELANMNRLFFQPHQAGLSKVQAAEHTLRNINPDVLFEVHNYNITTVENFQHFMDRISNGGLEEGKPVDLVLSCVDNFEARMTINTACNELGQTWMESGVSENAVSGHIQLIIPGESACFACAPPLVVAANIDEKTLKREGVCAASLPTTMGVVAGILVQNVLKFLLNFGTVSFYLGYNAMQDFFPTMSMKPNPQCDDRNCRKQQEEYKKKVAALPKQEVIQEEEEII","Homo sapiens","UBA5, UBE1DC1","Ubiquitin-like modifier-activating enzyme 5","1","6H78"
"6H7E",,"X-RAY DIFFRACTION",2.92,57.85,"VAPOR DIFFUSION, SITTING DROP",,"20 % w/v Polyethylene glycol 3,350, 100 mM BIS-TRIS propane; pH 6.5 200 mM Sodium Potassium phosphate",291.15,,,"6H7E",61.42,"2.3","2.3","GEF regulatory domain","GASTERVLRAGRQLHRHLLATCPNLIRDRKYHLRLYRQCCSGRELVDGILALGLGVHSRSQVVGICQVLLDEGALCHVKHDWAFQDRDAQFYRFPGPEPEPVGTHEMEEELAEAVALLSQRGPDALLTVALRKPPGQRTDEELDLIFEELLHIKAVAHLSNSVKRELAAVLLFEPHSKAGTVLFSQGDKGTSWYIIWKGSVNVVTHGKGLVTTLHEGDDFGQLALVNDAPRAATIILREDNCHFLRVDKQDFNRIIKDVEAKTMRLEEHG","Homo sapiens","RAPGEF3, CGEF1, EPAC, EPAC1","cDNA FLJ56134, highly similar to Rap guanine nucleotide exchange factor 3","1","6H7E"
"6H7X",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, SITTING DROP",6,"PEG 3350, Magnesium Chloride",303.15,"10.1038/s41598-018-31997-z",,"6H7X",51.84,"2.892","2.892","First X-ray structure of full-length human RuvB-Like 2.","MATVTATTKVPEIRDVTRIERIGAHSHIRGLGLDDALEPRQASQGMVGQLAARRAAGVVLEMIREGKIAGRAVLIAGQPGTGKTAIAMGMAQALGPDTPFTAIAGSEIFSLEMSKTEALTQAFRRSIGVRIKEETEIIEGEVVEIQIDRPATGTGSKVGKLTLKTTEMETIYDLGTKMIESLTKDKVQAGDVITIDKATGKISKLGRSFTRARDYDAMGSQTKFVQCPDGELQKRKEVVHTVSLHEIDVINSRTQGFLALFSGDTGEIKSEVREQINAKVAEWREEGKAEIIPGVLFIDEVHMLDIESFSFLNRALESDMAPVLIMATNRGITRIRGTSYQSPHGIPIDLLDRLLIVSTTPYSEKDTKQILRIRCEEEDVEMSEDAYTVLTRIGLETSLRYAIQLITAASLVCRKRKGTEVQVDDIKRVYSLFLDESRSTQYMKEYQDAFLFNELKGETMDTS","Homo sapiens","RUVBL2, INO80J, TIP48, TIP49B, CGI-46","RuvB-like 2","1","6H7X"
"6H7Y",,"X-RAY DIFFRACTION",3.37,63.52,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4,
2 % (w/v) PEG 3350,
100 mM Tris-HCl, pH 8.0",293,"10.1021/acsmedchemlett.8b00318","FVZ","6H7Y",84.62,"1.81","1.81","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor RNA 1-79-1","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6H7Y"
"6H7Z",,"X-RAY DIFFRACTION",3.28,62.54,"VAPOR DIFFUSION, HANGING DROP",8,"34% (v/v) pentaerythritol propoxylate PO/OH 5/4,
2 % (w/v) PEG 3350,
100 mM Tris-HCl, pH 8.0",293,"10.1021/acsmedchemlett.8b00318","FVW","6H7Z",84.49,"2","2","X-ray structure of human glutamate carboxypeptidase II (GCPII) in complex with a inhibitor RNA 2-65-1","KSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","6H7Z"
"6H8R",,"X-RAY DIFFRACTION",2.59,52.43,"VAPOR DIFFUSION, HANGING DROP",5.5,"24 % PEG 3350, 0.2 M ammonium sulfate and 0.1 M BIS-Tris pH 5.5",277,"10.1021/acs.jmedchem.8b00857",,"6H8R",35.52,"1.66","1.66","CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP) IN COMPLEX WITH COMPOUND 2","MHHHHHHSSGVDLGTENLYFQSMSRVLQAEELHEKALDPFLLQAEFFEIPMNFVDPKEYDIPGLVRKNRYKTILPNPHSRVCLTSPDPDDPLSSYINANYIRGYGGEEKVYIATQGPIVSTVADFWRMVWQEHTPIIVMITNIEEMNEKCTEYWPEEQVAYDGVEITVQKVIHTEDYRLRLISLKSGTEERGLKHYWFTSWPDQKTPDRAPPLLHLVREVEEAAQQEGPHCAPIIVHCSAGIGRTGCFIATSICCQQLRQEGVVDILKTTCQLRQDRGGMIQTCEQYQFVHHVMSLYEKQLSHQS","Homo sapiens","PTPN5","Tyrosine-protein phosphatase non-receptor type 5","1","6H8R"
"6HA3",,"X-RAY DIFFRACTION",2.11,41.66,"VAPOR DIFFUSION, HANGING DROP",7.9,"Reservoir mixture of 13.5-15 % PEG 6000 (w/v), 4% PEG 400 (v/v), 2 % glycerol (v/v) , pH 7.9, VAPOR DIFFUSION, HANGING DROP, temperature 279.0K",277,"10.1038/s41586-019-1581-9",,"6HA3",71.16,"1.08","1.08","Human transketolase variant E160Q in covalent complex with donor ketose D-fructose-6-phosphate","MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSQGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKALVPRGSLEHHHHHH","Homo sapiens","TKT","Transketolase","1","6HA3"
"6HAD",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, HANGING DROP",7.9,"13.5-15% PEG6000 (w/v)
4% PEG400 (v/v)
2% Glycerol (v/v)",277,"10.1038/s41586-019-1581-9",,"6HAD",70.16,"1.04","1.04","Human transketolase variant E160Q","MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAPILYAVWAEAGFLAEAELLNLRKISSDLDGHPVPKQAFTDVATGSLGQGLGAACGMAYTGKYFDKASYRVYCLLGDGELSQGSVWEAMAFASIYKLDNLVAILDINRLGQSDPAPLQHQMDIYQKRCEAFGWHAIIVDGHSVEELCKAFGQAKHQPTAIIAKTFKGRGITGVEDKESWHGKPLPKNMAEQIIQEIYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKALVPRGSLEHHHHHH","Homo sapiens","TKT","Transketolase","1","6HAD"
"6HAZ",,"X-RAY DIFFRACTION",2.81,56.16,"VAPOR DIFFUSION, SITTING DROP",6.1,"25% (w/v) PEG 6000, 0.1 M HEPES, pH 6.1, 0.01M zinc chloride, 0.01 M cobalt (III) hexamine chloride, 8% (v/v) ethylene glycol",277,"10.1038/s41589-019-0294-6",,"6HAZ",29.44,"1.31","1.31","Crystal structure of the bromodomain of human SMARCA2 in complex with SMARCA-BD ligand","SMAEKLSPNPPKLTKQMNAIIDTVINYKDSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLGDLEKDVMLLCHNAQTFNLEGSQIYEDSIVLQSVFKSARQKIAKEEE","Homo sapiens","SMARCA2, BAF190B, BRM, SNF2A, SNF2L2","Probable global transcription activator SNF2L2","1","6HAZ"
"6HB9",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M sodium phosphate, 0.1 M HEPES, pH7.5",293,"10.1080/15548627.2019.1606637",,"6HB9",15.19,"1.3","1.3","Crystal structure of the GABARAP in complex with the UBA5 LIR motif","EWGIELVSEVSEAMGFVYKEEHPFEKRRSEGEKIRKKYPDRVPVIVEKAPKARIGDLDKKKYLVPSDLTVGQFYFLIRKRIHLRAEDALFFFVNNVIPPTSATMGQLYQEHHEEDFFLYIAYSDESVYG","Homo sapiens","GABARAP, FLC3B, HT004","Gamma-aminobutyric acid receptor-associated protein","1","6HB9"
"6HBN",,"X-RAY DIFFRACTION",2.06,40.35,"VAPOR DIFFUSION, SITTING DROP",5.5,"90 MIKROLITER ENZYME STOCK SOLUTION (6 MG/ML IN 500 MM NACL, 25 MM TRIS/HCL, PH 8.5) WAS MIXED WITH 10 MIKROLITER INHIBITOR STOCK SOLUTION (10 MM INHIBITOR IN DMSO). THIS MIXTURE WAS INCUBATED FOR 30 MIN AT ROOM TEMPERATURE. THE RESERVOIR SOLUTION OF THE CRYSTALLIZATION EXPERIMENT WAS 4.4 M NACL, 0.1 M CITRIC ACID, PH 5.5. PRIOR TO EQUILIBRATION THE CRYSTALLIZATION DROP WAS COMPOSED OF 1 MIKROLITER RESERVOIR SOLUTION PLUS 1 MIKROLITER ENZYME/INHIBITOR MIXTURE.,VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K",293.15,"10.1021/acsomega.8b03415",,"6HBN",81.23,"1.59","1.59","HIGH-SALT STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA/CSKN2A1 GENE PRODUCT) IN COMPLEX WITH THE INDENOINDOLE-TYPE INHIBITOR THN27","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","6HBN"
"6HBU","3.09","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41586-018-0680-3",,"6HBU",145.83,"3.09",,"Cryo-EM structure of the ABCG2 E211Q mutant bound to ATP and Magnesium","MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVEKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMELITDPSILFLDQPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKKITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDSTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLPMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLLMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGNNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS","Homo sapiens","ABCG2, ABCP, BCRP, BCRP1, MXR","ATP-binding cassette sub-family G member 2","1","6HBU"
"6HCI",,"X-RAY DIFFRACTION",2.6,52.74,"VAPOR DIFFUSION, HANGING DROP",8,"0.2 M ammonium sulfate 
23% w/v polyethylene glycol 4000",293,"10.1371/journal.pone.0226693",,"6HCI",47.86,"2.12","2.12","Crystal structure of titin M3 domain","HPPPTDSTLRPMFKRLLANAECQEGQSVCFEIRVSGIPPPTLKWEKDGQPLSLGPNIEIIHEGLDYYALHIRDTLPEDTGYYRVTATNTAGSTSCQAHLQVERLR","Homo sapiens","TTN","Titin","1","6HCI"
"6HCY","3.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-06817-7",,"6HCY",164.31,"3.1",,"human STEAP4 bound to NADP, FAD, heme and Fe(III)-NTA.","MEKTCIDALPLTMNSSEKQETVCIFGTGDFGRSLGLKMLQCGYSVVFGSRNPQKTTLLPSGAEVLSYSEAAKKSGIIIIAIHREHYDFLTELTEVLNGKILVDISNNLKINQYPESNAEYLAHLVPGAHVVKAFNTISAWALQSGALDASRQVFVCGNDSKAKQRVMDIVRNLGLTPMDQGSLMAAKEIEKYPLQLFPMWRFPFYLSAVLCVFLFFYCVIRDVIYPYVYEKKDNTFRMAISIPNRIFPITALTLLALVYLPGVIAAILQLYRGTKYRRFPDWLDHWMLCRKQLGLVALGFAFLHVLYTLVIPIRYYVRWRLGNLTVTQAILKKENPFSTSSAWLSDSYVALGILGFFLFVLLGITSLPSVSNAVNWREFRFVQSKLGYLTLILCTAHTLVYGGKRFLSPSNLRWYLPAAYVLGLIIPCTVLVIKFVLIMPCVDNTLTRIRQGWERNSKH","Homo sapiens","STEAP4, STAMP2, TNFAIP9","Metalloreductase STEAP4","1","6HCY"
"6HCZ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"3.5 M sodium formate pH 7.0, 10% glycerol",291,"10.1038/s42003-020-0851-2",,"6HCZ",43.17,"2.3","2.3","Sjoegren syndrome/scleroderma autoantigen 1 (SSSCA1)","MALNGAEVDDFSWEPPTEAETKVLQARRERQDRISRLMGDYLLRGYRMLGETCADCGTILLQDKQRKIYCVACQELDSDVDKDNPALNAQAALSQAREHQLASASELPLGSRPAPQPPVPRPEHCEGAAAGLKAAQGPPAPAVPPNTDVMACTQTALLQKLTWASAELGSSTSLETSIQLCGLIRACAEALRSLQQLQH","Homo sapiens","SSSCA1, ZNRD2","Sjoegren syndrome/scleroderma autoantigen 1","1","6HCZ"
"6HD1","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41467-018-06817-7",,"6HD1",164.31,"3.8",,"human STEAP4 bound to NADPH, FAD and heme.","MEKTCIDALPLTMNSSEKQETVCIFGTGDFGRSLGLKMLQCGYSVVFGSRNPQKTTLLPSGAEVLSYSEAAKKSGIIIIAIHREHYDFLTELTEVLNGKILVDISNNLKINQYPESNAEYLAHLVPGAHVVKAFNTISAWALQSGALDASRQVFVCGNDSKAKQRVMDIVRNLGLTPMDQGSLMAAKEIEKYPLQLFPMWRFPFYLSAVLCVFLFFYCVIRDVIYPYVYEKKDNTFRMAISIPNRIFPITALTLLALVYLPGVIAAILQLYRGTKYRRFPDWLDHWMLCRKQLGLVALGFAFLHVLYTLVIPIRYYVRWRLGNLTVTQAILKKENPFSTSSAWLSDSYVALGILGFFLFVLLGITSLPSVSNAVNWREFRFVQSKLGYLTLILCTAHTLVYGGKRFLSPSNLRWYLPAAYVLGLIIPCTVLVIKFVLIMPCVDNTLTRIRQGWERNSKH","Homo sapiens","STEAP4, STAMP2, TNFAIP9","Metalloreductase STEAP4","1","6HD1"
"6HD2",,"SOLUTION NMR",,,,,,,,,"6HD2",29.35,,,"Active-site conformational dynamics of carbonic anhydrase II under native conditions: An NMR perspective","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","6HD2"
"6HDN",,"X-RAY DIFFRACTION",4.04,69.56,"VAPOR DIFFUSION",,"1.2-1.5M ammonium sulphate and 20-25% PEG3350.",277,"10.1021/acs.jmedchem.8b00862","FZB","6HDN",16.16,"1.9","1.9","Crystal structure of human ATAD2 bromodomain in complex with 3-methyl-8-((8-methyl-8-azabicyclooctan-3-yl)amino)-1,7-naphthyridin-2(1H)-one","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HDN"
"6HDO",,"X-RAY DIFFRACTION",3.96,68.95,"VAPOR DIFFUSION",,"0.1M trisHCl pH 7.0-8.0, 1.2-1.5M ammonium sulphate and 20-25% PEG3350",277,"10.1021/acs.jmedchem.8b00862","FZH","6HDO",16.3,"2.61","2.61","Crystal structure of human ATAD2 bromodomain in complex with 8-(((1R,2R,3R,5S)-2-(2-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)ethyl)-8-azabicyclo[3.2.1]octan-3-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)quinolin-2(1H)-one","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYVTVIKQPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","6HDO"
"6HDP",,"X-RAY DIFFRACTION",2.68,54.03,"VAPOR DIFFUSION, SITTING DROP",,"0.15M sodium malate and 20% PEG 3350",277,,,"6HDP",50.01,"2.3","2.3","Human DYRK2 bound to Scorzodihydrostilbene A","MHHHHHHSSGVDLGTENLYFQSMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR","Homo sapiens","DYRK2","Dual specificity tyrosine-phosphorylation-regulated kinase 2","1","6HDP"
"6HDQ",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION",8,"20% PEG6K, 0.2M LiCl, 0.1M tris pH8 at 20C",298,"10.1021/acs.jmedchem.8b00862","FZE","6HDQ",15.68,"1.7","1.7","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH : 8-(((1R,2R,3R,5S)-2-(2-(4,4-difluorocyclohexyl)ethyl)-8-azabicyclo[3.2.1]octan-3-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1H)-one","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","6HDQ"
"6HDR",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, SITTING DROP",,"0.2M sodium potassium phosphate,  20% PEG 3350 and  10% ethylene glycol",277,,,"6HDR",50.22,"2.2","2.2","Human DYRK2 bound to Curcumin","MHHHHHHSSGVDLGTENLYFQSMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR","Homo sapiens","DYRK2","Dual specificity tyrosine-phosphorylation-regulated kinase 2","1","6HDR"
"6HDU",,"X-RAY DIFFRACTION",2.17,43.22,"VAPOR DIFFUSION, HANGING DROP",8.5,"Morpheus A9
10% PEG 20000
20% PEG 550 MME
0.02M divalent cations
0.1M bicine/Trizma base pH 8.5",288,"10.1080/21541248.2019.1666623","GTP","6HDU",85.75,"1.793","1.793","Crystal structure of human Rab38 in complex with GTP","GSHMQAPHKEHLYKLLVIGDLGVGKTSIIKRYVHQNFSSHYRATIGVDFALKVLHWDPETVVRLQLWDIAGLERFGNMTRVYYREAMGAFIVFDVTRPATFEAVAKWKNDLDSKLSLPNGKPVSVVLLANKCDQGKDVLMNNGLKMDQFCKEHGFVGWFETSAKENINIDEASRCLVKHILANE","Homo sapiens","RAB38","Ras-related protein Rab-38","1","6HDU"
"6HEH",,"X-RAY DIFFRACTION",3.16,61.1,"VAPOR DIFFUSION, SITTING DROP",6.6,"12% (w/v) PEG 8000, 100 mM sodium chloride, 200 mM lithium sulfate, 100 mM MES pH 6.6",291,"10.1016/j.molcel.2019.02.030",,"6HEH",44.68,"2.26","2.26","Structure of the catalytic domain of USP28 (insertion deleted)","GPNPNDWRRVDGWPVGLKNVGNTCWFSAVIQSLFQLPEFRRLVLSYSLPQNVLENCRSHTEKRNIMFMQELQYLFALMMGSNRKFVDPSAALDLLKGAFRSSEEQQQDVSEFTHKLLDWLEDAFQLAVNVNSPRNKSENPMVQLFYGTFLTEGVREGKPFCNNETFGQYPLQVNGYRNLDECLEGAMVEGDVELLPSDHSVKYGQERWFTKLPPVLTFELSRFEFNQSLGQPEKIHNKLEFPQIIYMDRYMYGSGSGSRQVPYRLHAVLVHEGQANAGHYWAYIYNQPRQSWLKYNDISVTESSWEEVERDSYGGLRNVSAYCLMYINDKLPYFNAEAAPTESDQMSEVEALSVELKHYIQEDNWRFEQEVEEWEEEQSCKI","Homo sapiens","USP28, KIAA1515","Ubiquitin carboxyl-terminal hydrolase 28,Ubiquitin carboxyl-terminal hydrolase 28","1","6HEH"
,,,,,,,,,,,,,,,,,"Homo sapiens","USP28, KIAA1515"
"6HEJ",,"X-RAY DIFFRACTION",4.17,70.5,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.8 M ammonium sulfate, 100 mM sodium citrate pH 5.5",291,"10.1016/j.molcel.2019.02.030",,"6HEJ",129.34,"2.79","2.79","Structure of human USP28","GPNPNDWRRVDGWPVGLKNVGNTCWFSAVIQSLFQLPEFRRLVLSYSLPQNVLENCRSHTEKRNIMFMQELQYLFALMMGSNRKFVDPSAALDLLKGAFRSSEEQQQDVSEFTHKLLDWLEDAFQLAVNVNSPRNKSENPMVQLFYGTFLTEGVREGKPFCNNETFGQYPLQVNGYRNLDECLEGAMVEGDVELLPSDHSVKYGQERWFTKLPPVLTFELSRFEFNQSLGQPEKIHNKLEFPQIIYMDRYMYRSKELIRNKRECIRKLKEEIKILQQKLERYVKYGSGPARFPLPDMLKYVIEFASTKPASESCPPESDTHMTLPLSSVHCSVSDQTSKESTSTESSSQDVESTFSSPEDSLPKSKPLTSSRSSMEMPSQPAPRTVTDEEINFVKTCLQRWRSEIEQDIQDLKTCIASTTQTIEQMYCDPLLRQVPYRLHAVLVHEGQANAGHYWAYIYNQPRQSWLKYNDISVTESSWEEVERDSYGGLRNVSAYCLMYINDKLPYFNAEAAPTESDQMSEVEALSVELKHYIQEDNWRFEQEVEEWEEEQSCKI","Homo sapiens","USP28, KIAA1515","Ubiquitin carboxyl-terminal hydrolase 28","1","6HEJ"
"6HEL",,"X-RAY DIFFRACTION",3.54,65.3,"VAPOR DIFFUSION, SITTING DROP",8,"12% (w/v) PEG 3350, 167 mM magnesium acetate",291,"10.1016/j.molcel.2019.02.030",,"6HEL",130.16,"2.941","2.941","Structure of human USP25","GPNPYDRKRQDKAPVGLKNVGNTCWFSAVIQSLFNLLEFRRLVLNYKPPSNAQDLPRNQKEHRNLPFMRELRYLFALLVGTKRKYVDPSRAVEILKDAFKSNDSQQQDVSEFTHKLLDWLEDAFQMKAEEETDEEKPKNPMVELFYGRFLAVGVLEGKKFENTEMFGQYPLQVNGFKDLHECLEAAMIEGEIESLHSENSGKSGQEHWFTELPPVLTFELSRFEFNQALGRPEKIHNKLEFPQVLYLDRYMHRNREITRIKREEIKRLKDYLTVLQQRLERYLSYGSGPKRFPLVDVLQYALEFASSKPVCTSPVDDIDASSPPSGSIPSQTLPSTTEQQGALSSELPSTSPSSVAAISSRSVIHKPFTQSRIPPDLPMHPAPRHITEEELSVLESCLHRWRTEIENDTRDLQESISRIHRTIELMYSDKSMIQVPYRLHAVLVHEGQANAGHYWAYIFDHRESRWMKYNDIAVTKSSWEELVRDSFGGYRNASAYCLMYINDKAQFLIQEEFNKETGQPLVGIETLPPDLRDFVEEDNQRFEKELEEWDAQLAQKALQE","Homo sapiens","USP25, USP21","Ubiquitin carboxyl-terminal hydrolase 25","1","6HEL"
"6HEM",,"X-RAY DIFFRACTION",2.59,52.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% (w/v) PEG 4000, 600 mM sodium chloride, 100 mM MES pH 6.5",291,"10.1016/j.molcel.2019.02.030",,"6HEM",36.12,"1.72","1.72","Structure of the C-terminal domain of USP25 (748-1048)","GPDFSKHLKEETIQIITKASHEHEDKSPETVLQSAIKLEYARLVKLAQEDTPPETDYRLHHVVVYFIQNQAPKKIIEKTLLEQFGDRNLSFDERCHNIMKVAQAKLEMIKPEEVNLEEYEEWHQDYRKFRETTMYLIIGLENFQRESYIDSLLFLICAYQNNKELLSKGLYRGHDEELISHYRRECLLKLNEQAAELFESGEDREVNNGLIIMNEFIVPFLPLLLVDEMEEKDILAVEDMRNRWCSYLGQEMEPHLQEKLTDFLPKLLDCSMEIKSFHEPPKLPSYSTHELCERFARIMLSLS","Homo sapiens","USP25, USP21","Ubiquitin carboxyl-terminal hydrolase 25","1","6HEM"
"6HES",,"X-RAY DIFFRACTION",1.92,36.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"37.5 % MPD/PEG1000/PEG3350 (MD), 0.1 M Amino Acids Mix (MD), 0.1 M Tris pH 6.5",291,,,"6HES",35.02,"1.128","1.128","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT050","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6HES"
"6HET",,"X-RAY DIFFRACTION",1.97,37.43,"VAPOR DIFFUSION, SITTING DROP",6.5,"37.5 % MPD/PEG1000/PEG3350 (MD), 0.1 M Amino Acids Mix (MD), 0.1 M MES pH 6.5",291,,,"6HET",34.93,"1.208","1.208","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT055","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6HET"
"6HEU",,"X-RAY DIFFRACTION",1.98,37.91,"VAPOR DIFFUSION, SITTING DROP",8.5,"48.75 % MPD/PEG1000/PEG3350 (MD), 0.1 M Amino Acids Mix (MD), 0.1 M Buffer 3 Tris/Bicine pH 8.5 (MD)",291,,,"6HEU",34.99,"1.719","1.719","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT058","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6HEU"
"6HEV",,"X-RAY DIFFRACTION",1.96,37.14,"VAPOR DIFFUSION, SITTING DROP",7.5,"37.5 % MPD/PEG1000/PEG3350 (MD), 0.1 M Amino Acids Mix (MD), 0.1 M Tris pH 7.5",291,,,"6HEV",34.96,"1.28","1.28","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT061","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6HEV"
"6HEW",,"X-RAY DIFFRACTION",1.96,37.24,"VAPOR DIFFUSION, SITTING DROP",6,"37.5 % MPD/PEG1000/PEG3350 (MD), 0.1 M Amino Acids Mix (MD), 0.1 M Bis/Tris pH 6.0",291,,,"6HEW",34.97,"1.268","1.268","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT069","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6HEW"
"6HEX",,"X-RAY DIFFRACTION",1.96,37.25,"VAPOR DIFFUSION, SITTING DROP",6.5,"37.5 % MPD/PEG1000/PEG3350 (MD), 0.1 M Amino Acids Mix (MD), 0.1 M MES pH 6.5",291,,,"6HEX",34.97,"1.413","1.413","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATMM006","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6HEX"
"6HEY",,"X-RAY DIFFRACTION",1.96,37.13,"VAPOR DIFFUSION, SITTING DROP",7,"37.5 % MPD/PEG1000/PEG3350 (MD), 0.1 M Amino Acids Mix (MD), 0.1 M Hepes pH 7.0",291,,,"6HEY",34.99,"1.367","1.367","Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATNK002","GDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSG","Homo sapiens","EPHA2, ECK","Ephrin type-A receptor 2","1","6HEY"
"6HFD",,"X-RAY DIFFRACTION",2.49,50.58,"VAPOR DIFFUSION, HANGING DROP",,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7",291,"10.1074/jbc.RA118.005494",,"6HFD",43.31,"1.86996804092","1.86996804092","Human dihydroorotase mutant F1563L apo structure","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDGPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETLSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFD"
"6HFE",,"X-RAY DIFFRACTION",2.5,50.72,"VAPOR DIFFUSION, HANGING DROP",,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HFE",43.41,"1.47997437573","1.47997437573","Human dihydroorotase mutant F1563T apo structure","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETTSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFE"
"6HFF",,"X-RAY DIFFRACTION",2.5,50.89,"VAPOR DIFFUSION, HANGING DROP",,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HFF",43.38,"1.51000106105","1.51000106105","Human dihydroorotase mutant F1563Y apo structure","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETYSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFF"
"6HFH",,"X-RAY DIFFRACTION",2.51,51.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HFH",43.4,"1.44871265165","1.44871265165","Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETASELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFH"
"6HFI",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, HANGING DROP",,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7",291,"10.1074/jbc.RA118.005494",,"6HFI",43.33,"1.45994719309","1.45994719309","Human dihydroorotase mutant F1563A apo structure","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETASELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFI"
"6HFJ",,"X-RAY DIFFRACTION",2.51,51.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HFJ",43.4,"1.2","1.2","Human dihydroorotase mutant F1563A co-crystallized with carbamoyl aspartate at pH 7.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETASELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFJ"
"6HFK",,"X-RAY DIFFRACTION",2.5,50.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 6.5",291,"10.1074/jbc.RA118.005494",,"6HFK",43.44,"1.45914405408","1.45914405408","Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 6.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETLSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFK"
"6HFL",,"X-RAY DIFFRACTION",2.51,51.08,"VAPOR DIFFUSION, HANGING DROP",7,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.0",291,"10.1074/jbc.RA118.005494",,"6HFL",43.44,"1.35","1.35","Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETLSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFL"
"6HFN",,"X-RAY DIFFRACTION",2.51,50.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HFN",43.36,"1.44965143011","1.44965143011","Human dihydroorotase mutant F1563L co-crystallized with carbamoyl aspartate at pH 7.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDGPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETLSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFN"
"6HFO",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, SITTING DROP",,"1.4 M Na/K phosphate pH 8.2",293,"10.1016/j.molcel.2019.02.011",,"6HFO",19.72,"1.65","1.65","Human Hsp90 co-chaperone TTC4 C-domain","NQNEALLQAIKARNIRLSEAACEDEDSASEGLGELFLDGLSTENPHGARLSLDGQGRLSWPVLFLYPEYAQSDFISAFHEDSRFIDHLMVMFGETPSWDLEQKYCPDNLEVYFEDEDRAELYRVPAKSTLLQVLQHQRYFVKALTPAFLVCVGSSPFCKNFLRGRKVYQIR","Homo sapiens","TTC4, My044","Tetratricopeptide repeat protein 4","1","6HFO"
"6HFP",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, HANGING DROP",7,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.0",291,"10.1074/jbc.RA118.005494",,"6HFP",43.46,"1.19822864429","1.19822864429","Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDGPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETTSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFP"
"6HFQ",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HFQ",43.55,"1.14542458871","1.14542458871","Human dihydroorotase mutant F1563T co-crystallized with carbamoyl aspartate at pH 7.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDGPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETTSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFQ"
"6HFR",,"X-RAY DIFFRACTION",2.5,50.88,"VAPOR DIFFUSION, HANGING DROP",7,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.0",291,"10.1074/jbc.RA118.005494",,"6HFR",43.49,"1.29949373933","1.29949373933","Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.0","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDGPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETYSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFR"
"6HFS",,"X-RAY DIFFRACTION",2.5,50.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 6.5",291,"10.1074/jbc.RA118.005494",,"6HFS",43.49,"1.34904510922","1.34904510922","Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 6.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDGPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETYSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFS"
"6HFU",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP with 4 mM carbamoyl asparate.
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HFU",43.44,"1.39971025955","1.39971025955","Human dihydroorotase mutant F1563Y co-crystallized with carbamoyl aspartate at pH 7.5","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETYSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HFU"
"6HG2",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, HANGING DROP",,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP, 4 mM fluoroorotate
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HG2",43.2,"1.83","1.83","Hybrid dihydroorotase domain of human CAD with E. coli flexible loop, bound to fluoroorotate","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLANATTNSSHGVTSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPD","Homo sapiens","CAD","CAD protein","1","6HG2"
"6HG3",,"X-RAY DIFFRACTION",2.57,52.16,"VAPOR DIFFUSION, HANGING DROP",,"Protein at 2-3 mg/ml in 20 mM Tris pH 8, 0.15 M NaCl, 0.02 mM zinc sulfate, 0.2 mM TCEP, 4 mM dihydroorotate
Mother liquor: 2.5-3 M potassium formate, 0.1 M HEPES pH 7.5",291,"10.1074/jbc.RA118.005494",,"6HG3",40.76,"1.97","1.97","Hybrid dihydroorotase domain of human CAD with E. coli flexible loop, bound to dihydroorotate","GPMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLANATTNSSHGVTSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPP","Homo sapiens","CAD","CAD protein","1","6HG3"
"6HG7",,"X-RAY DIFFRACTION",1.98,37.73,"EVAPORATION",7,"1.5 M Ammonium sulphate and 0.1 M BIS-TRIS propane pH 7.0",298,"10.1038/s41598-018-35447-8",,"6HG7",10.4,"1","1","Crystal structure of a collagen II fragment containing the binding site of PEDF and COMP, (POG)4-LKG HRG FTG LQG-POG(4)","XPPGPPGPPGPPGLKGHRGFTGLQGPPGPPGPPGPPGX","Homo sapiens","COL2A1","Collagen alpha-1(II) chain","1","6HG7"
"6HG8",,"X-RAY DIFFRACTION",2.92,57.87,"VAPOR DIFFUSION, SITTING DROP",6.9,"protein in: 100 mM Tris,150 mM NaCl, 1 mM EDTA, pH 8.0

reservoir solution: 2 M (NH4)2SO4, 2 v/v% PEG-400, 0.1 M HEPES (pH 6.9)

volume ratio: 1",293.15,,,"6HG8",107.82,"1.76","1.76","Crystal structure of the R460G disease-causing mutant of the human dihydrolipoamide dehydrogenase.","MASWSHPQFEKGALEVLFQGPGADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFGEANLAASFGKSINF","Homo sapiens","DLD, GCSL, LAD, PHE3","Dihydrolipoyl dehydrogenase, mitochondrial","1","6HG8"
"6HGD",,"X-RAY DIFFRACTION",1.92,35.87,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M magnesium chloride hexahydrate, 0.1 M BIS-Tris pH 6.5, 25 % w/v PEG 3350",293,"10.1016/j.jsb.2019.05.006",,"6HGD",46.63,"1.9","1.9","Crystal structure of Alpha1-antichymotrypsin variant NewBG-0: a new binding globulin variant that is devoid of any cortisol-binding capabilities","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASALFILPDQDKMEEVEAMLLPETLNRWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGD"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWNIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGD"
"6HGE",,"X-RAY DIFFRACTION",2.46,49.92,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M NaCl, 0.1 M Tris-HCl, pH 8.5, 25 % PEG 3350 supplemented with 10 % of a 0.5 M NaF solution, and additional 0.1 ul of a silver bullets bio reagent mixture consisting of thymidine, adenosine 3,5-cyclic monophosphate sodium salt monohydrate, sarcosine, 4-aminobenzoic acid,  acarbose,  inosine, 0.02 M HEPES sodium pH 6.8",293,"10.1016/j.jsb.2019.05.006",,"6HGE",187.71,"2.8","2.8","Crystal structure of Alpha1-antichymotrypsin variant NewBG-I in the uncleaved S-conformation","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASALFILPDQDKMEEVEAMLSRETLNRWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGE"
,,,,,,,,,,,,,,,,"MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASALFILPDQDKMEEVEAMLSRETLNRWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGE"
,,,,,,,,,,,,,,,,"MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASALFILPDQDKMEEVEAMLSRETLNRWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","3","6HGE"
,,,,,,,,,,,,,,,,"MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASALFILPDQDKMEEVEAMLSRETLNRWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","4","6HGE"
"6HGF",,"X-RAY DIFFRACTION",2.34,47.48,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium sulfate, 20 % w/v PEG 3350",293,"10.1016/j.jsb.2019.05.006","HCY","6HGF",47.08,"1.651","1.651","Crystal structure of Alpha1-antichymotrypsin variant NewBG-II: a new binding globulin in complex with cortisol","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASALFILPDQDKMEEVEAMLSRETLARWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGF"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGF"
"6HGG",,"X-RAY DIFFRACTION",2.29,46.34,"VAPOR DIFFUSION, HANGING DROP",,"2 % v/v Tacsimate pH 5.0, 0.1 M sodium citrate tribasic dihydrate pH 5.6, 16 % w/v PEG 3350",293,"10.1016/j.jsb.2019.05.006","HCY","6HGG",47.32,"1.787","1.787","Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex with cortisol","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPVSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASVFFILPDQDKMEEVEAMLSRETLARWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGG"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGG"
"6HGH",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, SITTING DROP",,"4 % Tacsimate pH 4.0, 12 % w/v PEG 3350",293,"10.1016/j.jsb.2019.05.006",,"6HGH",46.75,"1.9","1.9","Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin without any bound ligand","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPVSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASVFFILPDQDKMEEVEAMLSRETLARWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","alpha1-Antichymotrypsin","1","6HGH"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGH"
"6HGI",,"X-RAY DIFFRACTION",2.32,47.09,"VAPOR DIFFUSION, HANGING DROP",,"2 % v/v Tacsimate pH 5.0, 0.1 M sodium citrate tribasic dihydrate pH 5.6, 16 % w/v PEG 3350",293,"10.1016/j.jsb.2019.05.006","C0R","6HGI",46.99,"1.517","1.517","Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex with corticosterone","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPVSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASVFFILPDQDKMEEVEAMLSRETLARWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGI"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGI"
"6HGJ",,"X-RAY DIFFRACTION",2.3,46.46,"VAPOR DIFFUSION, HANGING DROP",,"2 % v/v Tacsimate pH 5.0, 0.1 M sodium citrate tribasic dihydrate pH 5.6, 16 % w/v PEG 3350",292,"10.1016/j.jsb.2019.05.006","AS4","6HGJ",47.07,"1.825","1.825","Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex with aldosterone","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPVSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASVFFILPDQDKMEEVEAMLSRETLARWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGJ"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGJ"
"6HGK",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, HANGING DROP",,"2 % Tacsimate pH 6.0, 0.1 M BIS-Tris pH 6.5, 20 % w/v PEG 3350",293,"10.1016/j.jsb.2019.05.006",,"6HGK",47.08,"1.855","1.855","Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex with progesterone","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPVSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASVFFILPDQDKMEEVEAMLSRETLARWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGK"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGK"
"6HGL",,"X-RAY DIFFRACTION",2.34,47.54,"VAPOR DIFFUSION, HANGING DROP",,"2 % v/v Tacsimate pH 5.0, 0.1 M sodium citrate tribasic dihydrate pH 5.6, 16 % w/v PEG 3350",293,"10.1016/j.jsb.2019.05.006",,"6HGL",46.93,"1.92","1.92","Crystal structure of Alpha1-antichymotrypsin variant NewBG-III: a new binding globulin in complex with testosterone","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPVSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASVFFILPDQDKMEEVEAMLSRETLARWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGL"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGL"
"6HGM",,"X-RAY DIFFRACTION",2.34,47.44,"VAPOR DIFFUSION, HANGING DROP",,"0.3 M calcium chloride dihydrate, 20 % w/v PEG 3350",293,"10.1016/j.jsb.2019.05.006",,"6HGM",47.08,"1.369","1.369","Crystal structure of Alpha1-antichymotrypsin variant NewBG-III-allo: an allosterically controlled new binding globulin with an unprecedentedly high ligand release efficacy","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPVSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASVFFILPDQDKMEEVEAMLSRETLARWGDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTERSAATAVKITLL","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGM"
,,,,,,,,,,,,,,,,"SALVETRTIVRFNRPFLMIIVDHFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGM"
"6HGN",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, SITTING DROP",,"2 % Tacsimate pH 4.0, 0.1 M Sodium acetate trihydrate pH 4.6, 16 % w/v PEG 3,350",293,"10.1016/j.jsb.2019.05.006",,"6HGN",46.94,"1.478","1.478","Crystal structure of Alpha1-antichymotrypsin variant DBS-II-allo-L55V: an allosterically controlled doxorubicin-binding serpin with an unprecedentedly high ligand release efficacy","MKHHHHHHMKQNSPLDEENLTQENQDRGTHVDRGLASANVDFAFSLYKQLVLKAPDKNVIFSPVSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKFEMPFDPQDTHQSRFYLSKKKYVMVPMMSLHHLTIPYFRDEELSCTVVQLNYTGNASALFILPDQDKMEEVEAMLSQETLSRFFESLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTERSAATALEVLFQ","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","1","6HGN"
,,,,,,,,,,,,,,,,"GPLVETRTIVRFNRPFLMIIVDNFTWSIFFMSKVTNPKQA","Homo sapiens","SERPINA3, AACT, GIG24, GIG25","Alpha-1-antichymotrypsin","2","6HGN"
"6HGO",,"X-RAY DIFFRACTION",3.24,62.06,"VAPOR DIFFUSION, SITTING DROP",5.5,"200mM ammonium sulfate, 20.0% PEG 3350",293,"10.1016/j.immuni.2020.02.004",,"6HGO",63.97,"2.1","2.1","Crystal Structure of human IL-17F","EFRHDSRKIPKVGHTFFQKPESCPPVPGGSMKLDIGIINENQRVSMSRNIESRSTSPWNYTVTWDPNRYPSEVVQAQCRNLGCINAQGKEDISMNSVPIQQETLVVRRKHQGCSVSFQLEKVLVTVGCTCVTPVIHHVQ","Homo sapiens","IL17F","Interleukin-17F","1","6HGO"
"6HGP",,"X-RAY DIFFRACTION",2.28,45.95,"VAPOR DIFFUSION, SITTING DROP",8.5,"NaOAc, PEG4000, Glycerol, Tris",293,"10.1074/jbc.RA119.009087",,"6HGP",39.04,"1.7","1.7","Crystal Structure of Human APRT wild type in complex with Phosphate ion.","DSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6HGP"
"6HGQ",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"NaOAc, PEG4000, Glycerol, Tris",293,"10.1074/jbc.RA119.009087",,"6HGQ",80.29,"1.9","1.9","Crystal Structure of Human APRT wild type in complex with Hypoxanthine, PRPP and Mg2+","ADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6HGQ"
"6HGR",,"X-RAY DIFFRACTION",2.28,46.09,"VAPOR DIFFUSION, SITTING DROP",8.5,"NaOAc, PEG4000, Glycerol, Tris",293,"10.1074/jbc.RA119.009087","IMP","6HGR",39.55,"1.52","1.52","Crystal Structure of Human APRT wild type in complex with IMP","DSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE","Homo sapiens","APRT","Adenine phosphoribosyltransferase","1","6HGR"
